Clustering O 0 5.781429081253009e-06
of O 0 7.405942028526624e-07
missense O 0 1.626551238587126e-05
mutations O 0 2.8153413822451512e-08
in O 0 1.4179279972381664e-09
the O 0 1.9333607781391038e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.893674379971344e-06
in O 0 1.303178809308747e-08
a O 0 1.435841112673586e-09
sporadic B-Disease 0 7.035394901322434e-06
T I-Disease 1 0.9998992681503296
- I-Disease 0 0.0028197660576552153
cell I-Disease 0 3.785526496358216e-05
leukaemia I-Disease 0 0.10519908368587494
. O 0 6.469207392001408e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.275027261726791e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.042435996000961e-11
is O 0 3.703181424702384e-12
a O 0 1.3169974659443806e-11
recessive B-Disease 0 1.3442927127016446e-07
multi I-Disease 1 0.5413245558738708
- I-Disease 1 0.9999998807907104
system I-Disease 1 0.9994888305664062
disorder I-Disease 0 0.06444361805915833
caused O 0 3.6434826711229107e-07
by O 0 3.117735847268932e-09
mutations O 0 1.7448331668390438e-09
in O 0 5.222736132459715e-10
the O 0 1.2780917435506467e-09
ATM O 0 8.552312635856651e-08
gene O 0 2.803843823784291e-10
at O 0 1.3212911875726263e-09
11q22 O 0 6.351055503728276e-07
- O 0 7.10544043158734e-07
q23 O 0 2.616999154270161e-05
( O 0 9.99743732243985e-10
ref O 0 4.354352540758555e-07
. O 0 6.050950296376811e-10
3 O 0 2.793483888652304e-09
) O 0 7.664755635738985e-11
. O 0 3.2015481377101196e-09

The O 0 2.777640020212857e-07
risk O 0 1.5367305650215712e-07
of O 0 2.2728166015895113e-08
cancer B-Disease 0 7.269433126566582e-07
, O 0 9.563810160484465e-11
especially O 0 6.5506449153929225e-09
lymphoid B-Disease 0 1.9144574253004976e-05
neoplasias I-Disease 0 0.000722076219972223
, O 0 2.943131571786495e-10
is O 0 7.661288270455202e-12
substantially O 0 4.062224334688835e-09
elevated O 0 3.838348220597254e-06
in O 0 3.913548241030185e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9826610684394836
and O 0 5.216902465576823e-10
has O 0 1.3242770595389697e-11
long O 0 2.042417970860022e-11
been O 0 1.8800067405622123e-11
associated O 0 5.34084165781934e-10
with O 0 2.6816755482883536e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 5.2486634558590595e-06

By O 0 1.853035485055443e-07
analysing O 0 9.279043297283351e-06
tumour B-Disease 1 0.9999998807907104
DNA O 0 9.717356306282454e-07
from O 0 1.6723095797033238e-08
patients O 0 1.6267582836348993e-08
with O 0 4.1071968742700804e-11
sporadic B-Disease 0 5.363653485801478e-07
T I-Disease 0 0.00021968173678033054
- I-Disease 0 7.281714715645649e-07
cell I-Disease 0 2.689289146928786e-07
prolymphocytic I-Disease 0 6.161768396850675e-05
leukaemia I-Disease 1 0.6552919149398804
( O 0 2.8214774960844125e-10
T B-Disease 0 1.4956464156057336e-07
- I-Disease 0 5.2070163292228244e-08
PLL I-Disease 0 1.3209034932515351e-06
) O 0 2.9150397373722825e-11
, O 0 1.233027829145028e-11
a O 0 4.59097239391415e-11
rare O 0 2.4096729056566346e-09
clonal B-Disease 0 5.917656267229177e-07
malignancy I-Disease 0 6.925912430233438e-07
with O 0 6.738806040962331e-11
similarities O 0 6.448849232398857e-10
to O 0 1.1277673239717956e-10
a O 0 5.413577364166144e-10
mature B-Disease 0 8.924025252099455e-08
T I-Disease 0 6.341105063256691e-07
- I-Disease 0 3.98145267865857e-08
cell I-Disease 0 2.2491457585260832e-08
leukaemia I-Disease 0 5.123493451719696e-07
seen O 0 2.043490376912871e-10
in O 0 5.3050001891374876e-11
A B-Disease 0 0.021838143467903137
- I-Disease 0 9.551668335916474e-05
T I-Disease 1 1.0
, O 0 9.305416853733206e-11
we O 0 9.249335672367742e-12
demonstrate O 0 2.9923698935396814e-11
a O 0 2.7633477103772286e-12
high O 0 1.2609141508690414e-10
frequency O 0 2.9910132703925285e-10
of O 0 1.890172907081933e-09
ATM O 0 2.8685619781754212e-06
mutations O 0 3.90763332802635e-08
in O 0 1.4157889438592974e-07
T B-Disease 0 0.0006003039889037609
- I-Disease 0 2.9697910576942377e-05
PLL I-Disease 0 0.0006777627277188003
. O 0 3.4556452987999364e-07

In O 0 2.5159945238328874e-08
marked O 0 1.6742916386647266e-08
contrast O 0 8.253448591233337e-09
to O 0 1.8046987515507595e-10
the O 0 1.615619416028835e-09
ATM O 0 1.4996312813764234e-07
mutation O 0 5.122334778562276e-10
pattern O 0 9.659971711428739e-10
in O 0 7.445678518180898e-10
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999406337738037
T I-Disease 1 1.0
, O 0 2.277957128482555e-10
the O 0 9.42714517560006e-11
most O 0 2.4786804553311725e-11
frequent O 0 1.3035124195315273e-11
nucleotide O 0 9.496318315038721e-11
changes O 0 2.7692390047739934e-10
in O 0 7.576965721511897e-10
this O 0 4.761893102056547e-09
leukaemia B-Disease 0 0.0305449478328228
were O 0 2.1411538853044476e-07
missense O 0 1.1363955309207086e-05
mutations O 0 2.1504567371266603e-07
. O 0 1.8498538167932566e-07

These O 0 2.686428501874616e-07
clustered O 0 8.813605063551222e-07
in O 0 1.642101121746009e-09
the O 0 1.1195444571399094e-09
region O 0 4.609330139793144e-10
corresponding O 0 6.319872958293615e-10
to O 0 4.4177841940218343e-10
the O 0 4.325411584460426e-09
kinase O 0 4.314197887822502e-09
domain O 0 2.126078868514014e-09
, O 0 2.2264608559585675e-11
which O 0 1.791565680531182e-11
is O 0 1.1849387790419108e-11
highly O 0 1.5923958818220285e-09
conserved O 0 2.927557307685902e-09
in O 0 1.5986527657219085e-09
ATM O 0 6.229900009202538e-06
- O 0 1.6990470896871557e-07
related O 0 2.551515478899091e-07
proteins O 0 9.401293077360151e-10
in O 0 8.743935020483207e-10
mouse O 0 1.0371848269130624e-08
, O 0 4.964346642100104e-11
yeast O 0 1.1457078841203838e-07
and O 0 8.571056753226003e-09
Drosophila O 0 2.24827132910832e-07
. O 0 2.2821865286459797e-08

The O 0 1.1257080245741236e-07
resulting O 0 3.5077540871952806e-08
amino O 0 1.764445478613652e-08
- O 0 1.723608455961312e-08
acid O 0 1.948464145584694e-08
substitutions O 0 5.270032943371916e-08
are O 0 4.856754998172619e-10
predicted O 0 2.732925885595705e-08
to O 0 1.8493337972103063e-09
interfere O 0 1.3806670473570648e-08
with O 0 9.804704825810973e-10
ATP O 0 0.17911720275878906
binding O 0 5.075977469459758e-07
or O 0 1.4077210508389726e-08
substrate O 0 5.234799118625233e-07
recognition O 0 1.0461955923801725e-07
. O 0 1.294427107723095e-07

Two O 0 3.684539251480601e-08
of O 0 8.985323063370743e-08
seventeen O 0 4.1565061792425695e-07
mutated O 0 5.283015980239725e-07
T B-Disease 0 3.3454871299909428e-06
- I-Disease 0 1.8095938969509007e-07
PLL I-Disease 0 3.6387361888046144e-06
samples O 0 9.56834433907261e-09
had O 0 2.3397206394548675e-10
a O 0 2.6102104852543384e-11
previously O 0 8.221314740097796e-10
reported O 0 3.5184199997928545e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999845027923584
T I-Disease 1 1.0
allele O 0 2.0715299342555227e-06
. O 0 5.159394689258079e-08

In O 0 8.439754850542158e-08
contrast O 0 4.6968583689022125e-08
, O 0 5.003685799032098e-10
no O 0 3.182393237821657e-10
mutations O 0 1.098525270748496e-09
were O 0 9.803059475288478e-10
detected O 0 6.172428790307549e-09
in O 0 1.8108268218242074e-09
the O 0 7.454805661666342e-09
p53 O 0 3.52260998148779e-09
gene O 0 6.989940293244956e-10
, O 0 4.935211961321073e-11
suggesting O 0 6.130538299231603e-10
that O 0 1.1102293563658439e-11
this O 0 2.958768785532584e-09
tumour B-Disease 1 1.0
suppressor O 0 0.0006839767447672784
is O 0 1.420796952311676e-10
not O 0 2.0669070621703867e-11
frequently O 0 6.986804190756146e-11
altered O 0 6.289812226611957e-09
in O 0 1.3024922251858584e-09
this O 0 9.456093685855649e-09
leukaemia B-Disease 0 0.26857441663742065
. O 0 4.123656935917097e-07

Occasional O 0 7.396437922579935e-06
missense O 0 3.452137752901763e-05
mutations O 0 4.9976531357742715e-08
in O 0 1.4788342994620507e-08
ATM O 0 1.5688799976487644e-05
were O 0 3.471075871175344e-08
also O 0 8.352848968051774e-11
found O 0 2.257093678625921e-10
in O 0 4.974443634786496e-10
tumour B-Disease 1 0.9999996423721313
DNA O 0 9.064954298310113e-08
from O 0 5.560997884401786e-09
patients O 0 7.156141901276669e-09
with O 0 5.207375503024636e-11
B B-Disease 0 0.0006497325957752764
- I-Disease 0 6.316950162954527e-08
cell I-Disease 0 2.1018919937887404e-07
non I-Disease 0 1.8467566178514971e-06
- I-Disease 0 7.346556230913848e-05
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9991297125816345
( O 0 2.8330066070836324e-10
B B-Disease 0 3.625846147770062e-07
- I-Disease 0 1.888075917833021e-09
NHL I-Disease 0 3.9024720877023356e-07
) O 0 1.143297869571347e-11
and O 0 6.453349660207053e-11
a O 0 8.277897256547817e-10
B B-Disease 0 2.300352389283944e-05
- I-Disease 0 2.3026238693546475e-07
NHL I-Disease 0 4.67836216557771e-05
cell O 0 7.798263936820149e-07
line O 0 6.054332857274858e-07
. O 0 6.697849386227972e-08

The O 0 1.4127563119359365e-08
evidence O 0 3.052113894952413e-09
of O 0 1.6302610372775916e-09
a O 0 6.328820800760582e-11
significant O 0 8.58594140229485e-10
proportion O 0 1.0441040920738942e-08
of O 0 8.367447179580267e-09
loss O 0 1.8059367334899434e-08
- O 0 2.1491278090479682e-08
of O 0 2.1802050298447284e-07
- O 0 7.052537220886279e-09
function O 0 1.7879821234689786e-10
mutations O 0 2.6861008209366766e-11
and O 0 6.639441600675422e-12
a O 0 6.026710380746536e-12
complete O 0 5.452592821697522e-10
absence O 0 2.1298992791685123e-08
of O 0 2.134713517065734e-09
the O 0 9.106532888880636e-11
normal O 0 4.931570429800303e-11
copy O 0 1.5591666846503927e-10
of O 0 4.189948388244602e-10
ATM O 0 2.0943840439713313e-08
in O 0 3.724234809432403e-11
the O 0 7.643338739704575e-11
majority O 0 3.6264005687236534e-11
of O 0 1.969596929995987e-09
mutated O 0 1.991796580114169e-06
tumours B-Disease 1 1.0
establishes O 0 1.8032347171015317e-08
somatic O 0 9.453933813574622e-08
inactivation O 0 2.4749246563260385e-07
of O 0 1.0671322714372877e-09
this O 0 2.8702294013749352e-11
gene O 0 5.609580855381324e-11
in O 0 4.11552493473355e-11
the O 0 9.608446260855885e-10
pathogenesis O 0 6.358367500070017e-06
of O 0 5.2138638295673445e-08
sporadic B-Disease 0 3.1699551072961185e-06
T I-Disease 0 0.0002931941708084196
- I-Disease 0 1.6193080227822065e-05
PLL I-Disease 0 0.00010272448707837611
and O 0 5.85471227054768e-10
suggests O 0 2.6066346303643684e-10
that O 0 1.7044407335173317e-12
ATM O 0 2.4885471461288944e-08
acts O 0 4.2893755214379325e-10
as O 0 3.4231963930153597e-09
a O 0 1.2005468619236126e-08
tumour B-Disease 1 1.0
suppressor O 0 0.00015371035260614008
. O 0 3.8239343780333e-07

As O 0 3.0664381256428896e-07
constitutional O 0 5.133314289196278e-07
DNA O 0 5.4455416176324434e-08
was O 0 1.3579706248378898e-09
not O 0 1.137759331193422e-11
available O 0 1.021158366198982e-10
, O 0 1.630106986894031e-11
a O 0 2.562026146790686e-10
putative O 0 1.8209002519142814e-05
hereditary O 1 1.0
predisposition O 1 1.0
to O 0 0.00019381302990950644
T B-Disease 1 1.0
- I-Disease 1 0.6911831498146057
PLL I-Disease 0 0.007480775937438011
will O 0 3.0416341667560687e-10
require O 0 1.4820800142700818e-10
further O 0 2.211344440894436e-10
investigation O 0 1.7922511252876916e-09
. O 0 1.849573494361323e-09
. O 0 1.670384186525098e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 6.640278570557712e-06
kinase O 0 1.1319885118155071e-07
is O 0 1.2950648886622673e-10
involved O 0 3.497553982545476e-11
in O 0 2.0106496328997636e-11
the O 0 6.567539567736702e-11
modulation O 0 8.825215003227527e-10
of O 0 7.70301156194364e-10
the O 0 2.8105540117451255e-09
Ca2 O 0 3.8333393348466416e-08
+ O 0 9.820097091051139e-08
homeostasis O 0 7.454715387211763e-07
in O 0 5.723470053453639e-08
skeletal O 0 1.3474592378770467e-05
muscle O 0 1.2327577678661328e-05
cells O 0 2.3165950551629066e-05
. O 0 1.2026883950966294e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.523662490399147e-06
DM B-Disease 1 1.0
) O 0 2.542050792087025e-09
, O 0 6.835416260786431e-11
the O 0 1.757021750314891e-10
most O 0 2.712836177920508e-09
prevalent O 1 0.9999957084655762
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 5.267226151772775e-05
adults O 0 1.6733025631765486e-07
, O 0 6.608991999501601e-12
is O 0 1.3018569512343592e-12
caused O 0 1.06123526633084e-10
by O 0 7.025467430032961e-10
( O 0 1.9386053873304832e-10
CTG O 0 2.4096334527712315e-07
) O 0 8.823320546413882e-12
n O 0 1.6447677941844319e-10
- O 0 7.498510146142223e-10
repeat O 0 9.875236184342384e-10
expansion O 0 9.522246990911754e-09
in O 0 7.695180603839447e-11
a O 0 2.049911108914504e-11
gene O 0 1.6762861931862716e-11
encoding O 0 1.0834327879294392e-09
a O 0 8.502015758082848e-10
protein O 0 6.765898064031717e-09
kinase O 0 7.396019441330282e-08
( O 0 1.916050207384501e-09
DM B-Disease 1 0.9999997615814209
protein O 0 4.930947739012481e-08
kinase O 0 1.023676876599211e-08
; O 0 3.585220176294257e-10
DMPK O 0 0.00019870376854669303
) O 0 1.0487214568977166e-10
and O 0 4.898683195198039e-11
involves O 0 1.8582074767792278e-10
changes O 0 9.943010859103651e-10
in O 0 9.768160502687806e-09
cytoarchitecture O 0 0.0004450261767487973
and O 0 1.8059648709822795e-07
ion O 0 1.7250480595976114e-05
homeostasis O 0 2.7304897230351344e-05
. O 0 1.7247549521925976e-06

To O 0 5.164307737004492e-08
obtain O 0 8.786123117943134e-08
clues O 0 6.643533367878263e-08
to O 0 8.818933777687832e-11
the O 0 1.7352672077031173e-10
normal O 0 7.257277556682595e-10
biological O 0 1.1062544214013315e-09
role O 0 6.331696833505873e-10
of O 0 1.1639743036084838e-07
DMPK O 1 1.0
in O 0 6.215556368260877e-06
cellular O 0 3.9433180631931464e-07
ion O 0 2.203572790904218e-07
homeostasis O 0 2.169430217691115e-07
, O 0 8.374515525488846e-10
we O 0 1.355260764723809e-10
have O 0 3.708038737171293e-11
compared O 0 2.535339715947771e-09
the O 0 3.0220612678988346e-09
resting O 0 8.536065365660761e-08
[ O 0 4.563456557082901e-10
Ca2 O 0 1.545549799253365e-10
+ O 0 1.9855965482928895e-10
] O 0 3.787787306031021e-10
i O 0 5.658917084927495e-11
, O 0 2.2830309691357353e-12
the O 0 1.7884997302597405e-11
amplitude O 0 6.299414323507335e-10
and O 0 7.39823757811564e-11
shape O 0 1.5212667792141588e-09
of O 0 4.551167887001384e-09
depolarization O 0 7.989197570168471e-08
- O 0 3.1013797752166283e-08
induced O 0 3.4247133129383656e-08
Ca2 O 0 8.230665593522701e-10
+ O 0 2.937668996949583e-10
transients O 0 4.421428112522108e-09
, O 0 3.699750141666902e-12
and O 0 3.91077968620035e-12
the O 0 3.709326248935163e-11
content O 0 2.922579123154634e-10
of O 0 1.010581507365771e-09
ATP O 0 1.9004763089469634e-05
- O 0 2.250686748084263e-07
driven O 0 1.3190765457693487e-07
ion O 0 5.930888136163048e-08
pumps O 0 1.0468519384687625e-08
in O 0 1.4592312913563887e-09
cultured O 0 4.02798633558632e-07
skeletal O 0 2.0314614346261806e-07
muscle O 0 6.283481290836335e-09
cells O 0 1.0731460164947748e-08
of O 0 1.2900590817821467e-08
wild O 0 3.008352322808605e-08
- O 0 3.0788854799013166e-10
type O 0 6.599488178160584e-10
and O 0 2.011655564349013e-10
DMPK O 0 3.535557334544137e-05
[ O 0 5.480960041381877e-08
- O 0 9.012525197249488e-07
/ O 0 1.5210956689770683e-06
- O 0 1.922208866744768e-05
] O 0 1.8821926914824871e-06
knockout O 0 0.0002249536628369242
mice O 0 2.7501590693645994e-07
. O 0 1.3829335010484556e-08

In O 0 6.446113047786639e-07
vitro O 0 3.5756743272941094e-06
- O 0 1.037670585901651e-06
differentiated O 0 6.184207904880168e-06
DMPK O 0 0.03146187216043472
[ O 0 7.182618588785772e-08
- O 0 8.722373223690738e-08
/ O 0 6.424559018114451e-08
- O 0 1.3392626385666517e-07
] O 0 3.0700221032020636e-08
myotubes O 0 4.413948317960603e-07
exhibit O 0 4.516060414516687e-09
a O 0 1.5725527824361762e-10
higher O 0 2.0245794374318393e-08
resting O 0 1.1936791111111233e-07
[ O 0 8.220373826084426e-10
Ca2 O 0 5.28861621162946e-10
+ O 0 5.324871654721619e-10
] O 0 1.1767418151009679e-09
i O 0 1.5014278709202244e-10
than O 0 2.2702308782873715e-11
do O 0 4.362309471983572e-11
wild O 0 4.330273473129864e-09
- O 0 5.870960384513069e-10
type O 0 6.009547526275583e-09
myotubes O 0 7.762055815874191e-07
because O 0 1.1579547321005634e-09
of O 0 6.158866194816426e-10
an O 0 2.4239547001536632e-12
altered O 0 6.4934807531003e-10
open O 0 6.758955062302618e-10
probability O 0 1.489354473083182e-10
of O 0 3.351584565436383e-10
voltage O 0 1.291768398914428e-07
- O 0 3.116655378221367e-08
dependent O 0 8.711412036177535e-09
l O 0 7.469903584578219e-10
- O 0 8.580636756683191e-10
type O 0 1.3327391412687462e-09
Ca2 O 0 1.2271167415534023e-09
+ O 0 1.2320651165964591e-09
and O 0 4.4040959767954746e-10
Na O 0 1.1336890537450017e-07
+ O 0 1.4185453700577e-08
channels O 0 3.6325651375790358e-09
. O 0 7.446918193210195e-09

The O 0 4.27621398557676e-06
mutant O 0 1.7606889741728082e-05
myotubes O 0 5.090288686915301e-05
exhibit O 0 1.7323299061899888e-07
smaller O 0 1.6708556316302747e-08
and O 0 1.303667840346634e-09
slower O 0 1.841269892111086e-07
Ca2 O 0 3.147312455098472e-08
+ O 0 1.008873606878069e-08
responses O 0 1.6922860890389302e-09
upon O 0 1.5254130181219239e-09
triggering O 0 8.745541180132932e-09
by O 0 4.916274054522773e-10
acetylcholine O 0 7.4435098085245954e-09
or O 0 2.501628237894238e-09
high O 0 6.555847420486316e-08
external O 0 2.073267069135909e-08
K O 0 7.314615118048096e-07
+ O 0 2.78713621071347e-08
. O 0 9.39326838533816e-09

In O 0 6.018703402332903e-08
addition O 0 7.793459211313802e-09
, O 0 6.986554113019849e-10
we O 0 9.277769524862478e-11
observed O 0 1.2835560392332468e-10
that O 0 1.764441999625721e-12
these O 0 6.571750088557593e-11
Ca2 O 0 2.712737812160526e-09
+ O 0 6.5301488660907125e-09
transients O 0 7.663378198685677e-08
partially O 0 6.020006715345971e-10
result O 0 7.671103335882279e-11
from O 0 1.0254267573950315e-10
an O 0 3.7762345334035885e-12
influx O 0 2.836375023740345e-10
of O 0 4.055286106918743e-10
extracellular O 0 7.868630191865122e-10
Ca2 O 0 9.223817820647184e-10
+ O 0 3.0691640895419425e-10
through O 0 1.4994017139002835e-10
the O 0 2.7024077420279013e-10
l O 0 1.561256568471947e-09
- O 0 5.973298744521571e-09
type O 0 1.0283560669677172e-08
Ca2 O 0 7.817085645456245e-09
+ O 0 1.0172383824169628e-08
channel O 0 3.1811506762124964e-09
. O 0 4.50144943542341e-09

Neither O 0 4.189228093309794e-06
the O 0 9.651306243085855e-08
content O 0 4.08985663113981e-08
nor O 0 1.7361431403628558e-08
the O 0 9.250033516927658e-10
activity O 0 1.8452747108099743e-09
of O 0 3.495603584369178e-09
Na O 0 2.5357962840644177e-07
+ O 0 1.95351752552142e-08
/ O 0 2.3111503821837687e-08
K O 0 1.008845202932207e-07
+ O 0 2.0174741877099223e-09
ATPase O 0 4.333082337382166e-09
and O 0 2.536702237154742e-10
sarcoplasmic O 0 1.008579744166127e-07
reticulum O 0 8.798851780511541e-08
Ca2 O 0 1.995625886763719e-08
+ O 0 1.0876448186536436e-08
- O 0 9.141330359341282e-09
ATPase O 0 1.6728519014463927e-08
are O 0 2.6566455632592856e-11
affected O 0 2.0992690918930634e-10
by O 0 1.490088274991308e-09
DMPK O 1 0.999860405921936
absence O 0 0.00036002122214995325
. O 0 2.4115699943649815e-06

In O 0 1.1996179694051534e-07
conclusion O 0 1.6587694062764058e-07
, O 0 6.902814431164472e-10
our O 0 3.1911762121694665e-10
data O 0 1.361712548275662e-10
suggest O 0 1.2917615588303732e-10
that O 0 1.085667927086531e-11
DMPK O 1 0.9682874083518982
is O 0 8.897209358149638e-11
involved O 0 2.9370735010747495e-11
in O 0 4.117393925806567e-11
modulating O 0 4.020285437889015e-09
the O 0 4.980377221741605e-10
initial O 0 7.238780685980828e-10
events O 0 1.960461307182193e-11
of O 0 5.512004394581105e-11
excitation O 0 2.7245254941021813e-08
- O 0 1.0796772187404713e-07
contraction O 0 1.2808916594053699e-08
coupling O 0 4.976356038355334e-08
in O 0 7.402804147460529e-09
skeletal O 0 1.7463580093135533e-07
muscle O 0 4.812158493905372e-08
. O 0 2.678967270242083e-08
. O 0 1.0479411116648407e-07

Constitutional O 0 0.0024271586444228888
RB1 O 1 0.9992818236351013
- O 0 0.0622023269534111
gene O 0 1.1067784271290293e-06
mutations O 0 2.6806370101439825e-07
in O 0 1.0302053432553748e-08
patients O 0 2.98107806884218e-07
with O 0 1.0068604838764372e-09
isolated O 0 2.237423359474633e-06
unilateral B-Disease 0 3.41430350090377e-05
retinoblastoma I-Disease 1 1.0
. O 0 0.0010396746220067143

In O 0 3.7963840782140323e-07
most O 0 6.288747300686737e-08
patients O 0 4.332498093617687e-08
with O 0 2.9395968992318444e-10
isolated O 0 8.46060913772817e-07
unilateral B-Disease 0 1.2271251762285829e-05
retinoblastoma I-Disease 1 1.0
, O 0 2.4031687644310296e-05
tumor B-Disease 1 0.9992406368255615
development O 0 4.5716856078570345e-08
is O 0 3.299854139937608e-11
initiated O 0 5.734018815317654e-10
by O 0 2.613064625789363e-11
somatic O 0 1.8821586067474527e-08
inactivation O 0 2.1077794087887014e-07
of O 0 1.2791795400701744e-09
both O 0 2.3856353004170217e-10
alleles O 0 8.87309892227961e-10
of O 0 2.5432340677866705e-09
the O 0 3.920122537692805e-08
RB1 O 0 0.00010135149932466447
gene O 0 1.074854836247141e-07
. O 0 1.8850423089133983e-07

However O 0 6.664333795924904e-07
, O 0 1.2892170664358105e-09
some O 0 1.2327980303261654e-10
of O 0 1.7254658812859702e-09
these O 0 3.0396754002737225e-09
patients O 0 4.172112966216446e-08
can O 0 4.4867468074194505e-10
transmit O 0 4.646478757308614e-08
retinoblastoma B-Disease 1 0.8313165307044983
predisposition O 1 0.9020960330963135
to O 0 4.2322812987549696e-07
their O 0 5.279759989207378e-06
offspring O 0 5.910035724809859e-06
. O 0 9.249724541859905e-08

To O 0 7.522910294710528e-09
determine O 0 2.577285052041134e-09
the O 0 4.527822561328776e-10
frequency O 0 7.972901783226405e-10
and O 0 6.321497492134398e-11
nature O 0 3.407131521360185e-10
of O 0 3.110121493676843e-09
constitutional O 0 1.2250638064870145e-05
RB1 O 1 0.9869001507759094
- O 0 0.00011864408588735387
gene O 0 4.406680176316513e-08
mutations O 0 1.1268567412514585e-08
in O 0 2.1899890789711662e-09
patients O 0 2.7493950227608366e-08
with O 0 1.7003479180210945e-10
isolated O 0 3.4151318573094613e-07
unilateral B-Disease 0 1.4214157317837817e-06
retinoblastoma I-Disease 1 0.9999994039535522
, O 0 2.915611396758777e-08
we O 0 5.592779017682403e-10
analyzed O 0 1.338787636306904e-09
DNA O 0 2.3923576453199757e-09
from O 0 4.965172717419364e-10
peripheral O 0 1.155413542619499e-06
blood O 0 2.022534459911185e-07
and O 0 4.993048641210862e-09
from O 0 3.487666688783975e-08
tumor B-Disease 0 1.1132145118608605e-05
tissue O 0 6.131889449534356e-07
. O 0 1.3619248306895315e-07

The O 0 4.3851905218161846e-08
analysis O 0 1.3471722404290176e-08
of O 0 3.3158281098621956e-07
tumors B-Disease 1 1.0
from O 0 1.962290383517029e-07
54 O 0 2.930297000602877e-07
( O 0 7.167554050280245e-11
71 O 0 6.856537559940534e-09
% O 0 2.3899425841134025e-11
) O 0 1.0463069213123566e-12
of O 0 3.4566696727189594e-10
76 O 0 3.574238576220523e-07
informative O 0 2.326475936342831e-07
patients O 0 2.4501252937625395e-07
showed O 0 3.1392053401191333e-09
loss O 0 5.749145604028172e-09
of O 0 3.883070576193859e-08
constitutional O 0 5.91641801293008e-05
heterozygosity O 1 0.995612621307373
( O 0 3.262086423205801e-08
LOH O 0 0.001874278299510479
) O 0 8.549988494976901e-10
at O 0 1.6946092529224188e-08
intragenic O 0 1.2355259059404489e-05
loci O 0 3.7351287573983427e-06
. O 0 5.853244147147052e-07

Three O 0 3.9445886557132326e-08
of O 0 4.1832684871678794e-08
13 O 0 1.7057394074981858e-07
uninformative O 1 0.6765903830528259
patients O 0 0.0002049416070804
had O 0 6.577377575922583e-08
constitutional O 0 8.113289368338883e-06
deletions O 0 2.7747546482714824e-05
. O 0 3.7293909826985328e-06

For O 0 3.1662250421504723e-07
39 O 0 2.5665756311354926e-06
randomly O 0 1.641523397211131e-07
selected O 0 4.006916242360603e-06
tumors B-Disease 1 1.0
, O 0 4.3541032113125766e-08
SSCP O 1 0.9999995231628418
, O 0 8.812305196670422e-08
hetero O 0 1.9353433344804216e-06
- O 0 8.919664118423043e-09
duplex O 0 6.472315572381149e-09
analysis O 0 1.243825598074011e-10
, O 0 1.037230804717959e-11
sequencing O 0 3.4350675637284667e-09
, O 0 3.444997759283197e-11
and O 0 8.794241723730778e-11
Southern O 0 2.1889994261670154e-09
blot O 0 5.131082048137614e-08
analysis O 0 3.3984734471026457e-10
were O 0 3.0765373582042344e-10
used O 0 1.7639928406865124e-10
to O 0 8.840123633113706e-10
identify O 0 6.6247174856926e-08
mutations O 0 4.27454040163866e-07
. O 0 8.060659979491902e-07

Mutations O 0 4.580273582632799e-07
were O 0 1.0914831705122197e-08
detected O 0 1.009632111248493e-08
in O 0 2.1056179022593824e-09
21 O 0 2.5225006083928747e-08
( O 0 4.5117336949784814e-11
91 O 0 2.1524710902554034e-08
% O 0 7.974722965320424e-11
) O 0 7.430746122583098e-12
of O 0 1.02571151572306e-08
23 O 0 0.0003124060749541968
tumors B-Disease 1 1.0
with O 0 0.0016036080196499825
LOH O 1 1.0
. O 0 0.013028925284743309

In O 0 3.0973956199886743e-07
6 O 0 1.679736385540309e-07
( O 0 1.8773380072723e-10
38 O 0 5.419324100586209e-09
% O 0 6.782921446735202e-11
) O 0 9.00781966378661e-12
of O 0 7.78626851882791e-09
16 O 0 7.973037099873181e-06
tumors B-Disease 1 1.0
without O 1 0.9999772310256958
LOH O 1 1.0
, O 0 1.4514625057415742e-08
one O 0 4.018121391169416e-10
mutation O 0 5.781546769112467e-11
was O 0 7.941571705805117e-11
detected O 0 3.18684550970616e-10
, O 0 1.5121470048340413e-11
and O 0 3.523903044366783e-11
in O 0 2.1245737114039542e-10
9 O 0 6.962705523250179e-09
( O 0 1.132826644989482e-11
56 O 0 9.040601045562369e-10
% O 0 9.667998172868675e-12
) O 0 1.8526992006523413e-12
of O 0 1.9408594731373796e-09
the O 0 1.8300098645340768e-06
tumors B-Disease 1 1.0
without O 1 0.999985933303833
LOH O 1 1.0
, O 0 6.137143060414019e-08
both O 0 4.4468682069975785e-09
mutations O 0 4.305024337014629e-09
were O 0 3.640778123426003e-09
found O 0 1.867713539382976e-09
. O 0 1.3203647952764186e-08

Thus O 0 9.019613145255789e-08
, O 0 3.0005556372891817e-10
a O 0 3.535395240450434e-11
total O 0 9.588375926572468e-11
of O 0 8.155780495400222e-10
45 O 0 3.990566543876639e-09
mutations O 0 1.3990263392216207e-09
were O 0 3.073148846510776e-09
identified O 0 1.520681536248958e-08
in O 0 1.6432242944119935e-07
tumors B-Disease 1 1.0
of O 0 0.042231298983097076
36 O 0 0.0005546273314394057
patients O 0 5.665039498126134e-05
. O 0 2.3767366030824633e-07

Thirty O 0 1.3645757462654728e-05
- O 0 5.320832201505254e-07
nine O 0 1.9782611104801617e-08
of O 0 4.8608908009839524e-09
the O 0 3.1545108747366157e-09
mutations O 0 1.1782758102540924e-09
- O 0 1.543232919232196e-08
including O 0 6.271807073687796e-09
34 O 0 7.311874128390627e-08
small O 0 1.1233947105893094e-09
mutations O 0 5.850604445356566e-10
, O 0 1.1848626246813154e-10
2 O 0 4.081477378292675e-09
large O 0 1.8337875662410852e-09
structural O 0 7.175361815825454e-08
alterations O 0 2.1407511667348444e-05
, O 0 4.3821554385203854e-08
and O 0 1.2315564390519285e-07
hypermethylation O 1 0.9999886751174927
in O 0 4.890568561677355e-06
3 O 0 1.6617348592262715e-05
tumors O 1 1.0
- O 0 2.532552301204305e-08
were O 0 1.090885271004538e-09
not O 0 1.688154650791862e-11
detected O 0 6.055407286709169e-10
in O 0 6.520210066307541e-11
the O 0 6.720044520847068e-10
corresponding O 0 9.628135622108402e-09
peripheral O 0 7.0686319304513745e-06
blood O 0 4.4117348352301633e-07
DNA O 0 3.614963191012066e-07
. O 0 8.819148433758528e-08

In O 0 3.0288376251519367e-07
6 O 0 2.2785465603192279e-07
( O 0 2.6315116752329004e-10
17 O 0 1.6298942195902555e-09
% O 0 2.492224482342209e-11
) O 0 1.1930524927358799e-12
of O 0 1.3275097687781567e-10
the O 0 2.525233577799213e-09
36 O 0 1.984277844258031e-07
patients O 0 3.777863639697898e-07
, O 0 1.0350061085961926e-10
a O 0 2.8164126586460725e-10
mutation O 0 1.2956163919497499e-09
was O 0 8.599286616117752e-09
detected O 0 1.5125557695228053e-08
in O 0 2.0284669499659458e-09
constitutional O 0 1.2209146404984494e-07
DNA O 0 3.333144960038226e-08
, O 0 4.783243592876296e-11
and O 0 1.6706048003301e-11
1 O 0 6.375566186100912e-10
of O 0 3.776641777086809e-10
these O 0 1.999353876902532e-10
mutations O 0 1.081720546469711e-10
is O 0 5.468596062097042e-12
known O 0 6.07136424468635e-11
to O 0 1.5409748130301715e-11
be O 0 4.765649680438244e-11
associated O 0 1.3753229666235711e-09
with O 0 2.972518342581054e-10
reduced O 0 8.604357049080136e-07
expressivity O 0 0.00011669200466712937
. O 0 4.6877826775926223e-07

The O 0 5.613260256609465e-08
presence O 0 1.3903541651316687e-09
of O 0 3.475486121118365e-09
a O 0 1.490954582017423e-10
constitutional O 0 5.103061084810179e-08
mutation O 0 1.7702965759980316e-09
was O 0 4.099646455646422e-10
not O 0 2.2086867924875353e-12
associated O 0 2.3509250102193846e-11
with O 0 2.560558102354671e-12
an O 0 1.1723134398997082e-12
early O 0 4.515020535222902e-08
age O 0 3.9911544291726386e-08
at O 0 6.997547430387385e-09
treatment O 0 1.157673523266567e-06
. O 0 1.5971257028013497e-07

In O 0 8.69458389729516e-08
1 O 0 2.1758430079898972e-07
patient O 0 3.6926519442204153e-07
, O 0 1.2630617662878763e-09
somatic O 0 4.425249062478542e-05
mosaicism O 0 0.23167970776557922
was O 0 3.200072029585499e-08
demonstrated O 0 1.8101741217080303e-09
by O 0 2.5477130821682792e-11
molecular O 0 5.79657710719772e-10
analysis O 0 7.574375154861812e-11
of O 0 6.305604371981133e-10
DNA O 0 1.2531854665098763e-08
and O 0 1.8187534811531236e-09
RNA O 0 4.043835488687364e-08
from O 0 1.3680972799079427e-08
peripheral O 0 4.304704270907678e-05
blood O 0 6.697415756207192e-06
. O 0 6.888431016704999e-07

In O 0 2.932539189259842e-07
2 O 0 1.4988576424457278e-07
patients O 0 9.329808925429006e-09
without O 0 2.7124827384206185e-10
a O 0 2.9461699746491377e-10
detectable O 0 1.2723761528832256e-06
mutation O 0 4.423488775273654e-08
in O 0 3.917564495026227e-09
peripheral O 0 5.302689260133775e-06
blood O 0 1.4019418870248046e-07
, O 0 7.439333593595165e-10
mosaicism O 0 9.631391549191903e-06
was O 0 4.356792260296061e-09
suggested O 0 4.035140555025407e-10
because O 0 8.091952108379985e-11
1 O 0 1.7535676244406773e-09
of O 0 7.119461686855288e-10
the O 0 4.951868248781466e-09
patients O 0 2.2024654811048094e-07
showed O 0 2.4182111246773275e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 4.075710421602707e-06
the O 0 1.3836675805123377e-07
other O 0 2.224086248503454e-09
later O 0 3.3483036787629317e-08
developed O 0 8.91626683596769e-08
bilateral B-Disease 0 5.1844099289155565e-06
retinoblastoma I-Disease 0 0.04401766508817673
. O 0 4.1490070543659385e-06

In O 0 2.4547226473714545e-08
conclusion O 0 9.220308072599437e-08
, O 0 9.51508871693818e-10
our O 0 3.2803143534820833e-10
results O 0 4.4736384041677013e-10
emphasize O 0 1.098933832821558e-09
that O 0 4.822577233387637e-12
the O 0 3.249123747828264e-10
manifestation O 0 1.2433932283784088e-07
and O 0 2.2250026265879796e-09
transmissibility O 0 1.2852379768446553e-05
of O 0 1.120128558795841e-07
retinoblastoma B-Disease 0 1.0401018926131655e-06
depend O 0 1.5906026717971145e-08
on O 0 2.2691291068355213e-09
the O 0 2.5826621397051497e-10
nature O 0 4.1424433327996724e-11
of O 0 1.3110681984507266e-10
the O 0 7.62134313991858e-11
first O 0 6.265392371584966e-11
mutation O 0 1.3986807372023957e-11
, O 0 8.166757201055752e-13
its O 0 1.854434791490056e-12
time O 0 2.6976582426230244e-11
in O 0 9.952834389981291e-11
development O 0 6.517254513838111e-10
, O 0 9.28364156382866e-12
and O 0 7.589440360888933e-12
the O 0 6.885900183384308e-11
number O 0 6.567577731653174e-11
and O 0 2.2409634911624288e-11
types O 0 1.0169526332148848e-09
of O 0 2.0210484397154005e-09
cells O 0 2.9417226987682454e-10
that O 0 4.593098471006307e-12
are O 0 2.40252037014832e-11
affected O 0 9.573195569601012e-10
. O 0 1.1434604374471746e-09
. O 0 1.9841447596036232e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.24600034952163696
the I-Disease 0 1.546345174574526e-06
fifth I-Disease 0 7.904571930339443e-07
component I-Disease 0 4.355440452741277e-08
of I-Disease 0 1.4603290132697566e-08
complement I-Disease 0 4.430682665201857e-08
in O 0 2.6877918912759924e-07
man O 0 1.0096514415636193e-06
. O 0 1.0289372198712954e-07

I O 0 0.002631440293043852
. O 0 6.507660145871341e-06

Clinical O 0 6.63822065689601e-05
, O 0 8.720256516880909e-09
immunochemical O 0 0.4099951684474945
, O 0 1.6290526261286686e-08
and O 0 6.734598656521484e-09
family O 0 3.693494621259674e-09
studies O 0 4.486680360571427e-09
. O 0 1.0664614080724277e-08

The O 0 1.4018374372426479e-07
first O 0 1.788567338678604e-08
recognized O 0 1.895260481887817e-08
human O 0 1.3337622561948592e-08
kindred O 0 0.2735898494720459
with O 0 9.787206067812804e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 0 5.993209015286993e-06
fifth I-Disease 0 8.357527576663415e-07
component I-Disease 0 6.106177607989594e-08
of I-Disease 0 7.468015184031174e-08
complement I-Disease 0 9.874148645394598e-07
( O 0 9.847628490433635e-09
C5 O 0 0.033958762884140015
) O 0 1.8929861844707574e-10
is O 0 1.5112942841621901e-10
described O 0 7.558810466434807e-09
. O 0 4.279565501974503e-08

The O 0 5.062566970082116e-07
proband O 0 8.488255843985826e-05
, O 0 3.4694458417305896e-09
a O 0 2.9004881829663987e-10
20 O 0 4.2356040896862623e-10
- O 0 2.7117794121345185e-10
year O 0 6.387202433622008e-10
- O 0 1.1007342592961322e-08
old O 0 2.0491127017407962e-08
black O 0 3.0121213856482143e-10
female O 0 8.454657980661029e-12
with O 0 2.8057950060556003e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999228715896606
age O 0 0.2668741047382355
11 O 0 7.727737560969672e-09
, O 0 6.433023558294337e-11
lacked O 0 7.456529260707612e-08
serum O 0 2.139957615554522e-07
hemolytic O 0 0.001690767821855843
complement O 0 7.111976429996503e-08
activity O 0 2.7514724720845152e-08
, O 0 8.889864538952352e-11
even O 0 1.8235529752885782e-10
during O 0 7.006735636139183e-09
remission O 0 1.1002074415955576e-06
. O 0 8.827798581023671e-08

C5 O 0 0.1473274976015091
was O 0 2.022184617089806e-06
undetectable O 0 1.3904119441576768e-05
in O 0 1.2081732947422097e-08
her O 0 3.242740520548182e-10
serum O 0 2.9234057397076185e-09
by O 0 3.128760861503821e-10
both O 0 2.218299099965293e-09
immunodiffusion O 0 0.0003498939622659236
and O 0 2.1611104727981e-07
hemolytic O 1 0.9999964237213135
assays O 0 0.00047312179231084883
. O 0 2.298350636920077e-06

Other O 0 1.965361384748121e-08
complement O 0 7.623312647808689e-09
components O 0 1.5219148608025534e-08
were O 0 1.6229423360769601e-09
normal O 0 1.045542430411217e-09
during O 0 1.8047513483665512e-09
remission O 0 4.736956498163636e-07
of O 0 2.571014476870914e-07
lupus O 1 0.8529670834541321
, O 0 3.595843844905744e-09
but O 0 1.5640411632489304e-08
C1 O 0 3.9876762457424775e-05
, O 0 1.4137853110440801e-09
C4 O 0 1.4956428458390292e-05
, O 0 5.694640314857224e-10
C2 O 0 5.210603148952941e-07
, O 0 5.022953719624468e-10
and O 0 6.960660492438819e-09
C3 O 1 0.9999673366546631
levels O 0 1.9751862055272795e-05
fell O 0 0.00024385028518736362
during O 0 6.85776910813729e-07
exacerbations O 0 0.005133389960974455
. O 0 2.617354084577528e-06

A O 0 6.24533686277573e-06
younger O 0 1.8600553630676586e-06
half O 0 6.189242185428157e-08
- O 0 1.2783833653884358e-06
sister O 0 3.9852449162935955e-07
, O 0 2.478058036547992e-10
who O 0 1.3169303147986255e-10
had O 0 1.0470231348591597e-09
no O 0 1.9472754075877674e-08
underlying O 1 0.9999996423721313
disease O 1 0.5800974369049072
, O 0 3.9220779401993866e-10
was O 0 2.6144595821619987e-08
also O 0 1.1810628863795358e-10
found O 0 1.314125058771154e-10
to O 0 1.0067351813303205e-10
lack O 0 1.728558459035412e-06
immunochemically O 1 0.6980205774307251
detectable O 1 0.9905233979225159
C5 O 0 0.004181019030511379
. O 0 8.421164920946467e-07

By O 0 4.750773143769038e-07
hemolytic O 1 0.9707688689231873
assay O 0 3.468915747362189e-05
, O 0 2.0977781289843733e-08
she O 0 1.3860931846743085e-10
exhibited O 0 3.234432721654912e-10
1 O 0 6.442346101032115e-10
- O 0 6.12878525707572e-10
2 O 0 6.136645636090066e-10
% O 0 7.691596491665731e-12
of O 0 2.5423779401179125e-11
the O 0 1.0878470346753488e-10
normal O 0 3.134897230694378e-09
serum O 0 1.3033780987825594e-07
C5 O 0 2.5435808765905676e-06
level O 0 9.036088322034175e-09
and O 0 3.954224794822103e-11
normal O 0 1.735277199710339e-10
concentrations O 0 1.0817416962183302e-09
of O 0 1.926504095139947e-10
other O 0 3.109538737611217e-10
complement O 0 1.531755167150095e-08
components O 0 2.484710819317115e-07
. O 0 3.539611554970179e-07

C5 O 0 7.799812010489404e-05
levels O 0 1.5088915006344905e-07
of O 0 1.8398562673382912e-08
other O 0 5.347967069191384e-10
family O 0 1.7484567960135422e-10
members O 0 3.639863150467493e-12
were O 0 1.5916509776836563e-10
either O 0 1.595447246538484e-10
normal O 0 2.4486890293218266e-09
or O 0 9.193847766431062e-11
approximately O 0 4.9179219724360124e-11
half O 0 5.445411344062734e-10
- O 0 2.2170807412180693e-09
normal O 0 6.070142610781204e-09
, O 0 3.333502224256435e-11
consistent O 0 5.017610216206947e-10
with O 0 1.7048805076025353e-11
autosomal O 0 8.126222894588864e-08
codominant O 0 8.587473530496936e-06
inheritance O 0 1.9709476362095302e-07
of O 0 3.6245715318017346e-09
the O 0 1.5097104677508355e-09
gene O 0 1.0266040462170167e-08
determining O 0 2.390681220276747e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.2260209587111603e-05

Normal O 0 4.181002077530138e-05
hemolytic O 1 0.998964786529541
titers O 0 0.0014290735125541687
were O 0 6.264050966819923e-08
restored O 0 5.3409081601785147e-08
to O 0 6.113828332487969e-10
both O 0 5.760308230406963e-09
homozygous O 0 1.8810456822393462e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.6565393319042414e-08
C5D B-Disease 1 1.0
) O 0 5.1438964199235215e-09
sera O 0 1.08177324875669e-08
by O 0 4.646311807521286e-11
addition O 0 4.271088205332063e-10
of O 0 1.6215011555686942e-08
highly O 0 1.597365553607233e-05
purified O 0 0.0018758275546133518
human O 0 1.7561980030222912e-06
C5 O 0 0.001213926007039845
. O 0 4.982121026841924e-07

In O 0 2.281673516790761e-07
specific O 0 1.967015634818381e-07
C5 O 0 0.0001539529621368274
titrations O 0 1.5163859643507749e-05
, O 0 3.744529686322551e-10
however O 0 7.2750727664328e-10
, O 0 2.1501207064789085e-11
it O 0 3.653502847478229e-12
was O 0 9.795358968389678e-10
noted O 0 1.837284074879264e-10
that O 0 1.8107825352012275e-12
when O 0 4.096463099290126e-11
limited O 0 7.039600846692196e-11
amounts O 0 2.955332367715613e-10
of O 0 2.4855619784602823e-09
C5 O 0 1.8758563555820729e-06
were O 0 3.6072194120606582e-09
assayed O 0 2.29425847209086e-08
in O 0 1.175494007688016e-10
the O 0 2.8935354112746836e-11
presence O 0 1.2236937158016659e-11
of O 0 2.719834080178174e-10
low O 0 6.707066546596252e-08
dilutions O 0 1.3044955267105252e-05
of O 0 1.0279485707087588e-07
either O 0 1.0277466344632558e-07
C5D B-Disease 1 1.0
serum O 0 1.390091938446858e-06
, O 0 4.310148904451694e-10
curving O 0 3.6102960621064994e-09
rather O 0 5.321123056067911e-11
than O 0 8.180496210985488e-12
linear O 0 4.1133452199915155e-10
dose O 0 1.8424936243377488e-08
- O 0 2.962043943455228e-09
response O 0 1.0569229935697422e-09
plots O 0 7.836118420812e-09
were O 0 8.159078968006384e-10
consistently O 0 3.1199709482621074e-10
obtained O 0 9.961722419182806e-11
, O 0 2.9931231104729505e-11
suggesting O 0 7.345962171889653e-10
some O 0 1.6671804214940522e-10
inhibitory O 0 2.0631684805039185e-08
effect O 0 1.1578452330240907e-07
. O 0 2.1428820673463633e-07

Further O 0 9.060668304528008e-08
studies O 0 7.521016698319727e-09
suggested O 0 6.765300541999864e-10
that O 0 1.655812292833403e-11
low O 0 7.656467460037675e-08
dilutions O 0 0.0019232332706451416
of O 0 1.7701559045235626e-05
C5D B-Disease 1 1.0
serum O 0 2.306404667251627e-06
contain O 0 1.3161449707865813e-09
a O 0 4.566972147679316e-11
factor O 0 5.281660109268671e-10
( O 0 3.923316099080365e-12
or O 0 1.6505085492779514e-11
factors O 0 6.891264225927785e-10
) O 0 8.459513471670288e-12
interfering O 0 2.562871859179694e-10
at O 0 2.0683961210465895e-09
some O 0 1.6974510685940913e-10
step O 0 1.847536701404806e-08
in O 0 2.655397013384686e-09
the O 0 1.1584854853197157e-08
hemolytic O 0 0.002197116147726774
assay O 0 1.4137493053567596e-05
of O 0 0.00012203882943140343
C5 O 0 6.391240458469838e-05
, O 0 3.102191767356821e-11
rather O 0 2.4014666991090117e-11
than O 0 9.934148122170416e-12
a O 0 1.3411485810799206e-10
true O 0 6.441209166041517e-08
C5 O 0 6.959991151234135e-05
inhibitor O 0 1.3918282775193802e-06
or O 0 2.407491983547061e-08
inactivator O 0 1.842713936639484e-05
. O 0 5.012947781324328e-07

Of O 0 2.7600774501479464e-06
clinical O 0 4.332912067184225e-05
interest O 0 4.415944090396806e-07
are O 0 5.811145453726851e-10
( O 0 3.3285464662302644e-11
a O 0 2.6797758456709175e-11
) O 0 3.282245135405315e-12
the O 0 2.9163522291542066e-11
documentation O 0 2.061825821186858e-09
of O 0 1.3058883752137262e-08
membranous O 1 0.9999904632568359
glomerulonephritis B-Disease 1 1.0
, O 0 2.04083380594966e-06
vasculitis B-Disease 1 1.0
, O 0 1.3367832707444904e-07
and O 0 1.8494988580641802e-06
arthritis B-Disease 1 1.0
in O 0 5.696948619515751e-07
an O 0 1.3518888786201444e-10
individual O 0 1.0411662643150521e-09
lacking O 0 2.0128493360971333e-06
C5 O 0 1.3667896382685285e-05
( O 0 1.5326150071270916e-11
and O 0 2.970935650270512e-11
its O 0 2.8446521180280904e-11
biologic O 0 1.3343937155241292e-07
functions O 0 3.442502186090657e-11
) O 0 1.3201480924054931e-12
, O 0 2.3788581781508666e-12
and O 0 1.5116567719797303e-11
( O 0 5.578965241170852e-12
b O 0 2.4564168477070325e-09
) O 0 2.1221780843044824e-12
a O 0 2.3422734238276455e-11
remarkable O 0 2.2322204085156727e-09
propensity O 0 7.844765548270516e-08
to O 0 1.5852893442414029e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 9.650045207365565e-10
the O 0 1.2221618161945003e-10
proband O 0 1.398704174704335e-08
, O 0 6.878388483788633e-12
even O 0 1.3454265479495575e-11
during O 0 4.169370404483175e-11
periods O 0 4.554797872202698e-09
of O 0 2.532072551630904e-09
low O 0 1.9473867851615978e-08
- O 0 7.649701982970214e-10
dose O 0 3.348699806338118e-08
or O 0 1.3272362375804647e-10
alternate O 0 7.741649099557435e-09
- O 0 5.6065698750273896e-09
day O 0 1.42549971826611e-08
corticosteroid O 0 1.0710483365983237e-05
therapy O 0 2.262687758047832e-06
. O 0 3.611413390558482e-08

Other O 0 8.655997163486973e-08
observations O 0 1.5378265771914812e-08
indicate O 0 1.1533171084820992e-09
that O 0 1.9121745853389882e-11
the O 0 1.1328758375839243e-08
C5D B-Disease 1 1.0
state O 0 2.0875122075381114e-08
is O 0 1.1255968379586534e-10
compatible O 0 4.821867793936008e-09
with O 0 1.7439730215507154e-11
normal O 0 1.4089908129122364e-09
coagulation O 0 3.063412634674023e-08
function O 0 2.6286825494103994e-10
and O 0 7.332631724032979e-11
the O 0 1.4970898132293797e-10
capacity O 0 1.282976613836695e-09
to O 0 5.060852847904584e-10
mount O 0 1.803766735974932e-06
a O 0 4.418243904069641e-08
neutrophilic O 0 0.0419425442814827
leukocytosis O 0 0.0020480987150222063
during O 0 1.1487069059512578e-05
pyogenic B-Disease 0 0.0011512557975947857
infection I-Disease 0 1.0522455340833403e-05
. O 0 2.5661172742275085e-08
. O 0 5.770153421735813e-08

Susceptibility O 0 0.0006216668407432735
to O 0 2.8072904569853563e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9865004420280457
twins O 0 4.310878284741193e-05
: O 0 3.587139960070651e-11
the O 0 3.360698525023409e-11
role O 0 2.4749344934571482e-11
of O 0 6.122791162965768e-10
genes O 0 4.421400745524551e-10
, O 0 1.658110593272255e-10
HLA O 1 0.9969346523284912
, O 0 4.558796007358978e-09
and O 0 1.9329904343834414e-09
the O 0 2.370800267215145e-08
environment O 0 3.6706373407469073e-07
. O 0 5.1256336064398056e-08

OBJECTIVE O 0 1.1552984688023571e-05
To O 0 1.7991456102706138e-09
determine O 0 2.0230153108258264e-09
the O 0 7.42799044495257e-10
relative O 0 8.383665317523992e-08
effects O 0 5.3301008051676035e-08
of O 0 7.924212752641324e-08
genetic O 0 3.2413225881100516e-07
and O 0 4.911550055552993e-10
environmental O 0 1.0063790689684993e-08
factors O 0 1.5067272984836677e-09
in O 0 2.516980790456813e-10
susceptibility O 0 1.1811406466222252e-06
to O 0 6.993506076469203e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9974169731140137
AS B-Disease 1 1.0
) O 0 1.659554982325062e-08
. O 0 4.679474585600474e-08

METHODS O 0 0.00025462498888373375
Twins O 0 0.0001115985942305997
with O 0 9.148843349571223e-10
AS B-Disease 1 0.9999948740005493
were O 0 9.864090655398172e-10
identified O 0 1.8821307359861983e-11
from O 0 5.365320167316501e-12
the O 0 1.7925192580259264e-11
Royal O 0 7.591597039890985e-08
National O 0 1.0868443034439679e-08
Hospital O 0 2.62331868725596e-05
for O 0 1.027762337457716e-07
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 8.75050864124205e-06
. O 0 6.693046543659875e-07

Clinical O 0 4.213053762214258e-05
and O 0 1.1824234036339476e-08
radiographic O 0 2.3592137949890457e-05
examinations O 0 8.598826389061287e-05
were O 0 1.3453901104298893e-08
performed O 0 5.2066040368004e-10
to O 0 1.79728489035913e-11
establish O 0 1.469092181238807e-09
diagnoses O 1 0.9854483008384705
, O 0 6.502829830168366e-09
and O 0 1.2342790789432456e-08
disease O 0 1.3895669326302595e-06
severity O 0 1.0910929631791078e-05
was O 0 2.478972760400211e-08
assessed O 0 9.426507574517018e-09
using O 0 1.0108720110979519e-10
a O 0 4.2703042490988e-11
combination O 0 3.20406479126234e-09
of O 0 7.207400010145193e-09
validated O 0 1.963956037798198e-06
scoring O 0 1.093723426492943e-06
systems O 0 9.68714630289469e-07
. O 0 1.2972076035566715e-07

HLA O 0 0.003953435458242893
typing O 0 1.8583407381811412e-06
for O 0 1.1613260575416007e-08
HLA O 0 1.5487077689613216e-05
- O 0 1.267816855943238e-06
B27 O 0 1.7171430499729468e-06
, O 0 2.928393361134596e-10
HLA O 0 1.4968463801778853e-07
- O 0 2.159980816429652e-08
B60 O 0 2.707751320940588e-07
, O 0 7.670371976464807e-11
and O 0 3.0091010239097216e-10
HLA O 0 0.00011090320185758173
- O 0 0.004718700423836708
DR1 O 1 0.9999780654907227
was O 0 5.741003672454781e-09
performed O 0 1.6811665948246457e-10
by O 0 3.6637554101659475e-11
polymerase O 0 2.9392004385897508e-09
chain O 0 1.758310053112666e-09
reaction O 0 4.635320738355375e-10
with O 0 2.344436797474536e-11
sequence O 0 3.015603391998134e-11
- O 0 1.640763497290365e-10
specific O 0 1.4381783264294512e-10
primers O 0 1.7652533657042113e-08
, O 0 4.891904589743312e-11
and O 0 1.370689534097025e-10
zygosity O 0 6.961924441384326e-07
was O 0 1.4019012617438875e-08
assessed O 0 1.7598182466826984e-07
using O 0 5.2600508837485904e-08
microsatellite O 0 1.0211757398792543e-05
markers O 0 1.0323886954211048e-06
. O 0 3.0339546697177866e-07

Genetic O 0 1.231639089382952e-05
and O 0 4.511429008147161e-09
environmental O 0 1.2326839993193062e-08
variance O 0 3.904271572707785e-09
components O 0 1.9753766622443436e-08
were O 0 1.864748577773412e-09
assessed O 0 9.035485248887198e-09
with O 0 4.767167910424419e-11
the O 0 4.059737879202885e-09
program O 0 5.414713122320336e-10
Mx O 0 5.5588342817713965e-09
, O 0 1.352034586718509e-12
using O 0 1.3428288429123691e-12
data O 0 3.914802076260271e-12
from O 0 3.67911040174973e-12
this O 0 4.2604656781686234e-12
and O 0 7.399447374267787e-12
previous O 0 3.3372574148593515e-10
studies O 0 2.2002416555366722e-10
of O 0 5.228616983821155e-10
twins O 0 1.753305127749627e-07
with O 0 2.193031173325366e-10
AS B-Disease 1 1.0
. O 0 3.7817855513821996e-07

RESULTS O 0 1.4814881978963967e-05
Six O 0 5.621360088525762e-08
of O 0 2.357241690731371e-08
8 O 0 3.612798877838941e-07
monozygotic O 0 8.647531649330631e-05
( O 0 3.2919680315046662e-09
MZ O 0 0.00026917640934698284
) O 0 1.2558839523890697e-09
twin O 0 8.519994310063339e-08
pairs O 0 8.544966956236522e-10
were O 0 1.3473718807333057e-09
disease O 0 9.470950246281973e-09
concordant O 0 3.0800067634118022e-06
, O 0 3.0993779764898477e-10
compared O 0 1.2183337672055927e-09
with O 0 1.2519889638906712e-11
4 O 0 1.3201676418717057e-09
of O 0 2.9378144361658087e-10
15 O 0 2.8110136440773204e-10
B27 O 0 2.7522808920821262e-08
- O 0 4.7824908477878125e-09
positive O 0 6.041774192055982e-09
dizygotic O 0 2.0825191313633695e-06
( O 0 1.5710957534942338e-10
DZ O 0 3.8272327174126985e-07
) O 0 4.845242609907707e-11
twin O 0 8.366888515354276e-09
pairs O 0 1.2040679564506718e-10
( O 0 5.931441535850235e-12
27 O 0 1.8154401315584323e-09
% O 0 2.8283889119684602e-11
) O 0 1.1161271559756436e-12
and O 0 1.4922625635183095e-11
4 O 0 1.228287582755172e-09
of O 0 3.709308638022435e-09
32 O 0 1.0073800638110697e-07
DZ O 0 0.00010001210466725752
twin O 0 2.442324102958082e-07
pairs O 0 5.664362867641159e-10
overall O 0 1.0925704785336166e-08
( O 0 1.7598818236042035e-11
12 O 0 2.675915877770052e-10
. O 0 3.341962817593469e-11
5 O 0 8.147493235632908e-10
% O 0 7.049329175945473e-11
) O 0 4.1420797347591076e-11
. O 0 4.615525739382065e-09

Nonsignificant O 0 0.0006155000301077962
increases O 0 6.910210572641518e-07
in O 0 9.204420337027841e-09
similarity O 0 5.866362950968096e-09
with O 0 4.232000166970451e-11
regard O 0 1.2407181060325456e-08
to O 0 1.0597627636554918e-10
age O 0 6.716603451195624e-08
at O 0 5.471369135534587e-09
disease O 0 1.786102465928252e-08
onset O 0 7.439747605531011e-06
and O 0 1.0639598091444213e-09
all O 0 9.686701440969614e-11
of O 0 1.6417284198766424e-09
the O 0 2.1711983322347805e-09
disease O 0 6.406348784793181e-09
severity O 0 1.1881996719864674e-08
scores O 0 1.1467278238086465e-09
assessed O 0 2.5317827834214768e-09
were O 0 5.677970316142478e-10
noted O 0 3.690140970569189e-10
in O 0 3.850908758540328e-10
disease O 0 1.6906261635085684e-07
- O 0 2.0801096525246976e-06
concordant O 0 0.18735861778259277
MZ O 1 0.999263346195221
twins O 0 1.984903519769432e-06
compared O 0 8.13108780306493e-09
with O 0 3.499731060507827e-10
concordant O 0 0.0002199881710112095
DZ O 1 0.9619390964508057
twins O 0 6.316260987659916e-05
. O 0 2.1517739412502124e-07

HLA O 0 0.001974099315702915
- O 0 4.086600165464915e-05
B27 O 0 1.6449694157927297e-05
and O 0 3.3058045190159646e-09
B60 O 0 3.8041832794988295e-07
were O 0 5.234913613705316e-10
associated O 0 1.9129781092530607e-10
with O 0 1.2643983082760712e-11
the O 0 6.970997556976499e-09
disease O 0 2.4610335458419286e-07
in O 0 1.894858270290456e-09
probands O 0 0.0028646362479776144
, O 0 1.476656852350544e-10
and O 0 2.5116946716918775e-11
the O 0 1.105281560720428e-10
rate O 0 5.951869552767164e-10
of O 0 3.183558694441757e-10
disease O 0 4.358548366667492e-08
concordance O 0 1.0758208901506805e-07
was O 0 9.103394704723655e-10
significantly O 0 9.788915233954754e-10
increased O 0 1.1467912175433526e-09
among O 0 8.858103583975208e-09
DZ O 0 1.1168085620738566e-05
twin O 0 4.9238799704198755e-08
pairs O 0 6.448206552045477e-11
in O 0 1.1458389792551316e-11
which O 0 6.457310814528272e-12
the O 0 3.456682717839499e-10
co O 0 2.601574289329278e-09
- O 0 2.9486409758305854e-08
twin O 0 5.847820716553542e-08
was O 0 7.956647007922868e-10
positive O 0 5.022193771964112e-11
for O 0 5.2114895732202626e-11
both O 0 3.364638012648413e-10
B27 O 0 3.6049111713509774e-06
and O 0 5.3513701914198464e-08
DR1 O 0 0.006670949514955282
. O 0 2.8776017302334367e-07

Additive O 0 1.5680812794016674e-05
genetic O 0 8.884196631697705e-07
effects O 0 8.841261944780854e-08
were O 0 4.985549750813334e-09
estimated O 0 1.663070653412646e-10
to O 0 3.4630097400789595e-11
contribute O 0 3.6651692791878077e-10
97 O 0 6.837212396249015e-08
% O 0 5.428650237671029e-11
of O 0 4.0922615990313105e-11
the O 0 1.1964856883039943e-10
population O 0 7.536671807473194e-12
variance O 0 3.4497820156076386e-09
. O 0 5.30377377572222e-08

CONCLUSION O 0 6.24220774625428e-05
Susceptibility O 0 8.610519580543041e-05
to O 0 4.117588403573791e-08
AS B-Disease 1 1.0
is O 0 1.3288024014457278e-09
largely O 0 7.075226182706729e-09
genetically O 0 3.983570362464661e-09
determined O 0 1.9145851570812056e-09
, O 0 3.0113616461546755e-11
and O 0 4.662415939438169e-11
the O 0 8.100511927899845e-10
environmental O 0 2.2611533267991035e-07
trigger O 0 3.86610832237011e-09
for O 0 1.6273274394684734e-10
the O 0 2.6470496905517393e-08
disease O 0 1.5139910374273313e-06
is O 0 8.302944443094873e-10
probably O 0 8.653669425484622e-08
ubiquitous O 0 1.0035671493824339e-06
. O 0 1.9118846239507548e-07

HLA O 0 0.0006471227970905602
- O 0 9.024273822433315e-06
B27 O 0 2.7850826427311404e-06
accounts O 0 8.688640917853263e-10
for O 0 3.006271273586769e-11
a O 0 3.180340366060186e-11
minority O 0 6.13529713144878e-11
of O 0 1.3334784665364197e-10
the O 0 1.394204751647976e-09
overall O 0 5.740261599385121e-07
genetic O 0 4.667192285978672e-07
susceptibility O 0 1.3425491488305852e-05
to O 0 3.766128742199726e-08
AS B-Disease 1 1.0
. O 0 3.6844303394900635e-05

Cell O 0 1.7913519059220562e-06
cycle O 0 2.248206811827913e-07
- O 0 1.658173118812556e-07
dependent O 0 6.465716495540619e-08
colocalization O 0 2.289857775394921e-06
of O 0 2.4947686938503466e-07
BARD1 O 1 0.9999998807907104
and O 0 3.491601034966152e-07
BRCA1 O 0 1.2387181413942017e-07
proteins O 0 2.1079074596919156e-10
in O 0 1.2678498528817528e-10
discrete O 0 1.0177254594623264e-08
nuclear O 0 1.673558074344328e-07
domains O 0 2.5016993276949506e-07
. O 0 2.411817376923864e-07

Germ O 0 0.00291787413880229
- O 0 1.2514173249655869e-05
line O 0 7.271388540175394e-07
mutations O 0 7.187576755995906e-09
of O 0 8.804975415444005e-09
the O 0 1.6397015301095053e-08
BRCA1 O 0 3.9503408544305785e-08
gene O 0 6.06072192432805e-10
predispose O 0 9.418477020517457e-08
women O 0 2.0367973974089182e-10
to O 0 2.3378236846394174e-11
early O 0 1.0049367119790986e-05
- O 0 0.027165180072188377
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.0180899456813108e-09
compromising O 0 1.9557097274969237e-08
the O 0 1.4016117155790653e-09
genes O 0 7.068141072430478e-10
presumptive O 0 2.894385318086279e-07
function O 0 2.639685692251703e-10
as O 0 5.283715687198764e-10
a O 0 1.1803632515849927e-09
tumor B-Disease 0 7.345505537159625e-07
suppressor O 0 4.4416760829335544e-06
. O 0 1.7770778981684998e-07

Although O 0 1.321702370660205e-06
the O 0 1.0311887166380984e-07
biochemical O 0 8.764363883528858e-06
properties O 0 5.665638582286192e-06
of O 0 1.0349172043788712e-06
BRCA1 O 0 4.2936855493280746e-07
polypeptides O 0 7.245331445915326e-09
are O 0 2.601482744502004e-11
not O 0 1.2641498958743114e-11
understood O 0 2.5038957573997322e-09
, O 0 1.9127255335149584e-11
their O 0 2.3477839464214334e-11
expression O 0 7.495531972878666e-11
pattern O 0 1.1739502425722748e-10
and O 0 1.343680028353944e-11
subcellular O 0 2.303185198115898e-08
localization O 0 2.3217632261207655e-08
suggest O 0 6.233449867387719e-10
a O 0 5.412665801673988e-11
role O 0 5.299339300712802e-10
in O 0 2.12123429932376e-09
cell O 0 5.343822451209235e-08
- O 0 2.06519601420041e-08
cycle O 0 5.69804718963951e-08
regulation O 0 2.848104543318186e-07
. O 0 2.4206654458680532e-08

When O 0 1.835366902014357e-06
resting O 0 8.79297931533074e-06
cells O 0 8.82042350269785e-09
are O 0 7.287929981725227e-11
induced O 0 3.9804715079583275e-09
to O 0 7.661057899177592e-11
proliferate O 0 7.774944243976734e-09
, O 0 3.099110204574096e-11
the O 0 1.5391923846586053e-10
steady O 0 1.025891038786142e-09
- O 0 2.7914412101259778e-11
state O 0 5.497690844236125e-12
levels O 0 2.562182688237158e-10
of O 0 2.766182283231444e-10
BRCA1 O 0 3.728152786486305e-10
increase O 0 1.5940290754024034e-11
in O 0 1.2075800082111954e-10
late O 0 6.787394681850856e-07
G1 O 0 3.845822789116937e-07
and O 0 9.020357377709232e-11
reach O 0 8.459759975876224e-11
a O 0 1.4261604050491705e-12
maximum O 0 7.82402823085171e-11
during O 0 3.1459905791564324e-09
S O 0 2.346389692320372e-06
phase O 0 2.750061639744672e-06
. O 0 1.650046073109479e-07

Moreover O 0 6.5084359448519535e-06
, O 0 1.0401942418525323e-08
in O 0 1.1429725610412333e-08
S O 0 1.2283991054573562e-05
phase O 0 5.545796739170328e-06
cells O 0 3.761362066256879e-08
, O 0 3.3732358573068666e-10
BRCA1 O 0 8.908323856360312e-09
polypeptides O 0 5.194474628211765e-09
are O 0 1.768749868791275e-10
hyperphosphorylated O 0 6.168642130433e-07
and O 0 2.189880499159358e-09
accumulate O 0 5.10220452554222e-08
into O 0 2.164731061071734e-09
discrete O 0 5.3079432404956606e-08
subnuclear O 0 1.6359223081963137e-05
foci O 0 4.4824260839959607e-05
termed O 0 5.034525202063378e-06
" O 0 1.1630794460870675e-06
BRCA1 O 0 7.10603671905119e-07
nuclear O 0 4.5576854290629853e-07
dots O 0 4.6545326881641813e-07
. O 0 8.835412756980077e-08

" O 0 5.9159046941203997e-05
BRCA1 O 0 0.00011775604070862755
associates O 0 5.046611022407888e-07
in O 0 6.528193541299743e-09
vivo O 0 2.1473905320590347e-08
with O 0 4.5755690902815616e-11
a O 0 1.2404287597078678e-09
structurally O 0 2.1284347440087004e-06
related O 0 3.1314023090089904e-06
protein O 0 6.7212308749731164e-06
termed O 0 1.1040649042115547e-05
BARD1 O 1 0.9999992847442627
. O 0 4.638987775251735e-06

Here O 0 4.946631975144555e-07
we O 0 1.5657029006632683e-09
show O 0 2.58122440088826e-10
that O 0 4.307834904765384e-12
the O 0 2.358844786165548e-10
steady O 0 2.567868806480078e-09
- O 0 1.5004460174328216e-10
state O 0 7.850213534776884e-12
levels O 0 2.4332308390384583e-10
of O 0 1.8744755747590602e-10
BARD1 O 0 3.551202826201916e-05
, O 0 1.2334165633287597e-10
unlike O 0 9.700370506848799e-10
those O 0 1.4602218045833837e-10
of O 0 5.697978533447667e-09
BRCA1 O 0 3.4294526329858854e-08
, O 0 7.156653741846597e-11
remain O 0 8.128897555081949e-10
relatively O 0 2.989079816995144e-10
constant O 0 2.2228976992444416e-10
during O 0 2.660563103162872e-09
cell O 0 2.0944996848015762e-08
cycle O 0 2.5924714819325345e-08
progression O 0 3.018560619238997e-07
. O 0 2.126615150643829e-08

However O 0 2.3085481188900303e-06
, O 0 3.644809609681943e-08
immunostaining O 0 3.893522807629779e-05
revealed O 0 1.1500495133986988e-07
that O 0 1.9900032732778072e-09
BARD1 O 1 0.999866247177124
resides O 0 2.3170299812136363e-07
within O 0 2.1866512156520912e-08
BRCA1 O 0 1.8783355315576955e-08
nuclear O 0 1.7347925762578598e-08
dots O 0 2.3900041945523753e-09
during O 0 2.9927094136183996e-09
S O 0 6.68703705741791e-08
phase O 0 4.757265514854225e-08
of O 0 1.5867080982445714e-09
the O 0 7.598104784234394e-11
cell O 0 2.206127815151948e-11
cycle O 0 1.2195368846723564e-11
, O 0 6.135899080494944e-13
but O 0 4.071425922097527e-12
not O 0 8.65366892727204e-12
during O 0 1.0639576997206746e-09
the O 0 2.0646643505983775e-08
G1 O 0 3.2813427424116526e-06
phase O 0 2.2230071863305056e-06
. O 0 1.3030549439463357e-07

Nevertheless O 0 2.5361896405229345e-05
, O 0 6.907456651106259e-08
BARD1 O 0 0.00048422557301819324
polypeptides O 0 5.760333010584873e-07
are O 0 5.676335512738717e-10
found O 0 7.97965235554976e-11
exclusively O 0 1.1896883478357267e-10
in O 0 2.1376733716493845e-11
the O 0 1.4560638805782844e-10
nuclear O 0 1.9627838909741513e-08
fractions O 0 1.7748152458807454e-07
of O 0 1.63665490049425e-08
both O 0 1.2360124035382114e-09
G1 O 0 6.284790288191289e-07
- O 0 6.486084913603918e-08
and O 0 2.23754437200796e-09
S O 0 1.3767665905106696e-06
- O 0 3.67979176019162e-08
phase O 0 4.2395771515657543e-07
cells O 0 1.615832800894168e-08
. O 0 4.581529822189623e-09

Therefore O 0 3.214945536456071e-07
, O 0 1.6951806625087329e-09
progression O 0 2.9256719713544044e-08
to O 0 7.115918410072197e-10
S O 0 2.937894123533624e-07
phase O 0 8.141178398091142e-08
is O 0 1.0672472454398285e-11
accompanied O 0 3.116383193169092e-11
by O 0 1.651929114332429e-11
the O 0 1.0250826576463368e-10
aggregation O 0 2.542744237388206e-09
of O 0 2.7691979820332335e-09
nuclear O 0 7.731410960332141e-07
BARD1 O 1 0.905682384967804
polypeptides O 0 2.3151051209424622e-06
into O 0 2.432347798730916e-07
BRCA1 O 0 6.14826774381072e-07
nuclear O 0 5.956713380328438e-07
dots O 0 4.2993318061235186e-07
. O 0 6.813363029323227e-08

This O 0 3.906984957779969e-08
cell O 0 5.2833183161737907e-08
cycle O 0 2.3409906901861177e-08
- O 0 1.5036246026056688e-08
dependent O 0 1.6643605604826917e-08
colocalization O 0 1.0076449825646705e-06
of O 0 7.015645309138563e-08
BARD1 O 1 0.999954104423523
and O 0 5.739693165196513e-08
BRCA1 O 0 1.7780264371936028e-08
indicates O 0 2.576580615532009e-10
a O 0 3.576876642097382e-12
role O 0 2.168704452132353e-11
for O 0 2.84019169294325e-10
BARD1 O 1 0.9999997615814209
in O 0 7.85261217970401e-05
BRCA1 O 0 0.00011579760757740587
- O 0 1.0358451618230902e-05
mediated O 0 1.9723160221474245e-05
tumor B-Disease 0 0.0041687339544296265
suppression O 0 0.00011158209963468835
. O 0 5.888235818929388e-07

Ethnic O 0 5.870848553968244e-07
differences O 0 3.0127222316878033e-07
in O 0 1.6675349101547e-08
the O 0 5.1108930421150944e-08
HFE O 0 0.000299044739222154
codon O 0 2.4924813715188066e-06
282 O 0 5.113753104524221e-06
( O 0 1.4628213307332771e-08
Cys O 0 0.0007208791794255376
/ O 0 1.1583369087020401e-05
Tyr O 0 9.310525638284162e-05
) O 0 1.6711680927983252e-08
polymorphism O 0 8.490807772432163e-07
. O 0 1.6350675480225618e-07

Recent O 0 5.442187216431194e-07
studies O 0 3.188727504266353e-08
have O 0 6.616638487111359e-11
shown O 0 9.983845000727243e-11
that O 0 5.513206002838444e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 3.109452336502727e-06
HH B-Disease 1 1.0
) O 0 2.436620905044151e-10
is O 0 1.5529272312519993e-11
likely O 0 1.3967753342836176e-10
to O 0 9.082434457297062e-12
be O 0 2.386721896507904e-11
caused O 0 1.6293688620550029e-09
by O 0 8.066129986161741e-10
homozygosity O 0 1.8654664017958567e-06
for O 0 9.973343262359435e-10
a O 0 6.74222955243664e-10
Cys282Tyr O 0 3.0694593533553416e-06
mutation O 0 4.9158264125992446e-09
in O 0 9.63948698640138e-10
the O 0 1.0174440845389654e-08
HFE O 0 0.0002539183187764138
gene O 0 1.0323832810854583e-07
located O 0 2.7483462616828547e-08
4 O 0 9.469689388197366e-08
. O 0 7.288746672884372e-08

5 O 0 8.700490070623346e-06
Mb O 0 2.4295790353789926e-05
telomeric O 0 5.05237330798991e-05
to O 0 2.509888759050227e-07
HLA O 1 0.9998490810394287
- O 0 0.002496254863217473
A O 0 5.660637725668494e-06
. O 0 1.3478999960625515e-07

Population O 0 9.088062746798187e-09
studies O 0 8.942162010860955e-10
of O 0 7.349349601115662e-11
this O 0 1.1906615450529845e-11
polymorphism O 0 2.68599587016638e-09
are O 0 1.2325762806242313e-11
facilitated O 0 3.740358717196912e-11
by O 0 2.196131818066327e-11
the O 0 1.6088594345653462e-10
fact O 0 6.711202427123197e-11
that O 0 3.087056001452315e-12
the O 0 7.774526022963357e-10
Cys282Tyr O 0 1.1656160495476797e-05
mutation O 0 4.482918924963997e-08
creates O 0 4.629279182211121e-09
a O 0 8.096881498609321e-10
Rsal O 0 1.1164730494783726e-05
restriction O 0 3.5047160054091364e-06
site O 0 9.29885288769583e-07
. O 0 1.143779968515446e-07

We O 0 6.01381557885361e-08
have O 0 3.183425190123046e-10
studied O 0 6.5606351462577095e-09
the O 0 2.105710272815031e-09
codon O 0 1.4198452902292047e-07
282 O 0 8.125584827212151e-07
( O 0 5.65135094277025e-09
Cys O 0 0.0004941760562360287
/ O 0 1.969058757822495e-06
Tyr O 0 8.435105883108918e-06
) O 0 1.8525171674443897e-10
polymorphism O 0 6.476291503076936e-09
in O 0 1.206069827341949e-10
different O 0 1.961430878827386e-10
ethnic O 0 5.168825367718455e-10
groups O 0 2.394045239828557e-10
. O 0 3.537388604257785e-09

In O 0 4.9101217314273526e-08
agreement O 0 2.863939663200199e-08
with O 0 4.2532605215583885e-10
previous O 0 6.324425072534723e-08
observations O 0 4.744986270566187e-08
the O 0 6.5717569164291945e-09
Tyr O 0 5.3374733397504315e-06
allele O 0 1.640220759213662e-08
appeared O 0 1.9796153605255995e-09
to O 0 9.03721281836356e-12
be O 0 1.0162807227709347e-11
rare O 0 3.872578646646474e-10
or O 0 1.663844895194444e-10
absent O 0 5.706160521867787e-08
in O 0 1.4318672914015451e-09
Asiatic O 0 3.750938333269005e-07
( O 0 7.655532457961911e-12
Indian O 0 2.1632275137850598e-10
, O 0 2.361481843404789e-11
Chinese O 0 2.2108310737678494e-09
) O 0 1.4000239856315488e-10
populations O 0 8.943373264180821e-10
. O 0 4.819329824101715e-09

The O 0 1.4768448863833328e-07
highest O 0 8.598191669761945e-08
allele O 0 1.2317807884798526e-09
frequency O 0 1.4752106203275162e-09
( O 0 1.5905244135638874e-11
7 O 0 2.9902316733831924e-10
. O 0 9.1016144274092e-12
5 O 0 2.3589888376029933e-10
% O 0 1.2376577193662364e-11
) O 0 2.1549478781274223e-12
was O 0 8.616356517165968e-10
found O 0 5.135570857461857e-10
in O 0 7.029116400047997e-09
Swedes O 0 0.00021776337234769017
. O 0 1.9354911273694597e-06

Saamis O 0 0.00954902172088623
( O 0 1.869054422343197e-08
2 O 0 2.1601950450644836e-08
% O 0 2.3870236343093154e-10
) O 0 8.479205185207839e-12
and O 0 1.3087696204561183e-10
Mordvinians O 0 1.537122079753317e-05
( O 0 3.751819688257996e-11
1 O 0 1.9835761921882522e-09
. O 0 3.011809551756173e-11
8 O 0 4.4933409770742117e-10
% O 0 1.9896292946519623e-11
) O 0 1.4347411063028725e-12
had O 0 6.913220690352162e-11
significantly O 0 2.398351961474532e-09
lower O 0 5.435217076410481e-08
frequencies O 0 7.023059023225642e-09
of O 0 5.3964668289552264e-09
the O 0 7.804887047768716e-08
Tyr O 0 5.519160185940564e-05
allele O 0 1.143585109275591e-06
. O 0 1.2311218711147376e-07

Comparisons O 0 8.489819265378173e-07
with O 0 9.731558892056569e-10
allele O 0 5.582965201256229e-09
frequencies O 0 1.2608377675249471e-09
based O 0 1.9998648570496158e-10
on O 0 1.8162704673585495e-10
prevalence O 0 7.18224202334028e-10
estimates O 0 1.1426052465290937e-10
of O 0 1.4543133364242067e-09
HH B-Disease 1 0.9999998807907104
showed O 0 1.7423983535991283e-06
some O 0 1.9519523775102243e-09
disagreements O 0 8.080349545025456e-08
with O 0 7.62816337873673e-11
the O 0 1.1237976105249459e-09
RFLP O 0 5.647016791954229e-07
data O 0 2.426993050974602e-09
, O 0 5.848470319147481e-11
particularly O 0 3.399454051589146e-09
in O 0 2.58311660950028e-09
Finns O 0 3.2601760722172912e-06
. O 0 8.479949542561371e-08

The O 0 1.2598223975146539e-06
newly O 0 4.7398398237419315e-06
described O 0 2.8023930553899845e-07
HFE O 0 0.014822057448327541
marker O 0 1.1701251878548646e-06
provides O 0 4.3628856083444134e-10
a O 0 1.1268550328957794e-11
new O 0 1.254772397096815e-10
approach O 0 6.405220798200162e-10
to O 0 5.1533651478086195e-12
the O 0 1.528408302697848e-11
screening O 0 1.521452408503876e-09
of O 0 2.3664574744231004e-09
HH B-Disease 1 0.9999912977218628
as O 0 2.562286383067658e-09
well O 0 4.5822588778943185e-11
as O 0 2.2921543135767664e-12
studies O 0 3.354676562580816e-12
of O 0 3.4267319884428993e-12
the O 0 4.4402443527546964e-11
relationship O 0 6.270341190717232e-11
between O 0 2.0160009217562447e-09
the O 0 1.9354675373506325e-07
HFE O 1 0.8015434741973877
Tyr O 0 0.00027663353830575943
allele O 0 3.062367284201173e-07
and O 0 3.005213633500148e-09
different O 0 1.7305225696873094e-08
disorders O 0 0.0013027943205088377
including O 0 4.951907612849027e-06
cancer B-Disease 1 0.9999980926513672

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999568462371826
associated O 0 3.4602287257712305e-08
with O 0 1.607758232102796e-10
a O 0 9.503335895999498e-10
missense O 0 9.15744138296759e-08
mutation O 0 1.9341042101217454e-09
encoding O 0 9.132128830913189e-09
Gly23 O 0 5.912414962949697e-06
- O 0 4.115045442176779e-07
- O 0 1.7901308524415072e-07
> O 0 3.928221588012093e-07
Val O 0 1.318862672405885e-07
in O 0 3.793739544732944e-09
neurophysin O 0 0.00011243881453992799
II O 1 1.0
. O 0 8.004799383343197e-06

Autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.2329500975738483e-07
ADNDI B-Disease 1 1.0
) O 0 1.172617003497578e-09
is O 0 1.1874418115453977e-10
an O 0 1.937551924457992e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.06367314606904984
by O 0 1.9943517770570907e-07
progressive O 1 0.9999946355819702
degeneration O 1 1.0
of O 0 0.00014586839824914932
the O 0 1.921873149512976e-07
magnocellular O 0 3.5795637813862413e-06
neurons O 0 1.1757681495083716e-09
of O 0 1.0311523856998406e-09
the O 0 4.045638934968565e-09
hypothalamus O 0 8.758243907891483e-09
leading O 0 1.8422934289219484e-08
to O 0 3.3893590711819854e-10
decreased O 0 2.703896200273448e-07
ability O 0 1.056382870068262e-09
to O 0 5.357880805689774e-10
produce O 0 1.7536688545760626e-08
the O 0 5.0228052828060754e-08
hormone O 0 9.225163211112886e-08
arginine O 0 5.127608915245219e-07
vasopressin O 0 1.0142150586034404e-06
( O 0 1.0749897860762303e-08
AVP O 0 2.8286793167353608e-05
) O 0 4.819954657619974e-09
. O 0 4.903374062337207e-08

Affected O 0 1.7576389836904127e-06
individuals O 0 2.0538071243692002e-09
are O 0 6.39031813576274e-11
not O 0 7.911093308221595e-11
symptomatic O 0 1.8532595049691736e-06
at O 0 1.4001134474028731e-08
birth O 0 3.0248196480897604e-07
, O 0 7.363380738478753e-11
but O 0 2.709426849545338e-10
usually O 0 1.75712404626438e-08
develop O 0 6.144757094261877e-07
diabetes B-Disease 1 0.9999982118606567
insipidus I-Disease 0 0.40418288111686707
at O 0 6.788806672375358e-08
1 O 0 1.5494451588438096e-07
- O 0 2.060361339317751e-07
6 O 0 2.616096139718138e-07
yr O 0 3.2641708003211534e-06
of O 0 1.1466365634760223e-08
age O 0 1.4658859015526104e-07
. O 0 3.939475945458071e-08

The O 0 6.764803828218646e-08
genetic O 0 2.965148482303448e-08
locus O 0 1.2434520080262246e-08
of O 0 6.0621707653751855e-09
the O 0 1.3934477571808657e-08
disease O 0 2.8679798447228677e-07
is O 0 1.5863199642751624e-10
the O 0 1.3317209557328624e-08
AVP O 0 0.00026746190269477665
- O 0 3.563038717402378e-06
neurophysin O 1 0.9480882287025452
II O 1 1.0
( O 0 4.995353908299194e-09
NPII O 1 0.9026325345039368
) O 0 3.413122007245306e-10
gene O 0 4.4332651438772075e-10
, O 0 9.291795111110446e-11
and O 0 3.0165367426171485e-10
mutations O 0 1.0652451143400299e-09
that O 0 6.492536369639978e-11
cause O 0 2.085195092149661e-07
ADNDI B-Disease 1 0.9999998807907104
have O 0 4.89951990090276e-09
been O 0 4.31190028127304e-10
found O 0 4.2864291976973945e-11
in O 0 1.2125762199888257e-11
both O 0 8.35031176149581e-12
the O 0 6.493613285973865e-11
signal O 0 1.593078446937568e-10
peptide O 0 1.047949643728785e-10
of O 0 1.362713608621391e-09
the O 0 9.597846073461369e-09
prepro O 0 0.0025786564219743013
- O 1 0.6790967583656311
AVP O 1 0.995758593082428
- O 0 1.8301550881005824e-05
NPII O 1 0.9677571654319763
precursor O 0 1.1500978871481493e-05
and O 0 9.279053081456823e-09
within O 0 5.499610722381476e-08
NPII O 1 0.9971396923065186
itself O 0 3.2899930602070526e-07
. O 0 1.6276962355732394e-07

An O 0 1.668645310815009e-08
affected O 0 3.1756357543599734e-07
girl O 0 1.527225208519667e-07
who O 0 2.05396671892899e-10
presented O 0 2.0289623314795335e-09
at O 0 1.3085256211908813e-09
9 O 0 8.346290880645313e-10
months O 0 9.236964665371161e-11
of O 0 2.808543120291773e-10
age O 0 6.174182942686457e-09
and O 0 1.3831828737931318e-10
her O 0 5.3201790195522847e-11
similarly O 0 6.113304307220346e-10
affected O 0 4.371475625930543e-09
younger O 0 1.216628078282156e-07
brother O 0 1.466671761818361e-07
and O 0 2.0921948618024544e-09
father O 0 2.419608335912926e-08
were O 0 4.3598848975534565e-09
all O 0 6.867458685055894e-11
found O 0 2.1470309904958462e-11
to O 0 7.00338485121188e-12
have O 0 2.1176787753929283e-11
a O 0 1.151048562020307e-10
novel O 0 6.69200090896993e-08
missense O 0 2.5656871116552793e-07
mutation O 0 3.13931924900146e-09
( O 0 2.1268391561801714e-11
G1758 O 0 3.644809609681943e-08
- O 0 6.182715228675306e-09
- O 0 7.083057251833225e-09
> O 0 2.998264747589019e-08
T O 0 6.922436845968605e-09
) O 0 1.1002954190125758e-12
encoding O 0 9.50079251382796e-11
the O 0 1.054977008529967e-10
amino O 0 1.5745064974037604e-10
acid O 0 4.2746742257016024e-10
substitution O 0 4.668215325409619e-08
Gly23 O 0 2.4267458229587646e-06
- O 0 3.4757670164253796e-07
- O 0 2.848729536708561e-07
> O 0 1.284032009607472e-06
Val O 0 1.2016805612802273e-06
within O 0 1.818786188323429e-07
NPII O 1 0.9766789674758911
. O 0 1.3309714859133237e-06

The O 0 7.642212267455761e-07
mutation O 0 1.6199068397781957e-07
was O 0 1.0725730525962263e-08
confirmed O 0 1.209964572979061e-09
by O 0 2.268141507943966e-10
restriction O 0 8.11408042977746e-08
endonuclease O 0 5.644104135171801e-07
analysis O 0 1.53009942494009e-08
. O 0 7.146882552433453e-08

A O 0 2.5782193915802054e-05
T1 O 0 0.0028645528946071863
- O 0 2.6815653200173983e-06
weighted O 0 1.7636433540246799e-06
magnetic O 0 5.579157402735291e-08
resonance O 0 4.3279388961536824e-08
imaging O 0 2.515342885089922e-07
of O 0 9.56729024892411e-08
the O 0 7.193036253738683e-06
fathers O 0 0.002040308900177479
pituitary O 0 3.924725388060324e-05
gland O 0 2.3434936338162515e-06
demonstrates O 0 6.405483787830235e-08
an O 0 1.1158648449693942e-09
attenuated O 0 1.1961617929046042e-05
posterior O 0 3.7341883398767095e-06
pituitary O 0 0.0006558457389473915
bright O 0 0.28526487946510315
spot O 0 6.688437861157581e-05
. O 0 2.25753140625784e-07

This O 0 8.705718812507257e-08
mutation O 0 9.417525603794275e-08
may O 0 3.3811862198973586e-09
be O 0 4.131327502321369e-10
valuable O 0 9.167450798486243e-09
for O 0 3.7408867670229995e-11
developing O 0 8.045248911514591e-10
models O 0 1.463942633783688e-09
of O 0 9.429546921069232e-09
dominantly B-Disease 1 0.9584826827049255
inherited I-Disease 1 0.9999984502792358
neurodegeneration I-Disease 1 1.0
, O 0 8.112095883916481e-09
as O 0 1.5313533774374832e-10
the O 0 5.175511755273199e-11
early O 0 1.7954330244762673e-09
age O 0 4.912871220952297e-10
of O 0 1.2527348602908717e-10
onset O 0 2.2731430817657383e-06
of O 0 1.0530429790378548e-06
symptoms O 0 0.19825753569602966
suggests O 0 5.9801843477202965e-09
that O 0 2.5535348575217443e-12
this O 0 2.117484833308314e-11
mutation O 0 2.444600077922132e-10
may O 0 1.3712388169384582e-10
be O 0 5.819183676591955e-11
particularly O 0 3.2251816772799202e-09
deleterious O 0 6.440558308895561e-08
to O 0 2.4885884464254104e-09
the O 0 2.0736375461183343e-07
magnocellular O 0 0.00025491698761470616
neuron O 0 9.219276648764207e-07
. O 0 1.186216103121751e-08
. O 0 4.238258810573825e-08

Frequent O 0 4.6645223505947797e-07
inactivation O 0 0.00012554637214634567
of O 0 3.1489296816289425e-05
PTEN O 1 0.9999997615814209
/ O 1 0.7567821741104126
MMAC1 O 1 1.0
in O 0 8.287270611617714e-05
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4669932170363609e-05

Sporadic B-Disease 1 0.9999878406524658
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 7.864331763585142e-08
the O 0 1.3794771547281925e-08
most O 0 1.7758226000808008e-09
common O 0 1.67557896446624e-08
male B-Disease 0 1.8612271723839058e-09
cancer I-Disease 0 2.4042237090071694e-09
in O 0 3.276392351869717e-11
the O 0 3.963975536702691e-10
Western O 0 2.243477226215873e-08
world O 0 1.2156893547388137e-10
, O 0 3.681890296119983e-12
yet O 0 4.023549202147869e-11
many O 0 4.249153546381779e-12
of O 0 2.0889390911493777e-11
the O 0 5.646658488012157e-11
major O 0 1.4325912678359032e-09
genetic O 0 1.8077891961176817e-10
events O 0 1.5382759302462468e-11
involved O 0 7.987018164901105e-12
in O 0 4.0209252594181066e-11
the O 0 3.59594465315638e-10
progression O 0 1.1811948752438184e-08
of O 0 6.231571925141566e-10
this O 0 3.711727314392732e-10
often O 0 2.8912669591818485e-08
fatal O 0 0.002916536061093211
cancer B-Disease 1 0.9999940395355225
remain O 0 8.502248647346278e-07
to O 0 2.756445516283179e-09
be O 0 3.905539358584065e-08
elucidated O 0 0.00025728053878992796
. O 0 1.1785549531850847e-06

Numerous O 0 2.2081787847128e-06
cytogenetic O 0 0.00013712013605982065
and O 0 6.600690483082872e-08
allelotype O 0 0.0010413025738671422
studies O 0 1.535590712364865e-07
have O 0 2.332493365120314e-10
reported O 0 8.021433517413357e-11
frequent O 0 2.0245889686965057e-10
loss O 0 3.408695192774758e-08
of O 0 1.0148971796297701e-06
heterozygosity O 1 0.9993124008178711
on O 0 9.952040272764862e-06
chromosomal O 0 2.398610604359419e-06
arm O 0 2.954484216388664e-06
10q O 0 0.0002677063166629523
in O 0 6.352403488563141e-06
sporadic B-Disease 1 0.9999942779541016
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.241012018406764e-05

Deletion O 0 2.43469230554183e-06
mapping O 0 1.0075894607552982e-07
studies O 0 1.095560797637063e-08
have O 0 2.3321819475619066e-10
unambiguously O 0 4.453718283059516e-09
identified O 0 6.951131337196159e-10
a O 0 1.1201590349729784e-10
region O 0 1.0538471206800182e-09
of O 0 6.63642607534598e-09
chromosome O 0 9.866951700132631e-10
10q23 O 0 1.3714839042222593e-07
to O 0 4.9288528120028374e-11
be O 0 2.5682482182598498e-11
the O 0 1.8785700772738778e-10
minimal O 0 2.7766567711751122e-08
area O 0 3.59289060725132e-08
of O 0 2.0437809666873363e-08
loss O 0 3.17670674121473e-06
. O 0 7.191761710600986e-07

A O 0 5.925691766606178e-06
new O 0 1.0126186680281535e-06
tumor B-Disease 0 1.0514350833545905e-05
suppressor O 0 9.941737516783178e-06
gene O 0 3.330177023030956e-08
, O 0 4.890127858203641e-09
PTEN O 0 0.000864488712977618
/ O 0 4.567977612168761e-06
MMAC1 O 1 1.0
, O 0 1.3462730485969132e-08
was O 0 2.2570579005787295e-07
isolated O 0 1.729466880817654e-08
recently O 0 4.747724990927793e-10
at O 0 1.1688455758829264e-09
this O 0 7.95054438951226e-11
region O 0 1.8174635130208117e-09
of O 0 2.614852112614585e-09
chromosome O 0 8.25957080508033e-10
10q23 O 0 1.8799777024014475e-07
and O 0 2.2216938011521137e-10
found O 0 2.807465024345923e-11
to O 0 2.0498594141549198e-12
be O 0 4.804234267352658e-12
inactivated O 0 3.785340485507049e-09
by O 0 2.1988111331694427e-10
mutation O 0 9.730375616356923e-09
in O 0 1.2100644042334352e-08
three O 0 5.68644566101284e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.669447919994127e-05
lines O 0 5.2726267796288084e-08
. O 0 2.8006770236288503e-08

We O 0 9.777512786968146e-06
screened O 0 0.00021895320969633758
80 O 0 5.6977201893460006e-05
prostate B-Disease 1 0.999994158744812
tumors I-Disease 1 1.0
by O 0 6.21145161971981e-08
microsatellite O 0 2.0419436168594984e-06
analysis O 0 3.5998444225526782e-09
and O 0 2.1648290104980816e-10
found O 0 8.8101408113328e-11
chromosome O 0 1.8826952496997507e-10
10q23 O 0 1.8545453883689333e-07
to O 0 5.204240927092485e-10
be O 0 1.4880546794771021e-09
deleted O 0 1.9041451082557614e-08
in O 0 3.791251312890154e-09
23 O 0 3.311365759373075e-08
cases O 0 1.0292921182042392e-08
. O 0 6.88054058173293e-08

We O 0 5.091423460612532e-08
then O 0 1.1774962116462007e-09
proceeded O 0 4.746278481349009e-09
with O 0 7.152456795236906e-13
sequence O 0 1.1884783521903808e-12
analysis O 0 4.445140002612424e-12
of O 0 6.715544093038872e-11
the O 0 9.405777268156612e-10
entire O 0 1.1627162166405469e-07
PTEN O 0 0.0053450604900717735
/ O 0 1.0077592378365807e-05
MMAC1 O 1 0.9997408986091614
coding O 0 1.335526008006127e-06
region O 0 6.073144476204106e-08
and O 0 8.610787638474449e-10
tested O 0 1.4485667776398259e-08
for O 0 8.437815446349362e-10
homozygous O 0 1.065684607226558e-08
deletion O 0 4.442231027468324e-09
with O 0 7.434761833957637e-11
new O 0 9.936039546687425e-09
intragenic O 0 1.4386852853931487e-05
markers O 0 1.7048157019416976e-07
in O 0 3.2982511166679274e-10
these O 0 4.0057533678972135e-11
23 O 0 2.2729572390911557e-10
cases O 0 2.4262316114520566e-11
with O 0 3.459029243590983e-11
10q23 O 0 1.7486208889749832e-05
loss O 0 8.13899350760039e-06
of O 0 1.787569453881588e-05
heterozygosity O 1 0.968424379825592
. O 0 2.4242383460659767e-06

The O 0 1.0193087263132838e-08
identification O 0 3.607226295443411e-09
of O 0 2.0335921835368254e-09
the O 0 1.1458139992370775e-09
second O 0 2.0515257048714375e-08
mutational O 0 2.983455260618939e-06
event O 0 9.215452401178936e-09
in O 0 3.918204927177982e-10
10 O 0 3.6651900958695194e-10
( O 0 1.7472625776782102e-11
43 O 0 9.171998271995108e-09
% O 0 2.1771282554539084e-09
) O 0 6.658169571238659e-09
tumors B-Disease 1 1.0
establishes O 0 0.0002521802089177072
PTEN O 1 0.9999998807907104
/ O 0 0.006186026614159346
MMAC1 O 1 0.9999997615814209
as O 0 3.1254641097433478e-09
a O 0 5.745927691980235e-11
main O 0 4.036972978127551e-10
inactivation O 0 9.342167039960714e-09
target O 0 2.0279591894656335e-10
of O 0 2.0075245910078365e-09
10q O 0 2.1756324713351205e-05
loss O 0 1.9385319319553673e-05
in O 0 1.7629774902161444e-06
sporadic B-Disease 1 0.9999765157699585
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.165265004487992e-07
. O 0 7.154643810736161e-08

Risk O 0 3.358660251251422e-05
reversals O 0 4.144348622503458e-06
in O 0 7.951432401398506e-09
predictive O 0 1.2020801420931093e-07
testing O 0 2.5961040250876977e-07
for O 0 1.7564977952133631e-06
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.038979219942121e-06

The O 0 7.333355256378127e-08
first O 0 5.111513878830465e-09
predictive O 0 1.9865343148239845e-08
testing O 0 8.600356693477806e-08
for O 0 1.7422321434423793e-06
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.533981382148227e-10
HD B-Disease 0 2.0752629552589497e-06
) O 0 1.289348662558698e-11
was O 0 4.4446610281134724e-10
based O 0 9.855698895888665e-11
on O 0 2.9165261872243775e-10
analysis O 0 1.3165610268650596e-10
of O 0 6.383268358334249e-10
linked O 0 1.241996638867704e-08
polymorphic O 0 1.4106176138284354e-07
DNA O 0 3.296543837905119e-08
markers O 0 3.597922626497052e-09
to O 0 2.972301571535496e-11
estimate O 0 2.3107513125175672e-10
the O 0 4.808453635263277e-11
likelihood O 0 9.087330332668841e-10
of O 0 2.4489505978664283e-09
inheriting O 0 1.8531062551119248e-07
the O 0 1.6990787443660338e-08
mutation O 0 8.830438602558388e-09
for O 0 4.0529295475266736e-09
HD B-Disease 0 2.6767083909362555e-05
. O 0 1.6231604149652412e-07

Limits O 0 9.661893045631587e-07
to O 0 2.2057682347309537e-09
accuracy O 0 5.990392537569278e-08
included O 0 9.510049636674012e-09
recombination O 0 7.2667001305148915e-09
between O 0 1.6801096069940513e-09
the O 0 2.9501694420730473e-09
DNA O 0 2.3348625255437128e-09
markers O 0 4.9605937135766e-09
and O 0 7.019021475151987e-11
the O 0 4.653285257116835e-10
mutation O 0 3.382861768486123e-10
, O 0 2.06926593915302e-11
pedigree O 0 1.2711345753757541e-08
structure O 0 2.505003982022913e-09
, O 0 2.0384065269052343e-10
and O 0 1.6678801395553222e-10
whether O 0 9.88223947118172e-11
DNA O 0 3.341422971647745e-10
samples O 0 1.4269727066640314e-10
were O 0 5.5343059995882626e-11
available O 0 8.744531487803187e-11
from O 0 8.536659157343252e-10
family O 0 1.565329532660087e-09
members O 0 6.225691628891639e-10
. O 0 1.7805513508051263e-08

With O 0 5.255595514341849e-09
direct O 0 4.857443336447886e-09
tests O 0 5.876116926373243e-09
for O 0 1.7767068927199148e-09
the O 0 2.066926008126302e-08
HD B-Disease 0 6.117005796113517e-06
mutation O 0 7.003715829512203e-09
, O 0 6.977055738710547e-11
we O 0 2.3783558456003107e-11
have O 0 9.99521472533349e-12
assessed O 0 2.7038424832426244e-09
the O 0 4.2966957769507985e-10
accuracy O 0 4.4503809526474924e-09
of O 0 7.882660635338823e-10
results O 0 1.7607960922649823e-10
obtained O 0 2.4132673290266915e-11
by O 0 1.0602454678099171e-11
linkage O 0 2.767163720385213e-10
approaches O 0 1.670956817356739e-09
when O 0 6.572038052654605e-11
requested O 0 3.441847085117189e-10
to O 0 1.4030125672359617e-10
do O 0 1.1245539915938352e-10
so O 0 3.646785998179247e-11
by O 0 5.576233919057927e-11
the O 0 3.9557207509588466e-10
test O 0 1.732573551294081e-08
individuals O 0 8.137398532781503e-10
. O 0 1.6307376782265237e-08

For O 0 4.3649293957059854e-08
six O 0 2.8297462151272157e-09
such O 0 3.54482332376449e-10
individuals O 0 6.038564787091971e-11
, O 0 2.2721021245009076e-11
there O 0 2.1490833418402744e-11
was O 0 2.1632493574230693e-09
significant O 0 5.3872111216435314e-09
disparity O 0 4.685691123995639e-07
between O 0 7.431338655550235e-09
the O 0 3.048828034479811e-08
tests O 0 1.1963048507368512e-07
. O 0 5.44424345605421e-08

Three O 0 1.770858943928033e-07
went O 0 5.936093927516595e-08
from O 0 4.4251632913550054e-10
a O 0 1.5544276976697802e-10
decreased O 0 5.4320974385291265e-08
risk O 0 3.618237487401643e-09
to O 0 1.2912362151729084e-11
an O 0 6.431409224627593e-13
increased O 0 1.9242712978595478e-10
risk O 0 3.9301656373780247e-10
, O 0 6.797007835041002e-12
while O 0 4.5842087070813164e-11
in O 0 4.116011698140909e-11
another O 0 9.137015449800501e-11
three O 0 5.971140248917095e-11
the O 0 1.0072311873443596e-09
risk O 0 2.486910055665703e-08
was O 0 1.0006865558409572e-08
decreased O 0 5.426929305940575e-07
. O 0 1.6238232092291582e-07

Knowledge O 0 2.3435920866177185e-06
of O 0 1.8235850518522057e-07
the O 0 1.1094987151238911e-08
potential O 0 5.156391758021073e-09
reasons O 0 1.0169959097083847e-08
for O 0 4.698544331382948e-11
these O 0 2.463236212224551e-11
changes O 0 2.0088183894095835e-10
in O 0 2.248851799224738e-10
results O 0 2.0534234312918898e-09
and O 0 1.43057538037894e-10
impact O 0 9.518488219839583e-09
of O 0 3.655125091484024e-09
these O 0 8.063592016327448e-10
risk O 0 5.658448376522074e-09
reversals O 0 8.847436561154609e-08
on O 0 3.087980715577032e-08
both O 0 1.131631344186701e-09
patients O 0 6.098902360918146e-08
and O 0 4.1318004573298595e-10
the O 0 1.0545857520583013e-08
counseling O 0 1.0713258724592833e-08
team O 0 6.158722143378981e-11
can O 0 4.915181543024838e-12
assist O 0 1.541610450406239e-10
in O 0 9.899426417492307e-11
the O 0 5.307745354343751e-10
development O 0 1.1185946613423425e-09
of O 0 5.465942143345615e-10
strategies O 0 1.8240480237352585e-09
for O 0 1.8256472722466555e-11
the O 0 1.6075067665877185e-10
prevention O 0 1.3164890289019127e-09
and O 0 6.620991081784933e-12
, O 0 4.660881598207711e-13
where O 0 1.233412894388608e-12
necessary O 0 1.0508118680752077e-10
, O 0 1.4369437063843638e-11
management O 0 7.602719009902614e-10
of O 0 1.0092197078037657e-09
a O 0 5.673531644490026e-10
risk O 0 1.6204253938667534e-08
reversal O 0 1.3646650032228536e-08
in O 0 3.9790118422367016e-10
any O 0 2.5527924218948783e-10
predictive O 0 8.481692681527875e-09
testing O 0 6.804467034271511e-08
program O 0 2.0585368964987083e-09
. O 0 3.901864942257305e-10
. O 0 7.144004499082257e-09

A O 0 1.185831365546619e-06
novel O 0 5.67168683573982e-07
common O 0 1.1864926108273721e-07
missense O 0 2.087195298372535e-06
mutation O 0 1.8813437918652198e-08
G301C O 0 1.6965957172487833e-07
in O 0 6.620062831252937e-10
the O 0 7.444429517278195e-10
N O 0 2.5579906193229363e-08
- O 0 2.9645040200421136e-08
acetylgalactosamine O 0 6.491359272331465e-06
- O 0 3.176774896473944e-07
6 O 0 6.600614455010145e-08
- O 0 2.194062531657437e-08
sulfate O 0 3.0010170348759857e-07
sulfatase O 0 1.838085700001102e-05
gene O 0 5.3702660096632826e-08
in O 0 6.85499728092509e-08
mucopolysaccharidosis B-Disease 1 0.9866372346878052
IVA I-Disease 1 0.9999998807907104
. O 0 1.4041287613508757e-05

Mucopolysaccharidosis B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
( O 0 0.00018807822198141366
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.821798320151174e-09
is O 0 3.1042468595643413e-10
an O 0 3.9910061366832394e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 7.24176861695014e-05
by O 0 1.8239445509493635e-08
a O 0 2.527365552396077e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 8.86365185692739e-08
N O 0 8.238401250082461e-08
- O 0 4.414629728444197e-08
acetylgalactosamine O 0 9.02604642760707e-06
- O 0 2.46515355684096e-07
6 O 0 7.172775440267287e-08
- O 0 4.4311139646424635e-08
sulfate O 0 1.4394128129424644e-06
sulfatase O 0 0.00033676877501420677
( O 0 1.4128209713248907e-08
GALNS O 1 0.9977114200592041
) O 0 1.2191085474455576e-08
. O 0 1.2781831060237892e-07

In O 0 1.5030947508876125e-07
previous O 0 6.990946133100806e-08
studies O 0 1.591021359104161e-08
, O 0 9.988130461602296e-11
we O 0 6.018499587590043e-11
have O 0 3.2546920020193326e-11
found O 0 5.3446701925308204e-11
two O 0 1.6257909948858007e-11
common O 0 3.188245445429061e-09
mutations O 0 3.282826011030693e-09
in O 0 2.621003858394033e-09
Caucasians O 0 7.334991778407129e-07
and O 0 1.2180875197387309e-09
Japanese O 0 6.011906066305528e-07
, O 0 3.943952942009332e-10
respectively O 0 3.060451447822743e-08
. O 0 6.247488926192091e-08

To O 0 7.566804782754843e-08
characterize O 0 4.3712449837585154e-07
the O 0 1.7803128571358684e-07
mutational O 0 0.00011783601803472266
spectrum O 0 1.2692949894699268e-05
in O 0 1.015826422978705e-09
various O 0 3.437123641258921e-10
ethnic O 0 1.4203253850819664e-10
groups O 0 7.192283661000554e-12
, O 0 5.239053982308839e-12
mutations O 0 5.246215961651757e-11
in O 0 2.2624553619454701e-10
the O 0 1.7034594179676787e-08
GALNS O 1 0.9999891519546509
gene O 0 4.935840891562293e-08
in O 0 4.3320351750253394e-08
Colombian O 0 3.5699088130058954e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.9962778687477112
were O 0 1.0329225474947634e-08
investigated O 0 1.0002495720584648e-08
, O 0 1.9437147724676862e-10
and O 0 5.786359169590582e-10
genetic O 0 2.809397869896202e-08
backgrounds O 0 3.880990107063553e-08
were O 0 4.162977518262778e-09
extensively O 0 2.107558572106427e-09
analyzed O 0 4.319113067197122e-09
to O 0 2.7890054155044197e-10
identify O 0 2.0144441670311153e-09
racial O 0 1.1964133017627887e-09
origin O 0 1.356158629839399e-09
, O 0 2.5659030455926768e-11
based O 0 6.446878447752269e-11
on O 0 2.685041911032471e-10
mitochondrial O 0 1.8472395835189559e-09
DNA O 0 1.946390604246062e-09
( O 0 2.6534146407852788e-11
mtDNA O 0 6.04152838867833e-10
) O 0 1.0110957210374139e-10
lineages O 0 1.7747670000289872e-08
. O 0 1.8486611352841464e-08

Three O 0 1.0078352943310165e-06
novel O 0 8.62804245116422e-06
missense O 0 5.571900328504853e-05
mutations O 0 1.3369871965096536e-07
never O 0 1.1030187430094429e-08
identified O 0 9.610003903759434e-10
previously O 0 3.4897544853862428e-09
in O 0 3.3206723482059886e-10
other O 0 2.624599426681584e-10
populations O 0 6.584824352451335e-11
and O 0 2.784714299430835e-11
found O 0 8.75606392947148e-11
in O 0 4.0434844361669775e-10
16 O 0 7.233511567505957e-09
out O 0 2.0134981182362566e-10
of O 0 2.4509458906862847e-09
19 O 0 2.6225153604286788e-08
Colombian O 0 1.327096441627873e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 2.3654424694541376e-06
alleles O 0 8.660715700159471e-09
account O 0 6.233366600660872e-10
for O 0 3.845337936958515e-10
84 O 0 4.092924257292907e-07
. O 0 9.893342678424233e-08

2 O 0 1.9668618733703624e-07
% O 0 1.2866574472525372e-09
of O 0 5.276142855947796e-10
the O 0 1.2594437714952278e-09
alleles O 0 3.2166542762723793e-09
in O 0 3.165973871954719e-10
this O 0 2.390531939067131e-10
study O 0 1.85045567757669e-09
. O 0 4.610721582309907e-09

The O 0 5.944568783888826e-07
G301C O 0 1.9017126760445535e-05
and O 0 5.5456418124322227e-08
S162F O 0 7.46880823498941e-06
mutations O 0 2.934703502432967e-08
account O 0 3.6120111346349404e-09
for O 0 2.511304275643056e-09
68 O 0 1.038816094478534e-06
. O 0 1.8339744656259427e-07

4 O 0 6.837466571596451e-06
% O 0 8.305803333996664e-08
and O 0 7.55702256327595e-09
10 O 0 2.2051382941867814e-08
. O 0 5.133480485142172e-08

5 O 0 4.272979197139648e-07
% O 0 5.066167041434255e-09
of O 0 2.9264852763333238e-09
mutations O 0 6.521706508166858e-10
, O 0 5.501186312040218e-11
respectively O 0 2.8802902285463006e-09
, O 0 6.509424249623308e-11
whereas O 0 2.8568674093065738e-09
the O 0 9.472683970557227e-09
remaining O 0 4.089216417924035e-06
F69V O 1 0.9999059438705444
is O 0 4.079887816477168e-10
limited O 0 2.9861507711004265e-10
to O 0 3.0694731478764226e-11
a O 0 1.2364669010889173e-10
single O 0 3.365640877106557e-09
allele O 0 8.52319672617341e-08
. O 0 3.438871587491121e-08

The O 0 2.0676917245054938e-07
skewed O 0 3.736478788596287e-07
prevalence O 0 7.216880959504124e-08
of O 0 3.274158943966654e-09
G301C O 0 9.039915767061757e-07
in O 0 1.4982874940727697e-09
only O 0 4.4254758191364374e-10
Colombian O 0 7.032670445994427e-09
patients O 0 9.425213498559515e-09
and O 0 5.943630310145664e-11
haplotype O 0 6.642602023987365e-10
analysis O 0 3.730633510445891e-11
by O 0 2.6584552267894246e-11
restriction O 0 4.245052309670427e-09
fragment O 0 3.686801086644209e-09
length O 0 9.071259854387392e-10
polymorphisms O 0 3.42452866064491e-09
in O 0 5.862947904944349e-10
the O 0 4.941885567433246e-09
GALNS O 0 0.0004086517437826842
gene O 0 5.243590450731972e-09
suggest O 0 8.40357339271236e-10
that O 0 1.4881866572391544e-11
G301C O 0 1.2091764745036926e-07
originated O 0 8.114153793314927e-09
from O 0 2.8015931241576197e-10
a O 0 1.594556015005466e-10
common O 0 2.2867137516868752e-08
ancestor O 0 1.3241007081887801e-06
. O 0 1.534662601443415e-07

Investigation O 0 7.826112664588436e-07
of O 0 2.797031584123033e-07
the O 0 2.5027366845620236e-08
genetic O 0 8.71373817545873e-09
background O 0 8.913300098001287e-10
by O 0 3.219597505266236e-11
means O 0 1.100104007889513e-09
of O 0 4.148662302583261e-09
mtDNA O 0 9.114601295934222e-10
lineages O 0 3.236542978068968e-10
indicate O 0 3.594098282877489e-11
that O 0 2.0507352326698536e-12
all O 0 6.404399233161939e-11
our O 0 9.923269983502792e-10
patients O 0 1.8221320008393604e-09
are O 0 4.500197957335583e-12
probably O 0 4.3089243284555323e-10
of O 0 8.115775829153904e-10
native O 0 4.2517456222412875e-09
American O 0 1.3854549507641423e-08
descent O 0 5.682157393493981e-07

Low O 0 1.4579059097741265e-06
frequency O 0 3.3424843337570564e-08
of O 0 6.181455347586962e-08
BRCA1 O 0 2.5012964215420652e-06
germline O 0 1.7742173668011674e-06
mutations O 0 8.36634583833984e-09
in O 0 3.285442751188583e-10
45 O 0 1.1644890385298368e-08
German O 1 0.9998887777328491
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.2663788235586253e-07
. O 0 6.773596084030942e-08

In O 0 1.9264472683744316e-08
this O 0 3.493035860557825e-10
study O 0 2.517974717619609e-10
we O 0 7.803517380888803e-12
investigated O 0 6.605747060461908e-10
45 O 0 9.035795223155674e-09
German O 1 0.9998044371604919
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.822713339791562e-09
for O 0 7.589664452467559e-10
germline O 0 1.4777522494568984e-07
mutations O 0 1.275009209322775e-09
in O 0 7.001228485847832e-10
the O 0 2.9460942130299372e-08
BRCA1 O 0 2.510736294425442e-07
gene O 0 8.699323927885416e-09
. O 0 3.952436244958335e-08

We O 0 1.1857437698381545e-07
identified O 0 8.638119197712513e-08
four O 0 1.5044394174879017e-08
germline O 0 3.9183692024380434e-06
mutations O 0 1.7745401592605958e-08
in O 0 5.033284899980117e-09
three O 0 1.07617550426653e-08
breast B-Disease 1 0.9808458685874939
cancer I-Disease 1 0.7633932828903198
families O 0 3.5084686267339293e-09
and O 0 4.749411530724501e-09
in O 0 1.9789071359355148e-07
one O 0 0.0012505274498835206
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.6032735078729274e-08
. O 0 4.522926130845484e-11
among O 0 1.6925166129722058e-11
these O 0 3.30000978800149e-12
were O 0 6.290898357796948e-11
one O 0 4.8037417793578285e-11
frameshift O 0 7.166974125283332e-09
mutation O 0 1.9519140470602991e-10
, O 0 1.03300571221987e-11
one O 0 4.765631639314094e-11
nonsense O 0 1.4181018137549017e-08
mutation O 0 1.0674253703157888e-09
, O 0 1.8775125551484528e-11
one O 0 3.399580270069258e-11
novel O 0 5.010564851914978e-09
splice O 0 1.214271492244734e-07
site O 0 1.3727421865894485e-08
mutation O 0 1.104386582184702e-09
, O 0 2.9958705655142026e-11
and O 0 1.620290707160521e-10
one O 0 2.3398958326481534e-09
missense O 0 7.97699158283649e-06
mutation O 0 7.297746265066962e-07
. O 0 3.5901032902074803e-07

The O 0 9.598477390682092e-07
missense O 0 2.9742293918388896e-05
mutation O 0 2.3936559045978356e-07
was O 0 4.689866628382333e-08
also O 0 2.28004365387946e-10
found O 0 3.7865952040583295e-10
in O 0 8.666958262182334e-10
2 O 0 1.1755472684171764e-07
. O 0 5.8897978050254096e-08

8 O 0 1.2480050770591333e-07
% O 0 8.145146779270362e-10
of O 0 2.7773530697494664e-10
the O 0 1.1099907104572537e-10
general O 0 1.2161125440002252e-08
population O 0 8.786864291732144e-11
, O 0 1.2584843757379449e-11
suggesting O 0 1.440506325334212e-10
that O 0 3.0060801937958903e-12
it O 0 2.7801925692183538e-11
is O 0 4.5297467166083294e-11
not O 0 5.37359046148822e-10
disease O 0 2.1736860844612238e-07
associated O 0 3.0266258477240626e-07
. O 0 6.82732036239031e-07

The O 0 5.640348277324847e-08
average O 0 2.40052226985199e-08
age O 0 2.2805721755503328e-08
of O 0 4.686099952522227e-09
disease O 0 4.2599225480444147e-07
onset O 0 0.0007066206308081746
in O 0 9.774758780167758e-09
those O 0 1.2995466924792254e-09
families O 0 2.359654693862012e-10
harbouring O 0 3.903967993323931e-08
causative O 0 1.8655005362688826e-07
mutations O 0 3.161885686608912e-08
was O 0 3.304299411865941e-08
between O 0 1.8700422543815876e-08
32 O 0 4.93089089559362e-07
. O 0 1.0898963154204466e-07

3 O 0 1.2256772606633604e-05
and O 0 1.720065512245128e-07
37 O 0 2.5388767426193226e-06
. O 0 2.5727169372657954e-07

4 O 0 7.756875675113406e-07
years O 0 1.2426554008015955e-08
, O 0 2.3154984873929862e-10
whereas O 0 5.582847961704829e-09
the O 0 3.5564056144465894e-09
family O 0 1.1146226164271411e-09
harbouring O 0 5.6568648432175905e-08
the O 0 1.4495895150901106e-08
missense O 0 7.743807941551495e-07
mutation O 0 8.643289639564955e-09
had O 0 7.890272324395653e-10
an O 0 5.123590354066954e-12
average O 0 4.0246564414481156e-10
age O 0 9.584139037954742e-10
of O 0 5.003075176368554e-10
onset O 0 1.3855990800948348e-05
of O 0 7.173347967182053e-06
51 O 0 4.861802153754979e-06
. O 0 2.8852247169197653e-07

2 O 0 1.0282676157657988e-05
years O 0 2.8971248866582755e-07
. O 0 4.4347328298499633e-07

These O 0 1.362826509421211e-07
findings O 0 1.0159783414565027e-07
show O 0 6.090855819707031e-09
that O 0 2.2889062867292864e-10
BRCA1 O 0 9.473012596572516e-08
is O 0 1.1998176063787724e-10
implicated O 0 1.0251203219624472e-09
in O 0 1.6886965437112877e-10
a O 0 3.547113991420048e-11
small O 0 4.3361952917209123e-11
fraction O 0 3.059802189397942e-09
of O 0 9.093854714592453e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.974167661624506e-09
suggesting O 0 8.858466737926562e-11
the O 0 2.553867360644002e-11
involvement O 0 2.927392356300018e-11
of O 0 2.0191361083110593e-10
another O 0 5.079420217768416e-10
susceptibility O 0 6.501257132640603e-08
gene O 0 6.504355276604201e-09
( O 0 9.094821007415987e-10
s O 0 6.499050186903332e-07
) O 0 3.9025906062306603e-08

Paternal O 0 0.0024059901479631662
transmission O 0 0.00019821104069706053
of O 0 0.015372528694570065
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.15665288269519806

We O 0 8.283242891593545e-08
report O 0 8.410724894325483e-10
a O 0 1.5334197800420668e-10
rare O 0 1.8728969486403457e-09
case O 0 3.325713260338148e-09
of O 0 2.2195175120032218e-07
paternally O 1 1.0
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.679862518562004e-06
DM B-Disease 1 1.0
) O 0 2.3611880450857825e-08
. O 0 6.769824523189527e-08

The O 0 5.009821961721173e-07
proband O 0 2.9400785933830775e-05
is O 0 4.6049536406300717e-10
a O 0 8.065710599414189e-11
23 O 0 1.6117904788615078e-09
year O 0 1.3489044325964983e-09
old O 0 1.914270342240343e-06
, O 0 6.508925309844926e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.020590316504240036
who O 0 1.5313642620640167e-07
suffers O 1 0.8236942291259766
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.999998927116394

He O 0 3.3633707374747246e-08
presented O 0 1.3215822036727332e-07
with O 0 5.632669441979488e-09
respiratory O 1 1.0
and O 0 1.105934416045784e-06
feeding O 0 4.4717860873788595e-05
difficulties O 0 5.712350343856087e-07
at O 0 2.0520860743999947e-07
birth O 0 5.334210982255172e-06
. O 0 1.1735063765172526e-07

His O 0 6.568165190401487e-06
two O 0 6.793948728045507e-07
sibs O 1 0.9999998807907104
suffer O 0 1.2753518603858538e-05
from O 0 2.9843437232557335e-07
childhood O 0 6.438072887249291e-05
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
. O 0 0.0005139040877111256

Their O 0 7.91358019114341e-08
late O 0 1.4400525287783239e-05
father O 0 2.0781413923032233e-07
had O 0 6.635080818107042e-10
the O 0 6.245180761421665e-11
adult O 0 2.548461268403468e-11
type O 0 9.985159227232643e-11
of O 0 3.5937661735374604e-09
DM B-Disease 1 1.0
, O 0 4.2602370520228305e-09
with O 0 6.564884746929067e-11
onset O 0 7.175446808105335e-05
around O 0 9.145620261108434e-09
30 O 0 6.879500968892671e-09
years O 0 5.296785676733862e-09
. O 0 2.893865591602207e-08

Only O 0 4.78242085932834e-08
six O 0 7.814039970632791e-10
other O 0 1.1933490653981416e-11
cases O 0 2.4907988865896513e-11
of O 0 5.146053028148856e-10
paternal O 0 4.076343884662492e-06
transmission O 0 1.169475399365183e-05
of O 1 0.9868530035018921
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0075819906778633595
been O 0 2.629803574905054e-08
reported O 0 1.1022001089600053e-09
recently O 0 4.467603176294688e-09
. O 0 1.577803132590816e-08

We O 0 4.422965460548767e-08
review O 0 4.3564373441995485e-08
the O 0 6.617844494627434e-09
sex O 0 1.1108787223435002e-09
related O 0 3.4672362758669806e-09
effects O 0 3.365276768363401e-08
on O 0 3.295003736525359e-08
transmission O 0 7.449733061548613e-07
of O 0 5.2448112910497e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9973568916320801

Decreased O 0 1.1106769306934439e-05
fertility O 0 1.2429183016138268e-06
of O 0 2.8727078493773206e-09
males O 0 7.080402930625951e-11
with O 0 2.1885579286340384e-12
adult O 0 3.2656191639723886e-10
onset O 0 2.639739932419616e-06
DM B-Disease 1 1.0
and O 0 2.513270302983983e-08
contraction O 0 5.513534517831431e-09
of O 0 1.5645953421739023e-09
the O 0 1.7860735113117698e-10
repeat O 0 1.8459567208140015e-10
upon O 0 5.411285863843318e-10
male O 0 9.636044046024139e-11
transmission O 0 2.0330237493482173e-11
contribute O 0 3.697915671591057e-12
to O 0 6.787266061680786e-12
the O 0 3.347329913250263e-10
almost O 0 2.202899807013381e-10
absent O 0 1.0522464011231136e-09
occurrence O 0 1.5943613096425224e-10
of O 0 5.759536736427151e-10
paternal O 0 2.2368720919985208e-07
transmission O 0 3.7172046063460584e-07
of O 0 2.3131783564167563e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.2726602554321289

Also O 0 4.245281814974078e-08
the O 0 1.296541718431854e-08
fathers O 0 4.531965558385309e-08
of O 0 1.2258323245362135e-09
the O 0 2.2831649904020423e-09
reported O 0 7.1281069935480446e-09
congenitally O 0 0.289338082075119
affected O 0 5.775669364993519e-07
children O 0 4.441274015221097e-09
showed O 0 2.2951184008856984e-10
, O 0 6.820865053325242e-12
on O 0 6.404940466886444e-10
average O 0 5.027202210072801e-09
, O 0 2.0391531518892947e-10
shorter O 0 7.785355933265237e-07
CTG O 0 0.00013324507744982839
repeat O 0 1.2557772777199716e-07
lengths O 0 1.2063700296494062e-06
and O 0 2.731510573283913e-10
hence O 0 3.2023177443107897e-09
less O 0 2.8626763182160175e-09
severe O 0 1.1121284160253708e-07
clinical O 0 7.530270522693172e-07
symptoms O 0 1.3898676343160332e-07
than O 0 3.274806814612674e-10
the O 0 6.876299973868072e-09
mothers O 0 1.7844807853606426e-09
of O 0 2.2203976157708638e-10
children O 0 3.061954578775783e-10
with O 0 4.368040096291992e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8292460441589355

We O 0 4.543893084019146e-08
conclude O 0 4.111137741347193e-08
that O 0 4.0901233788748215e-11
paternal O 0 1.4143895441520726e-06
transmission O 0 1.7775774949768675e-06
of O 0 5.828537177876569e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.0130446526090964e-06
rare O 0 1.1401789734577505e-08
and O 0 2.346400504449342e-11
preferentially O 0 5.754262691337608e-11
occurs O 0 7.892040319867899e-12
with O 0 3.5067752196006607e-13
onset O 0 1.1999973459353441e-08
of O 0 1.7137681140866334e-07
DM B-Disease 1 1.0
past O 0 3.5262155506643467e-07
30 O 0 2.008144983633997e-09
years O 0 3.5281270960307864e-11
in O 0 1.9971878317814884e-11
the O 0 2.500725460041764e-10
father O 0 4.243303930451248e-09
. O 0 8.078678281897567e-10
. O 0 1.438297747569095e-08

The O 0 4.034578068967676e-06
RB1 O 0 0.0005132667138241231
gene O 0 5.0029846931920474e-08
mutation O 0 2.219836581218715e-08
in O 0 1.3891613415140114e-09
a O 0 3.5797622643940485e-09
child O 0 1.3574796753346163e-07
with O 0 2.0469993700089617e-08
ectopic B-Disease 1 0.9782190322875977
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.001064219744876027

The O 0 6.303124791884329e-06
RB1 O 0 0.00047878874465823174
gene O 0 8.810875584686073e-08
mutation O 0 1.8144509894568728e-08
was O 0 7.29472349192406e-09
investigated O 0 1.762417234374425e-08
in O 0 1.1529239785090795e-08
a O 0 3.765855538517826e-08
child O 0 5.895743697692524e-07
with O 0 1.6013451897833875e-08
ectopic B-Disease 0 0.0010599904926493764
intracranial I-Disease 1 0.9999992847442627
retinoblastoma I-Disease 0 0.0024961812887340784
using O 0 1.2305510388443963e-08
DNA O 0 4.224262273311297e-09
obtained O 0 3.636126399975126e-10
from O 0 3.598250031267014e-10
both O 0 3.673154558292424e-10
the O 0 1.4096286804488045e-08
pineal B-Disease 0 0.0009363760473206639
and I-Disease 0 8.925318439878538e-08
retinal I-Disease 1 0.9991613626480103
tumours I-Disease 1 1.0
of O 0 0.00017026190471369773
the O 0 4.712454483524198e-06
patient O 0 1.98572324734414e-05
. O 0 5.848535167274349e-08

A O 0 2.2375811568053905e-06
nonsense O 0 2.053653361144825e-06
mutation O 0 4.6601289938053014e-08
in O 0 3.6928606839126132e-09
exon O 0 2.1723472798385046e-07
17 O 0 9.902476172385377e-09
( O 0 6.351046771824187e-11
codon O 0 7.68562458119959e-09
556 O 0 2.8053497302948927e-08
) O 0 2.624738447420949e-11
of O 0 1.3250212038684595e-09
the O 0 2.9542027490947476e-08
RB1 O 0 7.077337795635685e-05
gene O 0 9.85958159560596e-09
was O 0 2.1183323539730736e-08
found O 0 1.2217515887869013e-10
to O 0 1.0993101394463078e-11
be O 0 3.0218161306549973e-11
present O 0 1.7701716759077613e-09
homozygously O 0 0.01572595350444317
in O 0 2.9779236854210467e-08
both O 0 1.3174836777096743e-09
the O 0 5.2867927813338156e-09
retinal B-Disease 0 3.6859637475572526e-06
and I-Disease 0 7.499046716930025e-08
the I-Disease 0 5.515849989023991e-05
pineal I-Disease 1 0.9999997615814209
tumours I-Disease 1 1.0
. O 0 1.6792871974757873e-05

The O 0 3.194912778781145e-08
same O 0 8.254043004640721e-10
mutation O 0 5.528654201114591e-10
was O 0 4.818022092401009e-10
present O 0 3.9896208559042634e-10
heterozygously O 0 2.4131802547344705e-06
in O 0 1.8171272264666527e-09
the O 0 3.5887640081888605e-10
DNA O 0 2.212513089405732e-10
from O 0 2.22509372038715e-11
the O 0 9.103216791483959e-11
constitutional O 0 5.854402740368414e-09
cells O 0 1.1523248327760527e-10
of O 0 2.0493375052499374e-10
the O 0 5.426965543620099e-10
patient O 0 4.0070126772207004e-08
, O 0 5.001183495112471e-11
proving O 0 1.983221586954187e-08
it O 0 1.0217461425543473e-11
to O 0 2.2187073359103415e-11
be O 0 1.596287407812369e-10
of O 0 2.513217545185853e-08
germline O 0 1.0098210623255e-06
origin O 0 8.15516543184458e-08
. O 0 5.399311220344316e-08

The O 0 1.6151740567238448e-07
initial O 0 2.7585619477576984e-07
mutation O 0 2.8252392425542894e-08
was O 0 6.557632659109913e-09
shown O 0 2.9419303104738503e-10
to O 0 6.311522138258141e-11
have O 0 5.24484518316104e-11
occurred O 0 8.271619833521981e-09
in O 0 3.7604255820333776e-10
the O 0 3.4138527560401144e-09
paternally O 0 1.3612020666187163e-06
derived O 0 1.2302128880037344e-06
RB1 O 0 0.00027263088850304484
allele O 0 1.4240669088394498e-06
. O 0 1.636914817026991e-07

The O 0 1.4368080769600056e-07
mutation O 0 6.411005948336879e-09
is O 0 5.178138126615828e-11
in O 0 2.2177509828580355e-11
an O 0 9.818501263761381e-13
area O 0 5.873357356023234e-10
of O 0 9.272077550193103e-10
the O 0 3.087661459844071e-09
gene O 0 1.6502198219026099e-10
that O 0 1.3705320732471105e-11
encodes O 0 2.3367134616147922e-11
the O 0 7.036164706430981e-11
protein O 0 5.39847923308745e-11
- O 0 4.4251632913550054e-10
binding O 0 3.0300666420401967e-09
region O 0 2.3142513683183097e-08
known O 0 3.314409857679834e-09
as O 0 9.95133975223439e-10
the O 0 1.700414387073579e-08
pocket O 0 9.848406625678763e-05
region O 0 3.842335871695468e-08
and O 0 1.8977266424968775e-09
has O 0 6.250007456021223e-11
been O 0 5.3153106915893034e-11
detected O 0 1.4233526579587874e-09
in O 0 1.1664841315095487e-10
other O 0 7.892705933265631e-11
cases O 0 1.872096921928801e-09
of O 0 9.34651893658156e-08
retinoblastoma B-Disease 0 0.0011672843247652054
. O 0 1.5024096455817926e-07
. O 0 1.7133531571289495e-07

Low O 0 3.325498028061702e-06
levels O 0 3.575806317712704e-08
of O 0 3.6632630262545263e-09
beta O 0 2.5936238046142535e-08
hexosaminidase O 0 5.24009146829485e-06
A O 0 4.124615671230458e-08
in O 0 2.45131537290888e-09
healthy O 0 5.416369130983867e-09
individuals O 0 7.290080865363091e-12
with O 0 5.0326461747962625e-11
apparent O 0 0.07387857139110565
deficiency O 1 0.9999998807907104
of O 0 0.062374360859394073
this O 0 1.5318960322474595e-07
enzyme O 0 8.413683190156007e-07
. O 0 2.0991436144868203e-07

Appreciable O 0 1.0015679436037317e-05
beta O 0 1.0098864322571899e-06
hexosaminidase O 0 7.208338502096012e-05
A O 0 1.9351882656337693e-06
( O 0 6.514598194229393e-09
hex O 0 3.284542572146165e-06
A O 0 7.435240689801503e-08
) O 0 5.158442076269587e-11
activity O 0 5.235222810817675e-10
has O 0 1.529679855005739e-11
been O 0 9.712899234903816e-11
detected O 0 2.9067106055435943e-08
in O 0 2.250544639537111e-08
cultured O 0 0.00030663571669720113
skin O 0 3.0998631700640544e-05
fibroblasts O 0 3.0920530207367847e-06
and O 0 5.9305826027866715e-08
melanoma B-Disease 0 0.0004709287895821035
tissue O 0 1.3806280207973032e-07
from O 0 1.051358200498953e-08
healthy O 0 8.617988989101377e-09
individuals O 0 4.7993618627895085e-12
previously O 0 9.302292963697667e-11
reported O 0 2.6795765259435278e-11
as O 0 9.572848069794304e-10
having O 0 1.216402978343467e-07
deficiency B-Disease 0 0.003127254080027342
of I-Disease 0 4.730952059617266e-05
hex I-Disease 0 5.4432016440841835e-06
A I-Disease 0 7.957500436361897e-09
activity O 0 2.070727755931756e-10
indistinguishable O 0 1.4229828426692848e-10
from O 0 1.0677781358756078e-12
that O 0 2.2375772906085313e-14
of O 0 1.1805353569704913e-11
patients O 0 1.4551733151790813e-09
with O 0 1.1011248801651163e-08
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.6725674118210918e-08
TSD B-Disease 1 0.9762930870056152
) O 0 6.947317388039664e-09
. O 0 1.3996694292472966e-07

Identification O 0 4.577867684929515e-07
and O 0 7.867253515314587e-09
quantitation O 0 0.00036571305827237666
of O 0 7.72098355810158e-05
hex O 0 0.007489989977329969
A O 0 9.333725188298558e-07
, O 0 2.7097990518143433e-10
amounting O 0 2.7996287510489992e-09
to O 0 5.30090638051206e-10
3 O 0 5.056400098624181e-08
. O 0 1.943464589260202e-08

5 O 0 3.1517033676209394e-06
% O 0 1.655483714557704e-07
- O 0 8.118861387629295e-07
6 O 0 7.078130010995665e-07
. O 0 1.170742010003778e-07

9 O 0 4.204057404422201e-07
% O 0 1.460378484807734e-09
of O 0 1.058738874348819e-09
total O 0 3.8417605208174166e-10
beta O 0 7.590132078405532e-09
hexosaminidase O 0 1.1643967354757478e-06
activity O 0 1.7590153333912895e-08
, O 0 1.2453828246439258e-10
has O 0 4.871780496379374e-12
been O 0 1.169830118191717e-11
obtained O 0 1.2306765329039848e-10
by O 0 9.625173991167912e-10
cellulose O 0 7.29109297026298e-06
acetate O 0 9.221545269610942e-07
gel O 0 7.382573130598757e-07
electrophoresis O 0 5.526835522573492e-08
, O 0 2.1720432119565203e-09
DEAE O 0 0.00012397128739394248
- O 0 1.844463355382686e-07
cellulose O 0 1.0490506383575848e-06
ion O 0 3.1746731110615656e-07
- O 0 1.1590041282261154e-07
exchange O 0 1.8557589953616116e-07
chromatography O 0 4.736911591862736e-07
, O 0 6.515539219265065e-10
radial O 0 1.1191206539251652e-07
immunodiffusion O 0 2.963371662190184e-05
, O 0 3.793240388461072e-09
and O 0 7.49645501230134e-09
radioimmunoassay O 0 0.0002874780329875648
. O 0 2.4601467885077e-06

Previous O 0 9.213725570589304e-05
family O 0 6.57934720038611e-08
studies O 0 3.960418215598338e-09
suggested O 0 9.131114198090984e-10
that O 0 3.842401657266903e-12
these O 0 6.018373299720992e-11
individuals O 0 8.833912767958196e-12
may O 0 2.197117349167499e-10
be O 0 1.4467374520599208e-10
compound O 0 3.073080279136775e-08
heterozygotes O 0 5.190090845985651e-08
for O 0 1.6833935634341657e-10
the O 0 1.626270229593274e-09
common O 0 3.760716538181441e-08
mutant O 0 4.887081672677596e-07
TSD B-Disease 0 2.4188750103348866e-05
gene O 0 2.4885504767979683e-09
and O 0 7.16088646712798e-11
a O 0 6.657528001108304e-11
rare O 0 7.959914505306642e-09
( O 0 9.764877795248594e-10
allelic O 0 1.864854539235239e-06
) O 0 1.4181308349847654e-09
mutant O 0 1.5378593332115997e-07
gene O 0 3.1449065573951884e-08
. O 0 4.3114113168485346e-08

Thus O 0 2.933988128006604e-07
, O 0 1.9569923459528127e-09
the O 0 4.166337497224504e-09
postulated O 0 4.4690037270811445e-07
rate O 0 2.9702713177925943e-08
mutant O 0 1.565760499033786e-08
gene O 0 5.199954355994407e-10
appears O 0 7.895104014998822e-10
to O 0 1.0356058025018378e-11
code O 0 5.365486527297847e-11
for O 0 5.445294215533636e-11
the O 0 1.1511868541758119e-10
expression O 0 8.32908048087333e-11
of O 0 9.163596270678198e-11
low O 0 1.263244842064637e-09
amounts O 0 6.495586291066502e-10
of O 0 5.4322191189726254e-09
hex O 0 1.0540614312049001e-05
A O 0 1.8663525906958967e-06
. O 0 3.506925452256837e-07

Heterozygotes O 0 0.00043596827890723944
for O 0 1.0130197836133448e-07
the O 0 9.531244415939e-08
rare O 0 1.221816319230129e-07
mutant O 0 4.477740489505777e-08
may O 0 7.671882018556175e-10
be O 0 7.302818766374841e-11
indistinguishable O 0 5.1879300855262045e-09
from O 0 1.6405757308213254e-10
heterozygotes O 0 3.678472282331313e-08
for O 0 3.2629857149579777e-10
the O 0 1.0170229991501856e-08
common O 0 1.680833747741417e-06
TSD B-Disease 1 0.9368160963058472
mutant O 0 1.0649140676832758e-05
. O 0 2.515961909921316e-07

However O 0 1.5005655029654008e-07
, O 0 4.810584153247532e-10
direct O 0 5.104136002742621e-10
visualization O 0 1.307212187384721e-07
and O 0 2.8883553326863876e-09
quantitation O 1 0.5724118947982788
of O 0 0.19179026782512665
hex O 0 6.547987140947953e-05
A O 0 1.2228579038264797e-08
by O 0 4.771616435306214e-11
the O 0 4.2524879451111275e-11
methods O 0 1.524060655455628e-09
described O 0 4.201079484289494e-10
may O 0 1.4207074405803155e-10
prevent O 0 2.725182857155062e-10
false O 0 2.5840332096294105e-09
- O 0 2.484538352831578e-09
positive O 0 3.958278982363339e-10
prenatal O 0 6.079367409483893e-08
diagnosis O 0 8.875696977383996e-08
of O 0 2.1705616859435395e-08
TSD B-Disease 1 0.9036023020744324
in O 0 6.11938730799011e-08
fetuses O 0 5.088986299028875e-08
having O 0 2.212297844916833e-10
the O 0 2.45238163110173e-09
incomplete O 0 2.1858939362573437e-05
hex B-Disease 0 0.0003884073521476239
A I-Disease 0 2.011448259509052e-06
deficiency I-Disease 0 1.4630886653321795e-06
of O 0 2.555381861668593e-08
the O 0 6.555603837554713e-10
type O 0 6.3638334601989754e-09
described O 0 1.5051934143528456e-09
in O 0 4.128357655730497e-10
the O 0 9.33053900809e-09
four O 0 8.682317087504998e-09
healthy O 0 1.9427980646469223e-07
individuals O 0 7.3743655626401505e-09

The O 0 8.625146620033775e-06
tumor B-Disease 0 7.224394357763231e-05
suppressor O 0 3.165477028232999e-05
gene O 0 1.401626406050127e-07
Smad4 O 0 0.00019848528609145433
/ O 0 1.8267824088979978e-06
Dpc4 O 0 4.966018605045974e-05
is O 0 1.682786826551208e-10
required O 0 2.4997762193557094e-10
for O 0 2.3322174746986946e-10
gastrulation O 0 3.4266718103026506e-06
and O 0 7.326945716812361e-10
later O 0 8.638791015869174e-09
for O 0 6.071841363031183e-10
anterior O 0 8.136192164442946e-09
development O 0 1.336739341439852e-08
of O 0 3.1540551503894676e-08
the O 0 6.246631301110028e-08
mouse O 0 3.759060120955837e-07
embryo O 0 3.94087436461632e-07
. O 0 6.140808039845069e-08

Mutations O 0 2.124986849594279e-06
in O 0 1.7798246432221276e-08
the O 0 5.950967363332893e-08
SMAD4 O 1 0.9999431371688843
/ O 0 5.3707946790382266e-05
DPC4 O 1 0.9575742483139038
tumor B-Disease 0 1.2185399100417271e-05
suppressor O 0 3.219378754693025e-07
gene O 0 2.5294022432120755e-10
, O 0 7.451595764040864e-12
a O 0 2.8508223559597923e-11
key O 0 6.626385129493428e-08
signal O 0 7.710441707331483e-08
transducer O 0 1.776786433538291e-07
in O 0 5.240080813706527e-09
most O 0 7.209517427497758e-09
TGFbeta O 0 0.0006368487374857068
- O 0 5.918062697674031e-07
related O 0 1.0326998562959488e-06
pathways O 0 1.8404355373036196e-08
, O 0 7.167523952827937e-12
are O 0 6.618386394485753e-13
involved O 0 2.6691641518555853e-12
in O 0 5.406248712591655e-11
50 O 0 1.763663881604316e-09
% O 0 1.1665203247801514e-09
of O 0 3.801825982918672e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0036724756937474012

Homozygous O 0 0.0006790204788558185
Smad4 O 1 0.8685411214828491
mutant O 0 0.0003967981319874525
mice O 0 1.2002456969639752e-05
die O 0 1.3851264668574004e-07
before O 0 9.347193241637797e-09
day O 0 1.2227067713865836e-07
7 O 0 4.656992587115383e-07
. O 0 7.887360453651127e-08

5 O 0 3.2820782962517114e-06
of O 0 3.2560512863710755e-07
embryogenesis O 0 0.00012427475303411484
. O 0 1.7042416402546223e-06

Mutant O 0 1.72638101503253e-05
embryos O 0 1.1222388138776296e-06
have O 0 5.792322177455844e-10
reduced O 0 1.5791240537410545e-09
size O 0 4.308392309582132e-09
, O 0 7.220798958762487e-10
fail O 0 2.635769291714496e-08
to O 0 1.0947914796943792e-09
gastrulate O 0 4.6422665036516264e-05
or O 0 1.0035881459202756e-08
express O 0 1.7512846728351406e-09
a O 0 8.524256994713042e-11
mesodermal O 0 8.232869390667474e-07
marker O 0 2.2068935834340664e-07
, O 0 2.0723794902366421e-10
and O 0 3.207640264513145e-10
show O 0 1.456267328947547e-09
abnormal O 0 2.0647863863132443e-08
visceral O 0 9.036572009790689e-06
endoderm O 1 0.6902385354042053
development O 0 1.8620236005517654e-05
. O 0 8.144142498167639e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.922631549357902e-06
the O 0 3.459483366441418e-07
Smad4 O 1 0.9967969059944153
- O 0 0.0001528754219179973
deficient O 0 3.363478754181415e-06
embryos O 0 2.2241509967102502e-08
results O 0 6.753851922169929e-10
from O 0 1.680224293032495e-10
reduced O 0 6.6874044080122985e-09
cell O 0 6.5849312669286064e-09
proliferation O 0 1.0385765136788905e-08
rather O 0 5.278226189453505e-10
than O 0 2.1857109178125e-10
increased O 0 1.7319226941481247e-08
apoptosis O 0 1.324996333096351e-06
. O 0 3.077955454955372e-07

Aggregation O 0 3.998861302534351e-06
of O 0 6.086898451940215e-07
mutant O 0 7.741357876511756e-06
Smad4 O 0 0.002436102135106921
ES O 0 1.45888752740575e-05
cells O 0 4.278004173130512e-09
with O 0 4.542742224056262e-11
wild O 0 1.3008989441232188e-08
- O 0 1.729789200766163e-09
type O 0 2.3053784659055054e-08
tetraploid O 0 1.2597643944900483e-05
morulae O 0 0.00017366315296385437
rescues O 0 7.00027885613963e-06
the O 0 8.822563302146591e-08
gastrulation B-Disease 0 0.00014569645281881094
defect I-Disease 0 7.389655365841463e-06
. O 0 7.553940690741001e-07

These O 0 7.720831263213768e-08
results O 0 3.920197499951428e-08
indicate O 0 6.301893229476718e-09
that O 0 6.162952786992193e-11
Smad4 O 0 3.7094068829901516e-06
is O 0 7.714814204140552e-11
initially O 0 1.677640110164802e-10
required O 0 1.7589188786026888e-11
for O 0 1.702157685634642e-11
the O 0 1.349874101386206e-10
differentiation O 0 1.3607032167683997e-09
of O 0 1.0766841862519527e-09
the O 0 4.952508403377465e-10
visceral O 0 3.433340367564597e-08
endoderm O 0 1.1634920156211592e-06
and O 0 3.370817514003477e-10
that O 0 6.737581846605334e-12
the O 0 9.626055508249465e-10
gastrulation B-Disease 0 1.5699522464274196e-06
defect I-Disease 0 2.965832912593669e-08
in O 0 9.353752217222677e-10
the O 0 2.6244204587300146e-09
epiblast O 0 4.21211052525905e-06
is O 0 2.2831725399186098e-10
secondary O 0 6.292430754228917e-08
and O 0 6.000049901366822e-10
non O 0 2.65671104671128e-07
- O 0 9.32112982354738e-07
cell O 0 5.809177991977776e-07
autonomous O 0 3.5618992200170396e-08
. O 0 2.996800674281985e-08

Rescued O 0 0.0004977932549081743
embryos O 0 1.2837056601711083e-05
show O 0 7.393071399519613e-08
severe O 0 1.07080791167391e-06
anterior O 0 1.4534150523104472e-06
truncations O 1 0.9991626739501953
, O 0 1.6638464828133692e-08
indicating O 0 2.1094258784160047e-08
a O 0 1.995231896367855e-10
second O 0 3.180683272319129e-09
important O 0 8.856663735734571e-10
role O 0 4.719321045065783e-10
for O 0 2.082865879771134e-09
Smad4 O 0 0.023461222648620605
in O 0 2.8693423814729613e-07
anterior O 0 2.3760159706398554e-07
patterning O 0 7.220595762191806e-06
during O 0 5.441322628030321e-06
embryogenesis O 0 8.222243195632473e-05
. O 0 1.4567925745723187e-06

Prevalence O 0 1.4770613233849872e-05
of O 0 2.372474625644827e-07
p16 O 0 4.276793333701789e-06
and O 0 1.2814199124022707e-07
CDK4 O 1 0.9999440908432007
germline O 0 0.0001672419166425243
mutations O 0 1.442620032321429e-07
in O 0 7.764630716167176e-09
48 O 0 4.77351704830653e-07
melanoma B-Disease 1 0.9999996423721313
- O 0 0.490370512008667
prone O 1 0.9824726581573486
families O 0 2.4081991512048262e-08
in O 0 9.215328944378598e-09
France O 0 9.292978120356565e-08
. O 0 2.933148834927124e-07

The O 0 8.468132932648587e-07
French O 0 7.86022501415573e-05
Familial B-Disease 1 0.999977707862854
Melanoma I-Disease 1 1.0
Study O 0 5.157651685294695e-06
Group O 0 1.4046688256996731e-08
. O 0 7.886649555643999e-09

Germline O 0 0.0006570888217538595
mutations O 0 4.504986463871319e-07
in O 0 6.4576908265223665e-09
the O 0 9.793682309577889e-09
p16 O 0 3.5127160913361877e-07
and O 0 1.1901094332245066e-08
CDK4 O 1 0.9983457326889038
genes O 0 4.0737955231406886e-08
have O 0 1.3896800377111163e-10
been O 0 9.374036269438335e-11
reported O 0 2.563911756514603e-11
in O 0 4.553116564331994e-11
a O 0 9.318666671642717e-11
subset O 0 3.427536654498908e-08
of O 0 2.6054541635289752e-08
melanoma B-Disease 0 0.0024226405657827854
pedigrees O 0 5.759135319749475e-07
, O 0 7.360292236802124e-11
but O 0 6.533767971106386e-11
their O 0 7.88925938466356e-11
prevalence O 0 1.4869878661727398e-09
is O 0 3.763212831631169e-12
not O 0 2.680869935767216e-11
well O 0 9.144953128092936e-10
known O 0 9.891055974264873e-09
. O 0 6.955089304483408e-08

We O 0 7.477636643216101e-08
searched O 0 3.576488722956128e-07
for O 0 1.641280666930811e-09
such O 0 6.793405304961198e-08
germline O 0 4.491098297876306e-05
mutations O 0 3.4263074155660433e-08
in O 0 3.861980957253763e-09
48 O 0 3.461278197391948e-08
French O 0 1.3766249367108685e-06
melanoma B-Disease 1 0.9999998807907104
- O 0 0.25656259059906006
prone O 0 0.2541160583496094
families O 0 1.00321639884271e-09
selected O 0 5.143550585451351e-10
according O 0 2.6499248975686562e-11
to O 0 9.67491625009087e-12
two O 0 5.51544053484232e-12
major O 0 7.714586303109172e-09
criteria O 0 3.8009125091775786e-07
families O 0 8.138340695795776e-11
with O 0 2.7337489910683743e-12
at O 0 3.0256988581278677e-10
least O 0 4.7005791620202686e-11
three O 0 2.1693789126198126e-11
affected O 0 8.71463179397125e-10
members O 0 7.140346647283025e-11
( O 0 4.175249122134739e-12
n O 0 7.144269897896294e-11
= O 0 2.6303112465875245e-11
20 O 0 5.922129453495018e-11
) O 0 6.301952232626307e-13
or O 0 1.2990200061457902e-11
families O 0 9.819966888258147e-12
with O 0 1.193742153737798e-12
two O 0 1.760694368080351e-11
affected O 0 1.2376543123693295e-09
members O 0 2.7788724446531354e-11
, O 0 9.641627773948613e-12
one O 0 9.667868935969715e-12
of O 0 2.0572758774317634e-10
them O 0 9.301472786438225e-12
affected O 0 8.501475912137124e-11
before O 0 5.162342220366156e-10
the O 0 6.02701555330043e-10
age O 0 3.781285062842699e-09
of O 0 1.4670565873231567e-09
50 O 0 8.063253953416449e-10
( O 0 2.8522947892462014e-12
n O 0 6.33206820310761e-11
= O 0 7.752472969135837e-11
28 O 0 8.927489303367508e-10
) O 0 4.818789464677842e-12
, O 0 9.52357637196144e-12
and O 0 6.2467982175906656e-12
one O 0 6.690455914976079e-12
additional O 0 9.185031901726148e-11
minor O 0 1.0300131947360569e-07
criterion O 0 0.35747256875038147
. O 0 3.125280500171357e-06

Sixteen O 0 3.9822421967983246e-05
different O 0 1.116870862460928e-07
p16 O 0 1.5227244148263708e-05
germline O 0 7.7667737059528e-06
mutations O 0 2.681411004346046e-08
were O 0 1.747994304857059e-09
found O 0 9.255182037426479e-11
in O 0 7.139529939470535e-11
21 O 0 6.380094674796055e-09
families O 0 9.113727134080207e-11
, O 0 9.628929598104463e-12
while O 0 8.460663419862513e-11
one O 0 1.577590835744047e-10
germline O 0 4.4761517159486175e-08
mutation O 0 2.0135222378314666e-09
, O 0 1.234828905793961e-10
Arg24His O 0 3.486925197648816e-05
, O 0 9.567208136829208e-10
was O 0 5.763297394878464e-09
detected O 0 2.74610894024363e-08
in O 0 3.790896929700693e-09
the O 0 7.182193684229787e-08
CDK4 O 1 0.9998364448547363
gene O 0 7.947309086375753e-07
. O 0 6.753722345820279e-07

The O 0 7.67272396728913e-08
frequency O 0 1.2904060930907235e-08
of O 0 1.505857483152795e-08
p16 O 0 8.043630117526845e-08
gene O 0 7.298059379046151e-10
mutation O 0 3.4926092573606127e-10
in O 0 1.5564746713714328e-10
our O 0 1.6222170828861238e-10
sample O 0 1.2697617957080354e-10
( O 0 1.9568177373613382e-12
44 O 0 2.6617696935460344e-10
% O 0 8.065998390038853e-12
) O 0 7.763014948751479e-13
is O 0 4.731195036439262e-12
among O 0 3.571458753737211e-11
the O 0 7.771793625321877e-11
highest O 0 1.5095729111180844e-08
rates O 0 3.959813810183732e-09
yet O 0 2.2381368980362026e-10
reported O 0 6.150270570604022e-11
and O 0 2.9061019216070072e-11
the O 0 6.823540066314138e-10
CDK4 O 0 6.795027729822323e-05
mutation O 0 1.5449551638013759e-09
is O 0 1.7483559738851184e-11
the O 0 6.630396925944027e-11
second O 0 9.431717629126979e-10
mutation O 0 3.872859255515948e-10
detected O 0 2.5974393746963642e-09
in O 0 3.6092684396749064e-10
this O 0 1.4110105306386345e-09
gene O 0 1.96322567092011e-08
worldwide O 0 1.6483937770317425e-08
. O 0 2.0027704294989235e-07

In O 0 6.465864288429657e-08
summary O 0 5.902044364347603e-08
, O 0 1.0584058074414315e-09
our O 0 7.425979275943462e-10
results O 0 1.4545934456933196e-09
show O 0 2.0272630796291935e-10
frequent O 0 3.8043949934785104e-11
involvement O 0 9.314188309517135e-11
of O 0 1.1333767258037142e-09
the O 0 7.384908240481991e-09
p16 O 0 1.1752714357271543e-07
gene O 0 5.787929691081217e-09
in O 0 8.305070409164728e-09
familial B-Disease 0 4.550295216176892e-06
melanoma I-Disease 1 0.9999876022338867
and O 0 6.0776730315126315e-09
confirm O 0 1.674293814701855e-09
the O 0 1.5479018067310335e-09
role O 0 2.617815131333856e-10
of O 0 3.574835760744577e-09
the O 0 2.4522471164800663e-08
CDK4 O 1 0.999053418636322
gene O 0 1.4253039637424081e-08
as O 0 2.216886230144155e-09
a O 0 3.4260836390132e-09
melanoma B-Disease 1 0.9959558844566345
- O 0 8.268823148682714e-05
predisposing O 0 0.00019921675266232342
gene O 0 4.9337696594875524e-08
. O 0 1.001691085633638e-08
. O 0 7.300155857592472e-08

Progression O 0 1.6905640222830698e-05
of O 0 7.82626216278004e-07
somatic O 0 0.00024453806690871716
CTG O 0 0.00011372379958629608
repeat O 0 3.769837064737658e-08
length O 0 4.717595647463213e-09
heterogeneity O 0 6.05291816668796e-08
in O 0 4.81892248327398e-10
the O 0 4.907954043176233e-10
blood O 0 1.9042096788268736e-09
cells O 0 2.7838884530950736e-09
of O 0 2.3776383528684164e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.999997615814209
. O 0 1.4191321042744676e-06

The O 0 1.1303250602168191e-07
genetic O 0 2.253843511823561e-08
basis O 0 3.0830605624032614e-08
of O 0 2.89626791527553e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.1416072115698626e-07
DM B-Disease 1 1.0
) O 0 1.1258996512886199e-10
is O 0 4.329928342955425e-12
the O 0 1.0658965030052592e-11
expansion O 0 1.5421111054791936e-09
of O 0 8.560268605073418e-10
an O 0 6.7717650931165e-11
unstable O 0 1.8720412242601014e-07
CTG O 0 7.7076256275177e-06
repeat O 0 1.4393406466695069e-08
in O 0 1.1771997820986257e-09
the O 0 1.33548994085686e-09
34 O 0 1.4330620246028047e-08
UTR O 0 9.781047992873937e-05
of O 0 5.598235208736924e-09
the O 0 2.9898927778049256e-08
DM B-Disease 1 1.0
protein O 0 7.732591029707692e-07
kinase O 0 1.1217364459525925e-07
gene O 0 3.12634651500332e-09
on O 0 1.563316409658455e-08
chromosome O 0 1.7043305433617206e-08
19 O 0 1.3491397510279057e-07
. O 0 1.368943713941917e-07

One O 0 2.5546752269178796e-08
of O 0 6.465898927388025e-09
the O 0 1.8920991440296575e-09
principal O 0 2.3100970025780043e-08
features O 0 1.521521519887159e-10
of O 0 1.1737112393106486e-09
the O 0 2.3641263169338345e-08
DM B-Disease 1 1.0
mutation O 0 8.760537895113885e-08
is O 0 5.6075161875002166e-11
an O 0 1.5089365304130076e-12
extraordinarily O 0 3.1251781162922043e-09
high O 0 3.916563073858015e-09
level O 0 4.663843533592171e-09
of O 0 1.0646890480359161e-08
somatic O 0 9.207984476233833e-06
mosaicism O 0 1.562276520417072e-05
, O 0 6.146001763074338e-11
due O 0 5.050257545491377e-09
to O 0 7.181073791162618e-11
an O 0 5.564851530970305e-12
extremely O 0 5.627436849842127e-10
high O 0 1.0811538331267911e-09
degree O 0 2.867846404797092e-09
of O 0 3.3123748188756963e-09
somatic O 0 2.6602147045196034e-06
instability O 0 1.4616137633538528e-08
both O 0 3.101323364784747e-10
within O 0 4.964936239915119e-10
and O 0 7.854231848236637e-11
between O 0 5.931843904960488e-10
different O 0 5.087305243733908e-09
tissues O 0 5.494346737577871e-07
. O 0 8.500889236984221e-08

This O 0 7.21734920716699e-08
instability O 0 1.1848349856791174e-07
appears O 0 7.161986559367506e-09
to O 0 3.5696678252206127e-11
be O 0 3.501331863331458e-11
biased O 0 1.2741682153816214e-09
towards O 0 9.840319670217923e-10
further O 0 1.6003144642784406e-10
expansion O 0 3.953158245195709e-09
and O 0 8.903779796787248e-11
continuous O 0 5.256114432583558e-10
throughout O 0 2.176985952617727e-10
the O 0 3.0651098326117676e-10
life O 0 3.033719664369272e-10
of O 0 4.65967986418292e-10
an O 0 4.805178390604459e-12
individual O 0 2.52128474348412e-11
, O 0 2.5227988101339527e-12
features O 0 1.1005772682093351e-11
that O 0 1.7046185697786737e-13
could O 0 3.139829542198047e-12
be O 0 3.745954501449544e-12
associated O 0 9.64597360320063e-11
with O 0 6.989719567029873e-12
the O 0 7.954921166231088e-09
progressive O 0 0.0002345444809179753
nature O 0 1.2889080025502153e-08
of O 0 1.4237689249796404e-08
the O 0 6.08977828164825e-08
disease O 0 2.0868569663434755e-06
. O 0 1.4534494141571486e-07

Although O 0 6.84252228211335e-08
increasing O 0 5.849580819727862e-09
measured O 0 6.132646834799971e-09
allele O 0 2.833429713078317e-09
size O 0 7.132808788057332e-10
between O 0 9.674667733605702e-10
patients O 0 1.9540436824172502e-07
clearly O 0 1.5900194494378184e-09
correlates O 0 2.2989925518857035e-09
with O 0 2.6567404960015084e-12
an O 0 2.4090202489085444e-13
increased O 0 2.2712659877854868e-11
severity O 0 2.6707073885745558e-08
of O 0 1.674486327374325e-08
symptoms O 0 3.221714450774016e-06
and O 0 2.0452491089617553e-10
an O 0 4.771839390640964e-13
earlier O 0 7.804533408428682e-11
age O 0 4.830241762121545e-10
of O 0 1.0759465540743918e-10
onset O 0 5.253192725263034e-08
, O 0 1.862969153942906e-11
this O 0 6.519187533554627e-12
correlation O 0 7.717165448339891e-12
is O 0 2.934931486210657e-13
not O 0 7.419893692517388e-13
precise O 0 8.353712721564932e-10
and O 0 1.0868431848942706e-10
measured O 0 9.893277308492543e-10
allele O 0 7.003792545923204e-10
length O 0 8.112985283581509e-11
cannot O 0 2.3772718169001728e-11
be O 0 2.6199903791629398e-12
used O 0 7.186441546014333e-12
as O 0 4.980524239556194e-12
an O 0 1.9931482137490464e-13
accurate O 0 3.508787982386963e-10
predictor O 0 2.600901893856644e-07
of O 0 2.0799559852235916e-09
age O 0 1.0293588204035586e-08
of O 0 2.54514609387968e-09
onset O 0 3.206649489584379e-05
. O 0 4.730609362013638e-07

In O 0 2.2834971247220892e-08
order O 0 4.9223189968472525e-09
to O 0 8.904017106958761e-11
further O 0 2.4723831315576206e-10
characterize O 0 1.6936496649577748e-08
the O 0 7.063091000958366e-09
dynamics O 0 1.0695744379063399e-07
of O 0 1.7044334299498587e-06
DM B-Disease 1 1.0
CTG O 1 0.999721348285675
repeat O 0 2.5565625492163235e-06
somatic O 0 1.1303717656119261e-05
instability O 0 1.3618359773204247e-08
, O 0 4.1752754031954e-11
we O 0 5.683794147143262e-12
have O 0 2.9093171014654695e-12
studied O 0 1.6297659055641844e-10
repeat O 0 4.112041263049093e-11
length O 0 5.168744252048718e-11
changes O 0 6.120826762101572e-11
over O 0 1.590215736868572e-10
time O 0 8.65806870642416e-10
in O 0 4.760766891820367e-09
111 O 0 6.334695353871211e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.2213926083859405e-06
with O 0 1.1796529898744357e-11
varying O 0 1.2151405437421658e-09
clinical O 0 6.1242895199598024e-09
severity O 0 1.2884440536709008e-07
and O 0 7.766200127434786e-09
CTG O 0 8.584006536693778e-07
repeat O 0 9.942251466554808e-10
size O 0 2.786851582836647e-10
over O 0 1.9334235601409233e-11
time O 0 1.1617143011455333e-11
intervals O 0 1.1455073695154638e-10
of O 0 1.4161621875175e-10
1 O 0 5.6394848790830565e-09
- O 0 1.1394767795991356e-08
7 O 0 1.5597930058675047e-08
years O 0 4.859352031871822e-09
. O 0 1.1688706891277434e-08

We O 0 1.1038127212259496e-07
have O 0 5.069064057394712e-10
found O 0 5.7614236298464405e-11
a O 0 6.8655168355968854e-12
direct O 0 4.645018397697598e-11
progression O 0 6.1781411098138506e-09
of O 0 1.3516086028175778e-09
the O 0 6.562209109439721e-10
size O 0 4.671141251577637e-10
heterogeneity O 0 6.269773589195893e-09
over O 0 1.8834316051208333e-10
time O 0 4.917042883967326e-10
related O 0 7.673262025775784e-09
to O 0 2.2665511689723417e-09
initial O 0 2.930950984136871e-07
CTG O 0 2.376845941398642e-06
repeat O 0 2.3062700638121214e-09
size O 0 7.632285914382919e-10
and O 0 5.1414098672930564e-11
the O 0 7.176254729346354e-11
time O 0 8.418296615353427e-11
interval O 0 2.6342148462532577e-09
and O 0 2.227107526175942e-10
always O 0 1.1630700846865238e-09
biased O 0 3.307482288050778e-09
towards O 0 5.040615036477902e-09
further O 0 4.78990402896784e-09
expansion O 0 8.963641562331759e-07
. O 0 2.7315246597936493e-07

Attempts O 0 5.86881640174397e-07
to O 0 1.4393617409069748e-09
mathematically O 0 5.552924520202396e-08
model O 0 6.482050451950272e-09
the O 0 6.318634948598856e-09
dynamics O 0 1.9116384919470875e-07
have O 0 1.87458737421764e-09
proved O 0 2.6746897674456704e-07
only O 0 6.822706843934156e-10
partially O 0 9.781603083069967e-09
successful O 0 2.280553745848124e-09
suggesting O 0 3.9814337937649213e-10
that O 0 1.5317460841379749e-12
individual O 0 1.517880092449797e-11
specific O 0 2.5728226840660007e-11
genetic O 0 2.5912685330808927e-09
and O 0 4.5169973317271683e-10
/ O 0 8.505592319352218e-08
or O 0 2.7792408374693878e-09
environmental O 0 4.0729725014898577e-07
factors O 0 1.3831684242404663e-08
also O 0 8.835028542097945e-11
play O 0 6.145512432276234e-10
a O 0 1.305321822853145e-10
role O 0 1.8298252912885005e-09
in O 0 3.725668662468706e-08
somatic O 0 0.0005816307966597378
mosaicism O 0 0.001449860050342977
. O 0 4.39642953153907e-08
. O 0 1.3042684088304668e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 6.148547072371002e-06
Palestinian O 0 3.7968147807987407e-06
Arabs O 0 1.7409100792065146e-06
. O 0 1.713323740659689e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9401463270187378
AGU B-Disease 1 1.0
) O 0 2.4845299151365907e-08
is O 0 3.9630304593529786e-10
a O 0 1.7267161311895762e-10
rare O 0 4.058176727994578e-07
disorder B-Disease 1 0.9975864887237549
of I-Disease 1 0.9989196062088013
glycoprotein I-Disease 0 0.11805152148008347
metabolism I-Disease 0 0.007062928751111031
caused O 0 4.6439804890496816e-08
by O 0 1.554182338381338e-09
the O 0 2.3931124815135263e-07
deficiency B-Disease 0 0.0007370629464276135
of I-Disease 0 2.415675339761947e-07
the I-Disease 0 5.352380583190097e-08
lysosomal I-Disease 0 1.8001348507823423e-05
enzyme I-Disease 0 1.8429986425871903e-07
aspartylglucosaminidase I-Disease 0 8.506195445079356e-05
( O 0 3.034241968791207e-09
AGA O 0 0.2844729423522949
) O 0 3.749255128582263e-09
. O 0 2.5230011857502177e-08

AGU B-Disease 1 1.0
is O 0 3.58545730705373e-06
inherited O 1 0.6974131464958191
as O 0 1.5603738745539886e-07
an O 0 5.131255864654349e-09
autosomal O 0 0.3242547810077667
recessive O 0 0.3608437478542328
trait O 0 2.166146441595629e-05
and O 0 1.9156154440480577e-09
occurs O 0 6.352742637494302e-11
with O 0 1.4057754526425326e-12
a O 0 4.547238887514515e-12
high O 0 3.865929243396238e-10
frequency O 0 7.806454094261284e-11
in O 0 4.400071973442721e-11
Finland O 0 1.3667794673821732e-09
because O 0 8.481555041628397e-11
of O 0 2.9818665314707005e-09
a O 0 2.859680492406369e-09
founder O 0 4.0470035855832975e-07
effect O 0 1.1605670380276933e-07
. O 0 1.1718667991544862e-07

While O 0 1.2359963648123085e-06
very O 0 3.324972652762881e-08
few O 0 2.6339497694038982e-08
patients O 0 2.926778108758299e-07
with O 0 1.6045676787257435e-08
AGU B-Disease 1 1.0
have O 0 2.5578742679499555e-07
been O 0 3.2526847881797494e-09
reported O 0 1.3754639094365473e-10
from O 0 1.2595560705541686e-10
non O 0 5.783295176087222e-09
- O 0 8.262501238753828e-10
Finnish O 0 7.20435124890173e-08
origin O 0 7.886149511193707e-10
, O 0 3.057033792774888e-11
we O 0 4.395888653085933e-10
diagnosed O 0 0.0859503448009491
the O 0 3.932737399736652e-06
disorder O 1 0.9538027048110962
in O 0 4.0538370171816496e-07
8 O 0 1.922479810900768e-07
patients O 0 2.187093350869418e-08
originating O 0 7.392739753697697e-10
from O 0 6.621979353749197e-11
3 O 0 3.9974512588969446e-10
unrelated O 0 1.346930011969505e-09
families O 0 1.4491919816950194e-11
, O 0 8.574046962868398e-13
all O 0 2.2637221958055065e-12
Palestinian O 0 2.2575628866317032e-10
Arabs O 0 1.371215224699185e-10
from O 0 3.146869570480604e-11
the O 0 5.499088684413067e-11
region O 0 2.5353336097211354e-10
of O 0 7.88657028572004e-10
Jerusalem O 0 5.2046407290617935e-06
. O 0 2.0348235807432502e-07

The O 0 2.5269315528930747e-07
clinical O 0 5.5885147958179004e-06
diagnosis O 1 0.9860091805458069
of O 1 0.999998927116394
AGU B-Disease 1 1.0
is O 0 1.9025042874432074e-08
often O 0 9.284389923536196e-11
difficult O 0 9.358404329251613e-11
, O 0 1.811314553207266e-12
in O 0 5.177957888846674e-12
particular O 0 4.676862369601409e-11
early O 0 4.876873127557246e-09
in O 0 3.3507134566956864e-11
the O 0 6.392171514324474e-11
course O 0 6.219542658669752e-10
of O 0 1.313571196259744e-10
the O 0 5.153399929014313e-10
disease O 0 7.935311963080949e-09
, O 0 4.791230780176736e-12
and O 0 1.4250598964760108e-11
most O 0 6.948012998275743e-11
of O 0 7.801784218663954e-10
the O 0 2.231564932841934e-09
patients O 0 2.3914008551173538e-08
are O 0 4.4192316472901894e-11
diagnosed O 0 3.5013687504914515e-09
after O 0 1.1912331121521902e-09
the O 0 1.7028641829952562e-09
age O 0 5.368706368358289e-09
of O 0 1.3342092985979548e-09
5 O 0 2.121266717836079e-09
years O 0 1.3978473933917712e-09
. O 0 1.2162517215585922e-08

However O 0 6.25970301371126e-07
, O 0 2.703058665787239e-09
since O 0 3.1588218707412352e-09
these O 0 1.4911715195964348e-09
patients O 0 1.7682996400480988e-08
excrete O 0 8.948722296509004e-08
early O 0 5.335593300515029e-08
large O 0 2.258997294779519e-10
amounts O 0 5.316854734260801e-10
of O 0 4.963698341242662e-09
aspartylglucosamine O 0 3.496782301226631e-05
in O 0 1.7159948129119584e-08
urine O 0 2.3835911022729306e-08
, O 0 1.794513669606257e-11
biochemical O 0 1.6749773790181166e-09
screening O 0 1.3736326742730398e-08
is O 0 1.5231822747541202e-10
easy O 0 1.7378118943867094e-09
by O 0 9.258470101691785e-10
urine O 0 4.546133993699186e-07
chromatography O 0 3.1652939469495323e-06
. O 0 1.1768367613740338e-08
. O 0 4.6909047313192787e-08

Detection O 0 4.881938821199583e-06
of O 0 9.868954720104739e-08
heterozygous O 0 1.4360335143237535e-08
carriers O 0 2.4879098781127595e-09
of O 0 1.9440977716556063e-09
the O 0 1.2137401483869326e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.4120797093019064e-07
ATM O 0 1.5461488146684133e-05
) O 0 1.9781347393443838e-10
gene O 0 2.54675697197726e-10
by O 0 4.2543718548060383e-10
G2 O 0 2.596247759356629e-05
phase O 0 2.2645099306828342e-06
chromosomal O 0 1.3004719221498817e-06
radiosensitivity O 0 0.00015408176113851368
of O 0 1.4911629477865063e-06
peripheral O 0 0.0020304990466684103
blood O 0 3.197302794433199e-05
lymphocytes O 0 1.008783328870777e-05
. O 0 1.4983032770032878e-07

In O 0 5.2445113396970555e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.676063715829514e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5120158458614696e-09
patients O 0 5.4413060723845774e-08
, O 0 1.8451988201273473e-11
mutations O 0 3.555649177866549e-11
in O 0 4.889936025542774e-11
a O 0 3.488619462754805e-11
single O 0 1.2277365235568993e-10
gene O 0 4.1295057651158373e-11
, O 0 9.963732096329725e-12
ATM O 0 2.642589969070741e-08
, O 0 2.341597618929492e-12
result O 0 2.904201358566727e-11
in O 0 1.3134717757878889e-09
an O 0 1.653021897141116e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 6.500649618601528e-08
embraces O 0 1.7493926307565744e-08
a O 0 8.501244846970124e-12
variety O 0 6.020531989614497e-11
of O 0 6.390257767385776e-11
clinical O 0 3.5001268550161058e-09
features O 0 1.4565167127944534e-10
and O 0 6.343733177649469e-11
manifests O 0 1.2176949448772234e-09
extreme O 0 5.165519567640331e-08
radiosensitivity O 0 2.9748921406280715e-06
and O 0 2.5675064296848404e-09
a O 0 7.884705666150182e-10
strong O 0 1.0673547379269621e-08
pre O 0 1.407990657753544e-05
- O 0 1.0676203601178713e-06
disposition O 0 0.00012677619815804064
to O 0 9.731993344530565e-08
malignancy B-Disease 0 0.0003307052538730204
. O 0 2.1087224411076022e-07

Heterozygotes O 0 2.2257725504459813e-05
for O 0 5.487790843972107e-08
the O 0 8.582102140053394e-08
ATM O 0 2.290207021360402e-06
gene O 0 1.6595099738836439e-09
have O 0 2.835378459797866e-11
no O 0 4.155675109585033e-11
clinical O 0 6.089763804340009e-09
expression O 0 4.294352373701571e-10
of O 0 5.803519442793004e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 9.488881902441904e-10
may O 0 1.545983063788725e-10
be O 0 1.2551337746913305e-10
cancer B-Disease 0 1.2268650095847988e-07
prone O 0 5.1521640287433e-09
with O 0 8.198413302407115e-12
a O 0 3.841386653213874e-10
moderate O 0 1.4237937762118236e-07
increase O 0 2.7508675337628574e-09
in O 0 5.709020811650589e-09
in O 0 7.852920980155886e-09
vitro O 0 7.119609790606773e-07
radiosensitivity O 0 7.789747542119585e-06
. O 0 2.943505705843563e-07

We O 0 2.067358337853875e-07
performed O 0 1.101560158645043e-07
a O 0 1.2883132782803841e-08
blind O 0 9.509091825066207e-08
chromosomal O 0 2.3820867056656425e-08
analysis O 0 1.2008605665414507e-08
on O 0 6.070191460594287e-08
G2 O 0 9.535538083582651e-06
- O 0 3.700456474575731e-08
phase O 0 2.7268865210317017e-07
lymphocytes O 0 5.523618451519496e-09
from O 0 9.206588269528027e-11
7 O 0 1.0799832139696264e-09
unrelated O 0 1.3520734754024488e-08
A B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.042985279113054276
, O 0 2.1404283900849919e-10
13 O 0 9.533981382148227e-10
obligate O 0 6.207659275503374e-09
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9953039884567261
T I-Disease 1 1.0
heterozygotes O 0 3.0048367989365943e-06
( O 0 3.722381430870669e-11
parents O 0 2.4866121314803813e-11
of O 0 9.334920857140272e-12
the O 0 4.4481276301189254e-11
patients O 0 3.365774048358361e-10
) O 0 2.1047113704653064e-12
, O 0 1.3234842041742745e-11
and O 0 8.274309709621619e-11
14 O 0 8.843429877281039e-10
normal O 0 1.4595653574644984e-09
controls O 0 1.4982075580149967e-09
following O 0 2.5546786908137165e-09
X O 0 1.923090167110786e-06
- O 0 4.415968746229737e-08
irradiation O 0 8.866286407283042e-07
with O 0 5.388109750037451e-11
1 O 0 6.74974742764789e-09
Gy O 0 1.977809915842954e-06
in O 0 2.42427952712454e-11
order O 0 2.6882430309571603e-11
to O 0 1.7389806608592018e-11
evaluate O 0 4.4267334242675815e-10
this O 0 2.473839362526764e-11
cytogenetic O 0 9.207267481770032e-08
method O 0 1.973666918786421e-08
as O 0 3.6618849619252103e-10
a O 0 7.898669218686649e-11
tool O 0 2.1315358367246517e-09
for O 0 9.130900202602987e-11
detection O 0 2.494302577815688e-07
of O 0 2.6398981844977243e-07
ATM O 0 0.00012893247185274959
carriers O 0 1.2777264828400803e-06
. O 0 2.0454741900266526e-07

Both O 0 3.239003262933693e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
homozygotes O 0 0.0005767607362940907
and O 0 6.364440086059631e-09
heterozygotes O 0 3.730532398549258e-07
showed O 0 2.51185539035248e-09
significantly O 0 1.8124716172351896e-09
increased O 0 4.5253531477662534e-10
levels O 0 2.08942330104378e-09
of O 0 5.319471529929842e-10
radiation O 0 8.494026587868575e-06
- O 0 3.0328263278533996e-07
induced O 0 5.524871085071936e-06
chromatid O 0 1.367363893223228e-06
damage O 0 2.5857504581949797e-08
relative O 0 3.150123362161139e-08
to O 0 3.519677951868694e-11
that O 0 5.92932647425215e-12
of O 0 1.1909081498728824e-09
normal O 0 3.8578011896106545e-08
controls O 0 1.0902768110554462e-07
. O 0 1.3307540314144717e-07

These O 0 8.93993643558133e-08
results O 0 1.3291990796915343e-07
show O 0 1.617657563457442e-09
that O 0 2.939534032853075e-11
the O 0 4.942979359157107e-09
G2 O 0 0.00014561616990249604
- O 0 4.086036540229543e-07
phase O 0 2.3270713427336887e-06
chromosomal O 0 8.905762882704948e-08
radiosensitivity O 0 4.190380309410102e-07
assay O 0 1.8694716885647722e-08
can O 0 2.4018927471947116e-11
be O 0 1.9460683065020135e-12
used O 0 3.227231632971228e-12
for O 0 1.6596087568446216e-12
the O 0 2.304895857507816e-11
detection O 0 1.0345412526646669e-08
of O 0 1.1268551247667347e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00022590886510442942
. O 0 3.870619025292399e-07

In O 0 3.4896038414444774e-07
combination O 0 4.5394747871796426e-07
with O 0 9.297722036727407e-10
molecular O 0 2.8903139082103735e-07
genetic O 0 2.0505281028704303e-08
analyses O 0 2.1464352517597263e-09
, O 0 7.378504925104057e-12
this O 0 5.069426215614792e-12
test O 0 1.5079146820085043e-09
may O 0 1.088930612347383e-10
be O 0 8.619570335266502e-12
of O 0 6.732883695015346e-11
value O 0 1.553917827745721e-10
in O 0 7.840591891017379e-12
studies O 0 1.4348731404434378e-11
of O 0 3.3691188727758004e-11
familial B-Disease 0 9.772596065715788e-09
and I-Disease 0 1.0172868769586785e-08
sporadic I-Disease 0 3.8242478694883175e-06
cancers I-Disease 0 0.000293998047709465
aimed O 0 4.778919659997882e-08
at O 0 6.141578356988475e-09
determination O 0 2.406448817993123e-09
of O 0 1.5207184400622964e-09
the O 0 2.5103644163415595e-10
potential O 0 2.781424535136523e-10
involvement O 0 2.6916049944425424e-10
of O 0 6.338612301703961e-09
ATM O 0 7.783613909850828e-06
mutations O 0 3.16608570471999e-08
in O 0 1.057631404677295e-08
tumor B-Disease 0 0.0001799747988115996
risk O 0 1.4434841943966603e-07
or O 0 1.125279647240518e-09
development O 0 1.8851011418519192e-08
. O 0 2.4261415099147143e-09
. O 0 2.7241513933518036e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 9.495675357129585e-09
identification O 0 2.637543072836479e-09
and O 0 5.109127964447735e-12
detection O 0 2.5396180713954664e-09
of O 0 1.141691363670816e-08
founder O 0 3.942092234865413e-07
- O 0 7.951177138920684e-08
effect O 0 1.842416992303697e-07
mutations O 0 5.543619785441933e-09
in O 0 2.2404227362216034e-09
the O 0 1.0093279101397457e-08
ATM O 0 5.450192929856712e-06
gene O 0 5.250505807907757e-09
in O 0 2.7172273320275053e-09
ethnic O 0 2.855146119529195e-09
populations O 0 4.981965950889844e-09
. O 0 5.672063263517657e-09

To O 0 2.007855037788886e-08
facilitate O 0 2.075973704052103e-08
the O 0 4.229559369406388e-09
evaluation O 0 1.2301900653710618e-07
of O 0 1.954163053596858e-07
ATM O 0 4.653932774090208e-05
heterozygotes O 0 2.3659183625568403e-06
for O 0 3.114193569686563e-09
susceptibility O 0 2.6844716103369137e-06
to O 0 3.774193180205998e-10
other O 0 2.5615289889202586e-09
diseases O 0 3.584796286304481e-05
, O 0 8.70914382278265e-11
such O 0 6.676036612418557e-09
as O 0 6.042547283868771e-06
breast B-Disease 1 0.9979257583618164
cancer I-Disease 0 5.0156966608483344e-05
, O 0 2.697186363143089e-10
we O 0 1.4443057860802355e-10
have O 0 5.321072402142413e-11
attempted O 0 6.491400195152153e-10
to O 0 9.536650635855182e-11
define O 0 1.0856172627526917e-09
the O 0 9.327526528934982e-10
most O 0 3.056907227350081e-10
common O 0 6.337097513409162e-10
mutations O 0 3.310584098525915e-11
and O 0 3.892413301398445e-12
their O 0 3.900008354457141e-12
frequencies O 0 1.67006394824476e-10
in O 0 1.1048585379924702e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 8.861706191964913e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
) O 0 1.3283006916608997e-09
homozygotes O 0 3.642461194885982e-07
from O 0 1.2081173839106896e-09
10 O 0 9.224521146933284e-10
ethnic O 0 1.0459773047699628e-09
populations O 0 4.153159149922203e-09
. O 0 1.1971078350825337e-08

Both O 0 3.5007934684472275e-07
genomic O 0 1.9619885733845877e-06
mutations O 0 1.0898547486704047e-07
and O 0 2.0084820473442733e-09
their O 0 4.940243769624431e-10
effects O 0 1.259823978472241e-08
on O 0 2.5486254884299342e-08
cDNA O 0 1.8170143789575377e-07
were O 0 5.884584819426664e-09
characterized O 0 2.3978818930459056e-08
. O 0 9.078537743789639e-08

Protein O 0 4.0364460573982797e-07
- O 0 7.046946137734267e-08
truncation O 0 2.8455687584028055e-07
testing O 0 4.217839943976287e-08
of O 0 2.6401366426398454e-08
the O 0 1.0175178033478005e-08
entire O 0 1.972078855771997e-08
ATM O 0 1.801463298534145e-07
cDNA O 0 1.7424726550530067e-08
detected O 0 7.663433443383383e-09
92 O 0 7.517305533610852e-08
( O 0 8.688304936610436e-11
66 O 0 7.539069812878552e-09
% O 0 1.5752786575173872e-10
) O 0 4.242126441789118e-11
truncating O 0 2.2300963564703125e-07
mutations O 0 1.2035158647449862e-08
in O 0 4.331239811250498e-09
140 O 0 7.552400660415515e-08
mutant O 0 2.2585693670862383e-07
alleles O 0 2.67071254000939e-08
screened O 0 3.1026641522657883e-07
. O 0 7.869568463547694e-08

The O 0 1.8537280084274244e-06
haplotyping O 0 0.001084442250430584
of O 0 5.6216026678157505e-06
patients O 0 2.4542089249735e-06
with O 0 7.712464000775299e-10
identical O 0 3.9414345565091935e-07
mutations O 0 1.1538457300730443e-08
indicates O 0 3.683132243637033e-09
that O 0 4.4130467509451154e-12
almost O 0 1.3004083053436144e-11
all O 0 2.0292649938885576e-12
of O 0 7.172967081414683e-12
these O 0 4.803959747362585e-12
represent O 0 5.980038512987118e-12
common O 0 2.1815665940394524e-10
ancestry O 0 7.025865306209411e-11
and O 0 9.838563991282356e-12
that O 0 2.0972778635303113e-12
very O 0 6.673028796200242e-10
few O 0 1.77748393781485e-08
spontaneously O 0 5.003795990887738e-07
recurring O 0 5.707541959054652e-07
ATM O 0 5.8809073379961774e-05
mutations O 0 1.598014023329597e-07
exist O 0 4.900728356460604e-08
. O 0 1.593326999227429e-07

Assays O 0 4.808186076843413e-06
requiring O 0 2.1792280335830583e-07
minimal O 0 6.249019861570559e-07
amounts O 0 6.028446364325646e-08
of O 0 1.9024353647978387e-08
genomic O 0 4.255147345588739e-08
DNA O 0 1.784713177244157e-08
were O 0 1.3376849627988463e-09
designed O 0 1.814657757392979e-09
to O 0 5.7694616445447267e-11
allow O 0 4.393348462805591e-10
rapid O 0 9.238612541651037e-09
screening O 0 6.721101897255721e-08
for O 0 1.9619930125003293e-09
common O 0 1.0884940593314241e-07
ethnic O 0 1.4558071192993793e-08
mutations O 0 6.532194163355598e-08
. O 0 1.0311612186342245e-07

These O 0 2.2713392411333189e-07
rapid O 0 3.640961097062245e-07
assays O 0 5.665546041200287e-07
detected O 0 5.558677571571025e-07
mutations O 0 2.110991559334252e-08
in O 0 1.3550546240637118e-09
76 O 0 1.3147135291546874e-07
% O 0 2.6398566665974954e-10
of O 0 9.813647672274328e-10
Costa O 0 1.688392181620202e-08
Rican O 0 8.943668490246637e-07
patients O 0 4.0023155634116847e-07
( O 0 1.3435313625520529e-11
3 O 0 4.4772405227710976e-10
) O 0 3.3605106544709606e-12
, O 0 4.759506590928941e-12
50 O 0 2.6038704178943384e-11
% O 0 1.1764842572370426e-12
of O 0 1.8094784351441184e-11
Norwegian O 0 6.989812817437269e-08
patients O 0 4.1518937621276564e-08
( O 0 3.9530540299481665e-12
1 O 0 4.5878933985221693e-10
) O 0 1.1863991776842053e-12
, O 0 2.210768677499142e-12
25 O 0 3.8006962160830327e-11
% O 0 4.0719688905455076e-12
of O 0 5.859636387217648e-11
Polish O 0 2.698825710467645e-06
patients O 0 5.109847734274808e-06
( O 0 2.7467699989514038e-11
4 O 0 9.543952295132385e-10
) O 0 2.303369517689391e-12
, O 0 4.4852962489960735e-12
and O 0 1.0610849872361161e-11
14 O 0 6.204350228022903e-11
% O 0 2.669820961531677e-12
of O 0 3.759341102305136e-11
Italian O 0 3.119614575552987e-07
patients O 0 5.857058113178937e-06
( O 0 2.9432968649129032e-12
1 O 0 5.681773385113331e-10
) O 0 2.1969431482360413e-12
, O 0 4.2991343991716224e-12
as O 0 4.9087001824377197e-11
well O 0 1.1929125742771163e-10
as O 0 6.175496225502286e-11
in O 0 1.210381656013837e-10
patients O 0 1.3983807445328011e-09
of O 0 6.6095440232061264e-09
Amish O 0 1.5355203686340246e-06
/ O 0 2.111918320224504e-07
Mennonite O 0 6.693563818771509e-07
and O 0 2.373616858619698e-10
Irish O 0 1.816740002880124e-08
English O 0 2.8609475677399132e-08
backgrounds O 0 6.954121545277303e-08
. O 0 2.0304730341536015e-08

Additional O 0 2.6836602273760946e-07
mutations O 0 4.0533802092568294e-08
were O 0 3.510516766169758e-09
observed O 0 5.828495464044181e-10
in O 0 3.561053396605729e-10
Japanese O 0 1.3690507216779224e-07
, O 0 4.465863234770495e-10
Utah O 0 1.382833971774744e-07
Mormon O 0 7.010908831261986e-08
, O 0 3.516785820889545e-11
and O 0 6.573969146828063e-11
African O 0 1.1985099579447933e-09
American O 0 3.324762021250649e-09
patients O 0 4.1160728159184146e-08
. O 0 5.6187342778457605e-08

These O 0 8.091022607459308e-08
assays O 0 1.2201441279557912e-07
should O 0 7.069341223520098e-10
facilitate O 0 3.926891034566893e-10
screening O 0 7.061232487615143e-09
for O 0 1.7772185945119645e-09
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998899698257446
T I-Disease 1 1.0
heterozygotes O 0 8.714504815543478e-07
in O 0 1.8241443078270692e-10
the O 0 3.733302555986029e-11
populations O 0 7.861826641086811e-12
studied O 0 1.010469138917891e-10
. O 0 9.256612143460075e-11
. O 0 5.7108828777074905e-09

The O 0 1.6669775959599065e-06
von B-Disease 1 0.9999794960021973
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999994039535522
Lindau I-Disease 1 0.999998927116394
tumor I-Disease 0 0.01528025884181261
suppressor O 0 5.597283688985044e-06
gene O 0 9.068526485300765e-10
is O 0 4.562755989007128e-12
required O 0 4.8731584739725164e-11
for O 0 9.233987185996995e-11
cell O 0 3.003918225275015e-09
cycle O 0 3.974371942661037e-09
exit O 0 9.758608143783931e-09
upon O 0 3.786785107706692e-09
serum O 0 3.502572809566118e-08
withdrawal O 0 9.971469694391999e-08
. O 0 9.75574607764429e-08

The O 0 2.493835538075473e-08
inactivation O 0 1.7942207932719612e-06
of O 0 4.510312479055756e-08
the O 0 7.790831801912645e-08
von B-Disease 1 0.9999978542327881
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 3.399651120616909e-07
VHL I-Disease 1 0.9999996423721313
) I-Disease 0 8.258854222731316e-08
tumor I-Disease 0 0.0001565730490256101
suppressor O 0 0.0001512820745119825
gene O 0 1.586266336062181e-07
predisposes O 0 1.2760557410729234e-06
affected O 0 2.4924233343881497e-08
individuals O 0 9.588869975818426e-11
to O 0 2.3389087888681104e-10
the O 0 6.007716706335486e-07
human O 1 0.9987108707427979
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.94958435453907e-09
is O 0 5.285887613032392e-12
associated O 0 5.689219928495248e-11
with O 0 5.7136337328067555e-11
sporadic B-Disease 0 1.8341354007134214e-05
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 4.158114919050604e-08
RCC B-Disease 1 0.8041496872901917
) O 0 3.800772585549339e-09
and O 0 8.523049643827108e-08
brain B-Disease 0 8.148095730575733e-06
hemangioblastomas I-Disease 0 0.0019408559892326593
. O 0 4.535659627435962e-06

VHL O 1 0.9987216591835022
- O 0 0.00029268197249621153
negative O 0 3.8077730550867273e-06
786 O 0 3.6888322938466445e-05
- O 0 3.775864342969726e-06
0 O 0 6.185808274494775e-07
RCC B-Disease 0 1.244787472387543e-05
cells O 0 1.3337901449972378e-08
are O 0 2.776855134722922e-10
tumorigenic O 0 4.43218341388274e-05
in O 0 6.417529334612482e-07
nude O 0 1.0832742418642738e-06
mice O 0 2.1251150172929556e-08
which O 0 1.3514165481121054e-11
is O 0 9.071630599488678e-12
suppressed O 0 1.4299104122983408e-09
by O 0 2.5999113972829946e-10
the O 0 5.220010201867353e-09
reintroduction O 0 1.6226540537900291e-06
of O 0 6.108145811367649e-08
VHL B-Disease 1 0.9517747759819031
. O 0 3.15583588417212e-06

Remarkably O 0 2.709014188440051e-05
, O 0 3.821225003086681e-10
this O 0 2.396218640177139e-11
occurs O 0 9.45069369984175e-11
without O 0 2.0748118501057178e-10
affecting O 0 1.3729798409300997e-09
the O 0 5.405323411089569e-10
growth O 0 1.0262178884445916e-09
rate O 0 7.731227880114488e-10
and O 0 1.778135624852517e-11
cell O 0 2.906535567781532e-10
cycle O 0 2.4928437092341937e-10
profile O 0 3.8929667822706904e-10
of O 0 7.435390081411697e-10
these O 0 6.28985696859985e-10
cells O 0 2.507317464761627e-09
in O 0 3.08205239107906e-10
culture O 0 1.6544856151767817e-08
. O 0 2.4367770024014135e-08

The O 0 1.8317595049666124e-06
786 O 0 7.220279258035589e-06
- O 0 2.178637856786736e-07
0 O 0 2.070856197633475e-08
cell O 0 2.1572954533866096e-09
line O 0 8.38974045791474e-09
, O 0 6.737971292025691e-11
like O 0 5.288051108109926e-10
many O 0 4.1679970586017134e-10
cancer B-Disease 0 2.28164687143817e-08
cells O 0 3.67995633965279e-10
, O 0 2.0570434244859825e-11
fails O 0 6.607271951786231e-10
to O 0 1.1597467430846109e-10
exit O 0 2.1166643549008768e-08
the O 0 9.667676659219637e-10
cell O 0 7.007494029487304e-10
cycle O 0 1.0027834812520453e-10
upon O 0 4.103604955840723e-10
serum O 0 1.2351292433265826e-08
withdrawal O 0 3.441706297735436e-08
. O 0 6.440693312015355e-08

Here O 0 4.7082491505534563e-07
, O 0 1.079538347603659e-09
it O 0 1.6743178024580807e-11
is O 0 4.7179122587837075e-12
shown O 0 4.071767228941425e-12
that O 0 5.385269053609365e-13
reintroduction O 0 1.904265012342421e-08
of O 0 6.999038570931759e-10
the O 0 1.510174096885919e-09
wild O 0 4.029345390677008e-08
- O 0 5.175476935903589e-09
type O 0 4.797659869382187e-08
VHL B-Disease 0 0.0006092962576076388
gene O 0 2.2554175416189537e-08
restores O 0 1.8079913388646673e-07
the O 0 8.223843828147892e-09
ability O 0 2.386205455451318e-09
of O 0 1.0868945565789545e-07
VHL O 1 1.0
- O 1 1.0
negative O 1 0.983126699924469
RCC B-Disease 1 0.9999988079071045
cancer I-Disease 0 7.261746759468224e-06
cells O 0 7.995882289613121e-10
to O 0 3.302624493328743e-11
exit O 0 1.8991606065554834e-09
the O 0 1.0613547540838653e-10
cell O 0 2.0475245110507245e-10
cycle O 0 1.6111349754321935e-10
and O 0 3.849900606645029e-11
enter O 0 1.9049188892950042e-08
G0 O 0 0.0001477192563470453
/ O 0 2.578693454324821e-07
quiescence O 0 2.1002058474550722e-06
in O 0 5.111864709306246e-09
low O 0 1.3446620528156927e-07
serum O 0 1.3426323164367204e-07
. O 0 2.7497305765677993e-08

Both O 0 4.008445102954283e-06
VHL O 1 0.9999932050704956
- O 0 0.00016564596444368362
positive O 0 3.71053516801112e-07
and O 0 2.7232060162418747e-08
VHL O 1 0.9999983310699463
- O 0 0.0003470232477411628
negative O 0 2.5451824967603898e-06
RCC B-Disease 0 0.0003070341772399843
cells O 0 2.741639448800015e-08
exit O 0 2.2353317419288032e-08
the O 0 2.5113125468045894e-10
cell O 0 5.273728120869237e-10
cycle O 0 2.1948011463823747e-10
by O 0 3.7693136806238314e-11
contact O 0 2.1025439167488003e-09
inhibition O 0 6.159154395390942e-07
. O 0 3.8302670191114885e-07

The O 0 3.359859192642034e-06
cyclin O 0 1.431497457815567e-05
- O 0 5.830257805428118e-07
dependent O 0 7.54140287995142e-08
kinase O 0 8.424106567872514e-08
inhibitor O 0 3.1602641570316337e-07
, O 0 1.112422376436939e-09
p27 O 0 1.266319713977282e-06
, O 0 5.463721697296364e-10
accumulates O 0 3.957458361014687e-09
upon O 0 3.046662366834596e-10
serum O 0 6.408141794977951e-10
withdrawal O 0 6.964919752050491e-10
, O 0 1.1293703819359457e-11
only O 0 6.273604032103197e-12
in O 0 7.631477914882279e-12
the O 0 1.6254870713328096e-11
presence O 0 1.6417894821429968e-11
of O 0 7.704528570684488e-09
VHL B-Disease 1 0.9999945163726807
, O 0 1.0803087313604465e-09
as O 0 7.757753467396711e-11
a O 0 1.987094950389734e-12
result O 0 1.2417081252102946e-11
of O 0 1.0338814526722473e-10
the O 0 1.8787421618426947e-10
stabilization O 0 1.3103919727086577e-08
of O 0 9.460820571405293e-09
the O 0 2.629848694368775e-08
protein O 0 9.371081688414051e-08
. O 0 7.102703847294833e-08

We O 0 1.0212644951934635e-08
propose O 0 1.160374107911366e-08
that O 0 3.045098201370777e-11
the O 0 1.3914895902189528e-09
loss O 0 4.963019151205117e-08
of O 0 5.137221847917317e-08
wild O 0 4.4217850359018485e-07
- O 0 1.2194224296990797e-08
type O 0 8.482230384743161e-08
VHL B-Disease 0 0.00047353957779705524
gene O 0 2.9964393188919303e-09
results O 0 5.095647015451732e-09
in O 0 2.6482993575882574e-10
a O 0 4.0552838864726937e-11
specific O 0 3.7598182345277564e-09
cellular O 0 1.724733778019072e-07
defect O 0 3.2785411718805335e-08
in O 0 1.9969690345789104e-09
serum O 0 1.640299700511605e-07
- O 0 7.682416480747634e-07
dependent O 0 8.002374585203142e-08
growth O 0 1.0369707315049936e-09
control O 0 1.4767251865777098e-09
, O 0 2.2825749970700748e-11
which O 0 4.10973581554952e-11
may O 0 4.332867842293808e-09
initiate O 0 1.0952477680348238e-07
tumor B-Disease 0 6.604854661418358e-06
formation O 0 2.998522461439279e-07
. O 0 1.4690766647618148e-07

This O 0 1.4237280687723342e-08
is O 0 3.3376265640150393e-10
corrected O 0 5.127567259677335e-09
by O 0 3.900295086900485e-10
the O 0 1.2728078591095482e-09
reintroduction O 0 8.21011809648553e-08
of O 0 3.656896341297511e-09
wild O 0 6.304395583356381e-08
- O 0 1.0038389675059989e-08
type O 0 2.4106907403620426e-07
VHL B-Disease 1 0.9999464750289917
, O 0 2.195569592799984e-08
implicating O 0 9.153194696409628e-06
VHL B-Disease 1 1.0
as O 0 9.521302786197339e-07
the O 0 6.966693888443842e-08
first O 0 7.66986740785569e-09
tumor B-Disease 0 4.4230162643543736e-08
suppressor O 0 4.910440409844341e-08
involved O 0 8.457791411675686e-11
in O 0 1.2038565977423588e-10
the O 0 3.6300840111636035e-10
regulation O 0 2.1699904095839884e-08
of O 0 3.6928042845829623e-09
cell O 0 1.0069641787069372e-09
cycle O 0 2.2424952172972468e-10
exit O 0 1.293946949587621e-09
, O 0 1.1777324991982252e-12
which O 0 4.0147597160818116e-13
is O 0 7.177232983282544e-13
consistent O 0 7.153350828348337e-11
with O 0 3.722053047716667e-12
its O 0 2.1500111413441658e-10
gatekeeper O 0 1.2683179839712011e-08
function O 0 2.0940421618931282e-10
in O 0 2.473435067873453e-10
the O 0 3.149887239928262e-09
kidney O 0 3.797466433752561e-06
. O 0 4.710861034595837e-09
. O 0 2.011803523771505e-08

Piebaldism B-Disease 1 1.0
with O 0 0.398335725069046
deafness B-Disease 1 1.0
: O 0 1.503268975966421e-08
molecular O 0 8.0856814577146e-09
evidence O 0 1.9452094102145878e-10
for O 0 3.1193030797238563e-11
an O 0 7.688842618147618e-11
expanded O 0 3.006510996783618e-05
syndrome O 1 0.9999997615814209
. O 0 1.9263945432612672e-05

In O 0 5.6120079250376875e-08
a O 0 1.5998239399905856e-09
South O 0 9.25903975712572e-09
African O 0 2.0772559228277032e-09
girl O 0 1.190903708980784e-09
of O 0 9.558636104856078e-10
Xhosa O 0 2.8412457595550222e-06
stock O 0 5.679123660229379e-07
with O 0 7.622796838191448e-11
severe O 0 2.6680436349124648e-05
piebaldism B-Disease 1 1.0
and O 0 0.04278971999883652
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.8544180591106851e-07
identified O 0 9.18939979666078e-10
a O 0 1.2794758308398713e-11
novel O 0 6.657442930269042e-10
missense O 0 8.48342374126787e-09
substitution O 0 4.0990251193306904e-08
at O 0 5.365911714960703e-09
a O 0 2.2431582979987041e-10
highly O 0 2.485486039205398e-09
conserved O 0 3.271212634103904e-09
residue O 0 4.3615255407303266e-08
in O 0 5.9713478606227e-10
the O 0 5.110409873054778e-10
intracellular O 0 3.3292210654956023e-10
kinase O 0 2.9581932459166183e-09
domain O 0 2.4985191693360775e-09
of O 0 4.105086492955934e-09
the O 0 2.7069708252724922e-08
KIT O 1 0.6608008146286011
proto O 0 0.00013939289783593267
- O 0 3.2179719710256904e-05
oncogene O 0 2.6639632778824307e-05
, O 0 4.765618122348769e-09
R796G O 0 4.456993792700814e-06
. O 0 1.1372537755960366e-07

Though O 0 1.0088477210956626e-05
auditory B-Disease 0 0.0008980792481452227
anomalies I-Disease 0 0.00030757702188566327
have O 0 5.530196744985005e-09
been O 0 1.921114822778236e-09
observed O 0 4.316428103834369e-09
in O 0 3.0905837888894894e-09
mice O 0 5.722156970477954e-09
with O 0 8.139054707978488e-11
dominant O 0 4.474983597901883e-06
white O 0 3.052794284030824e-07
spotting O 0 0.00033499032724648714
( O 0 1.6375472089436016e-09
W O 0 2.4375729026360204e-06
) O 0 6.287791121106778e-11
due O 0 4.811291773876292e-07
to O 0 6.246035155754726e-08
KIT O 1 1.0
mutations O 0 0.00027632329147309065
, O 0 5.597478889285412e-07
deafness B-Disease 1 1.0
is O 0 7.270509194690078e-10
not O 0 7.268300544760464e-11
typical O 0 8.29395840895586e-09
in O 0 1.0004513883998811e-09
human O 0 2.375062591042365e-09
piebaldism B-Disease 0 1.6587897334829904e-05
. O 0 4.18968085114102e-07

Thus O 0 3.9609943769391975e-08
, O 0 1.1061758453667636e-10
the O 0 9.43930905661361e-11
occurrence O 0 7.922578149077708e-09
of O 0 0.0001153248522314243
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.270267128944397
this O 0 3.547038218698617e-08
patient O 0 4.924636414216366e-07
extends O 0 1.9001786810690646e-09
considerably O 0 6.349914372094645e-09
the O 0 8.330101608500229e-10
phenotypic O 0 1.7092853354938597e-08
range O 0 7.713251193308679e-08
of O 0 1.573706676083475e-08
piebaldism B-Disease 0 3.822749022219796e-06
due O 0 1.6089767314042547e-06
to O 0 1.942356675499468e-08
KIT O 0 0.0009741895482875407
gene O 0 2.8307947985695137e-08
mutation O 0 1.1908293018336735e-08
in O 0 2.4212956639679817e-10
humans O 0 1.9490282721079666e-09
and O 0 1.034731675342293e-10
tightens O 0 2.8907376048437072e-08
the O 0 2.020200229324587e-09
clinical O 0 6.845002076261153e-08
similarity O 0 3.6178098294925576e-09
between O 0 2.1214607848207834e-09
piebaldism B-Disease 0 0.0016080635832622647
and O 0 6.452540723955735e-10
the O 0 5.978433026410102e-11
various O 0 2.2936645638349518e-11
forms O 0 1.0167277020300958e-09
of O 0 9.68538188317325e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999985694885254
. O 0 5.9520914419408655e-08
. O 0 8.610548718479549e-08

Cycloheximide O 0 8.826730481814593e-05
facilitates O 0 6.801041507742411e-08
the O 0 3.76647157906973e-09
identification O 0 2.80406062813654e-08
of O 0 2.9537519097289078e-08
aberrant O 0 9.73329292719427e-08
transcripts O 0 9.099233366782755e-09
resulting O 0 2.1862121002413915e-09
from O 0 8.575368193319832e-10
a O 0 3.411071980430336e-10
novel O 0 3.519824431919005e-08
splice O 0 1.0950676596621634e-06
- O 0 4.5434685347345294e-08
site O 0 5.712212036712572e-09
mutation O 0 8.931117512211983e-10
in O 0 1.0141300299526534e-10
COL17A1 O 1 0.9867280125617981
in O 0 1.4115705271322554e-09
a O 0 3.719005103874906e-10
patient O 0 2.749153793502046e-08
with O 0 2.9078223162670724e-10
generalized O 1 0.6585914492607117
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9976192116737366
. O 0 4.861421530222287e-06

Patients O 0 4.7538716898998246e-05
with O 0 1.821855022399177e-08
generalized O 0 0.30922171473503113
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
often O 0 1.3997936321175075e-07
show O 0 1.7906143234824867e-09
decreased O 0 7.051770278820868e-09
expression O 0 1.501285429306165e-09
of O 0 1.6496322086112514e-09
type O 0 7.703943083470222e-07
XVII O 1 0.9999997615814209
collagen O 0 2.3303062334889546e-05
, O 0 6.260369556088108e-09
a O 0 2.0085701990524285e-09
transmembrane O 0 2.7648610512187588e-08
hemidesmosomal O 0 2.431118559798051e-07
protein O 0 5.8175917416747325e-09
encoded O 0 2.2342052652390976e-09
by O 0 4.260399588673636e-09
COL17A1 O 0 0.08057860285043716
. O 0 2.0345396478660405e-06

This O 0 2.3494449052918753e-08
report O 0 3.3525195952677223e-09
documents O 0 1.1904091046233134e-08
a O 0 1.2015725081582218e-09
novel O 0 1.2237356372679642e-07
splice O 0 2.272861365781864e-06
- O 0 6.704188137973688e-08
site O 0 1.108136693517281e-08
mutation O 0 8.965952980055647e-10
in O 0 2.235001211881027e-10
COL17A1 O 1 0.9999843835830688
in O 0 9.50410150579728e-09
a O 0 1.419199646690572e-09
patient O 0 2.078531906590797e-07
with O 0 1.4095069555963846e-09
generalized O 1 0.9999078512191772
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9571818709373474
, O 0 1.6556276349888321e-09
and O 0 8.26413590337971e-11
applies O 0 3.5043332125006543e-10
a O 0 1.672645182082544e-11
new O 0 3.752823329872257e-10
methodology O 0 1.5848096168724624e-08
to O 0 1.715122766032806e-10
define O 0 3.837104856074802e-09
and O 0 7.455768780140204e-10
characterize O 0 6.098704830037605e-08
the O 0 1.0735738520395444e-08
resulting O 0 1.1703389191097813e-07
mRNA O 0 4.22991263349104e-07
splice O 0 1.6671541516188881e-06
variants O 0 3.4550257055343536e-07
. O 0 1.810455216855189e-07

Mutational O 0 5.937335663475096e-05
analysis O 0 6.833757026925014e-08
of O 0 2.5109471835094155e-07
COL17A1 O 1 0.999804675579071
identified O 0 3.001864286034106e-07
a O 0 6.460388668472206e-09
maternally O 0 2.996017883560853e-06
inherited O 0 1.8517494027037174e-05
G O 0 0.000325483619235456
- O 0 4.4226115392120846e-07
to O 0 6.00253668991968e-09
- O 0 9.309651431976818e-07
T O 0 3.010737145814346e-06
transversion O 0 7.145287668208766e-07
at O 0 1.2225308543278857e-09
the O 0 8.0905934729536e-11
- O 0 1.5503830164131926e-10
1 O 0 7.166437443473228e-10
position O 0 1.2038986474394164e-09
of O 0 3.4195422049521085e-09
exon O 0 3.7139199093871866e-07
32 O 0 1.0553507223676206e-07
. O 0 5.632447042103195e-08

This O 0 4.7579462147950835e-08
acceptor O 0 3.8244010625021474e-07
splice O 0 2.852349780368968e-06
- O 0 5.992094997964159e-08
site O 0 1.2719032937980046e-08
mutation O 0 8.20278456270529e-10
led O 0 7.115864009143991e-10
to O 0 3.336211862325911e-11
the O 0 4.005312470578559e-10
formation O 0 6.089008852683264e-09
of O 0 4.7165542582661146e-08
aberrant O 0 5.0705970977560355e-08
transcripts O 0 7.629160414523994e-09
present O 0 4.474995096703793e-10
at O 0 1.2478141186988978e-08
extremely O 0 8.046085042678897e-08
low O 0 1.25947030937823e-06
levels O 0 3.671358683732251e-07
. O 0 7.721391170889547e-08

Based O 0 6.542088613059605e-07
on O 0 1.6223464172071544e-07
our O 0 3.066561893305675e-09
recent O 0 8.236004656048124e-10
finding O 0 1.6840366878767554e-09
that O 0 3.48856638021644e-11
cycloheximide O 0 1.5559260646114126e-05
stabilized O 0 0.0002488742466084659
mutant O 0 5.201231942919549e-06
COL17A1 O 0 0.001057424466125667
transcripts O 0 2.1486630430445075e-07
in O 0 1.5075638515327228e-09
keratinocytes O 0 5.8001109692895625e-08
homozygous O 0 2.4834674317020244e-09
for O 0 3.771435247434951e-11
a O 0 1.3772201434836262e-10
frameshift O 0 4.1449389698300365e-08
mutation O 0 6.781423755874982e-10
, O 0 1.4816326984745665e-11
the O 0 8.610404750308831e-11
effects O 0 6.901014426574648e-09
of O 0 9.42155011784962e-08
the O 0 5.767644495335844e-08
splice O 0 1.1663939858408412e-06
- O 0 7.992199613227058e-08
site O 0 8.930729933354087e-09
mutation O 0 2.0654854215873542e-10
on O 0 1.5529075247933122e-10
splicing O 0 7.1942154455939544e-09
of O 0 2.782048014182692e-08
COL17A1 O 1 0.9369691610336304
transcripts O 0 2.983159959057957e-07
were O 0 2.96337177019268e-09
determined O 0 7.264797652339894e-10
using O 0 4.524887131651667e-10
reverse O 0 1.595692289413364e-08
transcriptase O 0 5.683087334062975e-09
polymerase O 0 1.377667424584672e-09
chain O 0 5.462242325116051e-10
reaction O 0 6.561132748217346e-10
of O 0 1.5963613764213846e-09
total O 0 1.739376143117255e-10
RNA O 0 2.4631716111223056e-10
from O 0 5.206640674160212e-11
keratinocytes O 0 9.223716901374246e-09
incubated O 0 4.4974438395684047e-08
for O 0 3.7481451276022426e-10
2 O 0 2.1858506116245735e-08
. O 0 1.2839907803652295e-08

5 O 0 8.111494480544934e-07
h O 0 2.781990531275369e-07
in O 0 2.1862955890128433e-09
the O 0 1.3362747575129674e-09
presence O 0 5.897424770751059e-10
or O 0 7.215044117714342e-10
absence O 0 3.4412016702844994e-07
of O 0 1.0124402649580588e-07
10 O 0 1.2752142453109627e-08
microg O 0 2.941447519333451e-06
cycloheximide O 0 7.76945580582833e-06
per O 0 5.032039780417108e-07
ml O 0 8.721175618120469e-06
. O 0 3.302523339243635e-07

Using O 0 1.7404523378061754e-09
this O 0 5.075052045278028e-10
approach O 0 8.960387276601978e-08
, O 0 1.583648434611007e-09
an O 0 2.7247773481953175e-10
abnormally O 0 1.9204239265491196e-07
spliced O 0 5.518945656035612e-08
transcript O 0 1.4455341101893282e-07
was O 0 1.9067801559913278e-08
identified O 0 3.825921801592358e-10
that O 0 4.3551572938282934e-12
contains O 0 2.3315002706247867e-11
an O 0 1.7854312863233024e-12
extra O 0 2.6579138889815113e-10
264 O 0 7.286269365636144e-09
bases O 0 6.396431162514205e-10
upstream O 0 6.808021257853625e-09
from O 0 3.640354462319806e-09
exon O 0 9.437449222104988e-08
32 O 0 6.434919708198095e-09
, O 0 2.4843556031828307e-11
resulting O 0 3.163909412240429e-10
in O 0 4.205184256367289e-10
a O 0 1.37390454568731e-09
premature O 0 3.2225150903286703e-07
termination O 0 1.3769333691016072e-06
codon O 0 5.489329168995027e-07
27 O 0 4.3000824234695756e-07
bp O 0 8.67662564019156e-08
downstream O 0 4.079502602394314e-08
from O 0 1.2076243338654535e-09
the O 0 7.663696344195614e-09
cryptic O 0 1.2533357676147716e-06
splice O 0 1.627446363272611e-05
site O 0 1.3653753967446391e-06
. O 0 1.912272864501574e-07

Three O 0 2.4443792767669947e-07
other O 0 6.853399181494524e-09
splice O 0 8.146425898303278e-07
variants O 0 6.866263646543302e-08
, O 0 4.386800644962108e-10
including O 0 1.1120737664072067e-10
one O 0 2.950037089610724e-11
derived O 0 3.2125510585068184e-10
from O 0 3.080418420342568e-10
the O 0 1.0637527525503288e-09
skipping O 0 6.784328121511862e-08
of O 0 2.3024869122423297e-08
exon O 0 1.8611150665037712e-07
32 O 0 1.2014996997322669e-08
, O 0 1.6371309863316696e-10
were O 0 4.399606456928495e-09
also O 0 1.1120298015754315e-09
identified O 0 2.385405828420062e-08
. O 0 1.332578989376998e-07

These O 0 1.0034005626380349e-08
results O 0 3.5089100514085203e-09
indicate O 0 1.8700805348714766e-09
the O 0 3.722560593111268e-10
usefulness O 0 5.347921216980467e-08
of O 0 2.3039661289914193e-09
cycloheximide O 0 2.2422082111006603e-06
treatment O 0 1.8619507500261534e-06
in O 0 8.956261843273694e-10
evaluating O 0 5.0911879156956275e-09
the O 0 7.045528604976425e-10
abnormal O 0 6.84096279623958e-10
processing O 0 2.3704023632831195e-08
of O 0 6.04804810677706e-08
mRNA O 0 3.612770882455152e-08
due O 0 2.0665049760282272e-07
to O 0 1.666198956584708e-09
splice O 0 8.512934073223732e-07
- O 0 6.001874908179161e-08
site O 0 7.716146832592585e-09
mutations O 0 2.0139975798194598e-10
, O 0 7.301937700321393e-12
because O 0 1.2825454587250817e-10
( O 0 7.262231094262717e-11
i O 0 1.8899999343346963e-09
) O 0 3.7693067417299275e-11
aberrant O 0 4.273999820725294e-09
splicing O 0 1.2918516034687855e-08
often O 0 2.0723794902366421e-10
generates O 0 9.272638906709929e-11
a O 0 2.8512844862937925e-11
premature O 0 5.547861281485211e-09
termination O 0 7.173309057861843e-08
codon O 0 2.4384970487290047e-08
, O 0 4.5519987779130133e-10
( O 0 2.3657058950687926e-11
ii O 0 1.1436985687396373e-06
) O 0 1.3802391174433382e-10
transcripts O 0 1.0512700043818768e-08
with O 0 2.680048127867707e-10
premature O 0 5.104910769659909e-07
termination O 0 2.9559004133261624e-07
codons O 0 1.1230011587315403e-08
can O 0 5.104182354553899e-11
occur O 0 9.73482128241443e-11
at O 0 3.79994397059491e-10
low O 0 4.8840314015308195e-09
or O 0 1.6194772953226355e-11
undetectable O 0 2.5440007878074766e-09
levels O 0 6.168412447493665e-10
due O 0 1.7127110840675641e-09
to O 0 3.603999043644279e-10
nonsense O 0 3.6820875237708606e-08
- O 0 4.764754812924821e-09
mediated O 0 4.841376632924721e-09
mRNA O 0 9.231192477088257e-10
decay O 0 6.897593163301963e-09
, O 0 1.2334864900320763e-11
and O 0 6.995961969458175e-12
( O 0 1.52544860423931e-12
iii O 0 7.050321215729127e-08
) O 0 1.9578193233282803e-11
the O 0 5.17374754149813e-10
levels O 0 3.85529830282394e-09
of O 0 1.2569958407482318e-09
these O 0 1.405390942510465e-10
transcripts O 0 1.5646849371719895e-09
can O 0 1.512299833972275e-11
be O 0 1.7621189229988232e-11
increased O 0 4.5644926727206325e-10
by O 0 3.5698823896979093e-09
cycloheximide O 0 9.317453077528626e-05
. O 0 1.9661974874907173e-06

A O 0 1.5144344160944456e-06
deletion O 0 3.925214571154356e-07
mutation O 0 9.227362340880063e-08
in O 0 5.970337113581081e-09
COL17A1 O 1 0.9997239708900452
in O 0 7.952038139080742e-09
five O 0 5.074268782934155e-10
Austrian O 0 6.937004854989937e-07
families O 0 5.872024533282172e-10
with O 0 3.3821456746352396e-10
generalized O 0 0.001389688695780933
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 0 0.030353957787156105
represents O 0 6.453494449942809e-08
propagation O 0 5.835130778564235e-08
of O 0 1.7941527152842696e-09
an O 0 7.745067781561588e-11
ancestral O 0 8.154776764968119e-08
allele O 0 1.9464366118882026e-07
. O 0 9.579688509120388e-08

Patients O 0 3.371859929757193e-05
with O 0 2.1269721983685486e-08
generalized O 1 0.8523297309875488
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999986886978149
, O 0 4.908911499512669e-09
a O 0 2.1303155073315594e-10
usually O 0 5.626223931187724e-10
nonlethal O 0 3.985495879987866e-07
form O 0 1.4331167363934583e-08
of O 0 1.8787101225825609e-06
junctional B-Disease 1 0.9999561309814453
epidermolysis I-Disease 1 0.9997408986091614
bullosa I-Disease 1 0.5748826265335083
, O 0 1.2666467874566933e-09
have O 0 7.399281881648179e-11
generalized O 0 3.499521028516028e-08
blistering B-Disease 0 4.583481768349884e-06
, O 0 2.2386000608776158e-08
nail B-Disease 1 0.9999974966049194
dystrophy I-Disease 1 1.0
, O 0 9.530383067613002e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999998807907104
, O 0 2.4625077799100836e-07
and O 0 4.017108949483372e-06
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.15308204293251038

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.9982155561447144
in O 0 1.5446531165252964e-07
most O 0 5.089770382937786e-09
cases O 0 1.0759861890363709e-09
is O 0 2.4058265796211842e-11
due O 0 1.8670057500003168e-08
to O 0 3.5644714957427936e-10
mutations O 0 9.02449226458657e-10
in O 0 1.524583237433319e-10
the O 0 2.0191938399083398e-10
gene O 0 4.622834059997416e-11
encoding O 0 6.3089888868717026e-09
type O 0 7.6232081482885405e-06
XVII O 1 1.0
collagen O 0 0.019482573494315147
( O 0 4.535321096454936e-08
COL17A1 O 1 0.9998694658279419
) O 0 1.491018686294865e-08
. O 0 7.017224135097422e-08

Recently O 0 2.9527770948334364e-06
, O 0 3.0788165350514873e-09
we O 0 4.6363107797375847e-10
reported O 0 3.5298922118620624e-10
five O 0 4.7747483050697426e-11
Austrian O 0 2.1920051551660436e-07
families O 0 2.53533832816899e-10
with O 0 8.914179117081034e-11
generalized O 0 0.0003804796433541924
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 3.2485823453498597e-07
share O 0 9.905347653216268e-09
the O 0 1.490233270118324e-09
same O 0 1.3736063841918167e-08
COL17A1 O 1 0.9633487462997437
mutation O 0 1.7871132058644434e-06
. O 0 8.843758791954315e-08

Affected O 0 3.837081749225035e-06
individuals O 0 2.860024217454793e-09
in O 0 2.284075373282235e-09
three O 0 4.3005493610692724e-10
families O 0 9.612236007150443e-11
are O 0 3.432580174961286e-12
homozygous O 0 9.434682202158484e-11
for O 0 1.4441726460534543e-11
4003delTC O 0 3.341961729574905e-08
, O 0 8.038741200477872e-11
whereas O 0 2.719259928340989e-09
those O 0 1.925321430062965e-10
in O 0 2.2538412802752816e-10
two O 0 5.066799757535989e-11
others O 0 1.8468018780914974e-10
are O 0 4.137910500356945e-11
compound O 0 3.59759475543342e-08
heterozygotes O 0 2.139603793693823e-06
. O 0 2.2020665824129537e-07

To O 0 2.3714605390523502e-08
determine O 0 9.099615283503226e-09
if O 0 1.909183644510648e-10
the O 0 4.1800662931024135e-10
occurrence O 0 1.2302359131410867e-09
of O 0 2.333277571153758e-09
4003delTC O 0 2.1372002834141313e-07
in O 0 3.457025499198352e-10
these O 0 5.0402258755521956e-11
unrelated O 0 2.2988655423716864e-09
families O 0 1.8676796220695735e-11
signifies O 0 6.017741860375736e-11
propagation O 0 1.9038572940388576e-09
of O 0 1.1867218319139283e-10
an O 0 6.187966805626388e-12
ancestral O 0 1.0645307746415256e-08
allele O 0 3.778567236878416e-09
or O 0 2.4925111974383185e-10
a O 0 4.953887855485561e-10
mutational O 0 9.431972102902364e-06
hot O 0 3.9994520193431526e-05
spot O 0 2.195279193983879e-07
, O 0 8.591392181012125e-11
haplotypes O 0 2.3243582614185243e-09
were O 0 9.870391309840798e-11
determined O 0 5.001624669986882e-10
for O 0 4.136484210714997e-10
polymorphisms O 0 5.4045347752662565e-08
both O 0 4.731183889106205e-09
within O 0 1.0967672103845416e-08
and O 0 1.2825490891543723e-08
flanking O 0 1.6953881640802138e-05
COL17A1 O 1 0.9999994039535522
. O 0 1.2104369488952216e-05

Five O 0 1.3250860320113134e-06
intragenic O 0 3.9942533476278186e-05
polymorphisms O 0 4.862998821408837e-07
were O 0 1.0460735389017373e-08
chosen O 0 5.8562230620395894e-09
based O 0 2.894278150478158e-09
on O 0 1.1489571072331728e-08
their O 0 5.5975837298660736e-09
informativeness O 0 3.8063957617850974e-05
. O 0 3.4736928000711487e-07

One O 0 2.943055754656143e-08
of O 0 3.670753923046277e-09
these O 0 1.9382133398249124e-10
, O 0 1.0214305096178933e-11
not O 0 9.045507398663943e-12
previously O 0 2.037784663233566e-10
reported O 0 6.450826678383592e-11
, O 0 2.8368876692219658e-11
was O 0 1.023780438202948e-08
2988 O 0 3.580898919608444e-06
A O 0 1.5629920824267174e-07
or O 0 4.7746984144225735e-09
C O 0 2.391755515418481e-05
that O 0 2.808557726663441e-11
introduces O 0 1.260784920908975e-09
a O 0 3.998158401574692e-11
new O 0 2.978596813640877e-10
restriction O 0 9.421492030980971e-09
site O 0 3.004439808051984e-09
for O 0 7.167845761379965e-10
Eco0109 O 0 9.852449693426024e-06
I O 0 7.219666258606594e-06
. O 0 2.5337703846162185e-07

All O 0 3.606526277621924e-08
the O 0 1.624200329786163e-08
4003delTC O 0 9.966181551135378e-07
alleles O 0 2.5998248887049158e-08
showed O 0 1.006966066086079e-09
the O 0 1.5680332032808053e-10
same O 0 2.1227185287298056e-10
haplotype O 0 5.215461840180069e-09
for O 0 1.7755136250130477e-10
these O 0 5.417523096795662e-10
five O 0 2.0630137598232068e-09
polymorphic O 0 4.932057890982833e-07
markers O 0 8.204934260902519e-07
. O 0 1.9864818057158118e-07

Fourteen O 0 4.2716419557109475e-05
microsatellite O 0 4.580193490255624e-05
polymorphisms O 0 9.665247944212751e-07
were O 0 2.3763734091630795e-08
selected O 0 1.6703967986586576e-08
based O 0 2.154749711991144e-09
on O 0 6.602891122753363e-09
their O 0 9.490384034194221e-10
high O 0 8.000054663170886e-08
heterozygosity O 0 8.64368848851882e-06
and O 0 1.2826683049027565e-09
their O 0 2.012346400626086e-10
location O 0 1.0747390755128094e-09
within O 0 1.346667888313391e-09
10q23 O 0 1.4087760291658924e-06
- O 0 1.3605400681626634e-06
q25 O 0 3.832226502709091e-05
near O 0 6.488487542810617e-06
COL17A1 O 1 0.8143128752708435
. O 0 1.6113829133246327e-06

Three O 0 3.0341283263624064e-07
families O 0 1.8965803150194915e-08
shared O 0 2.049761604894229e-08
microsatellite O 0 3.0458631954388693e-06
polymorphisms O 0 2.344297769241166e-07
covering O 0 6.953617059934913e-08
at O 0 1.6114869438865753e-08
most O 0 1.0568705910429799e-09
19 O 0 1.7285194386928993e-09
cM O 0 4.223069893782849e-09
, O 0 1.9175582996466822e-11
whereas O 0 6.434560662071931e-10
the O 0 1.3132487319822417e-09
others O 0 5.349017340172679e-10
shared O 0 5.175228023901468e-10
smaller O 0 4.3842160457607804e-10
regions O 0 5.089000887359418e-10
consistent O 0 1.3844477786406628e-09
with O 0 1.843327573913811e-11
cross O 0 1.0302264596973032e-09
- O 0 6.848603462117353e-09
over O 0 4.892877769613335e-10
events O 0 1.876971841840991e-11
during O 0 3.3754929407159295e-11
passage O 0 4.5704776074906306e-10
of O 0 3.0703571629597803e-11
this O 0 3.8329023982486277e-11
mutation O 0 2.8108204652710356e-10
through O 0 1.1810787070576367e-10
several O 0 4.917530271875137e-10
generations O 0 4.147603860360505e-08
. O 0 4.387608498745976e-08

These O 0 1.1309428771255625e-07
results O 0 3.975693019242499e-08
indicate O 0 1.0478608203356998e-08
that O 0 4.46885167759703e-11
4003delTC O 0 5.786905887816829e-08
occurs O 0 1.0812776229940368e-09
on O 0 7.481595898362059e-10
a O 0 6.57957646699181e-11
single O 0 5.124211055473893e-10
ancestral O 0 2.959278333491966e-08
allele O 0 1.702309582185535e-08
. O 0 2.405874832689392e-09
. O 0 1.3738213233693841e-08

The O 0 4.509969585342333e-06
haptoglobin O 0 0.00023965051514096558
- O 0 5.553370101551991e-06
gene O 0 4.386144070167575e-08
deletion O 0 5.094609889511048e-08
responsible O 0 5.878313835694371e-09
for O 0 7.705763138687871e-09
anhaptoglobinemia B-Disease 1 0.9118838310241699
. O 0 7.69505186326569e-06

We O 0 1.9262273553977138e-07
have O 0 1.0926657356691294e-09
found O 0 2.1144792861083062e-10
an O 0 1.1420185977439878e-11
allelic O 0 8.577176657809105e-08
deletion O 0 1.6732698782107036e-08
of O 0 5.9068081981195064e-08
the O 0 1.9297650055705162e-07
haptoglobin O 0 0.00013762024173047394
( O 0 6.492725246332043e-10
Hp O 0 8.759735692365211e-08
) O 0 2.1500153046805082e-10
gene O 0 8.975175047609696e-10
from O 0 1.7001866581267677e-09
an O 0 2.7649306455490574e-11
individual O 0 2.9660957023835977e-10
with O 0 3.8443553895817217e-10
anhaptoglobinemia B-Disease 1 0.8944175243377686
. O 0 1.6079726265161298e-05

The O 0 2.614121285660076e-06
Hp O 0 5.032965418649837e-06
gene O 0 2.658494757667995e-08
cluster O 0 7.743100383095225e-08
consists O 0 1.2916538949525602e-09
of O 0 7.540907343006609e-10
coding O 0 1.4440923123970606e-08
regions O 0 4.8339700242649997e-08
of O 0 1.653080971664167e-06
the O 0 1.2672270486291382e-06
alpha O 0 2.5139900117210345e-07
chain O 0 8.029734654968479e-10
and O 0 5.501448602229786e-11
beta O 0 6.923847051254484e-10
chain O 0 1.6759417464928816e-10
of O 0 8.614006730134349e-10
the O 0 5.471505026832801e-09
haptoglobin O 0 5.003476530873741e-07
gene O 0 1.3131110643271882e-09
( O 0 4.2295146551740714e-11
Hp O 0 6.087418125133581e-09
) O 0 2.8799029133663723e-11
and O 0 1.0147627182988117e-10
of O 0 2.431719492435036e-09
the O 0 9.48834344427496e-09
alpha O 0 2.000820664704861e-08
chain O 0 1.1211812589451142e-09
and O 0 1.3266920895205203e-10
beta O 0 2.3409403304697207e-09
chain O 0 3.5886268956453193e-10
of O 0 8.041536325720244e-10
the O 0 2.9175790672297808e-09
haptoglobin O 0 8.817683010420296e-07
- O 0 3.4642830826214777e-08
related O 0 1.281190264990073e-07
gene O 0 4.228357664004534e-09
( O 0 1.5163760525016556e-10
Hpr O 0 2.2850009884223255e-07
) O 0 7.10236869316816e-11
, O 0 1.2818508754453006e-10
in O 0 9.476039952716064e-10
tandem O 0 5.672628944353164e-08
from O 0 3.798627190576553e-09
the O 0 2.0659642885334506e-08
5 O 0 4.922067731172319e-08
side O 0 1.1167580282744893e-07
. O 0 7.266287838092467e-08

Southern O 0 2.3690119633101858e-05
blot O 0 1.7707618098938838e-05
and O 0 2.2977269864554728e-08
PCR O 0 3.3500802487651526e-07
analyses O 0 1.488103773539251e-08
have O 0 4.404194370311032e-11
indicated O 0 8.048069155552895e-11
that O 0 1.6952102699016591e-12
the O 0 4.8528635970823686e-11
individual O 0 8.830105049928427e-12
with O 0 3.5948574846067505e-12
anhaptoglobinemia B-Disease 0 1.1315843266856973e-06
was O 0 1.996863474573729e-08
homozygous O 0 1.0909602110587002e-09
for O 0 1.7031620558327631e-10
the O 0 1.0859734222989914e-09
gene O 0 1.441971542170961e-10
deletion O 0 1.5871439718040392e-09
and O 0 3.005647952747381e-10
that O 0 2.0311518092452907e-11
the O 0 1.1222531792753898e-09
gene O 0 1.5727177893332112e-10
deletion O 0 1.126162274545095e-09
was O 0 3.5825695743341157e-09
included O 0 1.6860485230196787e-09
at O 0 1.5043525314339945e-09
least O 0 4.90523767437967e-11
from O 0 1.4577701545892552e-10
the O 0 1.4960287453291699e-09
promoter O 0 2.0010617163279676e-07
region O 0 2.136131982410916e-08
of O 0 8.200023415838587e-08
Hp O 0 1.4857150745228864e-06
to O 0 1.3297619716468034e-07
Hpr O 0 5.613414032268338e-05
alpha O 0 5.619023468739215e-08
but O 0 1.0089728358364525e-10
not O 0 3.649527555160681e-11
to O 0 3.872349663147645e-10
Hpr O 0 5.024749498261372e-06
beta O 0 1.6512896650056064e-07
( O 0 1.4409493598321887e-09
Hpdel O 0 1.0443039172969293e-05
) O 0 5.514986245458431e-09
. O 0 6.864352286584108e-08

In O 0 5.5228209561164476e-08
addition O 0 2.6874462655257503e-09
, O 0 2.4497809336665455e-10
we O 0 5.425058319241671e-11
found O 0 1.1906055308319452e-10
seven O 0 6.844143307649375e-11
individuals O 0 4.89506612327828e-12
with O 0 1.692565185229533e-11
hypohaptoglobinemia B-Disease 0 0.37650248408317566
in O 0 2.3153558004196384e-07
three O 0 7.3270151057514e-10
families O 0 3.108303892052078e-11
, O 0 1.8470184149493862e-12
and O 0 4.387507284570047e-12
the O 0 3.0304811438064405e-10
genotypes O 0 7.765196130549157e-08
of O 0 5.822290205514946e-08
six O 0 1.4683863014397502e-09
of O 0 4.944846310195317e-09
the O 0 1.2679859384689962e-09
seven O 0 2.142311328334756e-10
individuals O 0 4.284498103523937e-12
were O 0 1.405554422850841e-10
found O 0 2.8761481044026205e-11
to O 0 4.585257867839587e-11
be O 0 3.6429383953873185e-09
Hp2 O 0 0.04770432412624359
/ O 0 6.58739372738637e-05
Hpdel O 0 0.010854072868824005
. O 0 1.8428366956868558e-06

The O 0 1.526334131085605e-06
phenotypes O 0 4.850196546613006e-06
and O 0 1.2250921166412354e-08
genotypes O 0 3.9552611497128964e-07
in O 0 5.723180263039751e-10
one O 0 2.1479483122699428e-11
of O 0 4.0422946240292745e-11
these O 0 1.3656419745045056e-11
three O 0 5.798915601179511e-12
families O 0 5.787324612593903e-12
showed O 0 5.329238092488531e-11
the O 0 1.9193191480582072e-10
father O 0 4.043016144095191e-09
to O 0 8.632489861826187e-11
be O 0 4.887982907320065e-09
hypohaptoglobinemic B-Disease 0 0.05209849774837494
( O 0 1.1227050400464123e-09
Hp2 O 0 2.8587712677108357e-06
) O 0 3.688415198266348e-11
and O 0 1.58049420773132e-10
Hp2 O 0 1.3273689773996011e-06
/ O 0 2.5502886913386646e-08
Hpdel O 0 2.4741702873143367e-05
, O 0 4.4061293502650756e-10
the O 0 2.7976696514997457e-09
mother O 0 1.4844686591075629e-09
to O 0 4.353481811159021e-11
be O 0 2.630578255224947e-10
Hp2 O 0 6.503807526314631e-06
- O 0 3.2691310991594946e-08
1 O 0 1.3457340131139972e-08
and O 0 1.6425952265031185e-10
Hp1 O 0 3.9719344613331486e-07
/ O 0 8.936336115539234e-09
Hp2 O 0 2.182577645726269e-06
, O 0 7.962031728370178e-11
one O 0 1.2230472710983431e-11
of O 0 2.708088475689152e-10
the O 0 5.094293320517806e-10
two O 0 9.839001141598303e-11
children O 0 4.011449158958236e-11
to O 0 3.181564386944835e-12
be O 0 3.7629369065150797e-10
hypohaptoglobinemic B-Disease 0 4.5278276957105845e-05
( O 0 1.0524571214531875e-09
Hp2 O 0 4.151160283072386e-06
) O 0 9.279433471620635e-11
and O 0 6.012800257693129e-10
Hp2 O 0 1.3294034943100996e-05
/ O 0 1.8604583829073817e-07
Hpdel O 0 0.002062416635453701
, O 0 1.2256079484629367e-09
and O 0 4.009286791450961e-10
the O 0 2.3740209798006617e-09
other O 0 1.4467934628115131e-09
child O 0 8.419842045803705e-10
to O 0 5.4575222813157964e-11
be O 0 8.518800109769131e-10
Hp1 O 0 3.949234451283701e-05
and O 0 2.7383208589526475e-08
Hp1 O 0 0.00018324896518606693
/ O 0 7.136284807529591e-07
Hpdel O 0 4.4267686462262645e-05
, O 0 4.025385580419538e-10
showing O 0 3.8562744664183413e-10
an O 0 1.1069941838193209e-11
anomalous O 0 2.261481029108836e-07
inheritance O 0 3.486049081402598e-06
of O 0 2.650515853019897e-06
Hp O 0 1.6020201655919664e-05
phenotypes O 0 7.5438147177919745e-06
in O 0 3.3350702199896887e-09
the O 0 1.5661628660623705e-09
child O 0 8.636018011820568e-10
with O 0 1.076279135259206e-10
Hp1 O 0 0.0006403343286365271
. O 0 1.6379062799387611e-06

The O 0 1.8885830286308192e-06
Hp2 O 0 0.0012267155107110739
/ O 0 1.230561247211881e-05
Hpdel O 0 0.0010392877738922834
individuals O 0 5.7455391555549795e-09
had O 0 3.3044993408282153e-09
an O 0 2.194980135150626e-11
extremely O 0 3.2779956526951537e-09
low O 0 9.890870700246523e-08
level O 0 1.6640971267634086e-08
of O 0 4.4889937100833777e-08
Hp O 0 1.7306401787209325e-06
( O 0 7.823315884003534e-10
mean O 0 1.6644877476323927e-08
+ O 0 2.209372462758097e-09
/ O 0 2.3325523734740727e-09
- O 0 9.424673486080337e-09
SD O 0 2.645228107667208e-07
= O 0 9.213215745873526e-10
0 O 0 1.1837157920524533e-09
. O 0 5.94866586545173e-11
049 O 0 3.191891551068693e-08
+ O 0 2.806695431623041e-10
/ O 0 4.672977005348855e-10
- O 0 1.2768441859378754e-09
0 O 0 1.0228703439807418e-09
. O 0 8.824250358197006e-11
043 O 0 7.46535278040028e-08
mg O 0 4.629723449056655e-08
/ O 0 3.0711333476318714e-09
ml O 0 1.0151489426846183e-08
; O 0 6.364822557891614e-11
n O 0 1.2121745274207285e-10
= O 0 3.9791465261673764e-11
6 O 0 1.8833418158337167e-10
) O 0 8.59526750988937e-13
, O 0 2.1999414009238327e-12
compared O 0 1.0692119412070156e-10
with O 0 9.924413721384973e-12
the O 0 1.0263925709352861e-08
level O 0 1.1477376204993561e-07
( O 0 1.755051486085346e-11
1 O 0 1.018431783350593e-09
. O 0 4.6629228256378497e-11
64 O 0 8.244523952427585e-10
+ O 0 1.0163433289411827e-10
/ O 0 2.5129609504404016e-10
- O 0 6.21642404219358e-10
1 O 0 5.513679512958447e-10
. O 0 1.9814415733176993e-11
07 O 0 4.6713215517968365e-09
mg O 0 4.634732775343764e-08
/ O 0 3.251189983899394e-09
ml O 0 9.495729536013187e-09
) O 0 2.720682186485579e-12
obtained O 0 8.560901293419576e-11
from O 0 6.100479565951389e-10
52 O 0 7.604162277630166e-08
healthy O 0 2.8970632115488115e-08
volunteers O 0 1.3984767788244312e-09
having O 0 5.176205020163138e-10
phenotype O 0 1.5261842634117784e-07
Hp2 O 0 8.889638593245763e-06
, O 0 2.6554511367571365e-10
whereas O 0 1.194873977539146e-09
the O 0 2.2580839975638867e-10
serum O 0 4.3259396065309375e-09
Hp O 0 9.074777373996312e-09
level O 0 3.4961771255836993e-09
of O 0 4.32211877399169e-10
an O 0 3.6161828739778024e-12
individual O 0 8.813010217434414e-12
with O 0 1.1253623033447013e-11
Hp1 O 0 2.9961242034914903e-05
/ O 0 1.396616198690026e-06
Hpdel O 0 0.0002000046952161938
was O 0 4.6262897512860945e-07
0 O 0 2.4249519015029364e-07
. O 0 2.130459897387027e-08

50 O 0 4.6134772446748684e-07
mg O 0 3.833102255157428e-06
/ O 0 1.4894445143909252e-07
ml O 0 1.011347535495588e-06
, O 0 1.7215170955431347e-10
which O 0 5.0552422491134674e-12
was O 0 1.5828049981791992e-10
approximately O 0 6.0945888093189016e-12
half O 0 2.4259354941547073e-11
the O 0 3.23085481979124e-11
level O 0 3.408335835786147e-09
of O 0 1.0154219687308341e-08
Hp O 0 3.6527268321151496e-07
in O 0 1.8915372379524342e-08
control O 0 1.1272398836581488e-07
sera O 0 5.033892236383508e-08
from O 0 5.074897724277605e-10
the O 0 2.800493836829787e-09
Hp1 O 0 8.329722732014488e-06
phenotype O 0 1.048348963195167e-07
( O 0 1.4199942437176372e-11
1 O 0 4.1710268572359155e-10
. O 0 3.3638022922666266e-11
26 O 0 7.099189569537145e-10
+ O 0 2.146118838197708e-10
/ O 0 4.662649710773792e-10
- O 0 2.448558245049526e-09
0 O 0 1.4279645244030803e-09
. O 0 2.2488849324431293e-11
33 O 0 6.564662702324142e-10
mg O 0 9.22260845470646e-09
/ O 0 1.3271863608110834e-09
ml O 0 1.0447136489233344e-08
; O 0 4.317626117744666e-11
n O 0 1.354028139610719e-10
= O 0 7.467947094053073e-11
9 O 0 5.737235686531506e-10
) O 0 6.9219773142503715e-12
, O 0 1.1981475707412148e-11
showing O 0 1.4580565921296085e-10
a O 0 1.5831642941055435e-10
gene O 0 1.0757809087991177e-09
- O 0 3.5748513482758426e-08
dosage O 0 6.570248660864308e-05
effect O 0 4.647312380257063e-06
. O 0 4.5505456114369736e-07

The O 0 1.7846764421847183e-07
other O 0 6.7144489968029575e-09
allele O 0 2.0827796376465813e-08
( O 0 1.4714668372661777e-10
Hp2 O 0 1.0614154462018632e-06
) O 0 7.799295237420623e-11
of O 0 7.404127866372789e-10
individuals O 0 2.1150066073505336e-11
with O 0 2.4594348779771735e-10
Hp2 O 1 0.9995290040969849
/ O 0 0.00014542968710884452
Hpdel O 1 0.9997952580451965
was O 0 2.710676199058071e-07
found O 0 2.2946851363503384e-10
to O 0 1.950272061901348e-11
have O 0 3.414487789732412e-11
, O 0 1.5488128141116775e-11
in O 0 7.38619651552419e-11
all O 0 1.051004283603163e-10
exons O 0 1.0310933218349305e-09
, O 0 6.745065443680698e-12
no O 0 1.3949960978032472e-11
mutation O 0 4.458235516868747e-11
, O 0 2.8751593120213137e-12
by O 0 5.59683098477759e-11
DNA O 0 1.3034547663437479e-08
sequencing O 0 3.6033983974448347e-07
. O 0 8.679870688865776e-08

On O 0 7.79032660602752e-08
the O 0 7.639757160227134e-10
basis O 0 8.491303771229752e-10
of O 0 2.690378475556088e-10
the O 0 8.515124022556719e-11
present O 0 1.0393265414965214e-10
study O 0 8.104354687343829e-11
, O 0 1.0554508655946648e-12
the O 0 1.24210849938855e-11
mechanism O 0 4.0977701787348053e-10
of O 0 1.9223242997412626e-09
anhaptoglobinemia B-Disease 0 2.3862216039560735e-05
and O 0 9.767783248904038e-10
the O 0 5.522204360453031e-10
mechanism O 0 1.2572093366358672e-09
of O 0 1.6383251422169565e-09
anomalous O 0 1.1664574230962899e-06
inheritance O 0 1.439383936485683e-06
of O 0 1.943995329156678e-07
Hp O 0 1.9053804862778634e-06
phenotypes O 0 5.664968739438336e-06
were O 0 5.814854375785217e-08
well O 0 7.802785084720654e-09
explained O 0 3.8492089515784755e-08
. O 0 5.3763738350198764e-08

However O 0 3.969056479036226e-07
, O 0 1.2073341215668165e-09
the O 0 9.601539563419692e-10
mechanism O 0 1.973971741620062e-08
of O 0 4.9021490866607564e-08
hypohaptoglobinemia B-Disease 1 0.7445592284202576
remains O 0 6.961597682675347e-05
unknown O 0 1.605969555384945e-05

ATM O 0 0.0009693994652479887
mutations O 0 1.109223489947908e-06
and O 0 1.6364989363637505e-08
phenotypes O 0 8.439546945737675e-06
in O 0 1.4549946172337513e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 9.804494993659318e-07
in O 0 4.321113189487136e-10
the O 0 5.271673722551107e-11
British O 0 3.9835529319631746e-10
Isles O 0 1.8470258211777946e-08
: O 0 3.944116214182891e-11
expression O 0 1.1578348696472673e-10
of O 0 2.114120267737718e-10
mutant O 0 1.7505400462525245e-09
ATM O 0 3.308594287432243e-08
and O 0 1.9393181505122925e-11
the O 0 6.22837267871823e-11
risk O 0 2.850976121848703e-10
of O 0 1.8568764303950047e-09
leukemia B-Disease 1 0.9999985694885254
, O 0 5.593135483650258e-07
lymphoma B-Disease 1 1.0
, O 0 8.348180017492268e-06
and O 0 2.2305410311673768e-05
breast B-Disease 1 0.9999959468841553
cancer I-Disease 0 0.015840640291571617
. O 0 2.0741215394082246e-06

We O 0 3.751081223413166e-08
report O 0 7.323871509257174e-10
the O 0 9.794948185870567e-10
spectrum O 0 1.1887169648616691e-07
of O 0 6.59605614572456e-09
59 O 0 6.91286103915445e-08
ATM O 0 2.0990353277738905e-07
mutations O 0 1.0552391183082932e-09
observed O 0 1.0206642198085092e-09
in O 0 6.856945589106545e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.811357262544334e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.532747038294872e-10
patients O 0 9.351098562149218e-09
in O 0 6.067543689702859e-11
the O 0 6.163402010983532e-10
British O 0 2.6407560582697442e-08
Isles O 0 1.7660687490206328e-06
. O 0 1.937317932743099e-07

Of O 0 3.673638275358826e-05
51 O 0 1.3915116142015904e-05
ATM O 0 6.021773151587695e-05
mutations O 0 1.0214694867727303e-07
identified O 0 4.8829886800660915e-09
in O 0 1.2210346067575983e-09
families O 0 7.762375187070347e-10
native O 0 1.6851153805674812e-10
to O 0 7.842297124194264e-12
the O 0 1.7281262532087283e-10
British O 0 5.48676259981562e-09
Isles O 0 3.578173846108257e-07
, O 0 1.6415710457629018e-10
11 O 0 6.357775972354318e-10
were O 0 8.617380586883883e-09
founder O 0 1.6536817781798163e-07
mutations O 0 1.333555488258753e-09
, O 0 1.5681618503737838e-10
and O 0 4.786595564354457e-10
2 O 0 7.854120021022482e-09
of O 0 3.6208405163051793e-09
these O 0 2.277665972494347e-10
11 O 0 2.3022914130699235e-10
conferred O 0 5.402996716696862e-09
a O 0 1.078085121175576e-10
milder O 0 3.638399448391283e-06
clinical O 0 1.998705556616187e-06
phenotype O 0 5.3244818332132127e-08
with O 0 3.343040427816746e-11
respect O 0 6.884879333313165e-10
to O 0 2.378878760644909e-10
both O 0 6.255835671709065e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.857890674727969e-05
cellular O 0 1.2470762840166572e-06
features O 0 1.2357019407716052e-08
. O 0 2.125856823909089e-08

We O 0 1.7960298137609243e-08
report O 0 9.624641084116092e-10
, O 0 8.356609154658301e-11
in O 0 1.0246154619197867e-10
two O 0 6.524265849794375e-11
A B-Disease 1 0.9998708963394165
- I-Disease 1 0.9998076558113098
T I-Disease 1 1.0
families O 0 3.316439789458059e-09
, O 0 9.914387019693827e-12
an O 0 2.2690955017723446e-12
ATM O 0 2.585296776658197e-08
mutation O 0 1.0401123295977754e-09
( O 0 1.8174130603232364e-11
7271T O 0 5.338280928413042e-08
- O 0 1.652921177708322e-08
- O 0 2.458743253441753e-08
> O 0 3.906433576617019e-08
G O 0 7.21535329262224e-08
) O 0 1.1178399785677362e-12
that O 0 1.9062224400952926e-13
may O 0 9.396228586866506e-12
be O 0 3.516012784740563e-12
associated O 0 7.806454094261284e-11
with O 0 2.540040226761686e-12
an O 0 8.389562915905868e-13
increased O 0 6.29062524293289e-10
risk O 0 2.5721837104697443e-08
of O 0 1.3544231478590518e-06
breast B-Disease 1 0.9998966455459595
cancer I-Disease 0 0.0001156947182607837
in O 0 1.2682042971334795e-08
both O 0 6.464702551056689e-09
homozygotes O 0 4.028993032534345e-07
and O 0 7.509617372392086e-10
heterozygotes O 0 2.489472805677906e-08
( O 0 9.477657374190596e-12
relative O 0 6.738453350862983e-09
risk O 0 5.968763261421373e-10
12 O 0 2.980186236678506e-11
. O 0 3.0031747488140637e-12
7 O 0 1.1654301135255452e-10
; O 0 2.4201954676450477e-11
P O 0 5.3341789651994986e-08
= O 0 1.392803372635143e-10
. O 0 8.73951258584249e-11
0025 O 0 1.2399207882651808e-08
) O 0 1.1360413477989884e-12
, O 0 8.614404220334826e-13
although O 0 1.147282355923318e-11
there O 0 6.5070132442002215e-12
is O 0 2.1015144919395157e-12
a O 0 1.739338881256991e-11
less O 0 1.836788321440963e-08
severe O 1 0.6539926528930664
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.7080243825139405e-08
in O 0 4.609518929749035e-12
terms O 0 1.3794540162925806e-11
of O 0 4.525141546196654e-12
the O 0 1.0097596370162165e-11
degree O 0 2.929417375341359e-09
of O 0 2.885779792904941e-08
cerebellar B-Disease 1 0.9999997615814209
degeneration I-Disease 1 1.0
. O 0 0.00011309560795780271

This O 0 2.879462357441298e-08
mutation O 0 1.4023317618239162e-08
( O 0 9.675769907513398e-11
7271T O 0 5.800675495493124e-08
- O 0 5.5538111887187824e-09
- O 0 6.8283729781626334e-09
> O 0 2.4691528821563224e-08
G O 0 8.904250847763251e-08
) O 0 3.5067504455810194e-12
also O 0 9.862721533568375e-13
allows O 0 1.3661518747862256e-12
expression O 0 1.5073380044139384e-11
of O 0 1.383699960166851e-10
full O 0 2.1793042370710225e-10
- O 0 8.880209345640822e-10
length O 0 9.307729031959866e-10
ATM O 0 2.8333985824247065e-08
protein O 0 2.0960562452376763e-10
at O 0 1.552294404127963e-10
a O 0 1.0041265562088508e-11
level O 0 4.687921162371822e-10
comparable O 0 7.616221431305803e-09
with O 0 1.4508209737751354e-11
that O 0 1.750571562708636e-11
in O 0 9.650561461072016e-10
unaffected O 0 3.864570032874326e-07
individuals O 0 8.236303306041748e-10
. O 0 2.5660487068535076e-08

In O 0 1.2878095922985722e-08
addition O 0 8.305859333646026e-10
, O 0 5.7581717172183744e-11
we O 0 7.781090008429636e-12
have O 0 2.117310233390457e-12
studied O 0 9.870357864372181e-10
18 O 0 2.3935762261118043e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.16733318567276
, O 0 8.7195277040375e-12
in O 0 6.038181673412302e-12
15 O 0 2.7677376016055355e-11
families O 0 4.4348084232703755e-12
, O 0 2.6645810124320546e-12
who O 0 1.8570587775879055e-11
developed O 0 6.77641338597823e-08
leukemia B-Disease 1 1.0
, O 0 2.5723620638018474e-05
lymphoma B-Disease 1 1.0
, O 0 1.6824053545860806e-06
preleukemic O 1 0.9999797344207764
T O 0 0.00455827871337533
- O 0 2.6080701331920864e-07
cell O 0 1.1130574684159456e-08
proliferation O 0 5.068902186877722e-09
, O 0 1.4649635671215577e-11
or O 0 4.596654612498696e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 6.285381459747441e-06
mostly O 0 5.359756727330023e-08
in O 0 3.4112752622661446e-09
childhood O 0 3.018796519427269e-07
. O 0 9.6068049515452e-08

A O 0 1.615131441212725e-05
wide O 0 2.7777775812865e-06
variety O 0 1.2587051401169447e-07
of O 0 1.0988845389192647e-07
ATM O 0 4.416046976984944e-06
mutation O 0 8.100746740069553e-09
types O 0 9.49183753817806e-09
, O 0 1.0056335625341362e-10
including O 0 1.3574138479910403e-09
missense O 0 3.051375642826315e-06
mutations O 0 1.8934972700890285e-08
and O 0 1.6684345016670932e-09
in O 0 3.935478609662368e-09
- O 0 2.753241545860874e-08
frame O 0 3.848798257877206e-08
deletions O 0 2.5460893837703225e-08
, O 0 3.9429376430533125e-10
were O 0 6.251837270099259e-09
seen O 0 1.426439966145665e-09
in O 0 2.930270748269237e-10
these O 0 2.161521184262938e-09
patients O 0 6.919443507058531e-08
. O 0 2.144881250387698e-08

We O 0 9.6465761600939e-08
also O 0 7.35235372584242e-10
show O 0 4.5314144797581335e-11
that O 0 3.233983447790273e-13
25 O 0 4.173826215203569e-11
% O 0 7.605452725933937e-12
of O 0 9.037337544981483e-11
all O 0 7.764996423631487e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.004518280271440744
carried O 0 7.976978522172828e-10
in O 0 1.4603890319264679e-10
- O 0 1.6514613010443213e-09
frame O 0 1.8241253840756144e-08
deletions O 0 5.790317558762581e-08
or O 0 5.4469545318625023e-08
missense O 0 8.64004687173292e-06
mutations O 0 1.971353036367418e-08
, O 0 1.6118879841986455e-10
many O 0 2.868472473438466e-11
of O 0 1.8481197128217275e-10
which O 0 1.4283280287685773e-11
were O 0 3.2138439132189944e-10
also O 0 3.6989669140174986e-12
associated O 0 2.0017527566085214e-11
with O 0 1.5669172556687094e-11
expression O 0 4.4325654258159375e-09
of O 0 4.904019590412645e-08
mutant O 0 6.801040512982581e-07
ATM O 0 5.427827090898063e-06
protein O 0 1.8685452118916146e-07
. O 0 1.310692567813021e-07

The O 0 1.7468739770265529e-06
DMPK O 1 0.9998537302017212
gene O 0 9.143319061877264e-07
of O 0 1.6174968777704635e-06
severely O 1 0.9999743700027466
affected O 1 0.9999364614486694
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999995231628418
is O 0 2.089806105942671e-09
hypermethylated O 0 1.6788313814686262e-06
proximal O 0 1.4619457942899317e-05
to O 0 3.618071842126369e-09
the O 0 5.689576099143778e-08
largely O 0 2.669246725872654e-07
expanded O 0 1.4484652410828858e-07
CTG O 0 6.519015732919797e-05
repeat O 0 1.0219191608484834e-06
. O 0 5.138613801136671e-07

Using O 0 1.5399875508137484e-07
methylation O 0 1.597543132447754e-06
- O 0 1.725238689687103e-06
sensitive O 0 2.418520807623281e-06
restriction O 0 1.4355713062741415e-07
enzymes O 0 5.940825609229705e-09
, O 0 1.476555405721669e-10
we O 0 2.8145531044687644e-11
characterized O 0 3.3231373208764126e-10
the O 0 1.4351503319076642e-10
methylation O 0 1.8539850765719734e-09
pattern O 0 2.242872776392346e-09
on O 0 1.7867932688986343e-09
the O 0 3.8730144091836394e-10
5 O 0 3.5203379100678944e-10
side O 0 3.2895938750776565e-10
of O 0 8.652225047534046e-10
the O 0 8.38876434983149e-09
CTG O 0 5.481667813000968e-06
repeat O 0 6.813646091785586e-09
in O 0 5.465723429409763e-10
the O 0 9.388749777627936e-10
DMPK O 0 6.448347903642571e-06
gene O 0 3.3823069345295664e-10
of O 0 3.1984700998854976e-10
normal O 0 9.988897486934434e-10
individuals O 0 4.192630184002288e-12
and O 0 2.766159697131787e-11
of O 0 5.9670930419031265e-09
patients O 0 9.440686881134752e-07
affected O 0 4.693759336760195e-08
with O 0 1.26523303833892e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.194246017164005e-08
showing O 0 3.818050320347766e-09
expansions O 0 6.480838976585801e-09
of O 0 6.742361779998873e-09
the O 0 7.701692616990385e-09
repetitive O 0 6.323472234726069e-08
sequence O 0 7.800151635706243e-09
. O 0 1.811871008783328e-08

The O 0 1.0085976782647776e-06
gene O 0 2.917380292899452e-08
segment O 0 2.082843053585748e-08
analyzed O 0 5.210420983559061e-09
corresponds O 0 2.9468065765314577e-09
to O 0 3.3634062202025916e-10
the O 0 4.737722214542828e-09
genomic O 0 7.912855437552935e-08
SacI O 0 1.1997970432275906e-05
- O 0 1.0783374904121956e-07
HindIII O 0 1.2527156059150002e-06
fragment O 0 2.1667892369237052e-08
carrying O 0 9.256214461572654e-09
exons O 0 4.245913132194801e-08
11 O 0 8.563343811829327e-09
- O 0 4.222282967702995e-08
15 O 0 3.3687381773006564e-08
. O 0 5.734014152380951e-08

There O 0 6.570004984496336e-08
is O 0 1.9807708806496294e-09
constitutive O 0 8.306973882099555e-07
methylation O 0 1.0110487664860557e-06
in O 0 2.3247149272265233e-07
intron O 0 6.713120910717407e-06
12 O 0 1.7912199723468802e-08
at O 0 1.5766290495378144e-09
restriction O 0 8.99209151583591e-09
sites O 0 2.646336261236115e-09
of O 0 4.849417312158266e-09
SacII O 0 7.511994772357866e-05
and O 0 1.779071290286538e-08
HhaI O 0 7.256942626554519e-05
, O 0 3.457407971030335e-10
localized O 0 6.653587014682216e-09
1 O 0 5.858211693521298e-09
, O 0 2.4948928339929566e-11
159 O 0 2.765281559291566e-09
- O 0 9.904360664947376e-10
1 O 0 4.698854194629121e-09
, O 0 9.075772078315225e-11
232 O 0 8.365707238056075e-09
bp O 0 8.944981644276595e-09
upstream O 0 1.3953227906426946e-08
of O 0 4.378769347113121e-09
the O 0 2.3485757338903568e-08
CTG O 0 1.566595892654732e-05
repeat O 0 1.5767470884497925e-08
, O 0 1.4526824188010323e-10
whereas O 0 8.887325875228669e-10
most O 0 8.414796637268296e-11
, O 0 3.8588828313312895e-12
if O 0 1.897756474536494e-12
not O 0 4.2895509193285886e-12
all O 0 1.861353085552686e-11
, O 0 6.66047121969382e-12
of O 0 1.2524291326254655e-10
the O 0 9.406472128992149e-11
other O 0 1.1686302966995576e-11
sites O 0 6.14744366522757e-11
of O 0 4.756807170380739e-10
SacII O 0 5.317647719493834e-06
, O 0 8.915544413845566e-10
HhaI O 0 3.62741484423168e-05
, O 0 1.4507338663705127e-09
and O 0 2.5729971486754266e-09
HpaII O 0 4.5983684685779735e-05
in O 0 3.2817366601989306e-09
this O 0 2.011916605537678e-10
region O 0 4.832096056617274e-09
are O 0 3.0802421724374085e-10
unmethylated O 0 3.1717678439235897e-07
, O 0 4.599693542717276e-11
in O 0 8.745648649721716e-11
normal O 0 2.6680635478726344e-09
individuals O 0 1.6296250807124046e-11
and O 0 7.389550082947949e-11
most O 0 3.8864156337581335e-10
of O 0 3.427122807764249e-09
the O 0 4.455640478795431e-08
patients O 0 5.739506150348461e-07
. O 0 6.181891620826718e-08

In O 0 1.8498461429317103e-08
a O 0 2.5289245697557305e-10
number O 0 1.7080256653478898e-10
of O 0 7.734653806323877e-09
young O 0 4.1341376544323793e-08
and O 0 2.108145658041849e-09
severely O 0 2.2136352981760865e-06
affected O 0 5.116813213135174e-07
patients O 0 3.55191036760516e-06
, O 0 5.943471409475265e-11
however O 0 1.8705337279101286e-09
, O 0 4.119341673325394e-11
complete O 0 9.30183707836818e-10
methylation O 0 8.346518143298454e-09
of O 0 7.555639669476477e-09
these O 0 1.1947297318126715e-10
restriction O 0 2.960258926876236e-09
sites O 0 5.784108192408155e-10
was O 0 4.1830730546088546e-10
found O 0 4.489509111693657e-11
in O 0 9.882390739068825e-11
the O 0 1.4110643764553288e-09
mutated O 0 1.0831115559994942e-07
allele O 0 2.2344542571772763e-07
. O 0 1.0103723013799026e-07

In O 0 5.104589462234799e-08
most O 0 1.5075752868298764e-09
of O 0 8.674962415078369e-10
these O 0 3.215910315823578e-10
patients O 0 3.4496765444202993e-09
, O 0 1.5350159294699739e-12
the O 0 1.2501038398893272e-11
onset O 0 9.000372074297047e-07
of O 0 4.1410004314457183e-07
the O 0 1.0901736459345557e-05
disease O 1 0.9987081289291382
was O 0 0.00020443691755644977
congenital O 1 1.0
. O 0 3.430694050621241e-05

Preliminary O 0 1.1676287613227032e-05
in O 0 2.3574267515868996e-07
vivo O 0 1.0482915513421176e-06
footprinting O 0 6.795157241867855e-05
data O 0 9.745011908535162e-09
gave O 0 2.3961250761317388e-09
evidence O 0 1.4182741647772446e-09
for O 0 1.8262436007887572e-10
protein O 0 1.983727626608811e-09
- O 0 1.429412233022731e-08
DNA O 0 7.3863728466960765e-09
contact O 0 1.0053497617734664e-10
in O 0 4.523661722988237e-10
normal O 0 3.277453686223453e-08
genes O 0 1.168883434488066e-09
at O 0 9.31408616899887e-10
an O 0 2.131257149928789e-11
Sp1 O 0 8.111542371125324e-08
consensus O 0 4.074712123269819e-08
binding O 0 7.2278023566241245e-09
site O 0 1.3193577785841626e-08
upstream O 0 3.0037980991437507e-09
of O 0 1.3393571807185367e-09
the O 0 3.902789647014515e-09
CTG O 0 2.424950480417465e-06
repeat O 0 3.277970783699402e-09
and O 0 8.918940586077895e-11
for O 0 8.256222962244042e-12
a O 0 2.4835869038425384e-12
significant O 0 1.4919324456408312e-11
reduction O 0 5.933529778623381e-10
of O 0 4.762799044044641e-10
this O 0 4.001980691281659e-11
interaction O 0 1.8035528626114683e-10
in O 0 6.11307948705786e-11
cells O 0 3.8975860733314605e-11
with O 0 4.223716428691793e-12
a O 0 3.7432296151607147e-10
hypermethylated O 0 4.931036164634861e-05
DMPK O 1 0.9998062252998352
gene O 0 2.935309169060929e-07
. O 0 3.8663017676299205e-08
. O 0 9.143792567556375e-08

The O 0 8.866041025612503e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.271139012715139e-06
product O 0 2.089747681566223e-07
complexes O 0 6.069496549798714e-08
with O 0 1.893155909815647e-10
the O 0 4.133654751825588e-09
transferrin O 0 9.710232689030818e-07
receptor O 0 4.678475207242627e-08
and O 0 7.770893373226784e-10
lowers O 0 1.0622652091285545e-08
its O 0 1.5879092485349133e-10
affinity O 0 7.209610131120314e-10
for O 0 2.1180635023654304e-10
ligand O 0 2.1480177281318902e-07
binding O 0 3.5024669386984897e-07
. O 0 2.928492506271141e-07

We O 0 4.185367856734956e-07
recently O 0 5.029314209537006e-08
reported O 0 1.905906321653106e-09
the O 0 9.185947558165708e-10
positional O 0 1.075831193020349e-07
cloning O 0 1.1095625751522675e-07
of O 0 9.18331966026642e-10
a O 0 1.7771023541612863e-10
candidate O 0 1.4788708924129423e-08
gene O 0 3.4882770005850716e-09
for O 0 5.0176250709910164e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 6.020338787493529e-06

The O 0 9.361773578575594e-08
gene O 0 1.2463624576852794e-09
product O 0 4.11241396491846e-09
, O 0 5.585281889763927e-11
a O 0 1.7206264191216292e-11
member O 0 4.0778162097021564e-11
of O 0 4.825011501452536e-10
the O 0 1.352849166025294e-09
major O 0 3.7098419625181123e-07
histocompatibility O 1 0.9915438890457153
complex O 0 1.6552814486203715e-05
class O 0 2.475543112723244e-07
I O 0 3.3787962649967085e-08
- O 0 3.4011986560500418e-09
like O 0 3.4522812386583723e-10
family O 0 1.6273236230768262e-11
, O 0 1.1727472291889196e-12
was O 0 1.1324382404032107e-10
found O 0 3.523191113852242e-11
to O 0 4.845464307567937e-11
have O 0 9.636136333313061e-11
a O 0 5.285237802965526e-10
mutation O 0 2.5491493360618733e-09
, O 0 5.116661538906442e-10
Cys O 0 3.5836078495776746e-06
- O 0 1.4405659953808936e-07
282 O 0 1.3399588283391495e-07
- O 0 2.0563561520248186e-08
- O 0 1.9314731147801467e-08
> O 0 1.0685284479450274e-07
Tyr O 0 1.0788389772642404e-06
( O 0 2.1670918531890848e-11
C282Y O 0 1.269666061176622e-08
) O 0 4.507534102915489e-12
, O 0 2.1296918222002414e-12
in O 0 1.4070906766139313e-11
85 O 0 2.2728632309565455e-09
% O 0 8.71535899005238e-11
of O 0 1.0264468164322693e-09
patient O 0 2.7134746005685884e-07
chromosomes O 0 1.1073975514364065e-07
. O 0 2.699109415971179e-07

This O 0 6.76464892990225e-08
mutation O 0 4.5463117714916734e-08
eliminates O 0 1.1542996247726478e-07
the O 0 4.203245307365933e-09
ability O 0 9.564763425728984e-10
of O 0 1.7655025885687792e-08
HFE O 1 0.7934795022010803
to O 0 5.1341433326967945e-09
associate O 0 1.5429761912599815e-09
with O 0 1.1804386461367056e-11
beta2 O 0 6.946776466065785e-06
- O 0 3.351519580974127e-06
microglobulin O 1 0.7746657133102417
( O 0 8.88647877506088e-10
beta2m O 0 2.176441739720758e-05
) O 0 1.5474434233997414e-10
and O 0 3.803526105183863e-10
prevents O 0 1.6390908630370404e-09
cell O 0 4.9864752327266615e-08
- O 0 1.7229410786967492e-08
surface O 0 5.981065100968408e-07
expression O 0 1.2289025619338645e-07
. O 0 6.680242137235837e-08

A O 0 2.589852783785318e-06
second O 0 5.300528300722362e-07
mutation O 0 5.898395105674581e-09
that O 0 1.2871912737077995e-11
has O 0 3.272118903954735e-12
no O 0 2.9399640274346828e-12
effect O 0 2.1589736942662086e-10
on O 0 7.724583639401317e-09
beta2m O 0 2.873212179110851e-05
association O 0 4.683401222393968e-09
, O 0 1.2863157761167088e-10
H63D O 0 0.4238038957118988
, O 0 2.2292111212518506e-10
was O 0 4.20538670553583e-09
found O 0 2.1800940219751652e-10
in O 0 1.734790644469797e-10
eight O 0 4.041402490440049e-10
out O 0 1.313010117298674e-10
of O 0 4.3402952343285506e-09
nine O 0 2.3893763412274893e-08
patients O 0 3.5052725166906384e-08
heterozygous O 0 6.026406040859911e-10
for O 0 8.577392962560992e-11
the O 0 1.0311529408113529e-08
C282Y O 0 6.286652478593169e-06
mutant O 0 1.2164533700342872e-06
. O 0 1.1807785682549365e-07

In O 0 1.4197499176304973e-08
this O 0 1.4185547181355673e-10
report O 0 2.346585425971881e-10
, O 0 3.215418209467913e-11
we O 0 1.77517046201503e-11
demonstrate O 0 2.005690336037702e-10
in O 0 4.517195506537064e-10
cultured O 0 4.980553285349743e-07
293 O 0 3.7606596947625803e-07
cells O 0 4.2471846484204434e-08
overexpressing O 0 1.3197287671573577e-06
wild O 0 6.037698341287978e-08
- O 0 5.3879305461634885e-09
type O 0 4.00746351658654e-08
or O 0 6.160831400592315e-09
mutant O 0 5.707596528736758e-07
HFE O 0 2.1715117327403277e-05
proteins O 0 3.3009700528552344e-10
that O 0 9.132707610992608e-12
both O 0 5.956749676849782e-11
the O 0 6.089644899454072e-10
wild O 0 6.264826879487373e-08
- O 0 7.990153427783753e-09
type O 0 5.3627015716983806e-08
and O 0 8.671889872857719e-09
H63D O 1 0.9990148544311523
HFE O 0 0.0052756983786821365
proteins O 0 3.9030876308743245e-09
form O 0 2.9244431321018283e-09
stable O 0 5.6846052309822426e-09
complexes O 0 3.4884214961117266e-10
with O 0 6.711711048046354e-12
the O 0 5.403055780561772e-10
transferrin O 0 2.804104042297695e-07
receptor O 0 7.24876301205768e-08
( O 0 6.019409970470235e-10
TfR O 0 1.6100556194942328e-06
) O 0 5.510830125565747e-10
. O 0 1.875893751446256e-08

The O 0 8.390782113565365e-07
C282Y O 0 3.2169562473427504e-05
mutation O 0 2.6476561743038474e-07
nearly O 0 1.6001597824555347e-09
completely O 0 8.695172915018645e-10
prevents O 0 1.8205295604367677e-10
the O 0 8.404086315749737e-10
association O 0 1.011416395080289e-09
of O 0 1.1358221030377535e-09
the O 0 4.9839430360520964e-09
mutant O 0 1.4093939171289094e-07
HFE O 0 3.080760870943777e-05
protein O 0 7.340643648490186e-09
with O 0 9.312056681309855e-11
the O 0 1.734759358384963e-08
TfR O 0 2.7932121156482026e-05
. O 0 1.1674517708115673e-07

Studies O 0 3.243499406835326e-07
on O 0 2.7368850297193603e-08
cell O 0 1.6088703702621387e-08
- O 0 2.7189381857084527e-09
associated O 0 2.2746020622577134e-09
transferrin O 0 7.14960265213449e-07
at O 0 2.3920213365613563e-08
37 O 0 3.2227587265509783e-09
degrees O 0 2.236031093616475e-08
C O 0 6.596675206083091e-08
suggest O 0 1.7058214563103746e-10
that O 0 2.9110156125888853e-12
the O 0 1.3761626282970951e-09
overexpressed O 0 1.6729305798435234e-06
wild O 0 2.1305294239937211e-07
- O 0 2.425795919691609e-08
type O 0 1.5383376705813134e-07
HFE O 0 1.9072738723480143e-05
protein O 0 3.802360204474553e-09
decreases O 0 2.459661363474197e-09
the O 0 2.991270009466973e-10
affinity O 0 1.0906376912700466e-09
of O 0 8.949926355583671e-10
the O 0 7.727442685734331e-09
TfR O 0 2.7234350454818923e-06
for O 0 3.4441605123447516e-09
transferrin O 0 8.453386726614553e-06
. O 0 3.5439214229882054e-07

The O 0 5.099091868032701e-05
overexpressed O 0 0.0018865220481529832
H63D O 1 0.9933537244796753
protein O 0 8.341412893742017e-08
does O 0 1.9334540912741005e-10
not O 0 2.841924265362117e-11
have O 0 2.540796132516343e-12
this O 0 2.0786399945044165e-12
effect O 0 2.7865326712728233e-10
, O 0 1.4031484307786002e-11
providing O 0 4.682735796346371e-11
the O 0 1.494293230819288e-11
first O 0 1.2948444400029402e-11
direct O 0 6.433522551502202e-12
evidence O 0 3.441215368216177e-11
for O 0 6.116295404173799e-12
a O 0 2.9669600110082683e-11
functional O 0 9.400150879912417e-09
consequence O 0 5.802136016086479e-08
of O 0 4.5880732102432376e-08
the O 0 1.9100949089079222e-07
H63D O 1 0.835081160068512
mutation O 0 1.9229396457376424e-06
. O 0 1.0555822882452048e-07

Addition O 0 2.3657462122628203e-07
of O 0 2.359689403874654e-07
soluble O 0 0.006239852402359247
wild O 0 1.0510761057958007e-05
- O 0 2.5008287707350974e-07
type O 0 1.245626208401518e-06
HFE O 1 0.9999818801879883
/ O 0 9.796909580472857e-05
beta2m O 0 0.006869204342365265
heterodimers O 0 4.298726707929745e-05
to O 0 3.57399732031638e-09
cultured O 0 1.1648182862700196e-07
cells O 0 1.9027828201956254e-09
also O 0 6.247584047325283e-12
decreased O 0 2.0138246625833744e-10
the O 0 3.0947688856031164e-11
apparent O 0 7.55023321641346e-10
affinity O 0 9.333115391640945e-10
of O 0 2.112851449354025e-09
the O 0 1.558703721649124e-09
TfR O 0 4.9041599226029575e-08
for O 0 1.24210849938855e-11
its O 0 3.830050426117948e-12
ligand O 0 3.835164130716606e-10
under O 0 3.983114282846145e-09
steady O 0 6.357766757503214e-09
- O 0 7.270699320383045e-11
state O 0 7.346767291749323e-12
conditions O 0 4.893076166467836e-09
, O 0 1.7672620311603993e-11
both O 0 2.2934763463378083e-11
in O 0 1.7537372942744156e-10
293 O 0 9.364145014956193e-09
cells O 0 1.4501639888919726e-09
and O 0 1.8342483087963046e-10
in O 0 6.382918638081492e-09
HeLa O 0 8.440207238891162e-06
cells O 0 6.543679376136424e-08
. O 0 2.9501428855382983e-08

Furthermore O 0 6.917779842297023e-07
, O 0 1.7461082579828258e-09
at O 0 1.384365955203748e-09
4 O 0 1.776300329048297e-09
degrees O 0 7.52367412815147e-08
C O 0 1.0560036116658011e-06
, O 0 1.8693333339592222e-11
the O 0 1.0802751748695272e-10
added O 0 6.203832447759794e-10
soluble O 0 5.093983190818108e-07
complex O 0 9.58140589091272e-08
of O 0 6.694706655707705e-08
HFE O 0 0.001947453012689948
/ O 0 5.303572265802359e-07
beta2m O 0 1.5260037571351859e-06
inhibited O 0 1.5039629985835745e-08
binding O 0 2.6097000116465097e-09
of O 0 4.447402446317028e-09
transferrin O 0 2.6626972271515115e-07
to O 0 9.291751368323276e-09
HeLa O 0 5.622202934318921e-06
cell O 0 4.933995612077524e-08
TfR O 0 2.0519098598015262e-07
in O 0 7.339572005715667e-11
a O 0 6.384275746951218e-11
concentration O 0 3.8721687189990917e-08
- O 0 3.4192961351209306e-08
dependent O 0 4.6891692306871846e-08
manner O 0 1.208272806252353e-07
. O 0 1.5921877150049113e-07

Scatchard O 0 0.00017642152670305222
plots O 0 1.3552513564718538e-06
of O 0 4.645335494046776e-08
these O 0 8.649618243872226e-10
data O 0 5.118184209784715e-10
indicate O 0 4.51673004553399e-10
that O 0 1.3541463089739025e-11
the O 0 1.7162558041405873e-09
added O 0 1.7735546364860966e-09
heterodimer O 0 5.1383100441171337e-08
substantially O 0 8.949776919564556e-09
reduced O 0 8.37001667974846e-09
the O 0 6.039765909626738e-10
affinity O 0 3.094488443267096e-09
of O 0 5.263982583159077e-09
TfR O 0 1.820311126721208e-06
for O 0 2.390783793160267e-09
transferrin O 0 5.829585006722482e-06
. O 0 5.171488624000631e-07

These O 0 2.29348842140098e-08
results O 0 1.3658550734874098e-08
establish O 0 4.340104720057525e-09
a O 0 1.323146731069258e-10
molecular O 0 3.330537623469354e-09
link O 0 9.061195682669165e-10
between O 0 6.764943272230539e-09
HFE O 1 0.9999998807907104
and O 0 2.0899071273561276e-07
a O 0 8.121260997029367e-09
key O 0 3.51184525015924e-07
protein O 0 1.7938652785431941e-09
involved O 0 3.7647962525255707e-10
in O 0 5.588929319344516e-10
iron O 0 2.1359055608627386e-06
transport O 0 3.519321865042002e-07
, O 0 1.7363796511737917e-10
the O 0 1.9621577695971837e-09
TfR O 0 8.971953775471775e-07
, O 0 2.0410742540555304e-11
and O 0 1.692949426479462e-11
raise O 0 7.327220774566712e-11
the O 0 5.502970648607608e-11
possibility O 0 2.367995799446021e-10
that O 0 1.922398438353179e-12
alterations O 0 1.50494745554397e-08
in O 0 1.3477721716448343e-10
this O 0 1.1503784903832415e-11
regulatory O 0 3.880359145114198e-09
mechanism O 0 2.0273569489859256e-09
may O 0 1.0287949381293515e-09
play O 0 4.953046861544408e-10
a O 0 1.0235680358849919e-11
role O 0 7.912119570629983e-11
in O 0 1.3189337122465616e-10
the O 0 4.58920856871714e-09
pathogenesis O 0 0.2650865316390991
of O 0 0.0022761260624974966
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9682365655899048
. O 0 8.499508794557187e-07

Genomic O 0 2.4743467292864807e-06
organization O 0 2.8478050140279265e-08
of O 0 2.1113539361294897e-08
the O 0 3.729539912455948e-07
UBE3A O 1 0.9999970197677612
/ O 0 0.0010348763316869736
E6 O 1 0.8833156824111938
- O 0 1.7865842892206274e-05
AP O 0 2.9094926503603347e-05
gene O 0 1.2530779081032506e-08
and O 0 4.5180398311472914e-10
related O 0 1.4963782746235665e-07
pseudogenes O 0 6.84042097418569e-05
. O 0 1.7899208160088165e-06

The O 0 9.203928129863925e-06
UBE3A O 0 0.001653492683544755
gene O 0 9.915974885643664e-08
encodes O 0 7.450157379906841e-09
the O 0 2.704885915250088e-08
E6 O 0 0.00010991669842042029
- O 0 1.8416491229800158e-06
AP O 0 9.00877876119921e-06
ubiquitin O 0 4.820554977413849e-07
- O 0 2.9334623263821413e-07
protein O 0 3.711778884252226e-09
ligase O 0 2.1066876243480692e-08
and O 0 3.868778630788938e-09
has O 0 9.41801567289069e-11
recently O 0 2.686998956669129e-10
been O 0 2.7654580014857544e-11
shown O 0 6.679261310704732e-12
to O 0 5.183540662673236e-12
be O 0 1.6596800322954408e-10
mutated O 0 4.331128366175108e-06
in O 0 0.0003029653453268111
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999856948852539
who O 0 1.189582321536875e-09
lack O 0 9.43425959576416e-09
15q11 O 0 6.942398727005639e-07
- O 0 1.4544477267008915e-07
q13 O 0 1.6582157513767015e-06
deletions O 0 8.721939792621924e-08
or O 0 3.0716018617482632e-09
chromosome O 0 1.6768803234867846e-08
15 O 0 3.016747029960243e-08
paternal O 0 1.6204015992116183e-05
uniparental B-Disease 1 0.9989691972732544
disomy I-Disease 1 0.9796590805053711
. O 0 2.578094063210301e-05

Previous O 0 0.00010697474499465898
UBE3A O 0 0.001956420950591564
cDNA O 0 2.123686272170744e-06
analysis O 0 2.4692706546147747e-08
has O 0 1.2422748940643658e-10
shown O 0 7.279344488297923e-11
a O 0 4.043212292748066e-11
coding O 0 9.300758385677454e-09
region O 0 5.346572518050152e-09
of O 0 6.176232414389915e-09
approximately O 0 1.5327713542845345e-09
2 O 0 2.042490976350564e-08
. O 0 1.5044394174879017e-08

6 O 0 2.8399341317708604e-05
kb O 0 2.895497891586274e-05
and O 0 8.198237644307937e-09
a O 0 2.179247005074103e-09
3 O 0 8.513009674970817e-08
- O 0 2.76357013717643e-07
untranslated O 1 0.9719770550727844
region O 0 7.965430626200032e-08
( O 0 1.7876071456424114e-10
UTR O 0 7.961710798554122e-05
) O 0 4.4942216614884956e-11
of O 0 1.611406230672685e-09
< O 0 3.406952941986674e-08
50 O 0 9.600207739879352e-09
bp O 0 3.347988997148832e-09
, O 0 3.415314558941063e-11
whereas O 0 7.604052942866701e-10
Northern O 0 1.3160295075920203e-09
analysis O 0 3.6660782742892195e-10
has O 0 2.4465157330566534e-11
indicated O 0 5.4127691911931564e-11
mRNA O 0 2.850372715634819e-10
sizes O 0 1.0661577176662718e-09
of O 0 1.4592758112996762e-09
5 O 0 2.2336312355264454e-08
- O 0 1.2111570413253503e-07
8 O 0 1.613429816416101e-07
kb O 0 4.058524154970655e-06
. O 0 3.029138042620616e-07

We O 0 3.54835862026448e-07
have O 0 3.032755158116629e-09
analyzed O 0 1.9065401701823248e-08
additional O 0 3.0485938218305364e-09
cDNA O 0 4.049601898259425e-07
clones O 0 3.372319667960255e-07
and O 0 4.2365735919425163e-10
provide O 0 3.035385137684088e-11
evidence O 0 1.0738984007607755e-10
for O 0 1.9741760309832657e-11
an O 0 5.379461199411795e-12
additional O 0 1.961468210076589e-10
0 O 0 4.723666791051073e-08
. O 0 1.3470025983508549e-08

5 O 0 8.24214566819137e-06
kb O 0 2.2170066586113535e-05
of O 0 4.331589593675744e-07
5 O 0 2.931208200607216e-07
- O 0 4.808924245480739e-07
UTR O 1 0.9320306777954102
and O 0 1.4470417086798193e-09
> O 0 3.515537372322797e-08
2 O 0 9.527987288038275e-09
kb O 0 6.661932161478035e-08
of O 0 7.719473060774362e-09
3 O 0 7.324827606680628e-07
- O 0 9.64945775194792e-06
UTR O 1 0.9999372959136963
. O 0 6.492483635156532e-07

We O 0 3.857352126601654e-08
have O 0 2.677590649202699e-10
established O 0 5.506301525848301e-10
the O 0 7.399676704711311e-11
genomic O 0 7.763293896623225e-10
organization O 0 1.2837103602336697e-10
of O 0 2.7097952770560596e-09
UBE3A O 0 0.0005968871992081404
and O 0 5.415208836900831e-10
the O 0 2.6193133773055877e-10
sequence O 0 1.5957303534097633e-10
of O 0 3.910688217700908e-09
intron O 0 1.2363689165795222e-06
- O 0 2.7423723167885328e-06
exon O 0 3.7246354622766376e-06
borders O 0 6.861197476837333e-08
. O 0 2.249210666604995e-07

We O 0 8.585717523601488e-07
have O 0 1.031019181141346e-08
also O 0 1.1064655858206152e-09
mapped O 0 2.5124077041027704e-08
two O 0 7.310040905927906e-10
highly O 0 2.6568168109974977e-08
homologous O 0 1.8795255130044097e-08
processed O 0 7.000579671512241e-07
pseudogenes O 0 4.740065833175322e-06
, O 0 2.6392690255505613e-09
UBE3AP1 O 0 0.45348528027534485
and O 0 4.3918198855408264e-08
UBE3AP2 O 1 0.9997496008872986
, O 0 1.6035449634799193e-09
to O 0 1.883065092744829e-10
chromosomes O 0 3.5521802166371685e-10
2 O 0 3.8686140402255376e-10
and O 0 2.9881378621476884e-11
21 O 0 1.236054814057752e-09
, O 0 2.116689289122231e-11
respectively O 0 8.626766523356366e-10
, O 0 2.7203413133225496e-11
and O 0 4.1807338840849084e-11
determined O 0 1.0030403174710045e-09
their O 0 5.047530171609083e-10
genomic O 0 1.438555674582176e-08
organization O 0 1.84769421984754e-09
. O 0 1.2220581879773817e-08

These O 0 6.624477322247913e-08
results O 0 3.5923353181033235e-08
will O 0 2.9481656005359014e-10
form O 0 2.534608078974543e-10
the O 0 1.1553155654375757e-10
basis O 0 4.308724557700039e-11
for O 0 1.2502510962283941e-12
studies O 0 2.732643972214177e-12
of O 0 4.733180861138386e-12
mutation O 0 4.357311733649283e-11
and O 0 8.612802832042021e-11
imprinting O 0 2.694366685318528e-07
of O 0 1.256938730875845e-06
UBE3A O 1 0.999993085861206
. O 0 9.177256288239732e-06

Mutation O 0 9.966589459509123e-06
spectrum O 0 1.642456481931731e-05
and O 0 2.2376267949653084e-08
genotype O 0 5.915934252698207e-06
- O 0 5.494131869454577e-07
phenotype O 0 1.0695907093349888e-07
analyses O 0 1.3669698706308964e-09
in O 0 4.872798275989965e-10
Cowden B-Disease 1 0.9999884366989136
disease I-Disease 0 5.774474630015902e-06
and O 0 6.1170979392954905e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.43994474308829e-09
two O 0 8.938977558159422e-09
hamartoma B-Disease 1 0.9999575614929199
syndromes I-Disease 1 0.9999529123306274
with O 0 3.2629257020744262e-06
germline O 1 0.9997140765190125
PTEN O 1 0.9991700649261475
mutation O 0 8.043175512284506e-06
. O 0 1.6520488088644925e-07

The O 0 0.00012194273585919291
tumour B-Disease 1 1.0
suppressor O 1 0.9617292284965515
gene O 0 2.106939791701734e-05
PTEN O 0 0.07794652879238129
, O 0 2.369325180495707e-09
which O 0 1.7020353182406467e-10
maps O 0 5.256317159307855e-09
to O 0 1.4186529728732467e-09
10q23 O 0 3.7287558370735496e-05
. O 0 9.748674756338005e-07

3 O 0 7.664312420274655e-07
and O 0 2.1050639009700944e-09
encodes O 0 7.531635315416452e-10
a O 0 2.783138441930788e-10
403 O 0 1.1041660030741696e-08
amino O 0 1.3992771386028835e-09
acid O 0 2.910081731144487e-09
dual O 0 4.385321883404458e-09
specificity O 0 2.439897528461188e-08
phosphatase O 0 3.7630090901075164e-06
( O 0 1.0073003542387937e-09
protein O 0 1.4787067126320608e-09
tyrosine O 0 4.554102872589283e-09
phosphatase O 0 2.5571907258381543e-08
; O 0 4.024595101626005e-10
PTPase O 0 1.207645482281805e-06
) O 0 5.991755702705603e-11
, O 0 2.9015602420745523e-11
was O 0 4.639663930827709e-10
shown O 0 5.0320511646440025e-11
recently O 0 1.705388746886527e-10
to O 0 1.4331097419884031e-10
play O 0 1.2622630052305794e-08
a O 0 2.3876076671314195e-09
broad O 0 1.2065817145412439e-06
role O 0 9.314570448282211e-09
in O 0 1.2437650909191689e-08
human O 0 4.723693791675032e-08
malignancy B-Disease 0 0.00037166557740420103
. O 0 4.1551666640771145e-07

Somatic O 0 0.15516909956932068
PTEN O 0 0.022581106051802635
deletions O 0 9.104996934183873e-06
and O 0 1.4462036901363717e-08
mutations O 0 6.062506052728622e-09
were O 0 8.075550783637198e-10
observed O 0 1.8687720260146534e-09
in O 0 4.2466155036890996e-09
sporadic B-Disease 0 0.002877774415537715
breast I-Disease 1 1.0
, I-Disease 0 1.2916195828438504e-06
brain I-Disease 1 0.9999029636383057
, I-Disease 0 1.0411687298983452e-06
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.3040773814718705e-06
lines O 0 1.4125050018520824e-09
and O 0 7.108575533765205e-11
in O 0 5.124941443446218e-11
several O 0 3.160875172714128e-10
primary O 0 1.0273737416355289e-06
tumours B-Disease 1 0.9999984502792358
such O 0 6.700478394350284e-09
as O 0 2.989721963331249e-07
endometrial B-Disease 1 0.9999988079071045
carcinomas I-Disease 1 1.0
, O 0 0.000833899131976068
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999988079071045
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9329426288604736

In O 0 5.329927788011446e-08
addition O 0 2.1134127337063546e-08
, O 0 1.1752126383157702e-08
PTEN O 1 0.9945560693740845
was O 0 2.669944194622076e-07
identified O 0 8.241053173208002e-09
as O 0 6.378667594120202e-10
the O 0 1.6960861604076172e-09
susceptibility O 0 8.055667422013357e-08
gene O 0 1.118037884495493e-09
for O 0 6.237410588028069e-10
two O 0 5.755172338695047e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 1.3623964179032555e-09
CD B-Disease 0 4.315378646424506e-06
; O 0 6.356081883041043e-09
MIM O 0 6.427380139939487e-05
158350 O 0 4.020839696750045e-07
) O 0 6.44583345033034e-11
and O 0 2.913184693476012e-10
Bannayan B-Disease 0 3.475557969068177e-05
- I-Disease 0 5.0707636546576396e-05
Zonana I-Disease 1 0.9990205764770508
( I-Disease 0 6.2289484681343765e-09
BZS I-Disease 0 0.0011503755813464522
) I-Disease 0 3.796358227781127e-10
or I-Disease 0 9.68098046172372e-10
Ruvalcaba I-Disease 0 4.782503310707398e-06
- I-Disease 0 1.4910265235812403e-06
Riley I-Disease 0 4.832034028368071e-05
- I-Disease 1 0.9982843995094299
Smith I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 1.0487609358733607e-07
MIM O 1 0.9999724626541138
153480 O 0 0.00012777074880432338
) O 0 3.730110442745627e-09
. O 0 3.10111971657534e-08

Constitutive O 0 2.2704311049892567e-05
DNA O 0 5.104132014821516e-07
from O 0 1.7117320894044497e-08
37 O 0 1.0625817026266304e-07
CD B-Disease 0 7.828770662854367e-07
families O 0 7.917799749179721e-10
and O 0 5.077579467993587e-10
seven O 0 9.340688222891913e-09
BZS B-Disease 1 0.9999912977218628
families O 0 3.2546956241219505e-09
was O 0 1.062717025490656e-08
screened O 0 8.477459090272532e-08
for O 0 4.169909573192854e-08
germline O 0 0.0008808793500065804
PTEN O 1 0.7375192046165466
mutations O 0 8.599110515206121e-06
. O 0 9.298896657128353e-07

PTEN O 0 0.018198218196630478
mutations O 0 1.1068142384829116e-06
were O 0 4.719577972878142e-08
identified O 0 2.2427615320452787e-09
in O 0 2.750477900992365e-10
30 O 0 1.4390763025673436e-09
of O 0 5.677756487187935e-09
37 O 0 6.321000256548359e-08
( O 0 8.420062563851971e-11
81 O 0 9.176114446063366e-08
% O 0 1.0823086871170062e-10
) O 0 4.725188990084561e-12
CD B-Disease 0 2.0721608962048776e-07
families O 0 1.6459415774772168e-10
, O 0 2.4799905185002302e-11
including O 0 6.72508326804433e-10
missense O 0 4.071902822033735e-06
and O 0 6.926084950009681e-08
nonsense O 0 1.485814846091671e-05
point O 0 2.2704125512973405e-07
mutations O 0 1.043727215765955e-09
, O 0 4.6656185859195176e-11
deletions O 0 3.7156180354713797e-09
, O 0 3.288552485880558e-10
insertions O 0 1.7340051172709536e-08
, O 0 1.847541702959532e-10
a O 0 5.98100236004484e-10
deletion O 0 1.051880147429074e-07
/ O 0 5.796637765342894e-07
insertion O 0 1.8978670368596795e-06
and O 0 2.644284791131213e-07
splice O 0 0.00011947388702537864
site O 0 2.638357955220272e-06
mutations O 0 2.2206162952898012e-07
. O 0 1.731641106061943e-07

These O 0 8.00915387344503e-08
mutations O 0 2.518193475964381e-08
were O 0 1.1720474368814848e-08
scattered O 0 1.3818571842350025e-09
over O 0 1.5962417498904813e-10
the O 0 1.263775084581198e-09
entire O 0 1.1048733039586978e-09
length O 0 2.854126379681077e-10
of O 0 6.510126659975413e-09
PTEN O 0 1.3925498024036642e-05
, O 0 4.404933709456493e-11
with O 0 1.0989866785701685e-12
the O 0 1.9241419221827094e-11
exception O 0 4.7112966305995485e-11
of O 0 4.4096580553709686e-11
the O 0 3.2276643163742236e-11
first O 0 2.3281332417468548e-10
, O 0 4.280203969031504e-11
fourth O 0 4.6902332684339854e-08
and O 0 3.362969902553914e-10
last O 0 3.716867169600846e-08
exons O 0 5.001363092560496e-07
. O 0 9.251417765199221e-08

A O 0 1.6124042303999886e-05
hot O 0 0.000421415752498433
spot O 0 3.1680299343861407e-06
for O 0 2.5898176048144705e-08
PTEN O 0 0.00011166757030878216
mutation O 0 3.13344017399686e-08
in O 0 3.4220801747864016e-09
CD B-Disease 0 8.61959222220321e-07
was O 0 1.739749500018206e-08
identified O 0 1.895744006219502e-09
in O 0 2.8259758977355887e-09
exon O 0 1.0049600263073444e-07
5 O 0 1.9649892823991877e-09
that O 0 4.46236754145235e-12
contains O 0 8.592489914027723e-11
the O 0 8.220044644957625e-10
PTPase O 0 5.3410996770253405e-05
core O 0 1.1403069038351532e-05
motif O 0 3.243453949863806e-09
, O 0 7.2513067599089265e-12
with O 0 1.2566774877653675e-12
13 O 0 1.2612219602026187e-10
of O 0 4.946316134457618e-10
30 O 0 1.5966657995747369e-09
( O 0 1.0507472496257275e-11
43 O 0 1.934768345535076e-09
% O 0 3.633316911222373e-11
) O 0 1.0618401123652088e-11
CD B-Disease 0 2.1417257300981873e-07
mutations O 0 3.098605150242406e-09
identified O 0 9.647506127308247e-10
in O 0 9.163565461989265e-10
this O 0 4.978195189409007e-09
exon O 0 3.943885076296283e-06
. O 0 3.5915346074943955e-07

Seven O 0 3.679146516333276e-07
of O 0 1.432331657724717e-07
30 O 0 4.6446000823152644e-08
( O 0 9.56072790381235e-11
23 O 0 1.823331374772863e-09
% O 0 1.7413039760105775e-11
) O 0 7.719281485719931e-13
were O 0 1.2859525944097783e-10
within O 0 2.4718929680922486e-10
the O 0 1.636111135461249e-09
core O 0 1.6035158978411346e-07
motif O 0 5.835903982287505e-10
, O 0 7.516401563656405e-12
the O 0 1.4250850499664125e-10
majority O 0 7.981722227601296e-11
( O 0 4.136842778057481e-12
five O 0 7.076649682913327e-11
of O 0 2.1505905944962933e-09
seven O 0 2.0683239843055645e-10
) O 0 1.606144362474582e-12
of O 0 5.60477844691043e-11
which O 0 4.1187917659835094e-11
were O 0 1.3054501479814462e-08
missense O 0 8.907170467864489e-07
mutations O 0 3.606435150516063e-09
, O 0 1.6155229931591464e-10
possibly O 0 6.068984870211125e-09
pointing O 0 7.378389010881392e-09
to O 0 1.1837016089533137e-10
the O 0 1.4531099656878155e-09
functional O 0 4.141003628888029e-08
significance O 0 6.274573394193794e-08
of O 0 5.713149064945355e-09
this O 0 1.4548875437725428e-09
region O 0 5.1398092892895875e-08
. O 0 4.343154458297249e-08

Germline O 0 0.06579598039388657
PTEN O 0 0.004873324651271105
mutations O 0 2.357790833684703e-07
were O 0 1.5823145460558408e-08
identified O 0 6.70093536214722e-10
in O 0 1.2791349923713113e-10
four O 0 8.311591692677922e-11
of O 0 1.8403327750604603e-09
seven O 0 2.11850892384291e-09
( O 0 7.82271539212509e-11
57 O 0 3.633939016367549e-08
% O 0 5.076485343202819e-10
) O 0 5.400603853011887e-10
BZS B-Disease 1 0.9994933605194092
families O 0 3.084695876509613e-08
studied O 0 7.293306794053933e-07
. O 0 3.1733773653286335e-07

Interestingly O 0 1.94286803889554e-06
, O 0 2.790347286563133e-09
none O 0 2.7347755171547306e-09
of O 0 1.0099937552965343e-09
these O 0 1.3904251361385178e-10
mutations O 0 2.596100834306725e-10
was O 0 4.738957559702328e-10
observed O 0 2.330030057784427e-10
in O 0 2.9187244288131353e-10
the O 0 1.3432209122754557e-08
PTPase O 0 0.01819186471402645
core O 0 0.00116787722799927
motif O 0 1.728901452224818e-06
. O 0 1.0022073837490098e-07

It O 0 8.906489767923631e-09
is O 0 2.3472435106697276e-10
also O 0 2.0614975004829006e-11
worthy O 0 9.303686709927206e-09
of O 0 4.4797518472527997e-10
note O 0 1.518069003836331e-10
that O 0 5.129845658501109e-13
a O 0 9.467394750106717e-12
single O 0 1.237620700367259e-10
nonsense O 0 8.11636713393682e-09
point O 0 1.5352290549941472e-09
mutation O 0 6.471345681546836e-11
, O 0 1.292880039138744e-11
R233X O 0 7.251583866718647e-08
, O 0 1.7131611407261715e-10
was O 0 1.989574283101092e-09
observed O 0 1.899522761306116e-09
in O 0 2.5876485398868e-09
the O 0 1.44783207645105e-08
germline O 0 1.6621724796550552e-07
DNA O 0 7.472871210723042e-09
from O 0 4.282263432742184e-10
two O 0 3.254046337941574e-11
unrelated O 0 9.754513641269114e-09
CD B-Disease 0 5.4781039580120705e-06
families O 0 9.039496928764379e-10
and O 0 6.552416387251014e-10
one O 0 1.091023182908657e-08
BZS B-Disease 1 0.9999985694885254
family O 0 2.537944681080262e-07
. O 0 1.7137813301815186e-07

Genotype O 0 6.634126475546509e-05
- O 0 3.3680462365737185e-06
phenotype O 0 1.3532711307107093e-07
studies O 0 8.282066699116797e-10
were O 0 6.411525477201252e-11
not O 0 2.728643916719009e-12
performed O 0 2.1388898985286176e-10
on O 0 3.0396157812973e-10
this O 0 6.599509827509564e-11
small O 0 5.949032377827734e-10
group O 0 6.843412642121294e-11
of O 0 5.155801563461182e-09
BZS B-Disease 1 0.9999998807907104
families O 0 6.751964178874914e-07
. O 0 4.209417454603681e-07

However O 0 9.750468734637252e-07
, O 0 1.2258985826463231e-08
genotype O 0 8.733165941521293e-07
- O 0 9.107709786349005e-08
phenotype O 0 6.873444391430894e-08
analysis O 0 1.7934342899650346e-09
inthe O 0 2.661925236679963e-06
group O 0 9.154337704542215e-11
of O 0 9.206346796020171e-10
CD B-Disease 0 8.282507042167708e-05
families O 0 8.254341654634345e-10
revealed O 0 2.0216602003575446e-10
two O 0 3.70651643058495e-12
possible O 0 4.004699002968515e-11
associations O 0 7.40257022346924e-11
worthy O 0 1.721134523791079e-08
of O 0 8.477208379709111e-10
follow O 0 6.784231509904259e-10
- O 0 3.4452445341059956e-09
up O 0 3.194672026918255e-10
in O 0 1.0390530796877684e-10
independent O 0 1.1990351767021679e-10
analyses O 0 2.9660802702835554e-09
. O 0 7.3978498882354415e-09

The O 0 1.4864902198041818e-07
first O 0 2.1930123494939835e-08
was O 0 2.527605680313627e-08
an O 0 3.400793188723661e-11
association O 0 2.8166810550622756e-10
noted O 0 1.1930856302910797e-10
in O 0 4.890122681788789e-11
the O 0 2.2805915489421125e-10
group O 0 4.542878226376779e-12
of O 0 4.320113711209217e-11
CD B-Disease 0 6.196351023390889e-05
families O 0 1.6868977326112145e-09
with O 0 6.880301217648821e-09
breast B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9938032627105713
. O 0 3.772387208300643e-05

A O 0 2.6154177135140344e-07
correlation O 0 6.919559147888776e-09
was O 0 3.741476017893319e-09
observed O 0 5.345804909850926e-10
between O 0 1.7021521692139885e-10
the O 0 9.430567438073467e-10
presence O 0 1.8065490214880242e-09
/ O 0 1.633923432109441e-07
absence O 0 9.2356884806577e-07
of O 0 7.636661791821098e-08
a O 0 4.50687043240805e-09
PTEN O 0 1.2155894182797056e-05
mutation O 0 2.138625943004513e-09
and O 0 1.7038597963092705e-11
the O 0 1.54048388628647e-11
type O 0 9.010440171763889e-10
of O 0 1.369138846740725e-08
breast O 0 9.319795708506717e-07
involvement O 0 9.955313018394918e-09
( O 0 1.219596201806894e-09
unaffected O 0 7.85934753366746e-05
versus O 0 0.27785229682922363
benign O 1 0.9998952150344849
versus O 1 0.8018912672996521
malignant O 0 0.33717480301856995
) O 0 9.54767109817567e-09
. O 0 4.52643682535836e-08

Specifically O 0 8.322295030893656e-08
and O 0 1.715607877983416e-09
more O 0 3.803234116528387e-11
directly O 0 9.955245655612899e-11
, O 0 1.0219468500605178e-11
an O 0 3.3590623772089545e-12
association O 0 3.6324249164110256e-10
was O 0 2.1383361747950858e-09
also O 0 7.873320918838633e-12
observed O 0 3.719549668268485e-11
between O 0 2.2554486056591827e-11
the O 0 1.3919985997201678e-10
presence O 0 6.535737229196315e-11
of O 0 3.641778212326585e-09
a O 0 5.889225107580387e-08
PTEN O 1 0.9999997615814209
mutation O 0 0.002053751377388835
and O 0 3.615065725171007e-05
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999672174453735
. O 0 1.6855541616678238e-05

Secondly O 0 7.088576967362314e-05
, O 0 1.0901723968004262e-08
there O 0 1.2310856778441348e-09
appeared O 0 3.837127060535295e-09
to O 0 2.710821150886389e-11
be O 0 7.993453815524632e-11
an O 0 1.2912935998254937e-10
interdependent O 0 2.159056577966112e-07
association O 0 2.5231358335986442e-08
between O 0 1.514108838307493e-08
mutations O 0 2.7027249771549577e-08
upstream O 0 3.7981291001187856e-08
and O 0 2.0819473922628617e-10
within O 0 6.217550918563575e-10
the O 0 8.238177251485013e-09
PTPase O 0 0.0007988566649146378
core O 0 4.3068273953394964e-05
motif O 0 2.2007643707411262e-08
, O 0 5.7618958215766014e-11
the O 0 4.815725596074572e-10
core O 0 3.048304719754924e-08
motif O 0 5.259603863549955e-10
containing O 0 5.869221775256506e-11
the O 0 5.19695744771731e-11
majority O 0 5.3243413150605434e-11
of O 0 1.7393970708212692e-09
missense O 0 2.0523678756489971e-07
mutations O 0 1.5123965413366136e-09
, O 0 4.5045626950734885e-11
and O 0 2.582778955984022e-11
the O 0 1.2517030467673607e-10
involvement O 0 5.6065534159710495e-11
of O 0 4.2722289594898655e-10
all O 0 5.189310439690509e-11
major O 0 4.313812951295404e-08
organ O 0 3.323469354654662e-05
systems O 1 0.9999432563781738
( O 0 2.051615766163195e-08
central O 0 0.0025539423804730177
nervous O 0 0.0009986255317926407
system O 0 1.4076630577619653e-05
, O 0 8.171401333356698e-09
thyroid O 1 0.999994158744812
, O 0 2.5165543775074184e-05
breast O 1 1.0
, O 0 5.95140909354086e-06
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 2.2073896488450373e-08
. O 0 6.897457183185907e-07

However O 0 4.2233060071339423e-07
, O 0 7.160944615058895e-10
these O 0 4.701242520277482e-11
observations O 0 9.720947380387202e-10
would O 0 6.147513748056e-11
need O 0 2.61633742448808e-10
to O 0 2.7481114606153767e-11
be O 0 1.8279050148506393e-11
confirmed O 0 2.636691698310045e-10
by O 0 4.729339142528488e-11
studying O 0 6.938692953539771e-10
a O 0 7.465764985392642e-12
larger O 0 1.1504954627872266e-10
number O 0 7.479480229610758e-11
of O 0 9.519808275015862e-10
CD B-Disease 0 1.858390351117123e-05
families O 0 1.0637087655140931e-08
. O 0 2.129062437461471e-08

Molecular O 1 0.987484872341156
defects O 1 0.9991538524627686
leading O 0 2.8752695016009966e-06
to O 0 4.754267535211909e-10
human O 0 1.5426436794641063e-09
complement B-Disease 0 5.067124675406376e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.671793257278068e-09
an O 0 5.149572174928396e-12
African O 0 1.711789321401369e-10
- O 0 2.197814374937934e-09
American O 0 7.312299654671506e-10
family O 0 5.497790556141524e-10
. O 0 3.794412783975076e-09

Complement B-Disease 0 3.122095949947834e-05
component I-Disease 1 0.9999719858169556
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.05816249890745e-09
C6D B-Disease 0 0.0038854177109897137
) O 0 6.677230435236936e-10
was O 0 1.8133582102564105e-07
diagnosed O 0 1.2496868293965235e-05
in O 0 1.1019148260515976e-08
a O 0 9.647395105005785e-10
16 O 0 3.993947395031228e-09
- O 0 1.0818510531862557e-09
year O 0 2.4833726186557215e-09
- O 0 1.001922278476286e-08
old O 0 2.903441398416362e-08
African O 0 5.38054434340296e-10
- O 0 4.3027481577695426e-10
American O 0 6.097847227160003e-11
male O 0 5.488326806912802e-11
with O 0 4.478100876226243e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.816281494233408e-06

The O 0 7.697260002714756e-07
patients O 0 2.7492671961226733e-06
father O 0 2.588326708519162e-07
and O 0 7.59863461041732e-09
two O 0 4.584746360336567e-09
brothers O 0 2.4940217713265156e-07
also O 0 2.3538743176843013e-10
had O 0 5.038740535923125e-09
C6D B-Disease 1 0.9999997615814209
, O 0 3.025098782583058e-10
but O 0 1.1196549937197986e-10
gave O 0 1.629747170550644e-10
no O 0 9.44070776415229e-12
history O 0 2.511638397262317e-10
of O 0 1.3367820184129187e-09
meningitis B-Disease 1 0.9999935626983643
or O 0 2.935743648180278e-09
other O 0 3.1566294023122055e-09
neisserial B-Disease 0 9.527045040158555e-05
infection I-Disease 0 2.7244655939284712e-05
. O 0 8.194689939955424e-07

By O 0 5.768524857785451e-08
using O 0 1.518038672543298e-08
exon O 0 2.4258335429294675e-07
- O 0 7.318051942206694e-09
specific O 0 1.2538686755547701e-09
polymerase O 0 7.126489176556561e-09
chain O 0 9.94714643987038e-10
reaction O 0 1.5462316982350899e-09
( O 0 2.3213965472113074e-11
PCR O 0 1.4583500629328228e-08
) O 0 5.5310773322547746e-11
/ O 0 1.2530987358871926e-09
single O 0 6.898550064526887e-10
- O 0 2.455985859128873e-09
strand O 0 3.9232843640490955e-09
conformation O 0 7.282847103162737e-10
polymorphism O 0 6.245065020671348e-10
as O 0 2.5448183491039167e-11
a O 0 7.630226311894361e-12
screening O 0 1.2267866722481813e-09
step O 0 1.4524116354053263e-09
and O 0 3.093541395271515e-11
nucleotide O 0 3.023691019787833e-10
sequencing O 0 1.267318583408894e-09
of O 0 5.593557284022665e-10
target O 0 8.93052132244776e-10
exons O 0 2.525980091760971e-09
, O 0 1.1178192919902852e-11
we O 0 3.152064330033677e-12
determined O 0 2.926069456177238e-11
that O 0 6.205006669070257e-13
the O 0 1.9015625185581086e-10
proband O 0 8.817178240860812e-07
was O 0 4.73629446773316e-09
a O 0 1.258420173622099e-10
compound O 0 1.4091931177517836e-08
heterozygote O 0 4.015834917936445e-07
for O 0 1.1326980464687608e-09
two O 0 5.974324146507115e-09
C6 O 0 0.0005084174335934222
gene O 0 2.079546987943104e-07
mutations O 0 1.1197548133168311e-07
. O 0 2.2606381833156775e-07

The O 0 1.3500277873390587e-07
first O 0 9.06196095940004e-09
, O 0 1.8667475898404007e-10
1195delC O 0 8.281394769937833e-08
located O 0 3.3352929307284285e-09
in O 0 5.073348963158253e-10
exon O 0 5.221675891675659e-08
7 O 0 1.620468559337951e-08
, O 0 3.525059757980564e-11
is O 0 5.018303914777755e-12
a O 0 1.0746027331864916e-11
novel O 0 1.0814342754628115e-09
mutation O 0 5.5874978255321395e-11
, O 0 3.874562563149775e-12
while O 0 1.7652405578938435e-11
the O 0 9.887217433668383e-11
second O 0 2.6778728123844076e-09
, O 0 8.444251548000992e-11
1936delG O 0 2.863726500379471e-08
in O 0 2.6344411097056764e-09
exon O 0 3.881559962337633e-08
12 O 0 3.165830486651089e-09
, O 0 5.577818762425579e-11
has O 0 1.14136313247859e-11
been O 0 3.4406442972478857e-11
described O 0 2.7289381865358564e-10
before O 0 5.3835442770377995e-09
to O 0 8.398830519951161e-10
cause O 0 5.554040853894548e-07
C6D B-Disease 1 0.9999998807907104
in O 0 2.4528738151730067e-08
an O 0 8.85405776474002e-11
unrelated O 0 1.9155505626144986e-08
African O 0 2.048517799835281e-09
- O 0 6.308014111056082e-09
American O 0 3.0470357348377775e-09
individual O 0 1.0848452136613673e-09
. O 0 8.061289413774375e-09

Both O 0 9.901665407596738e-07
mutations O 0 2.1368292379975173e-07
result O 0 4.150627219701164e-08
in O 0 2.127394083117906e-08
premature O 0 3.279546945123002e-06
termination O 0 4.238681412971346e-06
codons O 0 1.3832008107783622e-06
and O 0 8.18147967152072e-08
C6 O 0 0.00016922781651373953
null O 0 6.66837922835839e-06
alleles O 0 1.742809274674073e-07
. O 0 9.894154828771207e-08

Allele O 0 4.2636617081370787e-07
- O 0 2.96379152331383e-08
specific O 0 1.4498375833227328e-09
PCR O 0 3.832893469279952e-08
indicated O 0 1.5840048162019116e-09
that O 0 7.2039531458234496e-12
the O 0 8.037457366327772e-10
probands O 0 2.390152440057136e-05
two O 0 1.1517568232477515e-08
brothers O 0 1.3460014258726005e-07
also O 0 2.801251175466035e-10
inherited O 0 3.863500452894186e-08
the O 0 1.8866225914848656e-08
1195delC O 0 4.977310368303733e-07
mutation O 0 3.828697803243131e-09
from O 0 6.87383150399512e-10
their O 0 1.25347643376017e-09
heterozygous O 0 1.85045567757669e-09
mother O 0 2.0877252704387672e-10
and O 0 1.5615765625032196e-11
the O 0 2.3364474244225164e-10
1936delG O 0 2.3865435849756977e-08
mutation O 0 7.20008663801508e-10
from O 0 5.73591174557464e-10
their O 0 9.902093589531091e-10
homozygous O 0 1.2028158913324205e-08
father O 0 1.193309806524212e-08
. O 0 2.8132678409065193e-09
. O 0 3.2593252541346374e-08

PAX6 O 1 0.9947762489318848
mutations O 0 0.0001072284285328351
reviewed O 0 3.7653997424058616e-05
. O 0 4.976212494511856e-06

Mutations O 0 1.4542811186402105e-05
in O 0 2.3540164306723455e-07
PAX6 O 1 0.9406885504722595
are O 0 2.5235964429271007e-09
responsible O 0 7.552192204940411e-10
for O 0 4.080237814285681e-10
human O 0 2.089097606017276e-08
aniridia B-Disease 1 1.0
and O 0 2.0609108105418272e-05
have O 0 6.271304808791456e-09
also O 0 6.362625010192247e-11
been O 0 4.436350245495824e-11
found O 0 2.250043207308039e-11
in O 0 4.955624105518197e-11
patients O 0 1.4295996608737482e-09
with O 0 9.111710691511732e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.582429072452214e-08
with O 0 2.5826655019045575e-06
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.9911294657504186e-05
with O 0 8.424763109360356e-07
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 1.9904179637819652e-08
and O 0 2.381658648076268e-09
with O 0 5.374177547423642e-09
isolated B-Disease 0 0.01588285341858864
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9661840796470642

No O 0 1.5307175260659278e-07
locus O 0 1.0667302774436394e-07
other O 0 6.171424482559473e-10
than O 0 1.0563944857766572e-10
chromosome O 0 2.0534625111423566e-09
11p13 O 0 5.174656507733744e-07
has O 0 3.65225211185205e-10
been O 0 4.5184361807670825e-10
implicated O 0 4.266384578954785e-09
in O 0 4.066327363716482e-08
aniridia B-Disease 1 1.0
, O 0 4.977276901740879e-08
and O 0 2.356032524630791e-08
PAX6 O 1 0.9996300935745239
is O 0 8.19338707991335e-10
clearly O 0 7.407079949395268e-10
the O 0 3.8017636261322707e-10
major O 0 1.0709601205860508e-08
, O 0 2.8120096529082872e-11
if O 0 1.2500562217299116e-11
not O 0 1.0904057171079451e-11
only O 0 4.727021551964583e-11
, O 0 8.33270258349117e-11
gene O 0 3.820365135354109e-10
responsible O 0 5.242480227707347e-09
. O 0 2.8748149816237856e-07

Twenty O 0 4.902793989458587e-06
- O 0 3.813649698258814e-07
eight O 0 5.985981488265679e-09
percent O 0 1.260842541483953e-09
of O 0 5.364578781197338e-10
identified O 0 1.3593654202281868e-08
PAX6 O 0 0.01484808698296547
mutations O 0 3.694623984529244e-08
are O 0 1.2214679268041095e-09
C O 0 4.995307790522929e-06
- O 0 2.1545562844949018e-07
T O 0 1.4652290758476738e-07
changes O 0 1.4794456770772513e-09
at O 0 1.1044839709484222e-08
CpG O 0 1.6351516762824758e-07
dinucleotides O 0 2.16088892557309e-06
, O 0 4.5653197888739783e-10
20 O 0 4.4184328418239716e-10
% O 0 1.6728271545751738e-11
are O 0 1.8929554104762936e-12
splicing O 0 2.656850961457735e-09
errors O 0 6.980447153637215e-08
, O 0 2.87554591249517e-10
and O 0 1.7459107770623206e-10
more O 0 1.9955200686316843e-11
than O 0 4.4301947527136676e-11
30 O 0 6.236767768896812e-10
% O 0 7.174256327902029e-11
are O 0 1.131045430924349e-11
deletion O 0 1.0163495600679084e-09
or O 0 3.2111358017061775e-10
insertion O 0 3.3164351265213554e-08
events O 0 3.396779035824693e-08
. O 0 2.3586589747992548e-07

There O 0 2.4319989577747947e-08
is O 0 4.732860214851087e-10
a O 0 4.1064548983449356e-10
noticeably O 0 3.4612588706295355e-07
elevated O 0 3.1012730232760077e-06
level O 0 3.291304295771624e-08
of O 0 2.0879413753505105e-09
mutation O 0 6.146133602058512e-10
in O 0 1.236686308914159e-10
the O 0 3.1160696245535746e-10
paired O 0 2.80521300632941e-10
domain O 0 9.756644103742218e-11
compared O 0 2.7761559717731643e-10
with O 0 6.85094515839868e-12
the O 0 7.381073530154936e-10
rest O 0 7.608801588787628e-09
of O 0 2.2590931347821197e-09
the O 0 1.4148866966934293e-08
gene O 0 1.014382533526259e-08
. O 0 5.00346182263911e-08

Increased O 0 3.3188146630891424e-07
mutation O 0 6.044103884050855e-08
in O 0 1.3140881716111608e-09
the O 0 2.7289084325587964e-09
homeodomain O 0 2.0343281903478783e-06
is O 0 1.8156885717157678e-10
accounted O 0 1.3310853530512645e-09
for O 0 1.1494596073580166e-11
by O 0 1.1771429664353406e-10
the O 0 6.960063636540781e-09
hypermutable O 0 1.2328519005677663e-05
CpG O 0 3.7235627132758964e-06
dinucleotide O 0 1.7933192566488287e-06
in O 0 4.857871971353234e-08
codon O 0 2.385574759955489e-07
240 O 0 2.498835556252743e-07
. O 0 4.05228242073008e-08

Very O 0 8.94305458132294e-07
nearly O 0 1.3871445325719378e-08
all O 0 1.8406486335109662e-09
mutations O 0 3.596433595376425e-09
appear O 0 6.7173693274469315e-09
to O 0 8.05142008619697e-10
cause O 0 1.4677071646929107e-07
loss O 0 4.336598919962853e-07
of O 0 3.528758085735717e-08
function O 0 2.529923215366381e-10
of O 0 6.451740808266493e-10
the O 0 2.1379151227129967e-10
mutant O 0 5.374707345850993e-10
allele O 0 4.9883510516712803e-11
, O 0 4.374472138690688e-12
and O 0 3.348379733203455e-12
more O 0 2.371998431005551e-12
than O 0 1.03917933286235e-11
80 O 0 3.873834586443081e-10
% O 0 2.6319923671080936e-11
of O 0 3.178898810851649e-10
exonic O 0 5.615680152004643e-07
substitutions O 0 1.308853683212874e-07
result O 0 7.124765488697449e-08
in O 0 4.475921500102231e-08
nonsense O 0 1.5572712754874374e-06
codons O 0 5.612927793663403e-07
. O 0 2.161502123954051e-07

In O 0 3.2240089353763324e-07
a O 0 5.21071941150808e-09
gene O 0 1.4886196719743339e-09
with O 0 6.946767466819992e-11
such O 0 1.298635599056297e-08
extraordinarily O 0 2.453193246765295e-06
high O 0 5.402009151111997e-07
sequence O 0 1.0842886588591227e-09
conservation O 0 4.50216219860522e-09
throughout O 0 1.1309467251585659e-10
evolution O 0 4.322341096152371e-10
, O 0 9.322697128166801e-12
there O 0 2.0085912100231695e-11
are O 0 2.2145522915462124e-10
presumed O 0 7.634221219632309e-07
undiscovered O 0 0.00031311038765124977
missense O 0 1.2813622561225202e-05
mutations O 0 3.025107631060564e-08
, O 0 1.3758548467190934e-10
these O 0 8.988378097374294e-11
are O 0 3.576667087501484e-11
hypothesized O 0 1.2771316226789509e-09
to O 0 1.7032757149149091e-10
exist O 0 1.623765899516627e-09
in O 0 1.4778184231900582e-09
as O 0 6.449467626623573e-09
- O 0 1.7907217397805653e-07
yet O 0 2.797724540926083e-08
unidentified O 0 1.1001466404536586e-08
phenotypes O 0 6.07030656851748e-08
. O 0 2.4149455768451844e-09
. O 0 1.9033135956192382e-08

Genetic O 0 3.839914825221058e-06
heterogeneity O 0 1.3309714859133237e-06
and O 0 2.3725676978614274e-09
penetrance O 0 5.213282179283851e-07
analysis O 0 7.589331940671684e-10
of O 0 6.501738258890555e-09
the O 0 8.87762681145432e-08
BRCA1 O 0 6.660472536168527e-06
and O 0 2.1245359960175847e-07
BRCA2 O 0 8.43843663460575e-05
genes O 0 8.318883004676536e-08
in O 0 1.7513698935545108e-07
breast B-Disease 1 0.9999983310699463
cancer I-Disease 1 0.9996728897094727
families O 0 2.0312910464781453e-07
. O 0 8.69080167831271e-07

The O 0 0.005672112572938204
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.000337466160999611
Consortium O 0 2.231792905149632e-06
. O 0 6.517546324857904e-08

The O 0 4.034405520769724e-08
contribution O 0 1.887306950720813e-07
of O 0 2.270122365644056e-07
BRCA1 O 0 8.855741725710686e-06
and O 0 2.2618499428972427e-07
BRCA2 O 0 0.0007849811809137464
to O 0 1.879489673228818e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 4.986076964996755e-05
assessed O 0 4.948967671225546e-07
by O 0 3.983509522242912e-09
linkage O 0 1.456957221535049e-08
and O 0 9.375949322487642e-11
mutation O 0 1.8415949321060054e-11
analysis O 0 1.2446934975762769e-11
in O 0 1.8691978520557484e-11
237 O 0 1.5929213503795836e-09
families O 0 1.7091132328839187e-11
, O 0 8.2258191144019e-13
each O 0 1.2283483420954394e-13
with O 0 9.184532474837415e-13
at O 0 2.850177038826729e-10
least O 0 2.648237358571226e-11
four O 0 1.4247636924424878e-11
cases O 0 1.708947705569841e-10
of O 0 2.4867779302439885e-07
breast B-Disease 1 0.9995550513267517
cancer I-Disease 0 3.919170126209792e-07
, O 0 1.351009235039946e-11
collected O 0 1.0216453377731582e-10
by O 0 7.903883797455435e-11
the O 0 7.093361773513607e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 9.936248943631654e-07
Consortium O 0 1.0266239058864812e-07
. O 0 8.786605221189348e-09

Families O 0 5.0796572281797125e-08
were O 0 1.432427287895166e-09
included O 0 2.625936412758989e-10
without O 0 3.146145288734914e-10
regard O 0 3.1254403509706208e-09
to O 0 3.0729523092798416e-11
the O 0 2.1258141080782167e-10
occurrence O 0 8.64807248035504e-09
of O 0 1.0418787496746518e-05
ovarian B-Disease 1 1.0
or I-Disease 0 6.448378826462431e-06
other I-Disease 0 2.3334494017035468e-06
cancers I-Disease 1 0.989116370677948
. O 0 3.8118062093417393e-06

Overall O 0 0.00035402720095589757
, O 0 7.955500791467784e-08
disease O 0 2.2667467419523746e-05
was O 0 6.89433989009558e-07
linked O 0 6.930081895006879e-07
to O 0 2.5955390725584948e-08
BRCA1 O 0 2.3029494968795916e-06
in O 0 3.3937659349447813e-09
an O 0 5.9981785163754076e-12
estimated O 0 2.156536060837766e-11
52 O 0 1.2655305969833108e-10
% O 0 6.3278032987057475e-12
of O 0 1.3017389943748015e-10
families O 0 7.218289160837443e-11
, O 0 7.894542658481996e-11
to O 0 2.478981020459514e-09
BRCA2 O 0 4.3107044689350005e-07
in O 0 2.0626322871919456e-09
32 O 0 1.4693808392252095e-09
% O 0 5.134488320623909e-12
of O 0 4.3190506726631384e-11
families O 0 1.0929731945885646e-11
, O 0 3.0098612404522163e-12
and O 0 1.399425280518285e-11
to O 0 5.424944521381647e-11
neither O 0 1.4858170249709701e-09
gene O 0 1.631296070447874e-10
in O 0 5.685252824072506e-10
16 O 0 1.6684091885821317e-09
% O 0 4.843098838636095e-11
( O 0 1.795426871412098e-12
95 O 0 2.0824209023828644e-09
% O 0 1.2515764813425534e-10
confidence O 0 4.291889954544104e-09
interval O 0 1.7624341097643992e-08
[ O 0 4.5113623059478414e-08
CI O 0 6.549005775013939e-05
] O 0 4.404022924120454e-09
6 O 0 1.6714413186846855e-09
% O 0 2.7789413131751317e-11
- O 0 2.552067168704042e-10
28 O 0 8.867819811797517e-10
% O 0 3.139956697428836e-11
) O 0 2.306143340527478e-12
, O 0 1.553688774857953e-11
suggesting O 0 2.5436901474051865e-09
other O 0 6.948576380949589e-09
predisposition O 0 0.0010749624343588948
genes O 0 2.884404011638253e-06
. O 0 1.2588147910719272e-06

The O 0 1.8461317097262508e-07
majority O 0 5.740150132993449e-09
( O 0 1.405117411312773e-10
81 O 0 2.291660727848921e-08
% O 0 3.9157375258946914e-11
) O 0 1.4201721396100986e-12
of O 0 5.292006277635153e-10
the O 0 8.059521860559471e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.475104483006362e-08
were O 0 2.6473850889274786e-10
due O 0 6.012849773640028e-09
to O 0 9.884808527260702e-10
BRCA1 O 0 5.124340507478564e-09
, O 0 6.8282584447798556e-12
with O 0 1.266374266735426e-12
most O 0 1.1054291509937642e-10
others O 0 1.0253349558286828e-10
( O 0 2.9834719764143536e-12
14 O 0 2.538391441486709e-10
% O 0 1.3959968597765382e-11
) O 0 2.132777027902266e-12
due O 0 4.010920306996013e-08
to O 0 2.7548657044462743e-07
BRCA2 O 0 0.0002002407272811979
. O 0 2.745331812548102e-06

Conversely O 0 1.6169817627087468e-06
, O 0 1.4885059851366123e-09
the O 0 1.167188012907161e-09
majority O 0 2.8836749654814753e-10
of O 0 2.9806839219048697e-09
families O 0 8.3245695059464e-11
with O 0 2.3151352362971167e-11
male B-Disease 0 2.192237724685242e-09
and I-Disease 0 1.0825859098062551e-09
female I-Disease 0 1.619390310736435e-08
breast I-Disease 0 3.394071973161772e-05
cancer I-Disease 0 3.132304527753149e-06
were O 0 2.5033765282955756e-08
due O 0 0.00020381099602673203
to O 0 1.2277655514481012e-06
BRCA2 O 0 1.793347837519832e-05
( O 0 4.873067505073436e-10
76 O 0 2.2590798209876084e-07
% O 0 5.721455531570996e-10
) O 0 1.0748348738820468e-10
. O 0 1.1591219539752728e-08

The O 0 1.059108967638167e-06
largest O 0 1.7088362369577226e-07
proportion O 0 1.8071634855232332e-08
( O 0 4.074130963149791e-11
67 O 0 1.4685795912683375e-09
% O 0 6.360729217641525e-12
) O 0 6.682431301016645e-13
of O 0 3.9167627474689937e-10
families O 0 4.7655952101210985e-11
due O 0 5.643081379957948e-08
to O 0 1.522326154024256e-09
other O 0 3.265060444235246e-09
genes O 0 6.529098928176325e-10
was O 0 3.844973228694926e-09
found O 0 2.4346605287384193e-10
in O 0 4.260592156857257e-10
families O 0 6.964385318442012e-11
with O 0 8.077222050928423e-12
four O 0 6.581647032932736e-11
or O 0 4.675167891710075e-11
five O 0 6.176509304012257e-11
cases O 0 3.566171524749251e-10
of O 0 4.7254059154511197e-07
female O 0 8.482685188937467e-06
breast B-Disease 1 0.993466317653656
cancer I-Disease 0 1.4214091606845614e-05
only O 0 1.7297207222100042e-08
. O 0 2.475991607298056e-07

These O 0 3.5566991130053793e-08
estimates O 0 1.2881609556814055e-08
were O 0 5.50707923707705e-10
not O 0 5.04964611791614e-11
substantially O 0 1.0201858913205797e-08
affected O 0 1.718660214145018e-09
either O 0 7.386970896083866e-11
by O 0 2.4837300618973934e-11
changing O 0 1.4376770884894086e-09
the O 0 2.1541815553582921e-10
assumed O 0 2.0560726454732503e-09
penetrance O 0 1.1371692210104811e-07
model O 0 1.7929692175400191e-09
for O 0 1.0042157105871752e-09
BRCA1 O 0 8.308714605220757e-09
or O 0 9.17838981900898e-12
by O 0 2.0396887304152678e-11
including O 0 1.3692837141920933e-10
or O 0 1.723972520295547e-09
excluding O 0 1.0621075489325449e-05
BRCA1 O 0 3.034263727386133e-06
mutation O 0 2.3728540909928597e-08
data O 0 1.704255758738782e-08
. O 0 2.852050506874093e-08

Among O 0 4.2369336483716324e-07
those O 0 1.74562198029804e-09
families O 0 5.245378020823921e-10
with O 0 6.166915589300714e-11
disease O 0 5.203581281421066e-07
due O 0 0.04811752587556839
to O 0 6.830186549677819e-08
BRCA1 O 0 1.834471134998239e-07
that O 0 1.4142046041165646e-11
were O 0 1.175673447484371e-10
tested O 0 2.0670580525017357e-10
by O 0 3.38476399686094e-11
one O 0 3.218197583421123e-11
of O 0 6.097614774214222e-11
the O 0 9.626931890549528e-11
standard O 0 6.381259964882702e-10
screening O 0 9.756425667362123e-10
methods O 0 2.7263589164050472e-09
, O 0 8.432903680910542e-11
mutations O 0 1.6780496436830106e-10
were O 0 4.904622818990845e-10
detected O 0 4.726836699830983e-09
in O 0 4.62265975498255e-10
the O 0 9.1597213147665e-10
coding O 0 4.851091528479401e-09
sequence O 0 3.673154558292424e-10
or O 0 3.8257394474605633e-10
splice O 0 1.1227359664189862e-07
sites O 0 7.952918323894664e-09
in O 0 1.5165467492916918e-10
an O 0 3.3699009294868576e-12
estimated O 0 2.9753588481895576e-11
63 O 0 1.3846669366657238e-09
% O 0 6.804768554191654e-11
( O 0 7.911029470397679e-12
95 O 0 2.7062480256745403e-08
% O 0 1.4887047150580202e-09
CI O 0 3.7220124795567244e-05
51 O 0 2.2654200293459326e-08
% O 0 4.66343186289464e-10
- O 0 1.0082445989212374e-08
77 O 0 3.132950254780553e-08
% O 0 3.8244041267176954e-10
) O 0 9.3336442741343e-11
. O 0 1.2741153021522678e-08

The O 0 1.5088626525994187e-07
estimated O 0 2.21955187562628e-09
sensitivity O 0 9.035933778989147e-09
was O 0 2.6166282474093805e-09
identical O 0 8.006580398678409e-10
for O 0 5.43716807688277e-11
direct O 0 4.3081022083057974e-10
sequencing O 0 4.046288637482576e-08
and O 0 6.955017117782347e-10
other O 0 3.851709506896839e-10
techniques O 0 4.5945007798309234e-08
. O 0 8.257184447302279e-08

The O 0 8.009502607819741e-07
penetrance O 0 0.0004051131836604327
of O 0 1.0688932889024727e-05
BRCA2 O 0 2.3017086277832277e-05
was O 0 4.569155276357151e-09
estimated O 0 9.812027926270339e-12
by O 0 6.94921550858929e-12
maximizing O 0 1.3871445325719378e-08
the O 0 1.459605147857701e-08
LOD O 1 0.9995920062065125
score O 0 6.444459472731978e-07
in O 0 2.845443347609944e-08
BRCA2 O 0 3.375251083070907e-07
- O 0 3.653077840226615e-08
mutation O 0 2.6881896708630393e-09
families O 0 6.010641984133258e-11
, O 0 3.6207796743487064e-12
over O 0 1.2313379482709053e-11
all O 0 7.643601723783533e-11
possible O 0 3.6264731217983126e-09
penetrance O 0 1.2735494237858802e-05
functions O 0 6.49487432724527e-08
. O 0 8.502185977476984e-08

The O 0 2.051802283631332e-07
estimated O 0 6.638983141016297e-09
cumulative O 0 1.2205293842271203e-07
risk O 0 5.766027655340622e-08
of O 0 1.2528776949238818e-07
breast B-Disease 0 0.0005976562388241291
cancer I-Disease 0 1.0434338037157431e-05
reached O 0 4.809218125956249e-07
28 O 0 1.9254119365541555e-07
% O 0 2.966124290626482e-10
( O 0 2.5814480761332526e-12
95 O 0 3.803325210327557e-09
% O 0 3.483820454341924e-10
CI O 0 1.8234769640912418e-06
9 O 0 2.6643409700710663e-09
% O 0 5.7059121316704875e-11
- O 0 2.809475152520946e-10
44 O 0 3.618415567174793e-10
% O 0 4.9547141563188735e-12
) O 0 2.006685968650515e-13
by O 0 1.63231598376834e-11
age O 0 3.6491345500877514e-09
50 O 0 5.68727009930825e-10
years O 0 3.0894858893404376e-10
and O 0 2.2372403929438178e-10
84 O 0 2.4394507747160787e-08
% O 0 1.31974403627666e-10
( O 0 4.586173888571077e-12
95 O 0 1.0152863438861459e-08
% O 0 6.552778319957042e-10
CI O 0 1.6257489505733247e-06
43 O 0 2.4707673684787324e-09
% O 0 2.8968046711375095e-11
- O 0 1.7139978325531047e-10
95 O 0 1.2134150351172934e-09
% O 0 5.468982038070447e-12
) O 0 1.7101679230732691e-13
by O 0 1.669483301602881e-11
age O 0 8.738937573582461e-09
70 O 0 4.547471288418592e-09
years O 0 5.634130495479894e-09
. O 0 4.774555151243476e-08

The O 0 4.7539865590806585e-06
corresponding O 1 0.999771773815155
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.203781084768707e-05
were O 0 2.990229219790308e-08
0 O 0 1.0366414215923214e-07
. O 0 1.3849502877860687e-08

4 O 0 2.323687340322067e-06
% O 0 1.853904585402688e-08
( O 0 3.144069726790377e-10
95 O 0 1.1652404907636082e-07
% O 0 5.988562090664118e-09
CI O 0 6.749698968633311e-06
0 O 0 5.013527815123098e-09
% O 0 4.610031106855317e-11
- O 0 1.3698062129030575e-10
1 O 0 1.8780470234514013e-10
% O 0 2.339111326507548e-12
) O 0 8.549285818127902e-14
by O 0 3.129808044677329e-12
age O 0 1.3263842246757918e-09
50 O 0 2.600089865634203e-10
years O 0 6.740246555336782e-11
and O 0 6.21043633186602e-11
27 O 0 6.199269986240097e-09
% O 0 8.206975377067494e-11
( O 0 2.1543890803277232e-12
95 O 0 1.4273109361084835e-09
% O 0 8.688288977154457e-11
CI O 0 9.417920665555357e-08
0 O 0 4.5441050922079285e-10
% O 0 2.2723146281267148e-11
- O 0 1.911927560716009e-10
47 O 0 1.3084332506352325e-09
% O 0 8.978213138222113e-12
) O 0 2.75136033747736e-13
by O 0 1.9793942526713515e-11
age O 0 1.7741239588531243e-08
70 O 0 1.1490667084501638e-08
years O 0 7.623938813594577e-09
. O 0 7.719977190845384e-08

The O 0 7.83716586738592e-07
lifetime O 0 1.705147155917075e-06
risk O 0 5.769381914433325e-07
of O 0 2.522188879083842e-06
breast B-Disease 1 0.9999527931213379
cancer I-Disease 0 0.0014643671456724405
appears O 0 9.79196368433577e-09
similar O 0 9.913488918655844e-10
to O 0 4.649169105253037e-10
the O 0 2.2671965638210168e-08
risk O 0 2.465872483981002e-08
in O 0 1.6214664055880235e-09
BRCA1 O 0 1.773605373678322e-09
carriers O 0 1.4542349269230925e-10
, O 0 3.5555727199293452e-12
but O 0 6.081640833294211e-12
there O 0 2.7975107039918123e-12
was O 0 7.447024247264622e-11
some O 0 5.386997705553176e-12
suggestion O 0 1.5288238452981773e-09
of O 0 1.5219313587166994e-09
a O 0 6.920136685906186e-10
lower O 0 1.5155715118453372e-06
risk O 0 1.3595003345301393e-08
in O 0 2.4033937062739597e-09
BRCA2 O 0 1.3133020004829632e-08
carriers O 0 6.717725264948626e-10
< O 0 7.496368858994629e-09
50 O 0 6.099571958628758e-10
years O 0 8.908604409718635e-11
of O 0 5.787992862771318e-10
age O 0 6.71354243308997e-08
. O 0 5.717719631093132e-08

Eye B-Disease 1 0.9999948740005493
movement I-Disease 0 2.020159809035249e-05
abnormalities I-Disease 0 1.1466907380963676e-05
correlate O 0 1.3497086115421553e-07
with O 0 1.2859263653908215e-09
genotype O 0 2.717638562899083e-05
in O 0 4.419828059099018e-08
autosomal O 1 0.5797483325004578
dominant O 1 0.9999873638153076
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999974966049194
. O 0 2.607077931315871e-06

We O 0 6.528581764086994e-08
compared O 0 1.2400276716562075e-07
horizontal O 0 7.227639002849173e-07
eye O 0 2.1447442122735083e-05
movements O 0 9.25261787187992e-08
( O 0 5.92712767755188e-10
visually O 0 3.827558714419865e-09
guided O 0 1.9675255202855624e-08
saccades O 0 4.6074890747149766e-07
, O 0 1.7369693183777457e-10
antisaccades O 0 1.211009106327765e-07
, O 0 1.6594205176634347e-10
and O 0 6.817915676471387e-11
smooth O 0 4.3933906512805265e-10
pursuit O 0 1.1562294233158354e-08
) O 0 8.676244618588402e-12
in O 0 1.3248031838219987e-10
control O 0 3.844510931827472e-09
subjects O 0 1.2202255561533093e-07
( O 0 1.6084137494098982e-11
n O 0 5.133259373124588e-10
= O 0 2.751569250225572e-10
14 O 0 4.2248887721640926e-10
) O 0 7.5682923469933e-12
and O 0 1.434001112299299e-10
patients O 0 3.960539007863417e-09
with O 0 9.723014060547541e-12
three O 0 1.0269124439687971e-10
forms O 0 1.0748790302272937e-08
of O 0 7.672810511394346e-07
autosomal O 0 0.0007267326000146568
dominant O 0 0.009267830289900303
cerebellar B-Disease 1 0.9790071249008179
ataxias I-Disease 0 0.0007006293162703514
type I-Disease 0 0.00016288681945297867
I I-Disease 0 5.7377965276828036e-05
spinocerebellar B-Disease 0 0.0007620255928486586
ataxias I-Disease 0 2.997427509399131e-05
1 I-Disease 0 1.6389297741170594e-07
and I-Disease 0 8.860464584259375e-10
2 I-Disease 0 6.291516196910152e-09
( O 0 7.859356915274063e-11
SCA1 B-Disease 0 4.8184730985667557e-05
, O 0 3.687938843199845e-10
n O 0 2.776547880500857e-10
= O 0 1.4906162415506685e-10
11 O 0 1.154630488442443e-10
; O 0 3.4404736004578496e-11
SCA2 B-Disease 0 1.6602647519903257e-05
, O 0 4.919200602415685e-10
n O 0 6.225548965232974e-10
= O 0 2.231248796835672e-10
10 O 0 6.548602632383549e-11
) O 0 3.64719452555784e-12
and O 0 5.499101174422094e-10
SCA3 B-Disease 1 1.0
/ O 0 9.862269507721066e-05
Machado B-Disease 0 8.347256880369969e-06
- I-Disease 0 3.5430737170827342e-06
Joseph I-Disease 1 0.9157903790473938
disease I-Disease 0 0.009114176034927368
( O 0 2.3945534444180794e-09
MJD B-Disease 1 1.0
) O 0 2.9678628443718935e-09
( O 0 8.630365866402201e-11
n O 0 2.135470911213133e-09
= O 0 2.7148132630827604e-09
16 O 0 8.168472120928527e-09
) O 0 4.3583694986359944e-10
. O 0 3.1151756729741464e-08

In O 0 4.0573254977971374e-07
SCA1 B-Disease 0 0.0002668783417902887
, O 0 1.4698126049594862e-09
saccade O 0 5.1681212198673165e-08
amplitude O 0 1.5190176227974916e-08
was O 0 2.1181130183123287e-09
significantly O 0 1.7137435914804655e-09
increased O 0 1.3637692086732045e-09
, O 0 8.645573146282004e-11
resulting O 0 3.8731200469044325e-09
in O 0 1.2343355670907386e-08
hypermetria B-Disease 0 5.9329660871298984e-05
. O 0 6.480989327428688e-07

The O 0 3.060478093175334e-07
smooth O 0 4.058424565300811e-07
pursuit O 0 8.899733074940741e-06
gain O 0 1.8423869505568291e-06
was O 0 2.5314230356343614e-07
decreased O 0 5.401280759542715e-06
. O 0 4.786700742442918e-07

In O 0 5.867483992005873e-07
SCA2 B-Disease 0 0.0006427412154152989
, O 0 5.217043685945555e-09
saccade O 0 2.5240174750251754e-07
velocity O 0 1.2064765542163514e-07
was O 0 8.91157441174073e-08
markedly O 0 6.503019449155545e-06
decreased O 0 3.943456249544397e-06
. O 0 4.4319173753137875e-07

The O 0 1.9214679980450455e-07
percentage O 0 1.1845502001506247e-07
of O 0 1.3681625610217907e-08
errors O 0 1.4155596090859035e-06
in O 0 1.9143092799822625e-07
antisaccades O 1 0.9991845488548279
was O 0 3.842468458969961e-07
greatly O 0 7.568132787127979e-08
increased O 0 1.9333896261741756e-08
and O 0 2.950736321949421e-10
was O 0 7.160316228826957e-10
significantly O 0 1.4388786828689604e-09
correlated O 0 4.022448152340985e-09
with O 0 2.97106575453121e-11
age O 0 5.410661430005348e-08
at O 0 5.193229668520871e-08
disease O 0 4.824073016607144e-07
onset O 0 2.7671705538523383e-05
. O 0 7.932467269711196e-07

In O 0 3.17845341157863e-08
addition O 0 2.454253245076643e-09
, O 0 1.0185381704719276e-10
a O 0 2.417888458894346e-11
correlation O 0 5.675044115194261e-11
between O 0 1.4574476348006016e-10
smooth O 0 7.344732821934485e-09
pursuit O 0 2.3855793074289977e-07
gain O 0 1.6103900435382457e-08
and O 0 5.266417857363592e-11
the O 0 6.887949238754132e-11
number O 0 1.5535148167877821e-10
of O 0 2.6787616569379225e-09
trinucleotide O 0 2.6603415790305007e-06
repeats O 0 2.66832844708631e-09
was O 0 1.5451238510877374e-08
found O 0 3.1525859700565206e-09
. O 0 1.211089628583295e-08

In O 0 6.922228749317583e-06
SCA3 B-Disease 1 1.0
, O 0 9.972865200325032e-07
gaze B-Disease 0 0.00010790087981149554
- I-Disease 0 1.885115125332959e-05
evoked I-Disease 0 4.364096821518615e-05
nystagmus I-Disease 0 2.97872848022962e-05
was O 0 3.081837718355018e-08
often O 0 1.3905630813493275e-10
present O 0 7.271531293762123e-11
as O 0 7.627203035820429e-11
was O 0 1.5115487750350098e-09
saccade O 0 8.889539060419338e-08
hypometria O 0 1.2373337767712655e-06
and O 0 3.2455826914912222e-09
smooth O 0 2.7726347440193422e-08
pursuit O 0 1.028684550874459e-06
gain O 0 1.1329436802043347e-06
was O 0 3.2062067134575045e-07
markedly O 0 3.3357417123625055e-05
decreased O 0 2.29554880206706e-05
. O 0 6.059907491362537e-07

Three O 0 7.464597473472168e-08
major O 0 7.244920396942689e-08
criteria O 0 2.1824807561188209e-07
, O 0 9.79546999069214e-10
saccade O 0 4.661862362809188e-08
amplitude O 0 4.903034866998723e-09
, O 0 9.918230126082506e-11
saccade O 0 8.879061930144871e-09
velocity O 0 1.0594687793741286e-08
, O 0 1.2316063446871084e-10
and O 0 6.881698683125492e-11
presence O 0 3.442306717449384e-10
of O 0 1.2757182332734374e-07
gaze B-Disease 0 5.067611709819175e-05
- I-Disease 0 5.458172381622717e-06
evoked I-Disease 0 7.020502380328253e-06
nystagmus I-Disease 0 2.723081991007348e-07
, O 0 2.0859411420381946e-11
permitted O 0 2.966801457282564e-11
the O 0 3.526290370814422e-11
correct O 0 1.261176302280731e-10
assignment O 0 2.5627983069043125e-10
of O 0 4.842879985922366e-10
90 O 0 6.728855805882006e-10
% O 0 1.8960423509017943e-11
of O 0 1.138469804540243e-10
the O 0 7.600181595179833e-10
SCA1 B-Disease 0 0.4169277846813202
, O 0 1.0153788920774787e-09
90 O 0 2.4185919933472633e-09
% O 0 1.4076274867935723e-11
of O 0 5.1248144616877767e-11
the O 0 6.127218732387973e-10
SCA2 B-Disease 0 0.2841359078884125
, O 0 6.397919971590227e-10
and O 0 2.0236665121409203e-10
93 O 0 3.686913885303511e-09
% O 0 8.851267808973606e-12
of O 0 2.6760470575593054e-11
the O 0 4.414002496844205e-10
patients O 0 3.262682346516499e-09
with O 0 5.159547233901662e-10
SCA3 B-Disease 1 1.0
to O 0 1.484678364249703e-06
their O 0 1.4738508014033869e-07
genetically O 0 6.684805384793435e-07
confirmed O 0 4.7313491791101114e-08
patient O 0 1.486981454945635e-05
group O 0 1.7998304235877782e-11
and O 0 7.95363427896767e-12
, O 0 2.735006015067154e-12
therefore O 0 1.340452887577115e-10
, O 0 2.6901821048586072e-11
may O 0 7.913814048521317e-10
help O 0 1.1556842149929025e-09
orient O 0 7.196262572506384e-07
diagnoses O 0 5.4661322792526335e-06
of O 0 3.692775010222249e-07
SCA1 B-Disease 1 0.9967705011367798
, O 0 2.1168489183764905e-09
SCA2 B-Disease 0 0.2684326469898224
, O 0 4.0118799948807293e-10
and O 0 1.1583124459590977e-09
SCA3 B-Disease 1 1.0
at O 0 3.6666489222625387e-07
early O 0 7.696291390857368e-07
clinical O 0 1.7024923693043092e-07
stages O 0 9.058611283307982e-08
of O 0 9.52101153472995e-09
the O 0 5.958531801297795e-08
diseases O 0 1.6464147847727872e-05
. O 0 4.66290073219966e-09
. O 0 3.383406976809056e-08

Genetic O 0 9.287056741413835e-07
basis O 0 1.5124491881124413e-08
and O 0 1.813971611808185e-10
molecular O 0 7.029036019901014e-09
mechanism O 0 1.6716303008479372e-08
for O 0 2.858285874651756e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.00014152994845062494

Ventricular B-Disease 1 0.9999986886978149
fibrillation I-Disease 1 0.9985260963439941
causes O 0 6.766880460418179e-07
more O 0 5.560443772090196e-10
than O 0 9.248300042452584e-11
300 O 0 2.127659715078778e-10
, O 0 8.669314398301875e-12
000 O 0 4.843683787392195e-10
sudden O 0 1.7748566505382257e-10
deaths O 0 4.3676295219396977e-11
each O 0 3.0122675187538306e-12
year O 0 1.9708511211913304e-10
in O 0 1.4064616138398378e-09
the O 0 5.893382848398687e-08
USA O 0 2.4270505605272774e-07
alone O 0 6.311636546740829e-09
. O 0 7.018051029206163e-09

In O 0 1.1996179694051534e-07
approximately O 0 1.1052104786912764e-09
5 O 0 2.9592881478635036e-09
- O 0 5.263490532314563e-09
12 O 0 1.4132136572087006e-09
% O 0 2.5607545597883252e-11
of O 0 2.592215331276293e-11
these O 0 4.130787292083715e-12
cases O 0 4.9883226022062743e-11
, O 0 6.610668609741133e-12
there O 0 1.4669264067346255e-11
are O 0 6.594045622032585e-12
no O 0 1.8387565081656732e-10
demonstrable O 0 4.985646683053346e-06
cardiac O 1 0.5884110331535339
or O 0 5.846538542186863e-08
non O 0 7.990865560714155e-05
- O 0 6.0013990150764585e-05
cardiac O 1 0.9099790453910828
causes O 0 6.019080345254224e-09
to O 0 2.793358599983975e-11
account O 0 8.948397578478762e-12
for O 0 4.7595091062779815e-11
the O 0 6.655033857327908e-09
episode O 0 2.7507782718316776e-09
, O 0 4.954600531931197e-12
which O 0 9.705925299585694e-13
is O 0 8.104965266639286e-13
therefore O 0 2.9612329949246785e-11
classified O 0 5.116486123668551e-10
as O 0 1.3235872842187746e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.9289236661279574e-06
IVF B-Disease 1 1.0
) O 0 1.878546918021584e-08
. O 0 5.626637999966988e-08

A O 0 1.9072020904786768e-06
distinct O 0 1.7199965895997593e-07
group O 0 1.8604640050767784e-09
of O 0 1.941053540122084e-07
IVF B-Disease 1 1.0
patients O 1 0.9999991655349731
has O 0 2.2151142031745508e-10
been O 0 6.441371741550128e-11
found O 0 1.2780710517690252e-11
to O 0 4.057185143402364e-12
present O 0 7.171410687512036e-11
with O 0 3.4594115766450884e-11
a O 0 5.962982885243662e-10
characteristic O 0 9.089141173035387e-08
electrocardiographic O 0 1.9299215637147427e-05
pattern O 0 5.508365461537323e-07
. O 0 1.1738354288581831e-07

Because O 0 1.8960565739689628e-07
of O 0 8.887165137139164e-08
the O 0 9.09317865449566e-09
small O 0 2.0179888315929873e-10
size O 0 1.364944685056102e-10
of O 0 3.37591316013075e-10
most O 0 6.539356278700836e-10
pedigrees O 0 5.8297910499049976e-08
and O 0 1.0673271988448363e-10
the O 0 1.2777449931444806e-10
high O 0 1.5816379317357132e-09
incidence O 0 8.127021278170332e-10
of O 0 6.491796544771944e-10
sudden B-Disease 0 4.352066262924836e-09
death I-Disease 0 7.471759211341578e-09
, O 0 3.8803918411822735e-11
however O 0 3.189028208172573e-10
, O 0 9.313438041613775e-12
molecular O 0 1.6384806011959796e-10
genetic O 0 3.0319250582389046e-11
studies O 0 7.595783377278842e-12
of O 0 2.3947349658826056e-10
IVF B-Disease 1 1.0
have O 0 2.953052025134184e-09
not O 0 2.366356832705918e-10
yet O 0 5.9180935707559e-09
been O 0 2.3691311135110027e-09
done O 0 8.600664180846707e-09
. O 0 4.8835218535714375e-08

Because O 0 2.6270838134223595e-05
IVF B-Disease 1 1.0
causes O 1 0.704015851020813
cardiac O 1 1.0
rhythm O 1 0.6145884990692139
disturbance O 0 6.0323825891828164e-05
, O 0 4.1484465862495767e-10
we O 0 1.56406346207838e-10
investigated O 0 6.265147511896885e-09
whether O 0 8.765548287215097e-09
malfunction O 0 0.06727917492389679
of O 0 4.278792403056286e-06
ion O 0 0.0002020525571424514
channels O 0 6.694617837865735e-08
could O 0 2.5770194866936436e-09
cause O 0 4.8422844400874965e-08
the O 0 2.005000077076602e-08
disorder O 0 1.0518640891632458e-07
by O 0 6.861046730755049e-10
studying O 0 8.45892955680938e-09
mutations O 0 3.177898499906462e-10
in O 0 1.6466543406590262e-10
the O 0 4.600768210849537e-09
cardiac O 0 2.4660052986291703e-06
sodium O 0 1.2396756574162282e-05
channel O 0 3.163991380006337e-07
gene O 0 5.7979100631655456e-08
SCN5A O 0 0.008609555661678314
. O 0 3.7734848774562124e-06

We O 0 9.363684227992053e-08
have O 0 2.585551550637888e-09
now O 0 4.818647147963873e-10
identified O 0 7.857801631594441e-10
a O 0 3.3279390354579164e-10
missense O 0 6.342908136502956e-07
mutation O 0 1.0790530247106744e-08
, O 0 9.255429062049458e-11
a O 0 9.620251123498846e-11
splice O 0 2.719837652875867e-07
- O 0 6.274058961253104e-08
donor O 0 1.3663422393506153e-08
mutation O 0 1.544221639449006e-09
, O 0 7.585590142134002e-12
and O 0 1.7197241894417736e-11
a O 0 1.1121883969344992e-10
frameshift O 0 3.39763417400718e-08
mutation O 0 4.504324135901072e-10
in O 0 1.4279365190272841e-10
the O 0 1.8132349788313462e-10
coding O 0 1.801552795832606e-09
region O 0 9.373075648966278e-10
of O 0 1.1692742774016551e-08
SCN5A O 1 0.9999736547470093
in O 0 3.9493841086368775e-08
three O 0 1.4360608702190802e-08
IVF B-Disease 1 1.0
families O 0 1.4669341297235405e-08
. O 0 1.4168635154021558e-08

We O 0 1.7027748810960475e-07
show O 0 1.0934599892209462e-09
that O 0 8.45752894801377e-12
sodium O 0 7.407846780438376e-09
channels O 0 2.72777245236e-10
with O 0 5.249055964190452e-12
the O 0 1.660852566587323e-09
missense O 0 8.805195648164954e-07
mutation O 0 1.6356407783746363e-08
recover O 0 6.251124773370975e-08
from O 0 6.928483897716831e-10
inactivation O 0 4.422849542606855e-06
more O 0 2.207332788772831e-10
rapidly O 0 6.295333143668813e-09
than O 0 4.848468848628329e-11
normal O 0 5.922324852747352e-10
and O 0 1.5783124807100535e-11
that O 0 2.778325096028378e-12
the O 0 1.3960940181689807e-09
frameshift O 0 1.5268116726474545e-07
mutation O 0 8.995432176917006e-10
causes O 0 3.569328999031285e-10
the O 0 2.5604823816749445e-10
sodium O 0 8.685795194196544e-09
channel O 0 2.2837343127690701e-10
to O 0 1.3067983327397226e-11
be O 0 2.7545099534620476e-10
non O 0 4.950549055138254e-07
- O 0 4.491057836730761e-07
functional O 0 1.3035363508606679e-06
. O 0 9.186025806684484e-08

Our O 0 3.4028394679808116e-07
results O 0 3.1060860550269354e-08
indicate O 0 7.636235643815326e-09
that O 0 6.136502417319889e-11
mutations O 0 2.2115145270618086e-09
in O 0 2.891872297183795e-09
cardiac O 0 1.3545716228691163e-06
ion O 0 1.5258218581948313e-06
- O 0 1.8892689695348963e-05
channel O 0 2.1053500276480008e-08
genes O 0 1.838353219651978e-10
contribute O 0 2.4772390735949834e-11
to O 0 1.7866175552883057e-11
the O 0 6.872192259699261e-10
risk O 0 9.101941422784421e-09
of O 0 1.6956471782236804e-08
developing O 0 3.958581146434881e-06
IVF B-Disease 1 1.0
. O 0 8.331093681590573e-08
. O 0 3.495484790505543e-08

Molecular O 0 3.5207219752919627e-06
heterogeneity O 0 8.35590617498383e-06
in O 0 2.837287809143163e-07
mucopolysaccharidosis B-Disease 1 0.998392641544342
IVA I-Disease 1 1.0
in O 0 1.429791751661469e-07
Australia O 0 3.2871743105289397e-09
and O 0 2.526282794068635e-10
Northern O 0 6.990890089042523e-09
Ireland O 0 8.64066862504842e-09
: O 0 3.715601992748674e-10
nine O 0 3.0711508891556605e-09
novel O 0 1.3331669990179762e-08
mutations O 0 5.607165842747008e-10
including O 0 1.3379905516863744e-10
T312S O 0 6.483783749899885e-07
, O 0 5.864422142343173e-11
a O 0 3.764894992985823e-11
common O 0 2.4089652495007385e-09
allele O 0 4.444485224297523e-09
that O 0 1.851608449898734e-11
confers O 0 7.999441109518557e-09
a O 0 1.2888827782830958e-09
mild O 0 7.462449957529316e-06
phenotype O 0 7.236632518470287e-05
. O 0 3.9965868836588925e-07

Mucopolysaccharidosis B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
( O 0 0.00016803762991912663
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.583157213275626e-09
is O 0 2.771637641618696e-10
an O 0 2.7533017532554993e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 3.279752127127722e-05
by O 0 2.1463995025783333e-08
a O 0 5.428927352113533e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 8.612914115246895e-08
N O 0 1.458673466459004e-07
- O 0 6.118663975485106e-08
acetylgalactosamine O 0 5.819763828185387e-06
- O 0 1.838955370203621e-07
6 O 0 5.5359826944823e-08
- O 0 3.560153416515277e-08
sulfate O 0 1.3839621715305839e-06
sulfatase O 0 0.0005997648113407195
( O 0 1.421044970584262e-08
GALNS O 1 0.9996925592422485
) O 0 2.2401890120704593e-08
. O 0 1.6743497610605118e-07

Previous O 0 3.1380642440126394e-07
studies O 0 1.2282272088270929e-08
of O 0 7.712703364859408e-09
patients O 0 7.850855077151664e-09
from O 0 1.5218580562414985e-10
a O 0 2.4584391813964324e-11
British O 0 4.884935123072864e-09
- O 0 3.231642509149424e-08
Irish O 0 1.4992379249179066e-07
population O 0 2.1474403852361768e-11
showed O 0 8.685716208767236e-12
that O 0 1.9731124286520574e-13
the O 0 8.604281176438633e-11
I113F O 0 1.1445022352063461e-07
mutation O 0 1.3205379012504181e-09
is O 0 7.698964729629942e-12
the O 0 1.4573774478887636e-11
most O 0 2.4499525672072586e-11
common O 0 2.00419500440141e-10
single O 0 2.7683780268183966e-10
mutation O 0 3.6313254625497393e-09
among O 0 1.6624886356453317e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.9995848536491394
and O 0 1.9865749045777648e-09
produces O 0 1.1322488502329975e-09
a O 0 1.2650623604226752e-10
severe O 0 1.1131432984257117e-06
clinical O 0 7.310543878702447e-05
phenotype O 0 4.7382804041262716e-05
. O 0 2.258567235458031e-07

We O 0 8.683794305852643e-08
studied O 0 1.692574898015664e-07
mutations O 0 1.0922557969195168e-08
in O 0 1.7794233864165676e-09
the O 0 1.070527133606447e-08
GALNS O 0 0.009869007393717766
gene O 0 5.832323513033089e-09
from O 0 1.3156982170414722e-09
23 O 0 3.319394981105006e-09
additional O 0 7.893767417499475e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.9976432919502258
( O 0 2.311098361296171e-11
15 O 0 1.1031249524950937e-10
from O 0 2.4034142731554908e-11
Australia O 0 2.2137064750737956e-11
, O 0 1.3374610663766107e-12
8 O 0 3.5154580635410326e-11
from O 0 3.8406448160666073e-11
Northern O 0 7.936094559291007e-10
Ireland O 0 7.513241695455974e-10
) O 0 6.9625225723735085e-12
, O 0 3.874252047647575e-12
with O 0 1.0345945020834302e-12
various O 0 9.969559622291513e-10
clinical O 0 0.0002132074732799083
phenotypes O 0 0.02872280962765217
( O 0 2.062565451765863e-09
severe O 0 0.00040423712925985456
, O 0 1.8188019978992997e-09
16 O 0 7.902185017449881e-10
cases O 0 1.038379382478638e-10
; O 0 2.6231015623490173e-11
intermediate O 0 4.686889951699413e-06
, O 0 2.257290535045975e-11
4 O 0 1.3310136326438737e-10
cases O 0 4.412737883430218e-11
; O 0 1.2047203512555171e-10
mild O 0 1.4028278201294597e-05
, O 0 3.5052043489969265e-09
3 O 0 1.1112733844242939e-08
cases O 0 2.5685154003696198e-09
) O 0 3.8790914924646813e-10
. O 0 2.8619245640015833e-08

We O 0 4.195394467387814e-07
found O 0 1.1206068073477127e-08
two O 0 3.7070788105886265e-10
common O 0 7.749184405270171e-09
mutations O 0 1.453473008616868e-09
that O 0 3.135653542374328e-11
together O 0 1.1222162782376088e-10
accounted O 0 3.0129272410306385e-09
for O 0 9.165134623456694e-11
32 O 0 1.8789725331203044e-09
% O 0 2.2694473036932727e-11
of O 0 6.402543079042644e-11
the O 0 3.2211838751905475e-10
44 O 0 3.9589833633613125e-09
unrelated O 0 1.558207962659708e-08
alleles O 0 4.3416696904330365e-09
in O 0 1.534321669716121e-09
these O 0 2.4159638734033706e-09
patients O 0 4.861635360953187e-08
. O 0 2.2796546872427825e-08

One O 0 8.129463680006666e-08
is O 0 3.783195146045415e-10
the O 0 1.2303086327491997e-09
T312S O 0 1.0199368034591316e-06
mutation O 0 1.5348609494481025e-08
, O 0 6.368878341378448e-11
a O 0 6.691238535472266e-11
novel O 0 2.666335419121424e-08
mutation O 0 6.104533323281203e-09
found O 0 3.744586585252563e-10
exclusively O 0 7.643926047684602e-10
in O 0 5.303485428598265e-10
milder O 1 0.9987753033638
patients O 1 0.9999591112136841
. O 0 2.5138849650829798e-06

The O 0 1.9767607284393307e-07
other O 0 1.1816539968734219e-09
is O 0 4.572715817108275e-11
the O 0 1.715394215562327e-10
previously O 0 5.259904733989629e-10
described O 0 1.0864624755413388e-09
I113F O 0 7.370346111201798e-07
that O 0 8.579585653034627e-11
produces O 0 1.987287445714969e-09
a O 0 7.096766507785901e-10
severe O 0 3.636385372374207e-05
phenotype O 0 0.21800771355628967
. O 0 1.9710464584932197e-06

The O 0 9.739678716869093e-07
I113F O 0 2.4298571588587947e-05
and O 0 3.34853353933795e-08
T312S O 0 6.2765038819634356e-06
mutations O 0 1.9974043752313264e-08
accounted O 0 2.0409139267485443e-08
for O 0 3.420088379169073e-10
8 O 0 1.1610426398078744e-08
( O 0 2.0430218281020096e-11
18 O 0 5.57339729923001e-10
% O 0 1.5445441800543414e-11
) O 0 1.1766727999948379e-12
and O 0 4.90542467757038e-11
6 O 0 1.0224905366840176e-08
( O 0 2.0911597106709756e-11
14 O 0 1.0370418968008721e-09
% O 0 1.381207474782098e-11
) O 0 6.114099569513864e-13
of O 0 1.5732758151809634e-10
44 O 0 3.6762051180971866e-09
unrelated O 0 1.989814535363621e-08
alleles O 0 7.731261852939042e-09
, O 0 1.2607463961700205e-09
respectively O 0 6.148237474690177e-08
. O 0 9.009468726617342e-08

The O 0 4.729833449346188e-07
relatively O 0 2.0210730156122736e-07
high O 0 1.1160318535985425e-07
residual O 0 4.551275651465403e-06
GALNS O 0 0.01522075105458498
activity O 0 6.124548690422671e-08
seen O 0 3.41478401111317e-09
when O 0 7.779391020257265e-10
the O 0 2.2050110626281594e-09
T312S O 0 6.156617473607184e-07
mutant O 0 9.932916356092392e-08
cDNA O 0 6.910330085929672e-08
is O 0 8.394457906568675e-10
overexpressed O 0 6.359904318742338e-07
in O 0 1.581755504354021e-09
mutant O 0 1.519055281562487e-08
cells O 0 2.329394455102829e-10
provides O 0 5.379604747779432e-12
an O 0 3.547270983894624e-14
explanation O 0 4.8225892029796213e-11
for O 0 3.083456059926881e-11
the O 0 6.020618670277145e-09
mild O 0 0.0001396339648636058
phenotype O 0 0.00014728211681358516
in O 0 6.33630348190195e-09
patients O 0 4.341504489246972e-09
with O 0 5.985116048601302e-12
this O 0 3.8117761724798527e-10
mutation O 0 2.3897912981851732e-08
. O 0 2.91812050079443e-08

The O 0 7.492198506042769e-08
distribution O 0 4.381041751599923e-09
and O 0 1.8046505956270664e-10
relative O 0 3.1872360306550718e-09
frequencies O 0 5.671757508096675e-10
of O 0 5.620454102128747e-10
the O 0 1.5768425454254498e-09
I113F O 0 6.27970962341351e-07
and O 0 7.545112090667772e-09
T312S O 0 2.0403338112373604e-06
mutations O 0 8.16070144793457e-09
in O 0 9.975950066021255e-10
Australia O 0 4.1950179441307966e-10
corresponded O 0 3.2891547818714173e-10
to O 0 5.765611599262144e-11
those O 0 7.523318773516863e-11
observed O 0 7.529380452453438e-10
in O 0 7.400782209288082e-10
Northern O 0 1.0433794273012609e-08
Ireland O 0 2.919616548524573e-09
and O 0 1.3581226421255366e-10
are O 0 3.229659595316292e-11
unique O 0 5.924682966451655e-11
to O 0 1.3882991110880649e-11
these O 0 8.39675967645448e-11
two O 0 7.891682446414805e-11
populations O 0 7.278511127140064e-11
, O 0 3.283159334677155e-12
suggesting O 0 1.0611705958396556e-10
that O 0 4.354841574155666e-12
both O 0 1.589769982324185e-10
mutations O 0 4.2257997101557976e-10
were O 0 2.796341380673084e-09
probably O 0 2.0684234325329953e-09
introduced O 0 2.2062984772475147e-09
to O 0 7.401088769620756e-11
Australia O 0 3.705401610543113e-11
by O 0 3.6672165304452164e-11
Irish O 0 5.15942133461067e-09
migrants O 0 1.0080956208691205e-10
during O 0 1.3172166135611008e-10
the O 0 3.0300303932584427e-10
19th O 0 8.4335579231265e-07
century O 0 6.5156218624906614e-06
. O 0 6.672219683423464e-07

Haplotype O 0 1.6559873756705201e-06
analysis O 0 2.7062172947012186e-08
using O 0 9.917294541139654e-09
6 O 0 3.050736552268063e-07
RFLPs O 0 3.267399370088242e-05
provides O 0 3.905282208727101e-10
additional O 0 5.7901100580792786e-11
data O 0 1.8126160294951177e-10
that O 0 3.226548585602562e-12
the O 0 5.710923955959402e-10
I113F O 0 5.938755407441931e-07
mutation O 0 3.5470701931217263e-09
originated O 0 1.9620456370716965e-09
from O 0 4.885405621712913e-11
a O 0 6.309102545953849e-11
common O 0 6.101227079113869e-09
ancestor O 0 1.4061773754292517e-06
. O 0 2.1181995180086233e-07

The O 0 8.875508683559019e-07
other O 0 9.68358904174238e-09
9 O 0 2.549535338403075e-07
novel O 0 2.9209391527729167e-07
mutations O 0 6.1618421476339336e-09
identified O 0 7.667142476464051e-10
in O 0 1.0156844115760677e-10
these O 0 1.4464808517633543e-10
23 O 0 6.068591407171198e-09
patients O 0 7.207950236676197e-09
were O 0 3.458819619606146e-10
each O 0 6.509098381818346e-12
limited O 0 1.72749356486257e-10
to O 0 8.202452606020927e-11
a O 0 1.758739487378591e-09
single O 0 6.79943283898865e-08
family O 0 9.484796947845098e-09
. O 0 2.6947823528189474e-08

These O 0 4.496268957154825e-08
data O 0 6.56371446083881e-09
provide O 0 1.6993298435075133e-10
further O 0 1.7646926975256605e-10
evidence O 0 4.5924633540472826e-10
for O 0 1.8247151012396046e-10
extensive O 0 2.176448532509312e-08
allelic O 0 2.400718358330778e-06
heterogeneity O 0 5.38369295099983e-06
in O 0 1.6382014109694865e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 2.4824253763711113e-09
British O 0 3.8452521167187115e-09
- O 0 7.905550880593637e-09
Irish O 0 4.642536666210617e-08
patients O 0 9.273426471168023e-09
and O 0 9.885326064662525e-12
provide O 0 2.3192444058989237e-12
evidence O 0 3.487967553672533e-11
for O 0 5.389765023178228e-11
their O 0 1.1030349966745234e-09
transmission O 0 3.3674647514914113e-09
to O 0 6.975792166130645e-11
Australia O 0 6.596640594880299e-11
by O 0 1.5965971600362394e-11
British O 0 2.352843031516727e-09
- O 0 1.151403150601027e-08
Irish O 0 2.1829132279549412e-08
migrants O 0 1.573891794670601e-09
. O 0 1.2283409012159296e-10
. O 0 2.3543602623021798e-09

Identification O 0 3.451469012816233e-07
of O 0 3.06864109234084e-07
constitutional O 0 0.0005349615239538252
WT1 O 1 0.9999990463256836
mutations O 0 2.6192569748673122e-06
, O 0 6.728111401343995e-10
in O 0 7.611569152743414e-10
patients O 0 1.926866310952846e-08
with O 0 4.250876317613006e-10
isolated O 0 0.0002041828993242234
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 2.2035322899682797e-08
and O 0 1.6584396356211784e-10
analysis O 0 1.226821283450974e-10
of O 0 1.9973269704820495e-09
genotype O 0 6.729118240400567e-07
/ O 0 3.960669303637587e-08
phenotype O 0 1.7371963423329362e-08
correlations O 0 2.145989164148432e-09
by O 0 7.97258873502793e-12
use O 0 7.416915692726178e-11
of O 0 1.8601873374990419e-09
a O 0 2.4250035313144735e-09
computerized O 0 7.966492375999223e-06
mutation O 0 2.3631530154943903e-07
database O 0 9.409500023593864e-08
. O 0 7.489668973903463e-08

Constitutional O 0 2.0554249203996733e-05
mutations O 0 1.827744426918798e-07
of O 0 1.702969711914193e-07
the O 0 1.839407843817753e-07
WT1 O 0 9.815657540457323e-05
gene O 0 8.774647675124925e-09
, O 0 1.6349840925578008e-10
encoding O 0 1.2306660579497475e-08
a O 0 1.2376784930268059e-08
zinc O 0 0.0005600890726782382
- O 0 2.8732887585647404e-05
finger O 0 2.6317238734918647e-06
transcription O 0 7.098761898305384e-07
factor O 0 9.766636566155285e-08
involved O 0 1.747900935100688e-09
in O 0 1.2704751917169688e-08
renal O 1 1.0
and O 0 5.926171979808714e-06
gonadal O 1 0.9177845120429993
development O 0 8.144817002175841e-06
, O 0 3.5659061814463655e-10
are O 0 1.8018087022397822e-11
found O 0 2.8890244363477535e-11
in O 0 3.090280115136679e-11
most O 0 1.467761051587857e-10
patients O 0 1.4384451407778442e-09
with O 0 2.496831352782891e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.519260817734903e-07
DDS B-Disease 1 1.0
) O 0 3.749868471292217e-10
, O 0 8.940264500933992e-11
or O 0 4.005986653510263e-09
diffuse B-Disease 1 0.9999960660934448
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 4.669792019740271e-07
DMS B-Disease 0 0.05790058150887489
) O 0 1.0317106197144099e-10
associated O 0 9.923042387782743e-10
with O 0 4.018412547157624e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.0564739315886982e-05
/ O 0 0.0001120799861382693
or O 0 1.0305138857802376e-06
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9998700618743896
( O 0 8.44951131284688e-09
WT B-Disease 1 1.0
) O 0 3.227483169609968e-09
. O 0 2.2936109900228985e-08

Most O 0 1.6884474689504714e-06
mutations O 0 5.260823741082277e-07
in O 0 2.2855806491861586e-07
DDS B-Disease 1 1.0
patients O 1 0.999994158744812
lie O 0 1.1606659882090753e-06
in O 0 3.934037540176405e-09
exon O 0 1.6008603154205048e-07
8 O 0 1.9699811559803493e-08
or O 0 1.4410758142346936e-09
exon O 0 2.3363031687040348e-07
9 O 0 4.5775053081342776e-08
, O 0 8.369757664716815e-10
encoding O 0 5.615160603156255e-07
zinc O 0 0.3253035247325897
finger O 0 0.00022882148914504796
2 O 0 7.440672197844833e-05
or O 0 1.377178932671086e-06
zinc O 0 0.04185006394982338
finger O 0 2.0970876448700437e-06
3 O 0 6.811088582026059e-08
, O 0 7.725563244687095e-11
respectively O 0 1.4302378170683028e-09
, O 0 2.0604674216828656e-11
with O 0 3.663327887565293e-12
a O 0 2.9512431387601623e-10
hot O 0 1.8978862499352545e-05
spot O 0 1.8283162717125379e-07
( O 0 4.3730810639353024e-11
R394W O 0 5.2876934830692335e-08
) O 0 7.952061231719654e-11
in O 0 4.860344127166627e-09
exon O 0 7.286104732884269e-07
9 O 0 3.414819218505727e-07
. O 0 1.1758857709764925e-07

We O 0 1.1982431047385944e-08
analyzed O 0 1.280239469991784e-08
a O 0 1.4416415283768913e-10
series O 0 1.8978234261890492e-10
of O 0 2.5751462073841935e-10
24 O 0 6.079736714070805e-09
patients O 0 3.9811794749766705e-08
, O 0 1.591774628773024e-11
10 O 0 6.669805679981877e-11
with O 0 4.050143553868679e-11
isolated B-Disease 0 2.6757254545373144e-06
DMS I-Disease 1 1.0
( O 0 9.01010253073764e-07
IDMS B-Disease 1 1.0
) O 0 1.1791594367593916e-09
, O 0 1.103276428549016e-10
10 O 0 9.372140563623788e-11
with O 0 4.138462836311696e-11
DDS B-Disease 1 1.0
, O 0 1.9774943904593556e-09
and O 0 6.364582749718295e-10
4 O 0 7.292859649510319e-09
with O 0 5.092749000290553e-10
urogenital B-Disease 1 0.8460717797279358
abnormalities I-Disease 0 0.013381298631429672
and O 0 7.536161206189718e-07
/ O 0 2.5354349418194033e-05
or O 0 2.8471642963268096e-06
WT B-Disease 1 1.0
. O 0 9.7736040061136e-07

We O 0 2.0167035472695716e-06
report O 0 6.795581271035189e-07
WT1 O 0 0.40620219707489014
heterozygous O 0 3.153477109663072e-06
mutations O 0 5.091239074772602e-08
in O 0 1.518909664710577e-09
16 O 0 2.527384168615754e-08
patients O 0 1.87340525314994e-08
, O 0 5.984696765937159e-11
4 O 0 5.289042537270916e-09
of O 0 1.0650810899903718e-08
whom O 0 2.418574851503763e-08
presented O 0 2.4316796043422073e-07
with O 0 3.251365043865917e-08
IDMS B-Disease 1 0.9999982118606567
. O 0 1.454447556170635e-05

One O 0 2.2455692771927716e-07
male O 0 2.994749692675214e-08
and O 0 5.084945242650463e-10
two O 0 5.758130638966463e-10
female O 0 1.191819976043007e-08
IDMS B-Disease 1 0.9999969005584717
patients O 0 0.0017072365153580904
with O 0 7.925057161628501e-07
WT1 O 1 1.0
mutations O 0 0.0005183854955248535
underwent O 0 0.004697950556874275
normal O 0 4.383792474982329e-05
puberty O 0 0.00014413747703656554
. O 0 1.4124444192020746e-07

Two O 0 3.428714308029157e-07
mutations O 0 6.458198242853541e-08
associated O 0 8.226024306168256e-09
with O 0 2.483439009992594e-09
IDMS B-Disease 1 0.9999990463256836
are O 0 1.332441934565054e-09
different O 0 8.170255444417407e-11
from O 0 1.1186260251427882e-10
those O 0 6.992029871755179e-11
described O 0 2.227270146093474e-09
in O 0 7.899826215407302e-08
DDS B-Disease 1 1.0
patients O 1 0.9999861717224121
. O 0 8.956113219937833e-07

No O 0 6.6365942075208295e-06
WT1 O 0 0.002620099810883403
mutations O 0 3.788261437875917e-07
were O 0 1.4859396380018097e-08
detected O 0 2.627973216817736e-08
in O 0 1.0601333144677483e-09
the O 0 2.9686271219020455e-09
six O 0 4.421099042417609e-09
other O 0 3.020241479134711e-08
IDMS B-Disease 1 1.0
patients O 1 0.9999938011169434
, O 0 2.172407809197807e-09
suggesting O 0 1.0177254594623264e-08
genetic O 0 4.72670400597508e-08
heterogeneity O 0 6.390924909283058e-07
of O 0 1.4477704723958595e-07
this O 0 6.287847753583264e-08
disease O 0 0.0017990324413403869
. O 0 3.003084145802859e-07

We O 0 2.4668608489264443e-07
analyzed O 0 5.954009338893229e-07
genotype O 0 3.946006927435519e-06
/ O 0 3.714954175393359e-07
phenotype O 0 1.361405423949691e-07
correlations O 0 1.4452028018752117e-08
, O 0 1.644371791509336e-11
on O 0 3.3066778482027104e-11
the O 0 9.995023905751133e-12
basis O 0 4.8273472025295305e-11
of O 0 3.307724580348115e-11
the O 0 6.386370599020808e-11
constitution O 0 3.0605473710920705e-10
of O 0 1.3165473156107055e-08
a O 0 4.9892978637444685e-09
WT1 O 0 5.96255122218281e-05
mutation O 0 1.1938243282827443e-08
database O 0 1.5899648264650068e-09
of O 0 4.469802306061865e-09
84 O 0 1.3732376658026624e-07
germ O 0 0.0038816104643046856
- O 0 1.4517897398036439e-05
line O 0 3.2280378945870325e-05
mutations O 0 5.981963813184166e-09
, O 0 3.031444886780754e-11
to O 0 2.0005734915895523e-11
compare O 0 1.2856344877576475e-09
the O 0 1.877975414066313e-10
distribution O 0 7.385463768327938e-11
and O 0 1.5359744726106683e-11
type O 0 3.299234441200838e-09
of O 0 1.134701044236408e-08
mutations O 0 5.360435983980949e-10
, O 0 1.1910704193762722e-11
according O 0 4.092745586881108e-11
to O 0 2.04973520795404e-11
the O 0 7.732717799413535e-10
different O 0 3.4662774872629143e-09
symptoms O 0 2.4166569346562028e-05
. O 0 9.138123004959198e-07

This O 0 4.202782832862795e-08
demonstrated O 0 2.016356290823751e-07
( O 0 6.727466500544566e-11
1 O 0 2.4863584524581483e-09
) O 0 2.617394148640706e-11
the O 0 8.776015469891263e-10
association O 0 4.132028885717176e-10
between O 0 3.459215414114425e-10
mutations O 0 2.350488026436892e-09
in O 0 8.17334999680952e-09
exons O 0 4.313451285042902e-08
8 O 0 8.331137557604507e-09
and O 0 3.0374369686114733e-10
9 O 0 8.397553763472843e-09
and O 0 6.191822055079399e-10
DMS B-Disease 0 0.0007449796539731324
; O 0 6.920628514706095e-09
( O 0 2.220278821907229e-10
2 O 0 7.974396254439853e-09
) O 0 3.7071762326590374e-11
among O 0 8.812111595979388e-10
patients O 0 2.6362152460990274e-09
with O 0 7.649727379321902e-11
DMS B-Disease 0 0.0014095997903496027
, O 0 4.0426745284705135e-10
a O 0 4.437823025726928e-11
higher O 0 6.410929009881272e-10
frequency O 0 2.0712612180950885e-10
of O 0 7.245963828950153e-10
exon O 0 3.785104141229567e-08
8 O 0 1.1167043290072343e-08
mutations O 0 1.013215955580904e-09
among O 0 8.175918275732386e-10
46 O 0 7.81517695003231e-09
, O 0 1.3984260416322059e-09
XY O 0 6.218857743078843e-05
patients O 0 3.638038492681517e-07
with O 0 1.300781010682428e-10
female O 0 9.249962462654082e-10
phenotype O 0 1.091618528903382e-08
than O 0 4.634259920255346e-10
among O 0 6.589727652439592e-10
46 O 0 3.975244133869182e-09
, O 0 9.146627899525583e-10
XY O 0 0.0003302484401501715
patients O 0 7.636165264557349e-07
with O 0 1.2300335749948488e-10
sexual O 0 1.682177952488928e-09
ambiguity O 0 5.1971536407791064e-08
or O 0 2.972570856130119e-09
male O 0 6.001468766392293e-10
phenotype O 0 4.561124811175432e-10
; O 0 9.748863175063072e-12
and O 0 2.3552382266700533e-11
( O 0 3.866913733663324e-12
3 O 0 2.6782800977009913e-10
) O 0 5.365217818631418e-12
statistically O 0 1.328016308033142e-10
significant O 0 8.301213882955238e-11
evidence O 0 1.0817108320182456e-09
that O 0 7.122066131293181e-11
mutations O 0 3.9023060338649884e-09
in O 0 3.599036091372909e-08
exons O 0 1.1152658885293931e-07
8 O 0 1.6565380178690248e-08
and O 0 2.5807861403492893e-10
9 O 0 4.353220450781237e-09
preferentially O 0 2.212801275547349e-09
affect O 0 2.24900720269261e-09
amino O 0 1.999568288724163e-09
acids O 0 9.552330038076207e-10
with O 0 2.1764659519085683e-11
different O 0 1.6330517493834407e-10
functions O 0 4.1928902017041025e-10
. O 0 1.5634110672735346e-09
. O 0 3.623170385935737e-08

The O 0 5.246121418167604e-06
185delAG O 0 5.718786269426346e-05
BRCA1 O 0 2.2333090328174876e-06
mutation O 0 7.838645288416046e-09
originated O 0 6.812642117104417e-10
before O 0 1.2370990343235633e-10
the O 0 1.913334941872069e-11
dispersion O 0 2.8600515289411987e-09
of O 0 3.5555169919376794e-09
Jews O 0 5.969961858198758e-09
in O 0 2.565272994026202e-10
the O 0 7.725022288518346e-10
diaspora O 0 7.685342362506731e-10
and O 0 1.2396422430227538e-11
is O 0 3.4738108656978683e-12
not O 0 8.518693563053237e-12
limited O 0 8.391944916752436e-10
to O 0 2.880333971333471e-09
Ashkenazim O 0 0.00047185571747832
. O 0 5.689407203135488e-07

The O 0 7.121612952687428e-07
185delAG O 0 7.778649887768552e-06
mutation O 0 1.7517474759642937e-07
in O 0 9.437409964618837e-09
BRCA1 O 0 4.2726654214675364e-08
is O 0 1.3067061321869744e-11
detected O 0 6.349462622345925e-10
in O 0 1.3645126695216447e-10
Ashkenazi O 0 9.323532879079721e-08
Jews O 0 1.3212213545443774e-08
both O 0 2.7207316954935834e-10
in O 0 1.345749289782816e-08
familial B-Disease 1 0.9999393224716187
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.751967104723917e-08
in O 0 3.0760738400914533e-10
the O 0 2.763476947276189e-10
general O 0 8.158521858092627e-09
population O 0 1.3344886307109505e-10
. O 0 2.304942015030065e-09

All O 0 2.806190764204075e-07
tested O 0 7.541431159552303e-07
Ashkenazi O 0 1.414579742231581e-06
mutation O 0 3.7852775136570926e-08
carriers O 0 2.0083989582531103e-08
share O 0 1.4406005277578515e-09
the O 0 1.9503398895892587e-10
same O 0 5.082598786287917e-10
allelic O 0 2.4371681206503126e-07
pattern O 0 1.7948655894883814e-08
at O 0 1.1633789931408955e-08
the O 0 1.9698985553873172e-08
BRCA1 O 0 4.027187117117137e-07
locus O 0 7.045924377280244e-08
. O 0 2.7709747385529226e-08

Our O 0 1.4141710380499717e-06
previous O 0 6.210574952092429e-07
study O 0 1.4547079096871585e-08
showed O 0 3.435373652216356e-10
that O 0 1.458600276151023e-12
this O 0 1.0785108223165807e-10
Ashkenazi O 0 4.4566016299540934e-07
mutation O 0 4.406845999227471e-09
also O 0 1.5529539459935293e-11
occurs O 0 2.7073282851675096e-11
in O 0 8.648455215864992e-12
Iraqi O 0 3.021886352261305e-10
Jews O 0 1.111480685267452e-09
with O 0 4.02233454876999e-12
a O 0 1.1453195336574851e-10
similar O 0 5.924395640732882e-09
allelic O 0 6.298437710938742e-06
pattern O 0 5.713952191399585e-07
. O 0 1.638770470435702e-07

We O 0 9.559629177147144e-08
extended O 0 1.0188659871346317e-07
our O 0 1.3222138939283923e-09
analysis O 0 1.5391631025263308e-10
to O 0 5.4294166385027154e-11
other O 0 6.019681975111268e-11
non O 0 1.3066034476594268e-08
- O 0 1.1816230660599558e-08
Ashkenazi O 0 4.8634344551601316e-08
subsets O 0 1.3798245213081373e-08
354 O 0 6.820290554543362e-09
of O 0 1.0875669115284481e-10
Moroccan O 0 1.682964101412665e-09
origin O 0 2.0372015185898817e-10
, O 0 4.986534102302542e-11
200 O 0 4.214755766618339e-10
Yemenites O 0 7.581120371469297e-07
and O 0 2.991344116853867e-10
150 O 0 1.5248747819995856e-09
Iranian O 0 2.6089452376254485e-08
Jews O 0 1.5022378363482858e-07
. O 0 8.085622482667532e-08

Heteroduplex O 0 0.00012932515528518707
analysis O 0 5.8871357566658844e-08
complemented O 0 9.207163031987875e-08
by O 0 1.2335442667321672e-09
direct O 0 2.2129151844296757e-09
DNA O 0 1.0287955376497848e-08
sequencing O 0 1.0376819403745685e-07
of O 0 2.0148370083461487e-08
abnormally O 0 6.044934508508959e-08
migrating O 0 1.645353187029741e-08
bands O 0 4.568614819788763e-09
were O 0 9.638935205558141e-10
employed O 0 1.0139743267245649e-08
. O 0 3.850515994940906e-08

Four O 0 8.026879072531301e-08
of O 0 2.6748878667604004e-08
Moroccan O 0 2.418086353372928e-07
origin O 0 4.73522865362952e-09
( O 0 6.344807491898141e-12
1 O 0 1.207135502667711e-10
. O 0 3.7514743915501025e-12
1 O 0 7.61677942939798e-11
% O 0 2.8606307860695734e-12
) O 0 2.647668868004105e-13
and O 0 6.382130067483782e-12
none O 0 2.719445224563799e-10
of O 0 2.0104100606488373e-09
the O 0 2.2764826468346655e-08
Yemenites O 0 2.3278407752513885e-05
or O 0 7.182036632080724e-10
Iranians O 0 2.6238251571442106e-09
was O 0 3.9669478812953685e-10
a O 0 8.991648571543553e-12
carrier O 0 1.767286317289063e-10
of O 0 1.609436472982395e-10
the O 0 1.586205833348231e-09
185delAG O 0 5.113125780553673e-07
mutation O 0 7.075107788523383e-08
. O 0 3.6420022553329545e-08

BRCA1 O 0 0.00010436766751809046
allelic O 0 1.0405639841337688e-05
patterns O 0 3.394706382664481e-08
were O 0 3.2403251193358074e-09
determined O 0 1.8244238342290942e-09
for O 0 2.2526809584366703e-10
four O 0 8.215401275935008e-11
of O 0 3.36112304655245e-10
these O 0 2.4510884641393282e-11
individuals O 0 9.437714281954057e-13
and O 0 7.682843077005952e-12
for O 0 1.1138754849038257e-11
12 O 0 7.705784621503398e-11
additional O 0 3.632866230063314e-11
non O 0 7.321235173662899e-09
- O 0 7.583605743377575e-09
Ashkenazi O 0 3.1657901189419135e-08
185delAG O 0 3.774794876676424e-08
mutation O 0 5.387683632562812e-09
carriers O 0 9.928214694809867e-09
who O 0 1.1608648486927109e-09
had O 0 6.187354415487789e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.148720159311779e-05

Six O 0 9.995364962378517e-07
non O 0 1.9527858512446983e-06
- O 0 4.332680134666589e-07
Ashkenazi O 0 4.0127955003299576e-07
individuals O 0 1.1615464839964673e-10
shared O 0 5.954776671757145e-10
the O 0 2.51551224295099e-10
common O 0 4.365243277959507e-09
Ashkenazi O 0 1.6171006222975848e-07
haplotype O 0 3.062056919134193e-08
, O 0 4.119705410143837e-10
four O 0 1.1541526762082199e-10
had O 0 5.121446045031064e-10
a O 0 8.343787466502661e-11
closely O 0 4.029833688967699e-10
related O 0 4.1612967294213377e-08
pattern O 0 8.595502265507093e-08
, O 0 2.1978215081208674e-10
and O 0 2.8280505715017057e-10
the O 0 8.31868884887399e-09
rest O 0 3.51773721263271e-08
( O 0 1.3782337250634047e-11
n O 0 2.9588462235885515e-10
= O 0 1.648335634651943e-10
6 O 0 5.186749918451028e-10
) O 0 2.615641427408666e-12
displayed O 0 3.1060534699811626e-10
a O 0 8.050161093287045e-10
distinct O 0 6.106724725896129e-08
BRCA1 O 0 1.967298203453538e-06
allelic O 0 9.006081199913751e-06
pattern O 0 8.745175250624015e-07
. O 0 2.4867824777174974e-07

We O 0 1.0012674067638727e-07
conclude O 0 1.4806157366820116e-07
that O 0 1.523240422685035e-10
the O 0 7.100547705363169e-09
185delAG O 0 3.33335356117459e-06
BRCA1 O 0 2.5212457899215224e-07
mutation O 0 1.0957316165516318e-09
occurs O 0 1.3552788058479592e-10
in O 0 2.8287880718402825e-11
some O 0 2.422060989271113e-11
non O 0 2.7145039993570208e-08
- O 0 8.458029299163172e-08
Ashkenazi O 0 7.520789608861378e-07
populations O 0 1.048408027060077e-09
at O 0 1.3106506158155895e-10
rates O 0 1.0415730083979113e-10
comparable O 0 5.255342272469932e-10
with O 0 4.8615881285962725e-12
that O 0 3.0735095024603254e-11
of O 0 5.229619759461457e-08
Ashkenazim O 0 0.0007530319271609187
. O 0 2.984189961807715e-07

The O 0 3.711844840381673e-07
majority O 0 1.0567824837437456e-08
of O 0 1.4735212161554045e-08
Jewish O 0 1.2160133167071763e-07
185delAG O 0 2.69243003003794e-07
mutation O 0 7.593621731416533e-09
carriers O 0 1.3756455974345272e-09
have O 0 1.0991779535174384e-11
a O 0 2.5289667929251358e-11
common O 0 1.2377935343366175e-09
allelic O 0 1.1937781607684883e-07
pattern O 0 3.6992335861185666e-09
, O 0 5.014785461887605e-11
supporting O 0 6.759377085829854e-11
the O 0 9.987145555001575e-10
founder O 0 4.10549567675389e-08
effect O 0 1.97597973539132e-08
notion O 0 2.1361650226481288e-07
, O 0 4.499170480620762e-11
but O 0 3.022421202203418e-11
dating O 0 8.833686004905417e-10
the O 0 1.5831462529813933e-10
mutations O 0 3.4520095115730953e-11
origin O 0 1.431571666765663e-10
to O 0 9.700711588178645e-12
an O 0 1.0659508215341007e-12
earlier O 0 2.227506928909051e-10
date O 0 4.287719335138718e-08
than O 0 1.372600144655678e-09
currently O 0 3.1294353219912807e-10
estimated O 0 4.3768216828610207e-10
. O 0 1.2741201871335761e-08

However O 0 1.8640422183580085e-07
, O 0 4.985033497106883e-10
the O 0 3.521492819569261e-10
different O 0 1.5375552220309174e-10
allelic O 0 1.1688977963331126e-07
pattern O 0 9.689556712544345e-09
at O 0 1.3052060765517126e-08
the O 0 2.3759698208891677e-08
BRCA1 O 0 1.1568519653337717e-07
locus O 0 3.96906196797886e-09
even O 0 3.5019145916415084e-10
in O 0 3.9724126765783296e-11
some O 0 1.4107964796394867e-11
Jewish O 0 9.61754009765059e-10
mutation O 0 1.5686284215998825e-10
carriers O 0 2.7729385454478006e-10
, O 0 2.2173660477187163e-11
might O 0 2.643676111357962e-10
suggest O 0 2.2650634146081927e-10
that O 0 6.645117615888818e-12
the O 0 8.162845954728937e-10
mutation O 0 1.2298065898974642e-09
arose O 0 1.2693271322916644e-08
independently O 0 1.6487073928317386e-09
. O 0 8.472132995152037e-10
. O 0 1.2166415430669986e-08

Crystal O 0 2.1237316104816273e-05
structure O 0 4.425450867984182e-07
of O 0 6.40444568489329e-07
the O 0 2.9220582291600294e-06
hemochromatosis B-Disease 1 1.0
protein O 0 4.707603875431232e-05
HFE O 1 0.8287689685821533
and O 0 3.5412903720555278e-09
characterization O 0 7.956563052857746e-08
of O 0 1.1103941766066328e-08
its O 0 8.411077945247314e-10
interaction O 0 1.4042046414530773e-09
with O 0 4.4540557353478505e-10
transferrin O 0 6.06255343882367e-06
receptor O 0 8.766786550040706e-07
. O 0 1.3887546401747386e-07

HFE O 1 0.9999723434448242
is O 0 5.387511947674284e-08
an O 0 2.019237443917632e-09
MHC O 0 0.0003608899423852563
- O 0 2.1095294869155623e-05
related O 0 2.054194055745029e-06
protein O 0 6.787483020076479e-09
that O 0 1.1755673691438151e-11
is O 0 1.8173091503870253e-11
mutated O 0 4.670787312477387e-09
in O 0 3.0798016914523885e-10
the O 0 6.371183758346888e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9358720779418945

HFE O 0 0.00391820352524519
binds O 0 5.667264417752449e-07
to O 0 2.4992210967411665e-08
transferrin O 0 2.661874532350339e-06
receptor O 0 1.779723675099376e-07
( O 0 4.68511451856557e-10
TfR O 0 3.0876691425874014e-07
) O 0 3.357494837707975e-11
and O 0 3.595826414404257e-11
reduces O 0 8.698788911409849e-10
its O 0 2.6775598405137657e-10
affinity O 0 8.254755101688716e-09
for O 0 2.4943100918051186e-09
iron O 0 0.00015560977044515312
- O 0 7.613085699631483e-07
loaded O 0 2.218461503389335e-07
transferrin O 0 7.151252816584019e-07
, O 0 1.7669166130218628e-09
implicating O 0 5.832982310494117e-07
HFE O 1 0.9999693632125854
in O 0 7.957464731589425e-06
iron O 1 0.9999793767929077
metabolism O 0 0.01946507766842842
. O 0 1.327789277638658e-06

The O 0 7.416101652779616e-06
2 O 0 7.221959094749764e-06
. O 0 5.620255478788749e-07

6 O 0 1.6448077076347545e-05
A O 0 2.535888086185878e-07
crystal O 0 1.765056708791235e-06
structure O 0 3.4374951951576804e-07
of O 0 4.407135747896973e-06
HFE O 1 0.9999960660934448
reveals O 0 2.0426663027706127e-08
the O 0 4.691088073549565e-10
locations O 0 2.328085280112191e-09
of O 0 7.877797969513267e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 6.179609044920653e-06
and O 0 5.6321248109725275e-08
a O 0 6.542166364198465e-09
patch O 0 1.2584241630975157e-05
of O 0 0.0007080025388859212
histidines O 1 0.9560129046440125
that O 0 9.689583857497297e-11
could O 0 6.01773075814549e-11
be O 0 2.2226590359886167e-11
involved O 0 2.7125589968646224e-11
in O 0 3.161375605742478e-10
pH O 0 1.6250947965090745e-06
- O 0 2.800792344714864e-06
dependent O 0 2.3640275514935638e-07
interactions O 0 3.624123934287127e-08
. O 0 3.221340705295006e-08

We O 0 3.872450520248094e-07
also O 0 5.358813837119669e-09
demonstrate O 0 2.0384813836926696e-09
that O 0 7.156899378690795e-11
soluble O 0 1.3043339095020201e-05
TfR O 0 2.2851911126053892e-05
and O 0 2.6900666139084706e-09
HFE O 0 4.188101684121648e-06
bind O 0 1.5148591270275347e-09
tightly O 0 5.326753704792964e-09
at O 0 5.432506111624491e-10
the O 0 1.5393275543118534e-10
basic O 0 4.018690269447234e-09
pH O 0 3.782340485258828e-08
of O 0 1.5859344060231706e-08
the O 0 1.7994167267332273e-09
cell O 0 4.190411628801627e-10
surface O 0 5.381990964004046e-10
, O 0 7.695514364636225e-12
but O 0 2.1111293269093778e-11
not O 0 1.511498218254026e-11
at O 0 8.641142246190725e-10
the O 0 5.932964119992334e-10
acidic O 0 9.840704251473653e-08
pH O 0 5.298112455420778e-07
of O 0 4.838637579496208e-08
intracellular O 0 2.607681537369899e-08
vesicles O 0 6.175039857225784e-07
. O 0 5.985389606166791e-08

TfR O 0 0.010770464316010475
HFE O 0 0.026480816304683685
stoichiometry O 0 5.59234140382614e-05
( O 0 1.8155482450765703e-08
2 O 0 1.540788829856865e-08
1 O 0 3.9737657608895915e-09
) O 0 2.614510344334242e-11
differs O 0 3.6269505176989014e-09
from O 0 1.3278548260942102e-09
TfR O 0 8.399924809054937e-07
transferrin O 0 2.3861662157287356e-07
stoichiometry O 0 1.5910281092601508e-07
( O 0 5.409435399617024e-11
2 O 0 3.857856256672676e-10
2 O 0 1.5704545996975128e-10
) O 0 1.9976249387293477e-12
, O 0 3.640522779069233e-12
implying O 0 7.477111985121354e-11
a O 0 2.0959114652163713e-11
different O 0 3.71224231909828e-11
mode O 0 2.4387236674527912e-09
of O 0 1.6602530461540255e-10
binding O 0 1.9495414171899483e-09
for O 0 4.092655991883021e-09
HFE O 0 0.0005821987288072705
and O 0 4.7367101352335794e-09
transferrin O 0 2.948208646103012e-07
to O 0 2.155407630155537e-09
TfR O 0 1.502967279520817e-06
, O 0 5.372490993749146e-11
consistent O 0 8.984750166085576e-10
with O 0 1.7407957020321163e-11
our O 0 4.813337506348603e-10
demonstration O 0 5.433068661631069e-09
that O 0 4.056792402007403e-11
HFE O 0 3.554781142156571e-05
, O 0 3.2278507644534216e-10
transferrin O 0 2.243000807311546e-07
, O 0 2.8019672693169184e-10
and O 0 1.1369702401786697e-10
TfR O 0 1.0706868636134459e-07
form O 0 2.7858099160837924e-10
a O 0 3.4427402595405e-10
ternary O 0 1.3011368764637155e-06
complex O 0 4.504373464442324e-06
. O 0 3.9691627762294956e-07

Identification O 0 6.007006163599726e-07
of O 0 1.3707465029710875e-07
three O 0 3.92670607141099e-09
novel O 0 4.19183869837525e-08
mutations O 0 4.7188258855968e-10
and O 0 3.745313434388997e-11
a O 0 7.610691590831387e-12
high O 0 2.118718117616325e-10
frequency O 0 6.348757630725288e-11
of O 0 1.4295306605127678e-10
the O 0 1.1446955605620701e-09
Arg778Leu O 0 2.531868994992692e-05
mutation O 0 1.1478925365793202e-08
in O 0 6.909427474610652e-10
Korean O 0 5.134866114531178e-07
patients O 0 1.4902623135526483e-08
with O 0 1.0305344771976976e-10
Wilson B-Disease 0 1.5920313671813346e-06
disease I-Disease 0 4.415497869558749e-07
. O 0 1.0245719295198796e-07

Four O 0 1.397611271158894e-07
mutations O 0 6.054786449993799e-09
- O 0 1.746245459344209e-08
- O 0 3.2504722469184344e-08
R778L O 0 5.699948815163225e-07
, O 0 1.5227814842422305e-10
A874V O 0 3.4051534925083615e-08
, O 0 3.788348801325725e-11
L1083F O 0 2.88705699347247e-08
, O 0 2.4356532415947818e-11
and O 0 2.320860691129578e-11
2304delC O 0 8.115485172766057e-09
- O 0 1.1235624874927908e-08
- O 0 2.8971903986985126e-08
in O 0 2.5885025234373416e-09
the O 0 3.1466507177668745e-09
copper O 0 6.198385449351917e-08
- O 0 1.5125235508506307e-09
transporting O 0 6.067248925489821e-09
enzyme O 0 8.77678540955884e-10
, O 0 8.862843792201147e-11
P O 0 2.6295509769624914e-07
- O 0 1.6803571867285427e-08
type O 0 3.168296913713675e-08
ATPase O 0 2.0746554696415842e-08
( O 0 2.790993998413871e-11
ATP7B O 0 6.9194820753182285e-06
) O 0 1.3214965580155003e-11
, O 0 8.427931963428392e-12
were O 0 7.111830568895527e-11
identified O 0 5.500546546022278e-11
in O 0 1.234193164334485e-10
Korean O 0 8.700420721652335e-07
Patients O 0 1.3617352578876307e-07
with O 0 4.373592044082386e-10
Wilson B-Disease 0 2.470400431775488e-05
disease I-Disease 0 5.443415648187511e-05
. O 0 6.288219651651161e-07

Arg778Leu O 0 0.0024937132839113474
, O 0 2.8994678658023076e-08
the O 0 2.044178515347994e-08
most O 0 2.319415992602103e-09
frequently O 0 2.44848225028349e-10
reported O 0 3.194773612325008e-11
mutation O 0 2.2212744144045615e-10
of O 0 7.636231647012437e-10
this O 0 8.869439210856811e-11
enzyme O 0 7.836518656212377e-10
, O 0 8.966461600978803e-11
was O 0 3.829515371478465e-09
found O 0 2.868687509760548e-10
in O 0 4.4787606956475656e-10
six O 0 9.231808650866924e-10
of O 0 6.883674963376052e-09
eight O 0 4.166011535744474e-09
unrelated O 0 9.069815121165448e-08
patients O 0 2.6042270562243175e-08
studied O 0 2.369668905544131e-09
, O 0 8.74873177375557e-12
an O 0 3.2534864559397025e-12
allele O 0 3.236765300229649e-10
frequency O 0 3.2025311291761227e-09
of O 0 9.719951066244903e-09
37 O 0 3.225472653411998e-07
. O 0 1.013783261782919e-07

5 O 0 5.015194801671896e-07
% O 0 6.892608706010606e-09
, O 0 3.680740781608627e-11
which O 0 6.144099552046756e-12
is O 0 2.6584335861140618e-12
considerably O 0 5.8647855460947085e-09
higher O 0 2.6448390144651057e-08
than O 0 7.227960591160709e-11
those O 0 1.2335671373264745e-10
in O 0 4.076947113240692e-10
other O 0 7.05842717607652e-10
Asian O 0 7.192267226230342e-09
populations O 0 8.425079522922374e-10
. O 0 1.8427284143029965e-09

The O 0 3.4455953823453456e-07
novel O 0 1.091027783672871e-07
single O 0 1.1240313124716295e-09
nucleotide O 0 2.571505675064145e-09
deletion O 0 3.2712752506824927e-09
, O 0 6.19820028635587e-11
2304delC O 0 4.211063497905343e-08
, O 0 1.7474166558173465e-10
was O 0 2.012961575204031e-09
found O 0 1.8279965041667623e-10
in O 0 4.3548298300777333e-10
one O 0 2.162568568664369e-09
patient O 0 2.3728869109618245e-06
. O 0 2.6296689270566276e-07

Since O 0 1.7249969630483974e-07
a O 0 1.1695323598459595e-09
mutation O 0 1.1245180342456251e-09
at O 0 2.8977027444199166e-09
cDNA O 0 3.335039977514498e-08
nucleotide O 0 5.489664900437674e-08
2302 O 0 1.4269056009652559e-05
( O 0 1.0383358756138605e-10
2302insC O 0 2.352004990768819e-08
) O 0 4.796033015175283e-11
had O 0 2.4320429004021094e-10
been O 0 1.9432996878343545e-10
previously O 0 3.131931380906394e-10
described O 0 4.78975525908254e-10
, O 0 1.4799467207282646e-11
this O 0 2.6025794366835164e-11
region O 0 1.5762351424086773e-09
of O 0 1.0359590518760342e-08
the O 0 6.183212519772496e-08
ATP7B O 1 0.999991774559021
gene O 0 1.0216385071259992e-08
may O 0 4.4797028309062625e-09
be O 0 1.0886570533941153e-09
susceptible O 0 3.8763841985201e-06
to O 0 1.0825410790005208e-08
gene O 0 6.181131766425096e-07
rearrangements O 1 0.9994718432426453
causing O 1 0.9999804496765137
Wilson B-Disease 1 0.9990309476852417
disease I-Disease 0 0.0486280582845211
. O 0 2.21822324419918e-06

Disruption O 0 6.929520623089047e-06
of O 0 1.5736142700006894e-07
splicing O 0 1.4182295160480862e-07
regulated O 0 1.4388108482421558e-08
by O 0 2.3602717003079476e-10
a O 0 5.706350947320971e-10
CUG O 1 0.6834940314292908
- O 0 1.2212773299324908e-06
binding O 0 2.290966421014673e-07
protein O 0 5.618663863060647e-07
in O 0 1.9261042893958802e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.694960317574441e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.097941877669655e-06
DM B-Disease 1 1.0
) O 0 1.4583473095797217e-08
is O 0 1.97735008922173e-10
caused O 0 1.101918445378658e-09
by O 0 4.1721726073973286e-10
a O 0 2.4619235539091733e-09
CTG O 0 2.5277338863816112e-05
expansion O 0 1.8631820353220974e-07
in O 0 7.122382128521565e-10
the O 0 5.265144431554347e-10
3 O 0 2.913597363374265e-09
untranslated O 0 2.6007678570749704e-06
region O 0 3.7006503417202907e-10
of O 0 1.1261085397507031e-09
the O 0 1.339246011866635e-07
DM B-Disease 1 1.0
gene O 0 2.9180148430896224e-06
. O 0 3.834005610769964e-07

One O 0 8.450688149252983e-09
model O 0 1.3371397322714529e-08
of O 0 2.105170011645896e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
suggests O 0 1.0264438543572396e-07
that O 0 2.2125416082596772e-11
RNAs O 0 9.199588313357765e-10
from O 0 4.003515227668508e-11
the O 0 6.892365150834578e-11
expanded O 0 1.6480282694075754e-09
allele O 0 1.0234127989505737e-09
create O 0 1.3999758297078557e-10
a O 0 1.1869730198732498e-10
gain O 0 8.387307737223182e-09
- O 0 2.345601934905517e-09
of O 0 5.575175876515459e-09
- O 0 1.0443306219798387e-09
function O 0 3.696937200814432e-11
mutation O 0 1.3798698295097722e-11
by O 0 1.7802455473323042e-12
the O 0 1.1131639880701538e-11
inappropriate O 0 1.2950229777430877e-10
binding O 0 1.2375338531711577e-09
of O 0 6.194542656601243e-09
proteins O 0 1.1953087131200135e-10
to O 0 3.727889663629469e-10
the O 0 3.37109717918338e-08
CUG O 1 0.9998180270195007
repeats O 0 7.235059342747263e-07
. O 0 4.4941342025595077e-07

Data O 0 1.4687068983221252e-07
presented O 0 8.450821553651622e-08
here O 0 1.904046253997649e-09
indicate O 0 4.74366990133035e-10
that O 0 8.272395789210574e-12
the O 0 6.501201244013544e-10
conserved O 0 3.6849961304596945e-08
heterogeneous O 0 1.8723751793459087e-07
nuclear O 0 1.2915567140225903e-06
ribonucleoprotein O 0 4.268415523256408e-06
, O 0 9.391311062145746e-10
CUG O 0 1.331578278040979e-05
- O 0 2.4771436457626805e-08
binding O 0 6.3785861037501945e-09
protein O 0 2.938903342908361e-09
( O 0 5.7572273337580526e-11
CUG O 0 0.0004218225076328963
- O 0 5.38399831384595e-07
BP O 0 5.949106025582296e-07
) O 0 3.9488284170330346e-11
, O 0 3.678228208126022e-11
may O 0 6.090132287361882e-10
mediate O 0 2.7961919446539696e-09
the O 0 6.710275446408787e-09
trans O 0 6.504680527541495e-08
- O 0 1.337373987553292e-06
dominant O 0 7.916015647424501e-07
effect O 0 4.759870364523522e-08
of O 0 5.7116377405463936e-08
the O 0 2.8410722663352317e-08
RNA O 0 6.872395630352912e-08
. O 0 1.2698817108969251e-08

CUG O 1 0.9999979734420776
- O 1 0.8677431344985962
BP O 0 0.0008130690548568964
was O 0 2.0447915005661343e-07
found O 0 7.044628214103454e-10
to O 0 2.0824704807798078e-11
bind O 0 5.90838766800772e-11
to O 0 6.787942430364069e-11
the O 0 2.3680919447599535e-09
human O 0 4.800797537285462e-09
cardiac O 0 5.4325406381394714e-05
troponin O 0 0.0009060545125976205
T O 0 1.811554466257803e-05
( O 0 1.5476943338033067e-10
cTNT O 0 6.712953393162024e-08
) O 0 5.226460930707333e-11
pre O 0 6.190122121552122e-07
- O 0 1.341132502830078e-07
messenger O 0 2.6542082309788384e-08
RNA O 0 2.9160991399379554e-09
and O 0 3.6815835102732564e-11
regulate O 0 3.2337538202753535e-10
its O 0 3.122072600447723e-10
alternative O 0 1.2556623119053256e-07
splicing O 0 7.721978931840567e-07
. O 0 1.4259870795285678e-07

Splicing O 0 6.329843245111988e-07
of O 0 2.414203947864735e-07
cTNT O 0 0.0001013612563838251
was O 0 4.610684527506237e-07
disrupted O 0 5.097612302051857e-06
in O 0 1.9924203797927476e-07
DM B-Disease 1 1.0
striated O 0 5.536149183171801e-05
muscle O 0 5.183529992791591e-06
and O 0 1.1232200591848596e-07
in O 0 1.643176616994424e-08
normal O 0 1.4473744158749469e-07
cells O 0 1.3527905906585147e-08
expressing O 0 1.5731714819722242e-09
transcripts O 0 4.862105829062102e-09
that O 0 5.681846312888261e-11
contain O 0 2.7633902277557354e-08
CUG O 0 0.1137748435139656
repeats O 0 6.280332627284224e-07
. O 0 3.2672429028934857e-07

Altered O 0 2.8112528980273055e-06
expression O 0 7.716650429756555e-08
of O 0 2.841175295031917e-08
genes O 0 5.428759219938684e-09
regulated O 0 1.6790982826364598e-08
posttranscriptionally O 0 8.096222927633789e-07
by O 0 2.378980923367635e-08
CUG O 1 1.0
- O 0 0.130856454372406
BP O 0 2.3842650989536196e-05
therefore O 0 3.2652223147522363e-09
may O 0 2.765485895839248e-10
contribute O 0 2.8045069044857485e-10
to O 0 5.165023964082138e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9999988079071045
. O 0 2.146772430933197e-07
. O 0 1.0418069251727502e-07

Identification O 0 2.2169726321408234e-07
of O 0 1.2607374699769025e-08
a O 0 9.522859167887532e-10
novel O 0 3.898818690117878e-08
nonsense O 0 6.452140866031186e-08
mutation O 0 7.468592411186137e-10
and O 0 3.161127262729657e-11
a O 0 2.601586654438215e-11
missense O 0 7.727516404543167e-09
substitution O 0 3.431840767120775e-08
in O 0 1.6038875783053186e-09
the O 0 1.1898478868843654e-09
vasopressin O 0 9.118674704211571e-09
- O 0 2.6211752768290353e-08
neurophysin O 0 5.923934168095002e-06
II O 1 1.0
gene O 0 7.320914541253387e-09
in O 0 4.0815845148145513e-10
two O 0 4.8472854202730176e-11
Spanish O 0 5.3088111684473915e-09
kindreds O 0 1.7262344442769972e-07
with O 0 6.749782399673165e-10
familial B-Disease 0 0.002589605515822768
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 0 2.0830611902056262e-05

Familial B-Disease 1 0.9999971389770508
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 4.764266918755311e-07
FNDI B-Disease 1 1.0
) O 0 2.5139259562934058e-09
is O 0 1.2750572819797412e-10
an O 0 1.9220079694459713e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9998387098312378
by O 0 9.192191100737546e-06
deficiency O 1 0.9999988079071045
in O 0 1.3418250546237687e-06
the O 0 7.870991680647421e-07
antidiuretic O 0 1.8588707462185994e-06
hormone O 0 1.6562417215482128e-07
arginine O 0 1.713876116582469e-07
vasopressin O 0 2.2034109292690118e-07
( O 0 7.558720316325207e-10
AVP O 0 6.866616786282975e-07
) O 0 2.3436049975678053e-11
encoded O 0 6.401969232516791e-11
by O 0 1.5470863479194463e-10
the O 0 2.2032718760556236e-08
AVP O 0 0.00010893419675994664
- O 0 3.49095944329747e-06
neurophysin O 0 0.08777123689651489
II O 1 1.0
( O 0 1.6406187341999612e-07
AVP O 0 0.001978408545255661
- O 0 5.499471171788173e-06
NPII O 0 0.024697529152035713
) O 0 1.0922135418311996e-09
gene O 0 1.6382750711585459e-09
on O 0 5.7890781057778895e-09
chromosome O 0 9.787333610233873e-09
20p13 O 0 6.271932306844974e-06
. O 0 6.284550408963696e-07

In O 0 3.2056743037855995e-08
this O 0 6.811031183495686e-10
study O 0 8.528733830281965e-10
, O 0 1.6700535052094345e-11
we O 0 1.1314360039149651e-11
analyzed O 0 1.0002586536828062e-09
two O 0 2.7534948279783755e-11
families O 0 1.4930681691005532e-11
with O 0 9.266835562793396e-12
FNDI B-Disease 1 1.0
using O 0 1.3574836810192892e-09
direct O 0 7.566783311041547e-10
automated O 0 7.867103413161658e-09
fluorescent O 0 1.8312158900357645e-08
, O 0 1.787350475956906e-11
solid O 0 2.502180407315535e-10
phase O 0 1.5339470804676125e-09
, O 0 8.946776479390461e-12
single O 0 3.687226565740609e-11
- O 0 2.792300002329995e-10
stranded O 0 1.1232618168932618e-09
DNA O 0 5.175353895436885e-11
sequencing O 0 5.742588626844736e-10
of O 0 3.9202982526909125e-10
PCR O 0 8.471339469906525e-07
- O 0 3.238527642679401e-05
amplified O 0 7.760134758427739e-05
AVP O 0 0.004465886391699314
- O 0 1.341522602160694e-05
NPII O 0 0.0017227540956810117
DNA O 0 2.6831203285837546e-06
. O 0 1.4485894439530966e-07

In O 0 2.87743091575976e-08
one O 0 2.161346934759223e-10
of O 0 4.300951261804187e-10
the O 0 1.2878554889184102e-09
families O 0 1.6664969404445173e-10
, O 0 7.0118858636059045e-12
affected O 0 1.2368797652761998e-10
individuals O 0 2.8618967005261675e-12
presented O 0 1.6431883631540245e-09
a O 0 2.2242546693362897e-10
novel O 0 1.6771648958524565e-08
nonsense O 0 2.4600003811769966e-08
mutation O 0 5.231509669911816e-10
in O 0 1.372128244359061e-10
exon O 0 2.120946973604987e-09
3 O 0 3.43744505082455e-10
of O 0 2.278209149109145e-10
the O 0 6.33933405769227e-10
gene O 0 6.212545061723418e-11
, O 0 1.5649996923383647e-11
consisting O 0 1.0437566089205319e-10
in O 0 7.080848407614582e-11
a O 0 2.0540334710883457e-10
G O 0 1.377566491100879e-06
to O 0 4.217226567959642e-09
T O 0 1.8074018726110808e-07
transition O 0 3.5460354652627757e-09
at O 0 1.1151798373632005e-09
nucleotide O 0 5.877999864623007e-09
2101 O 0 3.64763423021941e-06
, O 0 4.6431671008040354e-11
which O 0 2.4932454104759083e-12
produces O 0 6.513346285930144e-12
a O 0 3.752347391139388e-12
stop O 0 8.478191065863783e-11
signal O 0 1.093606094570987e-09
in O 0 6.346072556340232e-10
codon O 0 4.294856736919428e-08
82 O 0 6.939413310647069e-07
( O 0 1.2774752367050723e-09
Glu O 0 7.933262168080546e-06
) O 0 8.743284984902289e-10
of O 0 3.706615814280667e-08
NPII O 1 0.9997350573539734
. O 0 2.9281172828632407e-06

The O 0 2.220947635578341e-06
premature O 0 6.7287087404110935e-06
termination O 0 5.965217724224203e-07
eliminates O 0 1.6995042528833437e-07
part O 0 2.940944376916832e-09
of O 0 2.370572849130781e-09
the O 0 3.0914444337781788e-09
C O 0 4.72182023258938e-07
- O 0 3.200101073019823e-09
terminal O 0 1.1346858563854312e-08
domain O 0 4.738569536755222e-10
of O 0 7.899864651328414e-10
NPII O 0 0.00020906221470795572
, O 0 2.9799832046428776e-10
including O 0 1.6272312663989652e-10
a O 0 1.0238027786657611e-10
cysteine O 0 1.2231604618051506e-09
residue O 0 3.480157673152462e-08
in O 0 1.0806466832491424e-09
position O 0 4.01230293434196e-09
85 O 0 1.7446144084942716e-08
, O 0 1.9082251404012318e-11
which O 0 4.171492144766642e-12
could O 0 1.1651049916516776e-11
be O 0 2.826598330396557e-11
involved O 0 1.3136038090610924e-10
in O 0 1.0839821401598115e-10
the O 0 5.991735441135404e-10
correct O 0 1.290792628338977e-08
folding O 0 1.4974689577229583e-07
of O 0 1.8825678793632505e-08
the O 0 1.5898208971520944e-07
prohormone O 0 0.003782484447583556
. O 0 1.011770223158237e-06

In O 0 3.903856438114417e-08
the O 0 1.2948316197025633e-08
second O 0 1.0367777747433138e-07
family O 0 2.570062773710191e-10
, O 0 6.455008402794782e-12
a O 0 5.743557972975877e-12
G279A O 0 5.979089223728806e-09
substitution O 0 2.3740401644545273e-08
at O 0 4.428661437572146e-09
position O 0 1.0330599709007515e-09
- O 0 2.832979684175285e-10
1 O 0 7.095954379643388e-10
of O 0 1.1976318547990417e-10
the O 0 4.5987109953404826e-11
signal O 0 1.8565070314391363e-10
peptide O 0 8.953695423974395e-11
was O 0 1.4058519626214405e-10
observed O 0 2.66041966234809e-10
in O 0 1.3587109215507098e-10
all O 0 2.4664156828002604e-10
affected O 0 4.8847392797313205e-09
individuals O 0 3.350613120289836e-10
. O 0 1.736447607925129e-08

This O 0 3.863361257572251e-07
missense O 0 2.61702425632393e-05
mutation O 0 9.668220002367889e-08
, O 0 6.984409162136274e-10
which O 0 2.9637828302675473e-10
replaces O 0 1.0522528555156896e-06
Ala O 0 1.5840056221350096e-05
with O 0 2.6382676043823494e-09
Thr O 0 0.00041134702041745186
, O 0 1.0223358826166873e-09
is O 0 3.50447865171688e-11
frequent O 0 2.565429535472674e-10
among O 0 7.347254804557224e-09
FNDI B-Disease 1 1.0
patients O 1 0.9999994039535522
and O 0 6.161124943560026e-09
is O 0 9.627906111253637e-11
thought O 0 1.8504618670700523e-10
to O 0 2.609576834136651e-12
reduce O 0 6.599887997227327e-11
the O 0 1.4031917294765606e-10
efficiency O 0 1.1002724953357301e-08
of O 0 7.777699040367736e-10
cleavage O 0 1.0546635786923275e-09
by O 0 3.25423438196637e-10
signal O 0 1.4693788408237651e-08
peptidases O 0 5.984146014270664e-07
. O 0 3.821051919317142e-09
. O 0 1.4403181758382289e-08

Genetic O 0 6.75512092129793e-06
heterogeneity O 0 5.9354192671889905e-06
of O 0 2.1688913420803146e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0553277141056583e-09
due O 0 1.2104860047656985e-07
to O 0 2.908056462302966e-09
TWIST O 0 0.02782442420721054
and O 0 1.4653379309947923e-07
FGFR O 1 0.9999986886978149
mutations O 0 4.1226203393307514e-06
. O 0 3.395225007807312e-07

Thirty O 0 7.579026714665815e-05
- O 0 4.2346246118540876e-06
two O 0 3.134245529778923e-09
unrelated O 0 6.156006406854431e-07
patients O 0 1.184000897325177e-08
with O 0 4.3989451838089e-12
features O 0 3.7288921950207055e-10
of O 0 1.2493958934101101e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.430030621169976e-10
a O 0 1.538857791194559e-10
common O 0 3.304602387288469e-07
autosomal B-Disease 0 0.010186687111854553
dominant I-Disease 0 0.39929524064064026
condition I-Disease 0 0.010135534219443798
of O 1 0.996917724609375
craniosynostosis B-Disease 1 1.0
and O 0 0.047412022948265076
limb B-Disease 1 1.0
anomalies I-Disease 1 0.8793491125106812
, O 0 5.399349412016363e-09
were O 0 7.0845977973021945e-09
screened O 0 1.2678705196833562e-08
for O 0 2.5061447361807154e-10
mutations O 0 9.683566171148072e-10
in O 0 1.009358263637239e-09
TWIST O 0 2.1765912606497295e-05
, O 0 2.0508597042834253e-09
FGFR2 O 1 0.9997325539588928
, O 0 3.3964404622111033e-09
and O 0 6.067040647650401e-09
FGFR3 O 1 0.997189462184906
. O 0 2.8051119898009347e-06

Nine O 0 6.900201242387993e-06
novel O 0 1.9489550595608307e-06
and O 0 8.83736372969679e-09
three O 0 3.181192864687432e-09
recurrent O 0 6.262222882469359e-07
TWIST O 0 0.00010854152060346678
mutations O 0 7.638482912852851e-08
were O 0 6.931183627045812e-09
found O 0 3.0530031280839864e-10
in O 0 4.372324169388264e-10
12 O 0 7.101360388617195e-09
families O 0 2.2618180661737597e-09
. O 0 2.4419179567303217e-08

Seven O 0 6.49348066872335e-07
families O 0 1.4130366210451939e-08
were O 0 1.840094077110166e-09
found O 0 8.73198111039919e-11
to O 0 3.366793302483906e-11
have O 0 6.999568979981774e-11
the O 0 3.994313324540144e-09
FGFR3 O 0 0.14491389691829681
P250R O 0 2.860366748791421e-06
mutation O 0 4.88112616991998e-09
, O 0 2.6155378210490632e-11
and O 0 1.9968984799056955e-11
one O 0 1.0846185061197389e-11
individual O 0 8.268168268099618e-12
was O 0 3.643297608046936e-10
found O 0 4.858772759130936e-11
to O 0 3.0272791218255435e-11
have O 0 1.6499585031581887e-10
an O 0 1.2618572853284604e-10
FGFR2 O 0 0.15404289960861206
VV269 O 0 0.00011346091923769563
- O 0 3.7590207284665667e-06
270 O 0 3.332544622480782e-07
deletion O 0 1.39797123210883e-07
. O 0 4.306298961864741e-08

To O 0 1.1580083558726528e-08
date O 0 9.023430607157934e-07
, O 0 1.90496152185915e-09
our O 0 5.245407996845586e-10
detection O 0 8.70500116434414e-09
rate O 0 8.193355993668661e-10
for O 0 4.7090144283945534e-11
TWIST O 0 1.0600083442113828e-06
or O 0 1.607391908464706e-08
FGFR O 0 0.07078757137060165
mutations O 0 1.3709158253050191e-08
is O 0 1.8082581265677078e-10
68 O 0 2.6003788011763618e-09
% O 0 3.752506985699178e-11
in O 0 4.8192238394362263e-11
our O 0 2.0574968395692395e-09
Saethre B-Disease 1 0.9996380805969238
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.915334961377084e-05
, O 0 5.0252794980831794e-11
including O 0 3.4607067211922526e-10
our O 0 7.363599063836546e-09
five O 0 1.5498041738837287e-09
patients O 0 1.770135504841619e-08
elsewhere O 0 1.7457385537156256e-09
reported O 0 1.6991581752723306e-10
with O 0 3.5820896249205703e-10
TWIST O 0 0.00017907971050590277
mutations O 0 6.558798304467928e-07
. O 0 3.2341711175831733e-07

More O 0 2.773766460961724e-08
than O 0 1.6228339783097567e-09
35 O 0 8.532854423037861e-09
different O 0 4.125154107192941e-10
TWIST O 0 9.624327503843233e-07
mutations O 0 4.9523785072835835e-09
are O 0 5.2869996575166667e-11
now O 0 5.0025761311189854e-11
known O 0 1.449687453414228e-10
in O 0 8.671947882010755e-11
the O 0 8.143842267216428e-10
literature O 0 3.68605768130692e-08
. O 0 7.758146125524945e-09

The O 0 8.471751584693266e-07
most O 0 2.3617870326120283e-08
common O 0 8.69232508193818e-09
phenotypic O 0 1.3674582355349685e-08
features O 0 1.2955323480667857e-09
, O 0 3.381169649818716e-11
present O 0 1.4092185751657382e-10
in O 0 6.286304116143171e-11
more O 0 2.4674387966855393e-12
than O 0 3.2931123106205717e-12
a O 0 1.7297182783315712e-11
third O 0 1.1968977808862746e-08
of O 0 2.894627293414942e-08
our O 0 2.4186947555904226e-08
patients O 0 1.8942666102361727e-08
with O 0 3.72585469421427e-11
TWIST O 0 4.503823220147751e-06
mutations O 0 6.227333315678152e-09
, O 0 7.758019920922621e-11
are O 0 8.699846398840805e-11
coronal B-Disease 0 2.082674200210022e-06
synostosis I-Disease 0 5.088111720397137e-06
, O 0 3.0475066914448234e-09
brachycephaly B-Disease 0 2.6002471713582054e-05
, O 0 2.1600508048891243e-08
low B-Disease 0 0.00019185761630069464
frontal I-Disease 1 0.9999902248382568
hairline I-Disease 1 0.9999998807907104
, O 0 6.099729148445476e-07
facial B-Disease 0 0.032299336045980453
asymmetry I-Disease 1 0.9715200066566467
, O 0 3.2716641840124794e-07
ptosis B-Disease 1 0.8432979583740234
, O 0 1.1032123659049375e-08
hypertelorism B-Disease 0 3.222821396775544e-05
, O 0 6.1358877978534565e-09
broad B-Disease 0 0.0004575467901304364
great I-Disease 1 0.9817745685577393
toes I-Disease 0 0.00023347686510533094
, O 0 2.6781536988096377e-09
and O 0 9.457699512438467e-09
clinodactyly B-Disease 0 0.005185942631214857
. O 0 5.973716270091245e-06

Significant O 0 1.3390507774602156e-05
intra O 0 0.0003049814549740404
- O 0 5.848257205798291e-05
and O 0 4.439150558255278e-08
interfamilial O 0 4.9648635467747226e-05
phenotypic O 0 1.434193450222665e-06
variability O 0 6.583891263289843e-07
is O 0 7.469243973323714e-11
present O 0 3.408104701230208e-11
for O 0 8.031170173339319e-11
either O 0 6.278701114581509e-09
TWIST O 0 0.00013898039469495416
mutations O 0 4.281696419639047e-07
or O 0 7.158479320423794e-08
FGFR O 1 0.9999278783798218
mutations O 0 2.7329367640049895e-06
. O 0 3.257306104842428e-07

The O 0 1.8310942095922655e-07
overlap O 0 5.608070097196105e-08
in O 0 1.426320395125913e-09
clinical O 0 4.811846565644373e-08
features O 0 8.579049692869489e-10
and O 0 1.9693742470128228e-10
the O 0 4.5088974220952593e-10
presence O 0 1.0064030164791404e-10
, O 0 2.5114023707861755e-11
in O 0 4.948624843237326e-11
the O 0 1.200518157107311e-10
same O 0 9.466263189983337e-11
genes O 0 4.0913720328328296e-11
, O 0 4.90127946908836e-12
of O 0 1.6927435841918026e-10
mutations O 0 4.669286138292428e-11
for O 0 5.074072412236674e-11
more O 0 1.3168995408041617e-11
than O 0 1.9761435543497186e-10
one O 0 1.6148235526536325e-10
craniosynostotic B-Disease 0 2.3138767346608802e-07
condition I-Disease 0 9.793686217562936e-08
- O 0 3.348093002841779e-08
such O 0 2.85136914079942e-09
as O 0 2.04053907104651e-09
Saethre B-Disease 0 2.9014843221375486e-06
- I-Disease 0 1.1589312265414264e-07
Chotzen I-Disease 0 1.582602817506995e-05
, I-Disease 0 3.7415454068323584e-10
Crouzon I-Disease 0 2.9230364816612564e-05
, I-Disease 0 1.8756853847889943e-09
and I-Disease 0 1.0443510944924128e-08
Pfeiffer I-Disease 1 0.6370530128479004
syndromes I-Disease 1 0.9999998807907104
- O 0 0.05125129222869873
support O 0 7.217362707478969e-08
the O 0 1.1351859008357224e-08
hypothesis O 0 2.1476731504321833e-08
that O 0 7.136081222464119e-12
TWIST O 0 8.63228777348013e-08
and O 0 4.613024129351828e-10
FGFRs O 0 1.1993175803581835e-06
are O 0 2.054471176515804e-11
components O 0 1.0472908096303968e-09
of O 0 6.818829945132165e-10
the O 0 1.8894368014610308e-10
same O 0 1.4211654075779734e-10
molecular O 0 1.5015287901931629e-09
pathway O 0 3.364060419119852e-10
involved O 0 4.786763867226096e-12
in O 0 3.1425795125883393e-12
the O 0 1.878304109470541e-11
modulation O 0 3.9208085667041814e-09
of O 0 9.012734381030896e-08
craniofacial O 1 1.0
and O 0 0.00017326668603345752
limb O 1 1.0
development O 0 0.0001572514302097261
in O 0 1.5064895109162535e-08
humans O 0 5.943885827974782e-09
. O 0 9.790781518859148e-10
. O 0 9.497994390983422e-09

Mutation O 0 5.884497866759375e-08
analysis O 0 4.428053479443861e-09
of O 0 1.0901957381292959e-07
UBE3A O 1 1.0
in O 1 0.999993085861206
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999895095825195
. O 0 8.862483014127065e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8038432244793512e-05
AS B-Disease 1 1.0
) O 0 9.176403525934518e-10
is O 0 3.018376867891526e-11
caused O 0 5.211770459645493e-10
by O 0 6.62142674023869e-10
chromosome O 0 5.376617817631768e-09
15q11 O 0 1.5389200598292518e-06
- O 0 2.3389472403323452e-07
q13 O 0 1.9129456632072106e-06
deletions O 0 2.8613296620960682e-08
of O 0 5.458308915962107e-09
maternal O 0 8.353413960549005e-09
origin O 0 2.0098223085796008e-10
, O 0 1.6685339091285223e-12
by O 0 2.8093400869511065e-11
paternal O 0 2.6898480882664444e-06
uniparental B-Disease 1 0.9999978542327881
disomy I-Disease 1 0.9999998807907104
( O 0 1.905264497281678e-07
UPD B-Disease 1 1.0
) O 0 9.724582250569824e-10
15 O 0 2.209440186362599e-09
, O 0 1.610851382838341e-11
by O 0 2.8344984692729724e-10
imprinting O 0 2.1151579858269542e-05
defects O 0 0.006427139975130558
, O 0 2.9409836788119037e-09
and O 0 3.7754174786464034e-10
by O 0 1.055206921840579e-09
mutations O 0 3.4838087970001652e-09
in O 0 4.658118335498784e-09
the O 0 1.60625702960715e-07
UBE3A O 0 0.005612518638372421
gene O 0 4.149792971475108e-07
. O 0 2.436912325265439e-07

UBE3A O 0 0.04814653471112251
encodes O 0 6.700039421048132e-07
a O 0 2.4487791350225052e-08
ubiquitin O 0 1.9787685232586227e-06
- O 0 4.239966983732302e-06
protein O 0 1.3179800362195238e-07
ligase O 0 3.098728313943866e-07
and O 0 2.7046382911066758e-08
shows O 0 1.0473672595878725e-08
brain O 0 1.5994166346899874e-07
- O 0 5.2799332905806295e-08
specific O 0 1.1124339494017477e-07
imprinting O 0 5.376123954192735e-05
. O 0 5.850620823366626e-07

Here O 0 1.0544498536546598e-06
we O 0 1.8081840025274687e-08
describe O 0 1.6982177442059765e-07
UBE3A O 0 0.000513151753693819
coding O 0 2.8501528959168354e-06
- O 0 2.8504734927992104e-06
region O 0 6.09267090112553e-08
mutations O 0 2.069031168616675e-09
detected O 0 1.9447430332775184e-09
by O 0 2.337789128947776e-10
SSCP O 0 0.2937553822994232
analysis O 0 1.0262906968705465e-08
in O 0 2.304177071366098e-09
13 O 0 1.4366554168532275e-08
AS B-Disease 1 0.9999998807907104
individuals O 0 6.466931434800927e-10
or O 0 1.8339588736537848e-09
families O 0 2.956817013455293e-09
. O 0 2.7286599646458853e-08

Two O 0 5.4652701919621904e-08
identical O 0 1.0462016319934264e-07
de O 0 1.0983396947494839e-07
novo O 0 5.543166707866476e-07
5 O 0 1.8795475398292183e-07
- O 0 1.1320467763198394e-07
bp O 0 1.6421951443135185e-07
duplications O 0 2.65283745193301e-07
in O 0 2.3299879359228726e-08
exon O 0 1.249571596417809e-06
16 O 0 3.5793270569683955e-08
were O 0 1.1108708619644858e-08
found O 0 6.40374642202346e-09
. O 0 5.198412722506873e-08

Among O 0 1.5269150708263624e-06
the O 0 1.168039354126904e-08
other O 0 6.772349903094721e-10
11 O 0 1.93620808275341e-09
unique O 0 5.789085877339062e-10
mutations O 0 3.7619968251689784e-10
, O 0 4.728094651906822e-11
8 O 0 3.6338956288517466e-09
were O 0 1.982184638649187e-09
small O 0 2.8084090608615497e-10
deletions O 0 5.974381434015186e-09
or O 0 1.3830918632606881e-08
insertions O 0 7.796739396326302e-07
predicted O 0 8.840838745527435e-07
to O 0 3.6222287391751706e-09
cause O 0 4.362241554645152e-07
frameshifts O 0 0.0008428831933997571
, O 0 7.514746047654342e-10
1 O 0 4.857776847444484e-09
was O 0 6.794085849470832e-10
a O 0 2.7087021861604832e-11
mutation O 0 5.0828188880025493e-11
to O 0 2.7518515244295827e-11
a O 0 1.1305951314044549e-10
stop O 0 1.1551178902280412e-09
codon O 0 4.749320936525692e-09
, O 0 9.047237958803578e-11
1 O 0 9.185369687081391e-10
was O 0 7.402743973372594e-10
a O 0 1.4388396030184936e-10
missense O 0 4.354925309257851e-08
mutation O 0 1.0572960285060162e-09
, O 0 4.206890738545077e-11
and O 0 6.845436023583673e-11
1 O 0 3.795476821721877e-09
was O 0 4.524233432334768e-09
predicted O 0 5.914403633511256e-09
to O 0 9.831872122001428e-11
cause O 0 8.362369130487934e-10
insertion O 0 2.910731211613893e-09
of O 0 2.009682731340945e-08
an O 0 5.244215131594565e-11
isoleucine O 0 8.729575284860402e-09
in O 0 4.553518673233725e-10
the O 0 1.3758634231919586e-09
hect O 0 5.04687136526627e-07
domain O 0 6.704645727495517e-09
of O 0 3.358249145435366e-08
the O 0 1.2598725618317985e-07
UBE3A O 0 0.0004658855905290693
protein O 0 1.9878228840752854e-08
, O 0 8.611226315347054e-11
which O 0 1.4538070400305081e-11
functions O 0 2.165861517910983e-10
in O 0 2.6482347426082242e-09
E2 O 0 1.1860500308102928e-05
binding O 0 9.55516199496742e-08
and O 0 8.006951546235541e-09
ubiquitin O 0 3.7579275158350356e-07
transfer O 0 7.074876975821098e-06
. O 0 1.0438928939038306e-06

Eight O 0 1.3663975551025942e-07
of O 0 5.370970335150105e-09
the O 0 5.318629425765664e-10
cases O 0 8.583844746112845e-10
were O 0 5.1822728330819245e-09
familial O 0 1.6494952603807178e-07
, O 0 1.3769949624986566e-09
and O 0 2.0097583597333823e-09
five O 0 1.707661567706964e-09
were O 0 9.446414317437757e-09
sporadic O 0 2.655170874277246e-07
. O 0 1.3596772419077752e-07

In O 0 5.30329828052345e-07
two O 0 4.073902104551053e-09
familial O 0 2.1959469620469463e-07
cases O 0 1.8342610985655483e-07
and O 0 1.9252683003401216e-08
one O 0 1.1137343269851385e-09
sporadic O 0 1.634181323595385e-08
case O 0 1.9796388528448006e-08
, O 0 7.8431877659213e-10
mosaicism O 0 1.1249002454860602e-05
for O 0 2.9834211545676226e-08
UBE3A O 0 0.00012392565258778632
mutations O 0 2.635873297407443e-09
was O 0 1.030607821306262e-09
detected O 0 7.107670563222257e-10
in O 0 5.760060831083713e-11
the O 0 3.332658315979842e-10
mother O 0 4.721085744563425e-10
of O 0 1.0393707006173258e-09
three O 0 2.5144664128617933e-10
AS B-Disease 1 1.0
sons O 0 3.342083516599814e-07
, O 0 6.983296753360069e-12
in O 0 6.52792186625617e-12
the O 0 9.067657041894606e-11
maternal O 0 1.2071943444880162e-08
grandfather O 0 9.990468896603488e-08
of O 0 3.9015858988022956e-08
two O 0 1.026936424786129e-09
AS B-Disease 1 1.0
first O 0 4.2132324296062507e-08
cousins O 0 9.499534492363182e-09
, O 0 1.0170118219798852e-11
and O 0 5.4759647337421224e-12
in O 0 1.999741865155169e-11
the O 0 3.0120755889484485e-10
mother O 0 3.502262091448216e-10
of O 0 5.820474657802777e-10
an O 0 8.24719320613454e-11
AS B-Disease 1 1.0
daughter O 0 1.129046631831443e-05
. O 0 2.2633733465227124e-07

The O 0 1.838248664398634e-07
frequencies O 0 9.323351868317786e-09
with O 0 2.477758796748386e-11
which O 0 2.6366551303391716e-11
we O 0 2.3767911250249796e-11
detected O 0 7.308925131788158e-10
mutations O 0 1.7652683481639286e-10
were O 0 1.2558167838960799e-09
5 O 0 6.78654799024514e-10
( O 0 3.2224587581675124e-12
14 O 0 1.2445824926210491e-10
% O 0 5.2261393997110606e-12
) O 0 5.676077555021031e-13
of O 0 1.9834996145551287e-10
35 O 0 1.4394303526898966e-09
in O 0 1.928128906536486e-10
sporadic O 0 6.956811571257049e-09
cases O 0 7.35760430359278e-09
and O 0 7.187111350503983e-09
8 O 0 1.3264987330785516e-08
( O 0 7.060709655837272e-12
80 O 0 2.248757291489767e-10
% O 0 2.6091587657789406e-12
) O 0 2.680616687823767e-13
of O 0 6.558614762397497e-11
10 O 0 1.7306694966023883e-10
in O 0 3.499704415155236e-10
familial O 0 2.2826872836390066e-08
cases O 0 5.292637439424652e-08
. O 0 3.284312199980377e-08
. O 0 1.2183465969428653e-07

The O 0 3.454654142842628e-05
hemochromatosis B-Disease 1 1.0
845 O 0 6.908032082719728e-05
G O 0 5.307707397150807e-06
- O 0 1.2133084226206847e-07
- O 0 2.3207004318237523e-08
> O 0 5.5975867496727005e-08
A O 0 5.590936158483828e-09
and O 0 4.651951740486382e-11
187 O 0 9.5034080604961e-10
C O 0 5.352510878964267e-09
- O 0 5.216483911496539e-10
- O 0 2.645957897229323e-09
> O 0 7.89351517482828e-08
G O 0 1.0321820127501269e-06
mutations O 0 1.6768665345168188e-09
: O 0 4.016939211815007e-11
prevalence O 0 3.511461121874504e-09
in O 0 2.894132988817688e-10
non O 0 2.3655385916754312e-07
- O 0 9.75466377894918e-07
Caucasian O 0 2.7903124077965913e-07
populations O 0 1.3004995302878797e-08
. O 0 5.3262563248779315e-09

Hemochromatosis B-Disease 1 0.9999997615814209
, O 0 2.3106750290935452e-07
the O 0 0.0024528398644179106
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 1.3588987712864764e-08
leads O 0 1.1777416375480243e-08
, O 0 3.910677337515267e-11
if O 0 4.968678246619618e-10
untreated O 1 0.9999985694885254
, O 0 2.7147187275922136e-10
to O 0 3.5585023816508965e-09
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 4.704650564235635e-06
premature B-Disease 0 6.95593626005575e-05
death I-Disease 0 1.1895418765561772e-06
. O 0 1.267958111839107e-07

The O 0 2.2617066861130297e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.8739825691227452e-06
, O 0 2.4783581409337785e-08
HFE O 1 0.9999792575836182
, O 0 1.9348505020388984e-08
recently O 0 9.708944759267979e-09
has O 0 1.473046858102567e-11
been O 0 1.894187931505975e-11
identified O 0 5.563113858464419e-11
, O 0 6.3518912352122925e-12
and O 0 3.5605626086399056e-11
characterization O 0 3.794653480326815e-08
of O 0 1.8874402485380415e-07
this O 0 5.814951187232964e-09
gene O 0 3.46035222698049e-09
has O 0 5.948348758000321e-11
shown O 0 1.585351294686177e-11
that O 0 8.91549583725143e-13
it O 0 1.9627687062456767e-12
contains O 0 1.018613318692907e-11
two O 0 5.059920798328177e-12
mutations O 0 1.951001166178301e-11
that O 0 1.8155794792931723e-12
result O 0 2.5652827084776675e-10
in O 0 6.737768676323697e-10
amino O 0 7.927864476009461e-10
acid O 0 1.7733989832180441e-09
substitutions O 0 9.423648528184003e-09
- O 0 6.899737670096329e-09
cDNA O 0 9.158118707830454e-09
nucleotides O 0 9.997932481908833e-10
845 O 0 1.008385019929392e-08
G O 0 1.0253163651441355e-08
- O 0 1.9517290006376697e-09
- O 0 1.7002320662484749e-09
> O 0 6.62878463231209e-09
A O 0 6.873663860318402e-09
( O 0 1.4236987457005856e-11
C282Y O 0 1.1769039964804051e-08
) O 0 7.0270681634676535e-12
and O 0 4.0025760483786144e-11
187 O 0 1.5923107277160398e-09
C O 0 1.096306956327453e-08
- O 0 1.7659125273183918e-09
- O 0 6.752103764995354e-09
> O 0 1.7273676178319874e-07
G O 0 9.222098015015945e-06
( O 0 6.17184858775488e-10
H63D O 0 0.0002862876863218844
) O 0 4.01094091273535e-09
. O 0 6.183731215969601e-08

Although O 0 0.0004015218000859022
hemochromatosis B-Disease 1 1.0
is O 0 1.20441882245359e-07
common O 0 2.4444071300422365e-07
in O 0 5.257590807161705e-09
Caucasians O 0 3.6674882153420185e-07
, O 0 1.1498592356051773e-10
affecting O 0 5.962641491663589e-10
> O 0 4.617560112052388e-09
= O 0 2.0859698690589568e-10
1 O 0 1.1603623617517655e-09
/ O 0 3.6309563689052027e-10
300 O 0 6.727415152729677e-11
individuals O 0 4.4954171678560084e-13
of O 0 9.870559924962663e-11
northern O 0 7.616856034786679e-10
European O 0 2.9119693323309548e-09
origin O 0 4.257101338112079e-09
, O 0 2.996819112310867e-11
it O 0 2.520254621315998e-12
has O 0 1.2531183772937493e-12
not O 0 2.1336313792141848e-12
been O 0 6.231010152291105e-11
recognized O 0 4.207149628676632e-10
in O 0 5.94791993435706e-10
other O 0 1.5912724471434103e-09
populations O 0 2.3951518546283523e-09
. O 0 7.497355625218916e-09

The O 0 1.9920594240829814e-07
present O 0 6.166839483512376e-09
study O 0 6.899523730119483e-10
used O 0 2.0500645625531888e-10
PCR O 0 1.0453838683588401e-07
and O 0 1.3004194387988832e-09
restriction O 0 7.633079235347395e-08
- O 0 7.574989524528064e-09
enzyme O 0 1.5804015873754906e-09
digestion O 0 2.635402118755792e-08
to O 0 8.565882725353191e-11
analyze O 0 2.119098091446503e-10
the O 0 2.5950153484388672e-11
frequency O 0 1.059546478332507e-10
of O 0 3.574650020432557e-10
the O 0 1.412195249628212e-09
845 O 0 2.2655409992466957e-08
G O 0 3.877874732438613e-08
- O 0 4.261862418530882e-09
- O 0 5.1061155303955275e-09
> O 0 9.852682225641729e-09
A O 0 3.3921416786597547e-09
and O 0 4.3525519993758977e-11
187 O 0 4.6516970830801085e-10
C O 0 9.717758819860478e-10
- O 0 1.1527490767493376e-10
- O 0 8.477111790305969e-10
> O 0 2.2937859611715794e-08
G O 0 4.143595901950903e-07
mutations O 0 1.4152881089302127e-09
in O 0 5.27290322516194e-10
HLA O 0 4.6103326667434885e-07
- O 0 4.413922738422116e-08
typed O 0 3.5849074819793714e-09
samples O 0 5.18902587565151e-10
from O 0 9.836129827300866e-11
non O 0 1.0175702058745628e-08
- O 0 2.673923660267974e-08
Caucasian O 0 1.0836069819220029e-08
populations O 0 2.136081034276316e-10
, O 0 4.926932559851105e-12
comprising O 0 6.446374684054845e-11
Australian O 0 4.499260519708059e-09
Aboriginal O 0 1.0388954585494048e-08
, O 0 1.5749804238573972e-11
Chinese O 0 1.4288853433797044e-09
, O 0 5.772070668652596e-11
and O 0 5.460075724883495e-10
Pacific O 0 7.078077146616124e-08
Islanders O 0 2.2545975753018865e-06
. O 0 7.640158372623773e-08

Results O 0 4.617320428224048e-06
showed O 0 6.547262643152862e-08
that O 0 6.49408443686994e-11
the O 0 4.058932745465427e-09
845 O 0 1.2873704235971672e-07
G O 0 3.384814988294238e-07
- O 0 2.6663606433885434e-08
- O 0 8.154151132089282e-09
> O 0 2.9373804721899432e-08
A O 0 3.023715944294736e-09
mutation O 0 1.1182976072943163e-10
was O 0 4.708817016862987e-11
present O 0 2.3289802378312352e-11
in O 0 2.7464296462054172e-11
these O 0 4.374958034736309e-11
populations O 0 1.0899565972000147e-11
( O 0 3.499138370548216e-13
allele O 0 1.1306377709074944e-11
frequency O 0 3.2994072751701964e-11
0 O 0 8.543903778912565e-11
. O 0 5.440837884396199e-12
32 O 0 4.4450235159310125e-11
% O 0 1.4273958534247178e-12
) O 0 1.3936914773290954e-13
, O 0 7.662453028849103e-13
and O 0 7.094025020193406e-12
, O 0 6.0545808817924485e-12
furthermore O 0 3.054680675074195e-10
, O 0 7.561942391709486e-12
it O 0 3.0702617098005147e-12
was O 0 3.3773832619488076e-09
always O 0 9.959524316371926e-10
seen O 0 3.7734229629826643e-10
in O 0 6.257545176469037e-11
conjunction O 0 5.338978148472506e-10
with O 0 1.0885402301763492e-10
HLA O 0 3.161175482091494e-05
haplotypes O 0 1.3851779101514694e-07
common O 0 7.793325096372428e-09
in O 0 2.6660781915488485e-10
Caucasians O 0 1.4623749322595359e-08
, O 0 1.5922726678829768e-11
suggesting O 0 7.683052111184807e-11
that O 0 7.51225991135751e-12
845 O 0 2.1442758679768303e-08
G O 0 1.399726841100346e-07
- O 0 4.9967383120019804e-08
- O 0 8.843657184343101e-08
> O 0 2.3475820398743963e-07
A O 0 3.0123082694899495e-08
may O 0 1.3559077194358338e-09
have O 0 3.9812420721263564e-11
been O 0 3.7494517907132874e-11
introduced O 0 7.755819320109936e-10
into O 0 1.8377782629031003e-10
these O 0 2.443740869384481e-11
populations O 0 2.5979867562808678e-11
by O 0 6.439873634356275e-11
Caucasian O 0 1.3964624123730118e-08
admixture O 0 1.7766035398381064e-07
. O 0 1.679669026088959e-07

187 O 0 6.320400643744506e-06
C O 0 7.690817369621072e-07
- O 0 1.6422992743514442e-08
- O 0 5.575197192797532e-09
> O 0 3.1098149833042044e-08
G O 0 2.67435297018892e-07
was O 0 2.467319126786549e-10
present O 0 1.3315563061888636e-11
at O 0 4.1669296485524754e-11
an O 0 5.026952161826803e-13
allele O 0 3.3355755657549224e-11
frequency O 0 2.2000863630911027e-10
of O 0 1.5777300577113351e-09
2 O 0 6.843461619610025e-08
. O 0 1.0277093309696284e-07

68 O 0 7.924755664134864e-06
% O 0 1.4903305256552812e-08
in O 0 1.016454365121433e-09
the O 0 1.5491511407006442e-09
two O 0 9.928905614353667e-11
populations O 0 1.0840978809101287e-10
analyzed O 0 1.6508031608353235e-09
( O 0 3.326693434613226e-11
Australian O 0 8.118073679952431e-08
Aboriginal O 0 5.824766802220438e-08
and O 0 2.2138089972312258e-10
Chinese O 0 6.570227917279681e-09
) O 0 2.1614086909149677e-10
. O 0 7.13179248990059e-09

In O 0 1.8501536658277473e-07
the O 0 2.7148249870379004e-08
Australian O 0 5.665405566901427e-08
Aboriginal O 0 3.6604010489327266e-08
samples O 0 9.476256446205866e-10
, O 0 3.251291944006418e-11
187 O 0 2.604657600713267e-09
C O 0 2.0078857687622076e-08
- O 0 1.521310299956724e-09
- O 0 4.451824242579505e-09
> O 0 1.3122132713760948e-07
G O 0 2.6375503239250975e-06
was O 0 5.286802995385642e-09
found O 0 4.6812623222258765e-11
to O 0 4.343129154926739e-12
be O 0 1.1702920750533696e-11
associated O 0 1.1608426442322184e-09
with O 0 6.581374889513825e-10
HLA O 1 0.7579343318939209
haplotypes O 0 5.136291747476207e-07
common O 0 1.2303397411983497e-08
in O 0 2.8350932712584154e-10
Caucasians O 0 1.1691872359165245e-08
, O 0 7.660177180068839e-12
suggesting O 0 3.5513383900287465e-11
that O 0 4.139611559355466e-13
it O 0 2.7991866637100404e-12
was O 0 3.6142078219114637e-10
introduced O 0 1.1993698256773655e-09
by O 0 5.045912576662204e-10
recent O 0 1.91153581852177e-08
admixture O 0 5.580060928878083e-07
. O 0 1.1211204054006885e-07

In O 0 2.579436113592237e-07
the O 0 2.381623431801927e-08
Chinese O 0 1.6567467397976543e-08
samples O 0 1.07318232078768e-09
analyzed O 0 1.7014584186014758e-09
, O 0 2.2047018724546952e-11
187 O 0 9.955820612361777e-10
C O 0 5.059436425369768e-09
- O 0 2.9377361654425727e-10
- O 0 6.330851953784133e-10
> O 0 7.046029537605136e-09
G O 0 1.2281668659852585e-07
was O 0 2.3529495019047886e-10
present O 0 6.079661080127252e-11
in O 0 2.1878003575448446e-10
association O 0 2.649451213976306e-10
with O 0 4.992021986754969e-12
a O 0 1.4406134618560884e-10
wide O 0 7.044631988861738e-09
variety O 0 2.2858273052150935e-09
of O 0 1.4094618805415848e-08
HLA O 0 3.2349780667573214e-05
haplotypes O 0 2.2386220166481507e-07
, O 0 2.0809985679104415e-10
showing O 0 7.909268379124867e-11
this O 0 8.087967795500361e-12
mutation O 0 1.3488259120730817e-11
to O 0 3.5226515714831264e-12
be O 0 3.2942256561474537e-11
widespread O 0 6.61640608967673e-09
and O 0 3.945307136543619e-10
likely O 0 8.57835047440858e-09
to O 0 3.257407676926505e-10
predate O 0 1.0483244068382191e-06
the O 0 1.1331222182775491e-08
more O 0 2.7083005282868555e-10
genetically O 0 3.65554555514791e-08
restricted O 0 2.137941734758897e-08
845 O 0 1.104469760093707e-07
G O 0 3.9494375414506067e-07
- O 0 8.462015443910786e-08
- O 0 9.690300117881634e-08
> O 0 3.5790887409348215e-07
A O 0 7.512661426289924e-08
mutation O 0 3.688294114567725e-08
. O 0 8.144684926492118e-09

Genotype O 0 0.00026741420151665807
- O 0 2.5899669708451256e-05
phenotype O 0 6.4665082391002215e-06
correlations O 0 2.2762494609196438e-06
in O 0 7.918109901083881e-08
attenuated B-Disease 1 0.9953018426895142
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.0004139860684517771

Germ O 0 0.1175968274474144
- O 0 5.178893115953542e-05
line O 0 3.0304609026643448e-06
mutations O 0 3.89444103632286e-08
of O 0 4.705131839699561e-09
the O 0 1.0117275017762495e-08
tumor B-Disease 0 3.338284386700252e-06
suppressor O 0 9.30394344322849e-06
APC O 0 2.0402119105256133e-07
are O 0 6.577668965057626e-11
implicated O 0 3.607501630753518e-09
in O 0 6.669140617532321e-08
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.201915776822716e-05
AAPC B-Disease 1 1.0
) O 0 3.179674856745862e-10
, O 0 6.659251709090208e-12
a O 0 6.187660193252009e-12
variant O 0 9.320545757418586e-08
of O 0 0.0006633248995058239
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.419642214590567e-06
FAP B-Disease 0 0.0005612550885416567
) O 0 6.3891065771315425e-09
. O 0 6.745129610408185e-08

AAPC B-Disease 1 1.0
is O 0 2.0399292921524648e-08
recognized O 0 1.8820356384452452e-09
by O 0 5.967325938938117e-11
the O 0 8.844454335577012e-11
occurrence O 0 5.990661300359079e-10
of O 0 1.380094927228015e-09
< O 0 3.385902971331234e-07
100 O 0 2.1566588515042895e-08
colonic B-Disease 0 1.199177040689392e-05
adenomas I-Disease 0 2.2634044398728292e-06
and O 0 3.4900921042080313e-10
a O 0 7.040594496299235e-11
later O 0 3.0729965239117973e-09
onset O 0 6.870271317893639e-05
of O 1 0.9988123178482056
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.703786220059072e-11
age O 0 1.3173806490129891e-09
> O 0 2.0580619430887737e-09
40 O 0 3.4878230859014536e-10
years O 0 7.055543649325813e-11
) O 0 1.4031757700205816e-10
. O 0 1.6893940468776236e-08

The O 0 4.771414410242869e-07
aim O 0 8.178484023346755e-08
of O 0 3.726277952864621e-09
this O 0 2.076732119604685e-10
study O 0 5.259343516250681e-10
was O 0 1.8960071013207624e-10
to O 0 3.246390309352698e-11
assess O 0 4.8809983610453855e-08
genotype O 0 6.787914117012406e-06
- O 0 5.844960924150655e-06
phenotype O 0 3.817332071776036e-06
correlations O 0 1.6738609929234372e-06
in O 0 1.684340134033846e-07
AAPC B-Disease 1 1.0
families O 0 3.234566179344256e-07
. O 0 1.4833096884103725e-07

By O 0 5.446715789503287e-08
protein O 0 2.9826303205027216e-08
- O 0 2.538161680831763e-08
truncation O 0 4.0647461219123215e-07
test O 0 8.389245635953557e-07
( O 0 5.223015353550409e-10
PTT O 0 5.511035539029763e-08
) O 0 2.0409641858509797e-12
assay O 0 9.274129797454123e-10
, O 0 1.5144503706654433e-11
the O 0 7.16681644585826e-11
entire O 0 3.627799727290437e-10
coding O 0 8.39487424020291e-10
region O 0 1.7324834900023234e-09
of O 0 6.944657826579714e-08
the O 0 9.738778317114338e-07
APC B-Disease 0 1.0963823342535761e-06
gene O 0 1.9656001271073364e-09
was O 0 7.575914118262972e-09
screened O 0 2.1096873581427644e-08
in O 0 3.6294539595971287e-10
affected O 0 1.4476656540196586e-09
individuals O 0 2.195511827896013e-11
from O 0 6.97887303502398e-09
11 O 0 1.2612276805157308e-06
AAPC B-Disease 1 1.0
kindreds O 0 0.0979151502251625
, O 0 2.7177562422764368e-09
and O 0 9.293359970463655e-10
their O 0 1.3586493041728431e-09
phenotypic O 0 1.5774668327139807e-07
differences O 0 3.7242904227241524e-07
were O 0 1.9652793525892776e-07
examined O 0 2.2736201117368182e-06
. O 0 2.1788871151784406e-07

Five O 0 4.3375669633860525e-07
novel O 0 9.012362056637357e-07
germ O 0 0.0010299129644408822
- O 0 3.192656367900781e-05
line O 0 3.792185816564597e-05
APC B-Disease 0 3.0169599085638765e-06
mutations O 0 9.429870218014003e-09
were O 0 3.721313035498497e-09
identified O 0 2.8506783600334984e-09
in O 0 2.461332027081653e-09
seven O 0 2.225878148465199e-08
kindreds O 0 3.406601899769157e-05
. O 0 3.5695921951628407e-07

Mutations O 0 1.2546631751320092e-06
were O 0 6.147510589471494e-08
located O 0 2.5988862173420557e-09
in O 0 1.4339682219421945e-10
three O 0 1.3999325136626606e-11
different O 0 2.114687765175649e-11
regions O 0 9.777215703721254e-10
of O 0 1.263573778942373e-07
the O 0 3.4255576792929787e-06
APC B-Disease 0 6.991412533352559e-07
gene O 0 6.498139248911627e-10
( O 0 5.769525048687774e-12
1 O 0 1.054096476771349e-09
) O 0 5.353983315720123e-12
at O 0 8.017980723806772e-10
the O 0 1.7795829254652062e-09
5 O 0 2.7725592932625887e-09
end O 0 9.389058419628782e-09
spanning O 0 1.775762470401787e-08
exons O 0 5.906501066021974e-09
4 O 0 1.747024303000444e-09
and O 0 8.145484287069849e-11
5 O 0 5.488873799919247e-10
, O 0 1.9413314705785112e-11
( O 0 2.307599857725995e-12
2 O 0 2.0943378975513127e-10
) O 0 4.232288564748332e-12
within O 0 2.3279066174719532e-10
exon O 0 5.2807567207935335e-09
9 O 0 3.880380905485481e-09
, O 0 7.40677935651135e-11
and O 0 1.4808736181759485e-10
( O 0 6.764855169094641e-12
3 O 0 4.2686448820106193e-10
) O 0 1.6091984515742563e-12
at O 0 1.1235784524998849e-10
the O 0 1.440511737671457e-10
3 O 0 1.6150401016545857e-09
distal O 0 3.445693153025786e-08
end O 0 6.718768474911485e-08
of O 0 2.2700574220380076e-07
the O 0 1.5659790619793057e-07
gene O 0 2.6852340795358032e-08
. O 0 8.770535231406029e-08

Variability O 0 1.4485258361673914e-05
in O 0 1.2525736892143868e-08
the O 0 1.928593285072111e-09
number O 0 1.6984235129413605e-09
of O 0 2.045149585683248e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.0986810177564621
most O 0 1.0451302046021738e-08
apparent O 0 1.453726117262022e-08
in O 0 1.7393694817791072e-10
individuals O 0 1.302717048817792e-11
with O 0 1.1008712171023394e-11
mutations O 0 1.2369580915105871e-09
in O 0 3.710490359409846e-09
region O 0 3.2769595037507315e-08
1 O 0 1.825194289040155e-07
, O 0 2.505886886883246e-10
and O 0 1.5499047600897597e-09
upper O 1 0.7216715216636658
- O 0 0.006432882975786924
gastrointestinal O 1 0.9999980926513672
manifestations O 1 0.7994966506958008
were O 0 4.5260787828738103e-07
more O 0 1.0897747149130055e-09
severe O 0 3.441063824993762e-07
in O 0 1.1188577175857972e-08
them O 0 2.915887753474067e-09
. O 0 3.2597480270624146e-08

In O 0 8.291114994563031e-08
individuals O 0 6.866349155920659e-10
with O 0 1.0656082960469604e-10
mutations O 0 1.9999306655194005e-09
in O 0 2.2573101166045717e-09
either O 0 2.0089763186348364e-09
region O 0 6.74278632928349e-09
2 O 0 2.004884480655278e-09
or O 0 8.461357309252904e-11
region O 0 1.204590094339153e-09
3 O 0 1.3380907493143468e-09
, O 0 9.35078056651939e-12
the O 0 7.112888750215873e-11
average O 0 2.2307170000068766e-10
number O 0 1.3101981999330548e-10
of O 0 5.409368952769e-09
adenomas B-Disease 0 2.6628749765222892e-06
tended O 0 2.6028297384073085e-07
to O 0 3.42529782315637e-10
be O 0 3.0805888395768477e-10
lower O 0 6.52082832175438e-08
than O 0 1.3234849327581344e-10
those O 0 5.5077272603787364e-11
in O 0 4.218863799976269e-11
individuals O 0 2.706428614204781e-12
with O 0 4.202910589001796e-12
mutations O 0 1.7984071176702088e-10
in O 0 9.282902918572589e-11
region O 0 3.2735517074833353e-10
1 O 0 8.270984452884989e-10
, O 0 3.652987200924995e-12
although O 0 2.712879920707678e-11
age O 0 2.5438648965092625e-09
at O 0 2.1758743695698968e-09
diagnosis O 0 7.375422796940256e-07
was O 0 1.7405593411012887e-08
similar O 0 2.23583924707782e-08
. O 0 1.7391165840763279e-07

In O 0 7.592609563289443e-07
all O 0 4.320338859997719e-07
AAPC B-Disease 1 1.0
kindreds O 0 5.811265509692021e-05
, O 0 7.615229002944091e-10
a O 0 1.650688891130514e-10
predominance O 0 3.0331938205563347e-07
of O 0 6.519883868350007e-07
right O 1 0.7699455618858337
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999960660934448
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9992660880088806
sparing O 0 2.3718282591289608e-06
was O 0 1.3456651970500388e-07
observed O 0 6.393277374172612e-08
. O 0 7.794518097625769e-08

No O 0 0.00010584499250398949
desmoid B-Disease 1 1.0
tumors I-Disease 1 1.0
were O 0 9.846577313510352e-07
found O 0 3.2652598402904687e-09
in O 0 7.655964195940612e-10
these O 0 7.402705559655942e-09
kindreds O 0 2.2196722056833096e-05
. O 0 3.204421830105275e-07

Our O 0 4.129244928208209e-07
data O 0 3.772474777008483e-09
suggest O 0 1.0654666038334426e-09
that O 0 1.6102064126499727e-11
, O 0 1.7200663116057058e-10
in O 0 1.9184682287232135e-08
AAPC B-Disease 1 1.0
families O 0 1.0134000305583868e-08
, O 0 8.383968866376712e-12
the O 0 1.2609736171897978e-11
location O 0 3.6113412260618816e-10
of O 0 2.4123540942611044e-09
the O 0 2.903137783505372e-07
APC B-Disease 0 5.050157415098511e-05
mutation O 0 2.604572841846675e-07
may O 0 3.6160180627575755e-08
partially O 0 5.460612584329283e-08
predict O 0 1.488024192752846e-08
specific O 0 7.376658395230606e-09
phenotypic O 0 2.4033663521549897e-06
expression O 0 1.5932859014355927e-06
. O 0 5.285268684929179e-07

This O 0 2.367637108591225e-08
should O 0 5.797708535482116e-09
help O 0 2.2907581387343612e-10
in O 0 5.579936512845052e-11
the O 0 4.854316948410542e-11
design O 0 2.0173587245153612e-09
of O 0 4.831955391360054e-10
tailored O 0 7.335929552709786e-08
clinical O 0 5.977575483484543e-07
- O 0 4.910309314709593e-08
management O 0 4.92585039424398e-09
protocols O 0 9.603159867310751e-08
in O 0 2.156594763880193e-10
this O 0 2.6568481789612797e-11
subset O 0 9.141888135388854e-09
of O 0 6.6516583352438374e-09
FAP B-Disease 0 0.0001668356271693483
patients O 0 2.0668098841269966e-06
. O 0 2.539172205828777e-09
. O 0 2.850152647226878e-08

Wilms B-Disease 1 1.0
' I-Disease 0 0.14178289473056793
tumor I-Disease 0 9.701683666207828e-06
1 O 0 8.91352840426407e-08
and O 0 1.8255897904495555e-09
Dax O 0 0.010718746110796928
- O 0 1.9773904114117613e-07
1 O 0 9.994090532927657e-08
modulate O 0 2.46612170684557e-08
the O 0 1.4366417389055641e-08
orphan O 0 4.280259418010246e-07
nuclear O 0 4.708644496531633e-08
receptor O 0 2.1159014096383544e-08
SF O 0 0.011888709850609303
- O 0 6.015776676804307e-08
1 O 0 1.0274011863486976e-08
in O 0 1.4953005500473182e-10
sex O 0 8.726736694386616e-11
- O 0 2.8095448190157413e-10
specific O 0 7.560667092398887e-10
gene O 0 2.749477312491422e-09
expression O 0 1.2289278927823943e-08
. O 0 2.8046219568977904e-08

Products O 0 4.119185632589506e-06
of O 0 1.3381676353674266e-06
steroidogenic O 1 0.9861240386962891
factor O 0 9.838636287895497e-07
1 O 0 8.555315389457974e-08
( O 0 2.9673691281928427e-10
SF O 1 0.987661600112915
- O 0 5.692908189303125e-07
1 O 0 6.741437630353175e-08
) O 0 1.6626235110894783e-10
and O 0 4.927513508334869e-09
Wilms B-Disease 1 0.9999946355819702
tumor I-Disease 0 0.018108902499079704
1 O 0 1.797821141735767e-06
( O 0 1.7861867540602816e-09
WT1 O 0 1.1841648301924579e-05
) O 0 1.784217912303987e-10
genes O 0 1.3350155703140132e-10
are O 0 4.141295379539445e-12
essential O 0 1.7191446877173888e-10
for O 0 3.925683736416552e-11
mammalian O 0 2.1930631532995903e-07
gonadogenesis O 0 3.0061839879635954e-06
prior O 0 1.3097270539219608e-06
to O 0 1.6576379380239814e-08
sexual O 0 4.855379742707555e-08
differentiation O 0 1.2673890523728915e-06
. O 0 2.5071426534850616e-07

In O 0 4.199841541208116e-08
males O 0 1.2805856375308622e-09
, O 0 4.6522560803730073e-10
SF O 1 0.9988864064216614
- O 0 3.106494432358886e-06
1 O 0 3.9247390759555856e-07
participates O 0 1.1763603424697067e-09
in O 0 9.581484217147107e-11
sexual O 0 3.0473061574110005e-11
development O 0 5.197968791503804e-11
by O 0 2.8599992166200572e-11
regulating O 0 4.724889812735e-09
expression O 0 1.1423051393677497e-09
of O 0 1.1813970912655236e-09
the O 0 6.173441313706007e-09
polypeptide O 0 5.233970910012431e-07
hormone O 0 9.563787273236812e-08
Mullerian O 0 1.3279831364343408e-05
inhibiting O 0 4.123711789816298e-07
substance O 0 4.885151611233596e-06
( O 0 2.96792670440027e-08
MIS O 0 0.0006967831868678331
) O 0 1.0304883168998913e-08
. O 0 7.546957192516857e-08

Here O 0 8.061075504883775e-07
, O 0 5.370170974572375e-09
we O 0 2.574321034121141e-10
show O 0 1.6996248852763074e-10
that O 0 4.353714611049497e-11
WT1 O 0 0.00011001578968716785
- O 0 1.6525826140423305e-05
KTS O 1 0.9129031896591187
isoforms O 0 7.06675848505256e-07
associate O 0 3.6306552431142336e-08
and O 0 3.7995454005290696e-10
synergize O 0 3.4335175769228954e-07
with O 0 9.164614067636023e-10
SF O 1 1.0
- O 0 0.00013123310054652393
1 O 0 1.1467675449239323e-06
to O 0 4.026239786014685e-09
promote O 0 2.1438141573071334e-07
MIS O 0 0.0005872860201634467
expression O 0 2.8048796707480506e-07
. O 0 7.148423719627317e-08

In O 0 2.474296820764721e-07
contrast O 0 5.117809109833615e-07
, O 0 3.965257633353758e-08
WT1 O 0 0.011911788024008274
missense O 0 6.903158646309748e-05
mutations O 0 3.756508348828902e-08
, O 0 9.594468275420098e-11
associated O 0 6.351788539582515e-10
with O 0 1.2383384595526792e-10
male B-Disease 0 3.039677309857325e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.852142097253818e-05
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.8326798684474852e-08
fail O 0 2.857082108675968e-07
to O 0 2.0075017204135293e-09
synergize O 0 8.893131962395273e-06
with O 0 2.8607185953433145e-08
SF O 1 1.0
- O 0 0.001843885751441121
1 O 0 2.446651024001767e-06
. O 0 2.998756443162165e-08

Additionally O 0 3.4470349419279955e-07
, O 0 8.343935542498571e-10
the O 0 7.921153177825602e-10
X O 0 1.3211629266152158e-06
- O 0 5.5993698566680905e-08
linked O 0 3.832703399098136e-08
, O 0 6.999995721956864e-11
candidate O 0 7.3827355340228e-10
dosage O 0 2.5099703293562925e-07
- O 0 1.2997258380664789e-08
sensitive O 0 2.4182131141969876e-07
sex O 0 7.630786558188163e-10
- O 0 1.5814448639517309e-09
reversal O 0 8.69093241817609e-09
gene O 0 2.0137986833645982e-09
, O 0 8.029428233413682e-10
Dax O 1 0.8998991847038269
- O 0 1.858695668488508e-07
1 O 0 1.4120618629931414e-07
, O 0 2.6541954745162855e-10
antagonizes O 0 5.0037961329962855e-08
synergy O 0 8.913015214773168e-09
between O 0 7.0691017484136864e-09
SF O 1 0.9666105508804321
- O 0 2.1268631655857462e-07
1 O 0 2.1603311139983816e-08
and O 0 6.606263869279871e-10
WT1 O 0 4.0634618017065804e-06
, O 0 1.2328778276060604e-10
most O 0 1.7807669228098177e-10
likely O 0 3.1347643925094815e-10
through O 0 2.4763933959004447e-11
a O 0 8.697818507097388e-12
direct O 0 3.6450266416299115e-11
interaction O 0 1.3650020003197483e-10
with O 0 3.018677807720138e-10
SF O 1 1.0
- O 0 7.631927292095497e-05
1 O 0 2.087615484924754e-06
. O 0 4.933563246822814e-08

We O 0 2.0501025232988468e-07
propose O 0 4.5366618905973155e-07
that O 0 2.579227498245018e-09
WT1 O 0 0.37258872389793396
and O 0 6.628761752835999e-07
Dax O 1 0.9999902248382568
- O 0 8.009579346435203e-07
1 O 0 6.312855305168341e-08
functionally O 0 5.0059987266593e-09
oppose O 0 2.471119697755597e-10
each O 0 3.609808415724891e-12
other O 0 1.2376506937361587e-11
in O 0 2.2623174167346605e-10
testis O 0 6.457520385083626e-08
development O 0 5.137285596923391e-10
by O 0 3.0631988612306316e-10
modulating O 0 8.704429887984588e-07
SF O 1 0.999993085861206
- O 0 5.325402526068501e-06
1 O 0 4.649288882774272e-07
- O 0 3.904362699813646e-08
mediated O 0 7.560269921214058e-08
transactivation O 0 3.412729938645498e-06
. O 0 8.446740196177416e-09
. O 0 2.7424031046052733e-08

A O 0 6.267354706324113e-07
mouse O 0 7.686257674777153e-08
model O 0 2.6149218346205316e-09
for O 0 1.5763621519226945e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9994174242019653
centre O 0 8.582066220697016e-05
mutations O 0 3.5292433153699676e-07
. O 0 6.355939063951155e-08

Imprinting O 0 2.4203796783694997e-05
in O 0 2.7400396618304512e-08
the O 0 1.1662072196827467e-08
15q11 O 0 1.8927083829112235e-06
- O 0 1.9297098674542212e-07
q13 O 0 2.4540261165384436e-06
region O 0 2.3442110475002664e-09
involves O 0 7.996934781040466e-10
an O 0 1.9044581883731482e-11
imprinting O 0 2.193607002709541e-07
centre O 0 3.6442332884689677e-07
( O 0 8.30162605325313e-11
IC O 0 3.655751925180084e-06
) O 0 1.7368490326519215e-11
, O 0 3.674012916815572e-12
mapping O 0 4.840956455143264e-11
in O 0 4.608378262327406e-11
part O 0 3.5637712225700113e-10
to O 0 1.475463223821194e-10
the O 0 7.728357509506623e-09
promoter O 0 8.819903314361e-07
and O 0 1.2906244961641278e-09
first O 0 1.2601220511498923e-08
exon O 0 3.2172241049011063e-07
of O 0 6.289431553341274e-08
SNRPN O 1 0.9996204376220703
. O 0 2.441502601868706e-06

Deletion O 0 2.472584810675471e-06
of O 0 1.079129603454021e-07
this O 0 8.11426215108213e-09
IC O 0 0.0002834168844856322
abolishes O 0 5.820673777634511e-06
local O 0 7.843778604410545e-08
paternally O 0 7.721279757788579e-07
derived O 0 1.4832948203036267e-08
gene O 0 6.197730106904942e-10
expression O 0 1.983423841833698e-10
and O 0 1.543784197699516e-11
results O 0 1.1800773691561517e-09
in O 0 6.429302601418385e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.3180761933326721
PWS B-Disease 1 1.0
) O 0 6.010925801547273e-08
. O 0 1.1788387865863115e-07

We O 0 4.446959849246923e-07
have O 0 8.599631229344595e-09
created O 0 2.0798736954930064e-08
two O 0 4.937099618018692e-09
deletion O 0 2.9040293725302035e-07
mutations O 0 1.2325457987572008e-07
in O 0 2.316658154200013e-08
mice O 0 6.356957271691499e-08
to O 0 1.5358616600735786e-09
understand O 0 2.9797188290103804e-06
PWS B-Disease 1 1.0
and O 0 1.0308053077778823e-07
the O 0 4.0279761748251985e-09
mechanism O 0 1.90401339139612e-09
of O 0 8.925037930929136e-10
this O 0 2.0174857340293784e-09
IC O 0 0.0006871448713354766
. O 0 3.9407541407854296e-07

Mice O 0 0.0005259110475890338
harbouring O 0 3.4875436540460214e-05
an O 0 9.02224162047105e-09
intragenic O 0 4.553296821541153e-05
deletion O 0 1.000134261630592e-06
in O 0 1.1516343079165381e-07
Snrpn O 0 0.0013600158272311091
are O 0 1.3610103266614715e-08
phenotypically O 0 2.508778743504081e-05
normal O 0 1.7472959257247567e-07
, O 0 2.883311922552423e-10
suggesting O 0 8.999516687424602e-10
that O 0 1.0220658520909698e-11
mutations O 0 1.9733950029632297e-09
of O 0 2.7664015078698867e-08
SNRPN O 1 1.0
are O 0 1.551972550473124e-09
not O 0 1.3335496595878737e-10
sufficient O 0 1.409029160015507e-08
to O 0 4.523836860670372e-09
induce O 0 1.90757946256781e-05
PWS B-Disease 1 1.0
. O 0 8.295216684928164e-05

Mice O 0 2.514380685170181e-05
with O 0 2.3916504332532895e-09
a O 0 2.2931725407460135e-09
larger O 0 1.3021227651677236e-08
deletion O 0 2.1865343313720587e-08
involving O 0 3.2873936905986056e-09
both O 0 3.731313036325901e-09
Snrpn O 0 0.0002312595897819847
and O 0 2.4337147852548924e-09
the O 0 1.1026171087280545e-08
putative O 0 8.027191142900847e-06
PWS O 1 1.0
- O 0 2.442467666696757e-05
IC O 0 0.0019370476948097348
lack O 0 8.05156616934255e-08
expression O 0 3.2923305748333576e-10
of O 0 1.9529718120470108e-10
the O 0 2.2437274260767026e-10
imprinted O 0 1.794564319368419e-08
genes O 0 2.6313125012222827e-09
Zfp127 O 0 1.3875911690774956e-06
( O 0 3.418510197139568e-10
mouse O 0 1.8762301934316383e-08
homologue O 0 1.35429999659209e-07
of O 0 4.819019849833239e-08
ZNF127 O 1 0.9999947547912598
) O 0 1.2291693884947108e-08
, O 0 1.5610250869713127e-08
Ndn O 0 3.0508983854815597e-06
and O 0 2.5507447265482597e-09
Ipw O 0 9.929571206157561e-06
, O 0 3.007553095457638e-09
and O 0 1.4217653721004808e-09
manifest O 0 8.972443765742355e-08
several O 0 2.0405312994853375e-09
phenotypes O 0 1.1837072406706284e-06
common O 0 3.9707526866550324e-07
to O 0 3.505166716877284e-07
PWS B-Disease 1 1.0
infants O 1 1.0
. O 0 1.196771904687921e-06

These O 0 1.7697134424565775e-08
data O 0 4.105446649305122e-09
demonstrate O 0 8.503118209546301e-10
that O 0 7.761346253187806e-12
both O 0 2.1378610687294852e-11
the O 0 1.1597533350338196e-10
position O 0 3.8692785087057757e-10
of O 0 4.0101738596476366e-10
the O 0 5.268500080646277e-10
IC O 0 4.508903293753974e-05
and O 0 1.9544810214711106e-10
its O 0 3.4541765281392856e-11
role O 0 3.940845219596589e-11
in O 0 5.725448240512243e-11
the O 0 1.3705379886541635e-10
coordinate O 0 2.0404720968425494e-10
expression O 0 9.334575334918327e-10
of O 0 5.649357426307233e-09
genes O 0 5.518845380692028e-10
is O 0 1.8212754221424987e-11
conserved O 0 6.049069578573096e-10
between O 0 7.762227527408072e-10
mouse O 0 7.770707810550448e-08
and O 0 2.443756030867661e-10
human O 0 2.402173460147594e-10
, O 0 5.7271413306247965e-11
and O 0 4.5831595463230457e-11
indicate O 0 1.8593952766376987e-10
that O 0 4.291097858988291e-12
the O 0 8.263036921363209e-10
mouse O 0 1.8746160179716753e-09
is O 0 1.054020586088722e-12
a O 0 1.5784560073936471e-12
suitable O 0 8.14242895330608e-10
model O 0 4.798314523490887e-10
system O 0 3.390194791563772e-09
in O 0 1.389097170623188e-10
which O 0 7.338169134840644e-12
to O 0 7.555353911947726e-12
investigate O 0 1.4769525880087286e-10
the O 0 2.871282378524853e-10
molecular O 0 2.503375284845788e-09
mechanisms O 0 3.692712802205733e-09
of O 0 5.7737064018681394e-09
imprinting O 0 1.612388444982571e-07
in O 0 6.214124215198069e-10
this O 0 4.5881711624451427e-11
region O 0 9.71714708697391e-10
of O 0 2.6832105426422004e-09
the O 0 2.626173278841293e-09
genome O 0 1.2015725081582218e-09
. O 0 3.100104895015221e-10
. O 0 6.020745235701952e-09

Mutations O 0 1.3214905720815295e-06
of O 0 4.611216581906774e-07
the O 0 3.015809681983228e-07
ATM O 0 1.4436618585023098e-05
gene O 0 4.475603443410137e-09
detected O 0 1.2502344937104226e-08
in O 0 2.091385065128293e-09
Japanese O 1 0.9171800017356873
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999994039535522
: O 0 4.568705830321207e-11
possible O 0 1.1137656769077964e-10
preponderance O 0 1.7519829498269246e-07
of O 0 1.2657893622147753e-09
the O 0 5.417533643914396e-10
two O 0 2.2080402783952735e-10
founder O 0 1.0768699354457567e-07
mutations O 0 1.3328442349802572e-08
4612del165 O 0 2.0849433894909453e-06
and O 0 4.154032851033662e-08
7883del5 O 0 2.680399666132871e-05
. O 0 8.176517098945624e-07

The O 0 5.4630522754450794e-06
ATM O 0 0.00160524423699826
( O 0 6.893939286101158e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.945789307455925e-09
mutated O 0 1.4158368699668245e-08
) O 0 7.357470882540795e-11
gene O 0 4.291134392264695e-10
on O 0 1.5649475049173134e-09
human O 0 1.7592829415491451e-09
chromosome O 0 1.3853677316433277e-08
11q22 O 0 7.062553777359426e-06
. O 0 7.926539069558203e-07

3 O 0 7.893145266280044e-06
has O 0 4.261277108952299e-09
recently O 0 3.932386860583392e-09
been O 0 2.7287039294776605e-10
identified O 0 2.7556554260677046e-10
as O 0 1.5670854891514097e-10
the O 0 1.0897950597499317e-10
gene O 0 1.4311421839274807e-11
responsible O 0 4.945612495921292e-12
for O 0 8.255183862881932e-12
the O 0 1.6496070065485924e-09
human O 0 1.669741322984919e-07
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00044083979446440935
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.56750928587735e-09
. O 0 3.98840747095619e-08

In O 0 4.3111150205277227e-08
order O 0 6.314165190701715e-09
to O 0 3.4203756493766946e-10
define O 0 3.6108196432849127e-09
the O 0 6.775670580161375e-10
types O 0 5.814440928730846e-09
of O 0 1.7334892632447918e-08
disease O 0 8.636353072688507e-07
- O 0 1.2174847086043883e-07
causing O 0 1.4065969367038633e-07
ATM O 0 1.0235626177745871e-05
mutations O 0 7.649599842451948e-10
in O 0 1.8512950894500335e-10
Japanese O 0 7.56781389554817e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.789682745671598e-06
as O 0 1.4319456731470837e-10
well O 0 2.583636603270545e-11
as O 0 1.5769854172509312e-11
to O 0 2.2896693221974296e-11
look O 0 1.476487820895045e-10
for O 0 2.0724338911648488e-11
possible O 0 4.1496512892535975e-09
mutational O 0 3.302647428427008e-06
hotspots O 0 4.48889977633371e-07
, O 0 3.003979842652882e-10
reverse O 0 3.632295131339447e-09
- O 0 2.4269466436521725e-09
transcribed O 0 6.823435705349823e-10
RNA O 0 1.212232259018009e-10
derived O 0 9.637018266728248e-11
from O 0 2.714241158219277e-11
ten O 0 6.397419261006121e-10
patients O 0 1.4670621384382798e-09
belonging O 0 1.3209629223798203e-10
to O 0 2.686725841805071e-11
eight O 0 7.809570767847163e-10
unrelated O 0 4.850141266388164e-08
Japanese O 0 0.00048644383787177503
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.6634681410110375e-09
was O 0 3.881852062015412e-10
analyzed O 0 5.862210161744486e-10
for O 0 3.321659267085941e-11
mutations O 0 2.525107345441313e-10
by O 0 3.156062078346622e-10
the O 0 1.990154929742971e-09
restriction O 0 1.1735264848766747e-07
endonuclease O 0 2.4501719053660054e-07
fingerprinting O 0 2.525568163491698e-07
method O 0 2.724474086335249e-07
. O 0 1.3971155965464277e-07

As O 0 1.383001631438674e-06
has O 0 1.2317667996697423e-09
been O 0 1.67327152134078e-10
reported O 0 3.57295790176515e-11
by O 0 9.218149854550717e-11
others O 0 6.635207383531849e-10
, O 0 3.8830647031140586e-11
mutations O 0 1.388299891713629e-10
that O 0 1.8854577621407742e-11
lead O 0 6.758881010426876e-09
to O 0 1.3874778659328513e-08
exon O 0 0.00010814666165970266
skipping O 0 0.0002227603690698743
or O 0 3.965023154250957e-08
premature O 0 3.386416267403547e-07
protein O 0 3.96304811189907e-09
truncation O 0 1.6476998609959992e-07
were O 0 1.3690318212411512e-08
also O 0 4.4543360666615683e-10
predominant O 0 6.98112501140713e-07
in O 0 4.411059073561319e-09
our O 0 3.9795470030412616e-08
mutants O 0 5.285485258355038e-07
. O 0 4.654843266393982e-08

Six O 0 3.076711152516509e-07
different O 0 4.015656251965538e-09
mutations O 0 3.3824245626590255e-09
were O 0 1.2114030889520677e-09
identified O 0 4.332113556770878e-10
on O 0 5.267645764028828e-10
12 O 0 3.844942142450236e-10
of O 0 2.9666616385704003e-10
the O 0 2.3758961464892536e-09
16 O 0 1.4140557169639578e-08
alleles O 0 1.4204324827460368e-08
examined O 0 9.179368021250411e-07
. O 0 1.9271460871550516e-07

Four O 0 1.7784580563784402e-07
were O 0 2.0285956026100394e-08
deletions O 0 6.04551075866766e-08
involving O 0 1.0244757930877313e-08
a O 0 6.923401407732399e-09
loss O 0 4.13894355233424e-07
of O 0 3.752434167836327e-07
a O 0 6.194802448789005e-09
single O 0 1.2948933481027325e-08
exon O 0 1.3637001927691017e-07
exon O 0 9.372619302894236e-08
7 O 0 2.8304656396471728e-08
, O 0 4.397179564907816e-10
exon O 0 9.694127101056438e-08
16 O 0 2.7707525163123137e-08
, O 0 2.5209794252134543e-09
exon O 0 1.2530226740636863e-06
33 O 0 5.316353508533211e-07
or O 0 2.6486253190682874e-08
exon O 0 1.5944464394124225e-05
35 O 0 2.5717727112350985e-06
. O 0 5.217718808125937e-07

The O 0 9.829980172071373e-07
others O 0 1.5834347166787666e-08
were O 0 3.627704581177227e-09
minute O 0 2.0204863560024933e-08
deletions O 0 2.7926649437404194e-08
, O 0 1.0718443910207043e-09
4649delA O 0 1.9106104787169897e-07
in O 0 2.303984913964996e-08
exon O 0 1.0549397302384023e-06
33 O 0 1.2689100969964784e-07
and O 0 1.9742232293396e-09
7883del5 O 0 3.6795784126297804e-06
in O 0 1.7811279917623324e-07
exon O 0 9.75251714407932e-06
55 O 0 1.8257251213071868e-06
. O 0 3.21316122153803e-07

The O 0 1.4976989177739597e-06
mutations O 0 1.2623164025171718e-07
4612del165 O 0 2.3275817966350587e-06
and O 0 8.950989283107447e-09
7883del5 O 0 2.202262976425118e-06
were O 0 1.8749995334133018e-08
found O 0 4.2207970452068366e-10
in O 0 4.695149130595766e-11
more O 0 5.186755105274221e-12
than O 0 1.2521513340080226e-11
two O 0 1.0542241558886278e-11
unrelated O 0 4.052589375191928e-09
families O 0 4.6908969764114516e-11
; O 0 1.323458963947699e-11
44 O 0 1.3215180061365572e-09
% O 0 3.357180852758823e-11
( O 0 9.230421331787864e-13
7 O 0 5.330644259338158e-10
of O 0 8.703718301639185e-10
16 O 0 6.252275364104776e-10
) O 0 2.24528338629848e-12
of O 0 1.5894455196452384e-10
the O 0 2.05343020365234e-10
mutant O 0 1.6712691230935661e-09
alleles O 0 1.6746444508886071e-10
had O 0 1.2353472411685829e-10
one O 0 7.22648199960596e-12
of O 0 1.0512950232577367e-10
the O 0 1.6549015491307273e-09
two O 0 8.540828599912231e-10
mutations O 0 1.4229841305279933e-08
. O 0 8.96060967647827e-08

The O 0 1.5499255141548929e-06
4612del165 O 0 2.0258066797396168e-05
mutations O 0 3.694208317028824e-08
in O 0 8.238503212965043e-10
three O 0 4.020434332674405e-11
different O 0 1.3551953829959995e-11
families O 0 1.7989859601996727e-11
were O 0 7.788814732068161e-11
all O 0 1.1570836302987608e-11
ascribed O 0 5.450526696648694e-09
to O 0 3.1422711654904845e-10
the O 0 8.202773571497346e-09
same O 0 3.2529576809992022e-09
T O 0 3.73459023705891e-08
- O 0 2.216983485681112e-09
- O 0 1.1510820074889239e-09
> O 0 2.3687469763444824e-09
A O 0 3.165671891292021e-10
substitution O 0 4.903109918075188e-09
at O 0 4.244111451168209e-10
the O 0 2.380462771345293e-10
splice O 0 6.421667819722643e-08
donor O 0 9.021725588809204e-09
site O 0 8.345563351497276e-09
in O 0 4.11054745796946e-09
intron O 0 4.936951427225722e-06
33 O 0 9.483223948336672e-07
. O 0 2.657577624631813e-07

Microsatellite O 0 0.0007652207859791815
genotyping O 0 0.00027113727992400527
around O 0 6.318745704447792e-08
the O 0 5.0983231858481304e-08
ATM O 0 1.1454294508439489e-05
locus O 0 8.455013755792606e-08
also O 0 1.5248972917714099e-10
indicated O 0 1.6062869090394116e-10
that O 0 1.2447664426984417e-12
a O 0 1.9787600377685344e-11
common O 0 8.506038096101065e-10
haplotype O 0 1.129204107996884e-08
was O 0 6.920232831220119e-09
shared O 0 1.5234205563707803e-10
by O 0 1.5333078556833968e-11
the O 0 3.850578467190502e-10
mutant O 0 1.2063587462307623e-08
alleles O 0 3.4600420306674096e-09
in O 0 1.442164720977246e-09
both O 0 6.41651087818218e-09
mutations O 0 6.890508075230173e-08
. O 0 1.348637965747912e-07

This O 0 3.223891553716385e-08
suggests O 0 2.4747304649963553e-08
that O 0 4.5851964586285376e-11
these O 0 2.5251456481356627e-10
two O 0 6.551528763942827e-10
founder O 0 4.463049378955475e-07
mutations O 0 3.5932590236598116e-09
may O 0 2.366479900928198e-09
be O 0 7.947895119819748e-10
predominant O 0 5.672131464962149e-06
among O 0 5.225508914463717e-09
Japanese O 0 2.8274016017348913e-07
ATM O 0 3.536248186719604e-06
mutant O 0 6.49537582830817e-07
alleles O 0 1.7299953469773754e-07
. O 0 1.0614493106686496e-07

W474C O 0 1.9585488189477473e-05
amino O 0 6.36825561173282e-08
acid O 0 1.5470170922071702e-08
substitution O 0 4.2900836660919595e-08
affects O 0 7.145622982207556e-10
early O 0 2.1274579875552035e-09
processing O 0 1.92763338624502e-09
of O 0 2.63238675302091e-09
the O 0 1.3708367774256658e-09
alpha O 0 1.0705266673127767e-09
- O 0 2.318428365954972e-10
subunit O 0 1.6893536569639878e-10
of O 0 1.4564055517141128e-10
beta O 0 7.105868116141778e-10
- O 0 7.967463133695674e-09
hexosaminidase O 0 4.028441708214814e-06
A O 0 1.9668387807314502e-08
and O 0 5.0611782126397387e-11
is O 0 1.5204813319860677e-12
associated O 0 2.5799282848959493e-11
with O 0 1.5149306809014718e-10
subacute O 1 0.9998455047607422
G B-Disease 1 0.9999996423721313
( I-Disease 0 1.7340578750690838e-08
M2 I-Disease 0 0.0003257810021750629
) I-Disease 0 2.7447042416639533e-09
gangliosidosis I-Disease 0 1.5548939700238407e-05
. O 0 4.015096237708349e-07

Mutations O 0 1.4066132507650764e-06
in O 0 2.352283345885553e-08
the O 0 3.96782979805721e-08
HEXA O 0 3.729527088580653e-05
gene O 0 1.3763831185897857e-09
, O 0 4.576110324006066e-11
encoding O 0 4.4897430218071577e-10
the O 0 1.2976518748430976e-09
alpha O 0 1.3184565661461534e-09
- O 0 3.5204655857157263e-10
subunit O 0 3.369763079685839e-10
of O 0 2.173641822089678e-10
beta O 0 8.594362999048144e-10
- O 0 3.0673457107610602e-09
hexosaminidase O 0 3.2951031698758015e-06
A O 0 3.8382603406716953e-07
( O 0 2.0284583734930806e-10
Hex O 0 2.5580985152373614e-07
A O 0 2.844844804172908e-09
) O 0 6.8142722367547925e-12
, O 0 2.9344571477601944e-12
that O 0 2.563900914492878e-12
abolish O 0 9.82080905487237e-08
Hex O 0 5.210416929912753e-06
A O 0 1.5333686320673223e-08
enzyme O 0 1.538025884428862e-08
activity O 0 2.9422924541222528e-08
cause O 0 0.00023581518325954676
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.021043663650971e-09
TSD B-Disease 1 0.9079411625862122
) O 0 1.4147663596197901e-10
, O 0 8.302496884438071e-11
the O 0 2.5008362047884702e-09
fatal O 0 3.7854732681807945e-07
infantile B-Disease 0 1.0182534424529877e-06
form I-Disease 0 2.3739586296755988e-08
of I-Disease 0 1.1143382835143711e-05
G I-Disease 0 0.0013274728553369641
( I-Disease 0 4.606781345284361e-10
M2 I-Disease 0 2.336637862754287e-06
) I-Disease 0 5.429188695837972e-11
gangliosidosis I-Disease 0 2.042606581653672e-07
, I-Disease 0 2.9456864725219134e-10
Type I-Disease 0 2.4007146492976972e-08
1 I-Disease 0 1.354128187358583e-07
. O 0 5.4167433205520865e-08

Less O 0 3.959517471230356e-06
severe O 0 0.0001616575027583167
, O 0 2.4725417802073935e-07
subacute O 1 0.9999921321868896
( O 0 7.816131741833487e-09
juvenile O 0 0.02731798030436039
- O 0 2.905131850639009e-07
onset O 1 0.9992172718048096
) O 0 4.525865016091757e-09
and O 0 2.2349230732743308e-07
chronic O 1 0.9999946355819702
( O 0 1.1571863467452204e-09
adult O 0 4.583603185892571e-08
- O 0 3.941788673245128e-09
onset O 0 9.389578394802811e-07
) O 0 8.625560682373745e-11
variants O 0 7.724318962232246e-09
are O 0 5.7426629423984465e-11
characterized O 0 6.139885821987434e-11
by O 0 3.5818962379474684e-11
a O 0 1.9534188155923005e-10
broad O 0 4.676994080909935e-08
spectrum O 0 2.2942853661334084e-07
of O 0 1.4533205749955869e-09
clinical O 0 4.415910126454037e-08
manifestations O 0 1.0439049624721974e-08
and O 0 6.753449188767746e-11
are O 0 2.546589458404802e-12
associated O 0 7.603784789311785e-12
with O 0 1.8256882550887754e-12
residual O 0 4.756712002063068e-08
levels O 0 8.703360521167269e-08
of O 0 1.5037342393497966e-07
Hex O 0 1.6819061784190126e-05
A O 0 1.7146739139661804e-07
enzyme O 0 7.607832230860367e-08
activity O 0 8.164752784978191e-08
. O 0 2.9453302019533112e-08

We O 0 8.579581844969653e-08
identified O 0 1.1681150269282625e-08
a O 0 9.516758492367217e-10
1422 O 0 5.879880518477876e-06
G O 0 2.0304362351453165e-06
- O 0 1.1856555914846467e-07
- O 0 4.2273196498854304e-08
> O 0 9.204037354493266e-08
C O 0 1.1241674258144485e-07
( O 0 3.129259221537617e-12
amino O 0 1.389838417964473e-11
acid O 0 8.669086976054174e-11
W474C O 0 3.728396258395605e-09
) O 0 7.267156169367406e-13
substitution O 0 7.662859236035047e-10
in O 0 7.520449540887597e-11
the O 0 1.0108893583327117e-10
first O 0 1.860661902330918e-10
position O 0 1.026826734751296e-09
of O 0 2.3506494528646726e-09
exon O 0 3.432469242170555e-08
13 O 0 2.229097573192007e-09
of O 0 1.1663006560524991e-08
HEXA O 0 0.25326165556907654
of O 0 6.083230914555315e-07
a O 0 6.033758825907398e-09
non O 0 9.381737413605151e-07
- O 0 1.2745071842346078e-07
Jewish O 0 4.4043275693184114e-07
proband O 0 3.9510425267508253e-05
who O 0 1.7971598653687693e-09
manifested O 0 1.975331542780623e-08
a O 0 8.800018491683659e-10
subacute O 0 8.421650818490889e-06
variant O 0 1.951456624738057e-06
of O 0 0.00018993334379047155
G B-Disease 1 0.9852310419082642
( I-Disease 0 4.314049562026412e-09
M2 I-Disease 0 4.652441566577181e-05
) I-Disease 0 2.2601749360973145e-09
gangliosidosis I-Disease 0 1.3448596291709691e-05
. O 0 4.550875303266366e-07

On O 0 6.594976298401889e-07
the O 0 4.41917080706844e-08
second O 0 3.3046592307073297e-07
maternally O 0 4.652962161344476e-06
inherited O 0 1.8282585187989753e-06
allele O 0 4.794266317276197e-08
, O 0 1.615085426509566e-10
we O 0 2.1159385008018283e-11
identified O 0 9.030927394793054e-11
the O 0 6.14307493762567e-10
common O 0 2.673010021680966e-05
infantile O 1 0.9996176958084106
disease O 0 0.0988471657037735
- O 0 6.009705089127237e-07
causing O 0 1.7628853754558804e-07
4 O 0 1.5690271482071694e-07
- O 0 1.0347208423411303e-08
bp O 0 1.0337444678043539e-08
insertion O 0 1.147739325801922e-08
, O 0 3.021022043636634e-10
+ O 0 4.0603729267729705e-09
TATC O 0 4.864930815529078e-05
1278 O 0 5.286192390485667e-05
, O 0 1.575483743465611e-09
in O 0 6.019137632762295e-09
exon O 0 1.406426804351213e-06
11 O 0 5.5291444311933446e-08
. O 0 7.555657077773503e-08

Pulse O 0 4.089422509423457e-05
- O 0 1.0434072237330838e-06
chase O 0 2.308925317606736e-08
analysis O 0 2.2235294161454533e-10
using O 0 3.34121896816697e-10
proband O 0 3.0749795314477524e-06
fibroblasts O 0 9.77384857492325e-08
revealed O 0 4.9692965298220315e-09
that O 0 1.7896462090050136e-11
the O 0 3.595149178359236e-10
W474C O 0 1.9168004072867006e-08
- O 0 1.076692401902335e-09
containing O 0 8.775613569156349e-10
alpha O 0 1.4024728045569645e-09
- O 0 2.9094754383507393e-10
subunit O 0 6.578688704905744e-10
precursor O 0 4.381927265484364e-09
was O 0 1.2014349515254708e-09
normally O 0 1.9666904216286696e-10
synthesized O 0 3.8620546760625984e-09
, O 0 3.7167342120669744e-11
but O 0 3.2384990522604795e-11
not O 0 1.76936330170685e-11
phosphorylated O 0 1.3039570312400883e-08
or O 0 1.4003764814418673e-10
secreted O 0 2.668286147589072e-10
, O 0 1.0961213707527673e-11
and O 0 3.3015350869858295e-11
the O 0 2.1127548599508827e-09
mature O 0 6.42959676611099e-08
lysosomal O 0 3.264942733949283e-06
alpha O 0 7.607673069287557e-08
- O 0 1.1580392644816584e-08
subunit O 0 6.006751096521157e-09
was O 0 3.789834224221522e-09
not O 0 5.163908745053902e-10
detected O 0 9.458659633310162e-08
. O 0 5.156669757866439e-08

When O 0 9.083561280931463e-08
the O 0 1.3839627222012041e-08
W474C O 0 3.58252378873658e-07
- O 0 1.0326940191873746e-08
containing O 0 2.079154626244417e-09
alpha O 0 2.0989778803937043e-09
- O 0 4.417539944956417e-10
subunit O 0 9.382304932969987e-10
was O 0 4.108485995857336e-09
transiently O 0 5.598814567520094e-08
co O 0 3.0620672664127824e-09
- O 0 2.66832844708631e-09
expressed O 0 2.902917906055791e-10
with O 0 8.142994958881822e-12
the O 0 1.0012507489776112e-10
beta O 0 1.9477042201287986e-10
- O 0 1.7427601028963124e-10
subunit O 0 5.21219525873029e-11
to O 0 7.130081247641584e-12
produce O 0 3.4281541494429746e-10
Hex O 0 2.0762713859312498e-07
A O 0 1.52575143630429e-08
( O 0 7.157909681643204e-11
alphabeta O 0 2.7111002509627724e-07
) O 0 6.821219977748427e-11
in O 0 1.079159539507657e-09
COS O 0 7.141036917346355e-07
- O 0 6.697273846612006e-08
7 O 0 3.965732187083404e-09
cells O 0 5.2791195026546944e-11
, O 0 1.7315559793298907e-12
the O 0 3.779341770093758e-11
mature O 0 1.6327776630742363e-10
alpha O 0 1.7910199712201091e-10
- O 0 3.948135221532034e-11
subunit O 0 1.9425240929682452e-11
was O 0 2.0273470402454308e-11
present O 0 5.050105299220231e-12
, O 0 1.887007477358038e-12
but O 0 3.703965086032657e-12
its O 0 3.6458730999500144e-12
level O 0 1.9555958241657123e-10
was O 0 1.906061697365402e-10
much O 0 1.6533041602428966e-10
lower O 0 3.2473412847622285e-09
than O 0 1.3850274226123727e-11
that O 0 1.9115247579248873e-12
from O 0 1.04885551632794e-10
normal O 0 1.1010592437799005e-09
alpha O 0 1.3790976138849942e-09
- O 0 2.8316993194721363e-10
subunit O 0 3.468980935839028e-10
transfections O 0 8.864899037064333e-09
, O 0 6.337200295775114e-12
although O 0 2.316999543616749e-11
higher O 0 8.643351034898217e-10
than O 0 1.1517858715393015e-11
in O 0 8.441288640304023e-11
those O 0 1.4383620683400267e-10
cells O 0 4.890685079139701e-10
transfected O 0 1.3620230276956136e-08
with O 0 4.0980005847068846e-12
an O 0 4.445903280941854e-12
alpha O 0 2.3564132867193166e-09
- O 0 2.2277715228113948e-09
subunit O 0 2.6608573122643975e-09
associated O 0 2.8605586788188475e-09
with O 0 4.460681157780755e-09
infantile O 0 0.00016842421609908342
TSD B-Disease 0 0.2125598043203354
. O 0 2.7373996545065893e-06

Furthermore O 0 2.6522508278503665e-07
, O 0 6.891395787356203e-10
the O 0 3.582547314362472e-10
precursor O 0 1.1559516011061532e-08
level O 0 4.028544609013807e-09
of O 0 1.012783190645905e-09
the O 0 1.2092170598165808e-09
W474C O 0 3.8612462560649874e-08
alpha O 0 3.0911260218147163e-09
- O 0 2.825532863237612e-10
subunit O 0 1.884153805198352e-10
was O 0 1.1058826077103845e-10
found O 0 8.529456654859935e-12
to O 0 7.542366904644826e-12
accumulate O 0 1.0877043710166845e-09
in O 0 4.7358381105588876e-11
comparison O 0 8.839770027080363e-10
to O 0 2.7656585355195773e-11
the O 0 3.1234839714677776e-10
normal O 0 3.0280213891842322e-09
alpha O 0 8.979357701832669e-09
- O 0 2.5126940528252817e-09
subunit O 0 3.8822540737726285e-09
precursor O 0 4.919421314752981e-08
levels O 0 1.0381214110566361e-07
. O 0 5.8830277538390874e-08

We O 0 1.0844282627431312e-07
conclude O 0 1.5958970323026733e-07
that O 0 1.4921153201896686e-10
the O 0 2.2519173192847575e-09
1422 O 0 6.2165286180970725e-06
G O 0 2.248319333375548e-06
- O 0 6.224830428891437e-08
- O 0 1.2265065407746079e-08
> O 0 4.0389558364495315e-08
C O 0 9.168678616333636e-08
mutation O 0 6.677048497438776e-11
is O 0 2.850738037556838e-13
the O 0 2.39011913559517e-12
cause O 0 1.2257710124696786e-10
of O 0 2.9591708639031822e-08
Hex B-Disease 1 0.9999790191650391
A I-Disease 1 0.9993284940719604
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.7152136539143612e-08
the O 0 1.642894709164011e-08
proband O 0 1.4433687283599284e-05
. O 0 2.1727367993662483e-07

The O 0 8.002344031865505e-08
resulting O 0 4.6105920858963145e-08
W474C O 0 1.6436880514447694e-06
substitution O 0 1.9927331322833197e-06
clearly O 0 3.6510300560621545e-08
interferes O 0 4.475142478810312e-09
with O 0 6.300997223984695e-11
alpha O 0 1.7561148091260748e-09
- O 0 1.7807329222296886e-10
subunit O 0 1.1235912894536071e-10
processing O 0 3.8828001924784417e-10
, O 0 5.482528060013481e-12
but O 0 5.276982410068465e-12
because O 0 6.609988164457681e-12
the O 0 1.331825622008509e-11
base O 0 7.843063698498298e-11
substitution O 0 2.915561303495906e-08
falls O 0 2.3891902856121305e-07
at O 0 4.689602595142617e-10
the O 0 8.80518505330663e-11
first O 0 2.1366187985538687e-10
position O 0 2.0414967494275515e-09
of O 0 1.1872256067135822e-08
exon O 0 2.564904377777566e-07
13 O 0 4.283058352427815e-09
, O 0 2.8931603640591774e-11
aberrant O 0 1.1394044596713115e-09
splicing O 0 1.1903818375458286e-08
may O 0 3.6097038691451644e-09
also O 0 1.2063712528931347e-10
contribute O 0 6.016253606411226e-10
to O 0 1.3143294452788723e-08
Hex B-Disease 1 0.9999984502792358
A I-Disease 1 0.9989499449729919
deficiency I-Disease 1 0.9885953068733215
in O 0 1.2307810770550986e-08
this O 0 1.7817191055868875e-09
proband O 0 4.261703907104675e-06
. O 0 7.727384065958631e-09
. O 0 2.53674361516687e-08

Two O 0 1.155632389782113e-07
frequent O 0 2.2112628528248024e-07
missense O 0 0.00010718855628510937
mutations O 0 2.0196368950564647e-06
in O 0 3.23056315210124e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00015295068442355841

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.706465013739944e-07
an O 0 2.0629408936656546e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.0005188555805943906
by O 0 8.637641002451346e-08
early O 1 1.0
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999997615814209
goiter B-Disease 1 1.0
. O 1 0.9998691082000732

A O 0 1.4463174125012301e-07
century O 0 3.829700858659635e-07
after O 0 1.138021499258457e-08
its O 0 1.7063747637102722e-10
recognition O 0 1.0172689357546005e-09
as O 0 7.520855049847341e-10
a O 0 7.031660809175833e-10
syndrome O 0 3.563740591516762e-08
by O 0 2.578921243223675e-10
Vaughan O 0 0.00016050248814281076
Pendred O 0 0.0004144379636272788
, O 0 1.908240648829107e-10
the O 0 9.783576171429331e-10
disease O 0 5.31124477731737e-08
gene O 0 3.9243923666276714e-09
( O 0 1.292950302378415e-09
PDS O 1 0.9932624697685242
) O 0 2.0456937532831176e-10
was O 0 6.794918405716999e-09
mapped O 0 3.952343785584844e-09
to O 0 9.367498998713586e-10
chromosome O 0 1.8286156588942504e-08
7q22 O 0 2.708420106500853e-05
- O 0 2.387573658779729e-05
q31 O 0 0.00015476750559173524
. O 0 5.733242574024189e-07

1 O 0 2.17387787415646e-06
and O 0 1.9262490269511545e-08
, O 0 1.2183476449934005e-09
recently O 0 3.8408685121282815e-09
, O 0 1.0041922154924166e-10
found O 0 8.1572075483205e-11
to O 0 1.3588663527741573e-10
encode O 0 1.0213891954435894e-08
a O 0 1.4524704994300919e-08
putative O 0 2.4631361156934872e-05
sulfate O 0 9.843533916864544e-05
transporter O 0 0.00028069925610907376
. O 0 1.7861215155789978e-06

We O 0 4.822219423772367e-08
performed O 0 2.9194604511673106e-09
mutation O 0 1.5841308820263578e-10
analysis O 0 8.704328230413338e-11
of O 0 9.971955483578654e-10
the O 0 2.7993259266168025e-08
PDS B-Disease 1 0.7580719590187073
gene O 0 5.702904370963324e-09
in O 0 1.907419333591065e-09
patients O 0 1.8212816144114186e-08
from O 0 3.6324943053500647e-10
14 O 0 3.3740932270376334e-09
Pendred B-Disease 0 5.548676199396141e-05
families O 0 6.753749226540151e-10
originating O 0 2.4341972881813945e-09
from O 0 4.731434688487468e-10
seven O 0 2.1344476186513361e-10
countries O 0 2.615338327849326e-11
and O 0 2.101207818849815e-10
identified O 0 2.597736470377754e-09
all O 0 6.037903510502929e-09
mutations O 0 4.141311649163981e-08
. O 0 1.0778563108715389e-07

The O 0 9.72628527051711e-07
mutations O 0 6.296680510331498e-08
include O 0 3.5590657088135913e-09
three O 0 2.3127708081993603e-10
single O 0 4.992141144910534e-10
base O 0 5.030002636630115e-09
deletions O 0 1.3278103949687647e-07
, O 0 2.7099142929642994e-09
one O 0 2.1695134577726094e-09
splice O 0 2.8467354695749236e-06
site O 0 1.552809010263445e-07
mutation O 0 1.4841297080181448e-08
and O 0 2.5709268047791056e-09
10 O 0 3.6727517027657086e-08
missense O 0 1.6731806681491435e-05
mutations O 0 7.942429647300742e-07
. O 0 7.500941023863561e-07

One O 0 2.4245059648819733e-07
missense O 0 1.7747215679264627e-06
mutation O 0 9.226742925250164e-09
( O 0 6.949775477327336e-11
L236P O 0 8.272790097407778e-08
) O 0 3.5053814018137786e-11
was O 0 8.539557949660548e-10
found O 0 5.099141942022101e-11
in O 0 5.79247413923234e-11
a O 0 4.729447389273389e-11
homozygous O 0 5.168234173957842e-10
state O 0 1.156841428207045e-10
in O 0 2.381302932619178e-10
two O 0 6.405987545976544e-11
consanguineous O 0 3.267858573963167e-06
families O 0 1.0670589967176625e-09
and O 0 1.2583097064311488e-10
in O 0 6.159477372591482e-10
a O 0 2.3582330532789797e-10
heterozygous O 0 3.6461966779199884e-10
state O 0 6.108708677787789e-11
in O 0 8.315301919248341e-11
five O 0 3.651553712180622e-11
additional O 0 2.6589230817108955e-10
non O 0 6.187259486978292e-07
- O 0 2.337460500712041e-06
consanguineous O 0 0.0009648885461501777
families O 0 4.4544083976916227e-08
. O 0 8.049447330904513e-08

Another O 0 1.3847146647094632e-06
missense O 0 8.902116860554088e-06
mutation O 0 3.285834537791743e-08
( O 0 3.170409212938097e-10
T416P O 0 1.3548930155593553e-07
) O 0 7.951757308166663e-11
was O 0 3.580806984260221e-09
found O 0 1.0621809681810035e-10
in O 0 7.910580523962096e-11
a O 0 2.4269952367261816e-11
homozygous O 0 2.2156339263279534e-10
state O 0 1.6917527101423246e-10
in O 0 6.187512724409316e-10
one O 0 1.4503817591382528e-10
family O 0 4.246360207904587e-11
and O 0 3.886132041164281e-11
in O 0 1.6334754382452132e-10
a O 0 1.738149207897166e-10
heterozygous O 0 5.46989453731328e-10
state O 0 9.013306073724081e-11
in O 0 8.961097974768961e-10
four O 0 1.7385943795744652e-09
families O 0 1.5147983978280877e-09
. O 0 1.29321247044345e-08

Pendred B-Disease 1 0.9997391104698181
patients O 0 0.0018321673851460218
in O 0 2.0898626829080058e-08
three O 0 1.423844153691789e-09
non O 0 6.371718086484179e-07
- O 0 1.6580037254243507e-06
consanguineous O 0 0.09840713441371918
families O 0 4.743237358439956e-09
were O 0 5.421048054898847e-10
shown O 0 3.100606230099778e-11
to O 0 6.603107817471088e-12
be O 0 8.17416828668982e-11
compound O 0 2.5851882412553095e-08
heterozygotes O 0 2.4702131895537605e-07
for O 0 2.3935762261118043e-09
L236P O 0 2.3479499304812634e-06
and O 0 1.8355729380914454e-08
T416P O 0 1.2077400242560543e-05
. O 0 3.8067818763920513e-07

In O 0 2.98933393594325e-08
total O 0 2.6814148679221717e-09
, O 0 1.788609815811526e-10
one O 0 1.0633039587704118e-10
or O 0 4.886654275670921e-11
both O 0 3.231113640533856e-11
of O 0 6.72787991984336e-10
these O 0 1.7287855869074775e-10
mutations O 0 1.5993167901129368e-10
were O 0 7.886269415280367e-10
found O 0 1.1411677852679603e-10
in O 0 1.5012932563784886e-10
nine O 0 1.1234889685241e-09
of O 0 5.333270713947513e-09
the O 0 1.9177841537043605e-08
14 O 0 1.3908350027236338e-08
families O 0 5.997544128000243e-10
analyzed O 0 1.3823006739244192e-08
. O 0 2.95272677419689e-08

The O 0 1.5473830217160867e-08
identification O 0 1.5731544067421055e-08
of O 0 1.3960868017193206e-08
two O 0 7.93288601474984e-10
frequent O 0 1.6316336726163172e-08
PDS B-Disease 1 0.8895655870437622
mutations O 0 7.631518528228298e-09
will O 0 4.0202962486857174e-11
facilitate O 0 4.044602708308531e-10
the O 0 2.782188368577465e-10
molecular O 0 2.0549407508951845e-08
diagnosis O 0 7.31484942662064e-06
of O 0 0.0016220438992604613
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.998413583554793e-05

Insertional O 0 0.00024203774228226393
mutation O 0 1.316090987302232e-07
by O 0 1.3827323730453145e-09
transposable O 0 4.375225671537919e-06
element O 0 2.0040830861489667e-07
, O 0 2.9433235848586037e-09
L1 O 0 1.8315533907298231e-06
, O 0 1.1239471159329995e-10
in O 0 2.336295878979655e-10
the O 0 2.071448790275099e-08
DMD B-Disease 1 1.0
gene O 0 1.8323198958114517e-08
results O 0 4.814371123984529e-08
in O 0 1.8268272228283422e-08
X B-Disease 1 0.999998927116394
- I-Disease 1 0.9988182187080383
linked I-Disease 0 0.0037112138234078884
dilated I-Disease 1 0.9974109530448914
cardiomyopathy I-Disease 1 1.0
. O 0 7.436869782395661e-05

X B-Disease 1 0.9999176263809204
- I-Disease 1 0.9999552965164185
linked I-Disease 0 0.4159543812274933
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 0 1.8258072032040218e-07
XLDCM B-Disease 1 0.9999985694885254
) O 0 1.3613878080409592e-10
is O 0 8.455819378028195e-12
a O 0 2.0679718354399412e-11
clinical O 0 1.4352722566002285e-08
phenotype O 0 2.547805024732952e-07
of O 0 5.537930860555207e-07
dystrophinopathy B-Disease 1 0.9818853735923767
which O 0 4.639469086686887e-10
is O 0 1.2075378891251987e-11
characterized O 0 1.1277093148187589e-10
by O 0 1.4256533453771425e-10
preferential O 0 1.5123619050427806e-06
myocardial B-Disease 0 0.00029293488478288054
involvement I-Disease 0 7.447912508951049e-09
without O 0 3.747094301509435e-10
any O 0 1.7562110099511585e-10
overt O 0 8.146285424004418e-09
clinical O 0 1.568864149703586e-07
signs O 0 1.8336351104153437e-07
of O 0 3.6696819734061137e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9289304614067078

To O 0 3.9269454354950994e-09
date O 0 2.828842013968824e-07
, O 0 5.20604725995355e-10
several O 0 8.974400389494264e-11
mutations O 0 4.2161066304835515e-10
in O 0 1.7141228436656775e-09
the O 0 4.064957920490997e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.000992266577668488
, O 0 4.915669933325262e-07
DMD O 1 1.0
, O 0 3.0253368699106886e-09
have O 0 4.147265864062888e-11
been O 0 6.116344930529038e-11
identified O 0 8.236739068578913e-11
in O 0 1.2059801768327105e-10
patients O 0 1.8797217116173215e-09
with O 0 4.9338377133834044e-11
XLDCM B-Disease 1 1.0
, O 0 2.5784208101953254e-09
but O 0 1.4233411671504825e-10
a O 0 2.477447066939753e-11
pathogenic O 0 5.057998464508273e-09
correlation O 0 6.738539726214299e-10
of O 0 3.166215345462575e-10
these O 0 3.7378075634642016e-10
cardiospecific O 0 7.788423204146966e-07
mutations O 0 7.813119928812284e-09
in O 0 4.3956727147076435e-09
DMD O 1 1.0
with O 0 7.703878646125872e-10
the O 0 8.164393960896632e-08
XLDCM B-Disease 1 0.9999995231628418
phenotype O 0 5.505193621502258e-05
has O 0 5.252356327645202e-10
remained O 0 5.82956571903992e-09
to O 0 2.470350313199532e-11
be O 0 5.556923254879109e-10
elucidated O 0 1.951672493305523e-05
. O 0 3.30838958007007e-07

We O 0 7.79683730911529e-08
report O 0 1.770755875263319e-09
here O 0 4.31320007487912e-10
the O 0 4.01018732110181e-11
identification O 0 1.8481938202086212e-10
of O 0 1.2920498004831416e-10
a O 0 7.514055350155147e-11
unique O 0 1.121288284444688e-09
de O 0 2.2693987133948212e-08
novo O 0 2.750565499809454e-07
L1 O 0 5.720020794797165e-07
insertion O 0 1.5950776699469316e-08
in O 0 3.2423774776191294e-09
the O 0 9.593467131807643e-10
muscle O 0 3.0788751548271875e-09
exon O 0 1.9493866432185314e-07
1 O 0 8.619389291197876e-08
in O 0 3.1338405648284606e-08
DMD O 1 1.0
in O 0 1.274366212555833e-07
three O 0 8.909665893952479e-09
XLDCM B-Disease 1 0.9999991655349731
patients O 0 5.338802111509722e-06
from O 0 1.122197557101856e-09
two O 0 1.5075687920251823e-10
unrelated O 0 2.927301778754554e-08
Japanese O 0 4.645654598789406e-07
families O 0 2.971267010209999e-09
. O 0 1.5073373660356992e-08

The O 0 1.6415077652709442e-07
insertion O 0 1.7012976627484022e-07
was O 0 7.569489923753281e-08
a O 0 3.5562952582779417e-10
5 O 0 1.4120712377163613e-09
- O 0 2.501455431680455e-10
truncated O 0 1.744380528911904e-09
form O 0 3.325045794255743e-10
of O 0 2.865572001908845e-09
human O 0 4.613446291656942e-10
L1 O 0 2.104173901784634e-08
inversely O 0 9.215648333338322e-08
integrated O 0 1.0319537224745545e-08
in O 0 2.0878287987358135e-10
the O 0 3.9353939551567407e-10
5 O 0 1.2231792245742668e-09
- O 0 6.5657679293451565e-09
untranslated O 0 0.000191221697605215
region O 0 5.489389831581093e-09
in O 0 6.839319111051623e-10
the O 0 1.4307670603841416e-09
muscle O 0 2.3830262207980013e-09
exon O 0 5.2917897619408905e-08
1 O 0 7.51496553874631e-09
, O 0 1.7864541443368687e-11
which O 0 4.895384011355253e-12
affected O 0 1.6962858895297472e-10
the O 0 3.2083441459107576e-10
transcription O 0 1.1682370626431293e-09
or O 0 5.1787504840028475e-11
the O 0 5.349262699461121e-10
stability O 0 2.1191879362447708e-09
of O 0 5.05344699419652e-09
the O 0 9.896770070128014e-10
muscle O 0 9.269920386856256e-10
form O 0 5.7730784597254114e-09
of O 0 4.845268222197774e-07
dystrophin O 0 2.7313399186823517e-07
transcripts O 0 5.9336686675237615e-09
but O 0 1.3596356679412835e-11
not O 0 1.2735878974698411e-12
that O 0 6.323902447709362e-13
of O 0 1.3603347337465266e-09
the O 0 7.6319288666582e-08
brain O 0 2.5957132265830296e-07
or O 0 4.7217909582286666e-09
Purkinje O 0 7.990453013917431e-06
cell O 0 3.9601708579084516e-08
form O 0 1.3577400315156751e-09
, O 0 1.9093474024067802e-10
probably O 0 4.396796260408564e-09
due O 0 9.309565740522885e-08
to O 0 4.125775832086731e-10
its O 0 6.899655291547901e-10
unique O 0 4.946240084180431e-10
site O 0 3.5435336886990854e-09
of O 0 3.567193873621477e-09
integration O 0 2.0803028633054055e-07
. O 0 2.4513218477295595e-07

We O 0 1.3882912242024759e-07
speculate O 0 7.811916447053591e-08
that O 0 1.3069828205813927e-11
this O 0 2.4359134501161783e-11
insertion O 0 8.066365353442961e-09
of O 0 1.4394998082423172e-08
an O 0 3.6137526304713674e-10
L1 O 0 2.424015690394299e-07
sequence O 0 4.2237607855710735e-10
in O 0 2.931552556262318e-09
DMD O 1 1.0
is O 0 1.8232608478552237e-10
responsible O 0 3.482729035719778e-11
for O 0 1.2865481249790811e-11
some O 0 8.909839879778225e-12
of O 0 1.0238086767255794e-10
the O 0 2.7906586763659647e-11
population O 0 3.000785655116883e-13
of O 0 2.8831659282246846e-12
Japanese O 0 1.1741664529552054e-08
patients O 0 4.300944933532946e-09
with O 0 7.902919291202792e-11
XLDCM B-Disease 1 0.9988893866539001
. O 0 1.0348949786020967e-07
. O 0 9.638152675961464e-08

Severe O 0 0.18589147925376892
early O 1 0.9999593496322632
- O 1 0.9946582913398743
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.1524136880325386e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 9.06768434560945e-07
red O 0 0.00014643309987150133
hair O 0 3.9614783986507973e-07
pigmentation O 0 4.360601815278642e-05
caused O 0 1.879771048152179e-06
by O 0 2.7960390980297234e-06
POMC O 1 1.0
mutations O 0 4.451034328667447e-06
in O 0 5.469900443699771e-08
humans O 0 1.5895722071945784e-07
. O 0 7.527808065788122e-08

Sequential O 0 7.023677994766331e-07
cleavage O 0 6.847508871032915e-07
of O 0 3.2916940995164623e-07
the O 0 8.525143257998025e-09
precursor O 0 6.433302246477979e-08
protein O 0 3.2028368845971045e-09
pre O 0 1.7839425936472253e-06
- O 0 5.423255515779601e-07
pro O 0 2.8775682494597277e-06
- O 0 1.2740663350996329e-06
opiomelanocortin O 0 0.013342524878680706
( O 0 5.757826215813111e-09
POMC O 0 4.120001904084347e-05
) O 0 1.528607240786073e-10
generates O 0 2.853462188756595e-10
the O 0 6.340688529782312e-10
melanocortin O 0 3.349688540765783e-06
peptides O 0 2.2187359505210225e-08
adrenocorticotrophin O 0 5.848763521498768e-06
( O 0 8.425046216231635e-10
ACTH O 0 1.9128492567688227e-07
) O 0 1.5578587031495061e-10
, O 0 2.100298268636891e-10
melanocyte O 0 1.113957864617987e-06
- O 0 6.14370208040782e-07
stimulating O 0 3.637108534348954e-07
hormones O 0 4.588142843431342e-08
( O 0 1.8327969697473634e-10
MSH O 0 7.530855327786412e-06
) O 0 2.1141242922961823e-10
alpha O 0 2.4269608545068877e-09
, O 0 1.1956364717735646e-11
beta O 0 1.4418367888513473e-10
and O 0 5.178859077692444e-11
gamma O 0 9.493262842497074e-10
as O 0 1.475564531672191e-10
well O 0 1.3382381314208658e-10
as O 0 1.4266215986324937e-10
the O 0 6.053328394095558e-10
opioid O 0 1.9488513203214097e-07
- O 0 6.5608006138973e-08
receptor O 0 2.2666734267318134e-08
ligand O 0 6.0113785593785e-07
beta O 0 1.0403052783658495e-06
- O 0 9.854919653662364e-07
endorphin O 0 3.8837402826175094e-05
. O 0 1.655616443940744e-07

While O 0 1.5429628774654702e-07
a O 0 1.1591700932456206e-09
few O 0 1.636457525044932e-09
cases O 0 5.109807688086221e-09
of O 0 2.2149059077491984e-05
isolated O 1 0.9999998807907104
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 5.6700542927501374e-08
been O 0 4.317696422617701e-09
reported O 0 1.7530125129283647e-09
( O 0 6.710015876265629e-10
OMIM O 0 5.009521555621177e-05
201400 O 0 7.60390662435384e-07
) O 0 1.23881571667539e-10
, O 0 9.114752702599205e-11
an O 0 2.918952579644696e-10
inherited O 1 0.9999606609344482
POMC O 1 1.0
defect O 1 0.9999990463256836
has O 0 1.956381368017901e-08
not O 0 2.7505514532677466e-10
been O 0 7.654226141795561e-10
described O 0 1.3988289415678423e-09
so O 0 7.136347068836812e-10
far O 0 1.8660267997461233e-08
. O 0 1.899701196350634e-08

Recent O 0 4.229747219142155e-07
studies O 0 1.7168591881500106e-08
in O 0 1.297470603178752e-10
animal O 0 2.120238151714915e-10
models O 0 4.225775562805012e-10
elucidated O 0 2.3720177466657333e-07
a O 0 4.740431380767518e-10
central O 0 1.6885105535990874e-09
role O 0 7.746313035461583e-10
of O 0 7.679180669128982e-08
alpha O 0 4.549391405817005e-07
- O 0 5.143958219377964e-07
MSH O 1 0.7112727165222168
in O 0 1.5346259818471708e-09
the O 0 1.660129672620414e-10
regulation O 0 1.7319879974664332e-09
of O 0 7.431501247712191e-11
food O 0 2.7371641064810603e-10
intake O 0 5.102722758221212e-11
by O 0 1.2733183648097612e-12
activation O 0 4.2635839303528655e-10
of O 0 1.1721905224248985e-08
the O 0 8.885606206376906e-08
brain O 0 4.848790808864578e-07
melanocortin O 0 1.9059592887060717e-05
- O 0 6.985414415794367e-07
4 O 0 1.0766235192249951e-07
- O 0 1.828350626453812e-08
receptor O 0 5.073670816813092e-09
( O 0 1.0974084835302378e-10
MC4 O 0 1.2957654689671472e-05
- O 0 7.641295241000989e-08
R O 0 4.9735472629208743e-08
; O 0 1.3140172283598872e-10
refs O 0 6.101437133310128e-09
3 O 0 2.3616417710314863e-09
- O 0 7.546633873367625e-10
5 O 0 1.927029646964229e-10
) O 0 1.3451974993985982e-12
and O 0 6.782089646828471e-12
the O 0 2.2500530605373825e-10
linkage O 0 1.2834521001536814e-08
of O 0 4.205370718324275e-09
human O 0 7.1605246176886794e-09
obesity B-Disease 1 0.999970555305481
to O 0 6.439458966056577e-10
chromosome O 0 3.5077507565262067e-10
2 O 0 2.4017210442650594e-09
in O 0 3.172078710811377e-10
close O 0 1.2000654914245956e-09
proximity O 0 1.2011949657164678e-08
to O 0 3.480698784752434e-10
the O 0 2.652588904084041e-08
POMC O 0 1.3835577192367055e-05
locus O 0 3.882513421871181e-09
, O 0 3.026759398672141e-11
led O 0 1.0818794471401105e-10
to O 0 5.238594280587705e-12
the O 0 5.4979135827304404e-11
proposal O 0 1.4439759388196194e-09
of O 0 6.254100570757259e-10
an O 0 8.314346607030121e-12
association O 0 8.302073473132054e-10
of O 0 1.259569248901471e-08
POMC O 1 0.9999812841415405
with O 0 1.5644468831510494e-08
human O 0 3.5639120596897556e-06
obesity B-Disease 1 1.0
. O 0 1.5767312788739218e-06

The O 0 3.649943991490545e-08
dual O 0 2.7599504903719208e-08
role O 0 1.0250582604953706e-08
of O 0 2.2585133763186604e-07
alpha O 0 3.3338112643832574e-06
- O 0 4.683163297158899e-06
MSH O 1 0.9833906292915344
in O 0 3.72980446528004e-09
regulating O 0 1.729202914191319e-08
food O 0 1.5654439522450048e-08
intake O 0 2.034221502356104e-08
and O 0 4.147552301603241e-10
influencing O 0 3.6235439893061994e-07
hair O 0 8.626739145256579e-07
pigmentation O 0 0.0003185296372976154
predicts O 0 1.5895926352982315e-08
that O 0 2.1723600349132788e-11
the O 0 2.41016817614792e-10
phenotype O 0 4.242203477389239e-09
associated O 0 2.208511984402861e-10
with O 0 1.3461555654903368e-11
a O 0 7.64834473532261e-10
defect O 0 1.140924950959743e-06
in O 0 2.257815481243597e-07
POMC O 0 0.08986130356788635
function O 0 1.4419502258888883e-09
would O 0 8.573336485184768e-11
include O 0 5.406810998920264e-09
obesity B-Disease 1 1.0
, O 0 2.2956175849131455e-10
alteration O 0 2.06487516152265e-06
in O 0 2.0814945855818223e-06
pigmentation O 1 1.0
and O 0 0.004505207762122154
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999951124191284
. O 0 6.970015874685487e-06

The O 0 1.932177440266969e-07
observation O 0 6.412280413314875e-07
of O 0 1.569770446963048e-08
these O 0 7.985171635027655e-09
symptoms O 0 0.00018257033661939204
in O 0 2.5472600029274872e-08
two O 0 1.0771258329711486e-09
probands O 0 0.00020130988559685647
prompted O 0 2.398353728949587e-07
us O 0 1.9697087016989911e-10
to O 0 5.3726956911193113e-11
search O 0 9.566277769934572e-10
for O 0 2.4933194398002456e-10
mutations O 0 7.047830763440288e-09
within O 0 2.4658771025087844e-08
their O 0 1.6188735685318534e-07
POMC O 1 0.818160891532898
genes O 0 9.82398205451318e-07
. O 0 2.6790038987201115e-07

Patient O 0 0.00017728694365359843
1 O 0 5.687031148227106e-07
was O 0 3.7028001997896354e-08
found O 0 2.836834933628296e-10
to O 0 2.5576990178577397e-11
be O 0 5.425327548325143e-11
a O 0 1.192262122362564e-10
compound O 0 1.9281971574969248e-08
heterozygote O 0 2.6165304234382347e-07
for O 0 3.2311892050884694e-10
two O 0 1.3577264312836235e-10
mutations O 0 3.915575086388401e-10
in O 0 1.5221608418158894e-09
exon O 0 9.180998716828981e-08
3 O 0 1.464758891955853e-08
( O 0 6.173116878782636e-11
G7013T O 0 3.988978960478562e-07
, O 0 6.500903704242944e-10
C7133delta O 0 1.9001943201146787e-06
) O 0 3.993440647609425e-11
which O 0 1.0796545948932312e-11
interfere O 0 4.6353535593235407e-11
with O 0 2.7529471757770096e-12
appropriate O 0 5.408685166408134e-10
synthesis O 0 1.119658232795473e-08
of O 0 4.191518954144158e-08
ACTH O 0 3.1738543384562945e-06
and O 0 4.75773731523077e-08
alpha O 0 2.453188699291786e-06
- O 0 2.547348458392662e-06
MSH O 0 0.0025830822996795177
. O 0 8.485723697049252e-07

Patient O 0 0.0008083804859779775
2 O 0 3.46970637110644e-07
was O 0 2.440353519261862e-08
homozygous O 0 3.6696548022518982e-09
for O 0 1.3480087879269576e-10
a O 0 9.021940833298103e-11
mutation O 0 5.302474015422831e-10
in O 0 7.16083525809097e-10
exon O 0 9.532553946201006e-08
2 O 0 1.0019662433080612e-08
( O 0 6.372997962689197e-11
C3804A O 0 1.5723450985660747e-07
) O 0 1.1084653334103578e-10
which O 0 1.0909206871190236e-09
abolishes O 0 1.2022964256175328e-05
POMC O 0 0.05701894313097
translation O 0 2.9996801913512172e-06
. O 0 3.873802256748604e-07

These O 0 5.0477083846089954e-08
findings O 0 2.3470487775512083e-08
represent O 0 6.985714784413233e-10
the O 0 2.9974953075218025e-10
first O 0 1.653439746229779e-10
examples O 0 1.1440057789968705e-09
of O 0 2.2795489940108382e-09
a O 0 4.577913159664604e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 9.889550511843481e-08
the O 0 3.931114278543646e-08
POMC O 0 8.11788413557224e-05
gene O 0 7.699559323448568e-10
and O 0 1.6192148316607202e-11
define O 0 1.1644701869428786e-10
a O 0 1.2067878640831253e-10
new O 0 6.565496732946485e-06
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9991160035133362
resulting O 0 3.4488763844819914e-07
in O 0 4.702691125402225e-09
early O 0 5.4030144383432344e-05
- O 0 1.6470556147396564e-05
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 0 8.708955192560097e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 3.1981735446606763e-06
red O 0 5.3584961278829724e-05
hair O 0 1.2438890450994222e-07
pigmentation O 0 2.305806447111536e-06
. O 0 1.4974741446849293e-08
. O 0 5.7834743216744755e-08

A O 0 7.246916311487439e-07
European O 0 5.479402034325176e-07
multicenter O 0 3.5290097002871335e-05
study O 0 2.158617640191096e-08
of O 0 9.058833825292822e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.7282632214232763e-08
classification O 0 1.1537662203409127e-06
of O 0 2.0900667152545793e-07
105 O 0 1.1282180594207603e-06
mutations O 0 1.541872851618109e-09
and O 0 1.451175846156616e-10
a O 0 9.639573167463666e-11
general O 0 4.2930629717830016e-08
system O 0 6.920773731877716e-09
for O 0 3.54482332376449e-10
genotype O 0 4.137979559004634e-08
- O 0 6.400461938227409e-09
based O 0 1.0812569728457788e-09
prediction O 0 1.474096791298507e-07
of O 0 3.2600511179481373e-09
metabolic O 0 8.614354737801477e-05
phenotype O 0 4.207830443192506e-06
. O 0 7.595377127245229e-08

Phenylketonuria B-Disease 1 0.9993461966514587
( O 0 6.3434947605856e-07
PKU B-Disease 1 0.999839186668396
) O 0 5.956279025554068e-09
and O 0 4.296665245817621e-09
mild B-Disease 1 0.9999723434448242
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.8108190894126892
MHP B-Disease 1 1.0
) O 0 3.217484589868036e-08
are O 0 2.1858630461224493e-08
allelic B-Disease 1 0.9999974966049194
disorders I-Disease 1 0.932475745677948
caused O 0 7.63347216548027e-08
by O 0 2.7773545685505496e-09
mutations O 0 2.2862634008191662e-09
in O 0 2.673992416379889e-10
the O 0 5.243457890102832e-10
gene O 0 2.838068946520167e-10
encoding O 0 2.1942467398616827e-08
phenylalanine O 0 2.085158121190034e-05
hydroxylase O 0 0.0011271432740613818
( O 0 5.833495109186515e-08
PAH O 1 1.0
) O 0 6.214781933522318e-08
. O 0 2.1308912323547702e-07

Previous O 0 5.435104412754299e-06
studies O 0 4.797669106437752e-08
have O 0 8.211688273807027e-11
suggested O 0 2.2662215160007548e-10
that O 0 1.8184697454445842e-12
the O 0 2.1347855427844564e-10
highly O 0 2.335122140095791e-08
variable O 0 1.5897236949058424e-07
metabolic O 0 0.06442956626415253
phenotypes O 0 0.00025256717344745994
of O 0 0.0599486380815506
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 7.967528654262424e-05
with O 0 1.0319615739717847e-06
PAH O 1 1.0
genotypes O 1 0.9724492430686951
. O 0 2.557472271291772e-06

We O 0 2.652576824857533e-07
identified O 0 6.374003191922384e-08
both O 0 5.129699776063035e-09
causative O 0 1.148022647612379e-06
mutations O 0 2.4085238692350686e-07
in O 0 3.784209212653877e-08
686 O 0 5.0626604206627235e-05
patients O 0 9.523587323201355e-06
from O 0 6.829949050768391e-09
seven O 0 6.062841340082059e-09
European O 0 7.574718097203004e-08
centers O 0 1.4122799996130198e-07
. O 0 4.907902706463574e-08

On O 0 2.4769505557742377e-07
the O 0 2.233774942794753e-09
basis O 0 1.5290017030267222e-09
of O 0 4.860156166408558e-10
the O 0 5.171251760138773e-10
phenotypic O 0 1.9397168316004354e-08
characteristics O 0 2.1084528611936548e-07
of O 0 3.9232872950378805e-07
297 O 0 9.227465511685295e-07
functionally O 0 8.64817479850899e-08
hemizygous O 0 4.170393367530778e-06
patients O 0 1.3437980328490085e-07
, O 0 4.951731386038105e-11
105 O 0 1.2589111975103151e-08
of O 0 5.879701725497455e-10
the O 0 3.347585264545927e-10
mutations O 0 1.0407388839617226e-10
were O 0 1.2781301017561475e-10
assigned O 0 6.798489549098008e-11
to O 0 3.17839400632014e-11
one O 0 5.763028249061719e-11
of O 0 4.4505060747823677e-10
four O 0 1.6904785904436892e-10
arbitrary O 0 5.5156803568934265e-09
phenotype O 0 4.2924983745251666e-07
categories O 0 1.9398099482259568e-07
. O 0 6.253844020420729e-08

We O 0 1.2566566454097483e-07
proposed O 0 2.303752779653223e-07
and O 0 2.675646815220034e-09
tested O 0 1.313492337118305e-08
a O 0 9.185522481525155e-11
simple O 0 5.452489015844719e-10
model O 0 1.5932091756987177e-10
for O 0 2.814209629220521e-11
correlation O 0 1.961962120544669e-10
between O 0 4.97084873263276e-10
genotype O 0 1.0908925673902559e-07
and O 0 9.43110589624041e-10
phenotypic O 0 8.126579587042215e-08
outcome O 0 1.1470955541881267e-05
. O 0 1.2452128430595621e-06

The O 0 3.1222606367009575e-07
observed O 0 6.508912520075683e-08
phenotype O 0 2.3165925711055024e-07
matched O 0 1.1493214202573654e-07
the O 0 5.159136229337946e-09
predicted O 0 2.5130736602818615e-08
phenotype O 0 4.955943566642418e-08
in O 0 3.0133048833924647e-10
79 O 0 3.1247726628436112e-09
% O 0 6.026089783423005e-12
of O 0 1.652572002852626e-11
the O 0 2.5571329775875284e-11
cases O 0 1.1625859996922117e-10
, O 0 6.216693826388564e-11
and O 0 7.414766023394748e-11
in O 0 1.0160583485685493e-10
only O 0 2.0475976816869412e-11
5 O 0 1.0260978872134174e-10
of O 0 9.42854821994743e-11
184 O 0 4.9113837441439046e-09
patients O 0 2.9193325534748737e-09
was O 0 2.351128181032891e-10
the O 0 1.7610075897511734e-10
observed O 0 4.70955552334118e-10
phenotype O 0 1.631072721330895e-09
more O 0 9.363756298119696e-12
than O 0 1.643493847958144e-11
one O 0 1.7721190834207867e-11
category O 0 5.756000120982208e-10
away O 0 2.505055329837802e-10
from O 0 5.4190294612732615e-11
that O 0 1.1390251589138423e-11
expected O 0 3.291015460149538e-08
. O 0 1.382446157549566e-07

Among O 0 1.6255628452199744e-06
the O 0 2.0387428634194293e-08
seven O 0 1.0048729626177533e-09
contributing O 0 7.609334273794843e-10
centers O 0 1.4166816608707222e-09
, O 0 8.747763798055974e-12
the O 0 4.715854790005025e-11
proportion O 0 9.901885977825486e-10
of O 0 1.432214125074438e-09
patients O 0 6.4171965519221885e-09
for O 0 1.952405598304452e-10
whom O 0 9.290985203413982e-10
the O 0 6.148689890572712e-10
observed O 0 4.458237390370101e-10
phenotype O 0 3.461382069858132e-09
did O 0 8.906973075761826e-11
not O 0 8.671000549520524e-12
match O 0 1.4935768177792852e-09
the O 0 5.622587395670564e-10
predicted O 0 3.1735145622491245e-09
phenotype O 0 2.5911599532690843e-09
was O 0 3.01898311905191e-10
4 O 0 1.579300856757726e-10
% O 0 5.909354602873229e-12
- O 0 8.876428758686217e-11
23 O 0 5.357216337209536e-10
% O 0 4.156959151901951e-11
( O 0 8.838698870028416e-12
P O 0 1.2593487497269962e-07
< O 0 1.3391330710987859e-08
. O 0 2.4643934115609056e-10
0001 O 0 9.069572826092553e-08
) O 0 2.1600929378529088e-11
, O 0 2.0187268523486068e-11
suggesting O 0 5.085469267918086e-10
that O 0 1.586543049714173e-11
differences O 0 2.3320676501015214e-09
in O 0 2.2632497265195894e-10
methods O 0 2.1597450494681425e-09
used O 0 3.32556593374278e-10
for O 0 2.2868859583802248e-10
mutation O 0 2.4842348178566453e-09
detection O 0 1.6227269838964276e-07
or O 0 7.716996486273331e-10
phenotype O 0 1.066408898964255e-07
classification O 0 8.484754943083317e-08
may O 0 3.000000525776869e-10
account O 0 2.172480251250164e-11
for O 0 4.215217584702113e-12
a O 0 9.798563002649807e-12
considerable O 0 9.679891332936563e-10
proportion O 0 3.111450652681924e-09
of O 0 9.542246104388141e-09
genotype O 0 2.6193187295575626e-05
- O 0 7.121892849681899e-05
phenotype O 0 4.341771636973135e-05
inconsistencies O 0 1.5752043509564828e-06
. O 0 1.1044571124330105e-07

Our O 0 1.0376537602496683e-06
data O 0 1.937771898496976e-08
indicate O 0 4.5476622467788275e-09
that O 0 2.5533998526672264e-11
the O 0 9.584966598197298e-09
PAH O 1 1.0
- O 0 1.1666959835565649e-05
mutation O 0 5.301505456856148e-09
genotype O 0 2.8368580817783595e-09
is O 0 3.133049646542735e-13
the O 0 9.863606242541123e-13
main O 0 2.0324433802620945e-10
determinant O 0 1.4321056340804716e-08
of O 0 1.3069200832660499e-08
metabolic O 1 0.9998160004615784
phenotype O 0 3.2805978662509006e-06
in O 0 1.1657952381227688e-09
most O 0 1.733237109391439e-09
patients O 0 2.305286699311182e-07
with O 0 4.273236129392899e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9514130353927612

In O 0 2.4284991795298083e-08
the O 0 1.1962809631782534e-09
present O 0 4.2259526433774397e-10
study O 0 2.2602557325779316e-10
, O 0 3.6375104317531992e-12
the O 0 1.5808944431316974e-11
classification O 0 3.645407886665453e-08
of O 0 1.0541798900476351e-07
105 O 0 0.0002966249012388289
PAH O 1 1.0
mutations O 0 1.1121517928813773e-07
may O 0 8.69114391566228e-10
allow O 0 4.854548360522237e-11
the O 0 2.1328767918493696e-10
prediction O 0 1.5823809818016343e-08
of O 0 4.5652759350645056e-10
the O 0 3.7125838514562304e-10
biochemical O 0 2.9748409957619515e-08
phenotype O 0 9.334988781972697e-09
in O 0 1.7254288275925234e-10
> O 0 1.4227345523920576e-08
10 O 0 4.981678403126466e-10
, O 0 2.7447745465369877e-11
000 O 0 3.394361680619795e-09
genotypes O 0 4.2301504521446986e-08
, O 0 3.2706979485874754e-11
which O 0 2.0844923009910588e-12
may O 0 2.4514812055342894e-11
be O 0 4.581155333555076e-12
useful O 0 6.190213619472473e-11
for O 0 1.298638453717249e-11
the O 0 2.9671198831238144e-10
management O 0 1.794672965793609e-09
of O 0 5.653194801169548e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.226915739811375e-06
newborns O 0 2.169412800867576e-05
. O 0 4.060421332496844e-08

Somatic O 0 0.00013188671437092125
instability O 0 6.281075570768735e-07
of O 0 6.688376288366271e-07
the O 0 1.7708500763546908e-06
CTG O 1 0.9997758269309998
repeat O 0 3.2593118248769315e-06
in O 0 1.1318071813093411e-07
mice O 0 6.748577874304829e-08
transgenic O 0 8.629852032981944e-08
for O 0 3.160857131589978e-10
the O 0 1.3408835002337582e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.3339566723734606e-06
is O 0 1.0873699163305162e-10
age O 0 1.0879720457879216e-09
dependent O 0 1.0028868013822745e-10
but O 0 3.2756219611740356e-12
not O 0 2.5375996876714213e-12
correlated O 0 3.5749772586690653e-10
to O 0 1.5992610014059494e-11
the O 0 2.959207323627311e-10
relative O 0 9.527754940563682e-08
intertissue O 0 8.787244951236062e-06
transcription O 0 3.8861904272380343e-07
levels O 0 3.173111338128365e-07
and O 0 1.0322706245347035e-08
proliferative O 0 0.005928670987486839
capacities O 0 1.0176042451348621e-05
. O 0 1.4795898550801212e-06

A O 0 2.8701339033432305e-05
( O 0 4.824905985856276e-08
CTG O 0 7.575587369501591e-05
) O 0 3.339742482566521e-09
nexpansion O 0 5.2504856284940615e-06
in O 0 2.4510347085282547e-09
the O 0 1.8313301985983799e-09
3 O 0 7.25722593131195e-09
- O 0 3.124011271893323e-08
untranslated O 1 0.7244716286659241
region O 0 6.91976040911868e-08
( O 0 1.4543846682535388e-10
UTR O 0 0.06842553615570068
) O 0 4.2603462424573024e-11
of O 0 2.8148456898691165e-09
the O 0 9.978433013202448e-08
DM O 1 1.0
protein O 0 2.921084103491012e-07
kinase O 0 2.2494202056577706e-08
gene O 0 2.814942501316864e-09
( O 0 7.454286493624451e-11
DMPK O 1 0.9955066442489624
) O 0 7.262951351449942e-11
is O 0 4.988176972170466e-12
responsible O 0 4.464072514420714e-11
for O 0 2.6400079344846006e-10
causing O 0 0.0003015032852999866
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.016657723899698e-06
DM B-Disease 1 1.0
) O 0 3.6319644181048716e-08
. O 0 8.442523835583415e-08

Major O 0 0.00011394394095987082
instability O 0 9.285976148021291e-07
, O 0 2.1346850953563035e-09
with O 0 8.79964504041375e-11
very O 0 1.2172352015227261e-09
large O 0 9.683104318369828e-10
expansions O 0 1.1031175972675555e-08
between O 0 4.407392228955587e-09
generations O 0 9.746334939109147e-08
and O 0 2.2386149878261818e-10
high O 0 1.970897223202428e-09
levels O 0 4.689549304437435e-10
of O 0 2.936621223970093e-10
somatic O 0 6.809036108279543e-07
mosaicism O 0 4.264680228516227e-06
, O 0 4.734302880282648e-11
is O 0 9.682687811263246e-12
observed O 0 4.671399933542375e-10
in O 0 1.9071428880579333e-09
patients O 0 1.6386641732424323e-07
. O 0 4.319271695862881e-08

There O 0 2.368224194526647e-08
is O 0 3.0728192212947647e-10
a O 0 1.9867255063310552e-10
good O 0 1.4887161503551738e-09
correlation O 0 1.8188982264799591e-10
between O 0 1.063691426606006e-10
repeat O 0 6.228470517122275e-10
size O 0 1.365877855263875e-09
( O 0 7.143394382957968e-12
at O 0 2.5697294292470474e-10
least O 0 2.7434976165863212e-11
in O 0 9.626693886488624e-11
leucocytes O 0 1.8578219851406175e-07
) O 0 2.0621502769269107e-11
, O 0 1.0100004166346821e-11
clinical O 0 8.858319078264287e-10
severity O 0 5.3451884696187335e-08
and O 0 1.3828563849571651e-09
age O 0 8.11959210977875e-08
of O 0 1.945845973239102e-08
onset O 0 0.0005760481581091881
. O 0 1.3174362720747013e-06

The O 0 3.609470877563581e-05
trinucleotide O 0 0.08365506678819656
repeat O 0 1.326360347775335e-06
instability O 0 6.017992291162955e-07
mechanisms O 0 9.1964736270711e-08
involved O 0 3.4526519421262947e-09
in O 0 7.464853979399777e-08
DM B-Disease 1 1.0
and O 0 3.0195274121069815e-06
other O 0 4.004606068974681e-08
human O 0 5.277220225252677e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.900642754293358e-09
unknown O 0 1.890567631335216e-07
. O 0 1.4498770184445675e-08

We O 0 1.0083681445394177e-07
studied O 0 3.142688171919872e-07
somatic O 0 3.40265842169174e-06
instability O 0 1.5966056921001837e-08
by O 0 4.4415848776679923e-10
measuring O 0 1.4402529302515177e-07
the O 0 5.714841222470568e-08
CTG O 0 1.859681105997879e-05
repeat O 0 6.180899347896229e-09
length O 0 8.556236830159492e-10
at O 0 4.802819253413304e-10
several O 0 4.6425207428368864e-11
ages O 0 2.3577353402970402e-09
in O 0 5.606104816480162e-11
various O 0 5.18463327825458e-10
tissues O 0 2.457739789463176e-08
of O 0 3.466755416070555e-08
transgenic O 0 3.598948069338803e-06
mice O 0 3.961642125460685e-09
carrying O 0 1.3014708755143545e-10
a O 0 5.185244247862819e-11
( O 0 7.65433966209983e-11
CTG O 0 1.8724676920101047e-06
) O 0 3.3506514229841855e-10
55expansion O 0 9.506214269094926e-07
surrounded O 0 1.213438682867718e-08
by O 0 2.189779330086239e-10
45 O 0 6.624121251519455e-09
kb O 0 9.579651560898128e-08
of O 0 1.1862069548840282e-08
the O 0 3.1771563158145e-08
human O 0 5.380231371532318e-08
DM B-Disease 1 1.0
region O 0 2.795474074446247e-07
, O 0 5.822758941675943e-11
using O 0 7.597220769151036e-11
small O 0 7.113041267103881e-10
- O 0 8.616837909869446e-09
pool O 0 7.839859961222828e-08
PCR O 0 8.078683890744287e-07
. O 0 1.8474402452284266e-07

These O 0 5.550939931708854e-06
mice O 0 1.364500690215209e-06
have O 0 4.4135983756632413e-10
been O 0 1.4783646529181738e-10
shown O 0 2.8718229183599675e-11
to O 0 2.1970744668031728e-11
reproduce O 0 1.0745956346980279e-09
the O 0 1.3091373540774498e-09
intergenerational O 0 6.800182639210561e-09
and O 0 1.9413953777913662e-10
somatic O 0 1.2277405403438024e-07
instability O 0 2.0664085997879056e-09
of O 0 1.7209071945245569e-09
the O 0 5.3877764472076706e-09
55 O 0 6.105979366566316e-08
CTG O 0 1.5725141565781087e-05
repeat O 0 2.2326389625959564e-08
suggesting O 0 3.267165871179145e-09
that O 0 1.224099814567392e-11
surrounding O 0 4.993925273311106e-09
sequences O 0 9.060759087464731e-11
and O 0 5.961444532465165e-11
the O 0 5.46422240788047e-10
chromatin O 0 3.225534328521462e-07
environment O 0 1.5122134300327161e-07
are O 0 1.9851496835254778e-10
involved O 0 3.077593735412165e-10
in O 0 9.745675377814678e-10
instability O 0 1.4100810119543894e-07
mechanisms O 0 2.6407569748698734e-06
. O 0 4.745973001263337e-07

As O 0 1.2121668646614125e-07
observed O 0 1.465057852811924e-08
in O 0 3.427238770559171e-10
some O 0 4.1589100219230346e-11
of O 0 3.1656599563945065e-10
the O 0 4.706358636141772e-10
tissues O 0 1.2644171931697201e-08
of O 0 2.677282395779912e-07
DM B-Disease 1 1.0
patients O 1 0.9993327260017395
, O 0 5.324727464506296e-11
there O 0 9.81843079062017e-12
is O 0 2.76130333876079e-12
a O 0 9.252000207626843e-12
tendency O 0 4.785618568092787e-10
for O 0 1.2046698361078967e-10
repeat O 0 6.638511407253134e-10
length O 0 8.73027039549612e-10
and O 0 5.141863046453921e-10
somatic O 0 2.095151643288773e-07
mosaicism O 0 4.1482931578684656e-07
to O 0 3.9592207984329164e-11
increase O 0 1.1473304944997764e-11
with O 0 5.141093280258691e-12
the O 0 2.727824355286401e-10
age O 0 4.461148783718727e-09
of O 0 1.2074515831628219e-09
the O 0 9.882419327311709e-09
mouse O 0 1.792519128684944e-07
. O 0 2.18210569613575e-08

Furthermore O 0 1.961659336302546e-06
, O 0 4.215046978117698e-09
we O 0 1.416451261837537e-10
observed O 0 1.3611178850680972e-10
no O 0 2.2993456097464282e-11
correlation O 0 5.999577917803478e-11
between O 0 7.422421011149538e-11
the O 0 1.6929253554565094e-09
somatic O 0 2.9589195946755353e-06
mutation O 0 6.432835419900584e-08
rate O 0 1.49958054862509e-08
and O 0 3.130199432987979e-10
tissue O 0 8.262635020628295e-08
proliferation O 0 9.586283340468071e-07
capacity O 0 2.445955544772005e-07
. O 0 1.5646833162463736e-07

The O 0 1.0300902886228869e-06
somatic O 0 2.1065419787191786e-05
mutation O 0 8.128625950121204e-08
rates O 0 5.20248644164667e-09
in O 0 3.109970267423101e-11
different O 0 1.6913614606095528e-11
tissues O 0 3.782331337021105e-09
were O 0 8.891734570859455e-10
also O 0 5.761728334024996e-12
not O 0 8.210493916693817e-12
correlated O 0 1.2990484243857736e-09
to O 0 1.3395558273732178e-10
the O 0 4.6750119331306905e-09
relative O 0 1.0975518307532184e-06
inter O 0 3.864805648845504e-07
- O 0 1.2800568072179885e-07
tissue O 0 4.1772171499587785e-08
difference O 0 1.853327491474488e-09
in O 0 1.6675612279914986e-11
transcriptional O 0 2.5671526016068924e-10
levels O 0 6.576518774004114e-10
of O 0 2.71228622894526e-10
the O 0 3.9012620911549334e-10
three O 0 1.162552762390412e-10
genes O 0 1.7750055592014036e-10
( O 0 2.8007474811575506e-11
DMAHP O 0 0.1700410395860672
, O 0 4.912395823453153e-09
DMPK O 1 0.9971407651901245
and O 0 1.1169855262949113e-08
59 O 0 3.326704600681296e-08
) O 0 3.508612150815438e-11
surrounding O 0 2.3445968722057842e-08
the O 0 1.1331869664843452e-08
repeat O 0 3.0839309772545676e-08
. O 0 1.281409733877581e-08
. O 0 4.354933480499312e-08

A O 0 3.338921032991493e-06
novel O 0 6.629218660236802e-06
missense O 0 1.6119829524541274e-05
mutation O 0 8.843809240488554e-08
in O 0 1.867831223023586e-09
patients O 0 1.3145675659131939e-08
from O 0 4.419848931291881e-10
a O 0 1.3046353997125948e-09
retinoblastoma B-Disease 0 0.04948614910244942
pedigree O 0 2.876814869523514e-05
showing O 0 2.4443506774218804e-08
only O 0 4.210697901463334e-10
mild O 0 4.2533787336651585e-07
expression O 0 1.5227596961153722e-08
of O 0 2.359954542896503e-08
the O 0 3.8377145017420844e-08
tumor B-Disease 0 2.03944864551886e-06
phenotype O 0 3.255082390296593e-07
. O 0 2.985185787451883e-08

We O 0 1.7913126271196234e-07
have O 0 6.282627196263491e-10
used O 0 1.5973199152252704e-10
single O 0 5.562215132925985e-10
strand O 0 1.0460730059946854e-09
conformation O 0 1.1822418044538097e-10
polymorphism O 0 7.07084807372027e-11
analysis O 0 8.096409827296203e-12
to O 0 5.420329116101463e-12
study O 0 4.464472541654274e-11
the O 0 1.8436729920523476e-10
27 O 0 1.1763519935925615e-08
exons O 0 1.940819771562019e-08
of O 0 9.439317771864353e-09
the O 0 5.170122818753953e-08
RB1 O 0 1.6103635061881505e-05
gene O 0 7.017832981404126e-10
in O 0 5.955943377378148e-11
individuals O 0 6.170547146161498e-12
from O 0 2.290168332752529e-10
a O 0 6.81551370895761e-10
family O 0 1.0591671983917195e-09
showing O 0 4.94252683225227e-09
mild O 0 4.32565093433368e-06
expression O 0 1.5688701182625664e-07
of O 0 3.7649010664608795e-07
the O 0 2.924071793586336e-07
retinoblastoma B-Disease 0 0.0002317792095709592
phenotype O 0 1.1425209777371492e-05
. O 0 1.2986805586479022e-07

In O 0 5.4320768327897895e-08
this O 0 3.6412710624489364e-09
family O 0 5.6663753689178975e-09
affected O 0 7.475237318033123e-09
individuals O 0 3.574493201430329e-10
developed O 0 3.0749558845855063e-06
unilateral B-Disease 1 0.9584975838661194
tumors I-Disease 1 1.0
and O 0 4.375734533823561e-06
, O 0 3.089863087613054e-10
as O 0 3.957642893959168e-11
a O 0 2.7399924776988493e-12
result O 0 4.271624026719323e-11
of O 0 2.7518265444115286e-10
linkage O 0 9.126691624672389e-10
analysis O 0 7.682040420453617e-11
, O 0 9.640836740043568e-12
unaffected O 0 1.1478881845050637e-08
mutation O 0 9.65420632326186e-10
carriers O 0 7.102060606278826e-10
were O 0 5.658769564043098e-10
also O 0 1.8460049461266337e-11
identified O 0 1.4656181823724523e-10
within O 0 5.119726864677432e-10
the O 0 8.910618021218397e-09
pedigree O 0 4.510787221079227e-06
. O 0 2.9860976269446837e-07

A O 0 6.348535634970176e-07
single O 0 1.2148884565021945e-08
band O 0 1.0026410812713493e-08
shift O 0 4.1839287590050844e-09
using O 0 1.1264973398539269e-09
SSCP O 0 0.007535036187618971
was O 0 4.2864112259621834e-08
identified O 0 1.6912856670714405e-09
in O 0 1.3702433632190036e-09
exon O 0 1.24810853208146e-07
21 O 0 6.248725981095049e-09
which O 0 1.3481726152120288e-11
resulted O 0 6.5591336806392064e-09
in O 0 2.0190524807617294e-09
a O 0 2.047490399448293e-09
missense O 0 4.912211011287582e-07
mutation O 0 7.175468219600134e-09
converting O 0 7.081628439209453e-08
a O 0 1.3832124334811624e-09
cys O 0 1.3564667824539356e-06
- O 0 7.636560184209884e-08
- O 0 4.598989633564088e-08
> O 0 8.222090741583088e-08
arg O 0 2.4079144012034703e-08
at O 0 2.74849032422253e-10
nucleotide O 0 4.4039447089083694e-10
position O 0 1.1467388150165903e-09
28 O 0 5.329569230383413e-09
in O 0 6.045286493616686e-10
the O 0 8.098754555874166e-09
exon O 0 1.4363999980560038e-06
. O 0 1.0129019045734822e-07

The O 0 1.1346855899319053e-06
mutation O 0 5.413329517978127e-07
destroyed O 0 4.7102346911742643e-07
an O 0 7.815411651179716e-10
NdeI O 0 5.229089947533794e-05
restriction O 0 6.667488833045354e-06
enzyme O 0 1.0416812301627942e-06
site O 0 4.418834294028784e-07
. O 0 8.782186000644288e-08

Analysis O 0 3.84680163278972e-08
of O 0 1.674014384889233e-07
all O 0 1.749559430663794e-08
family O 0 4.124802277516437e-09
members O 0 8.159307951505212e-11
demonstrated O 0 6.404451413644097e-10
that O 0 1.1449213972725136e-11
the O 0 2.8979569854925558e-09
missense O 0 7.113685001058911e-07
mutation O 0 4.685208665478058e-08
co O 0 4.9551779568446364e-08
- O 0 6.651101784882485e-07
segregated O 0 1.9122474270716339e-07
with O 0 9.485801033548569e-11
patients O 0 1.6432414895461989e-06
with O 0 9.144644153025183e-09
tumors B-Disease 1 1.0
or O 0 9.093010885408148e-05
who O 0 1.1363709084832863e-08
, O 0 1.9938842243938382e-11
as O 0 2.07981513955513e-11
a O 0 2.056163616107054e-12
result O 0 1.881818312288175e-11
of O 0 6.710604849580193e-10
linkage O 0 7.914432997857546e-10
analysis O 0 1.1705494906699698e-10
had O 0 6.553162873457197e-11
been O 0 7.69000071954018e-11
predicted O 0 2.190247982980509e-09
to O 0 1.3095337314528166e-10
carry O 0 1.3173706570057675e-09
the O 0 5.396940228052927e-09
predisposing O 0 6.033794306858908e-06
mutation O 0 4.456894657778321e-07
. O 0 1.0499758928972369e-07

These O 0 2.7460565377168678e-08
observations O 0 6.6323792680123e-08
point O 0 1.059369747480332e-08
to O 0 6.55272502925186e-11
another O 0 3.167012763150012e-10
region O 0 1.7097865345760965e-09
of O 0 1.5775261985595534e-08
the O 0 1.10594534419306e-07
RB1 O 0 2.7078931452706456e-05
gene O 0 3.4794394032644504e-09
where O 0 1.3424288347607671e-09
mutations O 0 1.177019592901729e-10
only O 0 4.310006865293481e-11
modify O 0 1.0654157556189148e-09
the O 0 7.948061653273442e-10
function O 0 1.0969166547303288e-10
of O 0 3.956220684386835e-09
the O 0 9.91114523785086e-10
gene O 0 1.6989928908195395e-10
and O 0 1.3387768671435651e-10
raise O 0 4.887187876612131e-10
important O 0 5.553151827264458e-10
questions O 0 2.189483705450357e-09
for O 0 1.2942376337310435e-10
genetic O 0 4.2580133197134273e-08
counseling O 0 5.426999294400048e-09
in O 0 1.0623531915276985e-10
families O 0 1.1093721427601899e-11
with O 0 4.935764470748172e-12
these O 0 3.8565026172499017e-10
distinctive O 0 3.874266951697791e-08
phenotypes O 0 5.428947815744323e-07
. O 0 1.6554103865473735e-08
. O 0 4.404755671316707e-08

Maternal B-Disease 0 0.0003031525411643088
disomy I-Disease 0 0.0021825884468853474
and O 0 7.989561709109694e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 3.95154747820925e-05
with O 0 1.1891332363234142e-09
gamete O 0 7.562287578366522e-07
complementation O 0 0.18411625921726227
in O 0 2.0989217031086582e-09
a O 0 5.036621814058506e-11
case O 0 1.2549452588217491e-09
of O 0 2.7264645652280706e-08
familial O 0 6.484043524324079e-07
translocation O 0 1.748190584294207e-06
( O 0 6.18804174568055e-11
3 O 0 4.417590460104037e-10
; O 0 1.1016714450418075e-11
15 O 0 1.9257841155084776e-10
) O 0 5.9755915493564515e-12
( O 0 1.3466716457244399e-11
p25 O 0 7.58726912408747e-08
; O 0 1.3517652275307768e-10
q11 O 0 1.1317099790630891e-07
. O 0 5.657053159247027e-10
2 O 0 3.892894451240636e-09
) O 0 2.036502216862246e-10
. O 0 1.0856405552317483e-08

Maternal B-Disease 1 0.9530083537101746
uniparental I-Disease 1 0.9999997615814209
disomy I-Disease 1 0.9999996423721313
( I-Disease 0 1.6917274479055777e-06
UPD I-Disease 1 1.0
) I-Disease 0 3.815153082342704e-09
for I-Disease 0 9.79733960626561e-10
chromosome I-Disease 0 5.054331397857936e-10
15 I-Disease 0 3.5513131324549363e-10
is O 0 3.4893765394478082e-12
responsible O 0 1.74546384290597e-11
for O 0 4.635583583656455e-11
an O 0 5.708108031382553e-12
estimated O 0 1.6869571711763953e-11
30 O 0 3.845174872951773e-11
% O 0 1.3267616172374375e-12
of O 0 1.6594441749548383e-12
cases O 0 2.792117578809261e-11
of O 0 2.502813742921717e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0018202299252152443
PWS B-Disease 1 1.0
) O 0 1.6957894644065163e-08
. O 0 3.4828271822107126e-08

We O 0 6.318276035699455e-08
report O 0 1.565849228057914e-09
on O 0 6.650247019734934e-10
an O 0 2.059217163105642e-12
unusual O 0 1.0767493147101348e-10
case O 0 5.939078118188945e-10
of O 0 1.543827643502027e-08
maternal B-Disease 0 4.5789297473675106e-06
disomy I-Disease 0 0.038700275123119354
15 I-Disease 0 3.693412509164773e-07
in O 0 1.723167031286721e-07
PWS B-Disease 1 1.0
that O 0 4.1778822068572197e-10
is O 0 4.1979694026528236e-11
most O 0 1.1031418140072802e-10
consistent O 0 5.775179223732607e-10
with O 0 7.007085883747877e-12
adjacent O 0 2.720094816055507e-09
- O 0 1.068659938319172e-09
1 O 0 2.9375133436815304e-09
segregation O 0 1.0464941135879258e-09
of O 0 1.2953194072906626e-10
a O 0 8.644534393864589e-11
paternal O 0 7.530177725811882e-08
t O 0 3.936131864890058e-09
( O 0 5.152146504566746e-12
3 O 0 1.8077821184458998e-10
; O 0 7.760324501060456e-12
15 O 0 1.0035986625078763e-10
) O 0 5.2997385126263286e-12
( O 0 1.0861131438666405e-11
p25 O 0 7.014708103270095e-08
; O 0 1.0129874716824361e-10
q11 O 0 4.714296863994605e-08
. O 0 8.642918325474369e-11
2 O 0 2.1094678781530263e-10
) O 0 1.2101819112791956e-12
with O 0 2.9683621012577266e-12
simultaneous O 0 6.198438984306165e-10
maternal O 0 2.520116026971664e-07
meiotic O 0 7.967776582518127e-06
nondisjunction O 0 0.00022433206322602928
for O 0 9.665859579399694e-08
chromosome O 0 4.59683242581832e-08
15 O 0 2.983973246273308e-08
. O 0 3.450678676131247e-08

The O 0 2.2570200144400587e-06
patient O 0 5.280384357320145e-06
( O 0 3.7994365986726564e-10
J O 0 2.718359439768392e-07
. O 0 1.1071024652586914e-10
B O 0 9.99099825094163e-09
. O 0 1.2612254990385097e-12
) O 0 2.0820872153118342e-13
, O 0 1.041589882920524e-12
a O 0 5.666529311748603e-12
17 O 0 2.35059027797746e-10
- O 0 2.3230807555396638e-10
year O 0 3.0039641885082347e-09
- O 0 2.1994592813712188e-08
old O 0 8.27894695021314e-08
white O 0 1.3150986966081746e-09
male O 0 6.65002705679818e-11
with O 0 1.038596812719117e-11
PWS B-Disease 1 1.0
, O 0 4.049792057259083e-09
was O 0 1.1998829485548868e-08
found O 0 3.704145878913323e-10
to O 0 1.9643510429379063e-10
have O 0 5.896940713512322e-10
47 O 0 6.84147538621005e-09
chromosomes O 0 1.4761669664409283e-10
with O 0 1.0417750863356279e-11
a O 0 3.663163383738066e-10
supernumerary O 0 1.7870313513412839e-06
, O 0 4.978316092696389e-10
paternal O 0 2.3223438461172918e-07
der O 0 3.6112487578066066e-07
( O 0 1.4288456702538088e-11
15 O 0 8.876174795169334e-11
) O 0 5.023338515985909e-13
consisting O 0 2.069100273061064e-11
of O 0 1.1479133615877046e-10
the O 0 1.5338330605629835e-09
short O 0 1.6920802536901647e-08
arm O 0 1.1476736894167061e-08
and O 0 9.952915158706332e-10
the O 0 4.3417383466248793e-08
proximal O 1 0.7475945949554443
long O 0 2.432496557958075e-06
arm O 0 2.4216120664277696e-08
of O 0 4.3060182086662735e-09
chromosome O 0 3.8896119658460293e-10
15 O 0 7.509187160970043e-10
, O 0 5.961569432555436e-11
and O 0 1.1416233514083274e-09
distal O 0 1.3158768524590414e-05
chromosome O 0 3.99749615098699e-06
arm O 0 2.176213456550613e-05
3p O 0 0.23839709162712097
. O 0 6.3882284848659765e-06

The O 0 4.3502786866156384e-06
t O 0 1.0831858787696547e-07
( O 0 8.264829792770101e-11
3 O 0 2.7962332449504856e-10
; O 0 4.952928258500355e-12
15 O 0 5.614483183924435e-11
) O 0 6.377258747122805e-13
was O 0 1.084465989231731e-10
present O 0 5.1051173705074504e-11
in O 0 1.675599659023419e-10
the O 0 2.8353744352394017e-10
balanced O 0 2.586857672515208e-10
state O 0 1.3153154780620735e-11
in O 0 1.6440581535048793e-11
the O 0 1.7879890623628825e-10
patients O 0 1.1593055404546249e-08
father O 0 2.9452500438509333e-09
and O 0 1.6133159252973428e-09
a O 0 1.9774802240135614e-08
sister O 0 2.0690520159405423e-06
. O 0 5.360830641620851e-07

Fluorescent O 0 0.00010576246859272942
in O 0 8.009978813561247e-08
situ O 0 3.010080149579153e-07
hybridization O 0 8.741738888318196e-09
analysis O 0 3.9282543884411325e-10
demonstrated O 0 1.2800434046056353e-09
that O 0 1.535192459267698e-11
the O 0 1.0800785155140602e-08
PWS B-Disease 1 1.0
critical O 0 0.000638999801594764
region O 0 1.472093487109305e-07
resided O 0 5.839717687194934e-08
on O 0 1.1679296418876106e-09
the O 0 2.529629006264855e-10
derivative O 0 3.3774929519836405e-09
chromosome O 0 4.332441697063594e-11
3 O 0 1.87124635231406e-10
and O 0 3.968798380216132e-12
that O 0 2.9020056214849876e-13
there O 0 4.46140607096579e-12
was O 0 1.290077489279895e-10
no O 0 1.582662473298413e-11
deletion O 0 4.439145717682891e-10
of O 0 6.386523310197845e-09
the O 0 1.4348348997827998e-07
PWS B-Disease 1 1.0
region O 0 1.6944515834893537e-07
on O 0 6.758288151331726e-09
the O 0 3.111401691846538e-10
normal O 0 1.0715174303399522e-09
pair O 0 1.586129422248561e-10
of O 0 1.8484476449476261e-10
15s O 0 1.2227208401327516e-07
present O 0 5.104694000834797e-09
in O 0 3.047851393489509e-08
J O 0 0.00019990747387055308
. O 0 3.811649946783291e-07

B O 0 0.015599931590259075
. O 0 4.002833520644344e-06

Methylation O 0 1.875835238251966e-07
analysis O 0 2.0718518456419588e-08
at O 0 3.680332127942165e-08
exon O 0 3.988358514561696e-07
alpha O 0 1.9683698226913293e-08
of O 0 7.759626718950585e-09
the O 0 6.8091119409530165e-09
small O 0 9.876686135612545e-10
nuclear O 0 1.0275721962216267e-07
ribonucleoprotein O 0 6.998630510679504e-07
- O 0 1.8247240163304923e-08
associated O 0 2.175041657892507e-08
polypeptide O 0 1.5703386679888354e-07
N O 0 1.972256313820253e-07
( O 0 3.222203892594422e-10
SNRPN O 0 8.126474131131545e-05
) O 0 5.054485718858359e-10
gene O 0 1.0398782945841845e-09
showed O 0 5.0415932539849e-10
a O 0 6.54237219954723e-11
pattern O 0 8.98714935804179e-10
characteristic O 0 2.704430457356466e-09
of O 0 2.799564580158176e-09
only O 0 2.1331941768565343e-10
the O 0 1.5850867285394088e-09
maternal O 0 3.850744079159085e-08
chromosome O 0 5.733723495993104e-10
15 O 0 1.3828220790657042e-09
in O 0 4.580550605481903e-09
J O 0 7.843175262678415e-05
. O 0 4.972551437276707e-07

B O 0 0.018731148913502693
. O 0 5.492825039254967e-06

Maternal B-Disease 0 0.0022250597830861807
disomy I-Disease 0 0.001534538227133453
was O 0 1.1719473036464478e-07
confirmed O 0 2.452016589771233e-09
by O 0 1.4570725181961564e-10
polymerase O 0 2.7890969533928e-09
chain O 0 2.534917553642657e-10
reaction O 0 1.319436920832473e-10
analysis O 0 1.7224102699664456e-10
of O 0 1.4691846628167582e-09
microsatellite O 0 2.839883848082536e-07
repeats O 0 1.1287363266276884e-09
at O 0 7.501486098959731e-10
the O 0 2.496745588054239e-10
gamma O 0 2.5164061945304184e-09
- O 0 4.752184423750805e-09
aminobutyric O 0 1.57003455569793e-07
acid O 0 1.4209283527577554e-08
receptor O 0 6.801090801644705e-09
beta3 O 0 5.64309175388189e-07
subunit O 0 1.2968484952580184e-08
( O 0 3.3266694954292575e-10
GABRB3 O 0 3.6070381611352786e-05
) O 0 4.5734447340350926e-09
locus O 0 1.4804238901433564e-07
. O 0 7.780807464996542e-08

A O 0 4.2174753616563976e-05
niece O 0 0.0001366742217214778
( O 0 2.2486768003204816e-09
B O 0 8.293564519590291e-07
. O 0 5.267532590669255e-11
B O 0 5.5012443489488305e-09
. O 0 1.5759171311663378e-12
) O 0 4.188591205649128e-13
with O 0 1.8167468397722875e-12
45 O 0 2.203714988269212e-10
chromosomes O 0 4.996683275471092e-11
and O 0 3.8650867228984254e-11
the O 0 1.93864604924876e-10
derivative O 0 3.045583341076963e-09
3 O 0 2.1709860298368966e-10
but O 0 8.844534479801602e-12
without O 0 6.836081006822425e-11
the O 0 1.0745976330994722e-09
der O 0 1.2170575303116493e-07
( O 0 9.612340437503697e-12
15 O 0 1.5113460483107133e-10
) O 0 5.486534403881249e-12
demonstrated O 0 8.245891747193923e-10
a O 0 9.557482583133492e-11
phenotype O 0 5.658159807353513e-08
consistent O 0 1.103753266562535e-08
with O 0 1.0046245953188038e-11
that O 0 2.5040494851247264e-12
reported O 0 1.6675867284265955e-11
for O 0 7.35069574653302e-11
haploinsufficiency O 0 4.672612703870982e-06
of O 0 7.766772114337073e-07
distal O 0 6.643090455327183e-05
3 O 0 1.0612125151965301e-05
p O 0 1.1384650861145929e-05
. O 0 2.646156644914299e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999998807907104
associated O 0 3.9594874579051975e-06
with O 0 1.0678739670311188e-08
unbalanced O 0 2.8031731744704302e-06
segregation O 0 2.994110275267303e-07
of O 0 6.975402300213318e-08
non O 0 5.775624458692619e-07
- O 0 2.0701460812233563e-07
Robertsonian O 0 0.00014815822942182422
translocations O 0 6.393900093826232e-07
has O 0 1.3319616520846012e-09
been O 0 3.5850969415385237e-10
reported O 0 9.005727413802234e-11
previously O 0 3.7940200980912664e-10
but O 0 5.873646014009637e-11
has O 0 6.175315900996958e-12
not O 0 4.22382094578122e-12
, O 0 7.425971296215472e-12
to O 0 3.033984521949584e-11
our O 0 6.472126168333148e-10
knowledge O 0 2.6798758767654363e-09
, O 0 8.892574177021828e-12
been O 0 2.0214701440535165e-11
observed O 0 7.769866694484762e-11
in O 0 3.995634725861841e-11
a O 0 7.652704858696069e-11
case O 0 1.6288725035451534e-08
of O 0 1.8241501038573915e-06
PWS B-Disease 1 1.0
. O 0 4.535995685728267e-05

Furthermore O 0 1.5065324078022968e-05
, O 0 3.145722260455841e-08
our O 0 1.1131614741088924e-08
findings O 0 6.9461649765401035e-09
are O 0 8.739828999404509e-11
best O 0 6.280806430503105e-10
interpreted O 0 1.884337796909108e-09
as O 0 5.927647817038917e-10
true O 0 7.477304997394185e-09
gamete O 0 3.118041433936014e-07
complementation O 0 1.736052581691183e-05
resulting O 0 1.1793876097954126e-07
in O 0 2.8043173116998332e-08
maternal B-Disease 0 6.359886901918799e-05
UPD I-Disease 1 1.0
15 I-Disease 0 5.380432412493974e-05
and O 0 5.871195753570646e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9998879432678223
- I-Disease 1 0.9999997615814209
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 5.12395081386785e-06
2 I-Disease 0 1.0597015176472269e-07
and O 0 7.175819938254335e-10
Stuve B-Disease 1 0.9999823570251465
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.643200463532281e-10
a O 0 4.4680249083883794e-11
case O 0 2.864302406369035e-10
for O 0 1.0740336398029626e-10
" O 0 2.974170243419394e-09
lumping O 0 2.7394021273607905e-08
" O 0 8.63832916309093e-09
. O 0 7.686372427428978e-09

Recent O 0 4.137822600114305e-07
studies O 0 1.0522569482418476e-08
demonstrated O 0 5.672128100542295e-09
the O 0 5.813772796514627e-10
existence O 0 8.390728667428959e-10
of O 0 9.595205741064206e-10
a O 0 5.418722137662257e-10
genetically O 0 5.903811484131438e-07
distinct O 0 1.4977389328763024e-09
, O 0 4.6186622235100394e-12
usually O 0 2.9672924273943524e-12
lethal O 0 4.0480449547963815e-10
form O 0 1.972549901196885e-11
of O 0 2.4248078545063834e-10
the O 0 1.7877682667588601e-09
Schwartz B-Disease 0 1.2719157894025557e-05
- I-Disease 0 0.030922751873731613
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999979734420776
( O 0 2.7370923305625183e-09
SJS B-Disease 1 0.9994174242019653
) O 0 2.7695887805379016e-09
of O 0 4.400953002914321e-06
myotonia B-Disease 1 1.0
and O 0 0.007405799347907305
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.8827821552113164e-07
which O 0 2.6452211532301817e-09
we O 0 2.340578619808298e-09
called O 0 7.70132579930305e-09
SJS B-Disease 0 0.09855340421199799
type I-Disease 0 1.2468498425732832e-05
2 I-Disease 0 1.2326603382462054e-06
. O 0 4.7392248347932764e-08

This O 0 7.020730663498398e-07
disorder O 0 0.001915185945108533
is O 0 1.90161442148451e-09
reminiscent O 0 1.0427228289699997e-06
of O 0 7.780065658380408e-08
another O 0 7.678485069995133e-10
rare O 0 1.1899500274026309e-09
condition O 0 7.36737781892316e-09
, O 0 2.7160483931365498e-11
the O 0 1.0694185537118983e-09
Stuve B-Disease 1 0.9999959468841553
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.81536209362821e-07
SWS B-Disease 1 0.8937006592750549
) O 0 5.2598828070848924e-11
, O 0 1.3067883580797357e-11
which O 0 1.8415879932121015e-11
comprises O 0 2.6988844492592534e-10
campomelia B-Disease 0 7.478519705728104e-07
at O 0 1.0911900716337186e-07
birth O 0 3.551914414856583e-05
with O 0 8.810603802089645e-09
skeletal B-Disease 1 0.9408298134803772
dysplasia I-Disease 1 0.9999998807907104
, O 0 6.095297777619635e-08
contractures B-Disease 0 0.22186438739299774
, O 0 2.2218897832715356e-09
and O 0 5.554295912091334e-10
early B-Disease 0 2.899065236761089e-07
death I-Disease 0 2.5610572151890665e-07
. O 0 6.771012550643718e-08

To O 0 2.2470187488465854e-08
test O 0 1.4070606901839255e-08
for O 0 3.2928831883438647e-10
possible O 0 1.6633864063919646e-08
nosologic O 0 0.297061562538147
identity O 0 5.754532406143653e-09
between O 0 5.027065430596167e-10
these O 0 2.877709404103257e-09
disorders O 0 6.316371923276165e-07
, O 0 4.8411687852967233e-11
we O 0 1.7370611893330334e-11
reviewed O 0 1.2062063570184023e-09
the O 0 2.0931878452756791e-10
literature O 0 5.455453866431981e-10
and O 0 9.861254608029002e-13
obtained O 0 2.0411083847399203e-12
a O 0 2.2632904665004228e-12
follow O 0 8.619804175991064e-11
- O 0 7.204372654001645e-10
up O 0 1.8525525558032996e-10
of O 0 2.1340203215647335e-10
the O 0 3.6108987327976294e-11
only O 0 6.005894566396552e-12
two O 0 6.761810729394302e-12
surviving O 0 3.517885005521748e-08
patients O 0 1.270770866312887e-08
, O 0 4.374858114664093e-11
one O 0 4.6266972891784164e-11
with O 0 6.662418533531778e-11
SJS B-Disease 0 0.00010650368494680151
type I-Disease 0 1.12395878204552e-06
2 I-Disease 0 1.8391476785950545e-08
at O 0 7.090421028088656e-10
age O 0 3.7430228361223783e-10
10 O 0 2.0060795039023027e-11
years O 0 1.574442833052192e-11
and O 0 1.0724978197207413e-11
another O 0 8.096984888128489e-11
with O 0 2.0646662157730589e-10
SWS B-Disease 0 1.293079367314931e-05
at O 0 9.37336608330952e-09
age O 0 2.0886353979676642e-08
7 O 0 9.94138460441718e-09
years O 0 2.9810194313029115e-09
. O 0 1.8944835034062635e-08

Patients O 0 0.00032840261701494455
reported O 0 6.824102616320715e-09
as O 0 1.1431289248520216e-09
having O 0 1.988197384505952e-09
either O 0 5.7450382229262686e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.007554956246167421
SWS B-Disease 0 0.000647651613689959
presented O 0 1.4768237743822965e-09
a O 0 1.2498869127186563e-11
combination O 0 1.255163195601483e-09
of O 0 9.467368000670717e-10
a O 0 2.239238378054509e-10
severe O 0 2.1869198008062085e-06
, O 0 1.3802510245852773e-08
prenatal O 1 0.9999992847442627
- O 1 0.9999991655349731
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 9.726851430968964e-07
with O 0 8.649889423395507e-06
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9962517619132996
respiratory O 1 1.0
and O 0 2.6117437300854363e-05
feeding O 0 0.004861921072006226
difficulties O 0 2.545192273828434e-06
, O 0 1.4714002238847002e-09
tendency O 0 4.490481764207743e-09
to O 0 8.558048159024167e-10
hyperthermia B-Disease 0 0.0029181893914937973
, O 0 1.9338523837841848e-10
and O 0 3.00369763783781e-11
frequent O 0 2.7298113422502546e-11
death O 0 2.6155653198856044e-09
in O 0 2.136774757133253e-09
infancy O 0 4.4902441231897683e-07
) O 0 3.502585808196068e-12
with O 0 1.7727740933212721e-12
a O 0 4.246230450588584e-11
distinct O 0 3.1558948787591135e-09
campomelic B-Disease 1 0.7946470379829407
- I-Disease 1 0.9993546605110168
metaphyseal I-Disease 1 0.9999953508377075
skeletal I-Disease 1 0.999679684638977
dysplasia I-Disease 1 0.9999997615814209
. O 0 0.0001059728383552283

The O 0 1.3139188581590133e-07
similarity O 0 1.1734839233668026e-07
of O 0 1.280003090187165e-07
the O 0 2.2514290876074483e-08
clinical O 0 3.81682241368253e-07
and O 0 1.7352516090696213e-09
radiographic O 0 0.0007084824028424919
findings O 0 5.760460226156283e-06
is O 0 1.4041376950046924e-09
so O 0 1.6588129481132086e-10
extensive O 0 1.4590809671588545e-09
that O 0 3.662973049878282e-11
these O 0 7.29831768353506e-08
disorders O 0 0.2405547946691513
appear O 0 5.8984880979551235e-08
to O 0 3.5331321202036747e-10
be O 0 3.3607897020893063e-10
a O 0 5.638406963548448e-10
single O 0 2.821096689586966e-09
entity O 0 2.250085273658442e-08
. O 0 9.684627855222061e-08

The O 0 3.061245763547049e-07
follow O 0 2.3583886843425717e-08
- O 0 3.17451522846568e-08
up O 0 5.589557705576453e-10
observation O 0 4.901511196919728e-09
of O 0 7.107328614530672e-11
an O 0 1.6229583866059216e-12
identical O 0 2.2395374443817673e-10
and O 0 3.3308394237208105e-11
unique O 0 1.7157542053780617e-10
pattern O 0 5.949625236922884e-09
of O 0 1.9927597350033466e-06
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 2.734918098212802e-06
the O 0 7.959265246881841e-08
two O 0 5.959753246465027e-10
patients O 0 1.561412332762302e-08
( O 0 3.3158968192753546e-12
one O 0 1.123667912189541e-11
with O 0 1.248888405885884e-11
SJS B-Disease 0 2.1540377929341048e-05
type I-Disease 0 4.1535898276379157e-07
2 I-Disease 0 2.894229922389968e-08
, O 0 3.424682412656033e-11
one O 0 1.863232138021864e-11
with O 0 3.465143796899106e-11
SWS B-Disease 0 7.991816914909577e-07
) O 0 5.025126148527903e-11
surviving O 0 5.746660036720641e-08
beyond O 0 2.0464926819840912e-07
infancy O 0 3.387224012385559e-07
adds O 0 3.943380899595894e-10
to O 0 7.278677660593758e-11
the O 0 8.15093895156771e-11
evidence O 0 2.330914350423541e-10
in O 0 1.2082272682345518e-10
favor O 0 2.2909876662424722e-08
of O 0 4.811476994603936e-09
identity O 0 7.385950517857509e-09
. O 0 2.4364886996863788e-08

The O 0 1.1348631687724264e-06
hypothesis O 0 4.385807187645696e-06
that O 0 2.7909914379620204e-09
SWS B-Disease 0 0.0005759893683716655
and O 0 1.971435814596134e-08
SJS B-Disease 1 0.9998297691345215
type I-Disease 0 4.281058136257343e-05
2 I-Disease 0 3.849114023068978e-07
are O 0 5.3771449098904966e-11
the O 0 3.0802069228563767e-10
same O 0 6.763136717324869e-09
disorder O 0 1.656562403695716e-06
should O 0 1.6680942183100456e-09
be O 0 9.202590356416351e-10
testable O 0 1.539608689427041e-07
by O 0 1.0472862854715714e-10
molecular O 0 1.6345983455678947e-09
methods O 0 3.673254367342338e-09
. O 0 1.1681279277198087e-09
. O 0 1.526417925390433e-08

A O 0 2.7240378130954923e-07
mouse O 0 4.087368665750546e-08
model O 0 2.078428984475522e-09
of O 0 2.503680818222165e-09
severe O 1 0.9636623859405518
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.0001802268816391006
defects O 0 0.34320223331451416
in O 0 3.7681411413359456e-07
hemostasis O 1 0.990693986415863
and O 0 2.892991801672906e-07
thrombosis B-Disease 1 0.9999977350234985
. O 0 2.064877116936259e-05

von B-Disease 1 0.9658021926879883
Willebrand I-Disease 1 0.9999995231628418
factor I-Disease 0 0.04471898451447487
( I-Disease 0 1.7446263882447965e-06
vWf I-Disease 1 0.9999967813491821
) I-Disease 0 9.57204701990122e-06
deficiency I-Disease 1 1.0
causes O 0 0.4910244643688202
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.879569411277771
humans O 0 3.043226797672105e-06
. O 0 7.726768558313779e-08

We O 0 7.022847370308227e-08
generated O 0 9.413571255834086e-09
a O 0 3.0577002041454193e-10
mouse O 0 1.8084693742537183e-09
model O 0 2.3018435768573653e-10
for O 0 2.2088605250436544e-11
this O 0 1.3860269876264653e-10
disease O 0 4.841266054711468e-09
by O 0 2.3082886990710705e-10
using O 0 1.0545830875230422e-09
gene O 0 3.1209606010662583e-09
targeting O 0 1.3290058831216811e-08
. O 0 6.180759726248652e-08

vWf B-Disease 1 0.9999321699142456
- I-Disease 1 1.0
deficient I-Disease 1 0.9999996423721313
mice O 0 1.0296954314981122e-05
appeared O 0 8.889059266437016e-09
normal O 0 7.716614014441348e-10
at O 0 3.786429225716148e-10
birth O 0 2.12613548988827e-09
; O 0 1.8825436001734808e-11
they O 0 2.450284419808213e-11
were O 0 1.6931610558046373e-09
viable O 0 1.995763625473046e-07
and O 0 4.536971243140897e-09
fertile O 0 5.244431122264359e-06
. O 0 9.789838628648795e-08

Neither O 0 6.395574746420607e-05
vWf O 0 0.0007178843370638788
nor O 0 2.3909115043352358e-05
vWf O 0 0.000673114147502929
propolypeptide O 0 0.000939050514716655
( O 0 3.818110982933831e-08
von B-Disease 0 0.0002724170626606792
Willebrand I-Disease 0 0.00104766886215657
antigen O 0 8.316744242620189e-06
II O 1 1.0
) O 0 1.2093507306687457e-09
were O 0 3.4164260309665906e-09
detectable O 0 8.327486966663855e-08
in O 0 4.3357839540902887e-10
plasma O 0 2.0843691217464766e-08
, O 0 3.180024993332253e-11
platelets O 0 9.148760860000493e-09
, O 0 3.7821037968122084e-11
or O 0 1.597227732019757e-11
endothelial O 0 2.8749442826381255e-09
cells O 0 4.840007838957661e-10
of O 0 5.127095414891869e-10
the O 0 6.088532789050305e-09
homozygous O 0 2.609194496017153e-07
mutant O 0 2.517635039112065e-06
mice O 0 4.7114565404626774e-07
. O 0 4.1504922165813696e-08

The O 0 6.860974281153176e-06
mutant O 0 6.328161543933675e-05
mice O 0 2.0387622043926967e-06
exhibited O 0 2.2884290729052736e-07
defects O 0 1.3909524341215729e-06
in O 0 6.624856041526073e-08
hemostasis O 0 4.5421729737427086e-05
with O 0 6.849697475885819e-10
a O 0 5.582965201256229e-09
highly O 0 1.8518341676099226e-05
prolonged O 1 0.9140753746032715
bleeding O 0 0.01663907989859581
time O 0 8.371425508357788e-08
and O 0 5.36070743351047e-08
spontaneous O 0 9.403593708157132e-07
bleeding O 0 1.3500716988801287e-07
events O 0 3.210596788427722e-10
in O 0 4.256415359060739e-11
approximately O 0 4.916665338750015e-11
10 O 0 3.8197656843097505e-11
% O 0 3.339522408607465e-11
of O 0 5.911118816648298e-10
neonates O 0 7.842661489121383e-07
. O 0 1.3736699600030988e-07

As O 0 9.703857273279937e-08
in O 0 2.1650530257488754e-09
the O 0 1.3194779713288085e-09
human O 0 1.3136663978841057e-10
disease O 0 1.374426128464279e-09
, O 0 5.890269175190532e-12
the O 0 7.790359329851171e-11
factor O 0 3.675931781188524e-09
VIII O 1 0.9999524354934692
level O 0 5.47075251233764e-06
in O 0 4.479549176039654e-09
these O 0 4.521065466445151e-10
mice O 0 1.300806351522965e-09
was O 0 2.570062773710191e-10
reduced O 0 1.8047581207270014e-09
strongly O 0 3.6943664794009123e-10
as O 0 6.413543307548508e-11
a O 0 1.517023312525012e-11
result O 0 2.223109613064267e-10
of O 0 2.4488617800244583e-09
the O 0 8.074472757080287e-10
lack O 0 3.904643719465639e-09
of O 0 7.607099394846273e-10
protection O 0 1.2063587462307623e-08
provided O 0 1.239421343335323e-09
by O 0 3.4310601026987797e-09
vWf O 0 1.1708223610185087e-05
. O 0 2.596693491341284e-07

Defective O 1 0.9999891519546509
thrombosis B-Disease 1 1.0
in O 0 3.7986425013514236e-05
mutant O 0 1.5992372937034816e-05
mice O 0 8.112331784104754e-08
was O 0 1.4153718197462695e-09
also O 0 2.4415511279407554e-11
evident O 0 3.96957098303119e-08
in O 0 2.050221103999661e-10
an O 0 2.666390979538802e-12
in O 0 4.250573851227735e-11
vivo O 0 9.927813016119558e-10
model O 0 8.903682791050471e-10
of O 0 9.801067335502012e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 1 0.7252956032752991

In O 0 6.966677457143078e-09
this O 0 3.765972256264405e-11
model O 0 1.05159836394364e-09
, O 0 4.4105497032376206e-11
the O 0 3.0839222842082847e-10
exteriorized O 0 4.635149707610253e-06
mesentery O 0 4.317074126447551e-05
was O 0 2.062531763158404e-07
superfused O 0 1.0875807674892712e-05
with O 0 4.8420325526876695e-09
ferric O 0 0.00013108928396832198
chloride O 0 5.725233677367214e-06
and O 0 1.2172333363480448e-08
the O 0 5.982055295561395e-09
accumulation O 0 2.5545978132868186e-07
of O 0 3.0150271612683355e-08
fluorescently O 0 4.982428436051123e-06
labeled O 0 5.2760270818907884e-08
platelets O 0 6.334481383873936e-08
was O 0 1.602670440803422e-09
observed O 0 2.7408106340054417e-10
by O 0 6.68603616915675e-10
intravital O 0 3.13923032990715e-06
microscopy O 0 3.7740642255812418e-06
. O 0 8.432391496171476e-07

We O 0 1.3588061165137333e-07
conclude O 0 3.2183075404645933e-07
that O 0 1.2343179256468773e-10
these O 0 2.001522059202898e-09
mice O 0 6.91196433422192e-08
very O 0 1.095999069278264e-09
closely O 0 1.7370803462313233e-08
mimic O 0 2.0446508642635308e-05
severe O 1 0.9883937239646912
human O 1 0.9416840076446533
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 9.135599299270325e-08
will O 0 1.116933212585991e-10
be O 0 1.2388835617105354e-11
very O 0 4.009106848584798e-12
useful O 0 6.523005659925252e-12
for O 0 8.0425672632084e-13
investigating O 0 2.5851744356319983e-11
the O 0 9.654091415178812e-11
role O 0 1.7073285840663033e-10
of O 0 1.2466246701592354e-08
vWf O 0 3.31833825839567e-06
in O 0 4.880530202200362e-09
normal O 0 3.515605158099788e-07
physiology O 0 2.6419913865538547e-06
and O 0 2.207989763247653e-10
in O 0 3.7750499948252525e-10
disease O 0 7.902023035910588e-09
models O 0 8.274775531447176e-09
. O 0 5.981963813184166e-09
. O 0 7.2731097588985e-08

Oral O 0 0.14216333627700806
contraceptives O 0 0.0010935820173472166
and O 0 3.1373976749904386e-09
the O 0 8.572952125973643e-09
risk O 0 5.035304297962284e-07
of O 0 0.0005475030629895627
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.65748086955864e-05

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9974529147148132
Study O 0 6.004646024848626e-07
Group O 0 7.821141956299016e-09
. O 0 1.2242745484059014e-08

BACKGROUND O 0 0.000359363533789292
Women O 0 3.474785614798748e-08
with O 0 8.969317649709652e-11
mutations O 0 4.983018442317189e-10
in O 0 7.388285538922901e-10
either O 0 4.8022079646159455e-09
the O 0 8.784832772334994e-08
BRCA1 O 0 1.7186981438044313e-07
or O 0 1.6992012241701104e-09
the O 0 6.514525807688187e-08
BRCA2 O 0 6.438666844132968e-08
gene O 0 1.572064006749585e-10
have O 0 5.9659456194682825e-12
a O 0 1.1927618615015234e-11
high O 0 1.780116853922209e-08
lifetime O 0 1.0941036521217029e-07
risk O 0 2.824781176968827e-06
of O 1 0.9275556206703186
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.672170694495435e-06

Oral O 1 0.9998296499252319
contraceptives O 1 0.9999995231628418
protect O 0 0.00022801352315582335
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.0278344397818273e-08
general O 0 1.8905922161138733e-08
, O 0 1.0814002471271067e-11
but O 0 7.129931627741781e-12
it O 0 4.5359931631107353e-13
is O 0 2.6560955583392054e-13
not O 0 4.4265494590113585e-13
known O 0 5.3908030817062524e-11
whether O 0 1.7946857888695433e-10
they O 0 2.147363536986191e-10
also O 0 5.856965606954034e-11
protect O 0 2.037702923063378e-10
against O 0 1.1479364125932534e-08
hereditary B-Disease 1 0.9999998807907104
forms I-Disease 1 0.9999998807907104
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.219214820797788e-07

METHODS O 0 9.092605978366919e-06
We O 0 4.794467400870417e-08
enrolled O 0 2.2149816913952236e-07
207 O 0 5.682775849891186e-08
women O 0 3.321065367156706e-10
with O 0 5.571038075302681e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.043709781053622e-09
161 O 0 1.331713406216295e-08
of O 0 8.85253026439159e-09
their O 0 7.471531837666134e-09
sisters O 0 4.460969815767157e-09
as O 0 9.34001972985321e-11
controls O 0 5.63238733430893e-10
in O 0 2.0193673122559375e-10
a O 0 1.677233629759911e-10
case O 0 2.0725870797377866e-08
- O 0 5.7143722642649664e-08
control O 0 3.2297570840000844e-08
study O 0 6.1301324016938e-09
. O 0 4.9376081001639704e-09

All O 0 2.0338846695722168e-07
the O 0 6.215314840574138e-08
patients O 0 2.9226823627936938e-08
carried O 0 2.4803797904482394e-10
a O 0 2.7227498033965958e-11
pathogenic O 0 1.9860227240542372e-08
mutation O 0 1.8425534875632366e-08
in O 0 1.891399037390329e-09
either O 0 1.0821033846752925e-08
BRCA1 O 0 5.965615201830587e-08
( O 0 2.855349810759744e-11
179 O 0 1.7480484615362002e-08
women O 0 1.331747490063151e-10
) O 0 1.624538698008493e-11
or O 0 3.0894873326303696e-09
BRCA2 O 0 4.3588456719589885e-06
( O 0 3.805049886285161e-10
28 O 0 3.8816642700112425e-07
women O 0 1.3416634470075905e-09
) O 0 1.6621509724146222e-10
. O 0 1.618877654152584e-08

The O 0 2.200771120897116e-07
control O 0 1.1139626820977355e-07
women O 0 4.743072601343101e-10
were O 0 4.312015466911845e-10
enrolled O 0 1.3468657300563791e-09
regardless O 0 7.08900105284016e-10
of O 0 5.493021593139247e-10
whether O 0 2.0489075713836513e-10
or O 0 2.929633480253102e-10
not O 0 1.6507549494004792e-10
they O 0 5.7194809999217e-10
had O 0 1.2217847844553376e-09
either O 0 5.2668749361828304e-09
mutation O 0 2.7749146980227124e-08
. O 0 7.475526331290894e-08

Lifetime O 0 2.066924025712069e-05
histories O 0 2.0126494746364187e-06
of O 0 2.1099937441704242e-07
oral O 0 6.0835600379505195e-06
- O 0 1.7845130173554935e-07
contraceptive O 0 8.627462761978677e-07
use O 0 1.5147023912920332e-10
were O 0 1.074599159656131e-10
obtained O 0 3.4965533940445326e-11
by O 0 4.561940061820202e-11
interview O 0 9.516626375827286e-11
or O 0 6.284982083382129e-12
by O 0 2.5690909469244794e-11
written O 0 9.080776408598723e-11
questionnaire O 0 2.1552624962506428e-10
and O 0 5.313736863715723e-12
were O 0 5.127855431941164e-11
compared O 0 4.108860196527786e-10
between O 0 2.1502982727739095e-10
patients O 0 9.307683512815856e-08
and O 0 3.992110253481229e-10
control O 0 8.096966297443942e-08
women O 0 2.7281732428718897e-10
, O 0 2.1138238728846126e-12
after O 0 9.030445835556122e-11
adjustment O 0 1.5953081078379228e-09
for O 0 2.1089277893460157e-11
year O 0 1.659300197243141e-10
of O 0 2.212197758311163e-09
birth O 0 6.990039480569976e-08
and O 0 2.359386019890053e-09
parity O 0 3.844220373139251e-07
. O 0 8.163180353903954e-08

RESULTS O 0 4.771660314872861e-06
The O 0 5.91186868348359e-08
adjusted O 0 1.6925909562814923e-07
odds O 0 3.050185569009045e-06
ratio O 0 6.611651883758896e-07
for O 0 2.1496418867172906e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 6.593917856179132e-09
with O 0 2.6017209220352555e-11
any O 0 1.3303690094002008e-10
past O 0 4.865601255232832e-10
use O 0 2.4501362050344255e-10
of O 0 8.18277090530728e-09
oral O 0 3.6812211874348577e-06
contraceptives O 0 5.4829542932566255e-06
was O 0 2.316057390316928e-08
0 O 0 4.949604814896702e-08
. O 0 1.738790800231982e-08

5 O 0 2.5659321636339882e-06
( O 0 7.938793622486173e-09
95 O 0 1.3862552350474289e-06
percent O 0 1.3029928425112303e-07
confidence O 0 5.532963953669423e-08
interval O 0 2.9355602393366098e-08
, O 0 5.7769608541313744e-11
0 O 0 3.5998423686400827e-10
. O 0 9.164010696116609e-12
3 O 0 3.8647991057461084e-11
to O 0 6.998230554083884e-12
0 O 0 6.201916202819291e-10
. O 0 6.871271607256091e-11
8 O 0 2.475989635541964e-09
) O 0 1.4740399179036245e-10
. O 0 1.0545635475978088e-08

The O 0 1.546106318528473e-06
risk O 0 2.0071932738119358e-07
decreased O 0 3.1731655525391034e-08
with O 0 2.4251673585995448e-11
increasing O 0 3.188140307308629e-10
duration O 0 3.41586559038376e-09
of O 0 6.157186427380168e-10
use O 0 6.128913487835064e-10
( O 0 7.300562931966681e-11
P O 0 6.232468763300858e-07
for O 0 7.25284998726039e-10
trend O 0 4.932910968591386e-09
, O 0 7.942325616627777e-12
< O 0 2.850111813224032e-10
0 O 0 1.5186395196931102e-10
. O 0 7.83154964489885e-12
001 O 0 4.0335784712297595e-10
) O 0 1.1947917427559268e-13
; O 0 2.4082943755540653e-13
use O 0 6.663698672720875e-12
for O 0 2.7430948137951994e-11
six O 0 9.11849137863463e-11
or O 0 1.2778125779711047e-11
more O 0 3.054724008466625e-12
years O 0 1.863847097494098e-11
was O 0 5.196779118143979e-11
associated O 0 2.7459581483646467e-11
with O 0 4.686486441973781e-12
a O 0 8.466636419734996e-11
60 O 0 1.7931127693771032e-09
percent O 0 3.1293637126061924e-10
reduction O 0 7.503564880551039e-09
in O 0 5.018608639772992e-09
risk O 0 2.0871566164260003e-07
. O 0 5.083224152713228e-08

Oral O 0 0.28811532258987427
- O 0 0.0002764384262263775
contraceptive O 0 0.02391158789396286
use O 0 1.940339160455551e-07
protected O 0 0.00856629665941
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.64773464159407e-09
for O 0 3.069585696735544e-10
carriers O 0 1.3873582282997177e-09
of O 0 2.369515250677523e-09
the O 0 7.12465419994146e-09
BRCA1 O 0 6.204913027829662e-09
mutation O 0 3.2978236808034467e-10
( O 0 3.817462405214522e-12
odds O 0 5.420068394101918e-09
ratio O 0 6.76607492255954e-10
, O 0 2.5554447880687947e-12
0 O 0 1.520998431370213e-11
. O 0 1.5293056534679272e-12
5 O 0 1.6537859623411144e-11
; O 0 8.22736063305074e-12
95 O 0 1.8431931536611046e-08
percent O 0 1.6204646513529042e-09
confidence O 0 1.861322984630931e-09
interval O 0 2.3420254624539893e-09
, O 0 3.020721173196961e-11
0 O 0 9.198899975082497e-11
. O 0 4.836367417659915e-12
3 O 0 2.2898790502656752e-11
to O 0 4.162971616733513e-12
0 O 0 1.3121613517963482e-10
. O 0 9.858738825307967e-12
9 O 0 2.387843256457245e-10
) O 0 1.0707251058006406e-12
and O 0 2.09013383857537e-12
for O 0 6.594045622032585e-12
carriers O 0 5.96090121707249e-10
of O 0 2.476292060293872e-09
the O 0 5.759784116321498e-08
BRCA2 O 0 2.206554796657656e-07
mutation O 0 1.0946160644564884e-09
( O 0 9.461780317576718e-12
odds O 0 1.2739232779779286e-08
ratio O 0 1.3983887381385784e-09
, O 0 6.283064346579437e-12
0 O 0 3.0092484060162406e-11
. O 0 1.7603508711480642e-12
4 O 0 4.0038285187282696e-11
; O 0 1.3278610849765116e-11
95 O 0 3.383652114052893e-08
percent O 0 5.5263162934693355e-09
confidence O 0 2.7821263071103886e-09
interval O 0 4.05104394474165e-09
, O 0 2.6190922694513397e-11
0 O 0 1.2563074192062373e-10
. O 0 4.290696704184471e-12
2 O 0 2.972301571535496e-11
to O 0 5.29690917863701e-12
1 O 0 2.9939525858502236e-10
. O 0 5.3151281986796306e-11
1 O 0 2.694585665707905e-09
) O 0 2.077009259027207e-10
. O 0 1.0915519155219044e-08

CONCLUSIONS O 0 0.000770090613514185
Oral O 0 0.0009441107395105064
- O 0 5.184054316487163e-06
contraceptive O 0 6.759412372048246e-06
use O 0 7.988519845625319e-10
may O 0 2.477708316295235e-10
reduce O 0 8.101330162268994e-10
the O 0 1.232297930364723e-09
risk O 0 2.1289451979100704e-07
of O 1 0.8782559633255005
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.5489658384003633e-08
women O 0 3.583522367733849e-11
with O 0 1.2127051749952211e-12
pathogenic O 0 1.9741262846650898e-08
mutations O 0 1.0499895175541951e-08
in O 0 4.543752041286098e-09
the O 0 3.6544861359288916e-07
BRCA1 O 0 5.868061180080986e-06
or O 0 4.6883641857675684e-07
BRCA2 O 0 5.0635058869374916e-05
gene O 0 2.3048125967761735e-06

A O 0 1.939837375175557e-06
Japanese O 0 1.7905791537486948e-05
family O 0 1.538738914064197e-08
with O 0 1.8357332320917408e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.4202561610973135e-09
a O 0 7.221697462256316e-09
codon O 0 2.41366279851718e-07
291 O 0 6.168817634488732e-08
deletion O 0 5.652698753522145e-09
: O 0 1.8111911276319503e-11
a O 0 1.9667869763373425e-11
clinical O 0 6.419742515362259e-09
, O 0 1.9989218613680748e-11
biochemical O 0 1.3926803887898132e-07
, O 0 3.696015715703993e-10
pathological O 0 0.006398680619895458
, O 0 2.2528152676670743e-09
and O 0 3.3423805945176355e-09
genetic O 0 1.7154721376755333e-07
report O 0 5.7925464425068185e-09
. O 0 1.1525088439157116e-07

We O 0 1.1443534120303411e-08
report O 0 2.716930569413023e-10
a O 0 7.220602588065006e-11
Japanese O 0 5.515672896194701e-08
family O 0 4.898975114464577e-10
with O 0 8.225706227271701e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 4.335507401265204e-05
ALD B-Disease 1 1.0
) O 0 6.739928060106593e-10
with O 0 5.729194896275658e-11
a O 0 2.0550443291522669e-10
three O 0 1.4049245100622443e-10
base O 0 3.311579011011645e-09
pair O 0 3.05840175407468e-09
deletion O 0 5.4225810508512495e-09
( O 0 1.2708617491696828e-10
delGAG O 0 6.377384238476225e-07
291 O 0 2.25400711428847e-08
) O 0 3.115794774966041e-11
in O 0 8.093978265399926e-10
the O 0 1.5483047377529147e-07
ALD B-Disease 1 1.0
gene O 0 4.47567481387523e-06
. O 0 1.434086811968882e-06

A O 0 6.837524324510014e-07
variety O 0 6.11878050449377e-08
of O 0 9.716039528484544e-09
phenotypes O 0 2.810229204897041e-07
were O 0 1.3688249422827425e-09
observed O 0 4.710390966167211e-10
within O 0 3.5490313465835754e-10
this O 0 7.556802961161679e-10
family O 0 7.612531938150369e-09
. O 0 3.443945573167184e-08

While O 0 1.0946442330350692e-07
the O 0 5.606883135556018e-08
proband O 0 0.0019432979170233011
( O 0 6.234249561032357e-09
patient O 0 7.460796496161493e-07
1 O 0 1.4813665849544577e-08
) O 0 2.299529837379577e-11
was O 0 1.1529696086753916e-09
classified O 0 2.5469428788227333e-09
as O 0 6.478116376662513e-10
having O 0 5.054148211058873e-10
a O 0 7.145632696659021e-11
rare O 0 1.6114708456527183e-09
intermediate O 0 2.4611952653685876e-07
type O 0 8.76675176897379e-09
of O 0 8.691860564624676e-09
adult O 0 9.112867793703572e-09
cerebral O 0 2.630570961059675e-08
and O 0 1.263847360100101e-09
cerebello O 0 2.3583903384860605e-05
- O 0 2.2013789475749945e-06
brain O 0 2.062118653611833e-07
stem O 0 6.136472663342829e-09
forms O 0 6.871157531840311e-10
, O 0 4.3978234248731596e-11
his O 0 6.953571052292773e-10
younger O 0 1.6180324280412606e-07
brother O 0 1.1845185809988834e-07
( O 0 7.967972115441313e-11
patient O 0 2.1898607371895196e-08
2 O 0 3.338002096953119e-10
) O 0 2.8347120657745695e-12
and O 0 1.0929258192904356e-10
nephew O 0 1.259317468793597e-05
( O 0 4.753759608178143e-10
patient O 0 2.1846601612196537e-06
3 O 0 8.24446466651807e-09
) O 0 2.6999746188804963e-11
had O 0 1.1336771521541777e-09
a O 0 6.9706649341583216e-09
childhood O 0 0.0004786771896760911
ALD B-Disease 1 1.0
type O 1 0.9179162383079529
. O 0 1.0247033060295507e-05

Another O 0 3.7806278214702616e-06
nephew O 0 0.2933291792869568
( O 0 1.0791065818693824e-08
patient O 0 1.3752077165918308e-06
4 O 0 8.388876260312372e-09
) O 0 7.399292116516687e-12
of O 0 2.144969979411826e-09
patient O 0 4.667467976560147e-07
1 O 0 3.123493286238954e-08
was O 0 7.322073170001886e-09
classified O 0 3.890994193511688e-09
as O 0 8.904599280157299e-10
having O 0 2.5622814980863495e-09
an O 0 2.965157008816277e-10
adolescent O 0 1.789086496728487e-07
form O 0 1.2682332517499617e-08
. O 0 1.2075815902790055e-07

The O 0 2.780616341624409e-07
tau O 0 1.2032546692353208e-07
level O 0 9.349601093333604e-09
in O 0 3.8525985179838074e-10
the O 0 6.334101021465699e-10
cerebrospinal O 0 1.1659135878971938e-08
fluid O 0 9.19889515671457e-08
( O 0 1.504120050732638e-09
CSF O 0 1.4492913578578737e-05
) O 0 2.7845720174113353e-10
in O 0 9.631037301005563e-09
patient O 0 1.8299749626748962e-06
1 O 0 1.5487773907807423e-07
was O 0 4.1150837404302365e-08
as O 0 1.5386177887322106e-09
high O 0 4.920462970403605e-08
as O 0 2.1182564383104285e-11
that O 0 3.5835191151273316e-13
of O 0 1.500471691340266e-10
patients O 0 4.1977896714229246e-09
with O 0 4.835016276238946e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9429948925971985
( O 0 7.170730675909454e-10
AD B-Disease 0 1.5020488035588642e-06
) O 0 1.0906938685550926e-09
. O 0 2.5195577180170403e-08

His O 0 5.921595857216744e-06
brain O 0 4.229464991567511e-07
magnetic O 0 1.8738774087978527e-07
resonance O 0 6.183926757330482e-07
image O 0 5.111180598760257e-07
( O 0 6.364610172227003e-09
MRI O 1 0.9694497585296631
) O 0 4.25232959955224e-09
showed O 0 3.121360947488938e-08
abnormalities B-Disease 0 2.011209403462999e-07
in I-Disease 0 2.101709917212702e-09
the I-Disease 0 1.1487423456912893e-08
bilateral I-Disease 0 0.0001039766866597347
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9872236251831055
and O 0 5.641138614009833e-07
brain O 0 1.3115202079916344e-07
stem O 0 6.1196421263787215e-09
, O 0 9.933788167049151e-12
but O 0 9.729322382467931e-12
not O 0 9.201668073333114e-12
in O 0 9.66286078929457e-11
the O 0 8.501561676865776e-10
cerebral O 0 1.4003112447369404e-08
white O 0 3.5990940783214853e-10
matter O 0 1.0650866855144159e-09
, O 0 2.2055042254304214e-12
where O 0 1.6759815106917597e-12
marked O 0 1.954483797028672e-11
reductions O 0 2.5709661066741774e-09
of O 0 8.605111290194145e-09
the O 0 3.008788240776994e-08
cerebral O 0 3.516684614623955e-07
blood O 0 4.418411947426648e-08
flow O 0 1.7708986277398253e-08
and O 0 9.516758492367217e-10
oxygen O 0 7.100400978288235e-08
metabolism O 0 7.352556963269308e-08
were O 0 1.900461343851134e-09
clearly O 0 9.636765829768024e-10
demonstrated O 0 8.993579214688907e-10
by O 0 8.669404638617095e-10
positron O 0 7.919225026853383e-07
emission O 0 1.3603195156974834e-06
tomography O 0 9.219917046721093e-06
( O 0 8.034625409436558e-09
PET O 0 2.9989740141900256e-05
) O 0 2.3007167282429464e-09
. O 0 2.5640918721592243e-08

In O 0 1.018824605125701e-06
patients O 0 1.8125523411072209e-06
2 O 0 1.908970759245676e-08
and O 0 4.473296733031873e-10
3 O 0 5.74790659513269e-09
, O 0 2.5881543436190313e-11
the O 0 1.2452165687459882e-10
autopsy O 0 1.981512554039e-08
findings O 0 3.65719117212393e-08
showed O 0 1.626252554842722e-08
massive O 0 2.3484419386932132e-07
demyelination B-Disease 1 1.0
of I-Disease 1 0.7484574913978577
the I-Disease 0 3.1465556276089046e-06
cerebral I-Disease 0 1.011887889035279e-06
white I-Disease 0 1.4352222743596599e-09
matter I-Disease 0 8.617737634608602e-10
with O 0 2.614957946359131e-12
sparing O 0 2.9891495945122415e-09
of O 0 3.5577031098910084e-08
the O 0 1.9693037245360756e-07
U O 0 0.0001861955679487437
- O 0 5.873340569451102e-07
fibers O 0 3.829685724099363e-08
, O 0 6.437798211189616e-11
compatible O 0 1.0946474837680853e-09
with O 0 2.2866480844235815e-12
the O 0 5.994018476007668e-11
findings O 0 1.4721132091111144e-09
of O 0 1.235584079495311e-08
childhood O 0 4.565510607790202e-05
ALD B-Disease 1 1.0
. O 0 1.782734580046963e-05

Oleic O 0 0.003333250293508172
and O 0 1.5162668205448426e-06
erucic O 0 0.0014710837276652455
acids O 0 4.2173974179604556e-07
( O 0 2.3708850438453055e-09
Lorenzos O 0 1.2947550203534774e-05
Oil O 0 2.163869936566698e-07
) O 0 3.752105917631532e-11
were O 0 6.425031062740061e-10
administered O 0 2.8514710037619295e-10
to O 0 1.9775536763688706e-10
patients O 0 3.927381797552698e-08
1 O 0 1.3338969928611277e-08
and O 0 5.334072072926688e-10
4 O 0 3.2139435557354545e-09
, O 0 4.616998190015709e-12
but O 0 8.763862031913039e-12
sufficient O 0 1.2368943647089736e-09
effectiveness O 0 8.727844225120407e-09
was O 0 1.802883065060712e-09
not O 0 1.5549020404570513e-10
obtained O 0 1.07092130718911e-08
. O 0 4.2442938053000034e-08

The O 0 5.551345338972169e-07
findings O 0 1.440321568679792e-07
in O 0 1.871297339306466e-09
this O 0 2.136194970914218e-10
family O 0 6.269851304807617e-11
suggest O 0 3.902882877993008e-11
that O 0 1.146070109474262e-12
delGAG291 O 0 1.462670606855454e-08
is O 0 1.5329423494470085e-11
part O 0 6.739076657824583e-11
of O 0 5.522994284135052e-10
the O 0 1.0814921180823944e-09
cause O 0 5.011787873598905e-09
of O 0 5.333954788966366e-08
Japanese O 0 0.000669329718220979
ALD B-Disease 1 1.0
with O 0 1.93010674109928e-08
phenotypic O 0 2.672058371899766e-06
variations O 0 8.583117050875444e-06
. O 0 7.574861342618533e-07

Moreover O 0 4.974733656126773e-07
, O 0 3.7787170614755894e-10
although O 0 1.6445420025767987e-10
the O 0 7.484460273765592e-11
scale O 0 1.0607481559787857e-09
of O 0 3.7630876192906726e-10
the O 0 1.188577014588077e-10
study O 0 8.749165454624563e-12
is O 0 2.2699385231715608e-13
limited O 0 1.1668151687904693e-11
, O 0 1.2759390983010932e-12
there O 0 5.111447723415985e-12
is O 0 4.554990499366918e-12
a O 0 3.775523296778438e-11
possibility O 0 8.65213056755465e-09
that O 0 3.831215900085283e-10
PET O 0 0.1623540222644806
can O 0 1.1435083990818384e-09
detect O 0 7.517319744465567e-08
an O 0 6.136703922798858e-10
insidious B-Disease 0 1.6106216207845137e-05
lesion I-Disease 0 4.481459836824797e-05
which O 0 6.525637807897056e-10
is O 0 4.359248378937863e-11
undetectable O 0 8.790925765111979e-10
by O 0 5.97773774924093e-11
computed O 0 3.52586511098707e-08
tomogram O 0 2.099861012538895e-05
( O 0 8.73993433181397e-10
CT O 0 1.1879800695169251e-05
) O 0 1.1458679838316499e-10
or O 0 1.3653118913214968e-10
MRI O 0 1.3078431493340759e-07
analysis O 0 2.1715326758986464e-10
, O 0 8.009108133644194e-12
and O 0 2.7110889488229928e-12
that O 0 3.394684977998247e-13
the O 0 2.3820239183902636e-11
higher O 0 5.92421112166619e-10
level O 0 4.819878940409694e-10
of O 0 1.5243796502861784e-10
tau O 0 1.2684648886818195e-09
reflects O 0 3.2230521029852355e-10
the O 0 1.883987583994884e-11
process O 0 2.45352183014802e-10
of O 0 1.4556294836154393e-08
neuronal B-Disease 0 0.00010515305621083826
degeneration I-Disease 1 0.9999998807907104
in O 0 2.7665375455399044e-05
ALD B-Disease 1 1.0
. O 0 2.165535079257097e-05

Lorenzos O 0 0.00017172799562104046
Oil O 0 3.92651372749242e-07
should O 0 1.8591718442539928e-10
be O 0 9.993346428149863e-12
given O 0 4.210535045623409e-11
in O 0 3.851957294798147e-11
the O 0 1.5924891960672483e-10
early O 0 4.652961749229689e-08
stage O 0 2.58334473812738e-08
. O 0 1.1291970691829079e-09
. O 0 1.1472732097672633e-08

Nonsense O 0 3.287706567789428e-05
mutation O 0 1.6671732794293348e-07
in O 0 1.1159462687260202e-08
exon O 0 5.156138627171458e-07
4 O 0 2.0426195845857364e-08
of O 0 2.020350775566726e-09
human O 0 1.1037863956175897e-09
complement O 0 2.140402557415655e-07
C9 O 1 0.9999992847442627
gene O 0 2.903136753218405e-08
is O 0 4.7326146473958275e-11
the O 0 3.069269560729282e-10
major O 0 5.331378893913552e-09
cause O 0 3.7128549124076926e-09
of O 0 9.290794800165258e-09
Japanese O 0 9.024273822433315e-06
complement B-Disease 0 6.35291580692865e-05
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9938403367996216
. O 0 2.419833435851615e-06

Deficiency B-Disease 1 0.9302932620048523
of I-Disease 0 1.488563520979369e-05
the I-Disease 0 2.6667757992981933e-06
ninth I-Disease 0 0.0002807939890772104
component I-Disease 0 6.495976663245528e-07
of I-Disease 0 3.9561996345582884e-08
human I-Disease 0 5.337094099999717e-10
complement I-Disease 0 3.098967127357355e-08
( O 0 1.472629906906775e-09
C9 O 1 0.9999980926513672
) O 0 5.5084627831325506e-11
is O 0 3.500735725608939e-12
the O 0 1.8813985092069885e-11
most O 0 8.544050189573937e-11
common O 0 2.773735445771308e-07
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.191414314571375e-08
Japan O 0 1.5676759446137112e-08
but O 0 8.300960613327746e-11
is O 0 1.04708203912951e-11
rare O 0 3.3915964481323613e-10
in O 0 1.0342956352493715e-10
other O 0 2.0503304609675865e-10
countries O 0 2.0612626883131924e-10
. O 0 1.105476687968121e-08

We O 0 1.3085612593499718e-08
studied O 0 1.169209529194859e-08
the O 0 2.2465708460206457e-10
molecular O 0 1.0891492152609317e-09
basis O 0 3.935230807883272e-09
of O 0 3.8124207435430435e-07
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 6.631038473869921e-08
four O 0 1.0946578088422143e-09
Japanese O 0 5.929802000537165e-07
C9 B-Disease 1 1.0
- I-Disease 1 0.9970512390136719
deficient I-Disease 1 0.9997128844261169
patients O 0 0.07334037125110626
who O 0 4.31284030710799e-09
had O 0 1.5618292437125092e-08
suffered O 0 2.3876009436207823e-05
from O 0 0.00012917759886477143
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.709397323196754e-06

Direct O 0 1.4341166831854935e-07
sequencing O 0 4.1645532178336e-07
of O 0 1.1283960787977776e-07
amplified O 0 1.9073330577157321e-06
C9 O 0 0.0007253682124428451
cDNA O 0 5.877957391930977e-07
and O 0 1.2253883463486659e-09
DNA O 0 2.9955877778320428e-09
revealed O 0 1.0117058302228088e-09
a O 0 1.5557179156022727e-10
nonsense O 0 2.332513382441448e-08
substitution O 0 1.7063152313312457e-07
( O 0 1.9834163478282818e-10
CGA O 0 2.2733454230206007e-08
- O 0 4.094482974892344e-09
- O 0 4.453038382479235e-09
> O 0 1.2592714426773455e-08
TGA O 0 1.866600314315292e-07
) O 0 3.1146182855046334e-11
at O 0 2.9470803575293303e-10
codon O 0 1.1421156242974462e-09
95 O 0 9.57305434923228e-09
in O 0 4.626329042078936e-10
exon O 0 1.8223865083655255e-08
4 O 0 2.9679818602801333e-09
in O 0 1.9192862577011027e-10
the O 0 2.5530468850121224e-09
four O 0 1.4542446358234429e-08
C9 B-Disease 1 1.0
- I-Disease 1 0.8202627897262573
deficient I-Disease 0 0.00011996201646979898
individuals O 0 8.912012461337326e-09
. O 0 7.258336154336575e-08

An O 0 1.4323898511747757e-08
allele O 0 3.528408143438355e-08
- O 0 1.2360720447190943e-08
specific O 0 2.3084001377071672e-09
polymerase O 0 9.50223455475907e-09
chain O 0 1.8479514585223455e-09
reaction O 0 3.8863268159161635e-10
system O 0 1.6237782229922004e-09
designed O 0 3.325402397891253e-09
to O 0 2.7964996984763957e-10
detect O 0 2.4043658175543214e-09
exclusively O 0 9.368250619701257e-10
only O 0 4.591742958082179e-11
one O 0 1.8078641014773744e-11
of O 0 2.582268010531408e-10
the O 0 3.125748826438013e-10
normal O 0 9.62322888042877e-10
and O 0 6.378397116035828e-11
mutant O 0 8.793323846845169e-10
alleles O 0 8.767879478011054e-11
indicated O 0 4.564394348594014e-11
that O 0 9.496816310780587e-13
all O 0 1.2704951674047393e-11
the O 0 1.3704673507142218e-10
four O 0 6.322932455393726e-11
patients O 0 4.566704514541442e-10
were O 0 1.4511786217141776e-10
homozygous O 0 8.587001942839123e-11
for O 0 4.391729688246748e-11
the O 0 1.8341652641140627e-09
mutation O 0 4.167838019153436e-10
in O 0 7.964314763242442e-10
exon O 0 2.6111106166126774e-08
4 O 0 3.798062309101624e-09
and O 0 1.5815095760762787e-11
that O 0 9.825694945175822e-13
the O 0 7.295610227053828e-10
parents O 0 5.728181817765687e-10
of O 0 1.7329396806431419e-09
patient O 0 4.1100645375991007e-07
2 O 0 5.549917148073291e-08
were O 0 1.4845769946703058e-08
heterozygous O 0 7.468414509048671e-08
. O 0 2.3374436608492033e-08

The O 0 1.8742849761110847e-07
common O 0 3.0632779868255966e-08
mutation O 0 7.728622186675693e-09
at O 0 2.1492456703242624e-09
codon O 0 6.946482944414356e-09
95 O 0 3.2679466244189825e-08
in O 0 1.2374135049952883e-09
exon O 0 7.302885052240526e-08
4 O 0 5.878392439484514e-09
might O 0 1.8398405021713415e-10
be O 0 8.757713304552439e-12
responsible O 0 5.150125464981059e-11
for O 0 6.562281273936321e-11
most O 0 1.2375275026954569e-08
Japanese O 0 0.035095229744911194
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9744768142700195
. O 0 4.329746872144824e-08
. O 0 4.810543430266989e-08

BRCA1 O 0 5.776799298473634e-06
required O 0 1.2877236166275452e-08
for O 0 2.040204449826888e-09
transcription O 0 2.294063278895919e-06
- O 0 8.126026841637213e-06
coupled O 0 8.051032637013122e-06
repair O 0 1.3935322158431518e-06
of O 0 1.573437202750938e-07
oxidative O 0 2.395199771854095e-05
DNA O 0 7.712566912232433e-06
damage O 0 1.4387606825039256e-05
. O 0 4.815078682440799e-07

The O 0 5.163388777873479e-05
breast B-Disease 1 0.9999991655349731
and I-Disease 1 0.9901076555252075
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9995947480201721
gene O 0 7.406380291286041e-07
BRCA1 O 0 3.7961561361044005e-07
encodes O 0 2.1775434788651182e-09
a O 0 7.78990372207744e-10
zinc O 0 2.2114957118901657e-06
finger O 0 1.5075652015639207e-07
protein O 0 1.9711613674644468e-08
of O 0 4.0612114560190093e-08
unknown O 0 2.554100717588881e-07
function O 0 5.9463807211557196e-09
. O 0 1.76449947986157e-08

Association O 0 9.84761982181226e-07
of O 0 1.905072082308834e-07
the O 0 2.9637303100571444e-07
BRCA1 O 0 6.911476901905189e-08
protein O 0 1.3592532654982392e-09
with O 0 3.0152064872668305e-11
the O 0 1.5275763987077084e-09
DNA O 0 2.2639815355773862e-08
repair O 0 2.0931504707277782e-07
protein O 0 6.617619874305092e-08
Rad51 O 0 9.307858022111759e-07
and O 0 2.7746949182727576e-10
changes O 0 3.2069122357647473e-10
in O 0 2.3147302130599456e-10
the O 0 8.43533368155569e-11
phosphorylation O 0 6.161521293179817e-10
and O 0 2.0369451958490714e-10
cellular O 0 1.1046541459336368e-09
localization O 0 4.190261915226756e-09
of O 0 2.1021910878715744e-09
the O 0 8.809036278201177e-10
protein O 0 4.248306706422511e-10
after O 0 6.9754664266952204e-09
exposure O 0 5.102331357420553e-08
to O 0 4.907870221337873e-10
DNA O 0 1.3220758710019709e-08
- O 0 1.423364270891625e-08
damaging O 0 1.434139385025901e-08
agents O 0 4.699685640652262e-10
are O 0 2.125885925630122e-11
consistent O 0 1.301480728743698e-10
with O 0 1.3622956929193464e-12
a O 0 3.512428542462587e-11
role O 0 1.1455931758774796e-09
for O 0 1.661075010872537e-08
BRCA1 O 0 1.6378374994019396e-06
in O 0 2.531243481485035e-08
DNA O 0 3.1192308824756765e-07
repair O 0 5.882533514522947e-06
. O 0 5.68181064863893e-07

Here O 0 7.751166890557215e-07
, O 0 2.014225231050659e-09
it O 0 4.8503930039078824e-11
is O 0 1.586334362480013e-11
shown O 0 7.649435251888548e-11
that O 0 4.9708463040198936e-11
mouse O 0 7.459758677441641e-08
embryonic O 0 1.0823097227330436e-06
stem O 0 1.9147840646382974e-07
cells O 0 2.6907096994932544e-08
deficient B-Disease 0 1.7235367977264104e-07
in I-Disease 0 1.8483181651873792e-09
BRCA1 I-Disease 0 7.904962906479795e-09
are O 0 3.4226184386643155e-11
defective O 0 2.6033628586219493e-08
in O 0 3.560810757363697e-09
the O 0 3.742889109759062e-09
ability O 0 1.7104968830228273e-10
to O 0 7.796974871299156e-11
carry O 0 2.2314446124216403e-10
out O 0 1.358096829440214e-10
transcription O 0 8.50677679409273e-08
- O 0 6.882849561407056e-07
coupled O 0 5.902386874367949e-06
repair O 0 2.1851935798622435e-06
of O 0 4.706785716734885e-08
oxidative O 0 1.4215308965503937e-06
DNA O 0 4.291360369279573e-07
damage O 0 5.190640308683214e-07
, O 0 3.159434658339677e-10
and O 0 5.252646650966142e-10
are O 0 3.7261693730528123e-10
hypersensitive O 0 1.8589735191198997e-06
to O 0 3.2261966431690325e-09
ionizing O 0 0.0001035551613313146
radiation O 0 0.0010883657960221171
and O 0 7.674316293559968e-09
hydrogen O 0 2.611026559407037e-07
peroxide O 0 5.4157490012585185e-06
. O 0 2.567405772424536e-07

These O 0 7.294698889381834e-08
results O 0 6.677083064232647e-08
suggest O 0 4.8264890750715495e-08
that O 0 1.6841972261261162e-09
BRCA1 O 0 1.8427508052809571e-07
participates O 0 4.848508261545703e-10
, O 0 1.4551609049673342e-11
directly O 0 3.212990290490936e-11
or O 0 2.4924432309725297e-11
indirectly O 0 3.766606471167222e-10
, O 0 4.7557159599254106e-11
in O 0 5.26663102018432e-10
transcription O 0 1.7583430462764227e-06
- O 0 5.0764389015967026e-05
coupled O 0 6.423152808565646e-05
repair O 0 2.065745547952247e-06
of O 0 1.1674340072431733e-07
oxidative O 0 5.1343313316465355e-06
DNA O 0 6.603296469620545e-07
damage O 0 5.033326146985928e-07
. O 0 1.547849493022113e-08
. O 0 7.940493418345795e-08

Truncation O 0 8.69792202138342e-05
mutations O 0 6.121851470197726e-07
in O 0 5.694241522746779e-09
the O 0 4.24252721842322e-09
transactivation O 0 1.0794934723890037e-06
region O 0 1.4008267434917343e-08
of O 0 6.85940477751501e-08
PAX6 O 1 0.7855204343795776
result O 0 3.2180281550608925e-07
in O 0 3.9726611333890105e-08
dominant O 0 6.930485596967628e-06
- O 0 6.91813625053328e-07
negative O 0 1.883365854382646e-07
mutants O 0 1.288263661081146e-06
. O 0 2.171116619820168e-08

PAX6 O 1 0.9992148876190186
is O 0 4.281386267734888e-08
a O 0 3.0239004633614286e-09
transcription O 0 1.2664499138281826e-07
factor O 0 4.109859830236928e-08
with O 0 1.6292810156581794e-10
two O 0 1.3214340732758956e-10
DNA O 0 1.2163161589029414e-09
- O 0 4.331058178763669e-09
binding O 0 1.7141694286237907e-08
domains O 0 2.3557360506742953e-08
( O 0 1.221099332759934e-10
paired O 0 5.91904170121893e-09
box O 0 3.293162720297005e-08
and O 0 7.804328849836395e-10
homeobox O 0 7.529459367106028e-08
) O 0 1.5368008948746237e-11
and O 0 1.0168998282322761e-10
a O 0 1.7421851461474347e-10
proline O 0 2.109715602216511e-08
- O 0 9.58738368694867e-08
serine O 0 1.0714074960560538e-06
- O 0 1.7643095588937285e-06
threonine O 0 3.431347977311816e-06
( O 0 1.8595984752067807e-09
PST O 0 0.00012365855218376964
) O 0 2.491951311967e-09
- O 0 2.755464549863973e-07
rich O 0 2.075485383556952e-07
transactivation O 0 2.528105142118875e-05
domain O 0 8.349584845745994e-07
. O 0 2.285096911691653e-07

PAX6 O 1 0.9999998807907104
regulates O 0 0.0010250293416902423
eye O 1 0.999994158744812
development O 0 2.2028659714123933e-06
in O 0 5.9928817464083295e-09
animals O 0 3.5883962468119535e-09
ranging O 0 1.4295620687221344e-08
from O 0 2.2654533804455923e-09
jellyfish O 0 1.7992221046370105e-08
to O 0 8.073533508401454e-10
Drosophila O 0 7.933635259860239e-08
to O 0 3.7132230623626583e-09
humans O 0 8.948978091893878e-08
. O 0 8.1788584793685e-08

Heterozygous O 0 1.560473356221337e-05
mutations O 0 2.184959129181152e-07
in O 0 3.630023392986459e-09
the O 0 7.579845195948565e-09
human O 0 4.299922196082662e-08
PAX6 O 1 0.9996598958969116
gene O 0 5.188724472304784e-08
result O 0 2.0413926549167627e-08
in O 0 1.7077169678358928e-09
various O 0 1.6205821129489095e-09
phenotypes O 0 6.04834795581155e-08
, O 0 2.1647288128701092e-11
including O 0 2.344491822903194e-10
aniridia B-Disease 1 1.0
, O 0 2.3258768067080382e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.3501372342925606e-08
autosomal B-Disease 0 0.0009863704908639193
dominant I-Disease 1 0.924728274345398
keratitis I-Disease 1 0.9999994039535522
, O 0 1.395121103087149e-07
and O 0 6.208750846781186e-07
familial B-Disease 1 0.9999977350234985
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9998656511306763

It O 0 8.370575343974451e-09
is O 0 3.833964534738499e-10
believed O 0 3.7988931445021024e-10
that O 0 7.7425788220023e-13
the O 0 6.799760754461204e-11
mutated O 0 9.898604602653904e-09
allele O 0 1.900897217410602e-08
of O 0 6.778765992976332e-08
PAX6 O 1 0.9997108578681946
produces O 0 2.3572990226483626e-09
an O 0 4.799178849462793e-12
inactive O 0 1.3263994347312291e-09
protein O 0 3.808876547495288e-10
and O 0 9.789362653833678e-10
aniridia B-Disease 1 1.0
is O 0 1.4820138005688932e-08
caused O 0 1.8818791147623415e-07
due O 0 1.33911462398828e-05
to O 0 3.019948024984842e-08
genetic O 0 2.113954451488098e-06
haploinsufficiency O 0 0.00030717995832674205
. O 0 1.9772367068071617e-06

However O 0 1.6640518651911407e-06
, O 0 9.5985237535956e-09
several O 0 1.5375910544790372e-09
truncation O 0 8.735456162867195e-07
mutations O 0 2.3740129861948844e-08
have O 0 1.8997790840469264e-10
been O 0 1.170984975651379e-10
found O 0 2.205362108209652e-11
to O 0 4.129582526629649e-12
occur O 0 3.92303377283465e-11
in O 0 1.5416073972929212e-10
the O 0 5.952448534074506e-10
C O 0 4.3816288552989135e-07
- O 0 5.617359466469907e-09
terminal O 0 8.089571679192886e-08
half O 0 7.673184865275573e-10
of O 0 1.8056326434034986e-09
PAX6 O 0 0.000418054754845798
in O 0 2.2591619686096465e-09
patients O 0 1.1467043314894454e-08
with O 0 6.093406335061502e-11
Aniridia B-Disease 1 1.0
resulting O 0 1.1309283536320436e-06
in O 0 5.715557804819582e-09
mutant O 0 2.8208115843142423e-09
proteins O 0 8.01607738520893e-12
that O 0 1.023850600655185e-12
retain O 0 2.946557720040488e-10
the O 0 3.65264929413911e-10
DNA O 0 1.1864280669016125e-09
- O 0 1.0073503142749018e-09
binding O 0 8.79488426530628e-10
domains O 0 7.034088866930688e-10
but O 0 2.8368674076517664e-10
have O 0 1.9456622424307568e-10
lost O 0 3.916772239875854e-09
most O 0 6.250770040461262e-11
of O 0 3.4068520227137356e-10
the O 0 4.586451662902391e-09
transactivation O 0 4.960851128998911e-06
domain O 0 2.641827165916766e-07
. O 0 1.2330818321970582e-07

It O 0 3.523060065901973e-09
is O 0 6.288534970533277e-11
not O 0 2.5865455610674104e-11
clear O 0 4.738171521800894e-10
whether O 0 1.2770189072863758e-10
such O 0 3.2229801050220885e-09
mutants O 0 8.498947136104107e-05
really O 0 6.241890559977037e-08
behave O 0 2.013476052553642e-09
as O 0 4.139475429099093e-10
loss O 0 5.278601555858131e-09
- O 0 5.838088679155362e-09
of O 0 1.1627180107609547e-08
- O 0 2.0880538187384445e-08
function O 0 8.926160921518544e-10
mutants O 0 1.537166660625644e-08
as O 0 1.5456763646781724e-10
predicted O 0 3.1934914712650198e-09
by O 0 2.996090708862198e-09
haploinsufficiency O 0 0.00014366493269335479
. O 0 1.0709804882935714e-06

Contrary O 0 6.313625817710999e-07
to O 0 2.8990776446136124e-10
this O 0 1.7928793172306e-10
theory O 0 2.067358337853875e-07
, O 0 1.7897633375341115e-10
our O 0 2.159702694459753e-10
data O 0 8.757149866367442e-11
showed O 0 7.396233625556192e-11
that O 0 5.518815656205267e-13
these O 0 2.8554479961084844e-11
mutants O 0 6.4473035799039735e-09
are O 0 1.3080209138038867e-10
dominant O 0 1.993871912020495e-08
- O 0 1.2829772799705097e-08
negative O 0 1.5794924479450856e-08
in O 0 1.1142888833859388e-09
transient O 0 9.345981766273326e-09
transfection O 0 2.939498955356612e-08
assays O 0 7.330918982972889e-09
when O 0 5.784130396868647e-10
they O 0 6.731547957938844e-11
are O 0 4.82784402733305e-11
coexpressed O 0 4.251513132658147e-07
with O 0 7.404621915618748e-10
wild O 0 5.33252750756219e-06
- O 0 4.817935632672743e-07
type O 0 4.1622047319833655e-06
PAX6 O 1 0.9934307932853699
. O 0 1.0374549219704932e-06

We O 0 3.2953618500641824e-08
found O 0 4.994188951279455e-10
that O 0 3.7520754732345285e-12
the O 0 8.419231423140161e-10
dominant O 0 3.5129440334458195e-07
- O 0 1.1969643765041837e-07
negative O 0 1.3849396296450323e-08
effects O 0 2.793155218228094e-08
result O 0 8.848698662689003e-09
from O 0 1.8879173779851044e-09
the O 0 5.276202807991126e-10
enhanced O 0 2.8309554700456374e-09
DNA O 0 4.16714840412169e-09
binding O 0 3.040858453928763e-09
ability O 0 1.2070509036732346e-09
of O 0 5.4136006788496616e-09
these O 0 6.610754610392178e-09
mutants O 0 4.376196329758386e-07
. O 0 3.991337393927097e-08

Kinetic O 0 5.741637323808391e-06
studies O 0 2.036954960260573e-08
of O 0 1.199605415003191e-09
binding O 0 1.4293059180658929e-08
and O 0 3.0824711672039484e-09
dissociation O 0 3.991908670286648e-08
revealed O 0 3.1297711089450786e-09
that O 0 4.811561739315184e-12
various O 0 9.99241800414552e-11
truncation O 0 7.1569097315205e-08
mutants O 0 4.301177369825382e-08
have O 0 1.4190933150803886e-10
3 O 0 3.750819932424321e-10
- O 0 2.7846042138790494e-10
5 O 0 3.63522489887913e-10
- O 0 3.4927491454617154e-10
fold O 0 1.0711781461836267e-09
higher O 0 8.964076592121728e-09
affinity O 0 1.1762032459117222e-09
to O 0 5.621340892769666e-11
various O 0 2.2736207361262473e-10
DNA O 0 4.3759035284196557e-10
- O 0 2.3222478107154387e-10
binding O 0 1.2310615027377736e-10
sites O 0 1.3348729066553489e-10
when O 0 3.423180142125837e-11
compared O 0 3.101110479519775e-10
with O 0 5.289447699285965e-12
the O 0 1.98891414449065e-09
wild O 0 2.7276408331999846e-07
- O 0 8.840806486887232e-08
type O 0 1.2582074759848183e-06
PAX6 O 0 0.027293477207422256
. O 0 1.1308227385598002e-06

These O 0 8.894893710476026e-09
results O 0 3.486693822551956e-09
provide O 0 1.4216995636306962e-10
a O 0 6.39756303488781e-11
new O 0 2.14366946416078e-09
insight O 0 3.939218284898516e-09
into O 0 1.217032585820732e-10
the O 0 2.8898069701077667e-11
role O 0 6.314135325702352e-11
of O 0 7.602051765864815e-10
mutant O 0 8.695792530488688e-07
PAX6 O 1 0.9999955892562866
in O 0 1.4656426117198862e-07
causing O 0 1.958728262252407e-06
aniridia B-Disease 1 1.0
. O 0 2.4528324615857855e-07
. O 0 2.5116176516348787e-07

Reversal O 0 1.0899939297814853e-05
of O 0 4.107715540158097e-06
severe O 1 0.9999610185623169
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.683787013462279e-05
excellent O 0 4.5169844042902696e-07
neuropsychologic O 0 2.3681714083068073e-06
outcome O 0 2.6131940558116185e-06
in O 0 7.331491858053596e-09
very B-Disease 0 5.554942061891666e-10
- I-Disease 0 2.5039863515985417e-09
long I-Disease 0 9.345727525200687e-10
- I-Disease 0 1.6029211291623824e-09
chain I-Disease 0 1.3760471651025341e-09
acyl I-Disease 0 1.4757974042822752e-07
- I-Disease 0 2.223827095804154e-07
coenzyme I-Disease 0 5.651132255479752e-07
A I-Disease 0 1.0753855121947709e-06
dehydrogenase I-Disease 0 9.079487426788546e-06
deficiency I-Disease 0 0.004328443668782711
. O 0 7.30347665012232e-07

Very B-Disease 0 4.653902294649015e-07
- I-Disease 0 1.485447143068086e-07
long I-Disease 0 6.6592491521078045e-09
- I-Disease 0 1.9895287639570824e-09
chain I-Disease 0 3.0789087945848337e-10
acyl I-Disease 0 5.714347661722741e-09
- I-Disease 0 9.297792535889471e-10
coenzyme I-Disease 0 1.9241070958742057e-09
A I-Disease 0 7.034611781975286e-10
dehydrogenase I-Disease 0 1.0630469837735745e-09
( I-Disease 0 1.8184820316236028e-10
VLCAD I-Disease 1 0.9999901056289673
) I-Disease 0 1.7592469703231473e-08
deficiency I-Disease 0 0.00033177706063725054
is O 0 6.126704699127572e-10
a O 0 1.289057305342567e-09
disorder O 0 0.056074127554893494
of O 1 0.8172948360443115
fatty O 0 0.014181895181536674
acid O 0 1.0058207635665894e-06
beta O 0 3.4818572913764e-08
oxidation O 0 1.1688996437442256e-08
that O 0 8.81237652294864e-11
reportedly O 0 4.534721487203797e-09
has O 0 2.6132042710291792e-11
high O 0 2.651626473948454e-09
rates O 0 1.2403388316428732e-09
of O 0 5.464034780189309e-10
morbidity O 0 1.5351618003478507e-06
and O 0 3.212485166770307e-09
mortality O 0 3.9133996665441373e-07
. O 0 3.920122537692805e-08

We O 0 4.271677234157778e-09
describe O 0 1.0819439788534169e-09
the O 0 2.6468752190034195e-10
outcome O 0 3.4334121323809086e-08
of O 0 9.413535728697298e-09
a O 0 6.440364214155281e-11
5 O 0 1.5849015155833257e-10
- O 0 5.133687919212093e-11
year O 0 2.0326139382742525e-10
- O 0 5.219562115854615e-09
old O 0 2.2085737327870447e-07
girl O 0 5.864192686999559e-09
with O 0 4.581588441965323e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.5450862633770157e-07
was O 0 9.84986403551602e-09
first O 0 3.849609242490004e-10
seen O 0 3.549769089783439e-10
at O 0 1.752951395150859e-10
5 O 0 6.687524839454895e-11
months O 0 8.27089698812733e-12
of O 0 7.912014099442644e-11
age O 0 2.4198285597520908e-09
with O 0 4.528070973730536e-11
severe O 0 1.9982113371952437e-05
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
, O 0 0.0076148658990859985
hepatomegaly B-Disease 1 1.0
, O 0 0.00020039542869199067
encephalopathy B-Disease 1 0.9999377727508545
, O 0 1.8525160783156025e-07
and O 0 7.973028459673515e-07
hypotonia B-Disease 1 0.9999938011169434
. O 0 0.0006856569088995457

Biochemical O 0 8.236212306655943e-05
studies O 0 1.6248529846052406e-06
indicated O 0 0.0027351726312190294
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 7.648990140296519e-05
by O 0 5.038721440087102e-09
a O 0 1.7693042586586216e-09
stable O 0 2.6913210149359656e-07
yet O 0 4.692882171752899e-08
inactive O 0 9.905612614602433e-07
enzyme O 0 4.954063115292229e-07
. O 0 1.2485502054460085e-07

Molecular O 0 1.1241431820963044e-06
genetic O 0 2.263048948236701e-08
analysis O 0 3.850205487765379e-09
of O 0 1.3563021639129147e-07
her O 0 5.2470145561756e-08
VLCAD O 1 1.0
gene O 0 2.2921923914509534e-07
revealed O 0 5.6051725039196754e-08
a O 0 1.1864462745592164e-09
T1372C O 0 2.365065711273928e-06
( O 0 3.4577246621481095e-10
F458L O 0 5.745837370341178e-07
) O 0 1.0489020763060353e-09
missense O 0 8.187644198187627e-07
mutation O 0 1.6770433930446416e-08
and O 0 6.77010281169288e-10
a O 0 6.545474384722638e-09
1668 O 0 0.0014667405048385262
ACAG O 1 0.9999990463256836
1669 O 1 0.5188257098197937
splice O 0 0.000281379820080474
site O 0 2.5053429908439284e-06
mutation O 0 3.4043424079754914e-07
. O 0 5.703157412995097e-08

After O 0 3.220591793251515e-07
initial O 0 5.627318842016393e-07
treatment O 0 2.13459816222894e-06
with O 0 7.958710912525646e-10
intravenous O 0 6.706132182898727e-08
glucose O 0 1.1641197517064938e-07
and O 0 6.610523795025358e-10
carnitine O 0 1.2090286105603809e-08
, O 0 4.9642897431700916e-11
the O 0 1.6405390379503615e-09
patient O 0 2.9052148420305457e-07
has O 0 1.5465728697705572e-10
thrived O 0 3.501450507314985e-08
on O 0 1.5860908142428798e-09
a O 0 8.156709335738199e-11
low O 0 4.793086816334835e-08
- O 0 7.531051338105499e-09
fat O 0 1.1031391267124491e-07
diet O 0 6.915220751579909e-08
supplemented O 0 2.143767607876157e-09
with O 0 1.994994967835506e-11
medium O 0 2.2091214191277686e-07
- O 0 1.0647195125557118e-08
chain O 0 5.489620313881005e-09
triglyceride O 0 4.7185116613945866e-07
oil O 0 5.16632745473089e-08
and O 0 3.6726222063521163e-10
carnitine O 0 7.217004593940146e-08
and O 0 3.625586220135091e-10
avoidance O 0 1.7453506018227927e-07
of O 0 4.4936797394257155e-08
fasting O 0 3.1673864668846363e-06
. O 0 2.7618207809609885e-07

Her O 0 6.5337417254340835e-06
ventricular O 0 0.003892255714163184
hypertrophy O 0 0.15577290952205658
resolved O 0 2.3985463485587388e-05
significantly O 0 1.8226809572752245e-07
over O 0 7.246682698358597e-10
1 O 0 1.4085475008585036e-09
year O 0 1.2569209562052208e-10
, O 0 1.2465110540982316e-11
and O 0 1.0999189753446714e-10
cognitively O 0 2.0886766378680477e-06
, O 0 1.302290358884406e-10
she O 0 2.730425954777793e-11
is O 0 2.9549856485344694e-12
in O 0 3.0224153041436e-11
the O 0 5.498357324995595e-10
superior O 0 3.093693692335364e-07
range O 0 1.7666150142758852e-07
for O 0 7.720077022099758e-09
age O 0 1.5560717656626366e-06
. O 0 1.966111682349947e-07

Clinical O 0 3.789192487602122e-05
recognition O 0 6.021234639774775e-06
of O 1 0.9999998807907104
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 7.705546067882096e-08
important O 0 7.574180393987717e-09
because O 0 5.4915523517440334e-11
it O 0 1.983736092059374e-12
is O 0 2.0740540361552373e-12
one O 0 1.2040392554507617e-12
of O 0 7.274735674966948e-11
the O 0 4.4140444077633845e-10
few O 0 1.5247235696236316e-09
directly O 0 3.517594659996348e-09
treatable O 1 0.9991312623023987
causes O 0 2.857168546199773e-08
of O 0 1.1489678399811964e-06
cardiomyopathy B-Disease 1 1.0
in O 0 0.2738496959209442
children O 0 1.8232523046890492e-08
. O 0 4.332485203928371e-10
. O 0 5.3879101180598354e-09

Cloning O 0 5.1783417802653275e-06
of O 0 2.6406048903027113e-08
a O 0 8.51566483994759e-10
novel O 0 2.4696332090456963e-08
member O 0 3.4909308777031356e-10
of O 0 2.7092561527553016e-10
the O 0 4.788969776292618e-10
low O 0 7.081101216499519e-08
- O 0 5.2866417910024666e-09
density O 0 2.1407450034871545e-08
lipoprotein O 0 1.356052507617278e-05
receptor O 0 2.4460680378979305e-06
family O 0 3.5433462386436076e-08
. O 0 7.774978172392366e-08

A O 0 1.4641088341704744e-07
gene O 0 2.4863491265847415e-09
encoding O 0 2.750575234244934e-08
a O 0 7.334989060581165e-09
novel O 0 7.455717536686279e-07
transmembrane O 0 2.4760714367744185e-08
protein O 0 2.330369008873845e-09
was O 0 1.0098781810796709e-09
identified O 0 2.665070247820367e-11
by O 0 9.68181958216352e-12
DNA O 0 3.631841008489012e-11
sequence O 0 4.872635281372162e-12
analysis O 0 1.1319648343666167e-11
within O 0 6.504261712558801e-11
the O 0 8.850853938646708e-10
insulin B-Disease 0 0.0006652127485722303
- I-Disease 1 0.9996716976165771
dependent I-Disease 1 0.9998207688331604
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 6.8570731315276134e-09
IDDM B-Disease 0 0.0017888577422127128
) O 0 4.748947346477905e-10
locus O 0 9.379715670831956e-09
IDDM4 O 0 8.48856052471092e-06
on O 0 3.4335105425498114e-08
chromosome O 0 1.2367299184745661e-08
11q13 O 0 3.0228088689909782e-06
. O 0 1.7651683492658776e-07

Based O 0 3.1809494771550817e-07
on O 0 2.396213183430973e-08
its O 0 9.16433484654533e-10
chromosomal O 0 2.743763261037202e-08
position O 0 7.142603664078706e-08
, O 0 1.2805263793769228e-10
this O 0 7.361443399300782e-11
gene O 0 1.2026632467687648e-10
is O 0 5.598216334945505e-12
a O 0 1.835510736458712e-11
candidate O 0 1.1345403505558238e-09
for O 0 1.5670734154760169e-10
conferring O 0 1.5966170394676737e-06
susceptibility O 0 0.0016011572442948818
to O 0 2.163143619782204e-07
diabetes B-Disease 1 0.9999998807907104
. O 0 1.5833124052733183e-05

The O 0 9.318872002950229e-07
gene O 0 3.362735867540323e-08
, O 0 5.675686032269311e-10
termed O 0 2.2102502938992075e-08
low O 0 5.631081876344979e-07
- O 0 1.1756835505138952e-08
density O 0 6.4918497244548234e-09
lipoprotein O 0 3.3071626148739597e-07
receptor O 0 8.883839441864438e-09
related O 0 4.698110345202622e-09
protein O 0 7.23948456737844e-10
5 O 0 1.2738717858340465e-09
( O 0 1.012237429293128e-11
LRP5 O 0 1.835843431763351e-05
) O 0 9.524288996365371e-11
, O 0 4.3508256025726055e-11
encodes O 0 2.7689467038682913e-11
a O 0 3.92165744322881e-11
protein O 0 1.2041374564120133e-09
of O 0 1.5803692576810136e-08
1615 O 0 1.4458430996455718e-05
amino O 0 3.9645691174428066e-08
acids O 0 5.039663353301194e-09
that O 0 2.0805808464974263e-11
contains O 0 3.354921548903711e-11
conserved O 0 3.931297787307386e-10
modules O 0 5.068251929252199e-10
which O 0 2.171824352303897e-12
are O 0 1.217414407131412e-12
characteristic O 0 4.621308544172642e-11
of O 0 1.5391807273168467e-10
the O 0 2.391991604788757e-10
low O 0 1.6899869947906154e-08
- O 0 1.1221996665256029e-09
density O 0 3.3165472590468426e-09
lipoprotein O 0 5.518386956282484e-07
( O 0 1.3949575938809744e-09
LDL O 0 1.1798969353549182e-05
) O 0 3.022332162316843e-09
receptor O 0 8.168085940951642e-08
family O 0 6.0100631138482186e-09
. O 0 1.6406900726906315e-08

These O 0 2.2248510589406578e-08
modules O 0 1.2230425738835038e-07
include O 0 5.613428832873524e-09
a O 0 9.454952376586334e-10
putative O 0 8.917287175336241e-08
signal O 0 6.9093908372508395e-09
peptide O 0 4.809813658468443e-10
for O 0 3.723446551084919e-11
protein O 0 4.898639271999627e-10
export O 0 3.127690106907721e-08
, O 0 2.5633165035010563e-10
four O 0 1.4813142379388466e-10
epidermal O 0 6.429313081923738e-09
growth O 0 1.129518034659327e-09
factor O 0 7.715557970300324e-09
( O 0 9.000970802031105e-11
EGF O 0 7.825233439007206e-08
) O 0 3.5476961646185856e-11
repeats O 0 9.366082909245677e-11
with O 0 1.028733088298539e-11
associated O 0 4.837905631660533e-09
spacer O 0 1.800049886924171e-07
domains O 0 9.65648041528766e-08
, O 0 1.3116790986700266e-09
three O 0 1.2753594846870442e-09
LDL O 0 6.445255166909192e-06
- O 0 1.1452286798885325e-06
receptor O 0 5.427799365520514e-08
( O 0 2.7299951188552996e-10
LDLR O 0 0.00023274651903193444
) O 0 1.0142169742932694e-10
repeats O 0 1.7052294298824933e-10
, O 0 2.814209629220521e-11
a O 0 8.0263767854305e-11
single O 0 1.602997623528779e-09
transmembrane O 0 5.465048413810791e-09
spanning O 0 7.533076384902415e-09
domain O 0 5.492385213301532e-09
, O 0 2.418184819052982e-10
and O 0 2.3613477839745656e-10
a O 0 1.115826653297347e-09
cytoplasmic O 0 6.449999290225605e-08
domain O 0 9.480911700165962e-08
. O 0 5.374354472564846e-08

The O 0 6.666304557256808e-07
encoded O 0 5.7365408423493136e-08
protein O 0 2.1458632204485184e-08
has O 0 5.796729068974216e-11
a O 0 4.440405335093267e-11
unique O 0 5.953629256261195e-10
organization O 0 2.885551242393092e-10
of O 0 1.0249213922008948e-08
EGF O 0 4.872573117609136e-05
and O 0 1.1114901354858375e-07
LDLR O 1 0.8809084892272949
repeats O 0 3.454311947592714e-09
; O 0 1.1262475674289618e-10
therefore O 0 1.3495683459652241e-09
, O 0 1.315032666093785e-10
LRP5 O 0 0.00013765542826149613
likely O 0 5.413686210431479e-08
represents O 0 3.7167077748812005e-10
a O 0 6.863775606907874e-12
new O 0 4.939506095813506e-11
category O 0 5.365980437765927e-10
of O 0 6.637966842859555e-10
the O 0 8.562755837715486e-09
LDLR O 1 0.9999992847442627
family O 0 2.54999264370781e-07
. O 0 1.0635427827310195e-07

Both O 0 5.315476414580189e-07
human O 0 5.120523383084219e-08
and O 0 4.3535465010791086e-08
mouse O 0 1.4988648899816326e-06
LRP5 O 1 0.9975383281707764
cDNAs O 0 0.000890720053575933
have O 0 6.200145286072711e-09
been O 0 1.311436514939146e-09
isolated O 0 3.1468849748250705e-09
and O 0 1.446185671216682e-10
the O 0 5.833903582441735e-09
encoded O 0 9.619949281614026e-09
mature O 0 1.243945391138368e-08
proteins O 0 2.1324527213484323e-11
are O 0 3.447539996537241e-12
95 O 0 2.3498594736715006e-10
% O 0 3.8045018524446306e-12
identical O 0 3.028636369473148e-11
, O 0 1.6546811663908922e-12
indicating O 0 8.322156158646621e-11
a O 0 1.1384605064224118e-11
high O 0 5.675371839153343e-10
degree O 0 1.1782915754210421e-09
of O 0 5.131947644620993e-10
evolutionary O 0 2.3316417241403542e-08
conservation O 0 5.844885464512117e-09
. O 0 2.1283091955481837e-10
. O 0 4.4597876502905365e-09

The O 0 6.611081062146695e-06
APC B-Disease 0 1.67748803505674e-05
variants O 0 1.432946646673372e-06
I1307K O 0 1.577877083036583e-05
and O 0 1.7047693035010525e-08
E1317Q O 0 2.1242776711005718e-06
are O 0 4.0917097487991327e-10
associated O 0 5.343058262496925e-08
with O 0 8.049881216720678e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.275866617968859e-07
but O 0 8.38842439954135e-10
not O 0 1.2033424257040792e-10
always O 0 2.021826039921848e-10
with O 0 7.67620775971034e-12
a O 0 2.1605472966257366e-10
family O 0 1.0919510851081782e-09
history O 0 2.1806370043009338e-08
. O 0 3.096633349741751e-08

Classical O 0 0.005243242718279362
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.2638999982737005e-06
FAP B-Disease 0 0.0022560972720384598
) O 0 7.047423200567948e-10
is O 0 2.962181888666038e-11
a O 0 1.3220921579737421e-10
high O 0 5.48014540981967e-05
- O 1 0.9999932050704956
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 6.75033939856462e-09
predisposes O 0 9.430050909031706e-07
to O 0 9.759570929190886e-10
hundreds O 0 3.5863847447359376e-09
or O 0 1.9707609155705796e-10
thousands O 0 1.9506163351223904e-09
of O 0 3.651256974990247e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 1.2711369734574873e-08
that O 0 2.9209058782786457e-11
results O 0 1.8290053915848148e-09
from O 0 2.9188704786520248e-09
truncating O 0 1.6774504274508217e-07
mutations O 0 3.257614622498295e-09
in O 0 1.551937023336336e-09
the O 0 5.013855641777809e-08
APC B-Disease 0 1.774467818904668e-06
gene O 0 7.47672359580065e-08
. O 0 9.604221418157977e-08

A O 0 1.8203652984993823e-07
variant O 0 6.292232797022734e-07
of O 0 5.040166115577449e-07
FAP B-Disease 0 0.017319750040769577
is O 0 1.3627668238314072e-07
attenuated B-Disease 1 0.9983805418014526
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 2.1859007048874446e-08
which O 0 7.942557028739472e-11
results O 0 1.0004150841069759e-09
from O 0 1.3852506919320717e-09
germ O 0 4.5701406634179875e-05
- O 0 4.305067875520763e-07
line O 0 1.0568115840214887e-06
mutations O 0 1.320822562433932e-09
in O 0 2.1279844553134808e-10
the O 0 3.2956978812670457e-10
5 O 0 5.177716033699653e-10
and O 0 4.09116907018614e-11
3 O 0 3.2789698733992623e-10
regions O 0 2.639111706947972e-10
of O 0 2.9926239264455035e-09
the O 0 1.798429991595185e-07
APC B-Disease 0 2.154234834961244e-06
gene O 0 3.5961882360879827e-08
. O 0 1.0351418211484997e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 2.0757090624101693e-07
" O 0 3.1559928004298854e-08
multiple O 0 2.7311539696484033e-08
" O 0 2.518484507163521e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 7.342124130893524e-10
typically O 0 3.135015302913047e-10
fewer O 0 7.981448141292091e-11
than O 0 1.2486883922691039e-11
100 O 0 6.363972543388385e-11
) O 0 4.424346631247411e-13
without O 0 5.7161733679755855e-11
the O 0 6.695569654269207e-10
florid O 0 5.425656013358093e-07
phenotype O 0 1.1246348918803051e-07
of O 0 1.1162315516344279e-08
classical O 0 6.923039563844213e-07
FAP B-Disease 0 1.746819179970771e-05
. O 0 1.2369804380796268e-07

Another O 0 5.037504138272197e-07
group O 0 4.458579727639744e-09
of O 0 1.2427691764571591e-08
patients O 0 3.3550935540915816e-07
with O 0 2.0733847971854402e-09
multiple O 0 2.4171558834495954e-06
adenomas B-Disease 1 0.9999997615814209
has O 0 1.7713107425265662e-08
no O 0 1.1046773495948514e-09
mutations O 0 6.617841274980663e-10
in O 0 1.2969367801929366e-09
the O 0 8.556176211982347e-09
APC B-Disease 0 2.2752152162297534e-08
gene O 0 2.5561491812098325e-10
, O 0 4.073314949226692e-11
and O 0 2.069345944599732e-10
their O 0 7.677357083402114e-10
phenotype O 0 2.35475656751305e-08
probably O 0 6.474756286678485e-10
results O 0 1.626802859089338e-10
from O 0 4.4532634524419024e-11
variation O 0 2.7446676043041407e-09
at O 0 4.915636231395126e-10
a O 0 2.759546237351973e-11
locus O 0 4.722833235604185e-10
, O 0 1.7896600867928214e-11
or O 0 5.874004060935079e-11
loci O 0 1.612150946073143e-08
, O 0 2.119583120130386e-10
elsewhere O 0 8.320355071589347e-09
in O 0 1.1573496605521427e-09
the O 0 1.5109643314303867e-08
genome O 0 4.3617834677434075e-08
. O 0 2.4193408165729124e-08

Recently O 0 1.3801214890918345e-06
, O 0 9.155389224524413e-10
however O 0 1.3468759441082057e-09
, O 0 4.610048801034772e-11
a O 0 5.2359297453286047e-11
missense O 0 3.4251577574195835e-08
variant O 0 1.2224946033256856e-07
of O 0 1.0170036148338113e-05
APC B-Disease 0 1.1993405678367708e-05
( O 0 3.9470382517947655e-10
I1307K O 0 6.101335543462483e-07
) O 0 5.64470935271455e-11
was O 0 1.4620645805152321e-09
described O 0 3.533650871911931e-10
that O 0 5.973221049726529e-12
confers O 0 1.2172212127126159e-09
an O 0 2.694016234053298e-12
increased O 0 1.5114910434377293e-09
risk O 0 5.218499836701085e-07
of O 1 0.884120523929596
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 9.044143922665171e-08
including O 0 6.86463685894978e-09
multiple O 0 5.005876957397959e-08
adenomas B-Disease 0 0.006610305514186621
, O 0 4.103059225712968e-09
in O 0 9.62343946753208e-08
Ashkenazim O 0 0.0025170159060508013
. O 0 3.1452128723685746e-07

We O 0 3.05256371291307e-08
have O 0 1.9404958195856636e-10
studied O 0 2.1708421726884808e-09
a O 0 3.318378904992869e-11
set O 0 4.1992287425074437e-10
of O 0 6.18199269553088e-10
164 O 0 1.1473326821942464e-07
patients O 0 1.437518815095018e-08
with O 0 1.9761133007722975e-10
multiple O 0 5.369181963033043e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9992992877960205
/ I-Disease 1 0.9662050604820251
or I-Disease 0 1.602834527147934e-05
carcinoma I-Disease 1 1.0
and O 0 2.6814058529112117e-08
analyzed O 0 4.916269702448517e-08
codons O 0 1.6430888649665576e-08
1263 O 0 5.199210590944858e-07
- O 0 2.5608954956624075e-08
1377 O 0 1.9528602024365682e-06
( O 0 6.688753440009521e-10
exon O 0 1.5205344539026555e-07
15G O 0 2.0664221267452376e-07
) O 0 3.371523199513504e-11
of O 0 2.012259248118653e-09
the O 0 2.402854093475071e-08
APC B-Disease 0 3.013561524767283e-07
gene O 0 1.889271850075147e-09
for O 0 1.8575849747293205e-09
germ O 1 0.5205920338630676
- O 0 2.6060013624373823e-05
line O 0 1.641082053538412e-05
variants O 0 1.4318989087769296e-06
. O 0 2.806522445553128e-07

Three O 0 2.238788567865413e-07
patients O 0 7.36715648486097e-08
with O 0 7.088158532342348e-11
the O 0 1.8258857759079206e-09
I1307K O 0 3.616859771682357e-07
allele O 0 4.453922120006837e-09
were O 0 2.1610582767728204e-10
detected O 0 1.8748402830226496e-10
, O 0 1.2689420911607407e-12
each O 0 6.057639199280596e-13
of O 0 6.071412816943678e-10
Ashkenazi O 0 1.1481179171823896e-06
descent O 0 7.570903903797443e-07
. O 0 2.2408903532777913e-07

Four O 0 2.4290891360578826e-06
patients O 0 6.300269888015464e-06
had O 0 9.839273396039516e-09
a O 0 1.1309430059114334e-09
germ O 0 2.8502987333922647e-05
- O 0 5.573966177507828e-07
line O 0 9.233240803041554e-07
E1317Q O 0 1.3865171695215395e-06
missense O 0 1.5482531523502985e-07
variant O 0 5.056920926449493e-08
of O 0 1.6705058669685968e-07
APC O 0 2.274117427703004e-08
that O 0 3.650792775727885e-12
was O 0 2.92039503690944e-10
not O 0 6.5642304959701026e-12
present O 0 1.1089093532312688e-10
in O 0 7.773632432206412e-11
controls O 0 4.973484957204732e-10
; O 0 3.213756344377927e-11
one O 0 4.953242677130376e-11
of O 0 4.1002798378819705e-10
these O 0 8.911612420225978e-11
individuals O 0 1.539133057115727e-11
had O 0 2.635510143456088e-10
an O 0 8.4299893454709e-12
unusually O 0 8.762989445187941e-09
large O 0 6.571854171966152e-10
number O 0 1.5136568387585925e-10
of O 0 3.914083723799422e-09
metaplastic B-Disease 0 0.00015466967306565493
polyps I-Disease 0 1.6484855223097838e-06
of I-Disease 0 6.868542072879791e-07
the I-Disease 0 5.410495305113727e-07
colorectum I-Disease 0 0.00011354013986419886
. O 0 5.689716431334091e-07

There O 0 9.366042519332041e-08
is O 0 3.7070788105886265e-10
increasing O 0 4.1189587851597764e-10
evidence O 0 4.990466373477886e-10
that O 0 1.6654632534196523e-11
there O 0 1.2506387592203794e-10
exist O 0 4.1742817535883603e-10
germ O 0 6.164477781567257e-07
- O 0 1.2961362649832608e-08
line O 0 1.8242019450553926e-08
variants O 0 5.7496500893705615e-09
of O 0 6.425965981549098e-09
the O 0 6.6007381782640095e-09
APC B-Disease 0 1.9952832275293986e-08
gene O 0 9.906225839628746e-11
that O 0 6.703970711896545e-12
predispose O 0 1.0754901857978894e-08
to O 0 2.0683713075619892e-10
the O 0 3.5661735786618465e-09
development O 0 2.3193729603576685e-08
of O 0 1.4338363030219625e-07
multiple O 0 0.43538546562194824
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 1.776429003896851e-09
but O 0 7.270630625333396e-11
without O 0 2.6932689412006994e-10
the O 0 9.436323944456149e-10
florid O 0 5.281010473368042e-08
phenotype O 0 3.4088885048078055e-09
of O 0 6.66331156917721e-10
classical O 0 2.5258563240981857e-08
FAP B-Disease 0 3.4304281371078105e-07
, O 0 3.402285397857696e-11
and O 0 8.61805765639545e-12
possibly O 0 5.031581054582013e-11
with O 0 3.5053594141937205e-12
importance O 0 6.289526766067866e-08
for O 0 1.9643737687147222e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.915607299451949e-06
in O 0 9.830465608207106e-11
the O 0 4.80721573659082e-11
general O 0 1.1143633793508911e-09
population O 0 1.9280323865222826e-11
. O 0 1.0762687963072892e-10
. O 0 7.272205060360193e-09

Genomic O 0 8.94430854714301e-07
structure O 0 6.846986622122131e-08
of O 0 3.3402475452248837e-08
the O 0 1.9581645460675645e-07
human O 0 4.846044248552062e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.177369788114447e-05
CLD B-Disease 1 0.9999984502792358
) O 0 2.8865670742561633e-08
gene O 0 6.31124166261543e-08
. O 0 1.2229236290295376e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.29675952141406e-05
CLD B-Disease 1 1.0
) O 0 7.652737332719539e-10
is O 0 2.4213589466803853e-11
caused O 0 3.2406385908068103e-10
by O 0 3.021679018111456e-10
mutations O 0 1.783980629888049e-09
in O 0 6.913816741338508e-10
a O 0 1.5380156870303807e-10
gene O 0 4.80074924258389e-10
which O 0 1.0350257456659406e-10
encodes O 0 4.1785355731072116e-10
an O 0 6.393537088644763e-11
intestinal O 0 3.651578299468383e-05
anion O 0 3.8162128475960344e-05
transporter O 0 4.185422585578635e-05
. O 0 1.283147071262647e-06

We O 0 1.0041418363471166e-07
report O 0 4.315407586830133e-09
here O 0 8.587153210726228e-10
the O 0 1.5852370804925187e-10
complete O 0 8.690894670593252e-10
genomic O 0 6.839635524613641e-09
organization O 0 1.5933580843618955e-10
of O 0 7.543712321478324e-10
the O 0 8.784845739739922e-09
human O 0 2.0142415735335817e-08
CLD B-Disease 1 0.9827319979667664
gene O 0 2.4500872441990396e-08
which O 0 6.96747104456108e-10
spans O 0 1.8027077608451236e-09
approximately O 0 7.374034716178812e-11
39kb O 0 5.17750436301867e-07
, O 0 3.847803187184695e-10
and O 0 1.8558282688374561e-09
comprises O 0 1.076095479390915e-08
21 O 0 8.037250154302455e-08
exons O 0 2.6126207330889883e-07
. O 0 1.0231951819150709e-07

All O 0 7.974914524311316e-07
exon O 0 1.0631168152031023e-05
/ O 0 1.1159322639286984e-06
intron O 0 2.373104280195548e-06
boundaries O 0 3.014009308799359e-08
conform O 0 2.7262876400868663e-08
to O 0 1.2224631307233835e-09
the O 0 4.342044590543992e-08
GT O 0 0.004190250765532255
/ O 0 2.5934812583727762e-05
AG O 1 0.6018218994140625
rule O 0 1.1459244888101239e-05
. O 0 9.225758503816905e-07

An O 0 6.302057764528968e-10
analysis O 0 5.809382974675259e-10
of O 0 2.6980313538871314e-09
the O 0 3.189007458104243e-08
putative O 0 6.802261395932874e-06
promoter O 0 3.6646110856963787e-06
region O 0 2.0160749514275267e-08
sequence O 0 9.486275098780084e-10
shows O 0 1.1478219485994146e-09
a O 0 1.8194022954887146e-09
putative O 0 0.000155826288391836
TATA O 1 0.9999995231628418
box O 0 2.945298547274433e-05
and O 0 6.64386012871887e-09
predicts O 0 1.7499866444836698e-08
multiple O 0 5.091117527555866e-10
transcription O 0 2.8945281727033034e-08
factor O 0 2.487659500616246e-08
binding O 0 4.075683790460971e-08
sites O 0 1.0834999386588606e-07
. O 0 9.473193784970135e-08

The O 0 9.762670316604272e-08
genomic O 0 7.528367973463901e-08
structure O 0 1.346155009684935e-08
was O 0 7.4143207129395705e-09
determined O 0 1.2204293131645727e-09
using O 0 3.0848457122090167e-10
DNA O 0 4.130801478652302e-09
from O 0 3.797045733389126e-10
several O 0 6.88810675164575e-11
sources O 0 1.99541538847825e-09
including O 0 5.080612042185351e-10
multiple O 0 6.173061506409283e-10
large O 0 4.147516818875374e-08
- O 0 7.713102831985452e-07
insert O 0 1.1846512961710687e-06
libaries O 0 0.010367291048169136
and O 0 2.4337390769346712e-08
genomic O 0 4.074106030316216e-08
DNA O 0 2.1383252502005234e-08
from O 0 6.9902101884622425e-09
Finnish O 0 0.0023746350780129433
CLD B-Disease 1 1.0
patients O 1 0.9664950966835022
and O 0 3.574319507038126e-08
controls O 0 2.161260965749534e-07
. O 0 3.11656066287469e-07

Exon O 0 2.607547867228277e-05
- O 0 2.2427290957693913e-07
specific O 0 1.1921314602147959e-08
primers O 0 9.416229431735701e-07
developed O 0 7.55327960177965e-08
in O 0 3.23429061310776e-10
this O 0 5.1692566893635217e-11
study O 0 5.949029463492295e-11
will O 0 2.4139288658242553e-12
facilitate O 0 5.899997851388505e-11
mutation O 0 8.103396426095699e-11
screening O 0 1.4773900991471578e-09
studies O 0 1.5600828962014646e-10
of O 0 1.4833158312743677e-10
patients O 0 5.828376004046731e-09
with O 0 5.325702379099795e-11
the O 0 2.682179172097676e-07
disease O 0 4.975964475306682e-05
. O 0 4.909944095743413e-07

Genomic O 0 1.779592594175483e-06
sequencing O 0 1.1218662621104158e-06
of O 0 1.345899960369934e-07
a O 0 9.275925094698323e-08
BAC O 0 0.011281216517090797
clone O 0 2.0490075257839635e-05
H O 1 1.0
_ O 0 6.601508317771732e-08
RG364P16 O 0 4.6234228534558497e-07
revealed O 0 2.8533768681171523e-09
the O 0 1.3966952594479665e-10
presence O 0 2.2281770178933513e-11
of O 0 3.283481819771339e-10
another O 0 2.047083336176314e-10
, O 0 5.265021404965431e-11
highly O 0 1.1399218236007869e-09
homologous O 0 2.1177241904535293e-10
gene O 0 9.054142852127356e-11
3 O 0 1.1561517299085722e-09
of O 0 3.064994480439509e-09
the O 0 1.1325521853677856e-07
CLD B-Disease 1 0.9711742401123047
gene O 0 1.6690083981529824e-08
, O 0 9.303499637347556e-11
with O 0 4.238605993966971e-12
a O 0 2.0467232075827013e-11
similar O 0 2.1722409981883573e-10
genomic O 0 3.6119631730002766e-09
structure O 0 3.2549685169414033e-09
, O 0 3.3540257377007165e-11
recently O 0 1.3155218581140105e-10
identified O 0 8.241406168618681e-11
as O 0 8.138836826709905e-11
the O 0 1.0205269518337445e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 8.538757469978009e-07
( O 0 1.462491350245898e-09
PDS B-Disease 0 0.00023135970695875585
) O 0 6.351134063109498e-10
. O 0 3.028437278729257e-09
. O 0 2.7943967140231507e-08

The O 0 5.205785100770299e-07
APCI1307K O 0 0.46483179926872253
allele O 0 6.533552436849277e-07
and O 0 4.5793299818797095e-08
cancer B-Disease 0 2.6474859623704106e-05
risk O 0 1.758951562180755e-08
in O 0 4.2757505869239765e-10
a O 0 1.9726713318402034e-10
community O 0 2.546990118812431e-10
- O 0 3.2716726550141573e-10
based O 0 2.681305732998851e-10
study O 0 1.222539430800751e-10
of O 0 2.6789392926218625e-10
Ashkenazi O 0 2.642308629674517e-07
Jews O 0 1.7228367710231396e-07
. O 0 4.8086260306945405e-08

Mutations O 0 1.3840935025655199e-05
in O 0 1.2296622742269392e-07
APC O 0 1.4278093658504076e-06
are O 0 3.122769265395675e-10
classically O 0 2.080940930682118e-08
associated O 0 3.1683675683069623e-09
with O 0 9.610412909921706e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.0976931434925064e-06
FAP B-Disease 0 5.3358609875431284e-05
) O 0 3.6942941761264336e-11
, O 0 6.718665988142414e-12
a O 0 8.3133985806505e-11
highly O 0 0.00023655853874515742
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 0 0.00020495508215390146
multiple O 0 0.002810492180287838
intestinal O 1 1.0
polyps B-Disease 0 8.830570004647598e-05
and O 0 4.638241346555105e-09
, O 0 3.5598291675542626e-11
without O 0 7.692674830472868e-10
surgical O 0 7.884984370321035e-05
intervention O 0 3.775946666451091e-08
, O 0 8.211233776256321e-11
the O 0 6.48125553226464e-10
development O 0 1.357505130528125e-08
of O 0 0.0029098198283463717
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.705892825360934e-07
CRC B-Disease 0 0.03503676876425743
) O 0 2.3214163924478726e-09
. O 0 5.567899563629908e-08

APC B-Disease 0 0.0002729125553742051
is O 0 3.5418597832403975e-08
a O 0 1.6269536828872333e-08
tumour O 1 0.9999998807907104
- O 0 1.2356613297015429e-05
suppressor O 0 8.113490366667975e-06
gene O 0 2.6787769780156623e-09
, O 0 5.966323962658393e-11
and O 0 6.2139227097191e-10
somatic O 0 0.00023470577434636652
loss O 0 2.3329297619056888e-05
occurs O 0 4.458396688278299e-06
in O 0 4.3604959500953555e-06
tumours B-Disease 1 1.0
. O 0 8.400330443691928e-06

The O 0 1.0489221494935919e-05
germline O 0 1.7811322322813794e-05
T O 0 1.2171716434750124e-06
- O 0 1.544239935924452e-08
to O 0 3.6748995513313787e-10
- O 0 2.6942930109186136e-09
A O 0 3.009687832289387e-09
transversion O 0 1.669505707013741e-07
responsible O 0 1.6627091370402525e-10
for O 0 5.0094223907892754e-11
the O 0 2.250002406611884e-09
APC O 0 9.272635281831754e-08
I1307K O 0 3.1930520094647363e-07
allele O 0 7.604288754237132e-09
converts O 0 5.465810026805684e-09
the O 0 4.789316720987813e-10
wild O 0 1.7746916158856152e-09
- O 0 7.387802175573555e-11
type O 0 1.4306598961066896e-10
sequence O 0 1.2441357839787504e-11
to O 0 1.6334746055779448e-11
a O 0 7.587913075646213e-10
homopolymer O 1 1.0
tract O 1 1.0
( O 0 1.9717545374220435e-09
A8 O 0 2.786769755402929e-06
) O 0 6.6342638847805e-12
that O 0 1.64985614146268e-12
is O 0 7.260167467215695e-11
genetically O 0 3.209784836144536e-06
unstable O 0 4.615639409166761e-05
and O 0 1.940337313044438e-07
prone O 0 2.5209114028257318e-05
to O 0 6.633998594907098e-08
somatic O 0 0.0018357064109295607
mutation O 0 5.075685294286814e-06
. O 0 1.2679677752203133e-07

The O 0 2.632539235492004e-07
I1307K O 0 5.733243597205728e-06
allele O 0 2.0917096321682038e-07
was O 0 1.2875222665797992e-08
found O 0 1.3608746352034018e-09
in O 0 2.847928559646107e-09
6 O 0 1.9766135039844812e-07
. O 0 7.197387930091281e-08

1 O 0 8.438079248662689e-07
% O 0 1.4102202960941668e-08
of O 0 2.0130164202214473e-08
unselected O 0 0.016992507502436638
Ashkenazi O 0 6.0216934798518196e-06
Jews O 0 7.044796035415857e-08
and O 0 3.0367766634675775e-10
higher O 0 5.063519825654339e-09
proportions O 0 6.9900503163466965e-09
of O 0 3.530528758233231e-08
Ashkenazim O 0 0.000253605714533478
with O 0 3.7018926812848463e-10
family O 0 5.107690936867471e-10
or O 0 1.531519772113299e-10
personal O 0 1.797455517760227e-08
histories O 0 4.161265678703785e-07
of O 0 0.0001186244044220075
CRC B-Disease 1 0.9999998807907104
( O 0 1.5452911172886274e-09
ref O 0 8.915125135899871e-07
. O 0 1.1813474642963229e-09
2 O 0 3.5133702613876494e-09
) O 0 8.633625758758257e-11
. O 0 6.069170055411632e-09

To O 0 2.3791987047161456e-08
evaluate O 0 6.692395970731013e-08
the O 0 4.005894727043824e-09
role O 0 1.4992852515050004e-09
of O 0 1.6729156726569272e-08
I1307K O 0 6.773252243874595e-05
in O 0 3.973047668637264e-08
cancer B-Disease 0 4.59136487052092e-07
, O 0 3.5908984119537024e-11
we O 0 5.309859496538394e-11
genotyped O 0 5.563227887250832e-07
5 O 0 1.576620789478511e-08
, O 0 4.636222517007127e-10
081 O 0 4.258989974914584e-06
Ashkenazi O 0 1.0726896562118782e-06
volunteers O 0 3.68410368878358e-08
in O 0 8.304560372707215e-10
a O 0 6.512196892849431e-10
community O 0 3.2440541364309183e-09
survey O 0 4.124778740788315e-09
. O 0 1.3152297029250803e-08

Risk O 0 6.810220656916499e-05
of O 0 1.300884014199255e-05
developing O 1 0.9999769926071167
colorectal B-Disease 1 1.0
, I-Disease 1 0.998570442199707
breast I-Disease 1 1.0
and I-Disease 0 7.611909609295253e-07
other I-Disease 0 6.257327527237067e-07
cancers I-Disease 1 0.8653386235237122
were O 0 1.1646794462194521e-07
compared O 0 1.9871480461119972e-08
between O 0 4.539221443167207e-09
genotyped O 0 3.01721302093938e-05
I1307K O 0 1.4380968877958367e-06
carriers O 0 7.754151987171554e-09
and O 0 1.2549805639139322e-10
non O 0 8.033288478870304e-10
- O 0 2.907495078030564e-10
carriers O 0 1.7020806986067782e-10
and O 0 1.5723840632309027e-11
their O 0 6.265735326416166e-12
first O 0 6.515461087319707e-11
- O 0 7.218127207053726e-10
degree O 0 1.1960739065841608e-08
relatives O 0 2.7065616414745364e-09
. O 0 2.311140390176547e-09

Sperm O 0 2.560644531968137e-07
DNA O 0 5.348714360309259e-09
analysis O 0 4.808364262309794e-10
in O 0 4.1409364825995e-10
a O 0 7.086597975103359e-09
Friedreich B-Disease 1 0.999997615814209
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 0 9.514734119875357e-05
suggests O 0 2.179161526782991e-07
both O 0 2.5018191962544734e-09
meiotic O 0 8.447886443718744e-07
and O 0 3.2951592565666488e-09
mitotic O 0 1.3468566351093614e-07
expansion O 0 4.802068360731937e-07
in O 0 5.28710586422676e-09
the O 0 4.820003596250899e-08
FRDA B-Disease 0 0.04522203654050827
gene O 0 3.084584818680014e-07
. O 0 1.8871160989419877e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.9654893890219682e-07
usually O 0 1.1801836841129898e-08
caused O 0 5.080226461728898e-09
by O 0 9.700383551969338e-11
an O 0 3.4925523844514528e-12
expansion O 0 6.06032068972695e-09
of O 0 8.574751575451955e-09
a O 0 8.21697643260677e-09
GAA O 0 1.3341102658159798e-06
trinucleotide O 0 7.137726697692415e-06
repeat O 0 2.6919826368043687e-08
in O 0 6.418028331012238e-09
intron O 0 1.0021595642228931e-07
1 O 0 3.571121842682601e-09
of O 0 1.900914536889786e-09
the O 0 3.2613773015555125e-08
FRDA B-Disease 1 0.943246066570282
gene O 0 3.885967885253194e-07
. O 0 2.23446704694652e-07

Occasionally O 0 4.471454531085328e-07
, O 0 2.4580011359631726e-09
a O 0 1.077392841608571e-09
fully O 0 6.893318804657156e-09
expanded O 0 2.693687939370193e-08
allele O 0 1.6545739001117e-08
has O 0 8.996817180140226e-11
been O 0 2.4959159738990877e-11
found O 0 2.947168897815544e-11
to O 0 1.5732901093024054e-11
arise O 0 2.661735498676876e-09
from O 0 4.451388979642701e-10
a O 0 1.253724485339447e-10
premutation O 0 4.954346195518156e-07
of O 0 3.5375862239561684e-08
100 O 0 4.904241457381886e-09
or O 0 1.8244818156265552e-10
less O 0 2.046870761773789e-08
triplet O 0 1.062216369973612e-06
repeats O 0 8.799489137345518e-08
. O 0 2.160010126317502e-07

We O 0 2.920883446222433e-07
have O 0 4.263618791355839e-09
examined O 0 6.455673684513386e-08
the O 0 2.4436872525512854e-09
sperm O 0 9.273350976002348e-10
DNA O 0 4.819464827221509e-10
of O 0 2.4486176974924945e-10
a O 0 4.1240133530351386e-10
premutation O 0 4.2791521991603076e-05
carrier O 0 2.257459300381015e-06
. O 0 2.7609991093413555e-07

This O 0 2.906789120515896e-07
mans O 0 8.678386075189337e-05
leucocyte O 0 4.6556546294596046e-05
DNA O 0 4.001159368272056e-07
showed O 0 4.197933556326916e-09
one O 0 3.9951549013483856e-11
normal O 0 1.203858956966286e-10
allele O 0 3.992719210810236e-10
and O 0 3.9559445996761866e-11
one O 0 3.0499398145922285e-11
allele O 0 4.90873119929347e-10
of O 0 2.0362460328993137e-10
approximately O 0 1.3375643648227964e-10
100 O 0 9.841314430047987e-10
repeats O 0 3.0806139861283555e-09
. O 0 1.9779781368356453e-08

His O 0 2.173969051000313e-06
sperm O 0 9.999123307125046e-08
showed O 0 1.9587960142786187e-09
an O 0 6.870992923929675e-12
expanded O 0 7.420131176161249e-10
allele O 0 1.4659041758235958e-09
in O 0 3.445860541351209e-10
a O 0 2.5763055577776584e-10
tight O 0 1.6133544988861104e-07
range O 0 1.1805353494764859e-07
centering O 0 7.880743169152993e-08
on O 0 6.532175911289073e-10
a O 0 3.3676152144668237e-11
size O 0 3.735840525820322e-10
of O 0 1.413796080207419e-09
approximately O 0 3.785441737846895e-09
320 O 0 1.1718847048314274e-07
trinucleotide O 0 1.304340003116522e-05
repeats O 0 1.9959082919740467e-07
. O 0 1.751650557935136e-07

His O 0 7.481582542823162e-06
affected O 0 2.2021678887540475e-05
son O 0 0.0002221473987447098
has O 0 1.4951587745670736e-09
repeat O 0 4.085278337839782e-09
sizes O 0 4.513797691174659e-08
of O 0 1.3289399802829394e-08
1040 O 0 3.585005288186949e-07
and O 0 2.929668729834134e-09
540 O 0 1.7673733054834884e-07
. O 0 3.906910350792714e-08

These O 0 3.062571352074883e-08
data O 0 5.559163351875895e-09
suggest O 0 1.1412510936281706e-09
that O 0 6.99660251610168e-12
expansion O 0 5.070806885498769e-09
occurs O 0 2.218513706075953e-10
in O 0 2.1607975825288506e-11
two O 0 2.0113619970951735e-12
stages O 0 5.404663938612941e-10
, O 0 1.3490130236840092e-12
the O 0 8.731860720589957e-12
first O 0 1.6645931161241023e-11
during O 0 1.1505787989030125e-10
meiosis O 0 3.264429837557259e-10
followed O 0 5.822661797161288e-10
by O 0 1.224635254315487e-10
a O 0 1.2129378057501583e-10
second O 0 3.6617402443539504e-09
mitotic O 0 1.8129675538602896e-07
expansion O 0 1.4097867051532376e-06
. O 0 2.243238270693837e-07

We O 0 3.5900211514672264e-07
also O 0 3.36598771077945e-09
show O 0 2.3818164107680673e-10
that O 0 3.3002678281185416e-12
in O 0 4.176478260453642e-11
all O 0 2.729551133728858e-11
informative O 0 9.987164428792994e-10
carrier O 0 9.630591879528083e-10
father O 0 8.85247486426266e-10
to O 0 1.9485588143020038e-10
affected O 0 4.810846121472423e-08
child O 0 2.2560671553151224e-08
transmissions O 0 3.832672401671289e-09
, O 0 4.676360427363635e-12
with O 0 6.378767956546905e-13
the O 0 4.2133470323779676e-11
notable O 0 1.083900080800504e-09
exception O 0 1.0430825092555551e-09
of O 0 5.75852587836323e-10
the O 0 4.226823335784502e-10
premutation O 0 2.2296605095561972e-07
carrier O 0 3.7849434697534434e-09
, O 0 4.635954814480314e-11
the O 0 3.7218367276992126e-10
expansion O 0 1.7507545635453425e-08
size O 0 4.549362664363343e-09
decreases O 0 5.8385261070270644e-08
. O 0 8.988010335997387e-09
. O 0 9.20347531518928e-08

The O 0 3.2724318543841946e-07
R496H O 0 3.573570893422584e-06
mutation O 0 3.5476475090945314e-08
of O 0 1.3417127853188049e-08
arylsulfatase O 0 0.03166303411126137
A O 0 7.988859920260438e-07
does O 0 8.683736507641981e-10
not O 0 1.8502369636408389e-09
cause O 0 1.64282778314373e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 6.3485640566796064e-06

Deficiency B-Disease 0 0.23457278311252594
of I-Disease 0 1.5660236385883763e-05
arylsulfatase I-Disease 1 1.0
A I-Disease 1 0.9975709319114685
( O 0 3.987164518548525e-07
ARSA O 1 0.9953702092170715
) O 0 9.379048648838761e-10
enzyme O 0 2.049026903705453e-08
activity O 0 1.5218191151689098e-08
causes O 0 2.5590603058844863e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.3352631589878e-07
MLD B-Disease 1 1.0
) O 0 4.470205183793041e-08
. O 0 1.496073025464284e-07

A O 0 7.337510510296852e-07
number O 0 2.7394964519089626e-08
of O 0 1.3216276784078218e-07
ARSA O 0 0.04210517928004265
gene O 0 1.2090289658317488e-07
mutations O 0 2.44684610350987e-08
responsible O 0 1.5477306103406363e-09
for O 0 2.0872017003625842e-08
MLD B-Disease 1 1.0
have O 0 5.015290867049771e-07
been O 0 1.507107327824997e-08
identified O 0 1.724384368628762e-08
. O 0 2.568315871087634e-08

Recently O 0 4.001499007699749e-07
, O 0 9.641177856067884e-10
the O 0 2.3060764409166268e-09
R496H O 0 4.4245649633012363e-07
mutation O 0 2.2654676357092285e-08
of O 0 8.038875165539139e-08
ARSA O 0 0.1836043745279312
was O 0 2.1069769928772075e-08
proposed O 0 7.579469496477031e-09
to O 0 5.440238884379944e-11
be O 0 3.4710706531271285e-11
a O 0 3.576708026975517e-11
cause O 0 1.5572950706754796e-09
of O 0 3.8803909774287604e-07
MLD B-Disease 1 1.0
( O 0 1.4649377710895806e-08
Draghia O 0 1.583220364409499e-05
et O 0 1.8231236964538766e-08
al O 0 2.4949380339478466e-09
. O 0 6.288103371332454e-11
, O 0 5.124433516412452e-11
1997 O 0 2.890912620401309e-09
) O 0 1.3940398835288192e-09
. O 0 5.6130890158101465e-08

We O 0 1.502927062801973e-07
have O 0 8.059901634993594e-10
investigated O 0 4.557631161361542e-09
the O 0 5.8925704315981875e-09
R496H O 0 1.2222420764373965e-06
mutation O 0 3.61528518233456e-09
and O 0 8.644435167681763e-11
found O 0 9.665491497445888e-12
this O 0 2.793756979230233e-12
mutation O 0 6.222518333931504e-11
at O 0 2.4592095027031746e-10
a O 0 1.5273882852939735e-11
relatively O 0 1.7403252450254314e-10
high O 0 3.2061539534389283e-10
frequency O 0 4.768750325179205e-11
in O 0 2.142065171073515e-11
an O 0 1.9378715212375885e-12
African O 0 5.5553520117435085e-11
American O 0 3.5742866999477485e-11
population O 0 1.8332356032518815e-12
( O 0 7.269679649923866e-13
f O 0 9.753857721506165e-10
= O 0 1.1776842001598453e-10
0 O 0 5.073242936859401e-10
. O 0 2.943792432041903e-11
09 O 0 3.94699517514141e-09
, O 0 4.626909272387181e-11
n O 0 1.007431027488792e-09
= O 0 3.0371718473531928e-09
61 O 0 2.854657310535913e-08
subjects O 0 1.6872009567237e-08
) O 0 7.281652503188241e-10
. O 0 4.169329059777738e-08

The O 0 3.209552960470319e-05
ARSA O 0 0.002229944569990039
enzyme O 0 1.1045835179857022e-07
activity O 0 1.126751492108724e-08
in O 0 5.297863814313075e-10
subjects O 0 2.594225945173889e-09
with O 0 4.071479698525282e-12
and O 0 4.68395044972425e-11
without O 0 3.5264330344730865e-10
the O 0 1.2485777967086165e-09
R496H O 0 9.135825962403032e-08
mutation O 0 7.843052873823808e-10
was O 0 3.408905935309292e-10
determined O 0 7.725936002067613e-10
and O 0 1.0908181302671238e-10
found O 0 4.300891587316613e-11
to O 0 3.126462630453908e-11
be O 0 1.0954223084169712e-09
normal O 0 3.5271369824840804e-07
. O 0 1.0977176856385995e-07

It O 0 9.628778663284265e-09
is O 0 3.084492938842942e-10
therefore O 0 7.778263033664246e-10
concluded O 0 1.8230532639051944e-09
that O 0 4.654842917367619e-12
the O 0 4.0329400929906e-10
R496H O 0 1.8478402807886596e-07
mutation O 0 5.0659352268667135e-09
of O 0 1.597617149684538e-08
ARSA O 0 0.00010603672853903845
does O 0 6.802812202444386e-10
not O 0 2.2550712686086882e-10
negatively O 0 9.061822403566566e-09
influence O 0 1.0404184180856646e-08
the O 0 1.0606651112965437e-09
activity O 0 2.1723334242551573e-09
of O 0 2.3119527625681258e-08
ARSA O 1 0.9959673881530762
and O 0 3.7178582434904683e-09
is O 0 6.250078232739043e-11
not O 0 6.340902802826065e-11
a O 0 3.371646850602872e-10
cause O 0 7.318278960610769e-08
of O 0 4.157903731538681e-06
MLD B-Disease 1 1.0

Down O 0 4.635003733710619e-06
- O 0 2.488913253273495e-07
regulation O 0 3.055208708246937e-07
of O 0 4.2794265908696616e-08
transmembrane O 0 6.138191110949265e-07
carbonic O 0 4.4004624214721844e-05
anhydrases O 0 0.001366439857520163
in O 0 1.657366556173656e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 1.0264208867738489e-05
lines O 0 9.748092333339287e-10
by O 0 4.4706530144544843e-10
wild O 0 7.291227461792005e-07
- O 0 5.3228060181709225e-08
type O 0 7.188388053691597e-07
von B-Disease 1 0.999955415725708
Hippel I-Disease 1 0.999976396560669
- I-Disease 0 0.34182387590408325
Lindau I-Disease 1 0.7598007917404175
transgenes O 0 0.0005125548341311514
. O 0 6.495989168797678e-07

To O 0 1.4397804193322372e-07
discover O 0 2.932280906975393e-08
genes O 0 1.1337485394946611e-09
involved O 0 1.8155499326155677e-10
in O 0 1.8957548864051432e-09
von B-Disease 1 0.9999996423721313
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 1.8458236183960253e-07
VHL B-Disease 1 0.9999997615814209
) O 0 1.1762307572382724e-08
- O 0 1.1464471754152328e-06
mediated O 0 3.5252844554634066e-06
carcinogenesis O 1 0.9999842643737793
, O 0 1.360251800086587e-09
we O 0 2.3440802077168144e-10
used O 0 9.707259884805808e-09
renal B-Disease 1 1.0
cell I-Disease 1 0.9999978542327881
carcinoma I-Disease 1 1.0
cell O 0 2.9580043701571412e-05
lines O 0 2.8982901412177853e-08
stably O 0 8.073261597019155e-07
transfected O 0 8.110134785965784e-08
with O 0 8.140855350946552e-11
wild O 0 8.853564281707804e-08
- O 0 3.3659571130328914e-08
type O 0 4.2086549001396634e-07
VHL O 1 0.9998998641967773
- O 0 2.363632302149199e-05
expressing O 0 6.533446708090196e-07
transgenes O 0 3.977513188146986e-05
. O 0 2.2778122854560934e-07

Large O 0 1.3945492582934094e-06
- O 0 2.432370820315555e-07
scale O 0 2.5396781211384223e-07
RNA O 0 4.6151846788689e-08
differential O 0 2.0952549917296892e-08
display O 0 2.6458872870449568e-09
technology O 0 3.617825683477349e-08
applied O 0 6.601619695345562e-09
to O 0 1.2980398700346285e-10
these O 0 8.013237295934061e-11
cell O 0 1.1794765164552246e-09
lines O 0 1.9890990243798257e-10
identified O 0 7.000583446270525e-11
several O 0 5.7516293811010755e-11
differentially O 0 1.406420011562659e-07
expressed O 0 2.4133663956149576e-09
genes O 0 1.3244678687129863e-09
, O 0 1.9684533517083658e-11
including O 0 5.2279163637036774e-11
an O 0 9.13525574630647e-11
alpha O 0 1.0662827776286576e-07
carbonic O 0 1.1873558833030984e-05
anhydrase O 0 5.713183054467663e-05
gene O 0 4.6849226720269144e-08
, O 0 3.0406031026330993e-09
termed O 0 1.262969362869626e-06
CA12 O 1 0.9999376535415649
. O 0 8.662883374199737e-06

The O 0 2.073204541375162e-07
deduced O 0 6.428174970096734e-08
protein O 0 9.988554428019825e-10
sequence O 0 8.342069396372054e-11
was O 0 3.681809856992402e-10
classified O 0 3.7287714582667775e-10
as O 0 1.4779810708631658e-10
a O 0 8.898635300846891e-11
one O 0 1.0525494920088363e-09
- O 0 8.105276947389939e-07
pass O 0 0.005727842915803194
transmembrane O 0 4.050925781484693e-06
CA O 0 8.159909157257061e-07
possessing O 0 2.8233968052404634e-08
an O 0 1.3425817402268336e-10
apparently O 0 1.5349165494171757e-08
intact O 0 3.9851833832926786e-08
catalytic O 0 3.2320556897502684e-08
domain O 0 6.419769960075428e-08
in O 0 9.425195734991121e-09
the O 0 4.026050248739921e-08
extracellular O 0 2.1605408164759865e-06
CA O 0 6.542051414726302e-05
module O 0 4.306490154704079e-06
. O 0 2.338675102464549e-07

Reintroduced O 0 0.0001102922615245916
wild O 0 1.8700262444326654e-05
- O 0 9.876558806354296e-07
type O 0 1.636788169889769e-06
VHL B-Disease 1 0.9461461305618286
strongly O 0 2.0931403810209304e-07
inhibited O 0 1.9941882101193187e-07
the O 0 6.548333875144863e-09
overexpression O 0 1.3807385812469875e-07
of O 0 2.275613253388542e-09
the O 0 3.4042231256137256e-09
CA12 O 0 0.00030032615177333355
gene O 0 1.2588456943518622e-09
in O 0 1.9068982504144572e-10
the O 0 2.911003216254926e-09
parental O 0 1.3184493582230061e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9529635906219482
lines O 0 4.978601850780251e-07
. O 0 1.8291900971689756e-07

Similar O 0 1.4779185164570663e-07
results O 0 1.9774651249804265e-08
were O 0 2.6848281375890792e-09
obtained O 0 7.08063552234961e-10
with O 0 1.28701757584615e-10
CA9 O 0 9.691945888334885e-05
, O 0 1.108389713344593e-09
encoding O 0 6.020943033036019e-08
another O 0 9.815209267571845e-08
transmembrane O 0 5.245143483989523e-07
CA O 0 3.1818566981201e-07
with O 0 6.07322872547833e-11
an O 0 6.338714275688773e-11
intact O 0 3.8997853835098795e-08
catalytic O 0 1.0422262874953958e-07
domain O 0 6.937190164535423e-07
. O 0 2.708154340780311e-07

Although O 0 6.377627528308949e-07
both O 0 1.6694762905444804e-08
domains O 0 2.2969686597207328e-08
of O 0 8.106206905722502e-08
the O 0 4.950388188262878e-07
VHL B-Disease 1 0.9747253060340881
protein O 0 9.481056650884057e-08
contribute O 0 3.1488900376075435e-09
to O 0 1.726222220721496e-10
regulation O 0 1.447653232844459e-07
of O 0 8.566254905417736e-08
CA12 O 1 0.9999991655349731
expression O 0 6.253223006069675e-08
, O 0 3.884338684034816e-11
the O 0 9.446440157878655e-11
elongin O 0 4.094094663287251e-08
binding O 0 1.2317861397548313e-08
domain O 0 3.971638307120884e-08
alone O 0 3.2734472910078694e-09
could O 0 6.614080949596257e-10
effectively O 0 3.040123530695382e-08
regulate O 0 1.287598024646286e-06
CA9 O 0 0.052410706877708435
expression O 0 3.561122639439418e-06
. O 0 6.285779363679467e-07

We O 0 9.655233270677854e-07
mapped O 0 3.79481639356527e-06
CA12 O 0 0.45142921805381775
and O 0 1.8797065877151908e-06
CA9 O 0 0.006761211436241865
loci O 0 4.657828412746312e-06
to O 0 1.2997828591210236e-08
chromosome O 0 1.5748776505120077e-08
bands O 0 9.64922577395555e-08
15q22 O 0 1.6690963775545242e-06
and O 0 1.3157038125655163e-08
17q21 O 0 1.4897706932970323e-05
. O 0 3.720272161444882e-07

2 O 0 8.875009029907233e-07
respectively O 0 3.6775608691641537e-07
, O 0 4.922994900624644e-09
regions O 0 1.7255727868814574e-07
prone O 0 3.3752648960216902e-06
to O 0 3.641764223516475e-09
amplification O 0 0.00017898135411087424
in O 0 1.7151300824025384e-07
some O 0 1.1956815981761793e-08
human O 0 1.5057059954415308e-07
cancers B-Disease 0 0.0034739177208393812
. O 0 9.066905590771057e-07

Additional O 0 1.103147511116731e-07
experiments O 0 1.2839667817843292e-07
are O 0 8.584447042103704e-11
needed O 0 1.5819185961163384e-09
to O 0 4.8267397023682435e-11
define O 0 1.4768040124124582e-09
the O 0 1.5102605832595373e-09
role O 0 1.668848281788371e-09
of O 0 1.6570128025250597e-07
CA O 0 3.82322832592763e-05
IX O 1 1.0
and O 0 1.489761530137912e-06
CA O 0 6.7633463913807645e-06
XII O 0 0.04028785973787308
enzymes O 0 5.0426729458763475e-09
in O 0 3.295861639163178e-10
the O 0 9.969592512648617e-11
regulation O 0 1.370930924338154e-09
of O 0 1.565708118711484e-10
pH O 0 1.4608389165005065e-08
in O 0 3.523367153590584e-10
the O 0 3.0429514463747864e-10
extracellular O 0 3.767010259281278e-09
microenvironment O 0 2.3397822133119917e-06
and O 0 2.2773358199223992e-10
its O 0 1.79864387273021e-10
potential O 0 6.772766791840468e-09
impact O 0 4.636028165805328e-07
on O 0 4.6314289647853e-06
cancer B-Disease 0 3.7578345654765144e-05
cell O 0 1.376996152657739e-07
growth O 0 1.1618533690693766e-08
. O 0 1.7634496529694843e-08

A O 0 1.7122489737175783e-07
gene O 0 4.452919810660205e-09
encoding O 0 8.758799907582215e-08
a O 0 2.4902325534981173e-08
transmembrane O 0 1.8816780311681214e-07
protein O 0 8.408098217671522e-09
is O 0 7.55370072047512e-11
mutated O 0 1.3466069148648785e-08
in O 0 4.859451729899433e-10
patients O 0 4.1270077133503946e-08
with O 0 6.016864784186282e-09
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.8102303147315979
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.839361521571163e-09
. O 0 2.349884198338259e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.657341822981834e-06
WFS B-Disease 1 0.967839777469635
; O 0 1.3253283270842076e-07
OMIM O 1 0.9997861981391907
222300 O 0 1.1151727449032478e-05
) O 0 1.3139621335422902e-10
is O 0 4.3518629672112397e-11
an O 0 3.012425864312718e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.416799986804108e-07
by O 0 1.9097866399420127e-08
young O 0 5.322186780176708e-07
- O 0 1.7157041156679043e-06
onset O 1 1.0
non O 1 1.0
- O 1 0.9999998807907104
immune O 1 0.9988840222358704
insulin B-Disease 1 0.9985003471374512
- I-Disease 0 0.00014925490540917963
dependent I-Disease 0 4.387986791698495e-06
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 8.54962199809961e-05
progressive O 1 0.9999995231628418
optic B-Disease 1 0.9999964237213135
atrophy I-Disease 0 0.01290885079652071
. O 0 3.494881821097806e-05

Linkage O 0 1.4914424355083611e-05
to O 0 1.0493288016277802e-08
markers O 0 1.691955162641534e-07
on O 0 2.7003494551536278e-08
chromosome O 0 1.7744351765713873e-08
4p O 0 0.0009500209707766771
was O 0 1.6270218949898663e-08
confirmed O 0 8.325244493789796e-09
in O 0 3.0486637658810878e-09
five O 0 2.2189845516606965e-09
families O 0 1.1590108872638893e-09
. O 0 1.579950215102599e-08

On O 0 3.385169975445024e-07
the O 0 2.8880413616150236e-09
basis O 0 9.992142224746203e-09
of O 0 2.1860257604089384e-08
meiotic O 1 0.6733006238937378
recombinants O 1 0.9999998807907104
and O 0 1.3297711802806589e-06
disease O 0 1.856094786489848e-05
- O 0 5.8173284855911334e-08
associated O 0 5.62983686336338e-08
haplotypes O 0 3.53541508957278e-07
, O 0 5.025627136667765e-10
the O 0 1.374707281343035e-08
WFS B-Disease 0 3.9312206354225054e-05
gene O 0 6.5077427890969375e-09
was O 0 1.6039251704569324e-08
localized O 0 1.0025744501263034e-07
to O 0 3.083864941189063e-09
a O 0 5.5055298986417256e-08
BAC O 0 0.004708211403340101
/ O 0 3.0931323635741137e-06
P1 O 0 1.239919220097363e-05
contig O 0 5.798684014735045e-06
of O 0 7.832756665493434e-09
less O 0 1.0761672442072268e-08
than O 0 1.3039065382969284e-09
250 O 0 4.340554227155735e-08
kb O 0 2.7076143851445522e-06
. O 0 2.6168450517616293e-07

Mutations O 0 8.155412274390983e-07
in O 0 1.0413753415150495e-08
a O 0 1.3724509306811683e-09
novel O 0 3.688336391860503e-08
gene O 0 2.060611237197918e-09
( O 0 1.5000023445566057e-10
WFS1 O 0 0.0001899826165754348
) O 0 2.9515809241154045e-10
encoding O 0 1.94041991363747e-08
a O 0 1.378945757579686e-08
putative O 0 1.8851568484024028e-06
transmembrane O 0 1.1342358163801691e-08
protein O 0 7.660828638123007e-10
were O 0 4.732408909191577e-10
found O 0 6.191465395932738e-11
in O 0 7.579736838181361e-11
all O 0 1.5337121850311775e-10
affected O 0 2.61237942389414e-09
individuals O 0 5.7995490354567636e-11
in O 0 1.081005951419911e-08
six O 0 2.8078102332074195e-07
WFS B-Disease 1 0.9999997615814209
families O 0 1.7261779561295043e-08
, O 0 7.25060497752672e-11
and O 0 3.97307985122719e-11
these O 0 1.0691691282316285e-10
mutations O 0 2.8896765535968427e-10
were O 0 3.9088593473124433e-10
associated O 0 1.1992692394713345e-09
with O 0 4.939895159594698e-10
the O 0 1.9454230368864955e-06
disease O 0 0.002816183026880026
phenotype O 0 4.4963486288907006e-05
. O 0 3.2272816952172434e-07

WFS1 O 1 0.999790608882904
appears O 0 3.036513476217806e-07
to O 0 5.728553187367424e-10
function O 0 1.2085598077860027e-09
in O 0 2.4115902608201623e-09
survival O 0 2.6549735139269615e-06
of O 0 2.7920151524085668e-08
islet O 0 1.7284482964896597e-06
beta O 0 1.8996112771674234e-07
- O 0 1.7473591640282393e-07
cells O 0 5.453407503352992e-09
and O 0 3.026541517403558e-10
neurons O 0 1.938628590991698e-09
. O 0 5.610942266365271e-10
. O 0 1.2559205231355008e-08

Stable O 0 1.8285172700416297e-05
interaction O 0 1.339265853772531e-08
between O 0 7.158145187702303e-10
the O 0 5.895625654339653e-10
products O 0 2.000133925150749e-08
of O 0 2.5436962758362824e-08
the O 0 3.4838510032386694e-07
BRCA1 O 0 1.3430848184725619e-06
and O 0 2.82370908877283e-08
BRCA2 O 0 1.4567093558071065e-06
tumor B-Disease 0 6.762996918041608e-07
suppressor O 0 7.09447135704977e-07
genes O 0 1.3950399724294016e-09
in O 0 3.0057853428466785e-10
mitotic O 0 1.835647083225922e-07
and O 0 3.5965381783853445e-08
meiotic O 0 6.214447785168886e-05
cells O 0 4.847102900384925e-06
. O 0 3.0762916480853164e-07

BRCA1 O 0 0.004369228146970272
and O 0 1.7551732298670686e-06
BRCA2 O 0 3.6914793781761546e-06
account O 0 1.6171014527444072e-10
for O 0 1.3535807891207341e-11
most O 0 1.405328544507034e-11
cases O 0 1.4477414926605814e-11
of O 0 8.21169243714337e-10
familial O 0 1.473555641950952e-07
, O 0 1.2384099301598894e-09
early O 0 5.793260788777843e-05
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.8521966338157654
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.811189834365905e-09
encode O 0 8.281324515024835e-10
products O 0 1.9537822026904905e-08
that O 0 1.8643482591063076e-11
each O 0 1.9443070417568542e-11
interact O 0 1.451126024898386e-10
with O 0 4.091871633193911e-11
hRAD51 O 0 6.365486910908658e-07
. O 0 5.6756697119908495e-08

Results O 0 2.159123596356949e-06
presented O 0 1.704127839730063e-06
here O 0 3.56727021255665e-08
show O 0 1.439520946888706e-09
that O 0 1.2422322892557958e-10
BRCA1 O 0 3.0263603889579827e-07
and O 0 3.1098622343961324e-08
BRCA2 O 0 6.519344879052369e-06
coexist O 0 3.6095197941676815e-08
in O 0 1.7179449529614033e-10
a O 0 3.299092596331654e-11
biochemical O 0 2.9207877005887894e-08
complex O 0 8.568444798129349e-08
and O 0 2.2115986819670752e-09
colocalize O 0 2.2333975721267052e-05
in O 0 1.053092617553375e-07
subnuclear O 0 0.05152296647429466
foci O 0 0.00012098812294425443
in O 0 1.2040209718122696e-08
somatic O 0 4.781490474670136e-07
cells O 0 1.2527259229955234e-09
and O 0 1.2686136863226949e-11
on O 0 5.909526340497351e-11
the O 0 4.4197541460011536e-11
axial O 0 5.701433214433393e-10
elements O 0 1.349645617487738e-09
of O 0 8.586043875880023e-09
developing O 0 3.774521530885977e-07
synaptonemal O 0 0.00030447568860836327
complexes O 0 5.240621248958632e-06
. O 0 5.486450618263916e-07

Like O 0 5.32465310243424e-05
BRCA1 O 0 0.0001069453646778129
and O 0 3.71571957202832e-07
RAD51 O 1 0.9975047707557678
, O 0 1.27271823657793e-06
BRCA2 O 0 3.27537018165458e-05
relocates O 0 1.2888461924376315e-06
to O 0 2.0538474032605336e-08
PCNA O 0 2.3591732315253466e-05
+ O 0 1.0394802352209354e-08
replication O 0 9.069875406275685e-10
sites O 0 2.508784846533274e-10
following O 0 3.7970748767435225e-10
exposure O 0 3.944724014104395e-08
of O 0 2.0447167514703324e-08
S O 0 1.438531580788549e-05
phase O 0 4.4932439777767286e-06
cells O 0 9.057242955634592e-09
to O 0 9.166292169737744e-10
hydroxyurea O 0 1.7203720972247538e-06
or O 0 1.67118408000988e-08
UV O 0 0.472686767578125
irradiation O 0 0.00015842534776311368
. O 0 6.183631739986595e-07

Thus O 0 2.7173043690709164e-06
, O 0 7.372118204784783e-08
BRCA1 O 0 6.301847292888851e-07
and O 0 1.769217483627017e-08
BRCA2 O 0 2.2999375914878328e-07
participate O 0 5.774804523461796e-10
, O 0 9.912817094948068e-12
together O 0 6.112306407540791e-12
, O 0 2.767768002634452e-12
in O 0 3.303349260797006e-11
a O 0 4.3735234184216765e-11
pathway O 0 3.477687915420802e-09
( O 0 7.292806983305589e-12
s O 0 2.5609317444441615e-10
) O 0 8.419026109943162e-13
associated O 0 7.941814567091754e-11
with O 0 1.1924388559902965e-11
the O 0 2.2927162945940438e-10
activation O 0 1.3801845222261022e-09
of O 0 2.9003693668983033e-08
double O 0 5.847773376643772e-09
- O 0 9.395080979857084e-08
strand O 0 1.9433867848306363e-08
break O 0 4.372301631860864e-09
repair O 0 4.5014431293566304e-08
and O 0 4.163215550079258e-09
/ O 0 6.452030021364408e-08
or O 0 4.6801686970354694e-09
homologous O 0 1.2922212633270647e-08
recombination O 0 9.365167130681584e-08
. O 0 8.353465830168716e-08

Dysfunction O 0 0.3773179054260254
of O 0 4.089314188604476e-06
this O 0 3.0544957674294437e-09
pathway O 0 2.815276900491881e-08
may O 0 1.0393324395563397e-10
be O 0 5.498802368303357e-12
a O 0 7.2133852710432045e-12
general O 0 4.211269999387923e-09
phenomenon O 0 5.4605160393350616e-09
in O 0 5.4980079516875335e-11
the O 0 5.968611715978511e-11
majority O 0 9.878540693786242e-12
of O 0 2.319245490101096e-11
cases O 0 3.658792158134361e-10
of O 0 2.5328188257844886e-07
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999991655349731
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4047469676370383e-07
. O 0 7.346417163489605e-08

A O 0 1.4039931102161063e-06
novel O 0 1.5310810113078333e-06
Arg362Ser O 0 1.9146291379001923e-05
mutation O 0 2.1910809167025036e-08
in O 0 5.268279146264376e-10
the O 0 7.616463570947474e-10
sterol O 0 3.3914841424120823e-07
27 O 0 1.4869580411414063e-07
- O 0 4.7670390301846055e-08
hydroxylase O 0 2.1048576854809653e-06
gene O 0 1.157540108209787e-08
( O 0 1.7683013386893265e-10
CYP27 O 1 0.9987039566040039
) O 0 2.171876428702646e-10
: O 0 5.492809332374726e-11
its O 0 7.59703272512624e-11
effects O 0 5.630048871552162e-09
on O 0 2.7734069263374295e-08
pre O 0 3.0033529583306517e-06
- O 0 2.5974313189180975e-07
mRNA O 0 5.1275112156190517e-08
splicing O 0 5.5011110333680335e-08
and O 0 5.946468317752363e-10
enzyme O 0 4.376297546571095e-09
activity O 0 6.529675466993012e-09
. O 0 1.4584474072876219e-08

A O 0 9.156966598311556e-07
novel O 0 7.541345325989823e-07
C O 0 1.9587207589211175e-06
to O 0 4.1918427062803687e-10
A O 0 3.296026784838091e-09
mutation O 0 6.755101478184145e-10
in O 0 8.205457147081319e-11
the O 0 1.120133430454473e-10
sterol O 0 1.3019196387631382e-07
27 O 0 6.690851961366207e-08
- O 0 2.231795726004293e-08
hydroxylase O 0 1.9292401702841744e-06
gene O 0 9.536169187640553e-09
( O 0 1.7429396814705456e-10
CYP27 O 1 0.9979052543640137
) O 0 2.501130691445752e-10
was O 0 3.967926431869273e-09
identified O 0 2.2778268160550397e-10
by O 0 2.755093098105732e-10
sequencing O 0 1.622640439791212e-07
amplified O 0 9.479896903030749e-07
CYP27 O 0 0.0019067045068368316
gene O 0 5.352388310342349e-09
products O 0 3.258386627180698e-08
from O 0 6.536226559994418e-10
a O 0 1.5464313163349175e-10
patient O 0 1.0195887689690153e-08
with O 0 1.4784999613493e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.0674915529307327e-07
CTX B-Disease 0 0.00540767889469862
) O 0 4.589278290723087e-09
. O 0 4.790637220253302e-08

The O 0 6.260240184019494e-07
mutation O 0 1.465760135488381e-07
changed O 0 2.6161904642663103e-08
the O 0 6.522319129231846e-09
adrenodoxin O 0 1.5763495184728527e-06
cofactor O 0 9.03552361819493e-08
binding O 0 1.2668577298313721e-08
residue O 0 1.3525253450552555e-07
362Arg O 0 1.4862321506825538e-07
to O 0 1.0215600587670792e-09
362Ser O 0 6.538825800816994e-07
( O 0 2.2031276802891853e-09
CGT O 0 1.452273045288166e-05
362Arg O 0 2.887679556806688e-06
to O 0 2.28040253347217e-08
AGT O 0 0.00033714430173859
362Ser O 0 3.5992701441500685e-07
) O 0 8.853349303672431e-11
, O 0 2.0065732062035657e-11
and O 0 1.5240678510886063e-11
was O 0 8.356708658396883e-10
responsible O 0 8.827235054020832e-10
for O 0 7.750458763666757e-08
deficiency O 1 0.9998379945755005
in O 0 8.118103096421692e-07
the O 0 8.995096578701123e-08
sterol O 0 3.5874786590284202e-06
27 O 0 2.8355026415738394e-07
- O 0 2.6480797998829075e-08
hydroxylase O 0 1.4675241573058884e-06
activity O 0 1.9916370774808456e-08
, O 0 2.66325104331111e-11
as O 0 3.5807419529465534e-11
confirmed O 0 1.361881302175405e-10
by O 0 9.030359099382324e-11
expression O 0 8.545293361805761e-10
of O 0 1.2143365202277323e-09
mutant O 0 5.938367131363975e-09
cDNA O 0 1.6236334943187103e-08
into O 0 6.272117936134691e-09
COS O 0 5.6134599617507774e-06
- O 0 5.820490969199454e-07
1 O 0 1.666016231638423e-07
cells O 0 2.3372207280658586e-08
. O 0 1.0517152482236725e-08

Quantitative O 0 5.665713729285926e-07
analysis O 0 1.4871192277610135e-08
showed O 0 2.725797365599192e-09
that O 0 8.33276243145109e-12
the O 0 2.220410244557769e-10
expression O 0 1.172292707352085e-09
of O 0 8.423347352959354e-09
CYP27 O 0 8.94906188477762e-05
gene O 0 1.7779780980831106e-09
mRNA O 0 2.0902124475696837e-09
in O 0 1.0032426278616668e-10
the O 0 5.443666628579535e-10
patient O 0 1.650797543106819e-08
represented O 0 1.9032690978804112e-09
52 O 0 1.4238020185075584e-07
. O 0 9.38843527364952e-08

5 O 0 2.3058584019963746e-07
% O 0 3.428947126238313e-09
of O 0 2.4145541122067016e-09
the O 0 3.0093549874266046e-09
normal O 0 6.596209800591168e-08
level O 0 5.468538688546687e-07
. O 0 1.5513673190525878e-07

As O 0 8.413653063144011e-08
the O 0 2.918102204318984e-09
mutation O 0 5.365652921973663e-10
occurred O 0 1.9646668736328365e-09
at O 0 2.3603299870167405e-10
the O 0 1.1610459121902394e-10
penultimate O 0 1.5667826858134504e-07
nucleotide O 0 3.4560252437643157e-09
of O 0 2.1816145334696557e-08
exon O 0 6.784728867614831e-08
6 O 0 1.136789329336807e-08
( O 0 1.6069541530772113e-11
- O 0 1.6543585390493831e-09
2 O 0 2.7075270914167504e-09
position O 0 2.0581993886992223e-09
of O 0 8.771735338086728e-09
exon O 0 5.9274277930398966e-08
6 O 0 5.0890641034584405e-08
- O 0 1.1338143934835898e-07
intron O 0 1.331216367361776e-06
6 O 0 5.936999869504689e-08
splice O 0 1.308735164684549e-07
site O 0 4.174411483148788e-09
) O 0 7.72507405266687e-12
of O 0 3.0618085844480447e-10
the O 0 6.229433080484625e-10
gene O 0 2.738218818354454e-10
, O 0 4.821789148512501e-11
we O 0 4.2943995581801175e-11
hypothesized O 0 4.3802539373416494e-10
that O 0 3.815940619045222e-12
the O 0 3.5120284458400874e-10
mutation O 0 6.085859594051612e-10
may O 0 9.521443633531135e-10
partially O 0 3.0991429422755346e-09
affect O 0 8.097777448590193e-10
the O 0 6.910033656382097e-10
normal O 0 5.312414397273812e-10
splicing O 0 2.58869992109112e-09
efficiency O 0 1.592278948692183e-07
in O 0 2.282585898072398e-09
exon O 0 5.916539080885741e-08
6 O 0 2.1026000940338463e-09
and O 0 1.3541308699349663e-11
cause O 0 6.00069924305835e-11
alternative O 0 1.5153995835959222e-09
splicing O 0 3.1725764237933163e-09
elsewhere O 0 1.847014208244957e-09
, O 0 2.840513848439974e-12
which O 0 1.0769166591470536e-12
resulted O 0 2.0084898189054456e-09
in O 0 9.317107085848875e-10
decreased O 0 3.7512169370756965e-08
transcript O 0 1.265848048603857e-08
in O 0 1.1003243871599011e-09
the O 0 9.679268053730539e-09
patient O 0 9.386641863784462e-07
. O 0 6.711199063147433e-08

Transfection O 0 2.6681862436817028e-05
of O 0 7.199131459856289e-07
constructed O 0 2.4417795430053957e-06
minigenes O 0 7.285100582521409e-05
, O 0 6.719954592782074e-10
with O 0 9.440527352910788e-12
or O 0 2.5178583176743707e-11
without O 0 2.64961774743e-10
the O 0 2.97633639956274e-10
mutation O 0 1.1721759674010457e-10
, O 0 4.1069463802001493e-11
into O 0 1.8450143635106997e-09
COS O 0 2.1711803128710017e-06
- O 0 1.3555391831232555e-07
1 O 0 1.0993348453780527e-08
cells O 0 9.931747091407317e-11
confirmed O 0 9.770084914706434e-12
that O 0 3.362990224839435e-13
the O 0 7.048603367643125e-11
mutant O 0 4.9867860951735565e-09
minigene O 0 2.8309364097367506e-07
was O 0 2.9638296261680352e-09
responsible O 0 1.497963836305516e-10
for O 0 8.788809263693409e-11
a O 0 3.3071081984026307e-10
mRNA O 0 7.472301000177595e-09
species O 0 4.980593021342017e-11
alternatively O 0 6.510818550964359e-10
spliced O 0 5.821209736467381e-09
at O 0 2.3701387519281525e-09
an O 0 6.519115802738895e-11
activated O 0 1.1005978421962936e-06
cryptic O 0 1.996023684114334e-06
5 O 0 2.8430076071117583e-08
splice O 0 7.352009561145678e-07
site O 0 1.8675868318496214e-07
88 O 0 6.275590749282856e-07
bp O 0 4.227327465855524e-08
upstream O 0 8.853104915829135e-09
from O 0 1.403146349110429e-10
the O 0 3.5782790619443006e-10
3 O 0 1.3392371656095747e-09
end O 0 2.8634847826225496e-09
of O 0 2.5496756705933876e-08
exon O 0 1.031869942380581e-06
6 O 0 2.118433855002877e-07
. O 0 3.7185831303077066e-08

Our O 0 2.813302444337751e-07
data O 0 3.487532040935548e-09
suggest O 0 4.2219566731560576e-10
that O 0 4.202622191223915e-12
the O 0 5.940550273919598e-10
C O 0 4.2999468519155926e-07
to O 0 9.471500667102006e-11
A O 0 9.053145455517608e-10
mutation O 0 1.5153525656508293e-10
at O 0 1.1077572886764031e-10
the O 0 7.077661373644517e-11
penultimate O 0 8.637920956289236e-08
nucleotide O 0 1.6099438449046488e-09
of O 0 4.334132164274251e-09
exon O 0 1.3129563214420159e-08
6 O 0 2.3255690706491805e-09
of O 0 8.596739986543867e-10
the O 0 3.900654022004346e-09
CYP27 O 0 0.00027158489683642983
gene O 0 1.3193822701040858e-09
not O 0 8.45122791193198e-11
only O 0 1.0358138652355464e-10
causes O 0 1.4013023630354837e-08
the O 0 8.341746848827825e-08
deficiency B-Disease 0 3.868526164296782e-06
in I-Disease 0 4.542304754551196e-09
the I-Disease 0 2.647512653553008e-09
sterol I-Disease 0 1.8659311251667532e-07
27 I-Disease 0 4.195878489099414e-08
- I-Disease 0 4.919878726639126e-09
hydroxylase I-Disease 0 8.418548702593398e-08
activity I-Disease 0 3.6986620433054895e-09
, O 0 2.2412882313971316e-11
but O 0 6.956061421314885e-11
also O 0 9.16558842711801e-11
partially O 0 4.363928329809141e-09
leads O 0 2.8443553068413507e-10
to O 0 4.059764677211142e-11
alternative O 0 8.09418310154797e-09
pre O 0 3.68410368878358e-08
- O 0 1.7383489092637205e-09
mRNA O 0 6.797209461950615e-10
splicing O 0 1.3498154816105057e-09
of O 0 3.2777752734247656e-10
the O 0 9.254074728737294e-10
gene O 0 2.294021195226037e-09
. O 0 1.035465135856839e-08

To O 0 1.8216393726788738e-08
our O 0 4.8098347527059104e-09
knowledge O 0 5.621764831431619e-09
, O 0 1.2142796317060611e-11
this O 0 2.7647920845114138e-12
is O 0 1.6889009721993142e-12
the O 0 1.927425580250386e-11
first O 0 8.243922211548238e-11
report O 0 3.5729849634513755e-11
regarding O 0 2.4484554383974455e-09
effects O 0 3.191847453010155e-09
on O 0 2.7175020012037976e-09
pre O 0 3.2872577548914705e-08
- O 0 9.44190503560094e-10
mRNA O 0 2.2198852478449993e-10
splicing O 0 3.4927757908143064e-10
of O 0 5.747857051430216e-11
a O 0 1.6169887694442164e-12
mutation O 0 5.359991530479169e-12
at O 0 5.15739916051583e-11
the O 0 1.7934505269767698e-10
- O 0 1.7246761796485544e-09
2 O 0 1.8230740250757549e-09
position O 0 7.848006133848173e-10
of O 0 5.508192235659237e-10
a O 0 4.039699408320274e-10
5 O 0 1.310669528464814e-08
splice O 0 5.23431026522303e-07
site O 0 1.1475866301680071e-07
. O 0 3.026769590519507e-08

ATM O 0 0.0019623262342065573
germline O 0 9.047429921338335e-05
mutations O 0 1.7697311704978347e-07
in O 0 6.419032416715709e-09
classical O 0 0.007134367246180773
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 3.542243165455261e-09
the O 0 1.114125236512109e-09
Dutch O 0 2.507572958165838e-07
population O 0 1.033033866781885e-10
. O 0 1.7513348549158536e-09

Germline O 0 0.005692936945706606
mutations O 0 1.5530860082435538e-06
in O 0 1.0283168094815665e-08
the O 0 6.672803198881638e-09
ATM O 0 4.1428532426834863e-07
gene O 0 1.955469119963027e-10
are O 0 9.178245186439171e-13
responsible O 0 2.4067479779954493e-12
for O 0 1.4479845274195657e-11
the O 0 0.00014411110896617174
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.3214914765267167e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.883925726531288e-08
. O 0 1.348151954516652e-07

In O 0 2.4298066136907437e-07
our O 0 1.1895694207453289e-08
study O 0 1.3105663221324448e-09
, O 0 1.568998750367534e-11
we O 0 7.142263343251631e-12
have O 0 2.909328160327629e-12
determined O 0 2.6702412503354367e-10
the O 0 4.785217222469385e-10
ATM O 0 7.099927046283483e-08
mutation O 0 1.135508020944087e-09
spectrum O 0 4.411162279893688e-08
in O 0 2.636761919916353e-10
19 O 0 3.497537592878075e-09
classical O 0 1.5897783214313677e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 1.0209576430497691e-05
, O 0 6.0997522137451465e-12
including O 0 3.303801242998672e-12
some O 0 5.744226708875866e-12
immigrant O 0 4.132438558013263e-10
populations O 0 2.4566392323177588e-11
, O 0 1.161308245747894e-12
as O 0 1.590724600653015e-11
well O 0 8.359574837912831e-11
as O 0 1.3638283558048414e-10
12 O 0 3.6910069445283966e-10
of O 0 6.028015309134105e-10
Dutch O 0 2.446361406782671e-07
ethnic O 0 5.814216330612965e-10
origin O 0 1.921526227022241e-08
. O 0 5.2583654763793675e-08

Both O 0 5.0922391636731845e-08
the O 0 5.0044710597774156e-09
protein O 0 1.9280268492849473e-09
truncation O 0 1.328179024540077e-07
test O 0 7.834423740860075e-07
( O 0 1.429714124867587e-09
PTT O 0 8.905506092560245e-07
) O 0 2.3509387145348448e-11
and O 0 2.8333942830860437e-11
the O 0 1.0414041157202902e-10
restriction O 0 9.491909480630056e-09
endonuclease O 0 1.2099447133095964e-07
fingerprinting O 0 5.572987902269233e-07
( O 0 4.457846314309677e-10
REF O 0 5.642144742523669e-07
) O 0 1.6641677619277928e-11
method O 0 1.085929901556426e-09
were O 0 1.2750279998474667e-10
used O 0 4.357436286794858e-11
and O 0 3.382821453512541e-11
compared O 0 1.0735017319518647e-09
for O 0 6.463487384200661e-11
their O 0 1.323381404461088e-10
detection O 0 4.679169496313307e-09
efficiency O 0 1.609864952456519e-08
, O 0 4.603168887729048e-11
identifying O 0 3.913051549453428e-10
76 O 0 9.482264751170533e-09
% O 0 2.3868722970332712e-11
and O 0 4.4971175221231174e-12
60 O 0 3.6500986261289725e-11
% O 0 6.423455951171109e-12
of O 0 7.104210969499647e-11
the O 0 5.516416656803358e-09
mutations O 0 9.874769446582832e-09
, O 0 2.0492367802660283e-09
respectively O 0 2.055972458947508e-07
. O 0 3.682158364881616e-07

Most O 0 2.7272815259493655e-06
patients O 0 1.920989461723366e-06
were O 0 1.042526065475613e-08
found O 0 4.5948556071095936e-10
to O 0 8.287529690287343e-11
be O 0 9.517049370799668e-10
compound O 0 1.6582679336352157e-06
heterozygote O 0 8.941641135606915e-05
. O 0 2.6839239808396087e-07

Seventeen O 0 1.5611862181685865e-05
mutations O 0 6.471848479350228e-08
were O 0 1.2700148488420382e-08
distinct O 0 7.290296699657972e-10
, O 0 6.616095865608074e-11
of O 0 9.224803143581539e-10
which O 0 4.11782552500739e-11
10 O 0 1.4926276881155331e-10
were O 0 4.1114237014916455e-10
not O 0 9.046392107636692e-11
reported O 0 1.6278344228126684e-09
previously O 0 2.5693399408055484e-08
. O 0 9.376748977274474e-08

Mutations O 0 2.2662019546260126e-05
are O 0 1.8080012154086944e-08
small O 0 1.4456383645722326e-08
deletions O 0 7.455561217284412e-07
or O 0 8.899766612557869e-07
point O 0 5.720569970435463e-05
mutations O 0 1.0575386113487184e-06
frequently O 0 5.609717845800333e-08
affecting O 0 3.8478000874420104e-07
splice O 0 5.120259083923884e-05
sites O 0 2.0675588530139066e-06
. O 0 5.050684990237642e-07

Moreover O 0 1.1489216376503464e-05
, O 0 1.789908488092351e-08
a O 0 1.0258778715410699e-08
16 O 0 3.811649946783291e-07
. O 0 3.3897765661095036e-07

7 O 0 6.720230885548517e-06
- O 0 8.589526032665162e-07
kb O 0 1.729204882394697e-06
genomic O 0 4.637447759137103e-08
deletion O 0 1.0024326257962457e-08
of O 0 2.0240428000306565e-08
the O 0 2.9818723046304285e-09
3 O 0 1.480097822081916e-09
end O 0 9.053283678284174e-10
of O 0 1.4701097006408759e-09
the O 0 5.745195985618068e-10
gene O 0 4.476896978133915e-11
, O 0 9.879369891607759e-12
most O 0 5.6405338733078736e-11
likely O 0 7.037148086475042e-10
a O 0 2.3945054272722643e-11
result O 0 4.908609629872274e-10
of O 0 3.421747329923619e-09
recombination O 0 2.5993163177417955e-10
between O 0 2.9717414640195727e-10
two O 0 7.904350785015168e-11
LINE O 0 4.902915975435462e-07
elements O 0 3.3402265398052577e-09
, O 0 3.2610317224346375e-10
was O 0 1.21314256418259e-08
identified O 0 1.1354588380640962e-08
. O 0 3.453865460301131e-08

The O 0 1.7446928950448637e-06
most O 0 2.3400176019094943e-08
frequently O 0 5.878804110182045e-10
found O 0 7.595743478638894e-11
mutation O 0 2.2364127216789598e-10
, O 0 2.435402574052503e-11
identified O 0 2.5118779278798797e-10
in O 0 4.548805221382679e-10
three O 0 1.720082687395319e-10
unrelated O 0 2.7983542594256505e-08
Turkish O 0 4.4967066514800536e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
individuals O 0 1.6621067022715152e-10
, O 0 4.825871473268517e-12
was O 0 2.052459036061549e-10
previously O 0 8.49393957946809e-11
described O 0 6.61520074829447e-11
to O 0 8.786256444626162e-12
be O 0 2.0412222259680313e-11
a O 0 9.87824405607185e-11
Turkish O 0 2.4836211309775535e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
founder O 0 1.8793385606841184e-05
mutation O 0 1.3848028856955352e-07
. O 0 3.466378473149234e-08

The O 0 1.903419359905456e-07
presence O 0 3.4474729737610232e-09
of O 0 4.284874322024734e-08
a O 0 9.032779857420792e-09
founder O 0 2.9029154120507883e-06
mutation O 0 4.2140122502587474e-08
among O 0 3.0403481954266454e-09
relatively O 0 1.7447598921194185e-09
small O 0 2.6165857675009008e-11
ethnic O 0 7.473700477933498e-12
population O 0 1.1738774015335185e-12
groups O 0 4.4806679525520587e-13
in O 0 8.76456459492081e-12
Western O 0 5.775182110312471e-09
Europe O 0 7.582589001131623e-10
could O 0 1.0704607339429018e-10
indicate O 0 4.83382667226806e-10
a O 0 3.947284513139415e-11
high O 0 7.250553490933953e-10
carrier O 0 4.850504026210345e-11
frequency O 0 2.5968285854993667e-10
in O 0 3.4010783772631115e-11
such O 0 6.990633072412322e-10
communities O 0 9.31261734393729e-09
. O 0 2.6164149957708105e-08

In O 0 2.836346482126828e-07
patients O 0 2.44729505993746e-07
of O 0 8.88967033318977e-09
Dutch O 0 3.4572776712593623e-06
ethnic O 0 3.042399943087304e-10
origin O 0 7.123183154433832e-10
, O 0 5.566889831054578e-12
however O 0 5.266708943962861e-11
, O 0 5.120171214095803e-12
no O 0 1.4056690707253683e-11
significant O 0 2.8845674737709714e-09
founder O 0 2.130387173338022e-07
effect O 0 6.853964151787295e-08
could O 0 6.395519225321777e-09
be O 0 3.359599265451152e-09
identified O 0 4.300528999579001e-08
. O 0 5.195875019126106e-08

The O 0 2.8989711609028745e-07
observed O 0 8.17101550865118e-08
genetic O 0 1.8325506445648898e-08
heterogeneity O 0 1.0965499797066514e-07
including O 0 1.0589368271141097e-09
the O 0 6.009146513719088e-09
relative O 0 2.3875190890976228e-06
high O 0 2.658092171259341e-06
percentage O 0 3.906865586600361e-08
of O 0 7.235816390505079e-09
splice O 0 1.6876225345185958e-05
- O 0 1.601800931894104e-06
site O 0 2.105430922938467e-07
mutations O 0 4.2389358689831624e-09
had O 0 7.101261245701096e-10
no O 0 1.3599500692240696e-10
reflection O 0 3.3887919137498557e-09
on O 0 5.166747918394776e-09
the O 0 7.178247329875376e-09
phenotype O 0 7.49339847061492e-07
. O 0 4.71624836961837e-08

All O 0 6.460021495513502e-08
patients O 0 4.0571389803290003e-08
manifested O 0 1.050570386240679e-08
classical O 0 3.0123023861960974e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999969005584717
T I-Disease 1 1.0
and O 0 2.949027466669918e-09
increased O 0 1.098620039385878e-08
cellular O 0 2.404142307455004e-08
radioresistant O 0 2.732274992922612e-07
DNA O 0 2.7551328329877833e-08
synthesis O 0 1.1693460066908301e-07
. O 0 5.647485679105557e-08

Determination O 0 9.068998565453512e-07
of O 0 2.990217851106536e-08
the O 0 2.2575425973059282e-09
genomic O 0 2.9577418292348057e-09
structure O 0 6.129895480100345e-10
of O 0 1.2194427689848908e-09
the O 0 3.0874256484736406e-09
COL4A4 O 1 0.7760027647018433
gene O 0 1.709219210610513e-09
and O 0 2.3791135728146173e-11
of O 0 1.2761089962509686e-09
novel O 0 3.221689894417068e-06
mutations O 0 4.65278480987763e-06
causing O 0 0.0002848088915925473
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00012185556988697499

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.0461134181127818e-08
a O 0 4.8169312982793144e-09
progressive O 0 0.0006190830026753247
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.00043957759044133127
by O 0 3.1539645988232223e-06
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 0 8.190656444639899e-06
abnormalities I-Disease 0 6.348212536977371e-06
and O 0 1.0055151156151965e-09
associated O 0 7.426804060628456e-09
with O 0 4.689656440959311e-10
mutations O 0 8.285862662660293e-09
in O 0 4.679650889016784e-09
either O 0 1.175131436603749e-09
the O 0 1.4796948555328981e-08
COL4A3 O 1 0.9999508857727051
or O 0 6.314285538877584e-09
the O 0 4.48825758780913e-08
COL4A4 O 0 0.033210448920726776
gene O 0 1.848258102121747e-09
, O 0 2.6535666025617743e-11
which O 0 7.575151443617312e-12
encode O 0 1.6522859469514373e-10
the O 0 3.724293373696952e-10
alpha3 O 0 1.3976474519949988e-06
and O 0 2.1486143975124605e-09
alpha4 O 0 6.731404482707148e-06
type O 0 6.614240191993304e-06
IV O 1 1.0
collagen O 0 0.006901193410158157
chains O 0 2.0093527837161673e-06
, O 0 2.7765070242935508e-09
respectively O 0 5.3662621013472744e-08
. O 0 5.01230701388522e-08

To O 0 3.6524072655197415e-09
date O 0 7.643058808071146e-08
, O 0 1.2125191128919965e-10
mutation O 0 2.7762871862568872e-11
screening O 0 3.715844743013008e-09
in O 0 3.758826583322161e-10
the O 0 2.359836104304236e-09
two O 0 2.8155477949098895e-10
genes O 0 1.4329465392037832e-09
has O 0 2.27826871951331e-11
been O 0 1.372620350714726e-10
hampered O 0 5.819902639814245e-07
by O 0 1.4230648881508046e-09
the O 0 1.7080990843965083e-08
lack O 0 4.5384449975927055e-08
of O 0 3.2626574775207473e-09
genomic O 0 5.7020121957407355e-09
structure O 0 2.0332509009790556e-09
information O 0 2.0144172996339194e-09
. O 0 1.3447666979971018e-08

We O 0 2.8066020618666698e-08
report O 0 8.086509795113273e-10
here O 0 2.0756313334757692e-10
the O 0 4.537909631396886e-11
complete O 0 9.877339918196171e-11
characterization O 0 1.8710617499806403e-09
of O 0 1.1164567048638219e-09
the O 0 1.118057091353819e-09
48 O 0 3.7901668470397e-09
exons O 0 3.2111007186585994e-09
of O 0 1.5843613088151187e-09
the O 0 7.199651541611729e-09
COL4A4 O 1 0.9347428679466248
gene O 0 6.232882654444438e-09
, O 0 1.2894869894086725e-10
a O 0 8.999872375126117e-11
comprehensive O 0 2.7458522566803367e-08
gene O 0 4.5803388859511074e-10
screen O 0 9.822342050824773e-09
, O 0 1.0708569447848149e-10
and O 0 4.041284668021561e-11
the O 0 4.571756861970755e-11
subsequent O 0 2.1211522815978157e-10
detection O 0 1.0352716017791863e-08
of O 0 1.3302275947424391e-09
10 O 0 6.899879001487363e-10
novel O 0 1.7695480636348293e-08
mutations O 0 9.48010780987829e-10
in O 0 2.1629387170207792e-10
eight O 0 8.308777665888556e-09
patients O 0 1.1072176675952505e-05
diagnosed O 0 0.13994672894477844
with O 0 1.0312362974218559e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.4041843062150292e-05

Furthermore O 0 3.2261664273391943e-06
, O 0 9.441028403500695e-09
we O 0 9.111211785040041e-10
identified O 0 1.7945429586774253e-09
a O 0 1.9186932598280748e-10
glycine O 0 4.129808939268287e-09
to O 0 6.314438416588075e-10
alanine O 0 2.6066173219874145e-08
substitution O 0 4.731570697913412e-06
in O 0 7.73901049910819e-08
the O 0 1.9911432502794923e-08
collagenous O 0 1.1014188885383192e-06
domain O 0 6.53090526103739e-10
that O 0 3.0089142982747674e-12
is O 0 5.744796131856855e-12
apparently O 0 3.651339508525808e-10
silent O 0 3.228591394233149e-09
in O 0 7.261317241935572e-11
the O 0 5.669258951179756e-10
heterozygous O 0 1.3803502785236788e-09
carriers O 0 2.6820439202879243e-09
, O 0 7.932912660102431e-11
in O 0 9.33382704459973e-10
11 O 0 1.824076711898215e-08
. O 0 3.900618494867558e-08

5 O 0 1.2054391618221416e-07
% O 0 1.1316960701890366e-09
of O 0 5.109913048251258e-10
all O 0 5.079417442210854e-11
control O 0 7.185654293806465e-10
individuals O 0 2.1891684645614085e-11
, O 0 6.089049403579239e-11
and O 0 2.742478744099941e-10
in O 0 8.22798162936067e-10
one O 0 7.26076282431265e-11
control O 0 6.522987150425763e-10
individual O 0 1.1241979569476257e-10
homozygous O 0 1.7028826959641918e-10
for O 0 2.166695121930129e-11
this O 0 2.778454966101407e-10
glycine O 0 4.5063742959428055e-08
substitution O 0 2.9498783078452107e-06
. O 0 4.817604803974973e-07

There O 0 7.617066444254306e-08
has O 0 2.97792068781888e-10
been O 0 1.042733885348035e-10
no O 0 2.827045889053359e-11
previous O 0 2.279392674608971e-09
finding O 0 2.902559526063442e-09
of O 0 6.767907900773196e-10
a O 0 4.234188347163048e-11
glycine O 0 6.337943503353927e-10
substitution O 0 6.43742623651633e-08
that O 0 3.945470686272934e-11
is O 0 6.893991887774176e-12
not O 0 1.6153240854285822e-12
associated O 0 5.7699570815694656e-11
with O 0 4.021168380913265e-12
any O 0 5.608781217247838e-10
obvious O 0 1.2495436862991482e-07
phenotype O 0 1.738572734666377e-07
in O 0 2.029926227109513e-09
homozygous O 0 1.906503754867117e-08
individuals O 0 5.941649949825489e-10
. O 0 1.558142770363702e-08

Founder O 1 0.9466639757156372
BRCA1 O 0 0.0006582151399925351
and O 0 1.7266575014218688e-06
BRCA2 O 0 1.640994378249161e-05
mutations O 0 8.291712205732438e-09
in O 0 5.409603320849499e-10
French O 0 2.198717368173675e-07
Canadian O 0 0.00012761926336679608
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.0349392444768455e-06
. O 0 2.984013462992152e-07

We O 0 4.3045993436408025e-08
have O 0 3.447399032907583e-10
identified O 0 1.2404287597078678e-09
four O 0 8.15118875174825e-11
mutations O 0 1.509868063909181e-10
in O 0 3.82506595841825e-11
each O 0 5.865246222730436e-12
of O 0 4.920235330274636e-09
the O 0 7.1517902142659295e-06
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999110698699951
- O 1 0.9778537154197693
susceptibility O 1 0.9993118047714233
genes O 0 3.865535802560771e-07
, O 0 4.507781703466662e-09
BRCA1 O 0 1.161492662049568e-07
and O 0 7.68672414608318e-09
BRCA2 O 0 4.406293285796892e-08
, O 0 5.362394122493397e-12
in O 0 2.2318265291421113e-11
French O 0 1.0130850824907611e-08
Canadian O 0 9.946563750418136e-07
breast B-Disease 0 0.009828254580497742
cancer I-Disease 0 0.005040038377046585
and O 0 0.008732226677238941
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.463345888907952e-08
from O 0 2.0139985235090307e-09
Quebec O 0 2.1680880024632643e-07
. O 0 2.6864533708703675e-08

To O 0 2.2015626655047527e-07
identify O 0 7.025741410870978e-07
founder O 0 2.4701272195670754e-05
effects O 0 8.12365578894969e-06
, O 0 6.3219260937330546e-09
we O 0 6.116044337645121e-10
examined O 0 9.979685522409909e-09
independently O 0 2.5640647938196537e-10
ascertained O 0 9.382063126395224e-08
French O 0 1.5413701248689904e-07
Canadian O 0 9.494752930550021e-07
cancer B-Disease 0 4.542711394606158e-06
families O 0 1.235333085825019e-10
for O 0 9.128876474195913e-12
the O 0 6.677226827012106e-11
distribution O 0 4.945976406212083e-10
of O 0 2.3424366890623105e-09
these O 0 4.011124321579018e-09
eight O 0 2.085315742306193e-08
mutations O 0 2.4827299327512264e-08
. O 0 5.142820214132371e-08

Mutations O 0 2.4028554435062688e-06
were O 0 4.107837625610955e-08
found O 0 1.939649330040538e-09
in O 0 1.297431606595012e-09
41 O 0 5.2680029227758496e-08
of O 0 1.2857209519268054e-08
97 O 0 6.626690264965873e-06
families O 0 1.675211613871852e-08
. O 0 4.8810633757057076e-08

Six O 0 3.6364707511893357e-07
of O 0 3.901273615269929e-08
eight O 0 9.900001707308093e-09
mutations O 0 2.8179079070156376e-09
were O 0 1.6437211591835421e-09
observed O 0 2.8450946043534486e-09
at O 0 1.0152128027129947e-08
least O 0 1.9734400780180295e-09
twice O 0 4.196654757038232e-08
. O 0 6.439648814193788e-08

The O 0 1.826401421567425e-05
BRCA1 O 0 1.0489131454960443e-05
C4446T O 0 6.419196779461345e-06
mutation O 0 3.290864825089557e-08
was O 0 4.002595588303848e-09
the O 0 4.888409121939219e-10
most O 0 3.764839273667775e-10
common O 0 1.2636472979110636e-09
mutation O 0 4.5368822587654734e-10
found O 0 4.459128205569485e-11
, O 0 2.527070349853111e-12
followed O 0 1.0459248744876248e-10
by O 0 6.030050903049755e-10
the O 0 1.0954860130141242e-07
BRCA2 O 0 3.321396661704057e-06
8765delAG O 0 2.0224470063112676e-06
mutation O 0 1.0817179685318479e-07
. O 0 3.523841485275625e-08

Together O 0 1.2566948726089322e-07
, O 0 2.746882721282873e-09
these O 0 2.7199223429086317e-10
mutations O 0 1.0427542163071735e-09
were O 0 1.9935895156919514e-09
found O 0 1.0801103761393094e-10
in O 0 7.611493380021983e-11
28 O 0 6.858603907033967e-09
of O 0 9.143492185614832e-09
41 O 0 4.592319058360772e-08
families O 0 1.1384870823860638e-10
identified O 0 6.220085557728794e-11
to O 0 9.694556268868837e-11
have O 0 5.924132295831441e-10
a O 0 4.7035344508117305e-09
mutation O 0 2.4939217269093206e-07
. O 0 3.0966219810579787e-07

The O 0 3.4300225593142386e-07
odds O 0 3.840710007807502e-07
of O 0 8.489619007789884e-10
detection O 0 1.3198813597625758e-08
of O 0 1.7134330621004779e-09
any O 0 1.0787021970104504e-10
of O 0 6.89153045740909e-09
the O 0 2.693343681414717e-08
four O 0 1.1705550306828627e-08
BRCA1 O 0 1.83213884952238e-07
mutations O 0 6.9129506563569976e-09
was O 0 4.047948465313311e-08
18 O 0 9.13329927243467e-08
. O 0 1.7141312014246068e-07

7x O 0 0.0013077161274850368
greater O 0 4.971115004082094e-07
if O 0 8.03574451424538e-09
one O 0 8.919149863118037e-10
or O 0 6.739243191278277e-11
more O 0 7.565130813458332e-12
cases O 0 1.298193996746022e-09
of O 0 0.3725619316101074
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.578179364969401e-08
also O 0 9.291206692907394e-12
present O 0 4.8999075630273836e-11
in O 0 3.425977557203197e-10
the O 0 6.954808284831415e-09
family O 0 2.623844919114049e-09
. O 0 1.0346004941652609e-08

The O 0 3.936247026103956e-07
odds O 0 5.475657189890626e-07
of O 0 6.717648104448415e-10
detection O 0 1.3643891350056947e-08
of O 0 1.400184856947817e-09
any O 0 1.0472583911180777e-10
of O 0 4.030658029563483e-09
the O 0 1.7508346772387995e-08
four O 0 1.4739064191360285e-08
BRCA2 O 0 5.788429007225204e-07
mutations O 0 3.05894998220424e-09
was O 0 1.749452671617746e-08
5 O 0 4.666444297640737e-08
. O 0 4.620637028551755e-08

3x O 0 2.9583666218968574e-06
greater O 0 1.3246302721370284e-08
if O 0 3.956369398760984e-10
there O 0 9.233441788936148e-11
were O 0 3.197024867063192e-10
at O 0 9.521983201921103e-11
least O 0 2.6312283515211865e-12
five O 0 1.3668582325015999e-12
cases O 0 1.810172324534509e-11
of O 0 7.596464257630942e-08
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9968798160552979
in O 0 1.1637168739753179e-07
the O 0 5.039084953750717e-07
family O 0 1.6714453821009556e-08
. O 0 1.7474050650889694e-08

Interestingly O 0 3.0204516860976582e-06
, O 0 2.4377750929005515e-09
the O 0 1.7316774680864455e-09
presence O 0 9.241515330771222e-10
of O 0 2.8701956367171988e-08
a O 0 1.1762649165802941e-07
breast B-Disease 0 0.0014398590428754687
cancer I-Disease 0 1.6746162145864218e-06
case O 0 6.084657400151627e-08
< O 0 1.3535343157400348e-07
36 O 0 9.018130242566258e-09
years O 0 1.0271356681856858e-10
of O 0 2.090745770955138e-10
age O 0 1.1914693676118304e-09
was O 0 2.258816189648627e-10
strongly O 0 3.734755560369507e-11
predictive O 0 6.509353056571854e-10
of O 0 3.63239716083541e-10
the O 0 4.6057862385096016e-11
presence O 0 1.0747830576918194e-11
of O 0 7.100675603055606e-11
any O 0 3.18492975048823e-11
of O 0 1.1440733915790702e-09
the O 0 3.6169542916297814e-09
eight O 0 5.3108371034227275e-09
mutations O 0 5.814396519809861e-09
screened O 0 2.0274242729101388e-07
. O 0 9.288725522083041e-08

Carriers O 0 4.689168804361543e-07
of O 0 2.8293321463479515e-08
the O 0 1.0205337686031157e-09
same O 0 3.0983493548575325e-10
mutation O 0 3.5263120201634024e-10
, O 0 3.086420008457935e-12
from O 0 9.862275059113745e-12
different O 0 1.906784452554433e-11
families O 0 1.3639448077917837e-11
, O 0 5.493215257668105e-12
shared O 0 1.009650418826169e-10
similar O 0 3.5648659024722917e-10
haplotypes O 0 1.055475085109947e-08
, O 0 6.387199102952934e-11
indicating O 0 3.230671563603238e-10
that O 0 3.48835825676741e-12
the O 0 3.1356434115892284e-10
mutant O 0 4.0154035652051334e-09
alleles O 0 3.4052344277668567e-10
were O 0 6.977179389799915e-10
likely O 0 3.366140144400731e-10
to O 0 6.951774225716356e-12
be O 0 1.001865344157915e-11
identical O 0 1.1540382538477445e-10
by O 0 1.1513729206158452e-11
descent O 0 7.109813293659784e-10
for O 0 1.653842687798779e-11
a O 0 2.5729746458424962e-11
mutation O 0 1.9886969848670333e-10
in O 0 1.5766311867171368e-10
the O 0 3.642201873432782e-09
founder O 0 3.5765293660006137e-07
population O 0 3.608972565238844e-10
. O 0 6.4368959051819274e-09

The O 0 1.4930876091057144e-08
identification O 0 4.2391967269850284e-08
of O 0 9.29874062194358e-08
common O 0 5.605529440799728e-05
BRCA1 O 0 0.0004865868831984699
and O 0 7.809672979419702e-07
BRCA2 O 0 1.028166661853902e-05
mutations O 0 3.6395075841966218e-09
will O 0 2.734877081744802e-11
facilitate O 0 2.7292920701249557e-10
carrier O 0 3.2108907199734915e-10
detection O 0 4.834409761400593e-09
in O 0 2.3257674952592566e-10
French O 0 1.678420176176587e-07
Canadian O 0 3.5860798561770935e-06
breast B-Disease 1 0.9966011047363281
cancer I-Disease 1 0.9427236914634705
and O 1 0.7031683921813965
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4628582789555367e-07
. O 0 2.5235978640125722e-08

Are O 0 1.567727423434917e-07
Dp71 O 0 0.00018212158465757966
and O 0 1.5810692843842844e-07
Dp140 O 0 0.0001359880989184603
brain O 0 4.68139933218481e-06
dystrophin O 0 1.561905628477689e-05
isoforms O 0 3.1063582355272956e-06
related O 0 2.104661007251707e-06
to O 0 5.4049163367153596e-08
cognitive B-Disease 0 0.3028672933578491
impairment I-Disease 1 1.0
in O 1 0.9998830556869507
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999817609786987

Molecular O 0 8.069374416663777e-06
study O 0 1.9895487923804467e-08
and O 0 4.957139143613176e-10
neuropsychological O 0 2.2891798323598778e-07
analysis O 0 2.4749604587981366e-09
were O 0 2.506413965264187e-09
performed O 0 8.560072650709571e-10
concurrently O 0 1.2363376988844266e-09
on O 0 1.0103622827273284e-08
49 O 0 7.131944812499569e-08
patients O 0 7.058393691750098e-08
with O 0 2.1193466537283712e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.765768143348396e-06
DMD B-Disease 1 1.0
) O 0 5.925644003257347e-11
in O 0 1.0107018520721933e-11
order O 0 2.0755548321704786e-11
to O 0 9.476609601211106e-12
find O 0 2.149907508963711e-11
a O 0 1.935370917346968e-12
molecular O 0 1.4584403129624945e-10
explanation O 0 1.3061013381943098e-10
for O 0 2.1507852790425552e-11
the O 0 4.390444008350869e-09
cognitive B-Disease 0 2.2548729248228483e-06
impairment I-Disease 0 1.1399926734156907e-05
observed O 0 6.690341791681931e-08
in O 0 1.3130164511210296e-08
most O 0 3.6577569062501425e-07
DMD B-Disease 1 1.0
patients O 1 0.9040778875350952
. O 0 1.0831605550265522e-06

Complete O 0 5.92042219693667e-08
analysis O 0 7.03076574737338e-09
of O 0 1.529466331362528e-08
the O 0 1.4172472084794663e-08
dystrophin O 0 2.1759001356258523e-06
gene O 0 1.7929425055740467e-08
was O 0 3.71440798119238e-08
performed O 0 2.7728077611754998e-09
to O 0 6.930806623062225e-11
define O 0 2.1855492970956902e-09
the O 0 3.1313056592097155e-09
localization O 0 2.6505867367632163e-07
of O 0 1.0398787608778548e-08
deletions O 0 7.520027267560181e-09
and O 0 6.44995667986592e-10
duplications O 0 1.4922704849595902e-08
in O 0 5.547498571623066e-10
relation O 0 1.8450599936770118e-09
to O 0 3.00821728638212e-10
the O 0 7.956862724256553e-09
different O 0 1.3505686524695193e-07
DMD B-Disease 1 1.0
promoters O 0 0.19209302961826324
. O 0 1.6280808949886705e-06

Qualitative O 0 1.9344673773957766e-07
analysis O 0 6.48877929165792e-09
of O 0 3.5137873055646196e-08
the O 0 1.0800459193660572e-07
Dp71 O 0 0.00023085444991011173
transcript O 0 4.061730507487482e-08
and O 0 9.51938597393287e-11
testing O 0 2.8909225013862283e-10
for O 0 1.2226367487877532e-11
the O 0 3.816641447329516e-11
specific O 0 1.149519368581764e-10
first O 0 1.0926970439584238e-09
exon O 0 2.075094762687968e-08
of O 0 6.988637224480954e-09
Dp140 O 0 3.25652808896848e-06
were O 0 2.1802003757898092e-08
also O 0 2.670934029502803e-10
carried O 0 7.949426117370706e-10
out O 0 8.977109611230105e-10
. O 0 1.118268855293536e-08

Neuropsychological O 0 3.65761443390511e-05
analysis O 0 7.552760905582545e-08
assessed O 0 7.990917083589011e-07
verbal O 0 6.506318186438875e-07
and O 0 1.5616267390328176e-08
visuospatial O 0 1.2868638350482797e-06
intelligence O 0 4.158882571658751e-09
, O 0 1.0645951897814143e-09
verbal O 0 1.2485852494137362e-06
memory O 1 0.9997462630271912
, O 0 1.6076800335440566e-08
and O 0 1.0882278189683348e-08
reading O 0 0.0001522313104942441
skills O 0 2.658224047991098e-06
. O 0 1.0531448424444534e-07

Comparison O 0 3.6756011922989273e-06
of O 0 2.8718665134874755e-07
molecular O 0 1.9178739876224427e-06
and O 0 1.4325892472299984e-08
psychometric O 0 0.00010849681711988524
findings O 0 8.319976245729777e-07
demonstrated O 0 1.235492561590945e-07
that O 0 1.1246440584367079e-10
deletions O 0 3.379769353273332e-08
and O 0 5.397382984995147e-09
duplications O 0 4.7026130545191336e-08
that O 0 5.203255534769191e-11
were O 0 8.926467898184853e-10
localized O 0 8.639565507451152e-09
in O 0 7.810375124428504e-10
the O 0 8.849030952440273e-10
distal O 0 1.3464277515140566e-07
part O 0 2.0247068022172243e-08
of O 0 3.174055507315643e-07
the O 0 2.0523130217497965e-07
gene O 0 1.539355487523153e-08
seemed O 0 1.2076102962055302e-07
to O 0 7.928556422509558e-11
be O 0 2.902115214808987e-10
preferentially O 0 2.46635210032764e-08
associated O 0 3.980724017083048e-08
with O 0 2.0863739180754237e-08
cognitive B-Disease 1 0.5805986523628235
impairment I-Disease 1 0.9999784231185913
. O 0 4.331623131292872e-05

Two O 0 3.279555187418737e-07
altered O 0 2.1502200979739428e-06
Dp71 O 0 0.0015659171622246504
transcripts O 0 4.023120709462091e-06
and O 0 9.990369420620482e-09
two O 0 7.263592505246663e-10
deleted O 0 9.935735789667888e-09
Dp140 O 0 1.778861644652352e-07
DNA O 0 1.888720735365723e-09
sequences O 0 5.521569659827641e-11
were O 0 1.5488400839647198e-10
found O 0 4.1100810255212394e-11
in O 0 8.332051021353593e-11
four O 0 2.786134101206983e-10
patients O 0 2.7446585448842598e-08
with O 0 1.3696580536404213e-09
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.004358382895588875

These O 0 1.996197482867501e-07
findings O 0 7.838453797148759e-08
suggest O 0 4.1404253359189624e-09
that O 0 1.0080296840297986e-11
some O 0 1.5331820882313885e-11
sequences O 0 9.857028387960654e-12
located O 0 8.910541055007215e-11
in O 0 4.037317355432002e-11
the O 0 5.678078562887379e-10
distal O 0 1.4232236367206497e-07
part O 0 2.186388492475544e-08
of O 0 4.045930950269394e-07
the O 0 2.574343405115087e-08
gene O 0 2.881024863121695e-10
and O 0 1.0265696626099441e-10
, O 0 1.0135474057260119e-11
in O 0 1.241369507187784e-11
particular O 0 1.3678794208438205e-10
, O 0 1.5239051340265597e-11
some O 0 5.12942049946119e-11
DMD B-Disease 1 0.9999523162841797
isoforms O 0 1.6139145486704365e-07
expressed O 0 2.6836314503952963e-08
in O 0 7.534757706650907e-09
the O 0 4.027716826726646e-08
brain O 0 2.8542054053559696e-08
may O 0 1.5150461440960328e-10
be O 0 6.062083474089874e-11
related O 0 2.9370275100859544e-08
to O 0 1.2548088124120227e-09
the O 0 3.032866970897885e-07
cognitive B-Disease 0 0.0004174176137894392
impairment I-Disease 0 0.0006180736236274242
associated O 0 1.0423061212350149e-05
with O 0 8.633570018901082e-07
DMD B-Disease 1 1.0
. O 0 2.62754315372149e-06
. O 0 3.241680985865969e-07

I1307K O 0 0.0012375478399917483
APC O 0 5.618362774839625e-05
and O 0 9.266835121479744e-08
hMLH1 O 0 6.362382919178344e-06
mutations O 0 5.150123527641881e-08
in O 0 9.607474815709338e-10
a O 0 2.379713648359427e-10
non O 0 5.623097720786063e-08
- O 0 5.513232892440101e-08
Jewish O 0 4.8917442541096534e-08
family O 0 7.691277476018499e-11
with O 0 1.488947506955718e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0019509827252477407

We O 0 9.180066484759664e-09
describe O 0 2.2782842279411852e-09
a O 0 2.3042287522478944e-10
French O 0 6.903835014782089e-08
Canadian O 0 1.3136524330548127e-06
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.081350415523048e-07
HNPCC B-Disease 1 0.9999995231628418
) O 0 5.4036459751216626e-09
kindred O 0 3.3416606584069086e-06
which O 0 3.6263195224428557e-10
carries O 0 3.6624245858263293e-09
a O 0 2.1679859296686033e-10
novel O 0 4.7743277775680326e-08
truncating O 0 1.1557594916666858e-06
mutation O 0 4.1228144453953064e-08
in O 0 1.0639907621623479e-08
hMLH1 O 0 4.634724973584525e-06
. O 0 3.8454743389593204e-07

Interestingly O 0 3.96519317291677e-06
, O 0 6.0154419223579225e-09
the O 0 1.4960722438672747e-08
I1307K O 0 5.230894657870522e-06
APC O 0 4.392574055600562e-07
polymorphism O 0 3.2495918844688276e-08
, O 0 4.035538569979735e-11
associated O 0 2.679174382347327e-10
with O 0 6.611475689838331e-12
an O 0 2.417905719392932e-12
increased O 0 1.998249121726303e-09
risk O 0 5.396530582402193e-07
of O 1 0.9999886751174927
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.9774832316652464e-08
is O 0 2.4469076070898765e-11
also O 0 1.930242857911546e-12
present O 0 2.3499299728335643e-11
in O 0 1.2009486460851093e-10
this O 0 5.443936967886032e-10
family O 0 3.370697054805305e-09
. O 0 1.6416791481788096e-08

The O 0 9.931549129760242e-07
I1307K O 0 8.28043539513601e-06
polymorphism O 0 3.7522335105677485e-07
has O 0 4.695778210717094e-10
previously O 0 1.8861422146354556e-10
only O 0 9.397393453680625e-12
been O 0 3.1274406675496635e-11
identified O 0 1.1647188769003947e-10
in O 0 4.227240432697066e-11
individuals O 0 1.3658869174593136e-11
of O 0 6.458368506656598e-09
self O 0 2.3698333961874596e-07
- O 0 8.06630453098478e-07
reported O 0 1.5773006012409496e-08
Ashkenazi O 0 6.06743697062484e-07
Jewish O 0 5.323527219047719e-08
origins O 0 1.2621359246622887e-07
. O 0 1.5912549500285422e-08

In O 0 1.1437075286835352e-08
addition O 0 1.0436357333887258e-09
, O 0 3.704716047825407e-11
in O 0 2.4914166216194467e-11
this O 0 1.2608124613788796e-11
family O 0 3.204807252910058e-11
, O 0 2.330520975854511e-12
there O 0 5.525432975744815e-12
appears O 0 1.0890573165500683e-10
to O 0 5.215245769962795e-12
be O 0 5.490662091656162e-11
no O 0 1.3372505880404617e-10
relationship O 0 7.42240643947234e-11
between O 0 1.5501552819152664e-10
the O 0 1.3036081103479091e-09
I1307K O 0 2.0352228347064738e-08
polymorphism O 0 2.0706263370584566e-09
and O 0 1.6444940895143922e-11
the O 0 3.01002903158043e-11
presence O 0 4.763214128677973e-11
or O 0 2.793504039200201e-10
absence O 0 8.185895694623468e-07
of O 0 1.9867634364345577e-06
cancer B-Disease 0 7.355843263212591e-05
. O 0 1.0149804552384012e-08
. O 0 4.609809423072875e-08

Identification O 0 9.772935527507798e-08
of O 0 3.069235976482787e-09
a O 0 2.0614120133100045e-10
novel O 0 5.327740026928041e-09
mutation O 0 7.456323336541004e-10
of O 0 5.412939874105405e-09
the O 0 1.1667083299471415e-07
CPO O 0 6.750889588147402e-05
gene O 0 1.2451507602762035e-09
in O 0 1.9461482425597865e-10
a O 0 2.111110175562203e-10
Japanese O 0 6.561390819115331e-06
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
family O 0 1.200898168463027e-06
. O 0 1.5739743730591726e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.7783136829384603e-05
HCP B-Disease 1 1.0
) O 0 4.743346160296369e-09
is O 0 5.757395116212649e-10
an O 0 8.639461923642955e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 9.296928169533203e-07
by O 0 1.9861856159764102e-08
a O 0 1.302560015403742e-08
deficiency B-Disease 0 0.0031947342213243246
of I-Disease 0 0.0008461342076770961
coproporphyrinogen I-Disease 1 0.9999911785125732
oxidase I-Disease 0 3.5510467569110915e-05
( O 0 8.281813568267182e-10
CPO O 0 5.22934044511203e-07
) O 0 4.107586666635132e-12
caused O 0 4.423338431647217e-11
by O 0 3.054911879019073e-11
a O 0 1.600506810417457e-10
mutation O 0 1.9508803461576463e-09
in O 0 4.297222577775983e-09
the O 0 4.347850222075067e-07
CPO O 0 0.0010117185302078724
gene O 0 1.2792574466402584e-07
. O 0 8.112161964390907e-08

Only O 0 9.633705388978342e-08
11 O 0 2.75978724317838e-08
mutations O 0 1.823881046192355e-09
of O 0 3.911948986967673e-09
the O 0 1.4139154735914872e-08
gene O 0 3.45420625436077e-09
have O 0 2.242580843248021e-10
been O 0 3.143721671872157e-10
reported O 0 7.840659788094229e-10
in O 0 1.1646216790950348e-07
HCP B-Disease 1 1.0
patients O 1 0.9998883008956909
. O 0 2.7581252197705908e-06

We O 0 5.598077734703111e-08
report O 0 1.8917851729582935e-09
another O 0 5.133475311502878e-10
mutation O 0 1.0712845055493858e-09
in O 0 1.358982926191743e-10
a O 0 4.3097134194702846e-10
Japanese O 0 1.8135136770069948e-06
family O 0 1.4793674729673967e-08
. O 0 3.566467654536609e-08

Polymerase O 0 1.8575043441160233e-06
chain O 0 8.719778321619742e-08
reaction O 0 2.6669965791370487e-08
- O 0 1.1543722422402425e-07
single O 0 2.627180029080023e-09
strand O 0 1.2237952873306313e-09
conformational O 0 1.2757286893538833e-10
polymorphism O 0 3.9327452405757413e-10
and O 0 7.510182579995028e-12
direct O 0 1.8651023434013148e-11
sequence O 0 1.1986435281829966e-11
analyses O 0 6.412858438720193e-11
demonstrated O 0 6.637181915181145e-10
a O 0 1.1841938540868568e-10
C O 0 2.1749758616351755e-07
to O 0 3.206331311567112e-10
T O 0 7.94067123166542e-09
substitution O 0 1.0100655423173066e-08
in O 0 1.0105313252850578e-09
exon O 0 3.191932718138446e-09
1 O 0 5.413546277921455e-10
of O 0 5.149390913672391e-10
the O 0 3.288447292248975e-09
CPO O 0 4.5556515715361456e-07
gene O 0 1.0627889540648638e-10
at O 0 3.489992184135815e-10
nucleotide O 0 8.710710486248274e-10
position O 0 3.164393636012619e-09
85 O 0 1.8144579172485464e-08
, O 0 3.6913992695897235e-11
which O 0 2.170243672272587e-11
lies O 0 1.2028567031308057e-09
in O 0 5.7198051850448905e-11
the O 0 8.567128673142577e-10
putative O 0 4.3204334332358485e-08
presequence O 0 3.636557153186004e-07
for O 0 1.3114015429138703e-09
targeting O 0 6.0314686578522014e-09
to O 0 3.3277376410012494e-09
mitochondria O 0 1.3851689573129988e-06
. O 0 2.2974425917254848e-07

This O 0 1.2088463563486584e-08
mutation O 0 6.399643925902865e-09
changes O 0 7.481809616294299e-10
the O 0 1.7605955582311594e-09
codon O 0 1.3091504769136009e-08
for O 0 2.3009612271085444e-10
glutamine O 0 3.5841689616233907e-09
to O 0 5.531013841375554e-11
a O 0 1.044087108437175e-10
termination O 0 3.131683712354061e-08
codon O 0 3.314727692327324e-08
at O 0 8.879773361059051e-09
amino O 0 1.710044217340112e-09
acid O 0 1.1354674533947673e-08
position O 0 2.9231506104565597e-08
29 O 0 2.773386427179503e-07
. O 0 1.914367686595142e-07

MaeI O 0 7.92336359154433e-05
restriction O 0 4.174537195922312e-07
analysis O 0 1.552464823362243e-08
showed O 0 3.666492665033161e-09
two O 0 1.9009597715391457e-11
other O 0 1.2902022332450525e-11
carriers O 0 1.2584449038399725e-09
in O 0 6.243600081390355e-10
the O 0 1.2320070297278107e-08
family O 0 4.683249787973409e-09
. O 0 2.773793106314315e-08

The O 0 7.94012692040269e-07
C O 0 7.354819535976276e-05
- O 0 3.787057949011796e-06
T O 0 6.917871928635577e-07
mutation O 0 1.0556779894699275e-09
is O 0 9.914537073274499e-12
located O 0 3.230103337581447e-11
within O 0 2.1414238438044464e-11
a O 0 2.132041938829321e-11
recently O 0 3.3352912098827403e-10
proposed O 0 1.0627616120473249e-08
putative O 0 1.2953286443462275e-07
alternative O 0 5.2212776324722654e-08
translation O 0 2.7073672193012044e-09
initiation O 0 6.907111771425889e-09
codon O 0 6.721419421040764e-09
( O 0 3.888304608845594e-11
TIC O 0 2.1561559204741343e-09
- O 0 1.2398824189574498e-09
1 O 0 6.109690531275191e-10
) O 0 4.596945653995155e-12
, O 0 1.200187865757485e-11
supporting O 0 6.134430463600182e-11
that O 0 9.038436665775862e-12
TIC O 0 1.2440474428387915e-08
- O 0 8.995200317940544e-08
1 O 0 3.916751722954359e-08
is O 0 2.9069835080774986e-11
the O 0 7.117316735971713e-10
real O 0 1.0357831925489336e-08
TIC O 0 5.5515688046625655e-08
rather O 0 5.140747827425685e-09
than O 0 2.3900863510561976e-09
TIC O 0 2.2111532871349482e-07
- O 0 2.041669944219393e-07
2 O 0 2.751650995946875e-08
. O 0 1.3016403510590635e-09
. O 0 7.490837283796736e-09

Human B-Disease 0 8.76013643846818e-08
complement I-Disease 0 8.701168212610355e-07
factor I-Disease 0 0.002889876486733556
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999943971633911
associated O 0 2.445819518470671e-05
with O 0 1.3036162272328511e-05
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.09939754009246826

This O 0 1.2719155506601965e-08
study O 0 4.686233623374392e-09
reports O 0 2.4034613188561593e-10
on O 0 5.889398968506043e-10
six O 0 7.254283979074572e-11
cases O 0 7.548678349067472e-10
of O 0 3.906444362655748e-06
deficiency B-Disease 1 0.9999994039535522
in I-Disease 0 3.2706472552490595e-07
the I-Disease 0 5.474573683272865e-09
human I-Disease 0 4.787296253860873e-11
complement I-Disease 0 8.932219547341802e-11
regulatory I-Disease 0 3.5030387479650926e-09
protein I-Disease 0 1.5472642056479913e-09
Factor I-Disease 0 1.026212856913844e-07
H I-Disease 1 0.9999992847442627
( O 0 1.8946044733070266e-10
FH O 0 3.9322321754298173e-07
) O 0 2.0064115299756047e-12
in O 0 1.3535518192386853e-12
the O 0 1.5924632489408563e-12
context O 0 7.534275980880523e-11
of O 0 7.836484933188004e-11
an O 0 2.3814028526913944e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.936919817235321e-05

Five O 0 1.4073751231080678e-07
of O 0 1.0658634863602856e-08
the O 0 1.4511435386665994e-09
cases O 0 1.0959824159328946e-09
were O 0 4.13945183685982e-10
observed O 0 3.062883557891638e-10
in O 0 5.72603769954938e-11
children O 0 9.406305595538456e-12
presenting O 0 3.3708752456007574e-10
with O 0 4.68575789280834e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.9561400373931974e-05
HUS B-Disease 1 1.0
) O 0 4.765011851759482e-08
. O 0 1.3665513165506127e-07

Two O 0 8.89642048917949e-09
of O 0 1.9303977083495738e-08
the O 0 3.113346025429564e-08
children O 0 1.2569359997272045e-09
exhibited O 0 9.367433051465923e-09
a O 0 6.4333978144759385e-09
homozygous O 0 1.1721897863026243e-05
deficiency O 0 0.00019977866031695157
characterized O 0 3.520730729178467e-08
by O 0 2.558023570742307e-09
the O 0 1.9202987644462155e-08
absence O 0 1.0398395744459776e-07
of O 0 3.02032212573522e-08
the O 0 1.5974395140005981e-09
150 O 0 3.416554539281691e-10
- O 0 8.206083035311451e-11
kD O 0 4.2300030145270284e-09
form O 0 1.2245955638423567e-10
of O 0 2.1177011255701927e-09
Factor O 0 3.605639165016328e-08
H O 1 0.9972482323646545
and O 0 2.9214311525471715e-10
the O 0 6.41420389024816e-11
presence O 0 5.781301219004442e-12
, O 0 3.1057302996712055e-12
upon O 0 1.9832234465777532e-10
immunoblotting O 0 2.1763867152913008e-07
, O 0 9.82109532587927e-11
of O 0 7.947242863792781e-10
the O 0 9.88277237823354e-10
42 O 0 4.216663462841552e-09
- O 0 2.7117392775721783e-09
kD O 0 1.3545260912906087e-07
Factor O 0 1.6214833920003002e-07
H O 1 0.9999964237213135
- O 0 3.491974212010973e-07
like O 0 1.580606645568139e-09
protein O 0 7.186695683003563e-10
1 O 0 5.9740505875538474e-09
( O 0 4.304182357750541e-11
FHL O 0 3.0787705327384174e-06
- O 0 3.5006760157330064e-08
1 O 0 1.2394975712481937e-08
) O 0 1.265541924727609e-11
and O 0 4.8385653123039774e-11
other O 0 2.623853634364792e-10
FH O 0 2.4299128199345432e-05
- O 0 2.0434346481579269e-07
related O 0 1.3812048393901932e-07
protein O 0 2.745318106178729e-08
( O 0 3.8530836854455686e-10
FHR O 0 0.0003274418995715678
) O 0 2.585995639847738e-09
bands O 0 4.2180573700534296e-07
. O 0 7.201301599479848e-08

Southern O 0 3.338093620186555e-06
blot O 0 1.7743627722666133e-06
and O 0 8.467221923602608e-10
PCR O 0 1.4963749350727085e-08
analysis O 0 2.104123542068237e-10
of O 0 1.626387219344494e-10
DNA O 0 7.253236899984472e-10
of O 0 1.9599657452573638e-09
one O 0 6.371239091862435e-10
patient O 0 1.4510645485188434e-07
with O 0 1.0529550564797319e-09
homozygous O 0 4.477571928873658e-05
deficiency O 1 0.7720587253570557
ruled O 0 8.48815579956863e-06
out O 0 4.6358179517369535e-09
the O 0 3.2737079713740513e-10
presence O 0 2.949356037174056e-11
of O 0 3.0084237878647e-10
a O 0 2.7518145748195444e-11
large O 0 1.4018596006248885e-10
deletion O 0 1.7685274078527158e-10
of O 0 2.4622428540510555e-09
the O 0 2.0820804635945933e-08
FH O 0 1.879869341792073e-05
gene O 0 9.102023579288243e-10
as O 0 1.7514141525953875e-10
the O 0 2.0712067616557306e-09
underlying O 0 2.8298502456891583e-06
defect O 0 3.254266403018846e-07
for O 0 1.6372451838719826e-08
the O 0 8.158273885783274e-06
deficiency O 1 0.9975679516792297
. O 0 6.405156000255374e-06

The O 0 8.174630465873634e-07
other O 0 9.60826795903813e-09
four O 0 2.474479066094659e-09
children O 0 2.3579452279598456e-10
presented O 0 4.032726597102965e-09
with O 0 3.354886368711618e-09
heterozygous O 0 4.622669075615704e-05
deficiency O 1 0.8056291341781616
and O 0 9.597040495634701e-09
exhibited O 0 3.443071960873567e-08
a O 0 2.279908761781968e-10
normal O 0 1.4095210332243369e-08
immunoblotting O 0 2.05565402211505e-06
pattern O 0 3.595253872390458e-09
of O 0 5.325258012334189e-10
proteins O 0 1.5860921950827667e-11
of O 0 4.405574516308519e-10
the O 0 1.5227627159219992e-08
FH O 0 0.0004989114822819829
family O 0 2.02236805080247e-08
. O 0 2.1941755079524228e-08

Factor B-Disease 1 0.9999997615814209
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
is O 0 1.5642431794304912e-09
the O 0 2.501876483762544e-09
only O 0 7.007617597309945e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.598090966581367e-05
with O 0 2.988407743487187e-07
HUS B-Disease 1 1.0
. O 0 0.00029405669192783535

These O 0 6.664359375463391e-08
observations O 0 6.528195939381476e-08
suggest O 0 4.522697771847106e-09
a O 0 1.6349996356801455e-10
role O 0 8.051358468819103e-10
for O 0 3.8933549717512506e-09
FH O 1 0.9996830224990845
and O 0 6.550610009981028e-08
/ O 0 4.232099399814615e-07
or O 0 7.583171424130342e-09
FH O 0 7.906783139333129e-06
receptors O 0 1.7481276426423165e-09
in O 0 5.3321055903943204e-11
the O 0 4.2534309407926685e-10
pathogenesis O 0 9.567237611918245e-06
of O 0 1.2916304115151434e-07
idiopathic O 1 0.9999980926513672
HUS B-Disease 1 1.0
. O 0 1.3185474472265923e-06
. O 0 2.372888729951228e-07

Further O 0 2.9048205618664724e-08
evidence O 0 7.950506919485179e-09
for O 0 3.6680297688107544e-10
a O 0 4.892233840259053e-10
major O 0 3.7312155143354175e-08
ancient O 0 8.558057743357494e-06
mutation O 0 6.32642513664905e-06
underlying O 0 0.046375274658203125
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 8.96811286565935e-07
linkage O 0 4.07859289452972e-07
disequilibrium O 0 8.854777888700482e-07
studies O 0 4.310124201989396e-10
in O 0 1.755707731976308e-11
the O 0 8.208838470080693e-11
Japanese O 0 2.1688938645070266e-08
population O 0 9.534558559343154e-11
. O 0 2.102752416632825e-09

The O 0 0.0003311829350423068
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.563234364875825e-07
DM B-Disease 1 1.0
) O 0 3.17189896570369e-09
mutation O 0 4.31396740552259e-09
is O 0 3.8575819621966545e-11
an O 0 1.6169586503078648e-11
unstable O 0 2.7219317644266994e-07
( O 0 1.1557746981694095e-09
CTG O 0 1.2296884051465895e-05
) O 0 7.58816967594278e-11
n O 0 3.819367044854971e-10
repeat O 0 8.3526607852491e-10
, O 0 2.575861919595912e-11
present O 0 7.668777418645689e-11
at O 0 3.627419198348747e-10
a O 0 1.3567911551215506e-11
copy O 0 3.6830810623555976e-10
number O 0 5.1436657017012166e-11
of O 0 2.441487012561083e-10
5 O 0 1.2057462805969976e-09
- O 0 4.067550740671777e-09
37 O 0 6.451953193931104e-09
repeats O 0 2.1430306140768351e-10
on O 0 6.401349450513294e-10
normal O 0 9.336675876880918e-10
chromosomes O 0 2.383620523183083e-10
but O 0 3.1893626628587413e-10
amplified O 0 8.527029748961468e-09
to O 0 2.701629475687639e-10
50 O 0 5.539888103811563e-09
- O 0 3.4233009760242794e-09
3000 O 0 7.183876604699435e-09
copies O 0 1.8663997014556344e-09
on O 0 3.018773142571263e-08
DM B-Disease 1 0.9999998807907104
chromosomes O 0 7.152050329750637e-07
. O 0 7.026465453918718e-08

Previous O 0 3.6406522667675745e-06
findings O 0 3.948676692289155e-07
in O 0 8.510001592298977e-09
Caucasian O 0 4.015581822613967e-08
populations O 0 1.240664793122903e-10
of O 0 1.9411101892519156e-10
a O 0 3.8615537434338876e-09
DM B-Disease 1 1.0
founder O 1 0.9996387958526611
chromosome O 0 1.3260610387533234e-08
raise O 0 1.5051159207857268e-09
a O 0 3.114392424508061e-11
question O 0 2.421849942813026e-10
about O 0 6.981379016557376e-12
the O 0 3.3430789386779125e-11
molecular O 0 2.626968365060378e-10
events O 0 3.194487382951472e-11
involved O 0 3.739973608585245e-11
in O 0 1.4356485444899647e-10
the O 0 1.5332538572110366e-09
expansion O 0 3.80496715024492e-07
mutation O 0 1.280552623939002e-07
. O 0 6.134626318043956e-08

To O 0 4.579749557365176e-08
investigate O 0 3.2447797337908924e-08
whether O 0 1.1400246080484067e-08
a O 0 7.094658194262138e-09
founder O 0 2.700205925521004e-07
chromosome O 0 1.1112708531157978e-09
for O 0 4.5876308307768454e-10
the O 0 1.1843175684589369e-07
DM B-Disease 1 1.0
mutation O 0 6.391534412841793e-08
exists O 0 2.7307606176307786e-10
in O 0 4.639136731016125e-12
the O 0 1.1404164071415757e-11
Japanese O 0 1.4947082460636807e-09
population O 0 1.4917836931027662e-12
, O 0 2.151760757421184e-12
we O 0 2.2931745044529883e-11
genotyped O 0 1.9771809434132592e-07
families O 0 2.8976127053326195e-10
using O 0 1.6247470036034883e-10
polymorphic O 0 2.134555820987316e-08
markers O 0 4.426003386015509e-08
near O 0 1.0497175395585145e-07
the O 0 1.4706489359639363e-08
( O 0 5.068590547274709e-10
CTG O 0 3.9510564420197625e-06
) O 0 2.4586890856603816e-10
n O 0 5.447387874113474e-09
repeat O 0 1.3066358661717459e-08
region O 0 7.694043624439928e-09
and O 0 1.4328754849302072e-09
constructed O 0 4.603860759289091e-07
haplotypes O 0 1.5313921721826773e-06
. O 0 1.486117469085002e-07

Six O 0 4.1610158518778917e-07
different O 0 4.024366617727537e-09
haplotypes O 0 2.1936821781309845e-07
were O 0 6.626092563521979e-09
found O 0 5.029693328495455e-10
and O 0 1.1254021048401341e-09
DM B-Disease 1 1.0
alleles O 0 4.269561770797736e-07
were O 0 7.263155765713236e-08
always O 0 7.540163160513202e-09
haplotype O 0 6.86591050680363e-08
A O 0 1.2259644677214965e-07
. O 0 1.5152708954246918e-07

To O 0 1.3778889140780848e-08
find O 0 1.1592629078904793e-09
an O 0 2.1712943942819862e-12
origin O 0 1.219758460901943e-10
of O 0 5.515172762926568e-10
the O 0 2.8382383110425735e-09
( O 0 1.632681212448972e-10
CTG O 0 1.2071434412064264e-06
) O 0 7.710930505222535e-11
n O 0 7.649847977297952e-10
repeat O 0 2.3900361689754845e-09
mutation O 0 5.132045899358673e-10
and O 0 2.9918390681560325e-11
to O 0 2.303858492869182e-11
investigate O 0 3.4434033402419573e-10
the O 0 7.373096022611492e-10
mechanism O 0 1.9431523057278355e-09
of O 0 2.7125981461040283e-09
the O 0 8.877771295878745e-10
expansion O 0 6.0344835794978735e-09
mutation O 0 4.673420678225071e-11
in O 0 8.372446833049274e-12
the O 0 2.4966159348216443e-11
Japanese O 0 1.907230151587669e-09
population O 0 1.1600088294441702e-12
we O 0 7.311117314855176e-13
have O 0 9.118639003602436e-13
studied O 0 2.2116060371946134e-10
90 O 0 3.6494110511320343e-10
Japanese O 0 8.998752321076608e-08
DM B-Disease 1 1.0
families O 0 4.386008001233677e-09
comprising O 0 7.323354700439211e-10
190 O 0 9.029278991157241e-10
affected O 0 4.257156294151798e-10
and O 0 3.7565400790029457e-10
130 O 0 2.579159819049437e-08
unaffected O 0 1.1936920145672048e-06
members O 0 6.1249081362291236e-09
. O 0 5.6314050311812025e-08

The O 0 4.682604526351497e-07
results O 0 8.010361085553086e-08
suggest O 0 1.215778588914418e-08
that O 0 2.328038629928475e-11
a O 0 2.0387019850076626e-10
few O 0 2.1401234118201273e-09
common O 0 2.2479104799799643e-08
ancestral O 0 4.0408059476249036e-07
mutations O 0 5.315326401245102e-09
in O 0 1.303767205307338e-09
both O 0 7.77390263273503e-10
Caucasian O 0 7.24383886208102e-09
and O 0 3.363136713563364e-10
Japanese O 0 4.824178745366225e-07
populations O 0 3.830200323573507e-10
have O 0 2.908035357657157e-12
originated O 0 4.32993051135977e-11
by O 0 9.916277868282641e-12
expansion O 0 5.978861405964153e-09
of O 0 1.6005016201248168e-09
an O 0 1.8194662790294025e-11
ancestral O 0 1.423401507771871e-09
n O 0 3.1866206895436733e-10
= O 0 1.2088151313260909e-10
5 O 0 2.0978320469655642e-10
repeat O 0 1.3611178850680972e-10
to O 0 8.801390172230583e-11
n O 0 2.1707511344004615e-09
= O 0 2.5769604228287335e-09
19 O 0 1.884364131399252e-08
- O 0 3.549975957639617e-08
37 O 0 4.125795882714556e-08
copies O 0 2.0476907280908563e-08
. O 0 4.092673577815731e-08

These O 0 1.504473878810586e-08
data O 0 1.5460133173661461e-09
support O 0 3.3808880695040955e-10
multistep O 0 1.1532806354352942e-07
models O 0 2.90123800539277e-08
of O 0 2.7690020942827687e-07
triplet O 0 3.1417939680977724e-06
repeat O 0 1.6308650430119087e-08
expansion O 0 4.1712933551707465e-08
that O 0 5.089082801001954e-12
have O 0 8.419635973665185e-13
been O 0 1.078131290840889e-12
proposed O 0 4.640466483296635e-11
for O 0 2.6796377616822298e-11
both O 0 2.5974740136547325e-09
DM B-Disease 1 1.0
and O 0 1.2012485512968851e-06
Friedreichs B-Disease 1 0.9999879598617554
ataxia I-Disease 1 0.9991017580032349
. O 0 4.418720322973968e-07
. O 0 2.4028179268498207e-07

The O 0 1.0248998982831381e-08
molecular O 0 1.6542616165793333e-08
basis O 0 4.349040239048918e-08
of O 0 0.009402235969901085
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.7568492438613248e-08
the O 0 1.379047653848886e-09
western O 0 6.7624661426179955e-09
Cape O 0 7.86164733312944e-08
, O 0 1.058855503277556e-10
South O 0 2.475314397898387e-09
Africa O 0 2.5895985356072515e-09
. O 0 4.528075248089181e-09

Deficiency B-Disease 1 0.808537483215332
of I-Disease 0 1.9331819203216583e-05
the I-Disease 0 1.2465757208701689e-06
sixth I-Disease 0 5.9225309087196365e-05
component I-Disease 0 4.040012413497607e-07
of I-Disease 0 5.7267786957027056e-08
human I-Disease 0 5.402210900840032e-10
complement I-Disease 0 2.6025537280816025e-08
( O 0 9.338279038928476e-10
C6 O 0 1.3353768736124039e-05
) O 0 4.037647993726523e-11
has O 0 8.847233709530222e-12
been O 0 2.799273486620013e-11
reported O 0 8.419897591649406e-12
in O 0 9.476681592235359e-12
a O 0 6.319035138896423e-12
number O 0 1.1365013097286436e-11
of O 0 6.545380210054574e-11
families O 0 5.281372995186162e-12
from O 0 9.331859937566911e-12
the O 0 7.151359365797916e-11
western O 0 3.485583377482726e-09
Cape O 0 6.726782686428123e-08
, O 0 1.322162795913684e-10
South O 0 5.545977899146237e-09
Africa O 0 5.326662666504944e-09
. O 0 9.607663109534315e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999977350234985
is O 0 1.893305778821741e-08
endemic O 0 1.7487812309369133e-09
in O 0 1.520459591564105e-10
the O 0 5.094769606195371e-10
Cape O 0 9.859754612762117e-08
and O 0 1.8923716760266274e-11
almost O 0 5.8016924597836805e-12
all O 0 1.7025529206946e-12
pedigrees O 0 2.098137219519458e-09
of O 0 4.512418438906707e-09
total O 0 2.6686611818149686e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.8959881421571936e-09
C6Q0 O 0 0.006297957617789507
) O 0 7.997510292900856e-11
have O 0 7.706280925889875e-12
been O 0 3.5971229467302024e-11
ascertained O 0 2.9259176415052934e-08
because O 0 3.8565337590057425e-09
of O 0 1.7625123405196064e-07
recurrent O 0 0.02290615253150463
disease O 0 0.01590896025300026
. O 0 1.1017802989954362e-06

We O 0 7.934043111390565e-08
have O 0 1.0250733595285055e-09
sequenced O 0 1.9987304256119387e-08
the O 0 1.7424551801425991e-09
expressed O 0 2.701450618758372e-09
exons O 0 6.860503987127231e-08
of O 0 2.121971753865637e-08
the O 0 8.495118208884378e-08
C6 O 0 1.4100950465945061e-05
gene O 0 3.995317132687859e-10
from O 0 1.1014661405184256e-10
selected O 0 1.3313419255922554e-09
cases O 0 2.1081245082932298e-10
and O 0 8.801222250998109e-11
have O 0 2.7048094666803912e-11
found O 0 1.9771162484971683e-10
three O 0 2.426640277608527e-10
molecular O 0 7.04937192494981e-05
defects O 1 0.9996311664581299
leading O 1 0.5833663940429688
to O 0 4.196894920482919e-08
total O 0 2.7782014058175264e-06
deficiency O 1 0.987400233745575
879delG O 0 8.342782530235127e-05
, O 0 4.2287992552125786e-10
which O 0 5.412601356696856e-12
is O 0 2.420074123737903e-12
the O 0 6.079823450244604e-11
common O 0 5.957267568135194e-09
defect O 0 9.287640878596903e-09
in O 0 1.0462765098750992e-09
the O 0 2.5091306810054448e-09
Cape O 0 8.082415803301046e-08
and O 0 1.503307756056671e-10
hitherto O 0 1.0071740774719729e-08
unreported O 0 3.690290517610606e-09
, O 0 2.2545153244291072e-11
and O 0 1.0996398930318563e-10
1195delC O 0 5.323882490415599e-08
and O 0 1.3983273428053167e-09
1936delG O 0 3.6230534306014306e-07
, O 0 1.9951938712292616e-10
which O 0 1.865956347768538e-11
have O 0 2.0813309409284386e-11
been O 0 1.6837435612426788e-10
previously O 0 7.902169474327536e-10
reported O 0 2.998101489293248e-10
in O 0 4.304258616194545e-10
African O 0 2.0434602898689036e-09
- O 0 2.696936896029456e-08
Americans O 0 3.7387861695492575e-09
. O 0 8.578661336855475e-09

We O 0 6.611721232729906e-07
also O 0 3.4249141300790598e-09
show O 0 2.0419320401199315e-10
that O 0 4.513986840565254e-12
the O 0 4.983798373991988e-10
879delG O 0 5.274638965602207e-07
and O 0 1.143580963258728e-08
1195delC O 0 2.3168555344454944e-05
defects O 0 7.999479748832528e-06
are O 0 1.5167492262158078e-10
associated O 0 1.6222366783225084e-09
with O 0 1.9106016768688505e-09
characteristic O 0 0.3757658302783966
C6 O 1 1.0
/ O 1 0.9995667338371277
C7 O 0 0.20984286069869995
region O 0 9.079369078790478e-08
DNA O 0 2.8379364636066384e-08
marker O 0 3.380065649594144e-08
haplotypes O 0 1.413128281058107e-08
, O 0 1.8160892928387184e-11
although O 0 1.5264076114185343e-10
small O 0 6.5784218350462e-11
variations O 0 2.480906147184214e-09
were O 0 4.661335761824148e-09
observed O 0 4.58810802683729e-08
. O 0 1.947740173591228e-07

The O 0 7.629482752236072e-07
1936delG O 0 1.0306652256986126e-05
defect O 0 9.065972221833363e-07
was O 0 3.087379951693947e-08
observed O 0 1.2565261053865129e-09
only O 0 2.0551149670922086e-10
once O 0 8.238550397443589e-10
in O 0 6.82710346588955e-11
the O 0 5.165375904780944e-10
Cape O 0 1.5370149242244224e-07
, O 0 8.985563161589827e-12
but O 0 1.2403707401464903e-11
its O 0 2.8419403982904434e-11
associated O 0 2.0678476708724247e-09
haplotype O 0 5.971660499426434e-08
could O 0 3.811618576321507e-09
be O 0 3.038376883424121e-09
deduced O 0 8.681821555001079e-07
. O 0 1.4689548777369055e-07

The O 0 1.177598392132495e-07
data O 0 2.939727350437238e-09
from O 0 1.2517180625337687e-09
the O 0 3.137325732538443e-09
haplotypes O 0 4.640217099449728e-08
indicate O 0 1.3472074567033587e-09
that O 0 5.303287756858177e-12
these O 0 6.828457244090202e-11
three O 0 6.276335701160818e-11
molecular O 0 4.412802923070558e-08
defects O 0 6.848436839845817e-08
account O 0 3.196494180457421e-10
for O 0 6.037819133553057e-10
the O 0 1.3881868881071568e-06
defects O 0 0.473105251789093
in O 0 1.3799329678931826e-07
all O 0 1.7102725902162774e-09
the O 0 3.0127260686185764e-09
38 O 0 6.3954952445044455e-09
unrelated O 0 3.267148684926724e-08
C6Q0 O 0 0.05379272252321243
individuals O 0 3.2559352436400957e-10
we O 0 3.4955216499099606e-10
have O 0 7.932549755951257e-11
studied O 0 1.8420184266787487e-09
from O 0 2.798783704793806e-10
the O 0 7.844956684266435e-09
Cape O 0 1.3902218825023738e-06
. O 0 3.4022125561250505e-08

We O 0 1.541798013704465e-07
have O 0 6.949341657680463e-10
also O 0 3.499782755267411e-11
observed O 0 2.3522675474119126e-10
the O 0 6.8555666699055e-10
879delG O 0 7.656328193661466e-07
defect O 0 3.414343723306956e-07
in O 0 6.2400555833619364e-09
two O 0 1.820072093039471e-09
Dutch O 1 0.9969381093978882
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
kindreds O 0 1.157990118372254e-05
, O 0 7.40969022250404e-11
but O 0 2.2698195753512174e-11
the O 0 3.1285879442677356e-10
879delG O 0 1.9909766990622302e-07
defect O 0 8.045594768191222e-08
in O 0 2.765956796935143e-09
the O 0 3.8443426220169385e-09
Cape O 0 3.755376951630751e-07
probably O 0 1.851882203141031e-09
did O 0 5.424613536142431e-11
not O 0 1.2124651976863632e-11
come O 0 1.0772546743531564e-10
from O 0 1.3467392478982987e-10
The O 0 1.094065060769367e-09
Netherlands O 0 1.2554558281863137e-08
. O 0 1.3773232554470383e-09
. O 0 2.7065940599868554e-08

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.2997882947729522e-07
seven O 0 5.056927765423325e-09
further O 0 1.5659328278516682e-09
molecular O 0 6.198461505846353e-06
defects O 0 1.2203052392578684e-05
and O 0 1.1122870624546977e-08
their O 0 2.826369360775516e-09
associated O 0 6.069925007068377e-08
marker O 0 2.702952315303264e-06
haplotypes O 0 2.7010298708773917e-06
. O 0 2.38714051192801e-07

Seven O 0 6.227739390851639e-08
further O 0 2.691827205580921e-09
molecular O 0 5.715430262398513e-08
bases O 0 7.9613904802045e-08
of O 1 0.6356275677680969
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.9771941595081444e-07
described O 0 6.362245841273761e-08
. O 0 5.865660668291639e-08

All O 0 4.6848242618580116e-08
these O 0 2.4996058556325806e-09
new O 0 1.5150794396845413e-08
molecular O 0 1.9196822620415332e-07
defects O 0 6.403248420383534e-08
involve O 0 2.0089878649542925e-09
single O 0 5.452835072361495e-09
- O 0 1.1954832679350602e-08
nucleotide O 0 9.764044683890916e-09
events O 0 1.404809935046103e-09
, O 0 1.0273119854797841e-10
deletions O 0 5.013260473418768e-09
and O 0 1.765575796675023e-09
substitutions O 0 6.958075005059072e-08
, O 0 3.0717994814466465e-10
some O 0 7.694754555753747e-11
of O 0 1.203210087119544e-09
which O 0 3.381120106116242e-10
alter O 0 4.87143694272163e-08
splice O 0 4.233002073306125e-06
sites O 0 7.368069532276422e-08
, O 0 3.9633177295606004e-10
and O 0 8.410917518020256e-10
others O 0 5.33363708754564e-09
codons O 0 4.0546061086388363e-07
. O 0 2.755532761966606e-07

They O 0 4.047238277848919e-08
are O 0 6.25998419767626e-10
distributed O 0 4.5157738659540314e-10
along O 0 3.776665202792628e-09
the O 0 8.928276784558875e-09
C7 O 0 5.815125859953696e-06
gene O 0 1.2894876277869116e-09
, O 0 6.39156158555032e-11
but O 0 8.294677444897758e-11
predominantly O 0 1.8243949406748783e-10
towards O 0 2.6577531286875455e-09
the O 0 2.892429407097552e-09
3 O 0 2.257009867889792e-08
end O 0 8.049430988421591e-08
. O 0 1.1515683695506596e-07

All O 0 7.217844455453815e-08
were O 0 1.0408233386272059e-08
found O 0 5.505062516952819e-10
in O 0 4.338050196839305e-10
compound O 0 2.0335451722530706e-07
heterozygous O 0 8.201556767062357e-08
individuals O 0 7.886359898456874e-10
. O 0 3.0231692704774105e-08

The O 0 0.0002187724894611165
C6 O 1 0.9997815489768982
/ O 0 0.0028200584929436445
C7 O 0 0.003009008476510644
marker O 0 5.63906451134244e-06
haplotypes O 0 7.147878022806253e-07
associated O 0 2.8456170753088372e-08
with O 0 5.1609272411212714e-09
most O 0 1.0747891792561859e-05
C7 B-Disease 1 1.0
defects I-Disease 1 0.9998466968536377
are O 0 2.0903531350313642e-08
tabulated O 0 1.4948620901122922e-06
. O 0 2.478362937097245e-08
. O 0 6.474774494336089e-08

A O 0 1.1421635463193525e-05
genome O 0 8.751032396503433e-07
- O 0 3.060714561797795e-07
wide O 0 7.197429852112691e-08
search O 0 2.6301782973803256e-09
for O 0 1.3780110386107935e-10
chromosomal O 0 3.9006192764645675e-07
loci O 0 8.46486545924563e-06
linked O 0 5.929478902544361e-06
to O 0 4.3706695151968233e-08
mental O 1 1.0
health O 1 1.0
wellness O 1 0.9999983310699463
in O 0 1.673419980363633e-08
relatives O 0 3.6023721783351448e-09
at O 0 1.8946044733070266e-10
high O 0 8.216851199449593e-09
risk O 0 8.991131394964214e-09
for O 0 7.788930389551751e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9992068409919739
the O 0 7.474890253433841e-07
Old O 0 1.1995417708021705e-06
Order O 0 1.2102148616577324e-07
Amish O 0 1.8033434798780945e-06
. O 0 2.397676190923903e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.037755124270915985
BPAD B-Disease 1 1.0
; O 1 0.9999998807907104
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.1467999172509735e-07
is O 0 7.726790873796574e-10
characterized O 0 1.3323325775971284e-09
by O 0 3.1931671196083755e-10
episodes O 0 5.576845651944495e-09
of O 0 1.273486560648962e-07
mania B-Disease 0 0.007066876161843538
and O 0 8.385580230196865e-09
/ O 0 2.76013565780886e-07
or O 0 1.685737593959402e-08
hypomania B-Disease 0 1.4705567082273774e-05
interspersed O 0 6.005834940481236e-09
with O 0 1.0494853250331282e-11
periods O 0 7.593524031790366e-08
of O 0 2.0220601015807915e-07
depression B-Disease 0 0.0014348410768434405
. O 0 6.505065357487183e-07

Compelling O 0 4.586893282976234e-06
evidence O 0 7.154725523150773e-08
supports O 0 4.789712182429184e-09
a O 0 2.270418297811716e-10
significant O 0 1.6266580304957756e-09
genetic O 0 5.346493736624325e-08
component O 0 5.917430598856299e-07
in O 0 3.6730931629591623e-09
the O 0 1.118055603654966e-08
susceptibility O 0 4.374758191261208e-06
to O 0 1.8918365540798732e-08
develop O 0 6.232162559172139e-05
BPAD B-Disease 1 1.0
. O 0 0.14058972895145416

To O 0 5.495853550030461e-09
date O 0 2.264124674411505e-07
, O 0 5.077356313165637e-10
however O 0 9.426430747083714e-10
, O 0 6.737315566551771e-11
linkage O 0 4.78806772008511e-09
studies O 0 3.640178991570764e-10
have O 0 4.670317084454201e-12
attempted O 0 5.672027847403172e-10
only O 0 5.0870672257952165e-11
to O 0 2.0059275074313376e-10
identify O 0 3.45349482344659e-09
chromosomal O 0 7.486540880563552e-07
loci O 0 4.176240054221125e-06
that O 0 8.370970583371218e-10
cause O 0 4.59270488306629e-08
or O 0 1.8767365439487094e-10
increase O 0 7.81815168160449e-11
the O 0 9.524566690899405e-10
risk O 0 1.0560590624208999e-08
of O 0 3.8776747146584967e-08
developing O 0 4.039434497826733e-05
BPAD B-Disease 1 1.0
. O 0 0.0006535965949296951

To O 0 2.9158060854683754e-08
determine O 0 2.0681957479951052e-08
whether O 0 6.35117380909378e-09
there O 0 1.373935964998907e-09
could O 0 5.000766467588846e-10
be O 0 3.2201147304178335e-10
protective O 0 5.616365683636104e-07
alleles O 0 6.323396917196078e-09
that O 0 2.2155820580960217e-11
prevent O 0 1.8504371646077544e-10
or O 0 6.851706008115244e-11
reduce O 0 6.007378483552372e-10
the O 0 1.256621917633538e-09
risk O 0 4.547028975565581e-09
of O 0 7.522207745580545e-09
developing O 0 1.1477391126391012e-06
BPAD B-Disease 1 1.0
, O 0 3.564690764790157e-09
similar O 0 9.344497398089402e-10
to O 0 7.042233463039338e-11
what O 0 3.2643471259419243e-11
is O 0 5.568621085083603e-12
observed O 0 1.196170801298635e-10
in O 0 4.217047266941165e-10
other O 0 1.8807416779509367e-07
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 2.1352062340440625e-09
we O 0 7.831762321997005e-11
used O 0 4.38404246239088e-09
mental O 1 0.9999282360076904
health O 1 0.9999988079071045
wellness O 1 0.999997615814209
( O 0 9.253275229381686e-11
absence O 0 2.1273697470292063e-08
of O 0 7.473754948250644e-09
any O 0 4.223555549742741e-08
psychiatric B-Disease 1 1.0
disorder I-Disease 0 0.03540103882551193
) O 0 2.3281020167242872e-10
as O 0 8.049577671087604e-10
the O 0 3.311250384996356e-09
phenotype O 0 4.6193061820076764e-08
in O 0 2.341748572831648e-09
our O 0 2.7497972787671188e-09
genome O 0 1.3842127444263497e-09
- O 0 5.676825232114879e-09
wide O 0 4.1893450486441e-08
linkage O 0 1.3384589436782335e-08
scan O 0 6.31667305128758e-08
of O 0 2.9661780587275643e-08
several O 0 2.0677530798707267e-09
large O 0 6.728782420140078e-09
multigeneration O 0 2.1157859464437934e-06
Old O 0 4.1408623019378865e-07
Order O 0 6.728194534844079e-08
Amish O 0 1.0341723282181192e-06
pedigrees O 0 2.200659992013243e-07
exhibiting O 0 3.033860052070736e-09
an O 0 8.555787155140049e-12
extremely O 0 4.8063402147136e-09
high O 0 2.1651450410331563e-08
incidence O 0 1.0353194568324398e-07
of O 0 3.956977820962493e-07
BPAD B-Disease 1 1.0
. O 0 0.0002158005809178576

We O 0 2.495829960480478e-07
have O 0 2.0476427220472715e-09
found O 0 3.545404525517881e-10
strong O 0 2.732709059038996e-10
evidence O 0 3.1703004110816835e-10
for O 0 1.4764964251234858e-10
a O 0 2.7668420332638277e-10
locus O 0 2.810286003906981e-09
on O 0 1.6761919630070565e-09
chromosome O 0 1.316667219697365e-09
4p O 0 3.355907028890215e-05
at O 0 4.554322430294633e-08
D4S2949 O 0 9.380037795381213e-07
( O 0 9.518786453499573e-11
maximum O 0 1.3226156170276226e-08
GENEHUNTER O 0 0.00010197785013588145
- O 0 3.765985638892744e-07
PLUS O 0 2.4935746978371753e-07
nonparametric O 0 2.9852600391677697e-07
linkage O 0 1.993712217540633e-08
score O 0 3.033142625952223e-09
= O 0 4.4135792243160665e-11
4 O 0 1.1442888997459377e-10
. O 0 1.0867742469833352e-11
05 O 0 3.015671268258302e-08
, O 0 1.2000579696636038e-10
P O 0 1.3192966719088872e-07
= O 0 2.7670846169947083e-10
5 O 0 1.570280849794159e-10
. O 0 3.866604085522862e-12
22 O 0 9.359046870827115e-11
x O 0 2.903622675631823e-09
10 O 0 1.0212367618223084e-09
( O 0 1.5917352505501192e-11
- O 0 1.5721787205436044e-09
4 O 0 1.2782574998482232e-09
) O 0 3.206823478638099e-12
; O 0 4.5892650790690936e-11
SIBPAL O 0 2.613333344925195e-05
Pempirical O 0 1.7999140027313842e-06
value O 0 9.966008462924947e-09
< O 0 2.778217877974498e-09
3 O 0 5.343674391866671e-10
x O 0 1.2766055990098835e-09
10 O 0 1.994588799680841e-10
( O 0 4.290647698246275e-12
- O 0 7.848873773141918e-10
5 O 0 7.497966691971669e-10
) O 0 4.52963187791422e-12
) O 0 8.841700809003594e-12
and O 0 5.80027935404015e-11
suggestive O 0 9.001421830134859e-10
evidence O 0 1.625444501218709e-10
for O 0 8.528680539576783e-11
a O 0 5.551964998851133e-10
locus O 0 1.2467911147950872e-08
on O 0 2.444751601160533e-08
chromosome O 0 1.2320541031840548e-08
4q O 0 7.353306727964082e-07
at O 0 2.022391143441382e-08
D4S397 O 0 6.519660473713884e-07
( O 0 1.7486770365060522e-10
maximum O 0 3.223707167876455e-08
GENEHUNTER O 0 0.0001680270506767556
- O 0 5.643436225000187e-07
PLUS O 0 3.0892715585650876e-07
nonparametric O 0 5.60630496693193e-07
linkage O 0 3.286849903361144e-08
score O 0 5.096444155583413e-09
= O 0 6.125427942649253e-11
3 O 0 1.6144570402776282e-10
. O 0 1.1892499138244084e-11
29 O 0 1.5249417284479705e-09
, O 0 8.65707436292773e-11
P O 0 1.3982219115860062e-07
= O 0 3.228700362623016e-10
2 O 0 3.9665090656448854e-10
. O 0 1.3498012603474496e-11
57 O 0 4.92162144372088e-10
x O 0 2.846011648571789e-09
10 O 0 5.426448179690624e-10
( O 0 1.6663465746136197e-11
- O 0 2.3480548616561236e-09
3 O 0 8.182111654875257e-10
) O 0 2.8955546727688075e-12
; O 0 4.2180106629707836e-11
SIBPAL O 0 1.3063715414318722e-05
Pempirical O 0 1.208997218782315e-06
value O 0 8.18508194555534e-09
< O 0 1.609845701189272e-09
1 O 0 4.250608476308315e-10
x O 0 1.50285550670759e-09
10 O 0 1.7190593393223708e-10
( O 0 3.6507233867888456e-12
- O 0 8.870577050679174e-10
3 O 0 6.079478587217579e-10
) O 0 1.7473249409871716e-12
) O 0 7.43336490451052e-13
that O 0 5.838255226486844e-13
are O 0 1.547498761078625e-11
linked O 0 1.22343184472129e-08
to O 0 4.955338894774286e-08
mental O 1 1.0
health O 1 0.9999998807907104
wellness O 1 0.9999611377716064
. O 0 2.6464492748345947e-06

These O 0 7.194368834007037e-08
findings O 0 3.6748961207422326e-08
are O 0 3.409673376975064e-10
consistent O 0 2.8028452891959432e-09
with O 0 9.339106744887804e-12
the O 0 4.920739371527816e-10
hypothesis O 0 6.377332883999998e-09
that O 0 1.4513211596053899e-12
certain O 0 5.770719457842688e-10
alleles O 0 4.2766012953165955e-09
could O 0 4.441398360199855e-10
prevent O 0 8.495272263431275e-10
or O 0 2.496060302892289e-10
modify O 0 6.732260970920834e-09
the O 0 2.3207080701581617e-09
clinical O 0 1.1063335136896058e-07
manifestations O 0 4.919158982374938e-07
of O 0 1.5258960956998635e-06
BPAD B-Disease 1 1.0
and O 0 2.6491962401564706e-08
perhaps O 0 9.02573571437415e-09
other O 0 4.1270037387519665e-10
related O 0 6.551379192387685e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 0.09959761798381805

Segregation O 0 0.000493199797347188
distortion O 0 0.0003439450229052454
in O 0 1.4845599253021646e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00021372671471908689

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.2878122763358988e-05
DM B-Disease 1 1.0
) O 0 1.4963806194145945e-08
is O 0 3.333777420788664e-10
an O 0 1.373403335502843e-10
autosomal B-Disease 1 0.9999222755432129
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.0497547275889474e-09
, O 0 2.026017201228747e-11
in O 0 1.8499528298132617e-11
the O 0 6.898467908023065e-11
typical O 0 2.25373075757318e-09
pedigree O 0 1.5603999869995278e-08
, O 0 1.576844037287639e-11
shows O 0 1.6219471946077313e-11
a O 0 3.764901931879727e-11
three O 0 5.259724322748127e-10
generation O 0 1.9661677015392343e-06
anticipation O 0 7.784638910379726e-06
cascade O 0 5.081134077045135e-06
. O 0 1.5119969987154036e-07

This O 0 1.4428533923194209e-08
results O 0 1.915872616109482e-07
in O 0 1.6222845999891433e-07
infertility B-Disease 1 0.9999523162841797
and O 0 5.555377811106155e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.5605702685661527e-07
CDM B-Disease 0 6.422809747164138e-06
) O 0 1.892594371152856e-12
with O 0 4.57167398555669e-13
the O 0 5.2271884737331575e-11
disappearance O 0 1.0221117285880155e-09
of O 0 1.2644888158774847e-07
DM B-Disease 1 1.0
in O 0 2.9395321234915173e-06
that O 0 2.544408239657514e-09
pedigree O 0 7.050952035569935e-07
. O 0 2.7718467521253842e-08

The O 0 8.076683144508934e-08
concept O 0 1.7910410576860158e-07
of O 0 5.2474451450734705e-08
segregation O 0 1.520470505056437e-07
distortion O 0 5.645912892759952e-08
, O 0 2.4576281981714132e-11
where O 0 9.983858358098008e-12
there O 0 9.771923938431404e-13
is O 0 6.247187554590805e-13
preferential O 0 1.2580536612460946e-09
transmission O 0 4.139191212004789e-10
of O 0 2.9191921102622587e-10
the O 0 1.75349651465595e-10
larger O 0 4.189948388244602e-10
allele O 0 1.4864823261184767e-10
at O 0 2.6283716869635043e-10
the O 0 1.5486341098380763e-09
DM B-Disease 1 1.0
locus O 0 4.142678378116216e-08
, O 0 5.244644996071912e-11
has O 0 3.782354204145966e-12
been O 0 1.6563523122514745e-11
put O 0 2.3960919359744537e-10
forward O 0 8.028941955728897e-09
to O 0 1.7085012571360636e-10
explain O 0 2.4690525179948963e-09
partially O 0 2.7815427738886456e-09
the O 0 1.5344291115493291e-10
maintenance O 0 3.789135050169534e-08
of O 0 4.778208904099301e-07
DM B-Disease 1 1.0
in O 0 1.3402221554770222e-07
the O 0 4.840185585663903e-09
population O 0 5.741983624685254e-11
. O 0 4.889127436236151e-10

In O 0 3.662028547068985e-08
a O 0 1.0494904945090866e-09
survey O 0 4.5207035337391233e-10
of O 0 2.0905714936958475e-09
DM B-Disease 1 1.0
in O 0 5.661802902068303e-07
Northern O 0 9.989192051307327e-08
Ireland O 0 1.3987895286504681e-08
, O 0 3.6959241223044614e-10
59 O 0 2.7281082282115676e-08
pedigrees O 0 1.5806563169462606e-07
were O 0 9.960098523720262e-09
ascertained O 0 1.3980328503748751e-06
. O 0 2.4411968979620724e-07

Sibships O 0 9.139641042565927e-05
where O 0 2.2969732782485153e-08
the O 0 1.0743661515988379e-09
status O 0 4.129194763891064e-09
of O 0 3.2636098268312708e-09
all O 0 2.7443675110205845e-10
the O 0 6.810459418638004e-10
members O 0 1.1929985645198204e-11
had O 0 4.0070141649195534e-11
been O 0 3.3430022639002743e-11
identified O 0 1.440355335002863e-10
were O 0 4.2311790182658626e-10
examined O 0 4.9404720314782935e-09
to O 0 6.212023256901844e-11
determine O 0 7.388765155269539e-10
the O 0 1.3863450387674447e-09
transmission O 0 5.390202062471872e-09
of O 0 1.0115712711922242e-08
the O 0 6.31602290468436e-08
DM B-Disease 1 1.0
expansion O 0 0.00013563611719291657
from O 0 5.264376667923898e-08
affected O 0 3.1922692045327494e-08
parents O 0 1.5940003761372168e-09
to O 0 2.554847999824972e-10
their O 0 6.522431483801938e-09
offspring O 0 1.968479494962594e-07
. O 0 5.429000538015316e-08

Where O 0 6.167911692500638e-08
the O 0 1.559554974051025e-08
transmitting O 0 1.6599022956143017e-06
parent O 0 1.8202118923227317e-08
was O 0 3.3548435141028676e-08
male O 0 6.615472170068415e-09
, O 0 5.94467697290213e-10
58 O 0 1.2082705325155985e-07
. O 0 3.9779536109563196e-08

3 O 0 3.318916128591809e-07
% O 0 2.486244543575822e-09
of O 0 2.916488606174994e-09
the O 0 2.4309683155365747e-09
offspring O 0 1.1992880466493716e-08
were O 0 1.0824495744188312e-09
affected O 0 8.730070555351688e-10
, O 0 2.3378727773137875e-11
and O 0 3.537769729944351e-11
in O 0 5.4210556182932024e-11
the O 0 6.257975387891079e-11
case O 0 2.453910408206639e-10
of O 0 3.519096125614851e-10
a O 0 1.3643045027045275e-10
female O 0 9.807024081709415e-10
transmitting O 0 5.970134253630022e-08
parent O 0 2.1682600159778076e-09
, O 0 9.200834538702907e-10
68 O 0 4.999598104404868e-07
. O 0 3.108463317857968e-07

7 O 0 4.349643859313801e-06
% O 0 3.7819077647327504e-08
were O 0 1.032367169528925e-08
affected O 0 7.5159434231864e-08
. O 0 2.810175772083312e-07

Studies O 0 5.173225190446828e-07
on O 0 5.2424429242137194e-08
meiotic O 0 1.7229698642040603e-05
drive O 0 1.436139768884459e-06
in O 0 3.639940189259505e-07
DM B-Disease 1 1.0
have O 0 1.1045535153186847e-08
shown O 0 7.171670202144043e-11
increased O 0 7.196005596954436e-11
transmission O 0 4.340696552196377e-11
of O 0 1.2345338293306973e-11
the O 0 1.2061636411875298e-11
larger O 0 5.989481133283903e-11
allele O 0 3.877210705272027e-11
at O 0 7.755475428528058e-11
the O 0 7.455981942960932e-10
DM B-Disease 1 1.0
locus O 0 2.7623151765965304e-08
in O 0 9.071173256991472e-10
non O 0 6.80312979284281e-08
- O 0 4.0854368421605614e-07
DM O 1 1.0
heterozygotes O 0 1.0481611752766185e-05
for O 0 2.94614483919986e-08
CTGn O 0 6.279505032580346e-05
. O 0 2.419078271032049e-07

This O 0 6.526639850790161e-08
study O 0 1.7252890671670684e-08
provides O 0 7.456063544353242e-11
further O 0 3.581021937315576e-11
evidence O 0 2.2990134795897177e-10
that O 0 1.6962396764963472e-11
the O 0 6.690264342523733e-08
DM B-Disease 1 1.0
expansion O 1 0.9961099028587341
tends O 0 1.294470621360233e-06
to O 0 6.108349936972957e-10
be O 0 8.337063261976141e-10
transmitted O 0 4.024768074373242e-08
preferentially O 0 6.349735031108139e-07
. O 0 1.0542562733917293e-07

Diagnosis O 1 0.9999213218688965
of O 0 0.2214767336845398
hemochromatosis B-Disease 1 1.0
. O 1 0.912340521812439

If O 0 1.4399865904124454e-05
untreated O 1 1.0
, O 0 7.94252002833673e-07
hemochromatosis B-Disease 1 1.0
can O 0 4.843808255827753e-06
cause O 1 0.9579116106033325
serious O 0 0.10435536503791809
illness O 1 0.8816543817520142
and O 0 5.812796910475981e-10
early B-Disease 0 5.0164192799684315e-08
death I-Disease 0 4.705122957915364e-09
, O 0 4.779429456369666e-12
but O 0 1.0582291119776155e-11
the O 0 6.604726765502278e-10
disease O 0 9.538533518593795e-09
is O 0 8.08492855997045e-12
still O 0 7.232814347446492e-11
substantially O 0 4.104460327170045e-09
under O 0 3.1904603474686155e-06
- O 1 0.9459249377250671
diagnosed O 1 0.9572680592536926
. O 0 1.2714082231468637e-06

The O 0 6.938089427421801e-07
cornerstone O 0 7.661736890440807e-05
of O 0 2.9794177791586662e-08
screening O 0 3.399995023301017e-07
and O 0 2.55187232456322e-10
case O 0 2.842370505629077e-10
detection O 0 7.033113202936647e-09
is O 0 6.551122491704753e-12
the O 0 2.8118809364263697e-11
measurement O 0 3.1132316724580278e-09
of O 0 1.4133700876328703e-09
serum O 0 1.1729397897397575e-08
transferrin O 0 1.519306636055262e-07
saturation O 0 1.1786882225806039e-07
and O 0 4.3260692250690624e-10
the O 0 5.346406650730273e-10
serum O 0 1.4666208691949123e-08
ferritin O 0 5.101231295157049e-07
level O 0 1.1368179286819213e-07
. O 0 3.966709982705652e-08

Once O 0 2.028667267950368e-06
the O 0 2.4914962537536667e-08
diagnosis O 0 9.033532842295244e-05
is O 0 5.722514129224976e-10
suspected O 0 2.627953143985451e-08
, O 0 1.2054633957703231e-09
physicians O 0 5.2876227840670253e-08
must O 0 1.1745443506683273e-09
use O 0 4.417752830221389e-09
serum O 0 1.2347710480753449e-06
ferritin O 0 8.241428440669551e-05
levels O 0 7.239190836116904e-06
and O 0 4.176722967486057e-08
hepatic O 1 0.9476962089538574
iron O 1 0.999847412109375
stores O 0 2.2359920421877177e-06
on O 0 8.819838370754951e-08
liver O 0 5.887854399588832e-07
biopsy O 0 1.0572647113349376e-07
specimens O 0 5.183775630968057e-09
to O 0 2.672909983625349e-11
assess O 0 1.0773050895807046e-08
patients O 0 1.6571954475352868e-08
for O 0 5.946011738533485e-11
the O 0 1.1970455737753127e-09
presence O 0 1.0352632084931201e-09
of O 0 2.1032033714618592e-07
iron B-Disease 1 0.9999969005584717
overload I-Disease 0 0.0058857593685388565
. O 0 2.195923116232734e-06

Liver O 1 0.9995911717414856
biopsy O 0 0.13499130308628082
is O 0 4.567542788436185e-09
also O 0 3.6655168483834544e-11
used O 0 8.016814295741526e-11
to O 0 5.729916541241664e-11
establish O 0 1.0767006175527172e-09
the O 0 9.067212536351121e-10
presence O 0 4.660390962030192e-10
or O 0 7.876348462332317e-10
absence O 0 7.618496624672844e-07
of O 0 8.58418206917122e-06
cirrhosis B-Disease 1 1.0
, O 0 5.277682180171439e-10
which O 0 1.2343713724771721e-11
can O 0 1.7632553403479356e-11
affect O 0 3.347831167843651e-08
prognosis O 1 0.9999997615814209
and O 0 8.857550426455418e-08
management O 0 2.9239825494187244e-07
. O 0 4.9170946425647344e-08

A O 0 7.577202154607221e-07
DNA O 0 6.802805785355304e-08
- O 0 1.7946669927937364e-08
based O 0 2.1254056292718815e-09
test O 0 5.769225985829962e-09
for O 0 4.669671316293034e-10
the O 0 6.250847839339713e-09
HFE O 0 9.443920134799555e-05
gene O 0 1.0756250334864603e-09
is O 0 5.457675977815768e-12
commercially O 0 3.9763337067455495e-10
available O 0 2.530139119050201e-11
, O 0 1.6864191250062777e-12
but O 0 3.4413119055776153e-12
its O 0 3.8361479791360065e-12
place O 0 1.7770653004678394e-10
in O 0 1.709194591414942e-11
the O 0 6.368004040746555e-11
diagnosis O 0 2.6572988076623005e-07
of O 0 3.4646737390175986e-07
hemochromatosis B-Disease 1 1.0
is O 0 8.957345443150189e-08
still O 0 2.4963564548841077e-09
being O 0 1.7105433736119835e-09
evaluated O 0 2.6691344601204037e-07
. O 0 8.955517927233814e-08

Currently O 0 1.1862730531220222e-07
, O 0 5.711784378803486e-10
the O 0 8.038316123837319e-10
most O 0 2.6820473619793006e-10
useful O 0 4.691839694537236e-10
role O 0 9.620525903697441e-11
for O 0 3.769536766062842e-11
this O 0 5.042677733713141e-11
test O 0 5.955358872711258e-09
is O 0 1.0335180627984997e-11
in O 0 3.552041039772691e-12
the O 0 6.489821700872422e-12
detection O 0 4.912629858466744e-09
of O 0 3.667935288831359e-08
hemochromatosis B-Disease 1 1.0
in O 0 4.975505817128578e-06
the O 0 2.864721579953766e-07
family O 0 2.2379574582398476e-10
members O 0 2.6343215803192876e-12
of O 0 5.186443496896231e-10
patients O 0 1.6194736218722028e-08
with O 0 2.5609793799508118e-11
a O 0 3.0028126651870934e-09
proven O 0 2.5923113753378857e-06
case O 0 1.4198533904163924e-07
of O 0 4.425066890689777e-07
the O 0 5.326762106960814e-07
disease O 0 2.577355871835607e-06
. O 0 7.927206269187081e-08

It O 0 3.931202030571512e-09
is O 0 4.3458764364956437e-10
crucial O 0 1.0351851642553811e-07
to O 0 1.0476210121623808e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.00813606008887291
because O 0 2.614669654121826e-07
phlebotomy O 1 0.9840333461761475
therapy O 0 4.469505074666813e-05
can O 0 3.3550846545438162e-09
avert O 0 0.0008787014521658421
serious O 1 0.9999996423721313
chronic O 1 1.0
disease O 1 0.9708938002586365
and O 0 1.336366572957104e-09
can O 0 3.509214099861602e-11
even O 0 2.7443886052580524e-10
lead O 0 3.926179659163864e-10
to O 0 5.7877251602445057e-11
normal O 0 2.1346046708003996e-08
life O 0 8.656257044492577e-09
expectancy O 0 1.497122781302096e-08
. O 0 3.343335608363418e-10
. O 0 5.4452686804040695e-09

Prevalence O 0 9.995640539273154e-06
of O 0 1.1559917822978605e-07
the O 0 8.896900283161813e-08
I1307K O 0 0.00012250005966052413
APC B-Disease 0 2.777189592961804e-06
gene O 0 3.852093310996452e-09
variant O 0 1.8340227114777008e-08
in O 0 5.524817270341487e-10
Israeli O 0 5.934370328475325e-09
Jews O 0 1.0759410029592686e-09
of O 0 1.3686518585132035e-10
differing O 0 1.5111278894863744e-09
ethnic O 0 4.542681508734603e-11
origin O 0 3.145041171936924e-10
and O 0 2.0712413728585233e-10
risk O 0 1.57683128776398e-08
for O 0 5.500433530869486e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009398280642926693

BACKGROUND O 0 0.0002553036902099848
& O 0 6.684628715447616e-06
AIMS O 0 1.6953050874235487e-07
Israeli O 0 7.061542461883619e-09
Jews O 0 2.9640896404004025e-09
of O 0 3.04197056433253e-10
European O 0 3.739478060538204e-09
birth O 0 1.0164881558694105e-07
, O 0 6.176673755797779e-11
i O 0 4.2618578804942686e-11
. O 0 5.7601020307662676e-12
e O 0 2.903475723736726e-11
. O 0 7.963774605046492e-12
, O 0 2.4445659038696554e-11
Ashkenazim O 0 1.336305672339222e-06
, O 0 4.927762017881143e-11
have O 0 1.987061730435169e-11
the O 0 2.956760614125642e-09
highest O 1 0.9992058873176575
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 2.56271414400544e-06
of O 0 4.969694877843267e-09
any O 0 3.400755788085519e-10
Israeli O 0 4.605573167282273e-08
ethnic O 0 4.441214507266977e-09
group O 0 1.406496474842811e-09
. O 0 3.8976644134436356e-09

The O 0 1.5054115465318318e-06
I1307K O 0 9.567767119733617e-05
APC B-Disease 0 6.3448351284023374e-06
gene O 0 1.1175097291982183e-08
variant O 0 5.943214205217373e-07
was O 0 2.1151029727661808e-07
found O 0 6.11819439555461e-09
in O 0 6.513057648760423e-09
6 O 0 6.267767389545043e-07
. O 0 8.016551333867028e-08

1 O 0 1.2908324720228848e-07
% O 0 7.737556706466364e-10
of O 0 1.8903957565985507e-10
American O 0 1.3835442513876473e-10
Jews O 0 1.6631033217251456e-09
, O 0 1.2618589333157626e-11
28 O 0 9.987393134736067e-10
% O 0 4.327890823496716e-11
of O 0 1.2086381895315412e-09
their O 0 2.20393644667638e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.14016053080558777
, O 0 1.8028442627660013e-10
but O 0 2.937241769251919e-11
not O 0 1.1866486959721811e-11
in O 0 2.5236002176853845e-10
non O 0 3.3847499025796424e-08
- O 0 1.79033179392718e-08
Jews O 0 1.8422161573994345e-08
. O 0 9.909126852392092e-09

We O 0 2.0849742554673867e-07
assessed O 0 1.5162913769017905e-06
the O 0 6.75429561169949e-08
I1307K O 0 4.248710411047796e-06
prevalence O 0 3.295085448939972e-08
in O 0 4.317337806702959e-11
Israeli O 0 4.36955666094363e-10
Jews O 0 4.737014669409234e-10
of O 0 7.879048802283961e-11
differing O 0 1.3801239040489577e-09
ethnic O 0 4.084697510786661e-11
origin O 0 4.954398002965377e-10
and O 0 2.5834751005149315e-10
risk O 0 3.400421988430935e-08
for O 0 4.0184096405937453e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0013938029296696186

METHODS O 0 7.109857961040689e-06
DNA O 0 2.3510101243573445e-07
samples O 0 2.0228734243232793e-08
from O 0 1.4722900676389372e-09
500 O 0 1.4351128063694318e-09
unrelated O 0 1.8692782877138825e-09
Jews O 0 3.2679947636893303e-09
of O 0 1.8542077873107132e-09
European O 0 2.271676713405668e-08
or O 0 7.609755048321176e-10
non O 0 1.3892600847498215e-08
- O 0 9.048967686275944e-10
European O 0 5.708462591513808e-10
origin O 0 1.0862007820966468e-10
, O 0 7.855602019574137e-13
with O 0 1.4851566699537744e-13
or O 0 3.0106134599194867e-12
without O 0 2.30612820506515e-10
a O 0 9.768300751611392e-11
personal O 0 2.3478770927454207e-08
and O 0 6.489274895216113e-09
/ O 0 2.3823463379812893e-07
or O 0 3.980395568703443e-09
family O 0 2.4617063942855566e-10
history O 0 1.5812819942340184e-09
of O 0 3.1961850943673653e-09
neoplasia B-Disease 0 1.411185621691402e-06
, O 0 2.2045641701051721e-10
were O 0 2.171665208772211e-10
examined O 0 1.6095325072740252e-09
for O 0 4.715692766832369e-11
the O 0 1.5211217840871427e-09
I1307K O 0 5.9503999949583886e-08
variant O 0 7.105844801458261e-09
by O 0 4.0125608391505807e-10
the O 0 5.71461766796233e-10
allele O 0 3.594223529912455e-10
- O 0 2.1876001010667778e-10
specific O 0 2.663150810988668e-10
oligonucleotide O 0 1.149175687942261e-07
( O 0 5.286416859817678e-10
ASO O 0 1.5430439816555008e-05
) O 0 3.673882864596578e-10
method O 0 1.2099516766284069e-07
. O 0 6.221281267926315e-08

RESULTS O 0 5.8842219004873186e-05
In O 0 2.722219250017588e-08
persons O 0 5.5694654443883e-10
at O 0 6.458746315551878e-10
average O 0 1.8371554277862856e-09
risk O 0 5.164629612863791e-09
for O 0 6.648020445254588e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.732926418502757e-07
I1307K O 0 1.2040381989208981e-05
was O 0 2.8938710983084093e-08
found O 0 4.784870277774189e-10
in O 0 9.219631724732835e-10
5 O 0 2.787933617298677e-08
. O 0 2.9345191165930373e-08

0 O 0 6.02760735546326e-07
% O 0 2.737238657957164e-09
of O 0 8.184921629350583e-10
120 O 0 5.49434453489539e-09
European O 0 7.66743912805623e-09
and O 0 1.6275022440837006e-09
1 O 0 1.8574782245650567e-07
. O 0 6.52609202234089e-08

6 O 0 2.051801629932015e-06
% O 0 7.881747698945674e-09
of O 0 8.651371175005806e-09
188 O 0 1.1750854156389323e-07
non O 0 6.133444685474387e-08
- O 0 1.017768180844314e-08
European O 0 3.729401143459654e-08
Jews O 0 4.621377414082417e-08
( O 0 6.20684822982831e-11
P O 0 9.765984998466593e-08
= O 0 4.0376965659838504e-10
0 O 0 1.0644916059732168e-09
. O 0 8.439936249882152e-11
08 O 0 3.640703383211985e-08
) O 0 4.604400472008052e-10
. O 0 1.834383134280415e-08

It O 0 2.5173722661975262e-08
occurred O 0 4.370090209704358e-07
in O 0 1.2034583996012316e-08
15 O 0 6.92641535238181e-08
. O 0 5.1559812419554873e-08

4 O 0 5.255392920844315e-07
% O 0 5.3341051575728216e-09
of O 0 2.8260083162479077e-09
52 O 0 4.208285275808521e-08
Ashkenazi O 0 2.7175767058906786e-07
Israelis O 0 4.156885680117739e-08
with O 0 1.0829535046497085e-09
familial O 0 0.0002699615724850446
cancer B-Disease 1 0.9999947547912598
( O 0 1.2197358678633918e-09
P O 0 8.049375423979654e-07
= O 0 1.554042172724479e-10
0 O 0 1.7611083424906582e-10
. O 0 7.559476482288385e-12
02 O 0 2.754206418487115e-09
) O 0 2.8553867170016956e-12
and O 0 1.6945195246975686e-11
was O 0 6.091596671531363e-10
not O 0 5.639544040092481e-11
detected O 0 8.645234750304098e-09
in O 0 2.367486651166928e-09
51 O 0 2.7099671839891926e-08
non O 0 6.763912807628003e-08
- O 0 1.9732830480734265e-08
European O 0 1.3436923573806325e-08
Jews O 0 1.4207928167309092e-08
at O 0 1.473669519747034e-09
increased O 0 1.882409783604544e-08
cancer B-Disease 0 1.515304120403016e-06
risk O 0 7.135876955999265e-08
. O 0 7.674933755197344e-08

Colorectal B-Disease 1 0.9999911785125732
neoplasia I-Disease 1 0.9896480441093445
occurred O 0 8.592613448854536e-05
personally O 0 1.227274566417691e-07
or O 0 7.042935679102413e-10
in O 0 4.763071603797187e-10
the O 0 8.881158031215364e-10
families O 0 5.553021584225881e-11
of O 0 1.4127926606377628e-10
13 O 0 2.352222583379415e-10
of O 0 7.337154217523789e-10
20 O 0 8.79810557741223e-10
Ashkenazi O 0 6.4243730335533655e-09
I1307K O 0 2.971087198488931e-08
carriers O 0 1.772337276939595e-09
, O 0 2.682772753948015e-11
8 O 0 4.409761444890137e-10
of O 0 2.942066590350123e-09
whom O 0 2.693989697988286e-09
also O 0 8.224886743901649e-11
had O 0 5.559213089867399e-10
a O 0 1.7878935831827647e-10
personal O 0 3.025857608918159e-08
or O 0 8.877805157680996e-10
family O 0 2.031009388447913e-10
history O 0 9.35876709462491e-10
of O 0 4.223698724103997e-09
noncolonic O 0 0.00013142569514457136
neoplasia B-Disease 0 0.08947421610355377
. O 0 2.0101290374441305e-06

CONCLUSIONS O 0 7.202567212516442e-05
The O 0 1.130895952883293e-06
I1307K O 0 4.499479473452084e-05
APC O 0 3.4125182537536602e-06
variant O 0 7.393507530650822e-07
may O 0 6.649135997349731e-08
represent O 0 1.2322773912387674e-08
a O 0 3.212760724125019e-09
susceptibility O 0 4.712952659247094e-07
gene O 0 5.060690533298384e-09
for O 0 2.1469684696739932e-08
colorectal B-Disease 1 1.0
, I-Disease 0 1.5432382497237995e-05
or I-Disease 0 6.902359359628463e-07
other I-Disease 0 1.5826773847038567e-07
, I-Disease 0 5.681244807931307e-09
cancers I-Disease 0 0.002395531628280878
in O 0 3.774103518594529e-08
Ashkenazi O 0 1.0232190106762573e-05
Jews O 0 3.209651708857564e-07
, O 0 1.8192278239403947e-10
and O 0 3.186486907669206e-10
partially O 0 7.4155086515759194e-09
explains O 0 3.5201833115117154e-10
the O 0 9.474065976178281e-11
higher O 0 9.658704946957641e-09
incidence O 0 3.966573558500386e-08
of O 0 6.165434115246171e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.5178634167086784e-08
European O 0 3.4638272694564876e-08
Israelis O 0 2.3904156876142224e-08
. O 0 6.499977445173499e-09

Systematic O 0 2.070228255490747e-08
analysis O 0 1.9791925875978222e-09
of O 0 8.652905947315048e-09
coproporphyrinogen O 0 0.0006202168297022581
oxidase O 0 0.00044216468813829124
gene O 0 6.291330464591738e-06
defects O 0 4.997020369046368e-05
in O 0 1.5997599689399067e-07
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 2.2165921109262854e-05
mutation O 0 9.510521863376198e-07
update O 0 6.951621003281616e-07
. O 0 4.386579064430407e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 8.585918294556905e-06
HC B-Disease 1 1.0
) O 0 4.035560152715334e-08
is O 0 1.0175716935734158e-09
an O 0 4.1810391260277413e-10
acute O 1 0.9999786615371704
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 1.692073783488013e-05
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9864472150802612
caused O 0 5.701895133825019e-07
by O 0 9.848412085844416e-10
deficient B-Disease 0 3.6896874888725506e-08
activity I-Disease 0 4.066742220754094e-10
of I-Disease 0 1.0696510344132548e-09
coproporphyrinogen I-Disease 0 2.158055576728657e-05
III I-Disease 1 1.0
oxidase I-Disease 0 0.0005440742243081331
( O 0 2.366467732883848e-08
CPO O 0 2.7068321287515573e-05
) O 0 2.362732232086273e-09
. O 0 3.574190188260218e-08

Clinical O 0 0.003537968499585986
manifestations O 0 0.0014636123087257147
of O 0 4.5043732825433835e-05
the O 0 7.880720659159124e-06
disease O 0 0.001235287287272513
are O 0 3.910721746436252e-11
characterized O 0 8.663814110576595e-11
by O 0 6.078606368253858e-11
acute O 0 6.121135811554268e-05
attacks O 0 3.776153612022881e-09
of O 0 0.06005612015724182
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.683611117186956e-07
precipitated O 0 2.446351388130097e-08
by O 0 2.2120445752893403e-10
drugs O 0 4.751751703224727e-08
, O 0 7.180635946957281e-11
fasting O 0 5.0896950654077955e-08
, O 0 1.5005812148416453e-09
cyclical O 0 2.192788087995723e-05
hormonal O 0 1.3023310430071433e-06
changes O 0 2.477488614260892e-08
, O 0 7.3641888143072265e-09
or O 0 5.66165681448183e-07
infectious B-Disease 1 0.9639540910720825
diseases I-Disease 0 0.0004074722819495946
. O 0 3.936993664410693e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.00013373488036449999
also O 0 9.931264699503117e-09
be O 0 7.593328188448822e-10
present O 0 1.2399137716556652e-08
. O 0 8.945377771851781e-08

The O 0 5.344801365936291e-07
seven O 0 6.399939422863099e-08
exons O 0 9.6454535025714e-08
, O 0 3.8379371902763637e-10
the O 0 3.4662182013533993e-09
exon O 0 2.3657146641653526e-07
/ O 0 4.6303416212367665e-08
intron O 0 2.902393134718295e-07
boundaries O 0 1.6252105439207298e-08
and O 0 3.689233085690802e-10
part O 0 6.12959183410311e-10
of O 0 5.364059862955628e-09
3 O 0 5.914189582512108e-09
noncoding O 0 7.931952872297643e-09
sequence O 0 7.674015589653749e-11
of O 0 4.2123464716326e-09
the O 0 4.301816858287566e-08
CPO O 0 6.2099156821204815e-06
gene O 0 2.420114775247839e-09
were O 0 2.0446844217758553e-09
systematically O 0 5.668026603622422e-10
analyzed O 0 7.898372511583318e-10
by O 0 1.0085994539554832e-10
an O 0 5.992303875324012e-11
exon O 0 2.3912321012176108e-08
- O 0 6.954489872867953e-09
by O 0 7.479515673480819e-09
- O 0 7.021219516900601e-07
exon O 0 1.0505663112780894e-06
denaturing O 0 7.307995474548079e-06
gradient O 0 3.457003288076521e-07
gel O 0 2.9276824875523744e-07
electrophoresis O 0 2.462605763753345e-08
( O 0 2.6875524028469044e-10
DGGE O 0 2.001487882807851e-05
) O 0 1.4971726636225924e-10
strategy O 0 2.4633983741750853e-09
followed O 0 1.0206657047318046e-10
by O 0 1.0622655532976921e-11
direct O 0 1.2849253605562438e-10
sequencing O 0 1.9955383123715364e-08
in O 0 2.8432283194490537e-09
seven O 0 3.785477709072893e-09
unrelated O 0 1.5653610319077416e-07
heterozygous O 0 1.3938949905423215e-07
HC B-Disease 1 0.9999964237213135
patients O 0 1.4692558579554316e-05
from O 0 5.636388245022772e-09
France O 0 3.2140172745442896e-09
, O 0 1.865426979552609e-10
Holland O 0 7.11527334829043e-08
, O 0 3.136642334755635e-10
and O 0 7.98172694604915e-10
Czech O 0 1.023229856400576e-06
Republic O 0 3.708618123710039e-07
. O 0 1.2481579005907406e-06

Seven O 0 3.6243636714061722e-06
novel O 0 4.656300461647334e-06
mutations O 0 5.139289882549747e-08
and O 0 8.91724472040778e-10
two O 0 1.2902226509403647e-10
new O 0 7.135697810412012e-09
polymorphisms O 0 4.515218847700453e-07
were O 0 6.532617646826111e-08
detected O 0 9.099537123802293e-07
. O 0 1.9963269437539566e-07

Among O 0 6.634714736719616e-06
these O 0 4.1572747022655676e-08
mutations O 0 1.1902637986338505e-08
two O 0 2.974089308160899e-10
are O 0 3.2743135980339844e-10
missense O 0 1.7792416429074365e-07
( O 0 1.7586143652437158e-10
G197W O 0 5.499715030055086e-07
, O 0 4.433172162698895e-10
W427R O 0 9.811672185833231e-08
) O 0 3.116882446585478e-11
, O 0 2.2162077728538065e-11
two O 0 1.734392837682286e-11
are O 0 4.5698913403446895e-11
nonsense O 0 2.516052255430168e-08
( O 0 9.75593633656402e-11
Q306X O 0 3.192903079707321e-07
, O 0 3.626416111845998e-10
Q385X O 0 2.0435224712400668e-07
) O 0 1.0750132034553772e-10
, O 0 5.652951370893611e-11
two O 0 2.1011947390348062e-11
are O 0 2.7152714104916598e-11
small O 0 1.0087650159640305e-10
deletions O 0 4.019211630179598e-09
( O 0 1.364871826670111e-10
662de14bp O 0 2.4549339627810696e-07
; O 0 9.61422053080696e-10
1168del3bp O 0 1.6883556099855923e-06
removing O 0 1.4083096289141395e-07
a O 0 1.4774351742019576e-09
glycine O 0 2.3749719968435556e-09
at O 0 1.3879332350086315e-08
position O 0 7.997808637583148e-09
390 O 0 4.789730390086788e-09
) O 0 7.633093809800151e-12
, O 0 1.470758931310101e-11
and O 0 2.6274982189988805e-11
one O 0 1.3398131562536442e-11
is O 0 3.0552019247842566e-12
a O 0 2.427296384721611e-11
splicing O 0 9.870531947342442e-09
mutation O 0 5.630671928713582e-09
( O 0 7.121223749573247e-11
IVS1 O 0 8.525692464900203e-06
- O 0 4.667120379053813e-08
15c O 0 7.95012851995125e-07
- O 0 6.169450728066295e-09
- O 0 2.4765043349361804e-09
> O 0 6.482285375142283e-09
g O 0 2.043319957678591e-09
) O 0 2.447275238362523e-12
which O 0 3.746940258064768e-12
creates O 0 5.12166802024705e-11
a O 0 2.8799029133663723e-11
new O 0 2.4615385285642333e-09
acceptor O 0 1.555868465175081e-07
splice O 0 2.998207264681696e-06
site O 0 2.474900782090117e-07
. O 0 3.405471815653982e-08

The O 0 2.03025493306086e-07
pathological O 0 1.1503317409733427e-06
significance O 0 4.049516917348228e-07
of O 0 5.670010949643256e-08
the O 0 7.18996284732043e-09
point O 0 5.568002947597961e-09
mutations O 0 1.4149283134035073e-10
G197W O 0 5.6635258260939736e-08
, O 0 1.0257183297168737e-10
W427R O 0 3.4609223575898795e-07
, O 0 2.481685967836711e-10
and O 0 2.102867879827386e-10
the O 0 9.980594128933262e-10
in O 0 9.895900765499732e-10
- O 0 4.2360746022040985e-09
frame O 0 7.084219433295402e-09
deletion O 0 4.04304723033988e-09
390delGly O 0 3.400856485313852e-08
were O 0 8.881531066151638e-10
assessed O 0 2.2814585776131935e-09
by O 0 2.4439983370427854e-10
their O 0 8.599560508137927e-10
respective O 0 1.02571151572306e-08
expression O 0 1.3721158653723364e-09
in O 0 1.1103866437434107e-10
a O 0 4.908644324341793e-11
prokaryotic O 0 2.702967272227852e-08
system O 0 1.4401581038825384e-09
using O 0 1.1364976321148745e-10
site O 0 4.4816341748799005e-09
- O 0 7.097392451527185e-09
directed O 0 6.9632637433869604e-09
mutagenesis O 0 1.626411722099874e-05
. O 0 1.3206222604367213e-07

These O 0 3.140147342151067e-08
mutations O 0 4.5195247544427275e-09
resulted O 0 1.0448172993449134e-08
in O 0 7.018622905086147e-10
the O 0 1.8385856170866077e-09
absence O 0 6.54675034184038e-08
or O 0 4.3607140121082466e-10
a O 0 3.379778679146739e-10
dramatic O 0 1.2783021752227341e-08
decrease O 0 9.691464697425545e-08
of O 0 5.285805855237413e-06
CPO O 0 0.3628075122833252
activity O 0 8.473424486510339e-07
. O 0 1.0484469470384283e-07

The O 0 2.940335548373696e-07
two O 0 5.046973949873745e-09
polymorphisms O 0 5.5675805299415515e-08
were O 0 4.570889444721615e-09
localized O 0 4.691620247854189e-08
in O 0 3.3282199218831465e-09
noncoding O 0 1.2247022596056922e-07
part O 0 2.7113411515955477e-09
of O 0 3.854815133763623e-08
the O 0 4.633271988296883e-09
gene O 0 7.216430231160587e-11
1 O 0 6.002121577530772e-10
) O 0 2.0981181202139876e-12
a O 0 6.975579142087796e-11
C O 0 9.187900218421419e-08
/ O 0 3.891061250982375e-09
G O 0 5.274900161111873e-08
polymorphism O 0 1.3307326351963411e-09
in O 0 3.414730442852232e-10
the O 0 2.9092548370357463e-09
promotor O 0 2.3314830741583137e-06
region O 0 1.2950439831627136e-08
, O 0 3.714666629850427e-10
142 O 0 2.898356399327895e-08
bp O 0 1.7414095054846257e-08
upstream O 0 4.8082382519964995e-09
from O 0 1.5820414422940132e-10
the O 0 2.2945362276871606e-10
transcriptional O 0 1.3166779666562434e-08
initiation O 0 2.990000780300761e-08
site O 0 1.172203933919036e-08
( O 0 1.922861522785091e-11
- O 0 1.1104507313675072e-09
142C O 0 1.2005632754608087e-07
/ O 0 7.394520107339986e-09
G O 0 1.4704700390666403e-07
) O 0 1.2988219007248336e-11
, O 0 2.8697093312768374e-11
and O 0 6.449978051659144e-11
2 O 0 8.041076138276537e-10
) O 0 7.858528064397241e-12
a O 0 1.5905221584233686e-10
6 O 0 6.0576512694865414e-09
bp O 0 4.4737942239692075e-09
deletion O 0 1.3311971525098443e-09
polymorphism O 0 1.7308485755762604e-09
in O 0 2.550120670186118e-10
the O 0 3.129041470373295e-10
3 O 0 9.928967648065168e-10
noncoding O 0 1.3585075286925985e-08
part O 0 5.699334892916852e-10
of O 0 1.3547529320590002e-08
the O 0 1.962136906286105e-07
CPO O 0 2.6849562345887534e-05
gene O 0 6.4414895639686165e-09
, O 0 6.996395685021639e-10
574 O 0 1.449523665542074e-07
bp O 0 1.8311391514203024e-08
downstream O 0 7.779098254445671e-09
of O 0 1.1285575807207238e-09
the O 0 2.181100716702744e-10
last O 0 3.1806876577000764e-10
base O 0 9.86612347375626e-10
of O 0 5.00366692524068e-10
the O 0 3.946827586975843e-10
normal O 0 3.11512038386752e-09
termination O 0 4.0593064909444365e-08
codon O 0 6.387914908145831e-08
( O 0 6.709581223951488e-10
+ O 0 1.4368308320911183e-08
574 O 0 2.4045144186857215e-07
delATTCTT O 0 1.3807165260004695e-06
) O 0 5.254553236966331e-09
. O 0 7.92415306705152e-08

Five O 0 1.3110103509461624e-06
intragenic O 0 4.917910337098874e-05
dimorphisms O 0 0.00012373237404972315
are O 0 1.5310094303444544e-09
now O 0 3.0464183953249346e-10
well O 0 8.495170539246644e-11
characterized O 0 2.0091554808754353e-10
and O 0 6.834072890926635e-11
the O 0 2.2793131271292566e-10
high O 0 2.733649084873946e-09
degree O 0 3.324184927322449e-09
of O 0 1.963202267418751e-09
allelic O 0 3.3445704161749745e-07
heterogeneity O 0 2.1985077580666257e-07
in O 0 9.160476821534758e-09
HC B-Disease 1 0.9998581409454346
is O 0 1.5099004269103489e-09
demonstrated O 0 4.3830139517808675e-09
with O 0 1.2743369727508114e-11
seven O 0 7.107871236033958e-11
new O 0 6.859408180348581e-11
different O 0 2.1149137996445688e-11
mutations O 0 3.297023071224814e-11
making O 0 1.3376733748460268e-11
a O 0 3.81059463497313e-12
total O 0 5.4361935092339664e-11
of O 0 4.6151207300226815e-09
nineteen O 0 8.305491064675152e-05
CPO O 1 0.9887867569923401
gene B-Disease 0 1.0674849590941449e-06
defects I-Disease 0 4.334814548201393e-06
reported O 0 1.2241134328405678e-08
so O 0 3.5940199705208897e-09
far O 0 1.2437390672914717e-08
. O 0 1.2651112379913343e-09
. O 0 2.491871775589516e-08

Coincidence O 0 5.263842467684299e-06
of O 0 1.3624055839045468e-07
two O 0 2.1290573748444785e-09
novel O 0 9.388220689743321e-08
arylsulfatase O 0 3.6735266348841833e-06
A O 0 5.008503478620696e-08
alleles O 0 1.4258259461996659e-08
and O 0 7.663794598933293e-10
mutation O 0 2.9387239308675817e-09
459 O 0 2.448190628001612e-08
+ O 0 2.7796598356388813e-09
1G O 0 2.4939556624303805e-06
> O 0 6.636339833221427e-08
A O 0 9.959529201353234e-09
within O 0 1.0525956772866607e-09
a O 0 1.945758693056021e-10
family O 0 4.391865759956204e-10
with O 0 7.396858126007544e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 2.7633990651310114e-09
molecular O 0 3.2193612220510204e-09
basis O 0 3.167882622889806e-10
of O 0 4.999430869290222e-10
phenotypic O 0 7.745418315607822e-07
heterogeneity O 0 8.479033567709848e-05
. O 0 4.969757810613373e-06

In O 0 2.1282873774453037e-07
a O 0 4.058282598862206e-09
family O 0 8.680177132625033e-10
with O 0 1.9192303996051763e-11
three O 0 7.785877498278637e-10
siblings O 0 7.403301793829087e-08
, O 0 1.7911214178489843e-11
one O 0 9.443841542111642e-12
developed O 0 7.820213365761219e-10
classical O 0 6.006605417496758e-07
late O 0 0.004362686537206173
infantile O 1 0.9976196885108948
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.719834936916527e-10
MLD B-Disease 1 1.0
) O 0 7.688387426707521e-11
, O 0 1.619446417244763e-11
fatal O 0 1.2418254202728463e-09
at O 0 1.7243999561600276e-09
age O 0 1.1126520149673524e-08
5 O 0 4.858423108267118e-10
years O 0 1.1464604959821045e-10
, O 0 1.05506488962126e-11
with O 0 2.923815703437249e-11
deficient O 0 7.80877144279657e-06
arylsulfatase O 0 0.3593742549419403
A O 0 7.741243462078273e-05
( O 0 3.0673514839207883e-09
ARSA O 0 1.4953519894334022e-05
) O 0 1.1066564331585482e-11
activity O 0 7.183800776466853e-11
and O 0 4.734905609954376e-12
increased O 0 1.4571814865860233e-09
galactosylsulfatide O 0 3.1519281037617475e-05
( O 0 2.8808026186766256e-08
GS O 1 1.0
) O 0 4.681508070092377e-09
excretion O 0 5.803989324704162e-07
. O 0 3.9906598914285496e-08

The O 0 4.9282772351944e-07
two O 0 1.9211552348963323e-09
other O 0 1.1162778479345548e-09
siblings O 0 5.932325208846123e-08
, O 0 1.5108848894218596e-10
apparently O 0 1.0192060528879665e-07
healthy O 0 6.01724607918186e-08
at O 0 1.16790346282869e-08
12 O 0 2.8449533839847163e-09
( O 0 6.408978816402344e-12
1 O 0 2.455976533255466e-09
/ O 0 6.714804268170838e-10
2 O 0 9.035773240739786e-10
) O 0 1.6319322195673669e-12
and O 0 1.57303198244918e-11
15 O 0 3.421084596166857e-11
years O 0 4.0284019175995667e-11
, O 0 6.1295270074868125e-12
respectively O 0 1.8443588323258098e-10
, O 0 5.547175566111839e-12
and O 0 1.8026337367249567e-11
their O 0 1.0050583282295023e-10
father O 0 2.6795945462509962e-09
, O 0 2.1536926408938228e-10
apparently O 0 3.0960134012048e-08
healthy O 0 3.941435622323297e-09
as O 0 5.35926754363647e-11
well O 0 1.3402048915089892e-10
, O 0 3.2784178150002674e-11
presented O 0 1.6467032182276853e-08
ARSA O 0 0.00014107102470006794
and O 0 1.4160583816646977e-08
GS O 1 0.9999997615814209
values O 0 1.1079611894615482e-08
within O 0 1.6756604437340172e-10
the O 0 9.434826531151685e-11
range O 0 5.444687367628376e-09
of O 0 1.6679898351412703e-08
MLD B-Disease 1 1.0
patients O 1 0.9802917838096619
. O 0 5.067387292001513e-07

Mutation O 0 5.371760494199407e-07
screening O 0 1.9469935352844914e-07
and O 0 6.242599770445167e-10
sequence O 0 6.498978438740366e-11
analysis O 0 5.154606255719507e-11
disclosed O 0 2.4818005428528522e-09
the O 0 1.078789169106642e-09
involvement O 0 2.1262651639375463e-09
of O 0 1.4469707210196248e-08
three O 0 1.968939677965409e-09
different O 0 2.1531198157731524e-08
ARSA O 0 0.37809181213378906
mutations O 0 1.7842024746528296e-08
being O 0 9.131218003943786e-10
the O 0 3.15837439535116e-10
molecular O 0 1.6447121442553225e-09
basis O 0 7.829899506539562e-10
of O 0 2.4689772448738267e-09
intrafamilial O 0 3.467837450443767e-05
phenotypic O 0 3.221505903638899e-05
heterogeneity O 0 0.00028806793852709234
. O 0 4.996813459001714e-06

The O 0 5.690372972821933e-07
late O 0 0.00024372733605559915
infantile O 0 0.001107116462662816
patient O 0 0.0001310850348090753
inherited O 0 6.721333920722827e-05
from O 0 5.63300488920504e-07
his O 0 6.369008929141273e-07
mother O 0 2.750071637080964e-08
the O 0 1.4142438331532503e-09
frequent O 0 2.7557919834997335e-10
0 O 0 3.6784424395364113e-09
- O 0 1.5957677401701176e-09
type O 0 4.4399524057325834e-09
mutation O 0 4.39956426845356e-09
459 O 0 9.354327978883248e-09
+ O 0 4.3227288415437215e-10
1G O 0 1.1682737266482945e-07
> O 0 1.978052832640742e-09
A O 0 1.6699563953892493e-09
, O 0 1.1134634880782812e-11
and O 0 5.979444803877465e-12
from O 0 1.0017931623140797e-10
his O 0 8.77440897717463e-10
father O 0 1.9085693025999717e-09
a O 0 6.963548487837201e-11
novel O 0 4.29930491208097e-09
, O 0 2.2303540958557022e-11
single O 0 1.6367188160337776e-10
basepair O 0 1.781663172550907e-07
microdeletion O 0 8.327739919877786e-07
of O 0 2.5397888236966537e-08
guanine O 0 2.1724545717916044e-08
at O 0 3.859712549569849e-09
nucleotide O 0 4.481283788493329e-09
7 O 0 4.35578728641417e-09
in O 0 8.998435330198618e-10
exon O 0 3.904787249098263e-08
1 O 0 1.734732890668056e-08
( O 0 2.108888619289928e-10
7delG O 0 3.503301968521555e-07
) O 0 2.133756948907717e-09
. O 0 5.784213641391034e-08

The O 0 4.360161653949035e-07
two O 0 2.196591708525375e-08
clinically O 0 0.02418658696115017
unaffected O 0 0.0003618817718233913
siblings O 0 4.2979257841579965e-07
carried O 0 1.7336140301082992e-09
the O 0 1.1345663297746e-09
maternal O 0 1.4515433122141985e-07
mutation O 0 2.296500234422183e-08
459 O 0 8.263706519073821e-08
+ O 0 2.8087587811143067e-09
1G O 0 1.3212802514317445e-06
> O 0 1.7877589186809928e-08
A O 0 3.824821792619559e-09
and O 0 6.781045863712976e-11
, O 0 1.101766074207422e-11
on O 0 1.8956888836463293e-10
their O 0 7.988545935866398e-11
paternal O 0 4.9742752139536606e-09
allele O 0 6.482244185868069e-10
, O 0 1.0081507677284218e-11
a O 0 1.9482753951804987e-11
novel O 0 2.328724768574375e-09
cytosine O 0 1.1891558848731165e-09
to O 0 1.1613093819917708e-10
thymidine O 0 9.665951949955343e-08
transition O 0 2.474725668832889e-08
at O 0 1.1878620753691393e-08
nucleotide O 0 7.204709362440553e-08
2435 O 0 1.0096755431732163e-05
in O 0 7.630790221924144e-09
exon O 0 1.3545364652145508e-07
8 O 0 4.980417855904307e-09
, O 0 1.161512639541451e-11
resulting O 0 6.269122027058316e-11
in O 0 4.282457721771493e-11
substitution O 0 1.6512196054918604e-08
of O 0 5.428935523354994e-09
alanine O 0 2.550921074373491e-08
464 O 0 1.2304106178362417e-07
by O 0 7.889704001229347e-09
valine O 0 3.90255718230037e-06
( O 0 3.3277376410012494e-09
A464V O 0 3.010475893461262e-06
) O 0 7.481443020651568e-09
. O 0 8.614245672333709e-08

The O 0 7.864629196774331e-07
fathers O 0 7.305113172151323e-07
genotype O 0 1.3970222312309488e-07
thus O 0 5.687229354123247e-09
was O 0 1.5512098272552066e-08
7delG O 0 3.5851053326041438e-06
/ O 0 1.8482257928553736e-06
A464V O 0 3.198034755769186e-05
. O 0 5.85820259857428e-07

Mutation O 0 2.640323828018154e-06
A464V O 0 9.090213097806554e-06
was O 0 2.7927182344456014e-08
not O 0 1.593479653783092e-10
found O 0 1.485127854028434e-10
in O 0 1.6362569632555335e-10
18 O 0 6.327161461427977e-09
unrelated O 0 6.046565431461204e-06
MLD B-Disease 1 1.0
patients O 1 0.999998927116394
and O 0 5.3561592494588695e-08
50 O 0 4.926970831320432e-08
controls O 0 6.672347296898806e-08
. O 0 1.8644192323336028e-07

A464V O 0 0.0001030153434840031
, O 0 1.9488917146759377e-08
although O 0 4.4139650157148935e-08
clearly O 0 1.3356668659980642e-07
modifying O 0 2.06451859412482e-05
ARSA O 1 0.9999988079071045
and O 0 4.127565716771642e-06
GS O 1 1.0
levels O 0 1.0212303095613606e-05
, O 0 6.127932050681295e-10
apparently O 0 3.948998017477834e-09
bears O 0 7.141947477862232e-09
little O 0 8.972038390009374e-11
significance O 0 5.238958711295538e-10
for O 0 4.556800423105578e-11
clinical O 0 1.6386884738039953e-08
manifestation O 0 1.5392210173104104e-07
of O 0 4.773326054419158e-07
MLD B-Disease 1 1.0
, O 0 8.57615845006876e-09
mimicking O 0 3.998164643803648e-08
the O 0 5.099380473438941e-09
frequent O 0 2.868219972640418e-08
ARSA O 0 0.0003799370606429875
pseudodeficiency O 0 0.00011839782382594422
allele O 0 6.085161658120342e-06
. O 0 9.445370210414694e-07

Our O 0 6.484142431872897e-07
results O 0 5.217604126528386e-08
demonstrate O 0 6.819145248471159e-09
that O 0 8.83583397420784e-12
in O 0 6.673687297231723e-11
certain O 0 8.27137858205873e-10
genetic O 0 3.029472850357706e-08
conditions O 0 1.8282295059179887e-05
MLD B-Disease 1 1.0
- O 1 0.9997544884681702
like O 0 2.5711447051435243e-06
ARSA O 1 0.9937122464179993
and O 0 4.414377485773002e-08
GS O 1 1.0
values O 0 2.995566816821338e-08
need O 0 2.0872913120140169e-10
not O 0 3.391974635197359e-12
be O 0 3.885070216924635e-12
paralleled O 0 1.576869745889553e-09
by O 0 1.3289208622424553e-10
clinical O 0 1.1392188753234223e-05
disease O 0 3.141187221444852e-07
, O 0 2.670428461692964e-11
a O 0 4.486059787534025e-11
finding O 0 1.0473028000390627e-09
with O 0 2.2180132730476032e-11
serious O 0 5.282058523903288e-08
diagnostic O 0 0.00010689010377973318
and O 0 9.382420529391311e-08
prognostic O 1 0.9999992847442627
implications O 0 0.00041695349500514567
. O 0 5.171908128431824e-07

Moreover O 0 2.0913514163112268e-05
, O 0 4.3276333627773056e-08
further O 0 2.609672264952678e-07
ARSA O 0 0.0013526194961741567
alleles O 0 1.342413838756329e-06
functionally O 0 1.2700590446002025e-07
similar O 0 3.2841660502214154e-09
to O 0 4.5061979148108833e-10
A464V O 0 1.9655901724036084e-06
might O 0 4.517654250690839e-09
exist O 0 5.723114204769786e-10
which O 0 2.7558115511805426e-11
, O 0 1.550618834722517e-11
together O 0 7.74803398523316e-12
with O 0 4.57510418439e-12
0 O 0 7.817562597267624e-09
- O 0 9.408724466197782e-09
type O 0 4.15539567200085e-08
mutations O 0 1.7976261590391118e-09
, O 0 2.985004951550074e-11
may O 0 2.1356378887560368e-09
cause O 0 5.619129979095305e-07
pathological O 1 0.9999947547912598
ARSA O 1 0.9999978542327881
and O 0 2.0614029949683754e-07
GS O 1 1.0
levels O 0 2.2905165053543897e-07
, O 0 3.688680437485825e-12
but O 0 1.0069453951211393e-12
not O 0 2.3868027779899714e-12
clinical O 0 1.3631918927003994e-09
outbreak O 0 3.033350903791643e-09
of O 0 1.3530021547580873e-08
the O 0 8.563216624679626e-08
disease O 0 3.3907113561326696e-07
. O 0 2.5907744838349345e-09
. O 0 2.1944224215530994e-08

Human O 0 0.34693029522895813
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.0010685225715860724
to O 0 2.9677633506253187e-07
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 0.9999997615814209
and O 0 1.5828948107809993e-07
neurofibromatosis B-Disease 1 0.9957031607627869
type I-Disease 0 6.3580887399439234e-06
1 I-Disease 0 4.648260983231012e-06
. O 0 1.1172907221634887e-07

Heterozygous O 0 7.014907623670297e-06
germ O 0 0.0005939265829510987
- O 0 6.064432909624884e-06
line O 0 1.2965463156433543e-06
mutations O 0 7.172061167182164e-09
in O 0 1.8918527855404932e-10
the O 0 7.902787868552252e-10
DNA O 0 5.6335963449782867e-08
mismatch O 0 0.01423045713454485
repair O 0 0.00114975287579
genes O 0 3.716272374276741e-07
lead O 0 1.802664399974674e-07
to O 0 8.352589730975524e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0015304872067645192

The O 0 1.2930615866935113e-06
disease O 0 1.9977869669673964e-06
susceptibility O 0 1.6889612197701354e-06
of O 0 2.1436179054035165e-07
individuals O 0 4.449218327096105e-09
who O 0 7.702912085960634e-09
constitutionally O 0 5.293708227327443e-07
lack O 0 2.892337306548143e-06
both O 0 3.906670098530185e-09
wild O 0 1.6756405329942936e-07
- O 0 4.5066554932304825e-09
type O 0 1.5663458086123683e-08
alleles O 0 9.477382434397441e-09
is O 0 2.653709751943012e-10
unknown O 0 4.539509745882242e-08
. O 0 2.1631473501315668e-08

We O 0 8.557469755032798e-08
have O 0 1.009824224240674e-09
identified O 0 2.7699478266640654e-09
three O 0 2.556158895661298e-10
offspring O 0 5.559905424945555e-09
in O 0 1.8014487124240475e-10
a O 0 1.5892098748082617e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.00807201862335205
who O 0 1.850088637844749e-09
developed O 0 6.277637965013128e-08
hematological B-Disease 1 0.999996542930603
malignancy I-Disease 1 0.9989373087882996
at O 0 6.451857359479618e-08
a O 0 1.375104474732325e-10
very O 0 6.144220549009205e-11
early O 0 7.113018174464969e-09
age O 0 5.561008542542822e-09
, O 0 1.8259362771777532e-11
and O 0 1.5726420166117805e-11
at O 0 2.904429752259574e-10
least O 0 7.618305292167449e-11
two O 0 1.6965406510194292e-11
of O 0 1.1455554560502179e-10
them O 0 2.474792766549161e-11
displayed O 0 1.303777308336862e-09
signs O 0 2.575383239999951e-09
of O 0 7.004851365621789e-09
neurofibromatosis B-Disease 0 4.185302532278001e-05
type I-Disease 0 3.3760525752768444e-07
1 I-Disease 0 3.4365709211670037e-07
( O 0 9.968437186813617e-10
NF1 B-Disease 0 5.5222611990757287e-05
) O 0 3.428077155476217e-09
. O 0 5.652691115187736e-08

DNA O 0 4.6362625738538554e-08
sequence O 0 4.820779886394178e-10
analysis O 0 1.866163751307326e-10
and O 0 6.196237967159846e-11
allele O 0 1.1652211140411595e-10
- O 0 1.8469499540874068e-10
specific O 0 6.312593503476904e-11
amplification O 0 1.3786932484549652e-08
in O 0 6.295102217279691e-10
two O 0 3.787194724491627e-10
siblings O 0 2.040867208563668e-08
revealed O 0 3.881817089990136e-09
a O 0 2.0737209727172967e-09
homozygous O 0 2.2648028163985146e-07
MLH1 O 0 0.00707963528111577
mutation O 0 5.2741256695298944e-08
( O 0 1.1921187648145093e-10
C676T O 0 9.489722430089387e-08
- O 0 5.0516380412091166e-08
- O 0 6.119655893144227e-08
> O 0 5.939927518738841e-07
Arg226Stop O 0 1.4182136510498822e-05
) O 0 2.255652997718016e-09
. O 0 3.521812175222294e-08

Thus O 0 6.430174153138069e-07
, O 0 5.060497798581309e-09
a O 0 2.175426505601763e-09
homozygous O 0 1.2464468568396114e-07
germ O 0 0.019507072865962982
- O 0 1.8871514839702286e-05
line O 0 5.178878200240433e-05
MLH1 O 1 0.9999780654907227
mutation O 0 9.126244435719855e-07
and O 0 3.6744873810334866e-09
consequent O 1 0.9328324794769287
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9999955892562866
results O 0 1.083342340280069e-06
in O 0 5.0800426087960204e-09
a O 0 8.031205145364595e-10
mutator O 0 0.007225710432976484
phenotype O 0 8.489366223329853e-07
characterized O 0 1.1288331380754357e-09
by O 0 1.2860587039753568e-09
leukemia B-Disease 1 1.0
and O 0 1.4579402886738535e-05
/ O 1 0.9999642372131348
or O 0 0.02025138959288597
lymphoma B-Disease 1 1.0
associated O 0 2.7723610401153564e-05
with O 0 1.9938415363185413e-08
neurofibromatosis B-Disease 1 0.9999971389770508
type I-Disease 0 1.9408475964155514e-06
1 I-Disease 0 2.6358301852269506e-07
. O 0 2.4454964719922145e-09
. O 0 1.3723285618993941e-08

Missense O 0 0.006426260340958834
mutations O 0 2.5897340947267367e-06
in O 0 1.6708174399582276e-08
the O 0 5.84283466054103e-09
most O 0 7.708523264149392e-10
ancient O 0 1.5463502478496594e-08
residues O 0 1.547660488654401e-08
of O 0 5.101579159116909e-09
the O 0 1.4521132740696885e-08
PAX6 O 0 0.00522399740293622
paired O 0 7.160650028481541e-08
domain O 0 1.348817679769354e-08
underlie O 0 6.325860368860958e-08
a O 0 3.115992464053363e-10
spectrum O 0 1.4798409893046482e-06
of O 0 2.1806043548622256e-07
human O 0 0.0001507878041593358
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0036696644965559244

Mutations O 0 1.6211290585488314e-06
of O 0 4.236076733832306e-08
the O 0 1.5114455464981802e-08
human O 0 2.1685504947299705e-08
PAX6 O 1 0.9830069541931152
gene O 0 2.0819154542550677e-06
underlie O 1 0.9998892545700073
aniridia B-Disease 1 1.0
( O 0 0.015672754496335983
congenital B-Disease 1 1.0
absence I-Disease 1 0.9975912570953369
of I-Disease 1 0.5943379402160645
the I-Disease 0 6.576388386747567e-06
iris I-Disease 0 2.7812002372229472e-05
) O 0 3.4851344032915677e-11
, O 0 5.884171622172474e-12
a O 0 3.412866170227069e-11
rare O 0 3.204775964604778e-07
dominant O 1 0.9999887943267822
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999560117721558
eye I-Disease 1 0.9998613595962524
. O 0 1.0956442793030874e-06

The O 0 5.333690182851569e-07
spectrum O 0 1.5636076568625867e-05
of O 0 2.2406627522286726e-06
PAX6 O 1 0.999963641166687
mutations O 0 1.487382291998074e-06
in O 0 1.336708095323047e-07
aniridia B-Disease 1 1.0
patients O 0 0.33862006664276123
is O 0 2.739608540025529e-10
highly O 0 4.786807838996765e-09
biased O 0 1.6199609431666318e-09
, O 0 1.0893726025418271e-11
with O 0 2.5543922445997458e-12
92 O 0 4.107219098159476e-08
% O 0 1.3147594124518491e-10
of O 0 7.035041438285816e-10
all O 0 5.960651416891949e-10
reported O 0 1.7165701082788587e-09
mutations O 0 2.047916058955934e-09
leading O 0 1.9624506464310798e-08
to O 0 4.5708434259772446e-10
premature O 0 1.3345362503969227e-07
truncation O 0 3.6421971572053735e-07
of O 0 2.8141769803369243e-07
the O 0 1.1797538945756969e-08
protein O 0 1.3260299525086339e-09
( O 0 2.546668431691046e-11
nonsense O 0 3.84042886381053e-09
, O 0 1.4193524827676995e-11
splicing O 0 1.4620534782849859e-09
, O 0 3.006661239424169e-11
insertions O 0 1.3082186445245725e-09
and O 0 1.3141024379770272e-10
deletions O 0 1.6202390540343004e-09
) O 0 3.8866288659678006e-11
and O 0 5.463940966343728e-10
just O 0 3.893122491049894e-10
2 O 0 8.656781402827107e-10
% O 0 2.206725427389422e-11
leading O 0 2.0248427934355107e-11
to O 0 4.527962477619135e-13
substitution O 0 3.5184266611310022e-09
of O 0 9.782591625651094e-09
one O 0 1.126228277303909e-10
amino O 0 2.7203723648727696e-11
acid O 0 8.160412623414715e-11
by O 0 6.406977726136631e-11
another O 0 1.4000967052396618e-09
( O 0 8.585204214206499e-10
missense O 0 1.1377412647561869e-06
) O 0 2.6006963249614046e-09
. O 0 8.255042871496698e-08

The O 0 1.1142388700591255e-07
extraordinary O 0 7.608499430489246e-08
conservation O 0 6.802001450978423e-08
of O 0 2.4901647410757732e-09
the O 0 9.57329149287034e-09
PAX6 O 0 0.00012629764387384057
protein O 0 2.043106483995416e-08
at O 0 2.982350144620227e-09
the O 0 1.1140020017563756e-09
amino O 0 7.936795221041848e-09
acid O 0 6.923390571955679e-08
level O 0 1.6757601315475767e-06
amongst O 0 4.24372137786122e-06
vertebrates O 0 6.785441655665636e-06
predicts O 0 9.240130793841672e-08
that O 0 1.43856848655588e-09
pathological O 0 0.00020961748668923974
missense O 0 3.079486123169772e-05
mutations O 0 3.5635370210229667e-08
should O 0 1.3253296238247003e-09
in O 0 3.1735855610115493e-10
fact O 0 2.2189834691932475e-10
be O 0 3.0214011847995437e-11
common O 0 4.1083036972366926e-10
even O 0 8.044753752045608e-11
though O 0 5.250560403124993e-11
they O 0 9.042212291421325e-12
are O 0 7.718107403187346e-12
hardly O 0 2.7262758717228053e-09
ever O 0 9.265254119483757e-10
seen O 0 3.9835401643983914e-09
in O 0 1.1382559783612578e-08
aniridia B-Disease 1 1.0
patients O 0 0.2716924548149109
. O 0 4.675255240726983e-07

This O 0 8.375159232798524e-09
indicates O 0 8.319624988928354e-09
that O 0 1.5334161024282977e-11
there O 0 2.4083244079542432e-11
is O 0 2.830136082085377e-12
a O 0 1.2843414699814648e-11
heavy O 0 2.8672963026110665e-07
ascertainment O 0 4.225970042170957e-05
bias O 0 7.407722790730986e-08
in O 0 3.606047960236225e-10
the O 0 2.2455171055923984e-10
selection O 0 1.5222603622078168e-08
of O 0 1.625510503977523e-09
patients O 0 7.467613194478417e-09
for O 0 3.191072406316664e-10
PAX6 O 0 0.00013227207818999887
mutation O 0 3.8416891889880844e-09
analysis O 0 1.5664160246675607e-10
and O 0 2.5389374630480077e-11
that O 0 3.663341765353101e-12
the O 0 5.8270752667510806e-09
missing O 0 2.0157576727797277e-06
PAX6 O 1 0.9999927282333374
missense O 0 0.001650049351155758
mutations O 0 3.724422015238815e-07
frequently O 0 8.58021564908995e-09
may O 0 1.3815099286773602e-08
underlie O 0 4.4408629946701694e-06
phenotypes O 0 3.0428525406023255e-06
distinct O 0 6.726241341681316e-09
from O 0 6.058321844193415e-09
textbook O 0 4.339470251579769e-05
aniridia B-Disease 1 1.0
. O 0 3.8608968679909594e-06

Here O 0 3.184525212418521e-07
we O 0 9.57876666873858e-10
present O 0 1.8699450876624724e-09
four O 0 1.8427670500642535e-09
novel O 0 6.168994559629937e-07
PAX6 O 1 0.8632628917694092
missense O 0 6.340847176034003e-05
mutations O 0 7.201645502163956e-08
, O 0 4.77994477332544e-10
two O 0 8.83583761712714e-11
in O 0 4.5850415131276634e-10
association O 0 1.2209835364984656e-09
with O 0 1.6461268459444511e-10
atypical O 0 0.00026479116058908403
phenotypes O 0 0.3058277666568756
ectopia B-Disease 1 0.9997783303260803
pupillae I-Disease 1 0.9993146657943726
( O 0 1.7184570433315116e-09
displaced B-Disease 0 1.4596162500879473e-08
pupils I-Disease 0 2.964159051543902e-08
) O 0 2.2793522624908746e-10
and O 0 2.3111150326826646e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9617924094200134
( O 0 4.06007849562684e-09
searching B-Disease 0 6.89321666413889e-08
gaze I-Disease 0 1.6022983828634096e-08
) O 0 9.64067194131335e-12
, O 0 2.0555059390692243e-11
and O 0 8.2762824371585e-11
two O 0 8.227177272779329e-11
in O 0 1.3632127648932624e-09
association O 0 1.228001700326331e-09
with O 0 6.598427360060555e-11
more O 0 1.4317990126855307e-09
recognizable O 0 1.2990887626074255e-05
aniridia B-Disease 1 1.0
phenotypes O 0 0.0003477180143818259
. O 0 1.5302416613849346e-06

Strikingly O 0 7.108140562195331e-05
, O 0 1.160960749757578e-08
all O 0 1.26231036734481e-09
four O 0 3.8518049860769565e-10
mutations O 0 3.4509251012337927e-10
are O 0 3.00983404866173e-11
located O 0 6.240623573461335e-10
within O 0 1.222819956403498e-09
the O 0 4.465739777970157e-08
PAX6 O 1 0.9999322891235352
paired O 0 7.910468866612064e-07
domain O 0 5.8617910525526895e-08
and O 0 6.008100128518379e-10
affect O 0 3.6102274503235776e-09
amino O 0 2.5563748895507388e-09
acids O 0 1.0023097907208012e-09
which O 0 3.528140279929204e-11
are O 0 2.7848204645075647e-11
highly O 0 1.7035723942626646e-09
conserved O 0 2.0597781258402392e-09
in O 0 1.9027127096116203e-10
all O 0 3.2832878082977857e-10
known O 0 3.99527344541184e-09
paired O 0 2.3116044189919194e-08
domain O 0 2.5263092950922328e-08
proteins O 0 2.800055964868875e-09
. O 0 2.178861713275637e-08

Our O 0 2.575417283878778e-07
results O 0 3.866478692771125e-08
support O 0 2.9090772013518063e-09
the O 0 1.2545766647775736e-09
hypothesis O 0 2.7773334743130818e-09
that O 0 4.2546090890834e-13
the O 0 1.2102010366055183e-11
under O 0 3.170651241557465e-10
- O 0 1.4660048730519293e-09
representation O 0 7.2196040257210825e-09
of O 0 3.7347753334415756e-08
missense O 0 7.393997748295078e-06
mutations O 0 1.3253606212515479e-08
is O 0 6.815095016099448e-11
caused O 0 1.0082999990501662e-09
by O 0 1.345964339982686e-09
ascertainment O 0 0.00032967529841698706
bias O 0 2.652063244568126e-07
and O 0 8.197733047943245e-10
suggest O 0 1.4682734195137215e-10
that O 0 8.67327910880622e-13
a O 0 5.212788967839943e-12
substantial O 0 9.485570107159447e-10
burden O 0 5.640492872771574e-07
of O 0 5.887702627660474e-06
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999812841415405
related I-Disease 1 0.9999955892562866
disease I-Disease 1 0.9999992847442627
remains O 0 8.05159459105198e-07
to O 0 5.804972127987362e-11
be O 0 2.4752330740618333e-10
uncovered O 0 4.249421436952616e-08
. O 0 4.306609291404584e-09
. O 0 4.0653191035744385e-08

The O 0 1.7936068275048456e-07
chromosomal O 0 9.805049216993211e-08
order O 0 5.1068585804614486e-08
of O 0 8.137853342304879e-07
genes O 0 5.090675969654512e-08
controlling O 0 3.577538976173855e-08
the O 0 4.498971151178921e-08
major O 0 0.0003497123543638736
histocompatibility O 1 1.0
complex O 0 0.0015420669224113226
, O 0 8.510988025456356e-10
properdin O 0 5.539108087759814e-07
factor O 0 8.84937705336597e-08
B O 0 0.00039969178033061326
, O 0 5.534264019280144e-11
and O 0 2.812536870067106e-10
deficiency B-Disease 0 6.000204280098842e-07
of I-Disease 0 1.8645557702257065e-06
the I-Disease 0 7.754804300930118e-07
second I-Disease 0 2.2612296106672147e-06
component I-Disease 0 1.6364979273930658e-06
of I-Disease 0 4.217075968426798e-07
complement I-Disease 0 8.854626116772124e-07
. O 0 6.923904720679275e-07

The O 0 7.79548258833529e-07
relationship O 0 2.1680378381461196e-08
of O 0 4.414158638610388e-08
the O 0 1.0135102535002716e-08
genes O 0 4.1305237008515405e-10
coding O 0 1.6835869365294798e-09
for O 0 7.255769318703642e-10
HLA O 0 3.5814788134302944e-05
to O 0 5.064232366791543e-10
those O 0 1.2264141091566927e-10
coding O 0 4.16132434066796e-10
for O 0 9.078975071741269e-11
properdin O 0 2.1214988521478517e-07
Factor O 0 5.4464560861333666e-08
B O 0 2.600046400402789e-06
allotypes O 0 2.9159238579268276e-07
and O 0 2.0533870437322577e-10
for O 0 4.519987717443996e-10
deficiency B-Disease 0 1.654531956774008e-06
of I-Disease 0 8.742708814679645e-06
the I-Disease 0 1.1154359924603341e-07
second I-Disease 0 3.889927668865312e-08
component I-Disease 0 1.4444779594668944e-08
of I-Disease 0 2.231561779808544e-08
complement I-Disease 0 3.118677227575972e-08
( O 0 2.46340670084777e-10
C2 O 0 6.199189783728798e-08
) O 0 2.3249223726762303e-12
was O 0 1.1920711640023285e-10
studied O 0 6.525687767933164e-10
in O 0 2.3442220387082102e-11
families O 0 1.7945684868680978e-11
of O 0 4.707705891782155e-10
patients O 0 1.8291639491962997e-07
with O 0 2.5796765612540185e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 2.947715256595984e-05

Patients O 0 0.00021072907838970423
were O 0 3.6717150209142346e-08
selected O 0 1.4300202799688577e-08
because O 0 5.512617029523881e-10
they O 0 7.069971691420207e-11
were O 0 1.1135813382523452e-09
heterozygous O 0 3.2407452277283255e-09
or O 0 6.567493215925424e-10
homozygous O 0 2.645975030191039e-07
for O 0 4.092661129107e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.0084442187217064e-05

12 O 0 2.8334366106719244e-06
families O 0 1.9606922307957575e-08
with O 0 2.1842978814579084e-10
15 O 0 1.2928819792534796e-08
matings O 0 7.4445028985792305e-06
informative O 0 5.699629127775552e-06
for O 0 2.563665657362435e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.981294523531687e-07
found O 0 1.5763472305252435e-08
. O 0 2.642202012737016e-08

Of O 0 8.447615982731804e-06
57 O 0 3.862587163894204e-06
informative O 0 4.856927375840314e-07
meioses O 0 5.8758000704983715e-06
, O 0 4.37647945661368e-10
two O 0 3.9562766257494886e-11
crossovers O 0 2.753560490731388e-09
were O 0 6.053455514631878e-10
noted O 0 3.758209854431982e-10
between O 0 2.4742476956163273e-09
the O 0 0.34991225600242615
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.290952813183594e-09
and O 0 3.479357912894443e-10
the O 0 2.542652088877162e-09
HLA O 0 1.5556368452962488e-05
- O 0 0.00017429851868655533
B O 0 0.0002650538517627865
gene O 0 1.173428715306457e-10
, O 0 1.0100461049142306e-12
with O 0 3.3112689023021e-13
a O 0 4.358464544135243e-12
recombinant O 0 1.5352467075402387e-09
fraction O 0 9.2953502672799e-09
of O 0 1.1441809277812354e-08
0 O 0 9.890474927942705e-08
. O 0 2.251021058441438e-08

035 O 0 0.04801153391599655
. O 0 4.0092279959935695e-05

A O 0 1.0308303899364546e-06
lod O 0 7.443624781444669e-05
score O 0 2.1203439359851473e-07
of O 0 5.171421513239238e-09
13 O 0 7.950684555169119e-10
was O 0 9.109816373475965e-11
calculated O 0 1.4595256947469437e-10
for O 0 2.1250803894368175e-10
linkage O 0 1.0401871577414568e-06
between O 0 0.0010209097526967525
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 8.773580617571497e-08
HLA O 0 7.3566907303757034e-06
- O 0 9.528206419417984e-07
B O 0 2.371950358792674e-06
at O 0 8.0875389718571e-11
a O 0 7.277587820569975e-13
maximum O 0 9.121287058988514e-12
likelihood O 0 1.3368298135141288e-10
value O 0 6.665167306962871e-10
of O 0 3.241856227909068e-10
the O 0 5.086701060363907e-10
recombinant O 0 7.818785618951551e-09
fraction O 0 1.0032359831768645e-08
of O 0 7.100561028039465e-09
0 O 0 9.3984333204844e-08
. O 0 1.797805104786221e-08

04 O 0 0.03197735920548439
. O 0 5.280709592625499e-05

18 O 0 1.779168314897106e-06
families O 0 6.911513583673923e-09
with O 0 2.325128700686463e-10
21 O 0 2.1990818055428463e-08
informative O 0 7.963331327687229e-09
matings O 0 2.184833469698333e-08
for O 0 2.9545660362728654e-10
both O 0 9.335251460740324e-10
properdin O 0 2.731678023337736e-06
Factor O 0 6.600589017580205e-07
B O 0 1.3538558050640859e-05
allotype O 0 8.642161901661893e-07
and O 0 1.4730625608194714e-09
HLA O 0 9.495689482719172e-06
- O 0 1.399256507284008e-05
B O 0 0.0004897184553556144
were O 0 4.1662344685278185e-09
found O 0 7.423882619761457e-10
. O 0 8.379712923556326e-09

Of O 0 1.1520924999786075e-05
72 O 0 5.519605110748671e-06
informative O 0 3.208758130313072e-07
meioses O 0 7.416702828777488e-06
, O 0 1.7726821122110437e-09
three O 0 4.621213967048732e-10
recombinants O 0 4.527249984676018e-06
were O 0 1.8915804034236317e-08
found O 0 1.979285763065164e-10
, O 0 1.3476892345154479e-11
giving O 0 6.19820028635587e-11
a O 0 4.785415466668219e-11
recombinant O 0 1.1058900462046495e-08
fraction O 0 1.2183088315964596e-08
of O 0 2.624677186702229e-08
0 O 0 9.58943147111313e-08
. O 0 1.3871551018951322e-08

042 O 0 0.009210136719048023
. O 0 3.065974306082353e-05

A O 0 1.4364932212629355e-06
lod O 0 7.916227332316339e-05
score O 0 2.6346540948907204e-07
of O 0 2.525292863708728e-08
16 O 0 7.753205188976153e-09
between O 0 4.2956960211171236e-10
HLA O 0 4.276341132936068e-05
- O 0 5.68526957067661e-06
B O 0 1.0348991963837761e-05
and O 0 2.5436198286543643e-11
Factor O 0 8.62480864505244e-10
B O 0 4.005408271723354e-08
allotypes O 0 8.879604607159308e-09
was O 0 1.223677964512504e-10
calculated O 0 3.4736885590191946e-10
at O 0 1.0363434416182926e-10
a O 0 2.838369079702363e-12
maximum O 0 3.557331512693551e-11
likelihood O 0 3.3859212655862336e-10
value O 0 6.671425079041171e-10
of O 0 2.0817528256777962e-10
the O 0 1.7679574471074488e-10
recombinant O 0 3.1330202876489466e-09
fraction O 0 4.184966595488504e-09
of O 0 3.287751182412535e-09
0 O 0 5.540641367929311e-08
. O 0 1.4004553960944577e-08

04 O 0 0.025213854387402534
. O 0 5.222925028647296e-05

A O 0 1.3566971119871596e-06
crossover O 0 6.03287560352328e-07
was O 0 2.372148166784882e-08
shown O 0 2.788361486150137e-10
to O 0 8.527476641484455e-11
have O 0 5.509765560463009e-11
occurred O 0 1.8553893976758218e-09
between O 0 7.48396067340451e-11
genes O 0 1.945572175587884e-11
for O 0 6.840708121486072e-12
Factor O 0 5.62644197898976e-09
B O 0 5.119254069541057e-07
and O 0 1.8072926488699181e-10
HLA O 0 4.072731485393888e-07
- O 0 1.679683350630512e-06
D O 0 8.020487598514592e-07
, O 0 3.8524496093206295e-11
in O 0 3.630663478193519e-11
which O 0 9.758542585114327e-11
HLA O 0 1.1462776683401898e-06
- O 0 7.027831088635139e-06
D O 0 1.5409702882607235e-06
segregared O 0 1.4958432075218298e-06
with O 0 6.312066425095963e-10
HLA O 0 0.0004146695137023926
- O 0 5.2111772674834356e-06
A O 0 4.949368985762703e-07
and O 0 6.350362458107384e-09
B O 0 5.434197191789281e-06
. O 0 6.61530830114998e-09

These O 0 4.340877168829138e-08
studies O 0 3.144652760411759e-09
suggest O 0 2.336950910564184e-10
that O 0 2.1547835130780735e-12
the O 0 6.895389120797901e-11
genes O 0 1.9248869859156414e-11
for O 0 2.4013796159905176e-11
Factor O 0 3.34786989242275e-07
B O 1 0.9999979734420776
and O 0 3.7670270103262737e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.73460573366691e-10
located O 0 1.7685677922152365e-10
outside O 0 1.939622490398918e-10
those O 0 1.6323907503501545e-11
for O 0 1.5358024574307905e-10
HLA O 0 9.865814354270697e-05
, O 0 2.3063569110082227e-10
that O 0 8.870343695677185e-13
the O 0 1.4097285838676754e-11
order O 0 9.562241276572792e-11
of O 0 2.302533941289653e-09
genese O 0 5.343475777408457e-07
is O 0 8.597834250112513e-11
HLA O 0 6.349238645952937e-08
- O 0 1.449440123479917e-08
A O 0 5.5831566037056746e-09
, O 0 1.4230037287399355e-11
- O 0 5.787926804501353e-10
B O 0 6.424767917678764e-08
, O 0 5.349042823260541e-12
- O 0 1.6220903786834384e-10
D O 0 1.4032380812878387e-09
, O 0 3.544035290931058e-12
Factor O 0 2.971199064560892e-09
B O 0 1.2730272828775924e-05
allotype O 0 0.0015558175509795547
, O 0 2.626445848363801e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 7.245438693459505e-10
that O 0 8.048693656004247e-12
the O 0 6.111939843123082e-10
genes O 0 8.778711646506565e-10
coding O 0 7.239960808647083e-08
for O 0 1.113436383093358e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.0015191342915841e-08
Factor O 0 4.5349317190357397e-08
B O 0 6.036385684637935e-07
allotypes O 0 4.0980086879471855e-08
are O 0 7.985829879320061e-12
approximately O 0 1.4380972541278014e-12
3 O 0 1.634777556380751e-11
- O 0 8.202561546655218e-11
- O 0 1.304040875282908e-09
5 O 0 9.525003008548083e-10
centimorgans O 0 6.481916869915949e-08
from O 0 6.511849393042723e-10
the O 0 2.0190755734006416e-09
HLA O 0 1.5185910342552233e-06
- O 0 3.0384256888282835e-07
A O 0 1.2667663895626902e-07
and O 0 6.861282653147782e-10
HLA O 0 8.570991667511407e-07
- O 0 3.940573947147641e-07
B O 0 1.5584241737087723e-06
loci O 0 3.12926395906743e-09
, O 0 3.547139361750884e-12
and O 0 6.75924160392638e-13
that O 0 6.68259325371616e-14
the O 0 1.2856846663689137e-11
apparent O 0 1.595612530991275e-09
lack O 0 4.1796459626652904e-09
of O 0 2.679334087929419e-09
recombinants O 0 1.5582919843382115e-07
between O 0 2.3508769930735696e-10
the O 0 9.99446303495688e-10
Factor O 0 6.588791023887097e-08
B O 0 7.498718332499266e-05
gene O 0 6.123240581246137e-08
and O 0 2.289255007781321e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 3.5006959109296076e-08
suggests O 0 2.1438126829309567e-09
that O 0 2.314957470508916e-12
these O 0 2.1800139818339836e-11
two O 0 2.9231575493504636e-11
genes O 0 3.6996622432283743e-10
lie O 0 3.312159879698129e-09
in O 0 2.2615451178431556e-10
close O 0 8.056155742508508e-09
proximity O 0 3.2319604770236765e-07
to O 0 4.998575331427446e-09
one O 0 8.363378434239621e-09
another O 0 3.123230740698091e-08
. O 0 1.1800648991311391e-07

Distribution O 0 5.70975302593979e-08
of O 0 3.238522694459789e-08
emerin O 0 0.00017225246119778603
and O 0 1.0370863634534544e-07
lamins O 0 0.004598528146743774
in O 0 1.936009574876607e-08
the O 0 1.5079786308547227e-08
heart O 0 1.845089627749985e-07
and O 0 3.7677846953521055e-10
implications O 0 5.018256388211739e-08
for O 0 4.886659077385502e-09
Emery B-Disease 0 0.011925569735467434
- I-Disease 1 0.9999949932098389
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0011260663159191608

Emerin O 1 0.9611966013908386
is O 0 9.326200256509765e-08
a O 0 5.224383148316747e-09
nuclear O 0 6.301348776105442e-07
membrane O 0 6.543067598840935e-08
protein O 0 9.490384034194221e-10
which O 0 1.2084018681524089e-11
is O 0 3.241842558288077e-11
missing O 0 3.2336076039030104e-09
or O 0 6.853487222180377e-10
defective O 0 3.536396434355993e-06
in O 0 1.6489667586938594e-07
Emery B-Disease 1 0.9989047050476074
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7812463966038194e-06
EDMD B-Disease 1 1.0
) O 0 7.907997456868543e-08
. O 0 1.1986185199930333e-07

It O 0 1.5640970740804505e-09
is O 0 1.4875545240045085e-10
one O 0 4.4938185117526785e-11
member O 0 4.2341800204903635e-11
of O 0 6.719288458967299e-10
a O 0 4.98467267462388e-10
family O 0 3.0319957655677854e-10
of O 0 2.7038799643719358e-08
lamina O 1 1.0
- O 0 8.704875654075295e-05
associated O 0 3.659745857476082e-07
proteins O 0 5.652835977087989e-10
which O 0 1.550163469810073e-11
includes O 0 1.723853143564824e-10
LAP1 O 0 0.002878832397982478
, O 0 4.0820533619978505e-09
LAP2 O 1 0.9791441559791565
and O 0 3.796420173785009e-07
lamin O 0 0.00013632941409014165
B O 0 0.0003302014956716448
receptor O 0 5.050472964285291e-07
( O 0 7.812792190975415e-09
LBR O 0 2.766661418718286e-05
) O 0 6.1470508683214575e-09
. O 0 1.1893906304294433e-07

A O 0 2.78975312539842e-06
panel O 0 1.6913872968871146e-07
of O 0 5.436347194631708e-08
16 O 0 5.2124715210766226e-08
monoclonal O 0 1.302871055486321e-07
antibodies O 0 4.489884375402653e-08
( O 0 3.7721997747652836e-10
mAbs O 0 3.97432899035266e-07
) O 0 8.673452928098513e-11
has O 0 1.6530131430325667e-11
been O 0 3.5666664066624776e-11
mapped O 0 4.960468702464027e-10
to O 0 1.6590913365366333e-10
six O 0 3.755157573781531e-10
specific O 0 1.049770714800502e-09
sites O 0 6.312708134004197e-09
throughout O 0 2.8418134512264714e-09
the O 0 7.565171600276699e-09
emerin O 0 1.0666107073120656e-06
molecule O 0 5.996437124622389e-09
using O 0 2.9034010751161077e-09
phage O 0 6.83490384290053e-08
- O 0 2.9783084887213818e-09
displayed O 0 4.155028765495672e-09
peptide O 0 1.7759784753934582e-09
libraries O 0 2.2560791013148673e-09
and O 0 6.895836679454703e-11
has O 0 6.105944742873515e-12
been O 0 2.0117621110649075e-11
used O 0 7.266678925255121e-11
to O 0 6.066308011476451e-10
localize O 0 1.5611716435159906e-06
emerin O 0 0.0003093488921876997
in O 0 3.311188834231871e-08
human O 0 4.924779251069822e-09
and O 0 1.220425360770605e-08
rabbit O 0 4.111603630008176e-06
heart O 0 1.3220729897511774e-06
. O 0 2.5043991058737447e-07

Several O 0 3.2614357223792467e-06
mAbs O 0 3.7838050047867e-05
against O 0 2.0715089021905442e-07
different O 0 2.3920028624502265e-08
emerin O 0 2.557782681833487e-05
epitopes O 0 1.7339442592856358e-06
did O 0 1.0782136072862158e-08
not O 0 7.703936932834665e-10
recognize O 0 4.910353457177052e-09
intercalated O 0 1.2091574035366648e-06
discs O 0 1.734382948370694e-07
in O 0 1.9833645836797587e-09
the O 0 3.156521044545002e-09
heart O 0 2.8073463553823785e-08
, O 0 3.830826975081969e-11
though O 0 9.694482716593456e-11
they O 0 2.43697770296869e-11
recognized O 0 6.198463409212707e-10
cardiomyocyte O 0 3.4529540471339715e-07
nuclei O 0 1.0411314832481366e-07
strongly O 0 3.5187153191174048e-09
, O 0 5.447901851862724e-11
both O 0 6.960095694230617e-11
at O 0 5.042037898306262e-09
the O 0 1.3015666766591494e-08
rim O 0 1.2198509580230166e-07
and O 0 6.614168657215203e-10
in O 0 4.411353504707449e-09
intranuclear O 0 0.00020225571643095464
spots O 0 1.3404896890278906e-06
or O 0 6.245675532312589e-09
channels O 0 9.021468017067491e-09
. O 0 2.8367512783233906e-08

A O 0 1.3116507943777833e-05
polyclonal O 0 0.00023072483600117266
rabbit O 0 3.980887413490564e-06
antiserum O 0 3.822727194346953e-06
against O 0 3.539965973686776e-07
emerin O 0 0.00040623353561386466
did O 0 9.613550844278507e-08
recognize O 0 1.0450325049760067e-08
both O 0 9.703552406037375e-10
nuclear O 0 6.036339073034469e-08
membrane O 0 6.888140280381094e-09
and O 0 8.23229401314407e-11
intercalated O 0 2.167793766716386e-08
discs O 0 5.039836104003825e-09
but O 0 2.1955842699483696e-10
, O 0 2.3292822531884028e-11
after O 0 3.448286656215771e-10
affinity O 0 2.385804886984033e-09
purification O 0 1.2633424262276094e-07
against O 0 3.300077766610343e-09
a O 0 2.7888669151820977e-10
pure O 0 2.5146176696466682e-08
- O 0 3.514858404329857e-09
emerin O 0 2.2208959649105964e-07
band O 0 1.3168379719985523e-09
on O 0 1.7392701168184033e-10
a O 0 1.9673047912949215e-11
western O 0 3.0809077511406713e-09
blot O 0 4.183420685421879e-07
, O 0 1.489610101934602e-10
it O 0 2.622321283729523e-11
stained O 0 1.8215149566458422e-07
only O 0 8.778225368821779e-10
the O 0 4.1179477605624015e-09
nuclear O 0 2.8630009296648495e-07
membrane O 0 2.725323895447218e-07
. O 0 1.9842470777575727e-08

These O 0 2.1912521575018218e-08
results O 0 1.3937215825876592e-08
would O 0 3.5559219457859115e-10
not O 0 3.1521861509897775e-11
be O 0 3.7489296389470184e-11
expected O 0 1.8775574428531172e-09
if O 0 5.667896707528541e-10
immunostaining O 0 1.5272761402229662e-06
at O 0 6.783730022164036e-09
intercalated O 0 1.458559353295641e-07
discs O 0 1.772277258282884e-08
were O 0 1.1584274650644488e-09
due O 0 1.4149244442762665e-08
to O 0 2.8484106739945503e-10
a O 0 1.478342032124047e-10
product O 0 3.636530632178392e-09
of O 0 1.6789220680379913e-08
the O 0 8.732405909483987e-09
emerin O 0 1.2227714023538283e-06
gene O 0 4.153172805665406e-10
and O 0 9.094643094176291e-11
, O 0 1.057339372306787e-11
therefore O 0 3.3749991690257275e-10
, O 0 4.5874887222296934e-11
cast O 0 9.245729182261186e-10
some O 0 5.0326461747962625e-11
doubt O 0 3.955933802757272e-09
upon O 0 1.3912136997973334e-09
the O 0 4.6561263178368506e-10
hypothesis O 0 1.8603300233621667e-08
that O 0 3.998348874212354e-11
cardiac B-Disease 0 6.90330343786627e-05
defects I-Disease 0 1.1254625860601664e-05
in O 0 1.4144166016194504e-06
EDMD B-Disease 1 1.0
are O 0 3.4464559206526246e-08
caused O 0 5.524482649121865e-09
by O 0 2.8840818622200004e-10
absence O 0 6.726654788735686e-08
of O 0 9.958031910173304e-08
emerin O 0 0.00020419379870872945
from O 0 1.9925116134800192e-07
intercalated O 0 2.629239133966621e-05
discs O 0 3.1235103961080313e-06
. O 0 4.033806533243478e-07

Although O 0 1.68904182373808e-06
emerin O 0 0.00021200618357397616
was O 0 4.965907578480255e-07
abundant O 0 1.9189373290373624e-07
in O 0 9.218136809430177e-10
the O 0 4.2126899191252676e-10
membranes O 0 3.666588699324791e-10
of O 0 7.739224261449351e-10
cardiomyocyte O 0 8.575145216127567e-07
nuclei O 0 4.3235907298821985e-08
, O 0 3.647641563797599e-11
it O 0 2.896675954655592e-12
was O 0 1.1433491931001072e-09
absent O 0 6.823126952326675e-09
from O 0 4.231921757469337e-10
many O 0 1.7837380184015927e-10
non O 0 2.9610115248601687e-08
- O 0 6.412586373016893e-08
myocyte O 0 9.067010068974923e-06
cells O 0 5.732315955242484e-09
in O 0 3.3111161035215275e-10
the O 0 3.2936888771928352e-09
heart O 0 1.3141945487404882e-07
. O 0 6.627902138234276e-08

This O 0 3.1925171395386087e-09
distribution O 0 3.757423705508245e-09
of O 0 7.972252191734697e-09
emerin O 0 2.0191006115055643e-05
was O 0 2.244834007569807e-08
similar O 0 5.633021271655991e-10
to O 0 2.055255098054598e-11
that O 0 3.9220892159019805e-12
of O 0 3.564806450029323e-09
lamin O 0 2.7174419301445596e-06
A O 0 3.692630201612701e-08
, O 0 4.680824824965235e-11
a O 0 6.664757634666785e-11
candidate O 0 4.389213437150374e-09
gene O 0 1.1693042367699746e-10
for O 0 3.5815822529983166e-11
an O 0 3.099589335198161e-11
autosomal O 0 1.3056224190677312e-07
form O 0 6.624388220188848e-07
of O 1 0.9989472031593323
EDMD B-Disease 1 1.0
. O 0 0.01432726252824068

In O 0 1.282909209976424e-07
contrast O 0 1.884677374164312e-07
, O 0 3.0783951388002606e-08
lamin O 0 0.0006459554424509406
B1 O 1 0.6437532305717468
was O 0 7.398996615393116e-08
absent O 0 1.6647138068037748e-07
from O 0 6.061373181154295e-09
cardiomyocyte O 0 4.526739212451503e-05
nuclei O 0 6.658135589532321e-06
, O 0 1.1444640790614358e-09
showing O 0 6.22431706176485e-09
that O 0 8.839803888882614e-10
lamin O 1 0.8559166789054871
B1 O 0 0.4968850612640381
is O 0 5.338648967345705e-11
not O 0 5.4171870982056e-12
essential O 0 1.2644399416394947e-10
for O 0 2.6886021187166875e-11
localization O 0 4.344157034097407e-08
of O 0 5.896763966006802e-09
emerin O 0 6.705967280140612e-06
to O 0 1.280033745665321e-09
the O 0 1.0459757504577283e-08
nuclear O 0 6.274636689340696e-06
lamina O 1 0.9892080426216125
. O 0 7.156266974561731e-07

Lamin O 1 0.9999716281890869
B1 O 1 0.9996987581253052
is O 0 1.0605059941326545e-08
also O 0 1.6352593723567566e-09
almost O 0 2.821446409839723e-09
completely O 0 1.1088009443938063e-07
absent O 0 1.2927459920319961e-06
from O 0 5.071051845106922e-08
skeletal O 0 2.03816616703989e-05
muscle O 0 2.0902687538182363e-05
nuclei O 0 0.037389133125543594
. O 0 8.742776117287576e-06

In O 0 1.9240385427110596e-06
EDMD B-Disease 1 1.0
, O 0 8.137324591928063e-09
the O 0 6.043545663914074e-10
additional O 0 1.639949981369071e-10
absence O 0 4.6842259848745016e-08
of O 0 2.236819682366331e-06
lamin O 1 0.9999793767929077
B1 O 1 0.9999997615814209
from O 0 1.6524378452231758e-06
heart O 1 0.9908512234687805
and O 0 9.434332923774491e-07
skeletal O 1 0.7419461607933044
muscle O 0 0.02981441840529442
nuclei O 1 0.9999532699584961
which O 0 1.6685189052623173e-07
already O 0 1.5875299652634567e-07
lack O 0 1.0044223017757758e-06
emerin O 0 1.8580325559014454e-05
may O 0 3.8547982583736484e-09
offer O 0 2.975348856182336e-10
an O 0 4.1002737229817177e-13
alternative O 0 3.6390540580910624e-10
explanation O 0 3.6550676374424995e-10
of O 0 3.0862817856913694e-10
why O 0 2.165721074698368e-10
these O 0 3.082756272476672e-11
tissues O 0 2.678511412668172e-09
are O 0 4.771034262107676e-11
particularly O 0 3.745731280702103e-09
affected O 0 9.399558464906477e-09
. O 0 6.201529068050604e-09
. O 0 6.698232368762547e-08

Genetic O 0 2.4967727085822844e-07
mapping O 0 2.0928784039142556e-08
of O 0 4.2263600619207864e-08
the O 0 3.742434273590334e-07
copper B-Disease 0 0.018643250688910484
toxicosis I-Disease 1 0.9845817685127258
locus O 0 1.3255245221444056e-06
in O 0 1.9578259013997013e-08
Bedlington O 0 2.8719343845295953e-06
terriers O 0 1.024256903292553e-06
to O 0 8.707902732218997e-10
dog O 0 1.5367328742854625e-08
chromosome O 0 4.935854502896575e-10
10 O 0 3.2986791076439204e-10
, O 0 1.9506478030062446e-11
in O 0 7.406341512306014e-11
a O 0 2.391503384213678e-10
region O 0 2.0827080504659534e-08
syntenic O 0 5.1387101848376915e-05
to O 0 2.5741113685029404e-09
human O 0 3.695897810018778e-09
chromosome O 0 4.850481349905067e-09
region O 0 1.98931360273491e-08
2p13 O 0 4.705027095042169e-06
- O 0 2.1990667846694123e-06
p16 O 0 3.1944457532517845e-06
. O 0 1.9976639009655628e-07

Abnormal O 1 0.992746889591217
hepatic B-Disease 1 1.0
copper I-Disease 0 0.031670957803726196
accumulation I-Disease 0 4.91859555040719e-06
is O 0 2.306708851707029e-10
recognized O 0 4.233907668904635e-10
as O 0 2.124367071143496e-10
an O 0 8.251178074125676e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9741544723510742
man O 0 3.856782313960139e-06
, O 0 1.025957541145317e-09
mouse O 0 1.2509816826877795e-07
, O 0 6.927571849502101e-10
rat O 0 6.951110663067084e-06
and O 0 2.3225027234730078e-08
dog O 0 1.3248446521174628e-05
. O 0 8.140562499647785e-07

The O 0 3.272045034918847e-07
major O 0 8.438248073616705e-07
cause O 0 9.086815566661244e-07
of O 0 5.27408737980295e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999992847442627
accumulation I-Disease 1 0.9977791905403137
in O 0 1.8142057456316252e-07
man O 0 1.7998090129367483e-08
is O 0 9.022801256142188e-11
a O 0 5.698791438746298e-10
dysfunctional O 0 1.5596790490235435e-06
ATP7B O 1 0.9999990463256836
gene O 0 4.6743366510781925e-07
, O 0 1.5115083629169135e-09
causing O 0 4.5008852112005115e-07
Wilson B-Disease 0 0.00502949021756649
disease I-Disease 0 0.052244145423173904
( O 0 1.032820140522972e-08
WD B-Disease 1 0.7820163369178772
) O 0 2.4342497795259987e-08
. O 0 2.0854992044405662e-07

Mutations O 0 2.1290072709234664e-06
in O 0 2.773613161366484e-08
the O 0 1.8390218770036881e-07
ATP7B O 1 0.9999934434890747
genes O 0 1.0931315586049095e-07
have O 0 1.9573050125121227e-10
also O 0 4.925460039828522e-11
been O 0 1.5274181919266994e-10
demonstrated O 0 1.2781679714635175e-08
in O 0 1.1087371021289982e-08
mouse O 0 9.727054930408485e-07
and O 0 3.9217528780000066e-08
rat O 0 2.2524383894051425e-05
. O 0 1.7351770509321796e-07

The O 0 7.434654889948433e-06
ATP7B O 1 0.9996084570884705
gene O 0 1.7457102785556344e-07
has O 0 2.9743499330159295e-10
been O 0 1.41387096475043e-10
excluded O 0 1.011160399855271e-08
in O 0 8.81172010358533e-11
the O 0 1.308170655134333e-10
much O 0 1.4463491515570581e-09
rarer O 0 0.4760204553604126
human O 0 0.0001913544547278434
copper B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
disease O 1 0.9999877214431763
non B-Disease 0 4.28238527092617e-05
- I-Disease 0 3.3230205076506536e-07
Indian I-Disease 0 4.0535809375796816e-08
childhood I-Disease 0 8.542463660887734e-07
cirrhosis I-Disease 1 0.9996488094329834
, O 0 1.7683797759460163e-09
indicating O 0 3.5203953530071885e-08
genetic O 0 1.9912768323138152e-07
heterogeneity O 0 3.7877332488278626e-06
. O 0 3.6445948126129224e-07

By O 0 6.636805327531192e-09
investigating O 0 1.6628217025527192e-08
the O 0 2.6189763246975417e-08
common O 0 8.60273667058209e-06
autosomal O 1 0.9999338388442993
recessive O 1 0.9999998807907104
copper B-Disease 1 0.9999998807907104
toxicosis I-Disease 1 0.9999996423721313
( O 0 5.398639313369813e-09
CT B-Disease 0 6.286563439061865e-05
) O 0 3.5858765956575667e-10
in O 0 8.20919066057968e-09
Bedlington O 0 5.418641649157507e-06
terriers O 0 2.5168931188090937e-06
, O 0 1.0980575476660093e-10
we O 0 1.777240507538913e-11
have O 0 2.0561245848288445e-12
identified O 0 6.251089056108494e-12
a O 0 2.611339530028678e-12
new O 0 1.3090417638750296e-10
locus O 0 1.14528075911835e-09
involved O 0 1.6853853035403432e-10
in O 0 3.9150712893842865e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.582801557262428e-05

We O 0 1.0172736608637933e-07
examined O 0 1.9069315726483183e-07
whether O 0 1.0622793311654277e-08
the O 0 1.0601018374245541e-07
WD B-Disease 0 0.35646337270736694
gene O 0 9.715400892673642e-07
ATP7B O 1 1.0
was O 0 4.2452981574570003e-07
also O 0 1.602556559676671e-10
causative O 0 6.3293459362512294e-09
for O 0 4.899863292884277e-10
CT B-Disease 0 1.0322961543351994e-06
by O 0 4.651874163652536e-10
investigating O 0 4.465098957240343e-09
the O 0 7.70167840613567e-09
chromosomal O 0 1.830217826181979e-07
co O 0 2.2320817549825733e-07
- O 0 3.008031228546315e-07
localization O 0 2.1258878405205905e-05
of O 0 1.291666308134154e-06
ATP7B O 1 0.9999092817306519
and O 0 2.5178896745359225e-09
C04107 O 0 6.712198086233911e-08
, O 0 9.822850866036958e-12
using O 0 4.85173229716751e-12
fluorescence O 0 1.219342737890372e-09
in O 0 5.397431945830533e-10
situ O 0 9.777783560593889e-08
hybridization O 0 2.9378174559724357e-08
( O 0 3.391079084202886e-10
FISH O 0 2.5429864081161213e-07
) O 0 3.238716794751184e-10
. O 0 1.7698519982900507e-08

C04107 O 0 0.00047395029105246067
is O 0 2.1133484295887683e-08
an O 0 6.654496953473199e-10
anonymous O 0 3.841669027337957e-08
microsatellite O 0 4.2798369577212725e-06
marker O 0 1.2497944226197433e-06
closely O 0 6.884741310386744e-08
linked O 0 3.050114116831537e-07
to O 0 7.538699975384588e-08
CT B-Disease 1 0.9999953508377075
. O 0 2.3648903152206913e-05

However O 0 1.800847348931711e-05
, O 0 6.573150699296093e-07
BAC O 0 0.0035498698707669973
clones O 0 9.751327525009401e-06
containing O 0 2.991079384173645e-07
ATP7B O 1 0.6130556464195251
and O 0 5.542892722587567e-08
C04107 O 0 2.497811465218547e-06
mapped O 0 3.0498053860128493e-08
to O 0 9.487216567904966e-10
the O 0 2.0650109178177445e-08
canine O 0 1.89823126106603e-07
chromosome O 0 9.92986315395683e-09
regions O 0 2.4030741840874725e-08
CFA22q11 O 0 0.00012419930135365576
and O 0 2.1751702661276795e-08
CFA10q26 O 0 0.005524749401956797
, O 0 8.154442676655549e-10
respectively O 0 6.274475605749785e-09
, O 0 1.3611491100906647e-10
demonstrating O 0 3.900237466325507e-09
that O 0 1.2066658783282946e-10
WD B-Disease 0 4.416366664372617e-06
cannot O 0 3.977511653374677e-09
be O 0 6.364048177331938e-10
homologous O 0 4.036220246916855e-09
to O 0 1.2403561733265178e-08
CT B-Disease 0 0.00024989116354845464
. O 0 8.509793474331673e-07

The O 0 8.539981536159758e-06
copper O 0 3.267555439379066e-05
transport O 0 5.948475518380292e-06
genes O 0 2.769136813185469e-07
CTR1 O 1 0.6491736173629761
and O 0 6.435536192839209e-08
CTR2 O 1 0.9999790191650391
were O 0 1.1805737187842169e-07
also O 0 4.705963951856518e-10
excluded O 0 2.9433870452066913e-08
as O 0 3.5773393136651066e-09
candidate O 0 2.658880049466461e-08
genes O 0 4.4916959041074733e-10
for O 0 2.5236965295327707e-10
CT B-Disease 0 5.4294960136758164e-05
since O 0 5.754194987162009e-08
they O 0 6.38038344380476e-10
both O 0 2.444823787861594e-10
mapped O 0 4.584335133728246e-09
to O 0 2.525541997755454e-09
canine O 0 8.544614615857427e-07
chromosome O 0 1.19162272937956e-07
region O 0 3.6900468103340245e-07
CFA11q22 O 0 0.0020444239489734173
. O 0 2.5303804704890354e-06

2 O 0 2.7411240807850845e-05
- O 0 9.576411684975028e-06
22 O 0 1.3718937452722457e-06
. O 0 1.7210204816819896e-07

5 O 0 7.126593845896423e-05
. O 0 4.782923042512266e-06

A O 0 1.2826538977606106e-06
transcribed O 0 2.054109771165713e-08
sequence O 0 5.145572301579193e-10
identified O 0 8.218962177508615e-10
from O 0 2.7202698427153393e-10
the O 0 1.4437170348102768e-09
C04107 O 0 8.123462293951889e-07
- O 0 8.931925776778371e-08
containing O 0 3.6215119791904726e-08
BAC O 0 5.775752288172953e-05
was O 0 1.2162471030308097e-08
found O 0 1.208467076407871e-10
to O 0 1.743108261897941e-11
be O 0 5.5789040054321504e-11
homologous O 0 3.2339758648802786e-10
to O 0 3.4178060381861997e-10
a O 0 5.957889182006681e-10
gene O 0 1.0605579747746674e-09
expressed O 0 8.221753278192523e-10
from O 0 7.949441105381538e-10
human O 0 2.586457992226343e-10
chromosome O 0 2.779048657863825e-10
2p13 O 0 7.655518174942699e-08
- O 0 4.685092491740761e-08
p16 O 0 7.947099334160157e-08
, O 0 8.488854064125917e-11
a O 0 7.978784993811772e-11
region O 0 1.3772575302439805e-09
devoid O 0 4.12279881345512e-08
of O 0 7.184557393458135e-10
any O 0 1.1170745439770258e-09
positional O 0 1.114554947889701e-06
candidate O 0 2.0196869172650622e-06
genes O 0 5.661905433385073e-08
. O 0 4.303868905708441e-08

Molecular O 0 2.7453076256733766e-08
analysis O 0 1.8469579199376085e-09
of O 0 1.1959096823943582e-08
the O 0 4.355780802711706e-08
APC B-Disease 0 7.275564257724909e-07
gene O 0 2.4332458270492907e-09
in O 0 8.383881366924584e-10
205 O 0 2.9565702774903002e-08
families O 0 2.8136740160000784e-10
: O 0 1.6585779624711527e-11
extended O 0 6.645584083031508e-09
genotype O 0 1.8634129617112194e-07
- O 0 2.3906147816887824e-07
phenotype O 0 2.112998060965765e-07
correlations O 0 6.588992107481317e-08
in O 0 1.6042209782796135e-09
FAP B-Disease 0 2.9283248181855015e-07
and O 0 2.938603527180561e-11
evidence O 0 3.039081139522004e-11
for O 0 3.0938934140328778e-12
the O 0 8.5501473956473e-11
role O 0 1.510729319420534e-10
of O 0 5.604420927340925e-09
APC B-Disease 0 9.474675266574195e-08
amino O 0 3.5555440813794803e-09
acid O 0 1.4802678194314467e-08
changes O 0 2.418021836092521e-07
in O 1 0.5631943941116333
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.000189566781045869

BACKGROUND O 0 0.0004990013549104333
/ O 0 3.7548361433437094e-05
AIMS O 0 3.024769966941676e-06
The O 0 1.8271967050509375e-08
development O 0 4.570116374225108e-08
of O 0 1.7915905118570663e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.084803049257516e-09
a O 0 4.410230167173346e-11
variable O 0 2.4570623313735496e-10
range O 0 8.70599259350513e-10
of O 0 4.6522560803730073e-10
extracolonic O 0 9.493915058556013e-06
manifestations O 0 5.478891034726985e-05
in O 0 9.022621270560194e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.699736339513038e-08
FAP B-Disease 0 9.375224180985242e-06
) O 0 3.350080976516345e-11
is O 0 2.6641744366173725e-12
the O 0 1.2217853681897872e-12
result O 0 1.0630579749815183e-11
of O 0 1.4650676505301163e-10
the O 0 1.2105554336727664e-09
dominant O 0 3.573543096990761e-07
inheritance O 0 1.4904762792866677e-06
of O 0 3.256962600062252e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.573786789776932e-07
APC B-Disease 0 2.467682634232915e-06
) O 0 5.524967150449811e-09
gene O 0 5.497618005279037e-08
mutations O 0 1.33351846898222e-07
. O 0 2.645647043664212e-07

In O 0 3.065341047658876e-08
this O 0 4.002761455623727e-10
study O 0 1.3390015485281737e-10
, O 0 1.24347797683666e-12
direct O 0 2.7960171070789963e-12
mutation O 0 4.854370377893602e-12
analysis O 0 2.2052444939579807e-11
of O 0 2.155407630155537e-09
the O 0 8.344038349150651e-08
APC B-Disease 0 8.736189442970499e-07
gene O 0 5.312265738410815e-09
was O 0 1.864315635202729e-08
performed O 0 2.2858186454755014e-09
to O 0 2.0741827699843896e-10
determine O 0 1.4689220506625134e-08
genotype O 0 2.6576410618872615e-06
- O 0 1.3108491430102731e-06
phenotype O 0 4.5805097670381656e-07
correlations O 0 5.020947213552063e-08
for O 0 3.4813760207974553e-10
nine O 0 3.7418752540929745e-09
extracolonic O 0 5.158133717486635e-06
manifestations O 0 8.095674388641783e-07
and O 0 3.591482389264655e-10
to O 0 1.525181717032531e-11
investigate O 0 7.327542045354463e-11
the O 0 9.128601347052623e-11
incidence O 0 2.3743651489382955e-09
of O 0 1.2461159215604312e-08
APC B-Disease 0 7.670111017432646e-07
mutations O 0 2.8174577337836126e-08
in O 0 6.624060233662021e-08
non O 1 0.9999436140060425
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.305132501438493e-06

METHODS O 0 1.8886385078076273e-05
The O 0 2.7867272365256213e-06
APC B-Disease 0 3.8395123738155235e-06
gene O 0 4.7895016841437155e-09
was O 0 3.343069154837508e-09
analysed O 0 9.302089765128585e-09
in O 0 4.6402476305829055e-10
190 O 0 4.7444048689726515e-09
unrelated O 0 3.787169688962422e-08
FAP B-Disease 0 6.2162080212146975e-06
and O 0 2.3224084877426776e-09
15 O 0 6.471441338362638e-08
non O 0 0.09506547451019287
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 6.468269566539675e-05
using O 0 3.284247540591423e-09
denaturing O 0 1.7212878447026014e-06
gradient O 0 1.24620441965817e-07
gel O 0 8.30178024102679e-08
electrophoresis O 0 7.779825672571405e-09
, O 0 3.0694921604457193e-10
the O 0 7.769855314698759e-10
protein O 0 8.451570554512955e-10
truncation O 0 6.235774208107614e-08
test O 0 4.0861372951894737e-08
, O 0 1.6419281212431969e-10
and O 0 3.5093414285647384e-11
direct O 0 8.66699101376156e-10
sequencing O 0 1.238629607769326e-07
. O 0 3.712417750989516e-08

RESULTS O 0 0.00029155571246519685
Chain O 0 8.672157036926365e-07
terminating O 0 2.551768432113022e-07
signals O 0 1.5543164977316337e-08
were O 0 1.3135167398203862e-09
only O 0 1.3271672823222946e-11
identified O 0 1.7121680462306443e-10
in O 0 1.5318529777985646e-10
patients O 0 4.483019289125423e-09
belonging O 0 4.2315909110079986e-10
to O 0 1.1881599870644521e-10
the O 0 8.213172009163827e-08
FAP B-Disease 1 0.9998183846473694
group O 0 4.889829430254622e-09
( O 0 6.034811539379348e-11
105 O 0 2.283118902823844e-07
patients O 0 5.525191326682943e-08
) O 0 1.8308893290353012e-10
. O 0 2.367587370599722e-08

Amino O 0 1.2611010902219277e-07
acid O 0 5.988105566956392e-09
changes O 0 1.8211729901906892e-09
were O 0 3.5342930804205253e-09
identified O 0 5.007314007876573e-10
in O 0 9.651587862258282e-11
four O 0 1.2214533551269113e-10
patients O 0 2.429809242698866e-09
, O 0 1.0215123018297856e-11
three O 0 2.1332338673296647e-11
of O 0 5.459821394993014e-08
whom O 0 7.734760743005609e-08
belonged O 0 1.0356038870895645e-07
to O 0 2.753595962357025e-10
the O 0 5.3571604041735554e-08
non O 0 0.0008692112751305103
- O 0 0.0018737056525424123
FAP O 0 0.3823338747024536
group O 0 6.799106166965885e-09
of O 0 7.772633239255811e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9998359680175781
. O 0 6.692153533549572e-07

Genotype O 0 0.001656282227486372
- O 0 0.00017729993851389736
phenotype O 0 1.7216989363078028e-05
correlations O 0 9.74738213699311e-07
identified O 0 5.593037144535629e-09
significant O 0 1.6307774020063448e-09
differences O 0 2.4327599490447938e-08
in O 0 2.863107972927992e-09
the O 0 3.1336837569284626e-09
nature O 0 2.62091265357256e-10
of O 0 1.697784551835113e-10
certain O 0 3.3935394494477578e-09
extracolonic O 0 0.0003118606109637767
manifestations O 0 1.9842902474920265e-05
in O 0 2.0040715753566474e-07
FAP B-Disease 0 0.00042068870970979333
patients O 0 4.517984280028031e-07
belonging O 0 4.756480764811499e-10
to O 0 8.209683627358189e-11
three O 0 1.7836505605828279e-09
mutation O 0 1.783910619224116e-07
subgroups O 0 3.801198545261286e-06
. O 0 1.2667386783959955e-07

CONCLUSIONS O 0 4.749051367980428e-05
Extended O 0 4.216498837195104e-06
genotype O 0 4.351963070803322e-06
- O 0 6.49812022857077e-07
phenotype O 0 9.470591777471782e-08
correlations O 0 2.490840600444244e-08
made O 0 2.1389388871195791e-10
in O 0 1.742902176748995e-11
this O 0 4.597822556712261e-12
study O 0 3.0436174414116834e-11
may O 0 3.907694307025977e-11
have O 0 1.0918292311923317e-11
the O 0 8.996989264709043e-11
potential O 0 1.6937060087762745e-10
to O 0 2.068670061639022e-11
determine O 0 3.6664349334358803e-10
the O 0 4.0624317798609866e-10
most O 0 1.419307171790507e-10
appropriate O 0 9.308456783152508e-10
surveillance O 0 2.3551958161505127e-09
and O 0 4.1693007379883795e-10
prophylactic O 0 0.09933912009000778
treatment O 0 0.03855379670858383
regimens O 0 4.689466004492715e-05
for O 0 1.200874333306956e-08
those O 0 2.3693988993045423e-08
patients O 0 4.3713530573086246e-08
with O 0 1.558612960916861e-11
mutations O 0 1.9853997612617746e-10
associated O 0 1.7526682327684284e-09
with O 0 4.820899235369325e-10
life O 0 2.4432350187453267e-07
threatening O 0 5.9573160626769095e-08
conditions O 0 0.0002763591182883829
. O 0 9.567104370944435e-07

This O 0 2.7992244966412727e-08
study O 0 7.827678949468009e-09
also O 0 2.2859819939768933e-11
provided O 0 1.9991773861360862e-11
evidence O 0 7.089957093642241e-11
for O 0 4.8305064809239795e-11
the O 0 5.872911934545755e-09
pathological O 0 2.1566524083027616e-05
nature O 0 9.557491686962294e-09
of O 0 1.928438964071688e-09
amino O 0 1.6461582097448968e-10
acid O 0 6.308576439018054e-10
changes O 0 1.2004591765091277e-09
in O 0 8.985267641037353e-09
APC O 0 8.173260113153447e-08
associated O 0 4.422786137325829e-09
with O 0 1.6534303093340696e-10
both O 0 7.2571983977809396e-09
FAP B-Disease 0 0.08968658745288849
and O 0 2.172082247398066e-07
non O 1 0.9999967813491821
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.010185707360506058
. O 0 1.4829178995867665e-09
. O 0 3.435179030120139e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.46115484833717346
cancer B-Disease 1 0.9994483590126038
risk O 0 1.457444227526139e-07
of O 0 2.2833622992379787e-08
the O 0 6.165512189681976e-08
APC O 0 1.915291250043083e-06
I1307K O 0 3.4522699934314005e-06
polymorphism O 0 5.933886200182314e-07
. O 0 6.075693192997278e-08

Germ O 0 0.011470641009509563
- O 0 1.8081540474668145e-05
line O 0 1.5085446420926019e-06
and O 0 3.138690418680312e-09
somatic O 0 7.319003998418339e-07
truncating O 0 4.6982469825707085e-07
mutations O 0 3.7188507828744832e-09
of O 0 6.078391567854169e-09
the O 0 2.4268183906883678e-08
APC B-Disease 0 2.618887151584204e-07
gene O 0 8.496763292953347e-10
are O 0 6.085090070717669e-11
thought O 0 5.601992203452255e-10
to O 0 2.2568784341370218e-10
initiate O 0 2.3004507454515988e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999990463256836
formation O 0 0.0001346161589026451
in O 0 5.2078848966630176e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.00017731162370182574
sporadic O 1 0.75334632396698
colorectal O 1 1.0
carcinogenesis O 1 0.9999995231628418
, O 0 3.8798429358166686e-08
respectively O 0 3.2432518537461874e-07
. O 0 2.7559008231037296e-07

Recently O 0 2.5500587526039453e-06
, O 0 5.242910106062482e-09
an O 0 3.0281813168109295e-10
isoleucine O 0 3.3799085485952673e-07
- O 0 1.9752229718505987e-07
- O 0 1.424415927431255e-07
> O 0 2.1018418294715957e-07
lysine O 0 6.213857517423094e-08
polymorphism O 0 3.2829512441878705e-09
at O 0 8.658118666460268e-10
codon O 0 5.451566309488953e-09
1307 O 0 3.0126793149065634e-07
( O 0 9.393222311082638e-11
I1307K O 0 3.7830975685437807e-08
) O 0 3.455573674426837e-11
of O 0 4.1191414723584785e-09
the O 0 4.777798423560853e-08
APC B-Disease 0 2.9992145300639095e-07
gene O 0 2.6041708789392715e-09
has O 0 9.968451758490815e-11
been O 0 1.7341687807981288e-10
identified O 0 1.978598812568677e-10
in O 0 1.169743746309848e-10
6 O 0 2.6321607116130963e-09
% O 0 3.1496860675162e-11
- O 0 2.40644282278879e-10
7 O 0 4.631228733842363e-10
% O 0 7.29108180080873e-12
of O 0 4.6046177287761836e-11
the O 0 5.715772855019452e-10
Ashkenazi O 0 1.685075972090999e-07
Jewish O 0 3.9763076387089313e-08
population O 0 2.0477433637644538e-10
. O 0 5.872105912629877e-09

To O 0 2.643709251515247e-08
assess O 0 1.8897419806762628e-07
the O 0 8.55462545246155e-09
risk O 0 2.9181133065492304e-09
of O 0 2.841979984680165e-10
this O 0 8.699033160475267e-11
common O 0 6.124945883811961e-08
APC B-Disease 0 1.4880973822073429e-06
allelic O 0 2.612605840113247e-06
variant O 0 6.063588443794288e-06
in O 0 1.399942107127572e-06
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 3.186100983043616e-08
we O 0 8.081483260369282e-10
have O 0 4.756994798071901e-11
analyzed O 0 6.07492278703603e-10
a O 0 8.352047352333525e-12
large O 0 2.1047176501642895e-10
cohort O 0 2.3751089983647944e-08
of O 0 1.3947871746466944e-09
unselected O 0 0.0009967255173251033
Ashkenazi O 0 2.1582486624538433e-06
Jewish O 0 2.232049638450917e-07
subjects O 0 2.327021775272442e-07
with O 0 1.6564550842090853e-09
adenomatous B-Disease 0 0.0008107164176180959
polyps I-Disease 0 1.3857628800906241e-05
and O 0 1.1850265657642467e-08
. O 0 1.591661735744765e-08
or O 0 0.0062609100714325905
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.4305188145158354e-09
for O 0 2.375935836962384e-10
the O 0 1.3846781499182725e-08
APC O 0 4.153146164753707e-07
I1307K O 0 2.834798806361505e-06
polymorphism O 0 7.131597499210329e-07
. O 0 1.4735697106971202e-07

The O 0 3.981631380156614e-06
APC O 0 9.701831913844217e-06
I1307K O 0 4.6788063627900556e-06
allele O 0 4.117007179615939e-08
was O 0 1.3471516346896806e-08
identified O 0 1.4960545025033412e-09
in O 0 8.007068896809244e-10
48 O 0 9.63383062213552e-09
( O 0 2.1050498150154695e-11
10 O 0 4.154716154447513e-11
. O 0 4.055838564304137e-12
1 O 0 3.1096336616798226e-10
% O 0 7.12764699692392e-12
) O 0 1.1954989949380934e-12
of O 0 4.760228877742634e-10
476 O 0 5.028920440963702e-06
patients O 0 7.2411171458952595e-06
. O 0 2.0141654033523082e-07

Compared O 0 2.031976862326701e-07
with O 0 7.490943976229403e-11
the O 0 2.4019489175408637e-10
frequency O 0 2.53322113286103e-10
in O 0 7.082860686846715e-11
two O 0 2.6456712255013004e-12
separate O 0 4.326461064407816e-12
population O 0 9.559897361580139e-13
control O 0 5.3039076602923174e-11
groups O 0 1.0136729997056726e-11
, O 0 9.785190019373502e-12
the O 0 1.583089659362713e-09
APC O 0 1.2072453614564438e-07
I1307K O 0 4.3977885866297584e-07
allele O 0 2.916850094791812e-09
is O 0 8.913307592006703e-12
associated O 0 3.285936106545151e-11
with O 0 8.983433571682631e-13
an O 0 3.914673218832071e-13
estimated O 0 5.809577211662864e-12
relative O 0 3.0629316860597555e-09
risk O 0 2.596072246063841e-09
of O 0 4.163334565987498e-09
1 O 0 5.142987333783822e-07
. O 0 1.0491390867173322e-07

5 O 0 7.826747605577111e-06
- O 0 2.917469373642234e-06
1 O 0 9.591349225956947e-07
. O 0 9.324848804226349e-08

7 O 0 5.276266620057868e-06
for O 0 1.9285323560325196e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999997615814209
( O 0 3.068815956908111e-08
both O 0 2.0231087916045e-08
P O 0 2.206645513069816e-05
= O 0 7.397708667866709e-09
. O 0 1.2263515758448307e-09
01 O 0 2.327443411331842e-07
) O 0 8.283583263768435e-10
. O 0 3.181667906915209e-08

Furthermore O 0 1.0173586133532808e-06
, O 0 4.2914725106868445e-09
compared O 0 9.007437462571488e-09
with O 0 2.2913175523608942e-10
noncarriers O 0 8.698121382622048e-05
, O 0 2.8282691744152544e-08
APC O 0 1.5456861319762538e-06
I1307K O 0 3.5910252336179838e-06
carriers O 0 2.14521271857393e-08
had O 0 6.250844841737546e-10
increased O 0 4.748621496020178e-10
numbers O 0 3.7478306569305175e-10
of O 0 6.282522946321478e-09
adenomas B-Disease 0 0.30696845054626465
and O 0 2.8936451599292923e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 9.850364222074859e-06
patient O 0 8.392646122956648e-05
( O 0 7.139897006958051e-11
P O 0 6.116820117085808e-08
= O 0 6.507711730607824e-11
. O 0 2.1985331957741217e-11
03 O 0 1.328498311359283e-09
) O 0 1.891800518322162e-12
, O 0 3.7833356239524996e-12
as O 0 3.506939183495206e-11
well O 0 4.5994125175141676e-11
as O 0 8.094715175932521e-11
a O 0 1.6387430301634254e-10
younger O 0 4.496148875432482e-08
age O 0 3.4046792052322417e-08
at O 0 3.6492618704642155e-08
diagnosis O 0 9.16402495931834e-06
. O 0 2.0016476298678754e-07

We O 0 1.2595386067459913e-07
conclude O 0 2.3360625789337064e-07
that O 0 2.2098266272418954e-10
the O 0 8.324911426882409e-09
APC O 0 1.6173179346878896e-06
I1307K O 0 6.188644420035416e-06
variant O 0 7.804053893778473e-06
leads O 0 1.918648138143908e-07
to O 0 8.026350695189421e-10
increased O 0 1.8676438173770293e-07
adenoma B-Disease 1 1.0
formation O 0 4.294080554245738e-06
and O 0 1.4468519715649109e-08
directly O 0 1.5162784361422155e-09
contributes O 0 6.650814621256274e-11
to O 0 1.510740144095024e-11
3 O 0 2.1403386007978753e-10
% O 0 1.4137920001378035e-11
- O 0 7.596714229896051e-11
4 O 0 1.423775541908867e-10
% O 0 4.720369928268298e-12
of O 0 1.9499447195814312e-11
all O 0 2.2036771019084966e-10
Ashkenazi O 0 1.0175692295888439e-05
Jewish O 0 0.008621325716376305
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.444824521167902e-06

The O 0 1.2193856946396409e-07
estimated O 0 2.1334150002161323e-09
relative O 0 9.01751491255709e-08
risk O 0 7.779202171320776e-09
for O 0 1.4106546486480909e-10
carriers O 0 9.170249448686718e-09
may O 0 8.30362556492048e-10
justify O 0 2.0596091498958913e-09
specific O 0 4.148557330996283e-10
clinical O 0 1.7299145449456432e-09
screening O 0 2.518110386873218e-09
for O 0 2.5298749206648097e-10
the O 0 1.4278119797594968e-09
360 O 0 2.8031872378875278e-09
, O 0 1.2704854529532739e-11
000 O 0 1.6275136793808542e-10
Americans O 0 2.395367541471738e-12
expected O 0 2.508132937451002e-11
to O 0 3.024301295506682e-11
harbor O 0 2.202112270310863e-08
this O 0 5.900278876591614e-11
allele O 0 5.169515926439772e-10
, O 0 9.14220522202358e-12
and O 0 4.806360604653337e-12
genetic O 0 3.5694294742150134e-11
testing O 0 2.1286096496542228e-10
in O 0 5.5148861172193975e-11
the O 0 2.167175605638505e-10
setting O 0 6.687710385477885e-09
of O 0 1.930400284066991e-09
long O 0 2.408959420829859e-10
- O 0 8.922824701329546e-10
term O 0 3.8816267533547943e-08
- O 0 4.102503670111446e-09
outcome O 0 3.468223752634003e-08
studies O 0 2.875622795439625e-10
may O 0 2.1657984433653965e-11
impact O 0 7.407517932378482e-10
significantly O 0 1.6133452618305455e-07
on O 1 0.8661154508590698
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.818051278591156
in O 0 2.344026639455876e-10
this O 0 6.129705770741012e-11
population O 0 5.0648575611322855e-11
. O 0 1.2893056622331756e-09

Localization O 0 5.086020792077761e-06
of O 0 3.363272469414369e-07
human O 0 1.8574226601231203e-08
BRCA1 O 0 1.834814185031064e-07
and O 0 1.185570752681997e-09
its O 0 7.23205995090126e-10
loss O 0 4.650184592946971e-08
in O 0 4.875896575384786e-09
high O 0 1.65624635428685e-06
- O 0 3.7799818386474726e-08
grade O 0 2.1743546767538646e-06
, O 0 1.0329629512861871e-10
non B-Disease 0 5.79908146391972e-07
- I-Disease 0 2.861475877580233e-05
inherited I-Disease 1 0.9999988079071045
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0031852980609983206

Although O 0 1.8460434603184694e-07
the O 0 1.3914161378636436e-08
link O 0 9.8789518787612e-09
between O 0 7.378220256981649e-09
the O 0 3.3775276619962824e-07
BRCA1 O 0 4.711676865554182e-06
tumour B-Disease 1 1.0
- O 0 1.6515099559910595e-05
suppressor O 0 7.668124453630298e-06
gene O 0 9.680652723886851e-09
and O 0 3.0029103648132605e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.7835993793013927e-09
established O 0 9.991603100445445e-10
, O 0 4.0308364285257525e-12
the O 0 3.6790070989667356e-11
role O 0 1.8244497926311887e-11
, O 0 1.9044971762832708e-12
if O 0 1.2688646791256253e-12
any O 0 8.994273208162706e-12
, O 0 1.1294006528606015e-11
of O 0 9.36492661196553e-10
BRCA1 O 0 2.3369755908220213e-08
in O 0 4.66263383458454e-09
non B-Disease 0 0.0861964076757431
- I-Disease 1 0.9982789754867554
familial I-Disease 1 0.9999858140945435
cancers I-Disease 1 1.0
is O 0 9.753565066716874e-09
unclear O 0 5.043628448220261e-07
. O 0 1.1086338957966291e-07

BRCA1 O 0 0.0003664394607767463
mutations O 0 2.8294678600104817e-07
are O 0 6.815474851151748e-10
rare O 0 6.095086213520062e-09
in O 0 3.0774780501729992e-09
sporadic B-Disease 0 6.272769951465307e-06
cancers I-Disease 1 0.983215868473053
, O 0 3.123342473543289e-09
but O 0 1.6700527183388658e-08
loss O 0 3.70662564819213e-05
of O 0 0.10753637552261353
BRCA1 O 0 8.172253274096875e-07
resulting O 0 1.5735505343172917e-08
from O 0 4.779051043790616e-10
reduced O 0 2.2002890620598237e-09
expression O 0 4.275114429130866e-10
or O 0 5.772863437281117e-11
incorrect O 0 2.9762809994338113e-09
subcellular O 0 9.67827489262163e-08
localization O 0 3.689982719379259e-08
is O 0 1.7817853095736247e-11
postulated O 0 5.800459002003322e-10
to O 0 4.834337791193022e-12
be O 0 3.930671326618507e-12
important O 0 1.7945761543458616e-10
in O 0 5.361744936926982e-10
non B-Disease 0 3.437322811805643e-05
- I-Disease 1 0.6864639520645142
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0017091319896280766

Epigenetic O 0 0.48958590626716614
loss O 0 0.0009079116280190647
, O 0 9.47640721449261e-09
however O 0 1.1838879210301911e-08
, O 0 6.554337628195128e-11
has O 0 2.447480803094426e-12
not O 0 6.627860695170018e-13
received O 0 3.286399971602627e-11
general O 0 2.517745567587326e-09
acceptance O 0 1.656933648064296e-07
due O 0 4.8272440267282946e-08
to O 0 1.8078132046905893e-10
controversy O 0 9.316898363920245e-09
regarding O 0 1.718355346902456e-09
the O 0 9.979586046426903e-10
subcellular O 0 3.545010258676484e-07
localization O 0 1.2007526493107434e-06
of O 0 2.4702413270460966e-07
BRCA1 O 0 2.2201371407959414e-08
proteins O 0 5.0951368124607654e-11
, O 0 9.724015863354918e-12
reports O 0 2.4181512695009566e-11
of O 0 1.0570314068480968e-10
which O 0 3.110931304228792e-11
have O 0 5.639694614090196e-11
ranged O 0 1.5766515559789696e-07
from O 0 4.782051421514666e-10
exclusively O 0 3.752651522859196e-10
nuclear O 0 6.189865509043102e-09
, O 0 2.6968092689538814e-11
to O 0 3.7825798049340165e-11
conditionally O 0 3.1358258212321743e-08
nuclear O 0 1.2132910853779322e-07
, O 0 4.200836900558613e-11
to O 0 8.237555776391403e-11
the O 0 8.293262077074814e-09
ER O 0 0.00013602440594695508
/ O 0 2.9293628855953102e-08
golgi O 0 4.3039142383349827e-07
, O 0 1.0296385272168251e-10
to O 0 7.023761433577747e-11
cytoplasmic O 0 7.476207208867436e-09
invaginations O 0 1.0055426855615224e-06
into O 0 9.445891180348553e-09
the O 0 5.2423003715773575e-09
nucleus O 0 5.821923565463294e-08
. O 0 2.604465443312165e-08

In O 0 1.0807795547407295e-07
an O 0 2.6985397250101073e-10
attempt O 0 5.241410416800818e-09
to O 0 1.3085674210877585e-10
resolve O 0 3.0364941672189616e-09
this O 0 1.57197699302003e-10
issue O 0 7.1569199455723265e-09
, O 0 3.238764464952304e-11
we O 0 2.2020248471865678e-11
have O 0 2.976936752663306e-11
comprehensively O 0 3.8778756561441696e-07
characterized O 0 8.89011531057804e-08
19 O 0 5.657188353325182e-07
anti O 0 5.910778418183327e-05
- O 0 0.000693033856805414
BRCA1 O 0 4.416695446707308e-06
antibodies O 0 2.515030814720376e-07
. O 0 7.895909703847792e-08

These O 0 2.462322186147503e-07
reagents O 0 1.2102776963729411e-05
detect O 0 4.5352734900916403e-07
a O 0 7.237527466230631e-09
220 O 0 1.2304541030516702e-07
- O 0 1.9089020497631282e-07
kD O 0 3.440493628659169e-06
protein O 0 1.6381166645373924e-08
localized O 0 4.133089248625765e-08
in O 0 1.7873489355224592e-09
discrete O 0 2.0373862597011794e-08
nuclear O 0 5.956167683507374e-07
foci O 0 6.822089289926225e-06
in O 0 2.2633199758814726e-09
all O 0 5.026892790915838e-10
epithelial O 0 4.412491705352295e-08
cell O 0 5.9905271854177045e-09
lines O 0 2.5507237988442455e-10
, O 0 3.4930387575460298e-12
including O 0 1.382562207080662e-11
those O 0 8.82411643754466e-11
derived O 0 4.189744728932965e-08
from O 0 2.6115918672076077e-07
breast B-Disease 0 0.00016474435687996447
malignancies I-Disease 0 0.00036620392347685993
. O 0 8.944248861553206e-07

Immunohistochemical O 0 0.0003398482222110033
staining O 0 5.407169010140933e-05
of O 0 4.523184543359093e-06
human O 0 4.380325435704435e-07
breast O 0 4.2642666812753305e-05
specimens O 0 1.5423435115735629e-06
also O 0 3.3457738801701e-09
revealed O 0 2.1327983290575503e-07
BRCA1 O 0 1.4152288940749713e-06
nuclear O 0 2.5091808311117347e-06
foci O 0 1.216094915434951e-05
in O 0 3.2789976955882594e-08
benign O 1 0.9978917241096497
breast O 1 0.9896069169044495
, O 0 1.122080917070889e-07
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.00010637864761520177
low B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 3.118144377367571e-05

Conversely O 0 4.1446666728006676e-05
, O 0 1.6134529801092867e-07
BRCA1 O 0 2.55694743600543e-07
expression O 0 1.0062193300797162e-09
was O 0 6.816294195743922e-10
reduced O 0 8.379836269334362e-10
or O 0 3.020847808010707e-11
undetectable O 0 1.0419892504387462e-08
in O 0 1.3207941684800772e-10
the O 0 9.143500540043092e-11
majority O 0 2.1144901801717353e-11
of O 0 5.806901626215222e-10
high O 0 9.094861752600991e-07
- O 0 3.193804332113359e-07
grade O 0 0.001215367577970028
, O 0 1.708698604829806e-08
ductal B-Disease 1 0.9999904632568359
carcinomas I-Disease 1 1.0
, O 0 4.6247436991109225e-09
suggesting O 0 3.237026424685041e-09
that O 0 4.153812363516529e-11
absence O 0 1.7849316691354034e-07
of O 0 1.0500986036277027e-06
BRCA1 O 0 9.109342613555782e-08
may O 0 3.629100908675298e-10
contribute O 0 4.891923324756853e-11
to O 0 1.9855651844924438e-11
the O 0 9.403463563373293e-10
pathogenesis O 0 2.6873713068198413e-06
of O 0 1.1230755214697297e-09
a O 0 8.557718422785854e-11
significant O 0 3.3612659322557192e-09
percentage O 0 1.1947246036925208e-07
of O 0 1.6279041403777228e-07
sporadic B-Disease 1 0.9805553555488586
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9990606904029846
. O 0 3.684005775994592e-07
. O 0 5.71566943108337e-07

